data_6ali_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6ali _Structure_validation_residue.Date_analyzed 2017-09-01 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.3 mmm . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.453 0.168 . . . . 71.319999999999993 110.638 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.58 96.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.953 0.406 . . . . 73.430000000000007 110.019 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 7.3 tp10 -67.09 125.87 27.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.759 -0.655 . . . . 70.140000000000001 110.862 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -85.8 128.12 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 71.409999999999997 109.423 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 31' ' ' PHE . 39.7 pt -134.62 146.37 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.728 0.299 . . . . 73.540000000000006 110.989 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.32 173.65 37.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.97 -0.559 . . . . 75.430000000000007 112.035 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.49 -47.21 27.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.074 0.549 . . . . 65.030000000000001 112.21 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -74.81 -20.97 59.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.107 -0.497 . . . . 74.420000000000002 111.513 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.8 -13.44 45.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 75.540000000000006 111.379 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.5 ' HA ' HD11 ' A' ' 26' ' ' ILE . 72.4 t80 -56.03 -62.25 1.83 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.952 0.353 . . . . 70.519999999999996 111.952 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -39.25 94.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.157 0.503 . . . . 73.420000000000002 110.112 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -55.7 -53.71 53.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.81 . . . . 43.219999999999999 110.395 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG3' HG23 ' A' ' 26' ' ' ILE . 74.6 mmtt -69.07 -32.9 72.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.444 -0.798 . . . . 63.340000000000003 111.375 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 31' ' ' PHE . 77.7 t -66.93 -36.18 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.967 0.413 . . . . 74.140000000000001 110.652 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 p -86.06 -19.63 29.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.381 -0.372 . . . . 53.409999999999997 111.525 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -63.29 -11.15 19.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 112.103 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.661 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 21.6 p -61.11 139.9 57.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.224 0.21 . . . . 71.299999999999997 111.482 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -72.15 -88.78 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.558 -0.292 . . . . 72.420000000000002 110.732 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.5 136.07 24.25 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.088 -0.338 . . . . 63.420000000000002 110.088 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 m120 58.22 16.43 3.95 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.627 -0.715 . . . . 72.450000000000003 111.897 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 41.5 mm -76.22 105.24 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.533 -0.543 . . . . 70.510000000000005 109.533 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 74' ' ' VAL . 53.5 tp -73.52 117.7 15.6 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.548 0.69 . . . . 72.329999999999998 109.974 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.504 HD13 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -102.0 113.0 37.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.959 . . . . 72.450000000000003 110.679 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.583 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.5 mp -97.28 118.75 34.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.313 -0.625 . . . . 73.209999999999994 109.313 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.83 107.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.935 -0.395 . . . . 72.450000000000003 109.935 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.67 136.69 36.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.983 -0.553 . . . . 62.130000000000003 111.246 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 100' ' ' LEU . 34.3 m-85 -111.13 81.9 1.51 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.435 0.636 . . . . 65.219999999999999 109.819 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.407 ' CZ2' ' SG ' ' A' ' 53' ' ' CYS . 23.0 t-105 -68.18 92.75 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.963 -1.017 . . . . 74.340000000000003 110.501 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 96' ' ' ILE . . . -77.09 137.94 65.15 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.324 -0.398 . . . . 54.329999999999998 110.074 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.34 -8.44 8.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.374 2.716 . . . . 64.329999999999998 113.763 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.71 ' HB3' HG22 ' A' ' 96' ' ' ILE . 67.5 t-105 -65.6 -52.42 52.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.632 -0.507 . . . . 73.150000000000006 109.632 177.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.407 ' SG ' ' CZ2' ' A' ' 49' ' ' TRP . 4.7 t 54.99 90.73 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.316 -0.856 . . . . 63.299999999999997 112.17 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.29 -100.88 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.138 -0.553 . . . . 43.399999999999999 111.949 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.93 6.29 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.017 2.478 . . . . 54.219999999999999 112.292 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.404 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 4.8 p -50.82 -29.74 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 71.349999999999994 111.449 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.417 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.07 -51.74 63.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.504 -177.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.2 m -75.33 -45.12 41.47 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.411 0.624 . . . . 74.230000000000004 111.286 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -63.35 -31.59 72.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 64.099999999999994 112.571 -172.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 1.9 tm-20 -61.55 -58.21 19.95 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.82 -0.352 . . . . 65.120000000000005 110.426 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.41 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 26.4 Cg_endo -63.39 -28.44 71.49 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.514 1.476 . . . . 64.230000000000004 112.039 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.578 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 42.8 mt-30 -69.53 -34.8 74.76 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 75.209999999999994 110.991 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 77.5 mt -68.89 -43.54 75.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.471 -0.566 . . . . 74.140000000000001 109.471 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 6.2 mm-40 -59.32 -35.8 74.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 65.510000000000005 110.218 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 11.6 ttmm -54.51 -57.69 10.4 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.386 0.612 . . . . 74.540000000000006 110.225 174.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.457 HD12 HD11 ' A' ' 123' ' ' ILE . 43.1 mt -69.47 -28.74 66.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.393 -0.821 . . . . 74.510000000000005 110.18 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.17 -44.6 79.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 43.32 110.273 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 85.9 mt-30 -73.69 -37.34 65.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 74.129999999999995 110.724 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -66.03 -45.26 82.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.028 0.442 . . . . 75.409999999999997 111.051 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -100.18 5.04 44.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.612 0.597 . . . . 75.219999999999999 112.612 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -53.64 -19.69 4.32 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.806 0.669 . . . . 72.120000000000005 112.806 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.6 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 10.5 pt-20 -66.98 -28.43 68.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.646 0.26 . . . . 74.019999999999996 111.13 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.6 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 44.7 m-80 -131.06 9.49 4.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.536 -0.302 . . . . 60.25 111.22 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 43' ' ' LEU . 39.7 t -136.39 141.2 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.989 0.423 . . . . 74.219999999999999 111.574 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -142.1 119.79 11.82 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.838 -0.801 . . . . 72.219999999999999 108.838 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.583 HG12 ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -99.61 138.89 22.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.761 0.315 . . . . 73.140000000000001 110.388 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 87.6 m-85 -124.55 160.27 28.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.872 -0.604 . . . . 73.109999999999999 109.457 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -137.33 120.66 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.252 -1.018 . . . . 62.329999999999998 108.252 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.77 132.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.742 -0.663 . . . . 75.129999999999995 111.561 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.01 96.32 7.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.613 -0.721 . . . . 60.109999999999999 109.471 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.462 HG13 ' HB3' ' A' ' 84' ' ' ASN . 10.6 tp -154.21 34.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 122.057 0.932 . . . . 65.230000000000004 108.921 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -18.82 1.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.473 -1.24 . . . . 64.209999999999994 113.751 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.67 -36.11 38.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.861 0.363 . . . . 63.520000000000003 111.167 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.462 ' HB3' HG13 ' A' ' 81' ' ' ILE . 4.6 t-20 -95.97 103.23 15.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 73.530000000000001 110.814 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.17 -22.44 55.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 73.430000000000007 110.387 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.9 m-20 -51.73 -36.1 45.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.034 -0.53 . . . . 63.32 111.089 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.0 t -52.85 -37.23 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 71.010000000000005 110.712 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.402 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . . . -64.63 -50.95 65.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.002 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -62.56 -33.09 74.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.633 -0.712 . . . . 72.420000000000002 111.171 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -74.49 -47.22 34.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 74.510000000000005 111.229 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.44 ' HB3' HD22 ' A' ' 100' ' ' LEU . 58.8 m-85 -87.07 -7.86 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.354 -0.385 . . . . 73.109999999999999 111.59 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 44.26 6.24 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.833 -0.699 . . . . 65.549999999999997 113.053 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 88' ' ' ALA . 61.6 t -84.12 123.54 39.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.392 -0.596 . . . . 75.310000000000002 109.392 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -136.03 6.69 3.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.441 -0.345 . . . . 72.219999999999999 111.041 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.24 176.26 11.02 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.641 0.258 . . . . 52.439999999999998 110.631 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.71 HG22 ' HB3' ' A' ' 52' ' ' TRP . 1.3 pp -128.13 108.2 19.79 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.179 -0.464 . . . . 75.510000000000005 110.997 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -89.47 -162.49 1.88 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.001 -1.25 . . . . 64.140000000000001 112.519 -0.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.3 m -146.95 126.29 13.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.578 -0.527 . . . . 74.0 109.578 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.575 ' HB ' HG22 ' A' ' 111' ' ' VAL . 48.3 mm -113.25 119.56 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.912 -0.586 . . . . 71.439999999999998 111.217 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.463 HD12 ' CE1' ' A' ' 48' ' ' PHE . 9.1 mp -100.85 149.85 23.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 72.510000000000005 109.328 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.498 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 24.6 mtt -115.69 146.67 41.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 65.120000000000005 110.631 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -143.93 150.73 38.8 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.253 -1.017 . . . . 74.140000000000001 108.253 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -149.28 120.65 7.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.613 -0.435 . . . . 74.239999999999995 110.942 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.661 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 5.7 t30 61.85 27.09 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.486 0.66 . . . . 72.219999999999999 109.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.89 -3.39 70.38 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.45 -0.796 . . . . 43.109999999999999 112.27 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -90.73 147.35 23.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.884 -0.413 . . . . 63.039999999999999 109.884 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.48 135.49 51.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.487 0.66 . . . . 71.430000000000007 110.845 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -135.76 168.19 19.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.719 -1.128 . . . . 72.319999999999993 108.947 -172.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.17 166.95 18.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.624 0.726 . . . . 72.409999999999997 111.964 -165.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.68 128.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.209 -0.905 . . . . 74.540000000000006 110.042 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 99' ' ' ILE . 15.7 m -113.14 109.41 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.633 0.73 . . . . 73.030000000000001 109.728 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.18 122.93 49.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.888 . . . . 62.140000000000001 110.198 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.75 -163.72 14.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.173 -0.537 . . . . 60.32 111.792 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.26 72.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.007 0.432 . . . . 75.109999999999999 110.697 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.6 t70 -125.03 92.37 3.63 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.745 -0.661 . . . . 64.239999999999995 109.348 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.84 -28.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 62.149999999999999 110.758 -173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.5 t -64.7 -45.8 85.07 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.041 -0.527 . . . . 72.200000000000003 109.93 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -67.96 -38.51 82.86 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.872 -0.603 . . . . 55.140000000000001 109.946 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.5 mt -60.25 -56.21 19.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.848 -0.615 . . . . 72.120000000000005 110.514 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.406 ' HA ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.46 -39.46 82.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 120.762 0.315 . . . . 74.510000000000005 110.165 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -54.41 -52.16 62.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.928 -0.578 . . . . 52.409999999999997 110.252 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.88 -32.5 70.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.357 -0.383 . . . . 73.040000000000006 111.278 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 119' ' ' ILE . 96.7 mt -57.64 -56.2 16.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 120.59 -0.444 . . . . 73.409999999999997 110.112 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -68.42 -32.94 73.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.499 -0.481 . . . . 70.219999999999999 110.039 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.73 -29.25 69.19 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.696 -0.684 . . . . 72.200000000000003 110.991 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.498 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.2 m-20 -98.11 -20.83 17.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.436 -0.347 . . . . 71.200000000000003 111.82 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.9 mt -74.48 -47.64 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.768 -0.456 . . . . 74.310000000000002 109.768 172.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.697 -0.683 . . . . 71.430000000000007 109.579 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.416 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 81.8 mmm . . . . . 0 N--CA 1.469 0.476 0 CA-C-O 120.651 0.262 . . . . 71.319999999999993 111.444 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.45 HG23 ' HE2' ' A' ' 78' ' ' LYS . 13.2 mm -93.96 119.94 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.476 . . . . 73.430000000000007 109.716 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 31.0 tt0 -86.82 118.45 26.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.904 0.383 . . . . 70.140000000000001 110.601 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -80.72 137.77 36.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.222 -0.445 . . . . 71.409999999999997 110.339 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.453 HG23 ' HG3' ' A' ' 34' ' ' LYS . 42.0 pt -139.53 154.51 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.562 0.22 . . . . 73.540000000000006 110.991 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.66 176.53 28.72 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.3 -0.476 . . . . 75.430000000000007 112.716 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.06 -55.1 5.92 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.367 0.667 . . . . 65.030000000000001 112.177 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 t -70.39 -34.54 72.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.941 0.401 . . . . 74.420000000000002 110.673 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.22 -24.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 75.540000000000006 111.326 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' O ' HG21 ' A' ' 35' ' ' VAL . 87.9 t80 -49.61 -56.96 8.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 70.519999999999996 110.473 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.25 -55.2 30.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.136 -0.484 . . . . 73.420000000000002 110.507 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -52.54 -46.37 66.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.431 -0.804 . . . . 43.219999999999999 111.405 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HG3' HG23 ' A' ' 26' ' ' ILE . 72.2 mmtt -77.17 -24.28 51.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.394 -0.821 . . . . 63.340000000000003 111.56 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.51 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 90.7 t -79.18 -33.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.841 -0.429 . . . . 74.140000000000001 109.841 174.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.2 p -79.58 -19.64 48.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.974 0.416 . . . . 53.409999999999997 110.479 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -61.7 -23.38 66.08 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.863 -0.608 . . . . 74.540000000000006 111.722 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.4 p -74.78 91.46 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 71.299999999999997 110.572 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -69.98 -61.71 1.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 72.420000000000002 111.511 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' ILE . 5.8 m-20 -123.62 120.87 34.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.483 0.182 . . . . 63.420000000000002 110.511 -172.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 51.04 3.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.1 1.519 . . . . 72.450000000000003 115.1 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.5 mm -63.92 124.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 118.134 0.424 . . . . 70.510000000000005 110.824 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -88.65 110.45 20.96 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.876 -0.787 . . . . 72.329999999999998 108.876 177.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 101' ' ' MET . 70.8 mt -90.82 118.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 72.450000000000003 110.734 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.457 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -107.56 109.08 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.41 -0.589 . . . . 73.209999999999994 109.41 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 57.3 t -92.59 106.86 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.046 -0.353 . . . . 72.450000000000003 110.046 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.501 ' HA ' HD11 ' A' ' 99' ' ' ILE . 11.7 t70 -85.74 133.05 34.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.919 -0.582 . . . . 62.130000000000003 111.894 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -94.51 95.23 8.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.71 -0.677 . . . . 65.219999999999999 109.659 172.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.409 ' HZ3' ' HG3' ' A' ' 82' ' ' GLU . 52.4 t90 -66.32 136.26 55.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.48 -0.782 . . . . 74.340000000000003 111.634 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.52 127.25 25.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.547 -0.752 . . . . 54.329999999999998 109.192 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.85 -64.8 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.736 2.291 . . . . 64.329999999999998 112.498 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -95.94 116.8 29.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.222 -0.445 . . . . 73.150000000000006 110.128 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.9 t -158.36 158.65 34.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.284 -0.416 . . . . 63.299999999999997 110.58 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -91.57 -83.56 1.45 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 116.01 -0.541 . . . . 43.399999999999999 112.279 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.49 -25.45 74.03 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.9 2.4 . . . . 54.219999999999999 112.768 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 67.5 m -51.01 -37.26 44.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 71.349999999999994 111.49 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 5.0 ptp180 -62.89 -33.41 75.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.703 0.287 . . . . 74.439999999999998 110.914 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 10.6 m -74.96 -40.53 60.71 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.865 0.84 . . . . 74.230000000000004 110.112 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.81 -29.58 70.08 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.169 -0.923 . . . . 64.099999999999994 111.457 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 46.1 mt-10 -56.78 -60.92 7.96 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.737 -0.385 . . . . 65.120000000000005 110.692 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.423 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.4 Cg_endo -64.33 -33.16 59.91 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.662 1.575 . . . . 64.230000000000004 111.898 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.6 mt-30 -62.62 -38.43 90.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.335 -0.546 . . . . 75.209999999999994 110.63 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 119' ' ' ILE . 77.5 mt -72.5 -43.34 63.77 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.127 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.8 mt-10 -60.56 -32.43 71.51 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.127 -0.488 . . . . 65.510000000000005 110.395 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -66.78 -56.82 8.77 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.025 -0.534 . . . . 74.540000000000006 110.599 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.469 HD12 HD13 ' A' ' 116' ' ' ILE . 63.6 mt -58.19 -32.05 67.88 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.917 -0.583 . . . . 74.510000000000005 109.451 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.22 -52.62 53.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.669 -0.696 . . . . 43.32 110.127 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.2 mt-30 -53.37 -41.56 65.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.78 0.324 . . . . 74.129999999999995 110.806 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.94 -44.41 48.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 111.63 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -101.49 4.82 41.56 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.602 0.593 . . . . 75.219999999999999 112.602 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.0 t -53.31 -23.96 10.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.898 0.703 . . . . 72.120000000000005 112.898 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.04 -18.88 60.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 74.019999999999996 111.141 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -130.94 7.7 4.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.975 -0.557 . . . . 60.25 110.567 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 43' ' ' LEU . 21.5 t -141.15 139.95 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.81 0.338 . . . . 74.219999999999999 111.329 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.478 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 4.7 tppp? -142.29 128.12 19.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.85 -0.614 . . . . 72.219999999999999 109.587 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.457 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.7 mt -107.89 137.78 37.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.788 -0.449 . . . . 73.140000000000001 109.788 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.478 ' CZ ' ' HG2' ' A' ' 75' ' ' LYS . 51.1 m-85 -120.77 147.03 45.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.782 0.325 . . . . 73.109999999999999 111.371 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 23' ' ' ILE . 59.7 mttm -120.69 105.45 10.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.893 -0.78 . . . . 62.329999999999998 108.893 169.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mt -71.29 107.56 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.769 -0.456 . . . . 75.129999999999995 109.769 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.22 68.78 5.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.653 0.739 . . . . 60.109999999999999 111.846 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.7 pt -120.84 55.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.197 -1.408 . . . . 65.230000000000004 107.197 167.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' HZ3' ' A' ' 49' ' ' TRP . 36.5 tt0 -49.74 -32.67 14.16 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.137 -1.847 . . . . 64.209999999999994 113.202 -168.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 -2.9 58.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.209 0.448 . . . . 63.520000000000003 112.209 -174.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.47 78.86 1.4 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 73.530000000000001 111.046 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.74 -24.34 62.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.988 -0.551 . . . . 73.430000000000007 110.388 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.33 -35.04 25.96 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.411 -0.813 . . . . 63.32 111.447 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.54 -39.16 44.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.828 -0.624 . . . . 71.010000000000005 110.828 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.14 77.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.8 -0.636 . . . . 74.239999999999995 110.49 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.1 m -67.52 -34.17 76.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.596 . . . . 72.420000000000002 110.962 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.59 -38.93 92.69 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.79 0.329 . . . . 74.510000000000005 111.137 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -95.39 -6.63 40.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.554 -0.294 . . . . 73.109999999999999 111.624 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.85 59.56 2.07 Favored Glycine 0 C--O 1.236 0.235 0 C-N-CA 120.96 -0.638 . . . . 65.549999999999997 113.215 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.537 HG11 ' OG1' ' A' ' 98' ' ' THR . 81.4 t -89.22 117.75 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.843 0.354 . . . . 75.310000000000002 110.116 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.8 m -95.58 -38.14 10.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 110.91 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 155.23 50.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 52.439999999999998 110.46 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.86 132.28 24.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.209 -0.451 . . . . 75.510000000000005 111.08 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -91.15 -165.32 2.27 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 123.964 -1.265 . . . . 64.140000000000001 111.923 -4.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.537 ' OG1' HG11 ' A' ' 93' ' ' VAL . 54.9 m -143.3 141.2 30.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.23 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 47' ' ' ASP . 46.2 mm -120.76 113.98 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.971 -0.559 . . . . 71.439999999999998 110.794 -175.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.474 HD23 ' HG3' ' A' ' 110' ' ' GLN . 47.4 mt -90.95 123.41 34.42 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.357 -0.609 . . . . 72.510000000000005 109.357 171.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 38.7 mtt -96.73 143.78 27.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.662 -0.415 . . . . 65.120000000000005 110.922 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.65 154.83 45.61 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.412 -0.588 . . . . 74.140000000000001 109.412 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -156.68 120.59 4.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.261 -0.176 . . . . 74.239999999999995 110.972 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.492 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 60.56 25.91 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.832 0.825 . . . . 72.219999999999999 110.182 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.66 -8.21 73.26 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.396 -0.82 . . . . 43.109999999999999 112.514 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -86.86 147.78 25.65 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.973 -0.38 . . . . 63.039999999999999 109.973 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -72.68 127.98 34.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.629 0.728 . . . . 71.430000000000007 110.844 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.405 HD12 ' OD1' ' A' ' 126' ' ' ASN . 3.9 mm? -119.72 168.71 10.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.48 -1.236 . . . . 72.319999999999993 109.315 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -178.91 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.254 0.55 . . . . 72.409999999999997 112.257 -162.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.474 ' HG3' HD23 ' A' ' 100' ' ' LEU . 47.0 tt0 -138.3 143.8 40.15 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 122.014 0.911 . . . . 74.540000000000006 111.205 -172.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 74.0 t -126.26 118.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.566 -1.652 . . . . 73.030000000000001 109.67 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.48 123.28 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.127 -0.323 . . . . 62.140000000000001 110.127 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.39 139.81 10.22 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.71 -0.556 . . . . 60.32 111.71 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.97 80.22 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 75.109999999999999 111.429 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 119' ' ' ILE . 22.2 t0 -123.37 102.45 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 64.239999999999995 110.162 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.469 HD13 HD12 ' A' ' 66' ' ' LEU . 9.1 tp -60.06 -31.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 62.149999999999999 110.634 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.9 t -61.64 -56.63 17.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.395 -0.366 . . . . 72.200000000000003 110.181 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.29 -45.26 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 55.140000000000001 110.699 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.1 mt -61.2 -56.37 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 111.35 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.75 85.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.091 0.472 . . . . 74.510000000000005 110.222 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 t -60.65 -48.16 83.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 52.409999999999997 109.591 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.436 ' HB3' ' HE1' ' A' ' 101' ' ' MET . 73.5 mm-40 -67.69 -35.46 78.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.81 -0.632 . . . . 73.040000000000006 111.111 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.503 ' O ' HG13 ' A' ' 127' ' ' ILE . 93.4 mt -56.46 -55.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.199 -0.667 . . . . 73.409999999999997 109.199 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -63.86 -35.69 81.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 70.219999999999999 110.919 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.85 -46.61 88.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.873 0.368 . . . . 72.200000000000003 111.041 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.458 ' HB2' HD12 ' A' ' 43' ' ' LEU . 56.1 m-80 -91.21 -5.19 55.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 71.200000000000003 111.507 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 123' ' ' ILE . 60.5 mt -78.82 -47.22 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.757 -0.46 . . . . 74.310000000000002 109.757 167.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.464 -0.779 . . . . 71.430000000000007 110.539 -177.141 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 89.5 mmm . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.724 0.297 . . . . 71.319999999999993 111.016 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mm -85.39 111.47 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 73.430000000000007 109.491 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -85.24 112.02 20.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.9 -0.591 . . . . 70.140000000000001 110.806 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -83.61 134.86 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.698 -0.482 . . . . 71.409999999999997 109.698 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.4 pt -132.4 167.72 25.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 120.994 0.426 . . . . 73.540000000000006 111.492 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 178.96 32.45 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.579 -0.737 . . . . 75.430000000000007 112.464 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.86 -55.43 35.03 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.059 0.543 . . . . 65.030000000000001 112.026 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 t -68.82 -2.7 10.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 111.888 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.11 -9.88 25.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.565 0.209 . . . . 75.540000000000006 111.565 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.73 -62.08 1.93 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.82 0.343 . . . . 70.519999999999996 110.761 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.55 -49.27 70.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.927 -0.579 . . . . 73.420000000000002 110.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.2 -53.68 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.361 -0.836 . . . . 43.219999999999999 111.05 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -63.77 -40.11 95.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.035 -0.529 . . . . 63.340000000000003 111.127 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 44' ' ' ILE . 80.0 t -71.29 -40.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.104 0.409 . . . . 74.140000000000001 112.104 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 p -86.06 -29.39 23.44 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.295 0.48 . . . . 53.409999999999997 112.295 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.7 t -82.37 10.39 7.15 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.341 0.497 . . . . 74.540000000000006 112.341 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.776 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.6 p -66.57 142.69 57.41 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.252 -0.28 . . . . 71.299999999999997 110.351 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.08 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.339 0.399 . . . . 72.420000000000002 112.06 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.29 128.85 17.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.37 -0.233 . . . . 63.420000000000002 110.37 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 55.92 11.41 0.71 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.477 0.547 . . . . 72.450000000000003 112.477 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 37.6 mm -62.87 131.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.671 0.272 . . . . 70.510000000000005 110.787 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.52 110.95 21.74 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.335 0.588 . . . . 72.329999999999998 109.544 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 38' ' ' CYS . 73.0 mt -100.32 114.19 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 72.450000000000003 110.659 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.589 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -99.68 128.45 45.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.394 -0.595 . . . . 73.209999999999994 109.394 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 85.6 t -107.42 110.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.738 0.304 . . . . 72.450000000000003 110.366 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.481 ' HA ' HD13 ' A' ' 99' ' ' ILE . 4.2 t70 -85.58 134.49 34.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.847 -0.615 . . . . 62.130000000000003 110.985 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -97.96 119.81 37.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.172 -0.467 . . . . 65.219999999999999 109.862 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.462 ' HB2' ' ND2' ' A' ' 80' ' ' ASN . 51.2 t90 -54.57 108.87 0.43 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.453 -0.794 . . . . 74.340000000000003 111.786 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.6 112.41 39.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.785 -0.643 . . . . 54.329999999999998 109.902 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.41 -68.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.765 2.31 . . . . 64.329999999999998 112.556 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -114.14 110.16 19.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.0 -0.37 . . . . 73.150000000000006 110.0 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.6 t -163.55 135.96 5.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.19 -0.459 . . . . 63.299999999999997 110.142 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.09 -76.78 0.59 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.227 -0.511 . . . . 43.399999999999999 112.599 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.23 -29.31 56.32 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.983 2.455 . . . . 54.219999999999999 112.928 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.629 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 78.8 m -55.48 -31.37 61.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 112.173 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 7.0 ptp85 -69.06 -30.42 68.75 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.997 -0.281 . . . . 74.439999999999998 110.404 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.5 m -74.94 -29.34 60.91 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.295 0.569 . . . . 74.230000000000004 109.798 174.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.64 -29.09 69.03 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.871 -0.604 . . . . 64.099999999999994 111.126 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -57.99 -57.74 23.67 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.93 -0.308 . . . . 65.120000000000005 110.588 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.57 -31.41 41.31 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.113 1.875 . . . . 64.230000000000004 112.641 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.9 mt-30 -62.99 -41.67 99.64 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 120.428 -0.509 . . . . 75.209999999999994 110.286 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.9 mt -65.62 -34.96 79.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 74.140000000000001 109.66 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 31.5 mt-10 -63.56 -37.22 86.47 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.128 -0.487 . . . . 65.510000000000005 110.505 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 1.4 tpmt? -58.35 -56.4 22.63 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.213 0.53 . . . . 74.540000000000006 109.809 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.438 HD12 HD12 ' A' ' 123' ' ' ILE . 19.1 mt -63.51 -36.43 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.467 -0.788 . . . . 74.510000000000005 110.079 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.28 -53.74 44.22 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.125 -0.489 . . . . 43.32 110.176 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 98.2 mt-30 -55.35 -42.41 73.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.746 0.308 . . . . 74.129999999999995 110.909 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.84 -41.51 64.76 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 111.398 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -104.87 4.8 32.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.193 0.812 . . . . 75.219999999999999 113.193 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.0 t -53.5 -20.02 4.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.997 1.11 . . . . 72.120000000000005 113.997 -168.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.97 -18.77 61.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.323 . . . . 74.019999999999996 111.052 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -123.16 -25.77 4.45 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.954 -0.567 . . . . 60.25 110.5 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.472 HG12 HD11 ' A' ' 45' ' ' LEU . 49.5 t -109.02 134.77 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.033 0.444 . . . . 74.219999999999999 111.766 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -138.21 127.36 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 72.219999999999999 109.284 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.589 HG12 ' HB2' ' A' ' 45' ' ' LEU . 41.1 mt -108.71 123.47 64.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.263 -0.273 . . . . 73.140000000000001 110.263 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 88.1 m-85 -107.54 131.9 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.371 -0.377 . . . . 73.109999999999999 111.025 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 58.9 mttm -97.22 99.86 11.33 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.327 -0.62 . . . . 62.329999999999998 109.327 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.3 mt -81.75 83.18 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.452 0.644 . . . . 75.129999999999995 109.338 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 49' ' ' TRP . 12.9 m120 -86.64 78.02 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.759 -0.655 . . . . 60.109999999999999 110.712 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' HD21 ' A' ' 84' ' ' ASN . 18.4 pt -112.68 64.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.405 -0.816 . . . . 65.230000000000004 109.337 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.39 -32.46 38.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.41 -1.268 . . . . 64.209999999999994 112.542 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.54 -15.58 62.29 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.976 0.417 . . . . 63.520000000000003 111.367 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.43 HD21 ' HB ' ' A' ' 81' ' ' ILE . 30.1 m-80 -105.53 76.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 73.530000000000001 110.573 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -62.94 -33.17 74.78 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.933 -0.576 . . . . 73.430000000000007 110.7 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.8 m-20 -51.55 -32.14 27.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.825 -0.625 . . . . 63.32 111.651 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -55.89 -39.64 58.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.37 . . . . 71.010000000000005 110.679 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.64 96.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 74.239999999999995 109.918 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.7 m -64.57 -39.24 93.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.551 -0.75 . . . . 72.420000000000002 110.744 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.5 mm100 -63.27 -52.21 62.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.176 -0.466 . . . . 74.510000000000005 110.727 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -81.52 -11.78 59.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.989 -0.55 . . . . 73.109999999999999 111.16 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.71 44.81 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.271 -0.49 . . . . 65.549999999999997 112.507 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.466 HG13 ' OG1' ' A' ' 98' ' ' THR . 87.9 t -60.14 112.83 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.137 0.494 . . . . 75.310000000000002 110.09 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 m -87.06 -44.9 11.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.495 -0.775 . . . . 72.219999999999999 111.561 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.93 163.5 32.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.438 -0.346 . . . . 52.439999999999998 110.445 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.7 pt -101.45 133.06 21.1 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 75.510000000000005 110.64 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.629 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 66.4 Cg_endo -90.21 -178.02 11.13 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.77 -1.346 . . . . 64.140000000000001 111.967 -3.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.466 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.2 m -136.24 130.9 33.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.328 -0.397 . . . . 74.0 110.008 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 47' ' ' ASP . 44.2 mm -119.46 115.88 49.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.604 -0.725 . . . . 71.439999999999998 110.264 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 19.8 mt -88.14 158.66 18.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.345 -0.613 . . . . 72.510000000000005 109.345 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 31.7 mtt -123.55 141.76 51.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 65.120000000000005 109.728 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -140.95 154.36 46.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.074 -0.713 . . . . 74.140000000000001 109.074 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.5 ttmm -150.47 110.52 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.042 -0.263 . . . . 74.239999999999995 110.542 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.776 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.7 t30 64.03 25.27 13.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.598 0.714 . . . . 72.219999999999999 110.3 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.76 -16.47 41.19 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.767 -0.651 . . . . 43.109999999999999 111.925 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 34.5 ttpt -75.12 145.29 42.35 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.805 0.442 . . . . 63.039999999999999 110.092 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -64.07 148.33 50.08 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.317 0.579 . . . . 71.430000000000007 110.849 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.49 168.18 26.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.872 -1.158 . . . . 72.319999999999993 107.872 -170.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 m -69.86 -177.99 1.43 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.0 0.741 . . . . 72.409999999999997 113.0 -164.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -149.15 146.29 27.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.767 0.794 . . . . 74.540000000000006 110.7 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.19 119.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 113.93 -1.487 . . . . 73.030000000000001 109.542 -173.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.1 mt -113.34 123.96 69.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.144 -0.317 . . . . 62.140000000000001 110.144 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.31 152.36 24.39 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.605 -0.598 . . . . 60.32 111.605 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 72.38 4.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 111.185 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 119' ' ' ILE . 8.5 t70 -115.59 88.1 2.81 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.293 0.568 . . . . 64.239999999999995 109.516 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.14 -33.09 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.502 -0.772 . . . . 62.149999999999999 111.289 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.3 m -61.2 -49.52 76.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.011 0.434 . . . . 72.200000000000003 110.518 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -60.32 -44.13 95.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.038 -0.528 . . . . 55.140000000000001 110.077 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 115' ' ' ASP . 66.7 mt -58.21 -56.54 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 72.120000000000005 111.317 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.03 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.001 0.429 . . . . 74.510000000000005 110.583 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 t -59.09 -52.14 67.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.773 -0.649 . . . . 52.409999999999997 110.362 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.94 -34.66 77.02 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.52 -0.309 . . . . 73.040000000000006 111.136 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 127' ' ' ILE . 81.7 mt -55.75 -56.57 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.514 -0.55 . . . . 73.409999999999997 109.514 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -63.37 -37.05 85.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.05 -0.523 . . . . 70.219999999999999 110.526 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.74 -36.15 78.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 72.200000000000003 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -103.26 -1.13 29.33 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.43 0.53 . . . . 71.200000000000003 112.43 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 123' ' ' ILE . 82.5 mt -84.8 -60.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.419 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.577 -0.738 . . . . 71.430000000000007 110.705 -172.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 75.9 mmm . . . . . 0 C--O 1.24 0.571 0 CA-C-O 120.818 0.342 . . . . 71.319999999999993 110.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' A' ' 78' ' ' LYS . 5.6 mm -66.83 108.86 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.824 -0.625 . . . . 73.430000000000007 110.094 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 10.4 tp10 -88.9 134.96 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.234 -0.284 . . . . 70.140000000000001 110.234 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -96.18 119.06 33.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 71.409999999999997 110.464 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.471 HG22 ' HG3' ' A' ' 34' ' ' LYS . 38.8 pt -134.58 160.97 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.294 -0.412 . . . . 73.540000000000006 111.305 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.51 -170.68 27.98 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 116.095 -0.502 . . . . 75.430000000000007 112.301 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.9 -50.37 73.68 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.002 0.43 . . . . 65.030000000000001 111.281 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -61.0 -21.21 63.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.979 -0.555 . . . . 74.420000000000002 111.319 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' CB ' ' HB ' ' A' ' 26' ' ' ILE . 5.8 mm-40 -88.8 -14.08 37.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 75.540000000000006 111.657 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -57.34 -62.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 70.519999999999996 110.837 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.92 -50.57 72.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.089 0.471 . . . . 73.420000000000002 110.263 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -50.74 -57.44 8.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.284 -0.871 . . . . 43.219999999999999 111.593 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HG3' HG22 ' A' ' 26' ' ' ILE . 49.1 mmtm -75.39 -28.9 59.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.98 -0.554 . . . . 63.340000000000003 111.757 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HA ' HD12 ' A' ' 44' ' ' ILE . 51.5 t -70.6 -37.51 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 121.1 -0.24 . . . . 74.140000000000001 111.292 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -86.44 -30.41 22.08 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.085 0.402 . . . . 53.409999999999997 112.085 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -74.33 7.44 2.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.043 0.386 . . . . 74.540000000000006 112.043 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.694 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 29.4 p -67.78 162.51 23.76 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.161 -0.311 . . . . 71.299999999999997 110.161 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -73.66 -82.71 0.05 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.637 0.256 . . . . 72.420000000000002 111.052 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -160.87 138.48 9.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.882 -0.414 . . . . 63.420000000000002 109.882 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 59.2 t30 62.09 1.99 0.75 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.97 0.508 . . . . 72.450000000000003 111.606 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -63.82 110.15 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.377 -0.374 . . . . 70.510000000000005 111.116 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB3' HG23 ' A' ' 74' ' ' VAL . 55.4 tp -76.27 114.41 14.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.174 -0.676 . . . . 72.329999999999998 109.174 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 38' ' ' CYS . 77.8 mt -99.86 110.46 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.989 -1.005 . . . . 72.450000000000003 110.492 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.664 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.9 mp -93.45 121.51 34.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 73.209999999999994 109.436 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 60.2 t -103.31 105.48 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.401 -0.592 . . . . 72.450000000000003 109.401 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HA ' HD12 ' A' ' 99' ' ' ILE . 27.2 t70 -83.63 129.37 34.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.872 0.368 . . . . 62.130000000000003 111.446 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.95 114.09 25.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.142 -1.059 . . . . 65.219999999999999 108.142 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.627 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 3.1 t90 -77.75 -42.26 34.76 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.486 0.491 . . . . 74.340000000000003 111.883 -164.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HB3' HG23 ' A' ' 96' ' ' ILE . . . 69.92 134.61 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.805 0.691 . . . . 54.329999999999998 110.964 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.75 -31.35 94.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.508 2.139 . . . . 64.329999999999998 111.4 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -127.82 136.32 51.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.543 -0.753 . . . . 73.150000000000006 109.014 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 5.2 p -146.64 -82.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.348 -0.141 . . . . 63.299999999999997 111.245 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . 108.86 -85.83 0.42 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.072 -0.585 . . . . 43.399999999999999 111.662 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 53' ' ' CYS . 19.4 Cg_endo -58.13 -9.83 7.05 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.916 2.411 . . . . 54.219999999999999 112.259 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.73 -37.52 63.42 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.004 -0.544 . . . . 71.349999999999994 110.676 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 14.2 ptm180 -56.88 -34.25 67.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 111.151 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.52 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.5 m -75.84 -54.86 6.27 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.8 0.81 . . . . 74.230000000000004 111.04 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -64.51 -41.99 96.08 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.188 -0.915 . . . . 64.099999999999994 113.222 -169.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.77 -53.92 60.67 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 117.962 0.346 . . . . 65.120000000000005 111.301 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.86 -27.88 58.98 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.678 1.585 . . . . 64.230000000000004 112.3 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.0 mt-30 -65.07 -38.82 92.04 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.426 -0.51 . . . . 75.209999999999994 110.069 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 95.8 mt -69.01 -40.04 78.92 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 74.140000000000001 109.499 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 5.7 mm-40 -53.85 -49.18 69.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.493 -0.776 . . . . 65.510000000000005 110.18 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -54.59 -52.39 62.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.711 -0.677 . . . . 74.540000000000006 110.775 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 123' ' ' ILE . 52.0 mt -65.02 -33.38 75.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 74.510000000000005 110.103 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.53 -14.91 61.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.46 . . . . 43.32 110.969 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.4 mt-30 -93.69 -39.22 10.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.882 0.373 . . . . 74.129999999999995 110.666 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -69.59 -34.01 73.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.542 0.687 . . . . 75.409999999999997 110.301 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.87 6.29 33.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.039 -0.982 . . . . 75.219999999999999 111.533 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 t -52.97 -22.15 5.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.634 0.975 . . . . 72.120000000000005 113.634 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -78.66 -23.04 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 74.019999999999996 111.166 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.19 5.59 6.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.132 -0.486 . . . . 60.25 111.483 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 43' ' ' LEU . 65.6 t -139.81 145.1 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.695 0.283 . . . . 74.219999999999999 111.578 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 28.5 tptp -148.77 127.86 12.8 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.649 -0.5 . . . . 72.219999999999999 109.649 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.9 mt -103.14 145.17 12.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.006 0.432 . . . . 73.140000000000001 111.052 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.452 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 98.4 m-85 -126.87 167.84 15.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.73 -0.668 . . . . 73.109999999999999 110.147 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.627 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 9.7 tppt? -136.49 108.52 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.273 -1.01 . . . . 62.329999999999998 108.273 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -75.65 128.29 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 75.129999999999995 110.347 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.6 21.31 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.443 0.64 . . . . 60.109999999999999 110.503 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 pt -94.55 32.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.427 0.632 . . . . 65.230000000000004 109.834 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.31 -18.58 50.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.822 -1.081 . . . . 64.209999999999994 111.59 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -89.29 5.99 42.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 63.520000000000003 111.623 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.406 ' ND2' HG22 ' A' ' 87' ' ' VAL . 49.9 t30 -116.43 89.06 3.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.963 0.411 . . . . 73.530000000000001 110.307 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -67.88 -21.77 65.13 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 73.430000000000007 111.521 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -50.13 -45.8 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.398 . . . . 63.32 110.547 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.406 HG22 ' ND2' ' A' ' 84' ' ' ASN . 74.0 t -60.35 -34.48 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.795 -0.639 . . . . 71.010000000000005 110.525 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.28 -51.5 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.041 0.448 . . . . 74.239999999999995 110.058 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -61.87 -42.23 98.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 72.420000000000002 110.914 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.89 -50.31 71.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.121 -0.491 . . . . 74.510000000000005 111.07 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.06 -4.69 58.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.398 -0.365 . . . . 73.109999999999999 111.493 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.72 34.86 37.7 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.202 -0.523 . . . . 65.549999999999997 113.53 170.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.519 HG11 ' OG1' ' A' ' 98' ' ' THR . 83.9 t -68.29 130.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 75.310000000000002 110.361 176.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.4 m -129.82 -71.3 0.61 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 72.219999999999999 110.083 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.64 136.18 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 110.027 -0.36 . . . . 52.439999999999998 110.027 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.51 HG23 ' HB3' ' A' ' 50' ' ' ALA . 2.2 pp -113.71 151.22 44.45 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.421 -0.354 . . . . 75.510000000000005 111.335 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.08 160.81 91.24 Favored 'Cis proline' 0 C--N 1.353 0.815 0 C-N-CA 124.079 -1.217 . . . . 64.140000000000001 112.365 -0.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.519 ' OG1' HG11 ' A' ' 93' ' ' VAL . 92.3 m -119.74 129.91 54.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 74.0 109.871 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.492 ' HB ' HG22 ' A' ' 111' ' ' VAL . 45.8 mm -110.16 113.48 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 71.439999999999998 110.899 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 38.0 mt -91.04 152.46 20.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.553 -0.906 . . . . 72.510000000000005 108.553 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 122' ' ' GLU . 36.9 mtt -124.12 141.38 52.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.883 0.31 . . . . 65.120000000000005 110.309 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 99.4 m-85 -143.94 154.94 43.83 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.851 -0.796 . . . . 74.140000000000001 108.851 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -144.19 104.86 4.16 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.683 -0.407 . . . . 74.239999999999995 111.04 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.694 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 7.9 t30 55.41 32.82 19.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.561 0.696 . . . . 72.219999999999999 110.627 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.0 -16.48 59.42 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.736 -0.666 . . . . 43.109999999999999 112.587 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -71.79 140.74 49.57 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 110.157 -0.312 . . . . 63.039999999999999 110.157 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.508 ' O ' HD21 ' A' ' 108' ' ' LEU . 12.2 mmmm -68.42 134.42 50.17 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.281 0.562 . . . . 71.430000000000007 110.961 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 2.3 mm? -139.0 168.84 18.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.44 -1.254 . . . . 72.319999999999993 109.057 -170.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -69.81 -178.62 1.57 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.252 0.834 . . . . 72.409999999999997 113.252 -163.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.415 ' HG3' HD21 ' A' ' 100' ' ' LEU . 48.4 tt0 -148.76 122.46 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.092 -0.958 . . . . 74.540000000000006 109.689 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.492 HG22 ' HB ' ' A' ' 99' ' ' ILE . 19.4 m -113.9 130.16 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.177 0.513 . . . . 73.030000000000001 110.028 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 98' ' ' THR . 58.0 mt -116.08 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 62.140000000000001 109.711 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.2 148.08 14.4 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.896 -0.482 . . . . 60.32 111.896 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.61 72.12 6.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.825 0.345 . . . . 75.109999999999999 111.174 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.4 t70 -122.76 91.94 3.6 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.349 -0.612 . . . . 64.239999999999995 109.349 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -59.33 -30.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 62.149999999999999 111.207 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.0 t -63.49 -49.22 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 72.200000000000003 110.071 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.47 -43.05 99.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.801 -0.444 . . . . 55.140000000000001 109.801 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . 70.9 mt -57.73 -56.27 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.718 -0.674 . . . . 72.120000000000005 111.104 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.425 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.19 -39.4 82.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 120.675 0.274 . . . . 74.510000000000005 110.436 -177.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.9 m -54.78 -52.0 63.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.794 -0.447 . . . . 52.409999999999997 109.794 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.505 ' HB3' ' HE1' ' A' ' 101' ' ' MET . 25.1 mm-40 -67.64 -32.19 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 73.040000000000006 111.478 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.517 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.7 mt -60.2 -56.18 19.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.383 -0.527 . . . . 73.409999999999997 109.918 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -68.01 -28.3 67.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.52 -0.472 . . . . 70.219999999999999 109.89 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 6.6 t30 -65.09 -44.49 88.68 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.664 -0.698 . . . . 72.200000000000003 111.403 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -91.32 -8.78 47.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.548 -0.296 . . . . 71.200000000000003 111.628 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.8 mt -76.44 -50.36 22.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.159 0.504 . . . . 74.310000000000002 109.645 167.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.401 -0.809 . . . . 71.430000000000007 109.667 -176.482 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.409 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 94.3 mmm . . . . . 0 C--O 1.238 0.474 0 CA-C-O 120.825 0.345 . . . . 71.319999999999993 110.507 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.707 HG23 ' HG3' ' A' ' 78' ' ' LYS . 3.3 mm -68.76 101.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.234 -0.654 . . . . 73.430000000000007 109.234 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 40.5 tt0 -90.65 127.2 36.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.888 -0.596 . . . . 70.140000000000001 111.532 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -85.51 128.53 34.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.799 0.333 . . . . 71.409999999999997 110.436 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.34 164.79 32.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.492 -0.322 . . . . 73.540000000000006 111.031 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 -178.56 38.96 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.825 -0.625 . . . . 75.430000000000007 112.404 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.36 -43.4 94.66 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.004 0.43 . . . . 65.030000000000001 110.995 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -64.99 -36.16 83.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 74.420000000000002 110.539 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -74.09 -17.45 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 75.540000000000006 111.859 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -52.93 -62.31 1.73 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.633 0.254 . . . . 70.519999999999996 111.22 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.447 ' O ' HG21 ' A' ' 36' ' ' THR . 24.7 t70 -64.38 -45.99 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.02 0.438 . . . . 73.420000000000002 110.686 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -56.63 -57.16 13.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.331 -0.85 . . . . 43.219999999999999 110.701 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HE3' ' CE2' ' A' ' 77' ' ' TYR . 24.1 mmmt -65.28 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.698 -0.683 . . . . 63.340000000000003 110.885 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.63 -51.72 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.667 0.27 . . . . 74.140000000000001 111.143 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 32' ' ' ASP . 8.9 t -86.01 -10.71 54.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.829 0.307 . . . . 53.409999999999997 111.829 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -72.81 -12.59 61.05 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.923 0.342 . . . . 74.540000000000006 111.923 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 15.5 p -55.13 143.59 26.79 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.591 0.234 . . . . 71.299999999999997 111.488 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -54.56 -79.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.067 -0.515 . . . . 72.420000000000002 111.588 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -159.33 125.8 4.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.473 0.178 . . . . 63.420000000000002 110.793 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 59.21 15.33 4.13 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.885 0.474 . . . . 72.450000000000003 111.418 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -76.32 118.71 23.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.191 -0.459 . . . . 70.510000000000005 110.309 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.466 ' HB3' HG23 ' A' ' 74' ' ' VAL . 63.7 tp -74.46 122.03 22.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.945 -0.57 . . . . 72.329999999999998 110.424 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 38' ' ' CYS . 37.6 mt -110.77 121.91 64.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.661 -0.7 . . . . 72.450000000000003 110.295 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.53 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 4.4 mp -104.79 112.59 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.243 -0.651 . . . . 73.209999999999994 109.243 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -93.95 104.67 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.944 -0.391 . . . . 72.450000000000003 109.944 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.21 146.65 30.37 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.982 -0.554 . . . . 62.130000000000003 110.916 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -107.89 129.04 55.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 65.219999999999999 109.819 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.41 140.52 45.39 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 74.340000000000003 111.576 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' HD12 ' A' ' 96' ' ' ILE . . . -99.33 107.94 47.54 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 54.329999999999998 110.922 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -52.46 -52.46 8.84 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.746 2.297 . . . . 64.329999999999998 111.471 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.561 ' HB2' HD13 ' A' ' 96' ' ' ILE . 45.3 m95 -80.15 75.85 6.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.407 -0.96 . . . . 73.150000000000006 108.407 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.445 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 7.6 t -75.65 79.19 2.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.502 -0.772 . . . . 63.299999999999997 110.27 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -108.57 -74.04 0.82 Allowed Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.5 -0.773 . . . . 43.399999999999999 111.432 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.88 -18.95 59.83 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.732 2.288 . . . . 54.219999999999999 111.612 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 27.8 p -52.13 -34.43 44.41 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.516 -0.765 . . . . 71.349999999999994 110.379 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -53.8 -49.37 68.47 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.948 -0.569 . . . . 74.439999999999998 111.083 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.626 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 48.0 m -75.24 -42.8 54.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.072 0.463 . . . . 74.230000000000004 111.526 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.7 -37.83 88.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.815 0.672 . . . . 64.099999999999994 112.815 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 58.5 mm-40 -55.81 -58.84 13.67 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 117.967 0.349 . . . . 65.120000000000005 110.736 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.29 -27.53 55.71 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.938 1.759 . . . . 64.230000000000004 112.372 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.626 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.2 mt-30 -68.32 -40.62 81.61 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.698 -0.401 . . . . 75.209999999999994 110.71 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.99 -43.03 84.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.633 -0.506 . . . . 74.140000000000001 109.633 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 2.9 mm-40 -52.73 -47.14 67.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.722 -0.672 . . . . 65.510000000000005 110.131 174.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -52.29 -57.08 10.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.824 -0.626 . . . . 74.540000000000006 110.837 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.437 HD12 HD12 ' A' ' 123' ' ' ILE . 31.4 mt -65.78 -31.36 72.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.676 -0.693 . . . . 74.510000000000005 110.379 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.513 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -68.46 -44.2 75.36 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.873 -0.603 . . . . 43.32 110.223 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.0 mt-30 -71.38 -37.52 71.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.271 0.558 . . . . 74.129999999999995 110.581 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -73.4 -37.34 65.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.719 -0.673 . . . . 75.409999999999997 111.122 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.96 5.25 32.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.121 -0.491 . . . . 75.219999999999999 112.166 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.7 t -52.86 -21.17 3.92 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.135 0.791 . . . . 72.120000000000005 113.135 -171.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.66 -28.27 69.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 74.019999999999996 110.472 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.14 8.37 3.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.2 -0.454 . . . . 60.25 111.765 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 43' ' ' LEU . 64.9 t -134.41 141.9 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.053 0.454 . . . . 74.219999999999999 112.068 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 57.0 tptt -145.17 126.09 14.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.429 -0.805 . . . . 72.219999999999999 109.31 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.428 HG12 ' HB2' ' A' ' 45' ' ' LEU . 36.0 mt -108.31 140.25 27.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.742 0.306 . . . . 73.140000000000001 110.542 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 86.2 m-85 -121.39 170.5 9.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 73.109999999999999 109.712 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.707 ' HG3' HG23 ' A' ' 23' ' ' ILE . 28.8 mtpp -136.12 128.5 30.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.63 -0.507 . . . . 62.329999999999998 109.63 173.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.67 67.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.661 -1.237 . . . . 75.129999999999995 107.661 168.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -85.24 66.09 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.241 -0.891 . . . . 60.109999999999999 110.656 -170.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.5 mt -100.81 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.182 -1.044 . . . . 65.230000000000004 108.182 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -23.23 2.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.35 -1.296 . . . . 64.209999999999994 113.069 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.77 -36.47 23.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.689 0.255 . . . . 63.520000000000003 111.689 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -96.9 82.24 3.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 111.258 -170.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -68.43 -20.59 64.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.628 . . . . 73.430000000000007 109.991 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.9 m-20 -47.97 -39.51 19.67 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.476 -0.784 . . . . 63.32 111.427 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.8 -36.98 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.903 -0.59 . . . . 71.010000000000005 110.935 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.07 79.02 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 74.239999999999995 110.44 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.6 m -67.56 -37.77 83.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.78 -0.645 . . . . 72.420000000000002 111.02 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.6 mm100 -63.62 -46.08 87.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 74.510000000000005 110.788 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -87.28 -15.07 39.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.345 -0.389 . . . . 73.109999999999999 111.631 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 41.94 9.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.165 -0.54 . . . . 65.549999999999997 112.911 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 98' ' ' THR . 93.4 t -65.23 103.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.888 -0.412 . . . . 75.310000000000002 109.888 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -77.76 -37.86 48.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 72.219999999999999 111.526 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.493 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -140.68 138.47 34.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.359 -0.382 . . . . 52.439999999999998 110.186 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 52' ' ' TRP . 18.6 pt -106.51 140.77 21.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.075 -0.512 . . . . 75.510000000000005 110.777 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.22 -179.57 26.22 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.774 -1.344 . . . . 64.140000000000001 112.408 -0.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.455 HG21 HG12 ' A' ' 112' ' ' ILE . 93.8 m -138.61 132.58 31.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 74.0 110.121 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 44.2 mm -115.86 110.84 33.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.956 -0.566 . . . . 71.439999999999998 111.001 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.437 ' N ' HD13 ' A' ' 100' ' ' LEU . 5.7 mp -93.22 123.3 36.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.436 -0.579 . . . . 72.510000000000005 109.436 174.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' SER . 12.1 mmt -91.56 140.61 29.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.308 . . . . 65.120000000000005 110.328 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -143.77 148.35 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.151 -1.055 . . . . 74.140000000000001 108.151 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -145.61 112.06 5.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.076 -0.65 . . . . 74.239999999999995 111.384 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.653 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.6 t-20 62.19 25.95 15.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.552 0.691 . . . . 72.219999999999999 110.434 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.34 -16.55 58.65 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.576 -0.738 . . . . 43.109999999999999 112.084 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -73.5 142.4 46.77 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.041 -0.355 . . . . 63.039999999999999 110.041 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.32 127.48 33.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.430000000000007 110.725 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 108' ' ' LEU . 2.8 mm? -126.93 168.5 14.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.095 . . . . 72.319999999999993 110.576 -172.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.24 163.25 26.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.608 -0.723 . . . . 72.409999999999997 111.913 -167.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -127.25 124.34 38.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 74.540000000000006 110.044 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 32.2 m -102.8 140.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 109.814 -0.439 . . . . 73.030000000000001 109.814 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.493 HG21 ' HB1' ' A' ' 95' ' ' ALA . 63.2 mt -127.92 134.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 62.140000000000001 110.03 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.21 145.24 13.4 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.093 -0.575 . . . . 60.32 111.672 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.8 79.77 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 75.109999999999999 111.101 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -132.19 98.32 4.38 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.57 -0.53 . . . . 64.239999999999995 109.57 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.96 -28.78 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 62.149999999999999 110.799 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 t -64.89 -43.68 92.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.764 -0.458 . . . . 72.200000000000003 109.764 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -67.02 -44.77 79.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.125 -0.489 . . . . 55.140000000000001 109.958 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.9 mt -56.66 -54.01 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.996 -0.547 . . . . 72.120000000000005 110.958 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.52 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.25 -37.33 79.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 116.318 -0.401 . . . . 74.510000000000005 110.199 -177.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.435 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 21.5 t -56.44 -48.81 76.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.451 -0.574 . . . . 52.409999999999997 109.451 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 49.4 mm-40 -66.47 -37.16 84.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.384 -0.371 . . . . 73.040000000000006 111.046 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.5 mt -53.27 -55.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 120.833 -0.347 . . . . 73.409999999999997 110.133 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 121' ' ' SER . 7.7 p30 -69.12 -29.56 67.64 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.561 -0.456 . . . . 70.219999999999999 110.111 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 44.2 t30 -66.68 -32.81 74.36 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.411 . . . . 72.200000000000003 111.017 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -86.91 -31.07 20.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.811 -0.177 . . . . 71.200000000000003 111.152 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.5 mt -69.25 -39.8 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.112 0.482 . . . . 74.310000000000002 110.108 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.474 -0.774 . . . . 71.430000000000007 110.032 -179.022 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.9 mmm . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 120.809 0.338 . . . . 71.319999999999993 110.553 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.651 HG22 ' HB2' ' A' ' 78' ' ' LYS . 11.8 mm -63.28 103.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.628 -0.714 . . . . 73.430000000000007 109.284 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.85 125.13 27.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 70.140000000000001 111.558 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.1 120.68 24.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.238 -0.437 . . . . 71.409999999999997 110.007 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 31' ' ' PHE . 37.4 pt -130.32 151.76 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.872 0.368 . . . . 73.540000000000006 111.607 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.77 -160.59 29.77 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.707 -0.678 . . . . 75.430000000000007 112.685 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -56.87 12.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.564 0.346 . . . . 65.030000000000001 111.769 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -65.16 -37.33 87.05 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.1 0.476 . . . . 74.420000000000002 110.23 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.87 -30.23 70.34 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.805 -0.634 . . . . 75.540000000000006 110.824 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.5 ' HA ' HD11 ' A' ' 26' ' ' ILE . 88.1 t80 -54.65 -58.01 9.22 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.335 -0.246 . . . . 70.519999999999996 110.335 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -53.48 -54.69 33.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.782 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.5 -56.85 16.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.793 -0.64 . . . . 43.219999999999999 111.054 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.1 mmtt -58.13 -35.71 71.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.203 -0.908 . . . . 63.340000000000003 111.655 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.85 -40.04 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.795 0.331 . . . . 74.140000000000001 110.933 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.8 p -78.18 -9.49 59.22 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.909 0.385 . . . . 53.409999999999997 110.933 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -61.71 -13.49 23.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.859 -0.609 . . . . 74.540000000000006 111.666 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 44' ' ' ILE . 75.7 m -49.79 113.79 0.92 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.681 0.277 . . . . 71.299999999999997 111.061 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -63.58 -69.37 0.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.238 -0.653 . . . . 72.420000000000002 109.238 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -161.88 133.2 5.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.943 -0.571 . . . . 63.420000000000002 110.59 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 58.4 15.61 3.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.971 0.508 . . . . 72.450000000000003 111.661 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 mm -75.83 124.51 34.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.84 0.352 . . . . 70.510000000000005 110.758 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HB3' HG23 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -82.78 118.34 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.777 -0.647 . . . . 72.329999999999998 109.438 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.613 HD12 ' SG ' ' A' ' 38' ' ' CYS . 21.3 mt -114.02 117.49 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 72.450000000000003 110.39 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.9 mp -104.31 131.15 51.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.684 -0.858 . . . . 73.209999999999994 108.684 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.2 108.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.204 -0.295 . . . . 72.450000000000003 110.204 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 22.2 t0 -81.86 138.25 35.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 62.130000000000003 110.02 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -78.51 177.65 8.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 65.219999999999999 111.128 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.592 ' HB2' ' HA ' ' A' ' 80' ' ' ASN . 20.1 t90 -85.81 129.1 34.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 74.340000000000003 110.653 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.07 86.62 7.57 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.846 -0.616 . . . . 54.329999999999998 109.912 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.37 -22.44 21.73 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.296 1.997 . . . . 64.329999999999998 111.982 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -117.77 111.17 18.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 73.150000000000006 110.339 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -175.86 135.88 0.3 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.114 -0.494 . . . . 63.299999999999997 110.387 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -74.91 0.95 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.355 -0.45 . . . . 43.399999999999999 112.418 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.19 -23.03 72.54 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 54.219999999999999 113.057 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 71.8 m -55.83 -30.71 61.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.595 -0.275 . . . . 71.349999999999994 111.446 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -59.45 -32.42 70.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.852 0.358 . . . . 74.439999999999998 110.774 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.5 m -74.67 -38.17 62.49 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.809 0.814 . . . . 74.230000000000004 110.138 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.5 mm? -67.33 -34.71 77.92 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.359 -0.837 . . . . 64.099999999999994 111.975 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 45.5 mt-10 -55.05 -58.43 14.82 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 120.994 -0.282 . . . . 65.120000000000005 110.817 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 38.2 Cg_endo -66.62 -31.11 41.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.106 1.87 . . . . 64.230000000000004 112.332 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.1 mt-30 -62.79 -40.75 98.3 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.296 -0.562 . . . . 75.209999999999994 110.18 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.8 mt -68.73 -33.77 74.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.871 -0.604 . . . . 74.140000000000001 109.991 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 40.8 mt-10 -62.49 -44.55 96.12 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.324 -0.398 . . . . 65.510000000000005 110.271 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -54.79 -52.48 62.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.127 -0.488 . . . . 74.540000000000006 110.474 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.445 HD13 HD13 ' A' ' 123' ' ' ILE . 47.5 mt -65.33 -37.19 86.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.519 . . . . 74.510000000000005 110.205 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.58 -36.46 83.87 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.86 -0.609 . . . . 43.32 110.879 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -74.43 -50.35 18.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 74.129999999999995 110.544 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -63.54 -34.66 78.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 75.409999999999997 110.914 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -104.97 5.07 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 75.219999999999999 112.203 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.4 t -53.34 -20.0 3.95 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.37 0.507 . . . . 72.120000000000005 112.37 -172.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.19 -39.22 92.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 74.019999999999996 110.739 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.46 -9.88 12.03 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.051 -0.522 . . . . 60.25 110.848 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 43' ' ' LEU . 68.2 t -125.85 145.63 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.037 0.446 . . . . 74.219999999999999 111.635 -171.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.721 ' HZ1' ' HB2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.11 128.64 13.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.324 -0.621 . . . . 72.219999999999999 109.324 171.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.6 mt -111.5 129.13 67.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.078 0.466 . . . . 73.140000000000001 110.964 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.492 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.5 m-85 -114.81 177.84 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 73.109999999999999 109.18 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.651 ' HB2' HG22 ' A' ' 23' ' ' ILE . 59.0 tttp -148.17 123.5 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 62.329999999999998 110.532 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.56 HG21 HG23 ' A' ' 81' ' ' ILE . 29.2 mm -86.49 108.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 75.129999999999995 109.857 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 49' ' ' TRP . 30.4 p-10 -114.98 4.9 14.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.451 -0.341 . . . . 60.109999999999999 111.116 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.56 HG23 HG21 ' A' ' 79' ' ' ILE . 6.1 tt -65.47 105.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.34 0.59 . . . . 65.230000000000004 109.782 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -54.99 -31.0 60.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.046 -0.979 . . . . 64.209999999999994 112.756 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.85 -19.39 61.97 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.787 0.291 . . . . 63.520000000000003 111.787 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.435 HD21 HG23 ' A' ' 79' ' ' ILE . 45.1 t30 -87.9 88.11 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.062 0.458 . . . . 73.530000000000001 111.786 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -107.14 -30.49 8.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 73.430000000000007 109.324 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.55 -55.98 5.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.041 -0.981 . . . . 63.32 111.411 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.99 -34.22 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.734 -0.666 . . . . 71.010000000000005 111.071 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.39 62.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.076 0.465 . . . . 74.239999999999995 110.162 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -67.1 -31.53 72.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.611 -0.722 . . . . 72.420000000000002 111.096 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -75.17 -38.52 60.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.228 -0.442 . . . . 74.510000000000005 111.666 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -91.95 -11.66 35.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.757 0.281 . . . . 73.109999999999999 111.757 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.87 53.21 2.76 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.908 -0.663 . . . . 65.549999999999997 113.394 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG21 HG21 ' A' ' 98' ' ' THR . 98.4 t -79.69 106.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.677 -0.49 . . . . 75.310000000000002 109.677 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -82.88 -43.27 16.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.875 -0.602 . . . . 72.219999999999999 111.402 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.24 12.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.594 -0.276 . . . . 52.439999999999998 110.59 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.701 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -109.3 150.68 41.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.262 -0.426 . . . . 75.510000000000005 110.426 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 95.9 Cg_endo -77.84 174.81 50.29 Favored 'Cis proline' 0 C--N 1.353 0.803 0 C-N-CA 123.696 -1.377 . . . . 64.140000000000001 112.244 -1.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.471 HG21 HG21 ' A' ' 93' ' ' VAL . 92.3 m -142.36 115.28 8.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.291 -0.413 . . . . 74.0 110.439 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 111' ' ' VAL . 32.3 mm -109.81 111.42 36.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.723 -0.671 . . . . 71.439999999999998 110.373 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 100' ' ' LEU . 2.2 mm? -88.42 125.81 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.194 -0.912 . . . . 72.510000000000005 109.835 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.617 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -94.76 138.28 32.77 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.749 -0.463 . . . . 65.120000000000005 109.749 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -135.88 144.14 45.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.69 -0.485 . . . . 74.140000000000001 109.69 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.7 tptp -132.59 106.38 7.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.927 -0.309 . . . . 74.239999999999995 110.216 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.86 26.23 15.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.119 0.485 . . . . 72.219999999999999 110.709 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.53 -6.36 82.51 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.707 -0.679 . . . . 43.109999999999999 112.299 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -87.9 152.1 22.33 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 120.581 0.229 . . . . 63.039999999999999 110.647 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 7.8 tmtm? -56.86 134.8 55.62 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 124.262 0.976 . . . . 71.430000000000007 110.809 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.529 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -145.09 169.08 18.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.534 -1.212 . . . . 72.319999999999993 108.539 -175.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 101' ' ' MET . 40.7 m -70.01 -177.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.211 0.529 . . . . 72.409999999999997 111.927 -164.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.486 ' HG3' HD11 ' A' ' 100' ' ' LEU . 49.2 tt0 -147.14 142.77 27.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.132 -0.486 . . . . 74.540000000000006 110.141 -173.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 99' ' ' ILE . 16.2 m -128.22 132.35 68.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.945 0.402 . . . . 73.030000000000001 110.247 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.31 135.69 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.802 -0.636 . . . . 62.140000000000001 109.424 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.92 154.53 21.27 Favored Glycine 0 C--O 1.235 0.156 0 C-N-CA 121.003 -0.618 . . . . 60.32 111.816 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.6 74.87 9.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.724 0.297 . . . . 75.109999999999999 111.377 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -123.96 93.61 3.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.292 0.568 . . . . 64.239999999999995 109.483 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.435 HD12 HD12 ' A' ' 66' ' ' LEU . 9.3 tp -59.11 -30.6 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.524 -0.762 . . . . 62.149999999999999 111.047 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.0 t -67.82 -41.23 83.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.442 -0.345 . . . . 72.200000000000003 110.25 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -70.74 -40.96 72.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 110.08 -0.341 . . . . 55.140000000000001 110.08 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.71 -55.77 20.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.123 -0.49 . . . . 72.120000000000005 110.635 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.483 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.58 -35.57 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.514 -0.55 . . . . 74.510000000000005 109.514 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.1 t -53.69 -52.28 60.54 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.913 -0.585 . . . . 52.409999999999997 109.901 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 33.6 mm-40 -67.1 -38.38 85.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.23 -0.441 . . . . 73.040000000000006 111.371 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.445 HD13 HD13 ' A' ' 66' ' ' LEU . 98.4 mt -54.19 -55.77 12.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 120.571 -0.452 . . . . 73.409999999999997 110.303 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -71.47 -27.3 63.15 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.751 -0.379 . . . . 70.219999999999999 110.525 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 54.5 t30 -73.16 -28.51 62.27 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.131 -0.486 . . . . 72.200000000000003 110.864 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.447 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.9 OUTLIER -85.73 -36.86 19.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 71.200000000000003 110.192 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 123' ' ' ILE . 70.6 mt -67.67 -44.88 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.136 0.493 . . . . 74.310000000000002 110.201 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.711 -0.661 . . . . 71.430000000000007 109.967 -178.73 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 C--O 1.234 0.243 0 N-CA-C 108.738 -0.838 . . . . 71.319999999999993 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.446 HG23 HG23 ' A' ' 76' ' ' ILE . 22.0 mm -67.34 93.37 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.811 -1.181 . . . . 73.430000000000007 107.811 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.77 111.83 6.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 70.140000000000001 111.759 -167.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 5.0 pm0 -69.97 129.38 39.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 71.409999999999997 110.202 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 36.8 pt -137.89 147.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.540000000000006 111.257 -174.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.53 -179.22 42.33 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.843 -0.617 . . . . 75.430000000000007 111.899 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.08 -48.4 67.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.745 0.418 . . . . 65.030000000000001 111.492 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 p -62.43 -35.35 78.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.039 -0.528 . . . . 74.420000000000002 111.158 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 44.8 mt-10 -77.49 -27.77 51.97 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.992 -0.549 . . . . 75.540000000000006 110.708 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.499 ' HA ' HD12 ' A' ' 26' ' ' ILE . 82.1 t80 -53.14 -61.02 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.165 0.291 . . . . 70.519999999999996 111.059 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.57 -52.61 61.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.159 0.504 . . . . 73.420000000000002 110.514 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -51.55 -57.24 9.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.086 -0.961 . . . . 43.219999999999999 111.035 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HG3' HG22 ' A' ' 26' ' ' ILE . 72.6 mmtt -61.92 -46.56 88.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.201 -0.909 . . . . 63.340000000000003 111.234 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 31' ' ' PHE . 73.8 t -59.44 -38.75 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.686 0.279 . . . . 74.140000000000001 111.107 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -84.89 -16.7 40.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.702 0.286 . . . . 53.409999999999997 111.435 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -68.33 -13.39 62.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.381 -0.372 . . . . 74.540000000000006 111.471 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -55.16 122.17 10.44 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.707 -0.224 . . . . 71.299999999999997 110.7 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.12 -75.18 0.05 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.37 -0.377 . . . . 72.420000000000002 110.811 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -161.93 124.62 2.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.45 -0.341 . . . . 63.420000000000002 110.096 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.87 17.37 9.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.69 0.618 . . . . 72.450000000000003 111.347 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -78.22 104.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.435 -0.58 . . . . 70.510000000000005 109.435 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.5 ' HB3' HG22 ' A' ' 74' ' ' VAL . 62.5 tp -68.9 108.18 3.38 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.509 0.671 . . . . 72.329999999999998 110.39 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mt -96.13 112.62 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.145 -0.934 . . . . 72.450000000000003 110.531 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -96.22 141.02 30.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.437 -0.949 . . . . 73.209999999999994 108.437 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.09 114.2 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 110.315 -0.254 . . . . 72.450000000000003 110.315 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -82.89 129.22 34.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.009 0.433 . . . . 62.130000000000003 110.117 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 100' ' ' LEU . 5.2 m-85 -90.05 -39.57 12.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.816 -0.629 . . . . 65.219999999999999 110.134 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.601 ' HZ2' HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -164.28 94.34 0.72 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.534 -0.303 . . . . 74.340000000000003 111.62 -176.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.666 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . . . -96.02 109.57 47.45 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.24 -0.436 . . . . 54.329999999999998 110.469 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HG3' HD11 ' A' ' 96' ' ' ILE . 76.1 Cg_endo -92.07 130.08 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.996 2.464 . . . . 64.329999999999998 111.633 173.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -63.95 82.66 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.268 0.556 . . . . 73.150000000000006 111.164 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.654 ' H ' ' HB2' ' A' ' 56' ' ' CYS . 10.5 p -88.41 -169.21 2.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.472 -0.786 . . . . 63.299999999999997 109.567 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.11 -71.0 0.81 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.91 -0.662 . . . . 43.399999999999999 112.111 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 53' ' ' CYS . 31.3 Cg_exo -60.3 -35.56 91.01 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.742 2.295 . . . . 54.219999999999999 112.468 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.654 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 14.2 m -60.24 -29.79 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.046 0.45 . . . . 71.349999999999994 110.595 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -53.42 -52.69 58.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.827 -0.624 . . . . 74.439999999999998 110.275 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.653 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.1 m -75.76 -30.53 59.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.056 -0.52 . . . . 74.230000000000004 111.521 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -59.23 -59.14 5.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.231 0.456 . . . . 64.099999999999994 112.231 -170.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.27 -51.24 51.56 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 111.798 0.295 . . . . 65.120000000000005 111.798 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.38 -48.37 22.35 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.701 1.601 . . . . 64.230000000000004 111.586 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.3 mt-30 -60.02 -29.85 68.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.944 -0.571 . . . . 75.209999999999994 111.147 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.33 -44.24 88.41 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.716 -0.476 . . . . 74.140000000000001 109.716 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 33.2 mt-10 -62.02 -37.38 84.69 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.046 -0.524 . . . . 65.510000000000005 110.062 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 22.0 ttmm -55.79 -53.81 52.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.005 0.431 . . . . 74.540000000000006 110.828 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 62' ' ' GLN . 35.5 mt -63.79 -35.7 81.48 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.026 -0.534 . . . . 74.510000000000005 109.635 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.19 -44.31 95.72 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.445 -0.798 . . . . 43.32 110.16 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.9 mt-30 -60.61 -49.46 77.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.971 0.415 . . . . 74.129999999999995 110.265 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -62.17 -42.23 99.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.519 -0.764 . . . . 75.409999999999997 111.326 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -104.7 4.58 32.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.776 0.658 . . . . 75.219999999999999 112.776 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.55 -20.04 4.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.641 0.608 . . . . 72.120000000000005 112.641 -172.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.614 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 8.3 pt-20 -65.05 -33.69 76.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.606 0.241 . . . . 74.019999999999996 111.129 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.614 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 23.2 m-80 -124.19 5.12 8.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.509 -0.314 . . . . 60.25 110.909 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 43' ' ' LEU . 51.2 t -137.17 141.36 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.906 0.384 . . . . 74.219999999999999 111.556 -173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.89 130.07 16.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.389 -0.597 . . . . 72.219999999999999 109.389 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' HB2' ' A' ' 45' ' ' LEU . 23.7 mt -109.39 138.47 36.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 120.951 0.405 . . . . 73.140000000000001 110.411 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 93.7 m-85 -119.27 170.4 9.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.676 . . . . 73.109999999999999 110.47 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -140.74 96.51 3.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.403 -0.962 . . . . 62.329999999999998 108.403 -179.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 12.7 tt -72.84 116.44 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.207 0.527 . . . . 75.129999999999995 111.239 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -90.83 68.94 6.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.753 0.787 . . . . 60.109999999999999 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.701 HG12 HG21 ' A' ' 87' ' ' VAL . 11.0 tp -94.91 29.82 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.964 0.888 . . . . 65.230000000000004 109.897 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.23 -18.24 1.45 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.752 -1.113 . . . . 64.209999999999994 113.451 -174.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.49 -23.75 61.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.887 0.328 . . . . 63.520000000000003 111.887 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -147.09 156.53 43.08 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.964 0.412 . . . . 73.530000000000001 111.255 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -3.9 23.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.941 -0.572 . . . . 73.430000000000007 110.163 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 6.0 m-20 -50.71 -40.41 54.11 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.094 -0.503 . . . . 63.32 111.027 -176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.701 HG21 HG12 ' A' ' 81' ' ' ILE . 85.5 t -54.27 -38.04 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 115.865 -0.607 . . . . 71.010000000000005 111.208 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.92 97.63 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.108 0.48 . . . . 74.239999999999995 109.963 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 m -62.63 -37.86 87.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 72.420000000000002 110.514 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 77.3 mm-40 -63.86 -54.92 27.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.797 -0.638 . . . . 74.510000000000005 110.706 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.09 -14.04 58.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.323 -0.399 . . . . 73.109999999999999 111.72 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.41 59.13 5.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.037 -0.602 . . . . 65.549999999999997 112.127 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.601 HG21 ' HZ2' ' A' ' 49' ' ' TRP . 78.6 t -67.56 109.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 75.310000000000002 110.8 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.0 t -67.7 -50.52 57.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.903 -0.59 . . . . 72.219999999999999 110.71 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.69 172.57 16.46 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.346 -0.388 . . . . 52.439999999999998 110.683 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 49' ' ' TRP . 23.8 pt -113.6 148.37 39.58 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.923 -0.581 . . . . 75.510000000000005 109.835 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.666 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 72.1 Cg_endo -73.36 168.49 75.95 Favored 'Cis proline' 0 C--N 1.355 0.902 0 C-N-CA 124.21 -1.162 . . . . 64.140000000000001 112.788 -0.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.2 m -128.27 110.96 12.88 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.956 -0.566 . . . . 74.0 110.406 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.4 mm -114.85 110.9 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.165 -0.47 . . . . 71.439999999999998 110.435 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 48' ' ' PHE . 8.5 mp -96.17 155.02 16.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.304 -0.258 . . . . 72.510000000000005 110.304 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.519 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 35.2 mtt -119.0 150.4 40.01 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 110.196 -0.298 . . . . 65.120000000000005 110.196 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -144.27 152.29 40.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.089 0.556 . . . . 74.140000000000001 109.609 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -148.03 122.5 9.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.513 -0.181 . . . . 74.239999999999995 110.513 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.9 m-20 57.67 32.53 22.0 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.292 0.568 . . . . 72.219999999999999 110.665 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.44 75.88 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.689 -0.687 . . . . 43.109999999999999 112.479 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -117.4 152.67 34.49 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.068 -0.345 . . . . 63.039999999999999 110.068 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 8.8 tmtt? -69.46 126.41 29.65 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.938 0.774 . . . . 71.430000000000007 111.286 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.494 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.6 mm? -126.44 168.99 13.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.225 1.41 . . . . 72.319999999999993 109.19 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -179.82 1.9 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.274 0.559 . . . . 72.409999999999997 111.879 -164.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -148.85 143.37 26.24 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.853 0.835 . . . . 74.540000000000006 111.009 -172.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 t -123.43 130.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 113.843 -1.526 . . . . 73.030000000000001 109.753 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.1 124.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.483 . . . . 62.140000000000001 109.697 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.94 149.21 21.2 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.544 -0.622 . . . . 60.32 111.544 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.64 87.52 7.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.777 0.323 . . . . 75.109999999999999 110.972 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -130.28 100.11 5.27 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.432 -0.581 . . . . 64.239999999999995 109.432 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.7 tp -61.01 -33.22 54.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.58 . . . . 62.149999999999999 111.084 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.412 ' O ' HG21 ' A' ' 120' ' ' ILE . 34.2 t -63.85 -50.08 70.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 72.200000000000003 110.482 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.53 -45.03 92.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.5 -0.318 . . . . 55.140000000000001 110.302 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.475 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -58.13 -53.39 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.358 . . . . 72.120000000000005 110.719 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.506 HD11 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -61.5 -39.49 83.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 110.062 -0.347 . . . . 74.510000000000005 110.062 -178.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.605 ' HA ' HD22 ' A' ' 124' ' ' ASN . 67.2 m -59.44 -49.94 75.87 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.542 -0.299 . . . . 52.409999999999997 110.528 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -61.27 -37.75 84.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.407 -0.36 . . . . 73.040000000000006 110.483 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.1 mt -59.43 -56.22 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.518 0.199 . . . . 73.409999999999997 110.938 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.605 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.5 p30 -70.25 -25.6 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.757 -0.377 . . . . 70.219999999999999 110.386 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -69.4 -38.05 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 72.200000000000003 110.284 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.519 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 93.1 m-20 -87.88 -18.6 28.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.697 -0.683 . . . . 71.200000000000003 111.519 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 123' ' ' ILE . 78.9 mt -78.3 -45.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 74.310000000000002 110.126 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.634 -0.698 . . . . 71.430000000000007 109.921 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.8 mmm . . . . . 0 C--O 1.233 0.198 0 N-CA-C 109.333 -0.617 . . . . 71.319999999999993 109.333 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -65.34 88.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.1 -0.704 . . . . 73.430000000000007 109.1 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 17.0 tt0 -67.8 111.81 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.599 -0.728 . . . . 70.140000000000001 109.679 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.2 135.75 33.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 110.88 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.4 pt -139.39 175.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.888 -0.596 . . . . 73.540000000000006 110.29 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.86 -167.83 13.2 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.267 -0.424 . . . . 75.430000000000007 112.177 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.23 -54.28 38.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.727 0.411 . . . . 65.030000000000001 112.007 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -66.68 -29.34 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.392 -0.367 . . . . 74.420000000000002 110.925 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.18 -21.31 31.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 75.540000000000006 112.005 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.486 ' HA ' HD12 ' A' ' 26' ' ' ILE . 86.8 t80 -55.74 -61.9 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.623 0.249 . . . . 70.519999999999996 111.461 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.09 -43.49 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 73.420000000000002 110.506 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -52.58 -57.46 9.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.78 -0.645 . . . . 43.219999999999999 111.063 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HG3' HG22 ' A' ' 26' ' ' ILE . 47.8 mmtm -70.95 -38.14 72.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 63.340000000000003 111.473 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.58 -37.89 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.632 0.254 . . . . 74.140000000000001 110.94 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.5 p -83.04 -22.49 33.54 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.728 0.299 . . . . 53.409999999999997 110.99 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t -64.86 -5.14 5.36 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.328 -0.397 . . . . 74.540000000000006 111.71 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 104' ' ' ASN . 85.8 m -62.66 106.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.536 0.208 . . . . 71.299999999999997 110.514 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -61.24 -68.23 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.286 -0.415 . . . . 72.420000000000002 111.269 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -147.05 128.96 15.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.659 0.266 . . . . 63.420000000000002 111.551 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.66 24.54 5.59 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.644 0.778 . . . . 72.450000000000003 112.046 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 50.2 mm -78.61 113.61 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.591 -0.277 . . . . 70.510000000000005 110.262 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 74' ' ' VAL . 2.5 tm? -90.21 112.3 23.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.422 0.629 . . . . 72.329999999999998 109.583 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 49.3 mt -101.76 135.23 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.504 -0.771 . . . . 72.450000000000003 111.003 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.466 ' N ' HD13 ' A' ' 45' ' ' LEU . 4.4 mp -111.07 116.99 32.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.773 -0.825 . . . . 73.209999999999994 108.773 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.4 t -99.12 105.03 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.978 -0.378 . . . . 72.450000000000003 109.978 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.49 ' HA ' HD11 ' A' ' 99' ' ' ILE . 7.7 t70 -77.04 139.55 40.07 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.826 -0.624 . . . . 62.130000000000003 111.335 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -107.51 87.21 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.641 -0.874 . . . . 65.219999999999999 108.641 170.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.726 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 27.1 t-105 -43.34 130.38 4.9 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.671 -1.149 . . . . 74.340000000000003 112.974 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.09 103.85 51.56 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.638 -0.71 . . . . 54.329999999999998 109.642 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.18 -26.19 75.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.761 2.307 . . . . 64.329999999999998 112.684 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -121.36 105.45 10.54 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.204 -0.453 . . . . 73.150000000000006 110.388 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -174.15 146.73 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 63.299999999999997 110.544 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.67 -66.83 1.28 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.229 -0.441 . . . . 43.399999999999999 112.828 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.78 -28.69 59.49 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.587 2.191 . . . . 54.219999999999999 112.308 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 59.1 m -56.59 -31.92 64.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.076 -0.511 . . . . 71.349999999999994 111.159 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -54.35 -60.86 2.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.358 0.599 . . . . 74.439999999999998 109.858 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.531 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 50.3 m -55.43 -38.26 68.75 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 114.448 -1.251 . . . . 74.230000000000004 111.695 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 3.6 mm? -57.77 -34.95 70.12 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.335 -0.393 . . . . 64.099999999999994 110.941 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.4 mt-10 -55.94 -64.07 2.65 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.228 -0.415 . . . . 65.120000000000005 111.052 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 57' ' ' ARG . 33.4 Cg_endo -64.77 -24.75 61.39 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.788 1.658 . . . . 64.230000000000004 112.18 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.0 mt-30 -63.26 -44.17 95.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.306 -0.558 . . . . 75.209999999999994 110.077 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.0 mt -68.4 -39.62 81.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.903 -0.589 . . . . 74.140000000000001 110.099 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 46.5 mt-10 -60.93 -35.82 77.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.002 -0.544 . . . . 65.510000000000005 110.281 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.51 -56.21 24.84 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.031 0.443 . . . . 74.540000000000006 110.264 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.3 mt -56.26 -39.06 72.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.659 -0.701 . . . . 74.510000000000005 109.572 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -61.8 -48.24 81.49 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.115 -0.948 . . . . 43.32 110.251 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -55.93 -42.42 76.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 74.129999999999995 110.805 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -66.65 -45.09 80.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.003 -0.544 . . . . 75.409999999999997 111.303 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -101.71 5.47 41.4 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.996 0.739 . . . . 75.219999999999999 112.996 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.44 -19.61 3.77 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.334 0.865 . . . . 72.120000000000005 113.334 -169.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.8 -29.59 66.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 74.019999999999996 111.211 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -119.28 -11.03 9.62 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.896 -0.593 . . . . 60.25 111.275 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 43' ' ' LEU . 57.2 t -125.62 142.7 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.056 0.455 . . . . 74.219999999999999 111.656 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 5.2 tppp? -145.63 131.73 19.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 72.219999999999999 109.578 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.5 mt -103.72 120.69 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.0 -0.37 . . . . 73.140000000000001 110.0 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 50.2 m-85 -107.37 153.75 22.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 73.109999999999999 110.667 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.726 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 24.9 ttpt -131.32 120.18 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.274 -0.639 . . . . 62.329999999999998 109.274 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.484 HG23 HG12 ' A' ' 81' ' ' ILE . 39.9 mt -73.1 106.82 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.23 -1.026 . . . . 75.129999999999995 108.23 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.13 73.0 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.044 0.45 . . . . 60.109999999999999 111.394 -171.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 79' ' ' ILE . 26.5 pt -147.0 31.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.385 -0.825 . . . . 65.230000000000004 109.165 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -20.31 64.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.639 -0.709 . . . . 64.209999999999994 111.474 -175.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.1 -27.85 62.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.21 0.529 . . . . 63.520000000000003 109.907 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.45 76.87 9.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.555 -0.748 . . . . 73.530000000000001 109.078 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -62.62 -27.87 69.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.188 -0.915 . . . . 73.430000000000007 110.624 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 27.2 t70 -50.11 -41.74 49.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.847 -0.615 . . . . 63.32 110.56 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 81' ' ' ILE . 92.3 t -54.24 -40.36 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 71.010000000000005 110.788 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . . . -62.3 -47.3 84.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.424 0.631 . . . . 74.239999999999995 109.823 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.9 m -64.7 -33.41 75.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.444 -0.798 . . . . 72.420000000000002 110.867 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.6 mm-40 -68.43 -44.54 74.75 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 110.862 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.16 0.31 57.14 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.239 -0.437 . . . . 73.109999999999999 111.619 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.21 43.72 20.06 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.031 -0.604 . . . . 65.549999999999997 113.401 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 88' ' ' ALA . 95.9 t -74.82 106.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.297 -0.631 . . . . 75.310000000000002 109.297 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.0 m -61.76 -39.32 91.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.316 . . . . 72.219999999999999 111.738 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.61 145.65 24.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.472 -0.331 . . . . 52.439999999999998 110.606 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.5 pt -104.32 141.43 22.51 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.219 -0.446 . . . . 75.510000000000005 110.098 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -85.21 169.86 47.46 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.712 -1.37 . . . . 64.140000000000001 112.116 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -145.53 155.57 43.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.969 -0.56 . . . . 74.0 109.554 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 47' ' ' ASP . 47.7 mm -118.67 110.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.395 -0.82 . . . . 71.439999999999998 109.926 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.449 ' N ' HD11 ' A' ' 100' ' ' LEU . 5.1 mp -97.75 123.01 41.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.064 -0.717 . . . . 72.510000000000005 109.064 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.6 mtt -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 65.120000000000005 110.397 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -144.87 145.79 31.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.614 -0.513 . . . . 74.140000000000001 109.614 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -142.11 119.79 11.81 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.925 -0.398 . . . . 74.239999999999995 109.925 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.603 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 13.7 p30 51.21 25.61 2.53 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.997 0.919 . . . . 72.219999999999999 112.099 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.59 64.96 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.835 -0.62 . . . . 43.109999999999999 113.166 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.456 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 47.9 tptt -73.12 142.14 47.5 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 117.067 0.433 . . . . 63.039999999999999 110.37 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 2.5 tmtp? -68.88 122.52 18.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.824 -0.626 . . . . 71.430000000000007 110.009 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -118.1 168.8 10.22 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.273 1.029 . . . . 72.319999999999993 109.749 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 101' ' ' MET . 0.3 OUTLIER -69.73 166.94 18.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.485 0.659 . . . . 72.409999999999997 112.566 -159.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 57.2 tt0 -129.25 136.84 50.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.211 1.005 . . . . 74.540000000000006 111.326 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.47 121.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.256 -1.793 . . . . 73.030000000000001 109.608 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.2 mt -107.02 133.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 110.269 -0.271 . . . . 62.140000000000001 110.269 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.54 168.24 36.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.322 -0.466 . . . . 60.32 112.465 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.43 98.99 11.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.641 0.258 . . . . 75.109999999999999 110.884 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.2 t70 -143.55 100.61 3.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.548 -0.538 . . . . 64.239999999999995 109.548 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.3 tp -62.96 -38.45 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.895 -0.593 . . . . 62.149999999999999 111.577 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -66.54 -43.65 84.58 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.095 0.474 . . . . 72.200000000000003 110.147 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -61.41 -48.06 82.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 55.140000000000001 110.295 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 115' ' ' ASP . 73.8 mt -61.78 -47.15 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 72.120000000000005 111.519 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.519 ' HA ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.24 -41.76 92.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.211 0.529 . . . . 74.510000000000005 110.233 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.4 t -56.22 -45.73 79.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.795 -0.639 . . . . 52.409999999999997 109.465 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 39.5 mm-40 -70.2 -32.39 70.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 73.040000000000006 111.491 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 120' ' ' ILE . 80.1 mt -54.55 -55.01 17.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 N-CA-C 108.936 -0.764 . . . . 73.409999999999997 108.936 173.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -66.82 -36.07 81.5 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.391 . . . . 70.219999999999999 111.093 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.8 t30 -63.37 -42.06 98.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.216 -0.447 . . . . 72.200000000000003 111.294 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.408 ' OD1' HD13 ' A' ' 108' ' ' LEU . 57.8 m-80 -93.66 -15.3 25.44 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.448 -0.342 . . . . 71.200000000000003 111.671 -174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 123' ' ' ILE . 38.7 mt -61.45 -43.59 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.231 -1.025 . . . . 74.310000000000002 108.231 166.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.869 -1.06 . . . . 71.430000000000007 109.982 172.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.445 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 96.0 mmm . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.548 0.214 . . . . 71.319999999999993 111.221 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.4 HG22 ' HE2' ' A' ' 78' ' ' LYS . 20.8 mm -77.33 93.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.114 -0.698 . . . . 73.430000000000007 109.114 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.2 tp10 -68.4 122.76 19.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 70.140000000000001 111.152 -175.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -90.93 122.13 33.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.436 -0.347 . . . . 71.409999999999997 110.353 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.8 pt -126.94 165.08 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.299 -0.409 . . . . 73.540000000000006 111.258 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.34 -167.56 40.99 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.87 -0.604 . . . . 75.430000000000007 113.479 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.48 -54.3 30.33 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 65.030000000000001 111.448 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 t -74.67 -28.19 60.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.225 0.536 . . . . 74.420000000000002 110.359 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.23 -17.55 64.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 75.540000000000006 111.636 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.418 ' O ' HG22 ' A' ' 35' ' ' VAL . 91.4 t80 -58.4 -62.04 2.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.8 0.333 . . . . 70.519999999999996 110.16 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.16 -45.72 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.156 0.503 . . . . 73.420000000000002 110.207 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -56.15 -57.47 12.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.381 -0.827 . . . . 43.219999999999999 111.484 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.67 -29.61 65.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.223 -0.444 . . . . 63.340000000000003 111.456 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 31' ' ' PHE . 49.4 t -68.33 -41.59 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.648 0.261 . . . . 74.140000000000001 110.758 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 p -81.25 -18.88 44.44 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.872 0.367 . . . . 53.409999999999997 111.028 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 t -61.67 -21.75 64.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.136 -0.484 . . . . 74.540000000000006 111.529 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 22.9 p -59.62 122.09 13.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.606 0.241 . . . . 71.299999999999997 110.601 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.77 -69.18 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.148 -0.478 . . . . 72.420000000000002 111.844 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -161.42 135.76 7.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 63.420000000000002 110.934 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 16.6 m-80 59.36 17.1 5.58 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.704 0.628 . . . . 72.450000000000003 112.156 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.2 mm -87.85 114.01 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 70.510000000000005 110.292 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.545 HD22 ' SD ' ' A' ' 101' ' ' MET . 0.3 OUTLIER -78.82 109.19 12.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 72.329999999999998 109.387 178.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 38' ' ' CYS . 43.6 mt -97.68 121.64 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.951 -0.568 . . . . 72.450000000000003 110.482 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.662 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.9 mp -106.37 116.0 31.18 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.526 -0.546 . . . . 73.209999999999994 109.526 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.4 t -99.64 105.86 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 110.269 -0.271 . . . . 72.450000000000003 110.269 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 18.0 t70 -81.58 132.87 35.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.085 -0.507 . . . . 62.130000000000003 110.427 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -89.19 137.86 31.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.642 -0.503 . . . . 65.219999999999999 109.642 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -46.24 -51.06 15.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.594 0.559 . . . . 74.340000000000003 111.944 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 67.58 153.03 0.13 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.636 0.585 . . . . 54.329999999999998 111.828 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.2 173.92 9.77 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.426 2.084 . . . . 64.329999999999998 112.092 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -49.89 120.45 4.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.089 -0.505 . . . . 73.150000000000006 110.958 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.65 147.33 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 63.299999999999997 111.103 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -64.09 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.182 -0.463 . . . . 43.399999999999999 112.642 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.18 -30.55 32.93 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.208 2.605 . . . . 54.219999999999999 113.191 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 19.9 p -57.75 -29.01 64.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 71.349999999999994 111.285 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -54.3 -39.55 67.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.538 0.209 . . . . 74.439999999999998 111.276 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.645 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 45.1 m -75.11 -42.21 56.97 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.651 0.739 . . . . 74.230000000000004 110.48 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -61.61 -31.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.311 -0.859 . . . . 64.099999999999994 112.07 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 43.1 mt-10 -59.28 -60.93 8.94 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 117.803 0.274 . . . . 65.120000000000005 110.749 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 28.8 Cg_endo -62.98 -29.38 75.65 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.846 1.697 . . . . 64.230000000000004 112.174 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.645 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.0 mt-30 -64.51 -44.7 90.09 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.058 -0.657 . . . . 75.209999999999994 110.161 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 119' ' ' ILE . 85.7 mt -64.43 -45.68 86.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 74.140000000000001 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.6 mt-10 -63.16 -34.08 76.85 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.031 -0.531 . . . . 65.510000000000005 110.563 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.79 -47.29 87.01 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.827 0.346 . . . . 74.540000000000006 110.21 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.49 -35.64 79.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.907 -0.588 . . . . 74.510000000000005 109.731 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.39 -42.68 98.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.785 -0.643 . . . . 43.32 110.234 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.1 mt-30 -67.16 -44.3 80.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 74.129999999999995 110.082 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -67.27 -38.74 85.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.482 -0.781 . . . . 75.409999999999997 111.352 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -105.14 4.63 31.57 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.756 0.65 . . . . 75.219999999999999 112.756 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.43 -19.93 4.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.424 0.527 . . . . 72.120000000000005 112.424 -172.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.03 -29.03 70.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.793 0.33 . . . . 74.019999999999996 110.875 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -130.62 4.65 4.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.3 -0.409 . . . . 60.25 111.021 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 43' ' ' LEU . 62.4 t -133.49 149.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.941 0.4 . . . . 74.219999999999999 111.242 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HB2' ' HZ2' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -156.16 127.96 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.345 -0.613 . . . . 72.219999999999999 109.345 174.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.662 HG12 ' HB2' ' A' ' 45' ' ' LEU . 42.2 mt -106.12 141.27 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.738 0.304 . . . . 73.140000000000001 111.01 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.7 m-85 -123.51 171.72 9.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 73.109999999999999 109.821 176.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 21.1 ttmm -146.6 139.06 25.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 62.329999999999998 109.94 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.7 mm -96.6 99.14 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.23 -0.656 . . . . 75.129999999999995 109.23 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.7 -19.14 61.46 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.093 -0.503 . . . . 60.109999999999999 110.943 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.71 87.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 65.230000000000004 110.462 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.34 -18.52 63.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 64.209999999999994 111.385 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.85 -15.77 60.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.124 -0.489 . . . . 63.520000000000003 111.406 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -86.04 93.73 9.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.056 0.455 . . . . 73.530000000000001 109.972 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -87.59 -20.6 26.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 73.430000000000007 110.212 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.01 -58.54 2.39 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.959 -0.564 . . . . 63.32 111.149 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.53 -34.09 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.731 -0.668 . . . . 71.010000000000005 111.001 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.22 69.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.518 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.8 m -67.42 -40.95 85.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 72.420000000000002 110.627 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.16 -44.56 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 74.510000000000005 111.789 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -99.12 -4.19 32.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.833 0.308 . . . . 73.109999999999999 111.833 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.47 83.41 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.214 -0.517 . . . . 65.549999999999997 113.271 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.05 144.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.371 -0.603 . . . . 75.310000000000002 109.371 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.402 ' HB2' HG23 ' A' ' 112' ' ' ILE . 31.2 m -138.62 -63.72 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.691 0.281 . . . . 72.219999999999999 111.489 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.92 178.01 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 52.439999999999998 111.354 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 10.3 pt -112.35 116.2 48.95 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.46 -0.791 . . . . 75.510000000000005 110.87 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -92.02 -162.54 1.43 Allowed 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 124.219 -1.159 . . . . 64.140000000000001 111.947 -3.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.6 m -138.08 118.17 13.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.231 -0.441 . . . . 74.0 109.935 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mm -110.14 130.46 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.735 -0.666 . . . . 71.439999999999998 110.584 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' A' ' 110' ' ' GLN . 40.9 mt -107.18 143.98 34.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.926 -0.768 . . . . 72.510000000000005 108.926 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.545 ' SD ' HD22 ' A' ' 43' ' ' LEU . 3.2 mtt -109.92 149.48 29.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.117 0.417 . . . . 65.120000000000005 110.666 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.0 m-85 -146.82 162.03 39.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.789 -0.641 . . . . 74.140000000000001 109.472 175.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.583 ' HZ1' ' HB2' ' A' ' 103' ' ' LYS . 4.9 ttmp? -160.49 131.27 5.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.277 -0.268 . . . . 74.239999999999995 110.277 176.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.498 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 3.5 m-20 58.19 27.17 14.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.149 0.5 . . . . 72.219999999999999 110.58 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.43 27.93 71.95 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.836 -0.62 . . . . 43.109999999999999 112.266 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -126.83 149.6 49.63 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.491 -0.559 . . . . 63.039999999999999 109.491 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.56 ' O ' HD22 ' A' ' 108' ' ' LEU . 26.9 ttpt -68.75 143.91 54.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.747 0.784 . . . . 71.430000000000007 112.438 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 107' ' ' LYS . 1.4 mm? -144.68 169.3 18.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.841 -1.527 . . . . 72.319999999999993 108.379 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.62 173.71 5.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.773 0.797 . . . . 72.409999999999997 112.51 -162.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.1 tt0 -127.66 150.57 49.69 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.027 -0.988 . . . . 74.540000000000006 110.793 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.69 111.63 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 114.514 -1.221 . . . . 73.030000000000001 109.418 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.402 HG23 ' HB2' ' A' ' 94' ' ' SER . 60.1 mt -114.23 121.83 67.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.483 -0.326 . . . . 62.140000000000001 110.183 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.39 145.17 9.19 Favored Glycine 0 C--N 1.328 0.134 0 N-CA-C 111.76 -0.536 . . . . 60.32 111.76 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.14 72.19 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.13 0.491 . . . . 75.109999999999999 110.906 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -125.88 93.34 3.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.025 -0.731 . . . . 64.239999999999995 109.025 175.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.95 -25.09 34.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.334 -0.848 . . . . 62.149999999999999 111.511 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 t -67.67 -46.14 73.21 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.292 -0.633 . . . . 72.200000000000003 109.292 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.3 tptt -61.41 -45.88 92.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.619 -0.719 . . . . 55.140000000000001 109.744 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.588 HD12 HD21 ' A' ' 63' ' ' LEU . 69.9 mt -56.71 -56.09 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.062 -0.517 . . . . 72.120000000000005 111.292 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.0 -37.51 78.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 116.5 -0.318 . . . . 74.510000000000005 110.272 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.466 ' HA ' HD22 ' A' ' 124' ' ' ASN . 36.8 t -56.63 -51.53 68.33 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.164 -0.471 . . . . 52.409999999999997 109.898 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 20.9 mm-40 -58.58 -44.39 89.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.054 -0.521 . . . . 73.040000000000006 110.135 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.8 mt -54.4 -56.14 11.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.489 -0.323 . . . . 73.409999999999997 111.011 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.5 p30 -68.51 -33.05 73.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.486 -0.486 . . . . 70.219999999999999 110.56 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -68.48 -31.92 71.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.287 -0.415 . . . . 72.200000000000003 110.854 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.43 ' OD1' HD11 ' A' ' 108' ' ' LEU . 23.6 m-80 -90.86 -14.09 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.35 -0.386 . . . . 71.200000000000003 111.565 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.0 mt -81.52 -60.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.553 -0.536 . . . . 74.310000000000002 109.553 168.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.448 -0.787 . . . . 71.430000000000007 110.8 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.2 mmm . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.741 0.305 . . . . 71.319999999999993 110.943 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.442 HG23 ' HE2' ' A' ' 78' ' ' LYS . 26.7 mm -87.89 101.03 11.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.241 -0.651 . . . . 73.430000000000007 109.241 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 8.8 tp10 -64.47 122.68 17.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.296 0.569 . . . . 70.140000000000001 110.534 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -100.53 109.61 21.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 71.409999999999997 110.22 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.3 pt -119.51 166.78 13.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.733 -0.667 . . . . 73.540000000000006 111.275 -174.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.65 -158.59 33.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.687 -0.688 . . . . 75.430000000000007 112.111 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.11 -51.17 41.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.052 0.454 . . . . 65.030000000000001 111.55 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.4 t -69.5 -36.77 76.81 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.924 -0.58 . . . . 74.420000000000002 111.646 -172.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 1.9 mp0 -65.16 -14.99 61.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 75.540000000000006 111.97 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CD2' HD12 ' A' ' 79' ' ' ILE . 81.5 t80 -51.85 -61.27 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.717 0.294 . . . . 70.519999999999996 110.926 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.11 -44.97 83.78 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.421 . . . . 73.420000000000002 110.394 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -53.69 -57.76 9.65 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.725 0.774 . . . . 43.219999999999999 110.662 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG3' HG23 ' A' ' 26' ' ' ILE . 75.3 mmtt -64.75 -38.1 89.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.083 -0.962 . . . . 63.340000000000003 111.354 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.8 t -70.62 -35.54 61.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.44 -0.345 . . . . 74.140000000000001 110.823 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -81.88 -14.99 55.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.653 0.263 . . . . 53.409999999999997 111.126 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -66.07 2.52 1.1 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.208 0.448 . . . . 74.540000000000006 112.208 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.513 ' SG ' HD11 ' A' ' 44' ' ' ILE . 89.9 m -60.54 169.37 1.78 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.294 0.569 . . . . 71.299999999999997 112.041 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.03 -82.01 0.61 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.401 -0.818 . . . . 72.420000000000002 109.138 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -162.05 137.92 7.61 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.45 -0.574 . . . . 63.420000000000002 109.45 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 61.92 10.47 3.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.645 0.378 . . . . 72.450000000000003 111.408 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.76 108.18 17.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.263 -0.643 . . . . 70.510000000000005 109.263 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 68.0 tp -83.46 121.67 27.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.177 0.513 . . . . 72.329999999999998 110.699 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.513 HD11 ' SG ' ' A' ' 38' ' ' CYS . 27.9 mt -105.83 118.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 72.450000000000003 110.084 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.616 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 3.6 mp -104.28 114.29 28.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.885 -0.783 . . . . 73.209999999999994 108.885 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.2 t -102.86 104.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.374 -0.232 . . . . 72.450000000000003 110.374 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.448 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 18.8 t0 -76.6 129.04 35.86 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.179 -0.674 . . . . 62.130000000000003 109.179 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -83.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 65.219999999999999 111.047 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -167.6 151.21 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 74.340000000000003 110.9 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.57 97.13 6.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.624 -0.717 . . . . 54.329999999999998 109.513 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.68 -50.42 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.581 2.187 . . . . 64.329999999999998 112.17 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -130.98 123.36 28.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.332 -0.618 . . . . 73.150000000000006 109.332 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.2 t -163.26 136.74 5.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 63.299999999999997 110.873 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.534 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -86.76 -66.52 1.37 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.955 -0.566 . . . . 43.399999999999999 112.249 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.13 -26.79 52.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.165 2.577 . . . . 54.219999999999999 113.066 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 79.0 m -55.7 -23.55 29.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.482 -0.326 . . . . 71.349999999999994 111.866 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 12.2 ptm180 -54.34 -44.36 72.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.694 0.283 . . . . 74.439999999999998 110.504 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 18.6 m -75.5 -35.61 60.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.239 0.542 . . . . 74.230000000000004 110.79 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -64.83 -36.46 84.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.45 0.537 . . . . 64.099999999999994 112.45 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.8 tt0 -58.18 -58.9 15.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 120.351 -0.54 . . . . 65.120000000000005 110.363 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.25 -32.99 95.01 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.819 1.68 . . . . 64.230000000000004 112.435 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 58' ' ' SER . 46.4 mt-30 -63.4 -44.19 95.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.028 0.442 . . . . 75.209999999999994 110.377 176.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.77 -37.82 82.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.963 -0.562 . . . . 74.140000000000001 110.222 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 52.9 mt-10 -65.51 -36.17 83.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.281 -0.418 . . . . 65.510000000000005 110.26 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -56.53 -52.07 66.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.016 0.436 . . . . 74.540000000000006 109.848 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 HD13 ' A' ' 116' ' ' ILE . 27.0 mt -68.33 -31.32 70.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 74.510000000000005 109.634 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.57 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -70.85 -13.37 62.01 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.643 -0.708 . . . . 43.32 110.982 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -96.06 -50.83 4.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.295 -0.411 . . . . 74.129999999999995 110.861 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.24 -43.05 99.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.36 0.6 . . . . 75.409999999999997 110.793 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.53 5.35 47.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.303 -0.862 . . . . 75.219999999999999 111.494 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.3 t -52.83 -25.88 12.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.258 0.836 . . . . 72.120000000000005 113.258 -168.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.75 -19.0 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.615 0.245 . . . . 74.019999999999996 111.403 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.7 2.0 7.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.521 -0.309 . . . . 60.25 110.991 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.71 144.48 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.784 0.326 . . . . 74.219999999999999 111.324 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -147.05 119.89 8.67 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.275 -0.639 . . . . 72.219999999999999 109.275 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.02 132.11 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.803 0.335 . . . . 73.140000000000001 110.558 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 74.3 m-85 -122.08 166.02 15.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 73.109999999999999 109.475 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HZ3' ' CB ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -148.72 142.58 25.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.411 -0.359 . . . . 62.329999999999998 110.371 172.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' A' ' 31' ' ' PHE . 61.3 mt -102.02 103.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 75.129999999999995 109.231 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -84.1 12.72 5.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 60.109999999999999 111.306 -174.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm -78.3 78.87 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.021 -0.733 . . . . 65.230000000000004 109.021 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -18.48 43.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 64.209999999999994 112.622 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.5 -11.66 60.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.756 0.312 . . . . 63.520000000000003 111.537 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.76 51.21 1.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.194 0.521 . . . . 73.530000000000001 110.281 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -61.42 -61.86 2.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.56 -0.746 . . . . 73.430000000000007 110.841 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 7.7 m-20 -52.83 -36.98 59.47 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.421 -0.809 . . . . 63.32 111.031 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.01 -42.16 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 71.010000000000005 110.202 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.85 -51.57 64.03 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.954 -0.566 . . . . 74.239999999999995 110.269 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.6 m -62.09 -31.48 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 72.420000000000002 111.01 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 25.3 mm-40 -68.81 -51.78 37.15 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.495 -0.32 . . . . 74.510000000000005 110.872 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -76.22 -10.91 59.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.494 -0.321 . . . . 73.109999999999999 111.415 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.42 44.34 2.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.814 -0.708 . . . . 65.549999999999997 113.694 167.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 98' ' ' THR . 72.4 t -77.83 106.13 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.557 -0.534 . . . . 75.310000000000002 109.557 173.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.531 ' HB3' HG22 ' A' ' 112' ' ' ILE . 22.8 t -92.91 -40.24 10.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 72.219999999999999 110.536 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.85 158.19 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 52.439999999999998 110.233 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.698 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.61 140.95 22.15 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.45 . . . . 75.510000000000005 110.406 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.43 -179.35 24.48 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.06 -1.225 . . . . 64.140000000000001 111.529 -3.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 93' ' ' VAL . 93.7 m -139.78 116.42 10.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.926 0.393 . . . . 74.0 110.206 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.1 mm -109.8 110.82 33.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 71.439999999999998 110.8 -173.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 123.44 33.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.737 -0.468 . . . . 72.510000000000005 109.737 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.616 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 17.7 mmt -90.19 140.14 29.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.221 -0.445 . . . . 65.120000000000005 110.078 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.4 144.44 36.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.219 -0.66 . . . . 74.140000000000001 109.219 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -138.42 112.43 8.51 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.587 -0.445 . . . . 74.239999999999995 110.671 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.51 32.33 22.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.615 0.722 . . . . 72.219999999999999 110.453 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.51 68.25 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 115.684 -0.689 . . . . 43.109999999999999 112.649 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -83.12 143.59 30.44 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.777 -0.453 . . . . 63.039999999999999 109.777 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.436 ' O ' HD23 ' A' ' 108' ' ' LEU . 21.5 tptm -65.88 130.62 43.9 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.83 0.706 . . . . 71.430000000000007 111.013 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -131.39 168.94 16.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.581 -1.191 . . . . 72.319999999999993 109.19 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' MET . 1.3 m -69.55 176.19 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.309 0.576 . . . . 72.409999999999997 111.937 -163.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.49 131.53 29.82 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.856 0.836 . . . . 74.540000000000006 110.992 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.83 107.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.926 -1.488 . . . . 73.030000000000001 109.752 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 94' ' ' SER . 64.0 mt -102.77 121.87 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.046 -0.524 . . . . 62.140000000000001 110.108 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.01 149.97 18.04 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.954 -0.458 . . . . 60.32 111.954 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.76 85.97 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.682 0.277 . . . . 75.109999999999999 111.129 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.8 t70 -132.64 92.11 3.01 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.349 0.595 . . . . 64.239999999999995 109.822 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 66' ' ' LEU . 9.2 tp -59.31 -32.89 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.265 -0.88 . . . . 62.149999999999999 111.651 -174.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.8 t -64.17 -48.49 75.77 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.898 0.38 . . . . 72.200000000000003 110.055 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -62.09 -43.37 98.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.013 -0.54 . . . . 55.140000000000001 109.711 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 71.2 mt -58.4 -56.27 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.036 -0.529 . . . . 72.120000000000005 111.117 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.506 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.34 -35.04 67.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 120.758 0.313 . . . . 74.510000000000005 110.187 -177.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.451 ' HA ' HD22 ' A' ' 124' ' ' ASN . 23.2 t -58.04 -51.9 67.77 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.109 -0.496 . . . . 52.409999999999997 109.791 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -61.64 -37.57 84.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.116 -0.493 . . . . 73.040000000000006 110.876 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.8 mt -58.51 -55.95 19.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.3 -0.409 . . . . 73.409999999999997 110.92 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.1 p30 -67.94 -31.42 71.15 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.651 -0.419 . . . . 70.219999999999999 110.011 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -58.06 -43.6 87.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.756 -0.656 . . . . 72.200000000000003 110.566 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -78.26 -38.94 41.54 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.254 0.465 . . . . 71.200000000000003 112.254 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.6 mt -58.07 -47.75 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.372 . . . . 74.310000000000002 110.939 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.926 -0.559 . . . . 71.430000000000007 110.657 -176.519 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.7 mmm . . . . . 0 C--O 1.234 0.238 0 N-CA-C 108.831 -0.803 . . . . 71.319999999999993 108.831 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.621 HG22 ' HD2' ' A' ' 78' ' ' LYS . 17.9 mm -64.99 93.69 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.368 -0.975 . . . . 73.430000000000007 108.368 171.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 9.7 tp10 -52.27 144.31 12.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.469 0.652 . . . . 70.140000000000001 111.98 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -101.67 115.61 30.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.157 -0.929 . . . . 71.409999999999997 110.276 -176.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.475 HG23 ' HG3' ' A' ' 34' ' ' LYS . 50.6 pt -133.96 179.94 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.956 0.408 . . . . 73.540000000000006 110.911 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.34 -153.52 7.93 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.896 -0.593 . . . . 75.430000000000007 111.852 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.97 -53.18 22.1 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.404 0.282 . . . . 65.030000000000001 111.487 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -70.82 -29.96 66.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.828 0.347 . . . . 74.420000000000002 111.565 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 mp0 -72.36 -27.3 62.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.438 . . . . 75.540000000000006 111.009 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -51.89 -61.83 2.01 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.13 0.269 . . . . 70.519999999999996 111.192 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 36' ' ' THR . 9.2 t70 -51.09 -53.59 32.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.986 -0.552 . . . . 73.420000000000002 110.549 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -54.07 -57.28 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.131 -0.941 . . . . 43.219999999999999 111.31 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 77' ' ' TYR . 75.9 mmtt -62.28 -33.37 74.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 63.340000000000003 111.014 -175.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' HD11 ' A' ' 44' ' ' ILE . 21.7 t -69.09 -55.66 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 112.16 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 32' ' ' ASP . 10.2 t -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.383 0.512 . . . . 53.409999999999997 112.383 -170.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 t -75.81 2.57 11.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.135 0.42 . . . . 74.540000000000006 112.135 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.778 ' SG ' HD13 ' A' ' 44' ' ' ILE . 92.0 m -82.8 128.62 34.57 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.666 0.27 . . . . 71.299999999999997 110.49 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.29 -72.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.769 0.655 . . . . 72.420000000000002 112.769 -172.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.43 121.93 35.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 63.420000000000002 111.361 -166.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 58.21 11.19 1.47 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.625 -1.171 . . . . 72.450000000000003 113.395 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 47.9 mm -73.04 95.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.971 0.415 . . . . 70.510000000000005 110.072 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HB3' HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -71.0 110.38 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.857 -0.794 . . . . 72.329999999999998 108.857 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.778 HD13 ' SG ' ' A' ' 38' ' ' CYS . 86.4 mt -94.38 123.24 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.393 -0.822 . . . . 72.450000000000003 110.526 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.668 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.3 mp -110.11 109.75 20.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.242 -0.651 . . . . 73.209999999999994 109.242 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.06 105.16 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.028 -0.36 . . . . 72.450000000000003 110.028 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -81.01 147.66 30.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.382 -0.372 . . . . 62.130000000000003 110.215 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -87.91 115.65 25.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.36 . . . . 65.219999999999999 110.624 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.545 ' HE1' ' HA ' ' A' ' 82' ' ' GLU . 51.6 t-105 -56.35 115.37 2.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.813 -0.631 . . . . 74.340000000000003 110.844 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -111.86 107.88 56.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 54.329999999999998 110.089 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 18.9 Cg_endo -59.81 -21.59 64.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.537 2.158 . . . . 64.329999999999998 111.79 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -131.95 128.63 38.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.531 -0.758 . . . . 73.150000000000006 109.383 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 47.6 t -164.37 175.13 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.889 0.376 . . . . 63.299999999999997 110.694 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -136.58 -61.17 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.553 -0.748 . . . . 43.399999999999999 111.435 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.455 ' O ' HD23 ' A' ' 59' ' ' LEU . 52.7 Cg_exo -55.0 -26.03 47.51 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.005 2.47 . . . . 54.219999999999999 112.684 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 56.6 m -57.29 -28.57 63.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.978 -0.555 . . . . 71.349999999999994 111.476 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -53.59 -49.12 68.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.935 0.398 . . . . 74.439999999999998 111.594 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.4 m -75.3 -38.17 60.46 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.765 0.793 . . . . 74.230000000000004 110.95 177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 55' ' ' PRO . 4.4 mm? -73.71 -24.24 59.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.607 -0.724 . . . . 64.099999999999994 112.043 -172.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.5 mt-10 -59.56 -59.06 15.08 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.786 -0.449 . . . . 65.120000000000005 109.786 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.73 -34.46 31.51 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.819 1.679 . . . . 64.230000000000004 112.376 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.2 mt-30 -62.61 -42.7 99.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.145 -0.622 . . . . 75.209999999999994 110.97 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.604 HD23 HD13 ' A' ' 119' ' ' ILE . 67.6 mt -64.76 -38.62 91.6 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.48 -0.327 . . . . 74.140000000000001 110.132 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.0 mt-10 -58.11 -43.53 87.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 116.419 -0.355 . . . . 65.510000000000005 110.087 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -56.07 -53.43 57.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.093 -0.503 . . . . 74.540000000000006 111.09 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' A' ' 116' ' ' ILE . 34.8 mt -63.26 -37.29 86.67 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.639 -0.504 . . . . 74.510000000000005 109.639 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.18 -26.9 68.35 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.588 -0.733 . . . . 43.32 110.906 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.5 mt-30 -80.15 -48.83 12.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.819 0.342 . . . . 74.129999999999995 110.599 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -47.62 83.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.436 0.636 . . . . 75.409999999999997 109.806 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -90.54 4.47 51.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.294 -0.866 . . . . 75.219999999999999 112.416 -175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -53.16 -21.28 4.8 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.848 0.356 . . . . 72.120000000000005 111.664 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.35 -35.26 78.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 74.019999999999996 110.962 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -133.9 15.71 3.91 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.494 -0.321 . . . . 60.25 111.19 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 43' ' ' LEU . 41.9 t -135.29 139.69 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.071 0.462 . . . . 74.219999999999999 111.351 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 24' ' ' GLU . 61.0 tptt -145.25 119.81 9.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 72.219999999999999 109.14 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.668 HG12 ' HB2' ' A' ' 45' ' ' LEU . 29.2 mt -101.79 141.65 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.227 -0.286 . . . . 73.140000000000001 110.227 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 91.4 m-85 -130.22 161.25 31.59 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.55 0.34 . . . . 73.109999999999999 110.518 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.621 ' HD2' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -163.54 154.86 16.73 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 62.329999999999998 109.147 168.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 28.1 pt -79.53 152.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.394 -0.225 . . . . 75.129999999999995 110.394 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -107.26 6.62 28.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.626 0.25 . . . . 60.109999999999999 111.342 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.503 HD11 ' N ' ' A' ' 81' ' ' ILE . 3.0 mp -78.5 96.58 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 65.230000000000004 110.167 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.545 ' HA ' ' HE1' ' A' ' 49' ' ' TRP . 7.5 tm-20 -61.62 -26.8 68.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.946 -0.57 . . . . 64.209999999999994 110.333 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.72 -9.01 57.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.686 -0.688 . . . . 63.520000000000003 111.28 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -91.4 105.83 18.05 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.093 0.473 . . . . 73.530000000000001 111.155 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -121.54 -32.91 3.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 73.430000000000007 109.776 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.3 m-20 -49.51 -43.18 45.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.011 -0.995 . . . . 63.32 111.939 -173.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.2 -34.05 26.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.283 -0.417 . . . . 71.010000000000005 111.403 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.19 -49.23 78.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.15 0.5 . . . . 74.239999999999995 109.978 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 m -66.73 -35.49 80.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.437 -0.801 . . . . 72.420000000000002 110.642 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 72.8 mm-40 -61.34 -55.41 32.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.691 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.97 -11.87 51.91 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.462 -0.335 . . . . 73.109999999999999 111.815 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.59 42.28 14.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.75 -0.738 . . . . 65.549999999999997 112.354 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t -75.3 114.43 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.55 -0.537 . . . . 75.310000000000002 109.55 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -98.03 -74.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 72.219999999999999 111.05 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.74 136.44 33.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.76 0.314 . . . . 52.439999999999998 110.899 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.684 ' H ' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.67 151.98 46.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 75.510000000000005 109.845 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.86 169.35 64.19 Favored 'Cis proline' 0 C--N 1.354 0.836 0 C-N-CA 124.157 -1.184 . . . . 64.140000000000001 112.921 1.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 112' ' ' ILE . 89.0 m -139.02 114.13 9.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.715 -0.675 . . . . 74.0 109.879 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 32.4 mm -109.79 110.7 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 71.439999999999998 111.012 -173.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -97.83 123.36 41.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.745 -0.835 . . . . 72.510000000000005 108.745 171.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.446 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 37.9 mtt -93.43 150.83 20.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.965 0.412 . . . . 65.120000000000005 110.923 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.7 m-85 -143.33 153.82 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.416 -0.957 . . . . 74.140000000000001 108.416 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -150.91 115.3 5.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 74.239999999999995 110.62 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.76 25.38 15.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.663 0.744 . . . . 72.219999999999999 110.171 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.29 -0.42 87.2 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.636 -0.711 . . . . 43.109999999999999 112.276 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -91.68 145.21 24.77 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 122.812 -0.228 . . . . 63.039999999999999 110.819 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -63.31 132.51 51.83 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.916 0.76 . . . . 71.430000000000007 110.765 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 1.2 mm? -137.19 169.43 17.79 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 125.036 1.334 . . . . 72.319999999999993 108.788 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.25 172.18 7.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.459 0.54 . . . . 72.409999999999997 112.459 -162.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -140.14 126.04 19.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.081 -0.508 . . . . 74.540000000000006 110.605 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.1 m -115.3 122.47 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.191 0.519 . . . . 73.030000000000001 110.422 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 98' ' ' THR . 51.3 mt -108.18 140.56 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.718 -0.674 . . . . 62.140000000000001 109.485 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.12 157.49 32.45 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.991 -0.623 . . . . 60.32 112.13 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.46 97.3 9.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.927 0.343 . . . . 75.109999999999999 111.927 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.9 t0 -146.1 104.27 3.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.317 0.579 . . . . 64.239999999999995 110.677 169.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 62' ' ' GLN . 8.7 tp -59.13 -32.97 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.148 -0.933 . . . . 62.149999999999999 110.809 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.0 m -67.91 -48.56 65.66 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.196 -0.456 . . . . 72.200000000000003 111.14 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -60.51 -47.66 85.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.374 -0.375 . . . . 55.140000000000001 110.301 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.604 HD13 HD23 ' A' ' 63' ' ' LEU . 78.5 mt -57.9 -55.56 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 72.120000000000005 111.081 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.427 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.86 -36.97 75.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.907 -0.405 . . . . 74.510000000000005 109.907 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -57.16 -52.02 66.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.847 -0.615 . . . . 52.409999999999997 110.082 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.86 -40.31 96.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.314 -0.403 . . . . 73.040000000000006 110.383 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.7 mt -55.32 -56.05 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.556 -0.293 . . . . 73.409999999999997 110.691 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.2 -30.65 66.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.624 -0.431 . . . . 70.219999999999999 110.007 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.53 -34.43 76.9 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.907 -0.588 . . . . 72.200000000000003 111.214 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.437 ' HB2' HD13 ' A' ' 43' ' ' LEU . 89.4 m-20 -92.62 -30.36 15.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 71.200000000000003 112.006 -175.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.431 HD12 ' CG2' ' A' ' 74' ' ' VAL . 79.0 mt -67.81 -51.6 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 74.310000000000002 110.253 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.9 m120 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.527 -0.76 . . . . 71.430000000000007 110.515 -175.816 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 85.1 mmm . . . . . 0 C--O 1.232 0.153 0 N-CA-C 109.929 -0.397 . . . . 71.319999999999993 109.929 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.14 113.27 10.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.705 -0.679 . . . . 73.430000000000007 109.862 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.456 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 3.5 tp10 -81.72 126.41 31.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.036 0.446 . . . . 70.140000000000001 111.166 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -80.35 119.37 22.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.804 -0.635 . . . . 71.409999999999997 109.697 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.3 pt -126.69 146.47 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.158 0.504 . . . . 73.540000000000006 111.726 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.44 -162.61 26.26 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.221 -0.899 . . . . 75.430000000000007 111.522 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.94 -55.46 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.717 0.294 . . . . 65.030000000000001 110.98 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 m -61.58 -37.73 84.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.265 0.555 . . . . 74.420000000000002 110.644 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -65.33 -36.65 84.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.518 -0.765 . . . . 75.540000000000006 111.573 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.421 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.9 t80 -51.97 -61.69 2.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.732 0.271 . . . . 70.519999999999996 111.732 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -55.66 -46.67 77.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.099 0.476 . . . . 73.420000000000002 110.853 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.97 -57.22 13.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.611 -0.722 . . . . 43.219999999999999 110.88 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 33.7 mmtp -61.8 -32.48 72.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 63.340000000000003 111.369 -175.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 31' ' ' PHE . 76.8 t -72.51 -48.11 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.716 0.293 . . . . 74.140000000000001 110.808 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.0 p -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 53.409999999999997 110.97 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.4 t -65.84 -4.1 6.16 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.17 -0.468 . . . . 74.540000000000006 112.06 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.5 p -65.29 112.77 3.63 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.298 -0.251 . . . . 71.299999999999997 110.788 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.37 -77.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 72.420000000000002 111.059 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -147.63 129.06 14.89 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.627 0.251 . . . . 63.420000000000002 110.851 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 52.33 21.48 1.71 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.84 -0.618 . . . . 72.450000000000003 112.045 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.0 111.09 14.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.349 -0.387 . . . . 70.510000000000005 109.989 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.4 tp -77.26 107.0 9.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.323 0.582 . . . . 72.329999999999998 110.113 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 101' ' ' MET . 27.4 mt -95.05 120.7 44.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.529 -0.76 . . . . 72.450000000000003 110.672 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.548 HD11 HG12 ' A' ' 74' ' ' VAL . 5.8 mp -105.83 123.59 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.327 -0.62 . . . . 73.209999999999994 109.327 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.58 106.8 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.228 -0.286 . . . . 72.450000000000003 110.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.69 132.53 41.75 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.845 0.355 . . . . 62.130000000000003 110.21 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -89.12 62.78 6.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.487 . . . . 65.219999999999999 110.9 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.437 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 11.9 t90 70.68 -70.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.575 -0.739 . . . . 74.340000000000003 112.173 171.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 64.59 74.21 0.42 Allowed Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 123.13 0.572 . . . . 54.329999999999998 111.495 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HG2' ' H ' ' A' ' 52' ' ' TRP . 83.2 Cg_endo -88.5 -66.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.85 2.367 . . . . 64.329999999999998 113.833 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' H ' ' HG2' ' A' ' 51' ' ' PRO . 83.7 m95 -85.56 79.43 9.39 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.826 0.346 . . . . 73.150000000000006 110.96 -174.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.5 p -171.38 139.08 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.571 . . . . 63.299999999999997 110.276 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -75.7 -66.22 1.92 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 116.008 -0.542 . . . . 43.399999999999999 112.556 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.82 -28.6 4.95 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.337 2.691 . . . . 54.219999999999999 113.686 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.472 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 81.5 m -52.96 -34.92 58.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.571 -0.286 . . . . 71.349999999999994 111.668 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 17.5 ptm180 -59.63 -38.01 80.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.585 -0.279 . . . . 74.439999999999998 110.56 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.5 t -75.21 -37.94 60.93 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.423 0.63 . . . . 74.230000000000004 110.319 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.3 mm? -61.24 -34.85 75.81 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 64.099999999999994 111.877 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.72 -58.3 20.47 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.313 -0.375 . . . . 65.120000000000005 111.262 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.67 -30.67 85.71 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.859 1.706 . . . . 64.230000000000004 111.909 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -63.32 -39.95 95.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.596 -0.442 . . . . 75.209999999999994 109.896 174.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 119' ' ' ILE . 82.7 mt -69.85 -35.81 75.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.977 -0.556 . . . . 74.140000000000001 110.093 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 75.8 mt-10 -59.24 -42.59 91.46 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.118 -0.492 . . . . 65.510000000000005 109.97 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -58.11 -54.28 48.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.226 -0.443 . . . . 74.540000000000006 110.461 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 123' ' ' ILE . 56.6 mt -62.17 -30.56 71.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.883 0.373 . . . . 74.510000000000005 110.038 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -69.67 -41.82 74.98 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.89 -0.596 . . . . 43.32 110.628 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.3 mt-30 -70.59 -40.46 73.22 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.04 0.447 . . . . 74.129999999999995 110.72 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -75.66 -35.82 60.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.805 -0.634 . . . . 75.409999999999997 111.012 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.7 5.35 36.21 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.018 -0.537 . . . . 75.219999999999999 112.006 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.8 t -52.44 -18.99 1.9 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.994 0.517 . . . . 72.120000000000005 112.167 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.97 -35.84 64.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.312 -0.404 . . . . 74.019999999999996 111.13 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -133.87 -11.16 2.66 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.717 0.266 . . . . 60.25 111.717 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.548 HG12 HD11 ' A' ' 45' ' ' LEU . 55.2 t -105.35 141.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.032 0.444 . . . . 74.219999999999999 112.047 -172.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -144.56 121.93 11.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 72.219999999999999 109.02 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.7 mt -109.93 143.36 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.012 0.434 . . . . 73.140000000000001 111.51 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 90.7 m-85 -126.73 172.87 9.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.629 -0.714 . . . . 73.109999999999999 110.438 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 49' ' ' TRP . 14.2 tppt? -138.73 115.85 10.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 62.329999999999998 110.418 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.65 99.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.051 -0.722 . . . . 75.129999999999995 109.051 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -108.37 30.81 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 60.109999999999999 111.023 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.71 74.25 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.443 -0.577 . . . . 65.230000000000004 109.443 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -35.58 25.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.137 -0.938 . . . . 64.209999999999994 112.54 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.58 -35.89 70.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 63.520000000000003 111.144 -176.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -93.86 42.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.697 0.761 . . . . 73.530000000000001 110.446 -171.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.38 -15.45 60.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.246 -0.888 . . . . 73.430000000000007 110.491 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.09 -33.91 58.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.757 -0.656 . . . . 63.32 111.086 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.6 t -56.21 -34.41 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.795 -0.639 . . . . 71.010000000000005 110.874 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.01 75.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.09 -0.505 . . . . 74.239999999999995 110.648 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -64.35 -41.76 96.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.963 -0.562 . . . . 72.420000000000002 110.562 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -63.69 -53.19 55.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.143 -0.48 . . . . 74.510000000000005 111.371 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.42 -18.06 60.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 73.109999999999999 111.106 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.74 55.67 3.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.988 -0.625 . . . . 65.549999999999997 112.507 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -69.53 106.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.559 -0.534 . . . . 75.310000000000002 109.559 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.42 ' HB3' HG23 ' A' ' 112' ' ' ILE . 23.3 t -65.72 -56.93 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.984 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.94 27.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.679 0.276 . . . . 52.439999999999998 110.682 -177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 pt -95.16 149.31 36.03 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.873 -0.603 . . . . 75.510000000000005 110.602 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.472 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.2 Cg_exo -71.01 170.46 63.79 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.147 -1.189 . . . . 64.140000000000001 112.516 -1.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.3 m -139.55 125.75 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.649 -0.5 . . . . 74.0 109.649 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.37 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 71.439999999999998 110.796 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -88.81 123.12 32.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.423 -0.584 . . . . 72.510000000000005 109.423 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 43.2 mtt -102.08 142.24 33.65 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.305 0.502 . . . . 65.120000000000005 111.32 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.57 144.96 33.11 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.478 -0.934 . . . . 74.140000000000001 108.478 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -146.42 115.97 7.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.457 -0.497 . . . . 74.239999999999995 111.342 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 62.58 25.72 15.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.823 -0.626 . . . . 72.219999999999999 110.54 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.83 -7.97 80.72 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.804 -0.635 . . . . 43.109999999999999 112.658 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -85.46 151.26 24.11 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 122.3 0.24 . . . . 63.039999999999999 110.952 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -77.56 116.95 18.53 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.558 0.694 . . . . 71.430000000000007 109.972 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.05 168.85 9.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.534 -1.212 . . . . 72.319999999999993 110.377 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.3 OUTLIER -70.08 -177.21 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 72.409999999999997 111.863 -162.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -147.49 147.12 29.83 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.681 0.753 . . . . 74.540000000000006 111.019 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.5 t -122.8 135.43 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 114.066 -1.424 . . . . 73.030000000000001 109.698 -174.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 94' ' ' SER . 65.5 mt -123.68 127.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.559 -0.291 . . . . 62.140000000000001 110.414 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.76 162.31 38.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.216 -0.516 . . . . 60.32 112.415 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.56 78.58 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.931 0.396 . . . . 75.109999999999999 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 119' ' ' ILE . 43.3 t0 -126.38 91.41 3.36 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.048 0.451 . . . . 64.239999999999995 109.799 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.412 HD11 HD11 ' A' ' 66' ' ' LEU . 9.0 tp -61.89 -27.5 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.605 -0.725 . . . . 62.149999999999999 110.654 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -69.87 -44.62 69.44 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.197 -0.456 . . . . 72.200000000000003 109.828 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -67.24 -38.96 86.07 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.69 -0.485 . . . . 55.140000000000001 109.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 115' ' ' ASP . 76.3 mt -60.32 -56.1 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.067 -0.515 . . . . 72.120000000000005 110.954 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -39.83 86.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.774 0.321 . . . . 74.510000000000005 110.197 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.443 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 32.9 t -56.74 -47.58 79.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.151 -0.477 . . . . 52.409999999999997 109.862 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -66.43 -40.83 89.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 73.040000000000006 110.793 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.9 mt -54.41 -56.18 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.79 -0.364 . . . . 73.409999999999997 110.125 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 121' ' ' SER . 8.6 p30 -67.42 -39.19 85.45 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.49 -0.484 . . . . 70.219999999999999 110.388 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.29 -38.4 90.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 72.200000000000003 111.86 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -83.15 -21.25 33.62 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.713 -0.221 . . . . 71.200000000000003 110.798 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.4 mt -72.4 -48.43 47.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.831 -0.433 . . . . 74.310000000000002 109.831 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.508 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.659 -0.686 . . . . 71.430000000000007 110.901 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.411 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 83.4 mmm . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 120.704 0.288 . . . . 71.319999999999993 111.279 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -75.17 112.26 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 73.430000000000007 110.108 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 7.6 tp10 -71.07 150.27 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 70.140000000000001 110.74 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -118.06 126.63 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 71.409999999999997 110.567 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 31' ' ' PHE . 24.9 pt -143.13 166.63 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 111.16 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.87 -164.38 27.93 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.909 -0.587 . . . . 75.430000000000007 112.561 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' N ' HD13 ' A' ' 81' ' ' ILE . 12.3 t70 -69.12 -57.04 5.93 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.821 0.344 . . . . 65.030000000000001 111.361 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.35 -0.386 . . . . 74.420000000000002 110.236 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.86 -31.39 70.3 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.540000000000006 110.569 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.505 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.7 t80 -52.85 -60.12 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.074 0.464 . . . . 70.519999999999996 110.009 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.46 -45.91 73.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 73.420000000000002 110.848 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -66.39 -57.36 7.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 43.219999999999999 111.613 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG3' HG21 ' A' ' 26' ' ' ILE . 46.8 mmtm -60.52 -31.14 70.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.683 . . . . 63.340000000000003 111.214 -176.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 31' ' ' PHE . 68.1 t -73.43 -44.75 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.687 -0.233 . . . . 74.140000000000001 110.663 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.9 p -72.11 -14.62 61.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.995 0.426 . . . . 53.409999999999997 110.966 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.9 t -71.24 0.53 7.72 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.834 -0.621 . . . . 74.540000000000006 111.351 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.0 p -58.65 120.3 8.66 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.698 0.285 . . . . 71.299999999999997 110.739 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -67.65 -73.35 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.402 -0.363 . . . . 72.420000000000002 111.152 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -156.77 125.62 5.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.361 -0.381 . . . . 63.420000000000002 110.449 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 59.49 5.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.623 0.601 . . . . 72.450000000000003 112.623 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 73' ' ' ASN . 40.0 mm -68.13 112.72 3.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 70.510000000000005 110.73 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.1 tt -80.34 120.87 24.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.831 -0.803 . . . . 72.329999999999998 108.831 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.96 114.16 46.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.459 -0.791 . . . . 72.450000000000003 110.472 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.604 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.0 mp -101.93 137.36 40.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.587 -0.894 . . . . 73.209999999999994 108.587 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -124.74 110.44 25.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 110.21 -0.293 . . . . 72.450000000000003 110.21 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.51 122.16 22.64 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.53 -0.544 . . . . 62.130000000000003 109.53 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.429 ' HE2' HG12 ' A' ' 87' ' ' VAL . 37.4 t80 -69.11 -74.7 0.12 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.573 -0.528 . . . . 65.219999999999999 109.573 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.635 ' HZ3' ' HA ' ' A' ' 80' ' ' ASN . 8.5 t-105 -171.89 160.53 5.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.15 -0.477 . . . . 74.340000000000003 109.861 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.612 ' HB1' ' SG ' ' A' ' 53' ' ' CYS . . . -164.37 96.3 0.94 Allowed Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.276 0.36 . . . . 54.329999999999998 110.538 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.74 -77.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.936 2.424 . . . . 64.329999999999998 112.063 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -98.69 90.88 4.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.783 -0.451 . . . . 73.150000000000006 109.783 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' ' HB1' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -134.53 -58.75 0.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.652 -0.703 . . . . 63.299999999999997 110.78 -178.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.52 -85.83 0.4 Allowed Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.028 -0.606 . . . . 43.399999999999999 112.574 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.68 -22.04 42.23 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.999 2.466 . . . . 54.219999999999999 111.876 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.5 p -52.72 -33.27 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.621 -0.718 . . . . 71.349999999999994 110.986 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -60.65 -36.2 78.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.375 0.607 . . . . 74.439999999999998 110.041 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.8 m -74.56 -35.87 63.08 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.824 0.821 . . . . 74.230000000000004 110.042 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.5 mm? -65.59 -22.1 66.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.232 -0.895 . . . . 64.099999999999994 111.464 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.506 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 44.0 mt-10 -57.92 -62.23 5.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.969 -0.382 . . . . 65.120000000000005 109.969 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.506 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 40.0 Cg_endo -67.08 -31.55 36.49 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 121.891 1.727 . . . . 64.230000000000004 112.079 176.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.551 ' OE1' ' HB ' ' A' ' 116' ' ' ILE . 79.5 mt-30 -60.3 -45.79 92.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.054 0.455 . . . . 75.209999999999994 110.824 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 HD22 HD11 ' A' ' 119' ' ' ILE . 73.4 mt -64.75 -40.78 95.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.127 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 30.0 mt-10 -57.57 -43.78 84.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.433 -0.349 . . . . 65.510000000000005 110.323 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.735 ' HB2' ' HZ3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -51.71 -57.22 9.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.008 -0.542 . . . . 74.540000000000006 110.688 178.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.466 HD12 HD12 ' A' ' 116' ' ' ILE . 19.7 mt -64.88 -34.92 79.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.941 -0.572 . . . . 74.510000000000005 109.654 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.545 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -66.58 -27.96 68.14 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.694 -0.684 . . . . 43.32 111.355 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.3 mt-30 -85.22 -37.11 20.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.832 0.349 . . . . 74.129999999999995 110.847 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.85 -37.99 70.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 75.409999999999997 110.953 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -104.89 5.89 33.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.577 -0.738 . . . . 75.219999999999999 111.925 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -22.66 5.5 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.578 0.955 . . . . 72.120000000000005 113.578 -169.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -77.42 -18.81 56.92 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.288 -0.258 . . . . 74.019999999999996 111.362 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.459 ' HA ' HD12 ' A' ' 42' ' ' ILE . 6.3 t30 -134.34 6.68 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.499 -0.319 . . . . 60.25 110.826 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 43' ' ' LEU . 54.6 t -139.13 139.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.71 0.29 . . . . 74.219999999999999 110.879 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 20.6 tptm -142.46 123.0 14.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 109.757 173.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' A' ' 45' ' ' LEU . 54.7 mt -98.08 125.39 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 73.140000000000001 110.508 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 62.3 m-85 -111.27 174.39 5.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.395 -0.594 . . . . 73.109999999999999 109.395 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.881 ' HZ2' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -156.08 152.71 28.34 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.295 -0.631 . . . . 62.329999999999998 109.295 167.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 34.4 pt -106.26 172.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.765 0.317 . . . . 75.129999999999995 111.016 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.635 ' HA ' ' HZ3' ' A' ' 49' ' ' TRP . 12.8 m120 -113.04 -90.19 0.52 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.961 -0.563 . . . . 60.109999999999999 109.523 171.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 81' ' ' ILE . 19.8 mm 52.69 23.26 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.075 0.464 . . . . 65.230000000000004 111.488 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -47.83 -28.48 2.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.401 0.68 . . . . 64.209999999999994 111.951 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -72.25 -35.66 68.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.783 -0.644 . . . . 63.520000000000003 111.592 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.21 99.16 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 73.530000000000001 110.681 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -73.33 6.56 2.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.971 -0.559 . . . . 73.430000000000007 111.68 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -45.19 -40.07 6.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.117 -0.492 . . . . 63.32 110.744 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG12 ' HE2' ' A' ' 48' ' ' PHE . 37.0 t -61.51 -39.9 84.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.679 -0.692 . . . . 71.010000000000005 110.703 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.37 -46.2 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.259 0.552 . . . . 74.239999999999995 110.076 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.5 m -67.38 -39.47 85.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.142 -0.935 . . . . 72.420000000000002 111.22 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -67.09 -43.04 83.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.351 -0.386 . . . . 74.510000000000005 111.625 -177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -92.58 -12.27 32.18 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.703 0.26 . . . . 73.109999999999999 111.703 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.3 45.52 6.52 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.951 -0.642 . . . . 65.549999999999997 113.562 171.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.33 128.52 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.063 -0.347 . . . . 75.310000000000002 110.063 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 -16.66 7.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.489 -0.323 . . . . 72.219999999999999 111.071 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.4 168.44 25.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.421 -0.354 . . . . 52.439999999999998 110.104 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.1 pp -127.84 140.14 37.3 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.514 -0.312 . . . . 75.510000000000005 110.672 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 96.4 Cg_endo -78.78 -176.02 17.85 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 123.875 -1.302 . . . . 64.140000000000001 112.919 -0.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 m -147.6 124.5 11.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.686 -0.688 . . . . 74.0 109.638 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.7 mm -109.82 111.08 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.557 -0.292 . . . . 71.439999999999998 110.54 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 110' ' ' GLN . 1.9 mm? -88.12 123.5 32.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 72.510000000000005 109.283 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' A' ' 122' ' ' GLU . 26.3 mtt -103.36 142.12 34.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.729 0.299 . . . . 65.120000000000005 110.662 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -140.06 142.78 36.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.214 -0.662 . . . . 74.140000000000001 109.214 172.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 23.6 tptm -124.08 104.06 8.65 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.08 -0.248 . . . . 74.239999999999995 110.94 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.756 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.3 t30 40.8 40.69 1.02 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.967 0.507 . . . . 72.219999999999999 112.28 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.99 53.03 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.169 -0.539 . . . . 43.109999999999999 113.214 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -120.79 148.94 43.32 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 122.935 0.494 . . . . 63.039999999999999 109.846 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.602 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.4 tmtt? -64.48 130.36 43.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.292 0.568 . . . . 71.430000000000007 109.752 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.602 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -136.29 167.79 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.148 -0.933 . . . . 72.319999999999993 109.244 -173.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' MET . 8.9 m -70.69 179.44 2.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.714 0.768 . . . . 72.409999999999997 112.731 -165.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.497 ' HG3' HD13 ' A' ' 100' ' ' LEU . 50.2 tt0 -148.78 131.97 16.41 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.233 -0.894 . . . . 74.540000000000006 109.963 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.57 113.87 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.55 -1.204 . . . . 73.030000000000001 109.995 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.0 mm -97.8 120.65 47.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.081 -0.508 . . . . 62.140000000000001 109.979 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.12 -173.19 30.09 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.657 -0.577 . . . . 60.32 111.657 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.45 98.41 7.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.647 0.26 . . . . 75.109999999999999 111.059 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -142.32 101.68 3.95 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.067 0.461 . . . . 64.239999999999995 110.482 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.551 ' HB ' ' OE1' ' A' ' 62' ' ' GLN . 11.4 tp -66.0 -30.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 62.149999999999999 110.853 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.1 t -58.67 -50.63 73.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.16 0.505 . . . . 72.200000000000003 110.009 176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -63.77 -46.78 83.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.65 -0.704 . . . . 55.140000000000001 110.515 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.464 HD11 HD22 ' A' ' 63' ' ' LEU . 77.0 mt -57.17 -56.3 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.288 -0.415 . . . . 72.120000000000005 111.19 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.438 HD11 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.16 -38.91 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.893 -0.41 . . . . 74.510000000000005 109.893 -177.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.405 ' HA ' HD22 ' A' ' 124' ' ' ASN . 22.2 t -57.21 -51.25 70.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.174 -0.466 . . . . 52.409999999999997 110.047 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.563 ' HB2' ' HE1' ' A' ' 101' ' ' MET . 65.8 mm-40 -63.0 -40.53 98.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 73.040000000000006 110.772 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.441 HD12 HD13 ' A' ' 66' ' ' LEU . 96.8 mt -56.98 -56.68 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.992 -0.283 . . . . 73.409999999999997 111.001 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 121' ' ' SER . 8.1 p30 -69.36 -35.98 76.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.872 0.368 . . . . 70.219999999999999 110.232 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.95 -36.61 84.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 72.200000000000003 110.961 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -95.73 -9.18 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 71.200000000000003 111.54 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.425 HD11 ' CG2' ' A' ' 74' ' ' VAL . 78.1 mt -82.83 -44.27 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.311 0.577 . . . . 74.310000000000002 109.773 165.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.547 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-N 115.502 -0.772 . . . . 71.430000000000007 110.424 -177.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.518 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.1 mmm . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 112.002 0.371 . . . . 71.319999999999993 112.002 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.527 HG23 ' HG2' ' A' ' 78' ' ' LYS . 10.8 mm -67.04 130.93 32.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 120.679 0.276 . . . . 73.430000000000007 110.771 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 78' ' ' LYS . 2.6 pt-20 -105.39 161.28 14.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.848 -0.427 . . . . 70.140000000000001 109.848 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -118.35 147.01 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.457 0.17 . . . . 71.409999999999997 110.772 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 pt -139.41 156.38 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.784 0.326 . . . . 73.540000000000006 110.823 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.1 179.01 48.31 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.908 -0.587 . . . . 75.430000000000007 112.492 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.58 -44.97 96.03 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.957 0.408 . . . . 65.030000000000001 111.342 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -65.08 -30.15 71.09 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.295 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -80.96 -20.31 42.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.836 -0.62 . . . . 75.540000000000006 111.474 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 35' ' ' VAL . 87.1 t80 -57.63 -61.91 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.482 0.182 . . . . 70.519999999999996 111.138 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.78 -44.6 96.58 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.071 0.462 . . . . 73.420000000000002 110.237 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -53.62 -57.53 10.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.262 -0.881 . . . . 43.219999999999999 110.998 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -62.01 -43.64 98.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.223 -0.444 . . . . 63.340000000000003 111.162 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.658 HG11 ' HA2' ' A' ' 105' ' ' GLY . 73.9 t -62.67 -36.93 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.34 -0.391 . . . . 74.140000000000001 111.524 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -86.43 -29.2 23.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.047 0.388 . . . . 53.409999999999997 112.047 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -83.76 11.06 8.03 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.363 0.505 . . . . 74.540000000000006 112.363 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.2 p -59.4 143.89 48.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.244 -0.28 . . . . 71.299999999999997 110.244 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.4 -74.12 0.06 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.634 0.254 . . . . 72.420000000000002 110.715 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -161.74 126.22 3.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 63.420000000000002 110.159 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 57.05 12.27 1.21 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.672 0.619 . . . . 72.450000000000003 112.672 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 51.1 mm -64.09 117.89 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.519 -0.549 . . . . 70.510000000000005 109.519 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.1 112.2 13.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 72.329999999999998 110.105 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 38' ' ' CYS . 72.4 mt -98.7 105.64 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.001 -0.545 . . . . 72.450000000000003 110.634 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.552 HD11 HG11 ' A' ' 74' ' ' VAL . 5.1 mp -90.51 116.29 28.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.082 -0.71 . . . . 73.209999999999994 109.082 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.72 105.26 18.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.768 -0.456 . . . . 72.450000000000003 109.768 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 56.5 t0 -84.28 123.24 29.93 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.854 -0.612 . . . . 62.130000000000003 110.381 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 100' ' ' LEU . 76.8 m-85 -102.9 125.3 49.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 65.219999999999999 110.592 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -117.35 148.32 41.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.03 -0.532 . . . . 74.340000000000003 111.103 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . -109.25 -178.19 0.54 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.093 -0.958 . . . . 54.329999999999998 109.245 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.638 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 85.6 Cg_exo -46.15 -26.6 3.83 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.515 2.143 . . . . 64.329999999999998 112.628 173.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -142.81 178.9 7.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.715 . . . . 73.150000000000006 109.648 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.611 ' HA ' HG12 ' A' ' 96' ' ' ILE . 14.1 p -157.8 165.4 35.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.426 -0.213 . . . . 63.299999999999997 110.426 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.52 -108.15 1.05 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.217 -0.516 . . . . 43.399999999999999 113.374 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.426 ' O ' HD22 ' A' ' 59' ' ' LEU . 95.1 Cg_endo -80.65 45.52 2.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.257 2.638 . . . . 54.219999999999999 113.514 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.457 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 95.9 m -65.33 -22.63 66.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.464 -0.334 . . . . 71.349999999999994 111.85 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 57' ' ' ARG . 35.0 ttt180 -54.06 -60.92 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.61 0.243 . . . . 74.439999999999998 111.458 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.4 m -75.58 -41.6 54.2 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.408 0.623 . . . . 74.230000000000004 111.615 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.463 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -67.84 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.881 0.697 . . . . 64.099999999999994 112.881 -169.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 42.5 mt-10 -59.54 -60.48 10.43 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 120.225 -0.59 . . . . 65.120000000000005 110.286 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.82 -36.53 96.87 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.615 1.543 . . . . 64.230000000000004 112.007 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -60.73 -47.01 88.24 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.805 -0.358 . . . . 75.209999999999994 110.86 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 119' ' ' ILE . 91.9 mt -67.4 -41.01 85.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 74.140000000000001 110.618 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 31.5 mt-10 -69.5 -24.18 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 65.510000000000005 110.712 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -68.43 -49.83 57.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.239 -0.282 . . . . 74.540000000000006 110.239 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.434 HD12 HD13 ' A' ' 123' ' ' ILE . 51.5 mt -62.54 -30.98 71.7 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.685 -0.487 . . . . 74.510000000000005 109.685 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.76 -51.55 64.34 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.927 -0.579 . . . . 43.32 109.772 173.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.518 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 35.7 mm-40 -51.97 -48.77 64.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 111.259 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -76.15 -36.8 58.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.744 -0.662 . . . . 75.409999999999997 111.577 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -104.53 3.88 32.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.989 0.737 . . . . 75.219999999999999 112.989 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.6 t -53.82 -19.43 4.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.934 0.397 . . . . 72.120000000000005 112.019 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.39 -24.18 64.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 74.019999999999996 111.168 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -134.48 1.19 3.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.347 -0.388 . . . . 60.25 110.781 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.552 HG11 HD11 ' A' ' 45' ' ' LEU . 5.2 t -127.32 138.75 53.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.851 0.357 . . . . 74.219999999999999 111.381 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -134.57 129.71 35.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.404 -0.961 . . . . 72.219999999999999 108.404 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 45' ' ' LEU . 17.1 mt -119.67 115.89 48.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.14 0.495 . . . . 73.140000000000001 110.778 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 87.3 m-85 -106.17 151.64 24.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 73.109999999999999 110.871 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HG2' HG23 ' A' ' 23' ' ' ILE . 61.0 mmtt -109.43 125.78 52.78 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.331 -0.849 . . . . 62.329999999999998 109.742 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -93.98 67.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.989 -1.486 . . . . 75.129999999999995 106.989 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.54 89.52 6.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.227 -0.897 . . . . 60.109999999999999 110.854 -171.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.44 112.94 20.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.542 -0.91 . . . . 65.230000000000004 108.542 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -18.15 58.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 64.209999999999994 110.948 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -83.68 17.02 2.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.566 -0.288 . . . . 63.520000000000003 111.753 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -76.25 52.37 0.75 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.856 0.687 . . . . 73.530000000000001 112.856 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -82.73 -61.14 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.765 -0.828 . . . . 73.430000000000007 108.765 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.2 m-20 -48.66 -49.18 38.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.988 -1.005 . . . . 63.32 110.985 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.49 -36.85 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 71.010000000000005 110.628 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.22 75.39 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.864 -0.421 . . . . 74.239999999999995 109.864 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 72.420000000000002 110.669 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.4 mm100 -75.03 -48.49 23.75 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.963 -0.562 . . . . 74.510000000000005 111.167 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.56 -10.27 52.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.381 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.34 56.11 11.0 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.109 -0.567 . . . . 65.549999999999997 111.887 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.4 t -77.25 109.37 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 75.310000000000002 110.468 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.445 ' HB2' HG21 ' A' ' 112' ' ' ILE . 12.1 m -63.27 -54.08 42.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.277 -0.419 . . . . 72.219999999999999 111.186 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.31 138.92 18.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 52.439999999999998 110.488 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.756 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.31 147.43 33.11 Favored Pre-proline 0 C--O 1.236 0.377 0 O-C-N 123.364 0.415 . . . . 75.510000000000005 110.504 -178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.3 Cg_exo -70.57 166.03 77.31 Favored 'Cis proline' 0 C--N 1.357 1.021 0 C-N-CA 124.24 -1.15 . . . . 64.140000000000001 113.12 3.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.477 HG23 HG12 ' A' ' 112' ' ' ILE . 88.6 m -145.8 130.75 18.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.642 . . . . 74.0 109.839 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.458 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 42.8 mm -109.8 110.79 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 71.439999999999998 111.193 -173.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.475 HD12 ' CD1' ' A' ' 48' ' ' PHE . 8.4 mp -101.13 123.41 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.501 -0.555 . . . . 72.510000000000005 109.501 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.539 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 22.2 mtt -92.26 145.6 24.36 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.138 -0.319 . . . . 65.120000000000005 110.138 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.4 m-85 -142.12 152.56 43.37 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.747 -0.464 . . . . 74.140000000000001 109.747 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -145.24 114.88 7.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.444 0.164 . . . . 74.239999999999995 110.814 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.521 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 32.0 t-20 57.4 41.04 26.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.371 0.605 . . . . 72.219999999999999 110.396 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.658 ' HA2' HG11 ' A' ' 35' ' ' VAL . . . 71.04 2.81 49.35 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 115.942 -0.572 . . . . 43.109999999999999 112.843 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -101.19 147.3 26.42 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 120.732 0.301 . . . . 63.039999999999999 110.797 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -56.62 129.57 41.55 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.638 1.212 . . . . 71.430000000000007 112.161 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -136.61 167.95 20.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.138 -1.392 . . . . 72.319999999999993 108.287 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.21 172.01 8.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.823 0.675 . . . . 72.409999999999997 112.823 -163.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -138.34 138.19 38.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.65 -0.704 . . . . 74.540000000000006 110.558 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.458 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.0 m -126.47 139.92 50.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.197 -0.456 . . . . 73.030000000000001 109.876 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.477 HG12 HG23 ' A' ' 98' ' ' THR . 38.7 mt -127.16 142.99 41.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.946 -0.57 . . . . 62.140000000000001 109.88 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.27 -152.16 21.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.036 -0.602 . . . . 60.32 112.417 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -125.98 93.18 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 75.109999999999999 111.741 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.5 t70 -145.03 91.21 2.12 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 64.239999999999995 108.655 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 tp -64.54 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.614 -0.721 . . . . 62.149999999999999 110.752 -171.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -66.93 -45.35 78.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.076 -0.511 . . . . 72.200000000000003 110.082 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -69.19 -39.82 78.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 55.140000000000001 110.277 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 63' ' ' LEU . 78.1 mt -58.66 -56.08 18.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.383 -0.371 . . . . 72.120000000000005 110.509 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.498 ' HA ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.4 -37.37 77.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.726 -0.472 . . . . 74.510000000000005 109.726 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.451 ' HA ' HD22 ' A' ' 124' ' ' ASN . 37.5 t -54.04 -52.01 62.21 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.102 -0.499 . . . . 52.409999999999997 110.491 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -72.17 -28.33 63.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 73.040000000000006 110.917 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 120' ' ' ILE . 97.6 mt -59.49 -56.21 18.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 120.634 -0.427 . . . . 73.409999999999997 110.143 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 121' ' ' SER . 9.1 p30 -71.19 -25.37 62.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.727 0.298 . . . . 70.219999999999999 110.325 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 30.4 t30 -62.31 -48.21 80.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.618 -0.719 . . . . 72.200000000000003 110.598 175.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.539 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.3 m-20 -80.88 -26.81 36.61 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.526 -0.761 . . . . 71.200000000000003 111.671 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.523 HD13 HG23 ' A' ' 74' ' ' VAL . 71.1 mt -74.86 -49.84 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.689 0.28 . . . . 74.310000000000002 110.814 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.578 -0.725 . . . . 71.430000000000007 110.673 -174.368 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.9 mmm . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.761 0.315 . . . . 71.319999999999993 111.058 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -91.03 100.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.023 -0.732 . . . . 73.430000000000007 109.023 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 28.9 tt0 -94.06 112.26 24.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 70.140000000000001 110.641 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.527 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 2.1 mp0 -72.36 132.0 43.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 71.409999999999997 110.089 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.2 pt -130.85 152.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 73.540000000000006 110.208 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.69 165.31 45.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.131 -0.557 . . . . 75.430000000000007 112.421 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -50.87 -39.05 52.86 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.843 0.457 . . . . 65.030000000000001 111.465 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -71.15 -36.84 72.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 74.420000000000002 110.546 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.44 -13.59 60.4 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 115.837 -0.62 . . . . 75.540000000000006 111.265 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' O ' HG21 ' A' ' 35' ' ' VAL . 75.8 t80 -56.36 -62.15 1.92 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.594 0.235 . . . . 70.519999999999996 110.714 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.79 -47.49 80.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 73.420000000000002 110.484 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.13 -57.57 10.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.619 -0.719 . . . . 43.219999999999999 111.094 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.6 mmtt -64.95 -36.98 86.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 63.340000000000003 111.236 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 31' ' ' PHE . 74.7 t -64.07 -41.72 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.96 0.41 . . . . 74.140000000000001 110.735 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.2 p -86.24 -9.96 55.52 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.31 -0.405 . . . . 53.409999999999997 111.702 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.3 t -74.42 -2.96 27.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.281 0.233 . . . . 74.540000000000006 111.556 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 44' ' ' ILE . 59.3 m -70.05 134.21 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.612 -0.267 . . . . 71.299999999999997 111.157 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -65.97 -78.03 0.06 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.833 -0.803 . . . . 72.420000000000002 108.833 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -162.49 156.43 21.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.316 -0.624 . . . . 63.420000000000002 109.316 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.633 ' HA ' ' HE2' ' A' ' 103' ' ' LYS . 53.2 m-20 62.06 13.08 5.42 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.1 0.56 . . . . 72.450000000000003 111.915 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 49.6 mm -86.85 106.65 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.897 -0.409 . . . . 70.510000000000005 109.897 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.51 109.13 16.45 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.804 -0.635 . . . . 72.329999999999998 109.437 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.607 HD12 ' SG ' ' A' ' 38' ' ' CYS . 46.3 mt -92.0 121.93 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.576 . . . . 72.450000000000003 110.836 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.55 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.7 mp -103.66 110.92 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.226 -0.657 . . . . 73.209999999999994 109.226 173.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 59.3 t -96.95 107.21 19.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.067 -0.345 . . . . 72.450000000000003 110.067 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.29 96.49 1.43 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.993 -0.743 . . . . 62.130000000000003 108.993 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.408 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 35.7 t80 -60.84 99.35 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.175 -0.92 . . . . 65.219999999999999 111.579 -172.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.46 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 59.05 -82.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.632 -0.713 . . . . 74.340000000000003 111.863 173.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.587 ' N ' ' HD3' ' A' ' 51' ' ' PRO . . . 53.69 48.3 4.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.185 0.594 . . . . 54.329999999999998 111.856 -175.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 50' ' ' ALA . 2.8 Cg_exo -75.29 -19.88 16.83 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.541 2.16 . . . . 64.329999999999998 112.345 -173.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -75.3 -38.58 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 110.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 8.3 t 54.95 82.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.441 -0.799 . . . . 63.299999999999997 111.084 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.93 -78.81 1.12 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.582 -0.607 . . . . 43.399999999999999 111.582 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.445 ' O ' HD22 ' A' ' 59' ' ' LEU . 6.0 Cg_exo -76.51 11.77 1.79 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.212 2.608 . . . . 54.219999999999999 111.81 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 5.6 p -63.73 -23.6 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.598 -0.728 . . . . 71.349999999999994 111.325 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -54.43 -52.48 61.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.313 -0.403 . . . . 74.439999999999998 110.492 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.9 m -75.29 -48.14 24.62 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.87 0.843 . . . . 74.230000000000004 111.806 178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 114' ' ' ALA . 4.1 mm? -68.09 -28.1 67.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 64.099999999999994 112.516 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.2 tt0 -58.56 -59.88 12.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.98 -0.378 . . . . 65.120000000000005 109.98 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.443 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 37.1 Cg_endo -66.04 -37.1 27.25 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.67 1.58 . . . . 64.230000000000004 112.107 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.87 -45.32 86.49 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.273 -0.571 . . . . 75.209999999999994 110.823 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 119' ' ' ILE . 84.8 mt -66.04 -41.18 91.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.416 -0.356 . . . . 74.140000000000001 110.678 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 51.9 mt-10 -57.41 -41.42 80.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.727 0.299 . . . . 65.510000000000005 110.344 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.04 -56.07 22.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.304 -0.407 . . . . 74.540000000000006 111.264 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.55 -34.71 71.32 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 74.510000000000005 109.902 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.11 -49.15 71.05 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.509 -0.769 . . . . 43.32 110.571 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.8 mt-30 -62.27 -41.56 98.58 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.004 0.43 . . . . 74.129999999999995 110.725 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -68.25 -38.49 81.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 75.409999999999997 110.937 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -104.49 4.18 32.84 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.347 0.499 . . . . 75.219999999999999 112.347 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.4 t -54.03 -19.66 5.17 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.785 0.661 . . . . 72.120000000000005 112.785 -172.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -61.3 -36.64 80.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.043 0.449 . . . . 74.019999999999996 110.094 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -120.57 -4.49 9.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.877 -0.601 . . . . 60.25 111.281 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.451 HG11 HD12 ' A' ' 45' ' ' LEU . 43.8 t -123.02 148.15 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.016 0.436 . . . . 74.219999999999999 111.569 -174.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.2 tptm -149.44 133.15 16.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.773 -0.649 . . . . 72.219999999999999 109.41 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 45' ' ' LEU . 52.6 mt -108.99 135.76 46.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.888 0.375 . . . . 73.140000000000001 111.082 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 49.3 m-85 -130.77 168.04 17.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.734 -0.666 . . . . 73.109999999999999 110.176 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.533 ' HZ2' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -174.18 153.46 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 62.329999999999998 109.997 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tp -121.02 119.68 60.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.51 -0.922 . . . . 75.129999999999995 108.51 170.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -94.96 44.31 1.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.23 -0.441 . . . . 60.109999999999999 111.689 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.0 pt -71.05 78.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 122.105 0.955 . . . . 65.230000000000004 109.409 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -47.48 -44.69 25.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 113.9 -1.5 . . . . 64.209999999999994 114.092 -167.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.726 0.298 . . . . 63.520000000000003 111.393 -173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.41 51.61 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 73.530000000000001 110.136 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -85.53 3.17 41.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.97 -0.559 . . . . 73.430000000000007 111.986 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.49 -39.0 64.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.19 0.519 . . . . 63.32 110.055 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.03 -34.45 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.195 -0.912 . . . . 71.010000000000005 110.495 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 48' ' ' PHE . . . -64.46 -52.08 59.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 110.301 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.8 m -62.25 -32.72 73.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 72.420000000000002 111.034 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -53.89 16.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.466 -0.334 . . . . 74.510000000000005 111.346 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -79.51 -10.24 59.76 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.507 -0.315 . . . . 73.109999999999999 111.732 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.23 43.01 5.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.926 -0.654 . . . . 65.549999999999997 113.558 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.98 135.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.52 -0.548 . . . . 75.310000000000002 109.52 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.8 m -133.04 1.42 3.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.057 0.391 . . . . 72.219999999999999 112.057 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.98 156.57 47.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.016 0.436 . . . . 52.439999999999998 111.635 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 pt -125.98 122.02 24.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.749 -0.659 . . . . 75.510000000000005 110.074 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.31 -172.62 9.13 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.737 -1.36 . . . . 64.140000000000001 112.647 -0.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.498 HG22 HD13 ' A' ' 112' ' ' ILE . 47.2 m -145.06 128.29 16.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.501 -0.772 . . . . 74.0 109.177 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 47.6 mm -110.13 116.08 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.578 0.228 . . . . 71.439999999999998 111.018 -174.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.3 mt -99.02 123.48 43.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.312 -0.625 . . . . 72.510000000000005 109.312 174.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.3 mtt -97.96 144.38 27.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.203 -0.295 . . . . 65.120000000000005 110.203 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.422 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -143.6 144.83 32.09 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.003 -0.369 . . . . 74.140000000000001 110.003 175.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.633 ' HE2' ' HA ' ' A' ' 41' ' ' ASN . 52.9 tttm -131.82 105.2 7.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.092 -0.243 . . . . 74.239999999999995 110.57 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 59.1 t30 58.9 30.67 20.46 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.717 0.77 . . . . 72.219999999999999 110.199 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.4 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 88.74 -16.37 54.62 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.614 -0.721 . . . . 43.109999999999999 112.517 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.612 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 2.4 tmmm? -76.1 140.19 41.71 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 109.608 -0.515 . . . . 63.039999999999999 109.608 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 106' ' ' LYS . 2.3 tmtp? -57.68 139.09 54.6 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.196 0.935 . . . . 71.430000000000007 110.742 -176.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.565 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -146.51 168.36 21.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.967 -1.015 . . . . 72.319999999999993 108.636 -171.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 m -70.32 175.45 4.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.601 0.963 . . . . 72.409999999999997 113.601 -161.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -141.01 142.03 34.28 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.956 -1.02 . . . . 74.540000000000006 110.769 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.561 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 15.3 t -123.55 114.56 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.995 -1.457 . . . . 73.030000000000001 109.946 -174.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 98' ' ' THR . 46.2 mm -106.71 121.1 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.763 -0.653 . . . . 62.140000000000001 109.972 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.03 163.96 33.69 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.433 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.48 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -85.6 79.99 9.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.288 . . . . 75.109999999999999 111.021 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.434 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.7 t70 -124.52 91.9 3.54 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.398 -0.593 . . . . 64.239999999999995 109.398 175.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.57 -31.94 52.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.883 -0.599 . . . . 62.149999999999999 111.205 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.6 t -62.7 -44.08 97.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.16 -0.473 . . . . 72.200000000000003 109.978 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -70.52 -37.47 74.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 55.140000000000001 109.952 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.472 HG12 HG13 ' A' ' 111' ' ' VAL . 72.8 mt -56.74 -56.27 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.257 -0.429 . . . . 72.120000000000005 110.674 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.515 ' HA ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.54 -37.91 81.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 110.22 -0.289 . . . . 74.510000000000005 110.22 -177.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.479 ' HA ' HD22 ' A' ' 124' ' ' ASN . 22.9 t -56.99 -51.97 67.13 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.937 -0.394 . . . . 52.409999999999997 109.937 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.49 -41.83 97.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.121 -0.49 . . . . 73.040000000000006 110.755 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.1 mt -53.06 -56.18 9.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.625 0.25 . . . . 73.409999999999997 110.412 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.0 p30 -71.57 -35.46 70.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.718 -0.393 . . . . 70.219999999999999 110.727 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -63.97 -35.18 79.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 72.200000000000003 111.208 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB3' HD12 ' A' ' 108' ' ' LEU . 84.8 m-20 -91.21 -31.15 16.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 71.200000000000003 111.707 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 123' ' ' ILE . 71.9 mt -58.55 -53.26 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 74.310000000000002 110.599 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 . . . . . 0 C--O 1.25 1.11 0 CA-C-N 115.79 -0.641 . . . . 71.430000000000007 110.358 -175.556 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.493 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.7 mmm . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.202 0.525 . . . . 71.319999999999993 109.832 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -78.92 133.69 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.404 -0.816 . . . . 73.430000000000007 110.3 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -94.18 155.36 17.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 70.140000000000001 110.111 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -119.0 139.45 51.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.028 -0.73 . . . . 71.409999999999997 109.028 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 31' ' ' PHE . 32.6 pt -141.75 159.72 21.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.031 0.444 . . . . 73.540000000000006 111.558 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.72 -168.52 33.78 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.475 -0.784 . . . . 75.430000000000007 112.203 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.12 -48.87 72.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.657 0.383 . . . . 65.030000000000001 111.451 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 t -72.0 -40.83 68.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.420000000000002 110.371 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.31 -23.92 64.58 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.267 -0.424 . . . . 75.540000000000006 111.08 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.502 ' HA ' HD11 ' A' ' 26' ' ' ILE . 89.5 t80 -49.97 -58.2 5.95 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.851 0.357 . . . . 70.519999999999996 110.288 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -56.4 -57.52 11.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.89 -0.596 . . . . 73.420000000000002 110.599 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.87 -50.44 63.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.719 -0.673 . . . . 43.219999999999999 111.453 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG3' HG23 ' A' ' 26' ' ' ILE . 74.3 mmtt -68.32 -41.82 80.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 63.340000000000003 111.561 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HA ' HD11 ' A' ' 44' ' ' ILE . 76.1 t -70.46 -36.26 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 111.791 0.293 . . . . 74.140000000000001 111.791 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.3 p -85.96 -37.32 19.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.833 0.309 . . . . 53.409999999999997 111.833 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.5 t -83.82 10.83 8.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.033 0.383 . . . . 74.540000000000006 112.033 -173.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.81 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 19.9 p -59.99 146.99 40.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 110.32 -0.252 . . . . 71.299999999999997 110.32 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -45.98 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.406 0.682 . . . . 72.420000000000002 111.996 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.75 122.62 3.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.419 -0.215 . . . . 63.420000000000002 110.419 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.529 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.8 OUTLIER 62.56 7.25 2.34 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.787 0.435 . . . . 72.450000000000003 112.024 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.26 137.46 22.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.872 0.367 . . . . 70.510000000000005 111.247 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -81.12 123.61 28.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.534 -0.913 . . . . 72.329999999999998 108.534 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 82.1 mt -115.44 121.57 67.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.266 -0.425 . . . . 72.450000000000003 110.207 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -109.86 113.08 25.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.111 -0.7 . . . . 73.209999999999994 109.111 175.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.25 105.0 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.946 -0.39 . . . . 72.450000000000003 109.946 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.92 127.89 32.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.81 -0.632 . . . . 62.130000000000003 110.692 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -94.59 125.82 39.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.528 -0.916 . . . . 65.219999999999999 108.528 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -53.49 139.8 30.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.17 0.509 . . . . 74.340000000000003 111.622 -174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -95.33 108.49 39.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.446 -0.797 . . . . 54.329999999999998 111.102 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 21.0 Cg_endo -60.74 -32.27 92.82 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.402 2.068 . . . . 64.329999999999998 111.061 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -101.16 93.08 5.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.485 -0.931 . . . . 73.150000000000006 108.485 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.468 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 10.4 t -91.82 89.23 6.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 63.299999999999997 110.32 -174.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.49 -86.25 1.62 Allowed Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.735 -0.666 . . . . 43.399999999999999 111.449 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.72 -11.92 16.22 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.139 2.559 . . . . 54.219999999999999 112.153 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 15.4 p -50.62 -43.59 56.93 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.534 -0.757 . . . . 71.349999999999994 110.948 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -54.89 -41.02 70.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.513 -0.767 . . . . 74.439999999999998 111.524 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.576 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.3 m -75.88 -53.39 8.51 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.991 0.9 . . . . 74.230000000000004 111.701 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.436 HD11 HD12 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -61.28 -44.42 97.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.853 -1.067 . . . . 64.099999999999994 111.914 -168.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.3 -52.63 73.07 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 119.516 -0.278 . . . . 65.120000000000005 111.336 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HG2' ' O ' ' A' ' 58' ' ' SER . 17.7 Cg_endo -61.67 -31.66 86.58 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.512 1.475 . . . . 64.230000000000004 112.137 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.1 mt-30 -62.88 -35.98 81.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.185 -0.606 . . . . 75.209999999999994 109.75 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.79 -39.08 76.8 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.792 -0.64 . . . . 74.140000000000001 109.937 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 mt-10 -53.69 -47.74 70.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.801 -0.444 . . . . 65.510000000000005 109.801 175.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -58.79 -52.45 65.65 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.942 -0.572 . . . . 74.540000000000006 111.251 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.479 HD12 HD12 ' A' ' 116' ' ' ILE . 48.9 mt -62.26 -34.89 77.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.912 0.387 . . . . 74.510000000000005 110.093 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.07 -43.41 95.55 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.946 -0.57 . . . . 43.32 109.99 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 51.3 mt-30 -64.86 -46.49 81.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.129999999999995 111.05 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -72.87 -34.41 66.71 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.996 0.427 . . . . 75.409999999999997 111.21 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -104.7 4.04 32.09 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.328 0.492 . . . . 75.219999999999999 112.328 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -53.32 -19.55 3.43 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.957 0.408 . . . . 72.120000000000005 111.536 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.63 -38.08 69.04 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.981 -0.554 . . . . 74.019999999999996 110.836 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -135.21 12.08 3.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.075 -0.511 . . . . 60.25 111.331 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.55 139.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.617 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -143.63 119.93 10.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.419 -0.81 . . . . 72.219999999999999 109.187 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 45' ' ' LEU . 40.5 mt -104.8 137.25 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.715 0.293 . . . . 73.140000000000001 110.706 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.45 151.15 40.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.935 -0.575 . . . . 73.109999999999999 109.895 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -120.8 102.74 8.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.624 -0.88 . . . . 62.329999999999998 108.624 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 79' ' ' ILE . 14.7 tt -80.47 102.2 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.613 0.72 . . . . 75.129999999999995 110.134 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.82 75.46 10.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 60.109999999999999 111.172 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.415 HD11 HG12 ' A' ' 87' ' ' VAL . 29.5 pt -124.03 24.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.011 -0.737 . . . . 65.230000000000004 109.011 171.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -58.02 -18.64 25.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.552 -1.204 . . . . 64.209999999999994 111.561 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.16 -23.23 62.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.317 0.58 . . . . 63.520000000000003 109.661 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.35 95.25 7.94 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.508 -0.923 . . . . 73.530000000000001 108.508 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.211 -0.45 . . . . 73.430000000000007 111.667 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 14.5 m-20 -56.61 -32.96 65.79 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.471 -0.331 . . . . 63.32 111.286 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 81' ' ' ILE . 75.0 t -53.06 -38.63 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.467 -0.333 . . . . 71.010000000000005 110.537 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.7 -48.81 75.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.17 0.509 . . . . 74.239999999999995 109.827 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -59.34 -36.99 76.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.486 -0.779 . . . . 72.420000000000002 110.726 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 11.6 mm-40 -71.7 -51.27 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.006 -0.543 . . . . 74.510000000000005 110.492 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -73.98 -13.32 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 111.548 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.8 21.44 36.57 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.904 -0.665 . . . . 65.549999999999997 112.777 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.467 HG11 ' OG1' ' A' ' 98' ' ' THR . 64.5 t -70.42 117.28 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.156 -0.312 . . . . 75.310000000000002 110.156 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 t -136.45 8.03 3.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 72.219999999999999 110.985 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.477 ' HB3' HG21 ' A' ' 112' ' ' ILE . . . -147.18 164.06 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.794 -0.447 . . . . 52.439999999999998 109.794 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 96' ' ' ILE . 2.5 pp -122.51 122.0 27.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.439 -0.346 . . . . 75.510000000000005 111.207 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -87.06 -166.78 3.92 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.825 -1.323 . . . . 64.140000000000001 112.022 -3.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.486 HG21 HG12 ' A' ' 112' ' ' ILE . 81.5 m -138.92 120.35 14.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.535 -0.302 . . . . 74.0 110.202 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.636 ' HB ' HG23 ' A' ' 111' ' ' VAL . 47.5 mm -110.35 117.34 54.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.86 -0.609 . . . . 71.439999999999998 110.881 -174.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 100' ' ' LEU . 5.3 mp -100.59 123.22 44.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.535 -0.543 . . . . 72.510000000000005 109.535 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 109' ' ' SER . 11.6 mmt -87.65 148.08 24.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.686 0.279 . . . . 65.120000000000005 110.42 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.6 m-85 -145.45 160.99 40.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.956 -0.757 . . . . 74.140000000000001 108.956 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -148.79 109.46 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.621 0.248 . . . . 74.239999999999995 110.88 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.81 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER 59.9 31.84 20.91 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.746 -0.661 . . . . 72.219999999999999 110.352 177.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.462 ' HA2' HG11 ' A' ' 35' ' ' VAL . . . 87.52 -14.43 58.06 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.918 -0.583 . . . . 43.109999999999999 112.411 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.635 ' HZ2' ' HB3' ' A' ' 106' ' ' LYS . 7.7 ttpm? -81.76 139.56 34.76 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 110.301 -0.259 . . . . 63.039999999999999 110.301 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -58.88 149.6 26.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.812 -0.631 . . . . 71.430000000000007 111.511 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -154.39 168.01 28.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.127 0.971 . . . . 72.319999999999993 108.845 -170.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 101' ' ' MET . 3.1 m -70.35 148.17 48.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.571 0.7 . . . . 72.409999999999997 112.875 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -110.14 118.52 36.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 74.540000000000006 110.204 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.636 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.5 m -101.62 116.0 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 73.030000000000001 109.527 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 98' ' ' THR . 47.4 mt -107.59 120.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 62.140000000000001 110.577 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.11 160.84 12.44 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.246 -0.502 . . . . 60.32 112.238 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.76 83.42 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 75.109999999999999 111.017 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.5 t70 -133.75 92.22 2.94 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.344 -0.613 . . . . 64.239999999999995 109.344 174.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.479 HD12 HD12 ' A' ' 66' ' ' LEU . 8.8 tp -62.3 -32.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 62.149999999999999 111.413 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -65.29 -43.62 90.54 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.151 0.501 . . . . 72.200000000000003 110.065 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 14.8 tppt? -68.38 -43.13 78.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.935 -0.575 . . . . 55.140000000000001 110.19 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.436 HD12 HD11 ' A' ' 59' ' ' LEU . 70.8 mt -57.25 -51.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.709 -0.223 . . . . 72.120000000000005 110.676 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.509 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.02 -35.63 75.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.957 -0.386 . . . . 74.510000000000005 109.957 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.5 t -54.11 -51.23 64.86 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.147 0.498 . . . . 52.409999999999997 110.094 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 12.7 mm-40 -71.09 -31.84 68.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 73.040000000000006 110.766 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 120' ' ' ILE . 88.7 mt -58.15 -56.26 17.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.902 0.382 . . . . 73.409999999999997 110.037 176.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -65.8 -36.58 83.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.76 -0.459 . . . . 70.219999999999999 109.76 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -58.71 -41.57 86.65 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.097 -0.501 . . . . 72.200000000000003 110.966 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.417 ' HB2' HD11 ' A' ' 43' ' ' LEU . 81.5 m-20 -87.2 -12.75 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 71.200000000000003 111.371 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 123' ' ' ILE . 74.3 mt -80.88 -48.36 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.032 -0.359 . . . . 74.310000000000002 110.032 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.563 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.464 -0.779 . . . . 71.430000000000007 110.739 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.424 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 92.5 mmm . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.882 0.372 . . . . 71.319999999999993 110.725 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 78' ' ' LYS . 18.3 mm -78.13 87.98 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.744 -0.835 . . . . 73.430000000000007 108.744 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.06 112.12 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.635 -0.711 . . . . 70.140000000000001 111.341 -171.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -72.83 132.36 43.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.692 -0.485 . . . . 71.409999999999997 109.692 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.495 HG22 ' HG3' ' A' ' 34' ' ' LYS . 39.0 pt -133.12 160.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.794 0.33 . . . . 73.540000000000006 110.952 -176.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.22 -177.36 40.45 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.921 -0.581 . . . . 75.430000000000007 112.95 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.01 -43.24 99.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.96 0.504 . . . . 65.030000000000001 111.622 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -74.09 -37.17 64.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.074 0.464 . . . . 74.420000000000002 110.67 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.85 -26.74 68.75 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.783 -0.644 . . . . 75.540000000000006 110.762 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.444 ' HD2' HG21 ' A' ' 79' ' ' ILE . 88.8 t80 -46.14 -61.66 1.67 Allowed 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.33 0.394 . . . . 70.519999999999996 111.122 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -50.31 69.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.914 -0.585 . . . . 73.420000000000002 110.891 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.75 -57.39 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.74 . . . . 43.219999999999999 110.75 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HG3' HG22 ' A' ' 26' ' ' ILE . 74.4 mmtt -58.01 -44.19 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.12 -0.945 . . . . 63.340000000000003 111.181 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.04 -48.13 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.714 0.292 . . . . 74.140000000000001 111.313 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.4 p -77.43 -15.28 59.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.701 0.286 . . . . 53.409999999999997 111.595 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 t -69.55 -5.38 23.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.322 -0.399 . . . . 74.540000000000006 111.983 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 13.4 p -62.41 108.63 1.15 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.621 0.248 . . . . 71.299999999999997 110.501 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -58.43 -73.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.185 -0.462 . . . . 72.420000000000002 111.625 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -153.97 121.89 6.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.7 0.286 . . . . 63.420000000000002 110.913 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 61.3 8.3 2.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.6 0.76 . . . . 72.450000000000003 111.968 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -73.89 113.85 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.245 -0.434 . . . . 70.510000000000005 110.123 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HB3' HG23 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -82.21 119.26 23.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.103 -0.499 . . . . 72.329999999999998 109.656 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.45 119.98 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.596 -0.729 . . . . 72.450000000000003 110.483 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -103.95 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.052 -0.721 . . . . 73.209999999999994 109.052 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 98.3 t -115.71 109.57 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.07 -0.344 . . . . 72.450000000000003 110.07 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.3 t70 -87.0 127.86 35.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 62.130000000000003 111.949 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -101.46 87.31 3.16 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.393 -0.595 . . . . 65.219999999999999 109.393 170.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.508 ' HB2' ' HZ2' ' A' ' 78' ' ' LYS . 84.3 t90 -65.37 119.84 11.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.408 -0.815 . . . . 74.340000000000003 110.508 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 144.4 29.61 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.446 . . . . 54.329999999999998 110.397 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.51 -34.38 85.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.701 2.267 . . . . 64.329999999999998 112.523 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -119.76 119.16 32.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 73.150000000000006 110.087 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.588 ' SG ' ' HB ' ' A' ' 96' ' ' ILE . 47.9 t -163.88 140.79 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.299999999999997 110.567 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.03 -72.14 1.21 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.216 -0.447 . . . . 43.399999999999999 112.652 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.35 -22.36 20.5 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.056 2.504 . . . . 54.219999999999999 113.29 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 98.3 m -54.17 -24.91 19.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.57 -0.286 . . . . 71.349999999999994 111.375 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -53.95 -49.95 67.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.38 0.61 . . . . 74.439999999999998 110.165 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.609 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 12.6 m -75.0 -40.72 60.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.399 -0.819 . . . . 74.230000000000004 111.079 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.4 mm? -62.42 -41.6 98.82 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.774 0.657 . . . . 64.099999999999994 112.774 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 44.5 mt-10 -55.43 -54.64 48.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 117.873 0.306 . . . . 65.120000000000005 111.272 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HG2' ' O ' ' A' ' 58' ' ' SER . 21.1 Cg_endo -63.15 -35.73 62.36 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.524 1.483 . . . . 64.230000000000004 112.005 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.609 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.9 mt-30 -64.01 -31.12 72.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.643 -0.423 . . . . 75.209999999999994 110.584 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 76.0 mt -70.0 -42.02 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 74.140000000000001 109.982 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -63.53 -34.02 76.87 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 120.866 -0.334 . . . . 65.510000000000005 110.337 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 36.7 ttmt -55.6 -57.18 13.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.784 0.326 . . . . 74.540000000000006 110.298 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.411 HD13 HD11 ' A' ' 123' ' ' ILE . 33.0 mt -66.61 -38.42 86.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 74.510000000000005 110.367 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.32 -45.86 90.17 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.733 -0.667 . . . . 43.32 110.515 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.424 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 16.8 mm-40 -69.85 -46.08 66.34 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.393 -0.367 . . . . 74.129999999999995 110.956 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.75 -41.95 82.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.856 -0.611 . . . . 75.409999999999997 110.953 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -104.66 4.3 32.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.687 -0.688 . . . . 75.219999999999999 112.235 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.1 t -53.16 -21.69 5.38 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.612 0.967 . . . . 72.120000000000005 113.612 -170.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -73.53 -18.7 61.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.797 0.332 . . . . 74.019999999999996 110.925 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.409 HD21 HG12 ' A' ' 127' ' ' ILE . 5.9 t30 -135.1 5.05 3.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.262 -0.426 . . . . 60.25 110.896 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 43' ' ' LEU . 43.5 t -139.34 145.26 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.913 0.387 . . . . 74.219999999999999 111.33 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -148.69 128.29 13.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 72.219999999999999 109.541 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.0 mt -106.56 128.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 120.852 0.358 . . . . 73.140000000000001 110.479 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -110.63 168.22 9.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.836 -0.62 . . . . 73.109999999999999 109.934 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HZ2' ' HB2' ' A' ' 49' ' ' TRP . 22.6 ttmm -135.05 99.27 4.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.219 -0.66 . . . . 62.329999999999998 109.219 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -119.31 97.04 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.861 0.838 . . . . 75.129999999999995 108.942 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -150.49 94.9 2.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.193 -0.912 . . . . 60.109999999999999 110.089 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.476 HD11 ' N ' ' A' ' 81' ' ' ILE . 2.7 mp -72.98 109.93 5.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.595 -0.891 . . . . 65.230000000000004 108.595 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.89 -31.09 68.28 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.059 0.457 . . . . 64.209999999999994 110.464 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.69 -19.08 49.83 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.946 -0.57 . . . . 63.520000000000003 111.608 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -119.7 79.84 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.4 0.619 . . . . 73.530000000000001 110.132 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.78 -21.84 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.444 -0.798 . . . . 73.430000000000007 111.06 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 26.2 t70 -45.77 -47.62 15.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.011 -0.54 . . . . 63.32 111.809 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.66 -42.02 49.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.314 -0.403 . . . . 71.010000000000005 110.988 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.84 -45.02 87.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 74.239999999999995 110.551 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -68.39 -29.86 68.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 72.420000000000002 110.587 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.1 mm100 -70.49 -46.47 63.67 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.356 -0.384 . . . . 74.510000000000005 111.089 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -79.91 -17.19 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.109999999999999 111.092 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.06 64.46 0.95 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.772 -0.728 . . . . 65.549999999999997 113.091 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' OG1' ' A' ' 98' ' ' THR . 91.5 t -97.04 133.15 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.399 -0.593 . . . . 75.310000000000002 109.399 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.2 m -138.71 -64.68 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.472 -0.331 . . . . 72.219999999999999 110.833 -175.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 112' ' ' ILE . . . -85.49 170.57 12.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.343 -0.39 . . . . 52.439999999999998 110.488 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.588 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -110.97 118.63 47.76 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.08 -0.509 . . . . 75.510000000000005 111.718 -175.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -92.62 -160.25 0.99 Allowed 'Cis proline' 0 C--N 1.352 0.738 0 C-N-CA 123.957 -1.268 . . . . 64.140000000000001 111.3 -6.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 112' ' ' ILE . 87.9 m -137.27 129.33 29.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.145 -0.317 . . . . 74.0 110.145 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.97 120.34 62.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.944 -0.571 . . . . 71.439999999999998 110.729 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 27.3 mt -88.23 146.55 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.208 -0.664 . . . . 72.510000000000005 109.208 172.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.54 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 14.6 mmt -112.37 143.24 43.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.54 -0.541 . . . . 65.120000000000005 109.54 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 89.2 m-85 -144.36 151.2 38.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.044 -0.724 . . . . 74.140000000000001 109.044 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.79 125.17 5.7 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.363 -0.535 . . . . 74.239999999999995 111.086 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 60.94 29.26 18.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.308 0.575 . . . . 72.219999999999999 110.836 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 38' ' ' CYS . . . 71.32 11.59 71.61 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.833 -0.621 . . . . 43.109999999999999 112.023 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -98.69 144.95 27.39 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.157 -0.682 . . . . 63.039999999999999 109.157 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -74.1 118.61 17.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.716 0.769 . . . . 71.430000000000007 109.768 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 3.5 mm? -113.57 169.59 8.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.19 -1.368 . . . . 72.319999999999993 110.204 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 101' ' ' MET . 8.0 m -69.49 -177.39 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.487 0.715 . . . . 72.409999999999997 112.432 -163.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -141.63 136.27 30.81 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.301 1.048 . . . . 74.540000000000006 111.366 -172.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.86 107.27 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 113.335 -1.757 . . . . 73.030000000000001 109.332 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.471 HG23 ' HB1' ' A' ' 95' ' ' ALA . 50.4 mt -105.66 118.73 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.051 -0.352 . . . . 62.140000000000001 110.051 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.09 151.71 11.01 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.164 -0.471 . . . . 60.32 112.102 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.93 80.17 1.17 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.145 0.498 . . . . 75.109999999999999 111.134 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.459 ' O ' HG13 ' A' ' 119' ' ' ILE . 63.5 t0 -126.41 89.85 3.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 64.239999999999995 109.849 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.19 -33.37 50.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.838 -0.619 . . . . 62.149999999999999 110.831 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.3 t -63.64 -46.29 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.91 -0.586 . . . . 72.200000000000003 109.905 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.728 ' HZ1' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -66.37 -38.56 87.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 55.140000000000001 110.003 -179.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 115' ' ' ASP . 78.0 mt -61.88 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.104 -0.498 . . . . 72.120000000000005 111.119 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -40.04 85.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.819 0.342 . . . . 74.510000000000005 110.089 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.512 ' HA ' HD22 ' A' ' 124' ' ' ASN . 30.7 t -54.92 -50.95 67.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.639 -0.709 . . . . 52.409999999999997 109.825 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.409 ' HB3' ' HE2' ' A' ' 101' ' ' MET . 20.2 mm-40 -66.43 -33.06 74.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 73.040000000000006 111.528 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 119' ' ' ILE . 98.0 mt -61.23 -56.17 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 120.308 -0.557 . . . . 73.409999999999997 109.857 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.512 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.0 p30 -70.41 -25.26 63.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.842 -0.343 . . . . 70.219999999999999 110.801 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -69.99 -53.63 16.83 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.061 -0.518 . . . . 72.200000000000003 110.685 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -80.72 -18.51 47.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.008 0.373 . . . . 71.200000000000003 112.008 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 123' ' ' ILE . 49.9 mt -63.18 -49.98 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.084 0.469 . . . . 74.310000000000002 109.917 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.448 -0.787 . . . . 71.430000000000007 110.091 -178.606 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.632 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 62.4 mmm . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.603 0.24 . . . . 71.319999999999993 110.847 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -68.7 84.52 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.497 -0.927 . . . . 73.430000000000007 108.497 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.19 112.23 2.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.085 -0.961 . . . . 70.140000000000001 110.682 -169.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.93 131.35 35.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.005 -0.543 . . . . 71.409999999999997 110.732 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.0 pt -136.87 162.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 73.540000000000006 110.534 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.39 174.64 36.89 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.145 -0.55 . . . . 75.430000000000007 111.868 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.9 -47.8 73.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.007 0.432 . . . . 65.030000000000001 110.176 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 m -59.45 -25.19 64.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.649 -0.705 . . . . 74.420000000000002 111.252 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 24.3 mm-40 -88.58 -20.03 25.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 75.540000000000006 111.56 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -55.89 -61.7 2.2 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.727 0.298 . . . . 70.519999999999996 110.978 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.77 -48.97 79.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 109.945 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -49.87 -57.3 7.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.068 -0.969 . . . . 43.219999999999999 111.48 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -66.94 -43.97 81.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.066 -0.515 . . . . 63.340000000000003 111.278 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.85 -38.85 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.296 -0.411 . . . . 74.140000000000001 111.715 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.5 p -86.37 -31.07 21.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.222 0.453 . . . . 53.409999999999997 112.222 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 t -82.01 -8.64 59.68 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.407 0.521 . . . . 74.540000000000006 112.407 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 10.9 p -58.48 129.52 42.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.001 -0.279 . . . . 71.299999999999997 110.251 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -49.94 -74.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.68 0.622 . . . . 72.420000000000002 112.68 -168.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -161.7 131.71 4.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.919 -0.128 . . . . 63.420000000000002 110.716 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 51.86 25.67 3.15 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.659 0.6 . . . . 72.450000000000003 112.421 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.6 mm -83.41 99.18 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.462 -0.57 . . . . 70.510000000000005 109.462 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' A' ' 74' ' ' VAL . 59.2 tp -67.72 107.4 2.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.669 . . . . 72.329999999999998 110.205 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -94.18 118.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 72.450000000000003 110.517 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.516 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.2 mp -100.26 108.27 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.5 -0.555 . . . . 73.209999999999994 109.5 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.29 104.98 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.312 -0.625 . . . . 72.450000000000003 109.312 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 98' ' ' THR . 37.3 t0 -91.6 145.16 24.82 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.162 -0.472 . . . . 62.130000000000003 110.069 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.446 ' CE1' HD12 ' A' ' 100' ' ' LEU . 10.1 m-85 -103.2 92.17 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.016 -0.538 . . . . 65.219999999999999 110.202 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -86.48 168.63 13.57 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.615 -0.72 . . . . 74.340000000000003 111.004 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.03 154.95 10.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.331 -0.849 . . . . 54.329999999999998 108.778 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.74 -38.02 21.95 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.841 2.361 . . . . 64.329999999999998 111.795 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -123.92 84.13 2.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.565 -0.902 . . . . 73.150000000000006 108.565 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -52.31 5.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.424 -0.353 . . . . 63.299999999999997 111.469 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.558 ' N ' ' SG ' ' A' ' 56' ' ' CYS . . . 151.66 -116.86 0.78 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.703 -0.76 . . . . 43.399999999999999 112.717 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HG2' ' HB1' ' A' ' 114' ' ' ALA . 5.9 Cg_exo -79.54 37.01 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.365 2.71 . . . . 54.219999999999999 111.384 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 1.8 m -59.94 -35.54 75.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.095 -0.957 . . . . 71.349999999999994 111.156 -171.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -54.18 -44.2 71.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.959 -0.564 . . . . 74.439999999999998 111.378 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.639 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.2 m -74.75 -42.98 57.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.635 0.731 . . . . 74.230000000000004 110.5 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.3 mm? -72.24 -17.57 61.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 64.099999999999994 111.982 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 44.9 mt-10 -56.93 -63.94 3.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.529 -0.545 . . . . 65.120000000000005 109.529 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 53.4 Cg_endo -68.66 -35.4 16.8 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.595 1.53 . . . . 64.230000000000004 112.179 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.6 mt-30 -63.33 -46.73 85.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.335 -0.546 . . . . 75.209999999999994 111.465 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.5 mt -70.32 -43.25 70.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.874 -0.148 . . . . 74.140000000000001 110.666 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.632 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 35.4 mt-10 -59.07 -35.78 73.95 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.16 -0.311 . . . . 65.510000000000005 110.16 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.19 -57.21 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 74.540000000000006 110.458 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 123' ' ' ILE . 41.6 mt -62.44 -32.58 73.46 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.306 -0.406 . . . . 74.510000000000005 109.947 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.65 -51.71 57.38 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.866 -0.606 . . . . 43.32 110.547 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -67.23 -30.32 70.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.747 0.308 . . . . 74.129999999999995 111.296 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -81.32 -38.31 26.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.101 -0.5 . . . . 75.409999999999997 110.818 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -104.87 5.39 32.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.959 -0.564 . . . . 75.219999999999999 112.142 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 9.8 t -53.47 -19.8 4.06 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.424 0.527 . . . . 72.120000000000005 112.424 -173.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.4 -32.66 73.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.808 0.337 . . . . 74.019999999999996 111.101 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -133.56 14.04 4.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.277 -0.419 . . . . 60.25 110.748 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 71' ' ' THR . 50.5 t -140.84 142.57 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.965 0.412 . . . . 74.219999999999999 111.76 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -149.89 127.75 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.8 -0.637 . . . . 72.219999999999999 109.501 170.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.516 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.0 mt -99.14 122.21 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.099 -0.334 . . . . 73.140000000000001 110.099 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -110.81 155.42 22.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.322 -0.399 . . . . 73.109999999999999 110.137 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HZ1' ' CD ' ' A' ' 82' ' ' GLU . 50.2 pttt -137.83 130.87 30.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.006 -0.738 . . . . 62.329999999999998 109.006 168.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 81' ' ' ILE . 14.0 pt -79.07 149.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 75.129999999999995 110.025 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -74.8 30.18 0.09 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.929 0.395 . . . . 60.109999999999999 111.871 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 81' ' ' ILE . 29.7 mm -99.01 19.19 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.481 0.657 . . . . 65.230000000000004 109.691 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.429 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 38.3 mt-10 -57.74 -19.03 24.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.677 -0.692 . . . . 64.209999999999994 112.231 -176.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.14 -6.79 54.99 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.614 0.245 . . . . 63.520000000000003 111.547 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.425 ' HB2' HG23 ' A' ' 81' ' ' ILE . 30.5 m-80 -119.58 88.32 2.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.797 0.332 . . . . 73.530000000000001 110.717 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -64.72 -30.87 71.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.609 -0.515 . . . . 73.430000000000007 109.609 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.1 m-20 -43.55 -51.44 6.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.33 -0.85 . . . . 63.32 110.999 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.33 -36.16 51.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.46 -0.791 . . . . 71.010000000000005 111.054 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . . . -63.93 -50.95 66.65 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.309 0.576 . . . . 74.239999999999995 109.674 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -60.38 -34.4 73.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.341 -0.845 . . . . 72.420000000000002 110.808 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -60.71 -55.15 36.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.958 0.409 . . . . 74.510000000000005 110.369 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -73.57 -15.24 61.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 112.21 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.44 0.69 18.38 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.506 -0.854 . . . . 65.549999999999997 112.99 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 88' ' ' ALA . 88.4 t -67.78 109.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.047 0.451 . . . . 75.310000000000002 109.947 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 t -97.04 -7.12 33.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.856 -0.611 . . . . 72.219999999999999 111.404 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.44 158.66 42.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.973 -0.38 . . . . 52.439999999999998 109.973 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.12 144.56 52.08 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 110.186 -0.301 . . . . 75.510000000000005 110.186 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 114' ' ' ALA . 8.1 Cg_exo -73.32 -179.71 25.95 Favored 'Cis proline' 0 C--N 1.354 0.847 0 C-N-CA 124.33 -1.113 . . . . 64.140000000000001 112.323 -3.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 47' ' ' ASP . 18.5 m -160.36 137.24 9.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 74.0 110.717 -178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.572 ' HB ' HG21 ' A' ' 111' ' ' VAL . 36.1 mm -109.92 110.87 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.533 -0.758 . . . . 71.439999999999998 111.307 -174.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.446 HD12 ' CE1' ' A' ' 48' ' ' PHE . 7.3 mp -96.39 123.26 39.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.106 -1.072 . . . . 72.510000000000005 108.106 168.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.437 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 44.4 mtt -98.76 143.29 29.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.501 . . . . 65.120000000000005 110.995 -175.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -142.81 146.13 33.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.394 -0.965 . . . . 74.140000000000001 108.394 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 107.21 4.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.482 -0.487 . . . . 74.239999999999995 110.859 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.621 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 58.96 28.32 17.48 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.746 0.784 . . . . 72.219999999999999 110.469 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.85 -16.22 59.89 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.612 -0.722 . . . . 43.109999999999999 112.596 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.517 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 13.4 tmtt? -75.33 141.32 43.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.997 -0.742 . . . . 63.039999999999999 108.997 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.59 124.35 25.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.437 0.637 . . . . 71.430000000000007 111.529 -175.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -120.46 168.08 11.69 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.393 1.077 . . . . 72.319999999999993 109.981 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.63 176.68 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.224 0.535 . . . . 72.409999999999997 111.913 -164.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -141.11 126.86 19.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 74.540000000000006 110.524 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.572 HG21 ' HB ' ' A' ' 99' ' ' ILE . 35.5 m -114.21 130.06 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.695 -0.483 . . . . 73.030000000000001 109.695 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.1 117.8 56.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.748 -0.66 . . . . 62.140000000000001 109.679 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.72 144.92 9.0 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.289 -0.724 . . . . 60.32 111.289 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.557 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . . . -83.21 72.34 10.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 111.334 -176.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 119' ' ' ILE . 30.2 t70 -113.07 104.66 12.59 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.185 -0.461 . . . . 64.239999999999995 109.833 175.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.3 tp -60.94 -34.07 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 62.149999999999999 111.422 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.419 ' O ' HG23 ' A' ' 120' ' ' ILE . 21.1 t -64.45 -50.11 68.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 72.200000000000003 110.105 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.9 tptt -61.74 -46.69 88.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 55.140000000000001 110.174 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 115' ' ' ASP . 77.4 mt -57.67 -51.08 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.489 . . . . 72.120000000000005 111.146 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.45 ' O ' HD12 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.51 -39.99 87.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 110.1 -0.333 . . . . 74.510000000000005 110.1 -177.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.7 m -55.81 -50.69 69.82 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.924 -0.399 . . . . 52.409999999999997 109.924 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 61.5 mm-40 -62.62 -44.29 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 73.040000000000006 110.711 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.513 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.7 mt -53.44 -56.39 8.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.603 0.239 . . . . 73.409999999999997 110.777 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -70.18 -32.0 69.74 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.624 -0.431 . . . . 70.219999999999999 110.322 -175.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -64.55 -33.8 76.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.906 -0.588 . . . . 72.200000000000003 111.361 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.99 -20.7 19.14 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 111.984 0.365 . . . . 71.200000000000003 111.984 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.0 mt -71.49 -58.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.027 0.441 . . . . 74.310000000000002 110.028 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.247 -0.883 . . . . 71.430000000000007 110.249 -175.562 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 54.7 mmm . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 109.418 -0.586 . . . . 71.319999999999993 109.418 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.437 HG22 HG21 ' A' ' 76' ' ' ILE . 12.1 mm -71.95 89.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.55 -1.278 . . . . 73.430000000000007 107.55 169.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.63 112.15 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.465 -0.789 . . . . 70.140000000000001 111.442 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.68 117.11 18.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.701 -0.681 . . . . 71.409999999999997 109.983 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.9 pt -110.55 159.18 10.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.842 -0.617 . . . . 73.540000000000006 111.254 -172.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.88 -177.72 36.48 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.681 -0.691 . . . . 75.430000000000007 112.975 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.96 -56.92 10.08 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.734 0.814 . . . . 65.030000000000001 111.947 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -73.19 -18.59 61.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.944 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -83.9 -12.41 55.5 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.125 0.417 . . . . 75.540000000000006 112.125 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.499 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.3 t80 -58.19 -61.45 2.55 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.688 -0.486 . . . . 70.519999999999996 109.688 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.82 -52.82 61.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.689 -0.687 . . . . 73.420000000000002 110.745 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -55.98 -57.34 12.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.605 -0.725 . . . . 43.219999999999999 111.717 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -65.41 -34.13 77.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.027 -0.533 . . . . 63.340000000000003 111.552 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.8 t -70.26 -36.32 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.604 0.24 . . . . 74.140000000000001 110.96 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.87 -13.32 48.29 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.671 0.272 . . . . 53.409999999999997 111.172 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -62.83 -10.08 11.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.424 0.528 . . . . 74.540000000000006 112.424 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 17.4 p -76.7 116.97 17.86 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.927 -0.483 . . . . 71.299999999999997 110.695 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.12 -78.04 0.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.035 -0.53 . . . . 72.420000000000002 111.359 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.68 127.62 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.519 0.2 . . . . 63.420000000000002 110.844 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.5 14.0 5.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.781 -0.645 . . . . 72.450000000000003 111.378 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.7 mm -81.72 120.39 33.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.197 -0.456 . . . . 70.510000000000005 109.854 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HG21 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.38 123.85 28.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 109.963 -178.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 38' ' ' CYS . 44.2 mt -113.94 117.55 55.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 72.450000000000003 110.077 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.601 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.4 mp -105.37 126.15 51.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.03 -0.73 . . . . 73.209999999999994 109.03 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 67.0 t -104.93 105.08 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.698 -0.482 . . . . 72.450000000000003 109.698 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.16 145.33 32.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 62.130000000000003 111.995 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.42 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 23.6 m-85 -108.57 98.57 8.06 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.402 -0.817 . . . . 65.219999999999999 109.181 169.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -42.96 139.06 1.83 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.901 -1.045 . . . . 74.340000000000003 112.484 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.54 112.7 56.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 54.329999999999998 111.083 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.39 -40.14 11.34 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.616 2.211 . . . . 64.329999999999998 111.256 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -164.75 139.89 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.149 -0.932 . . . . 73.150000000000006 109.399 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.8 p -166.33 -67.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 63.299999999999997 110.395 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.06 -94.87 0.16 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.992 -0.623 . . . . 43.399999999999999 112.927 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.91 -7.19 20.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.986 2.457 . . . . 54.219999999999999 113.249 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.581 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 5.3 m -55.11 -30.48 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.458 -0.337 . . . . 71.349999999999994 111.537 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -53.75 -30.59 44.98 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.231 -0.44 . . . . 74.439999999999998 111.574 -172.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 42.5 m -75.3 -37.26 60.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.349 0.595 . . . . 74.230000000000004 110.998 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.1 mm? -66.68 -47.56 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.937 -0.574 . . . . 64.099999999999994 112.434 -172.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -47.75 -55.28 17.89 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 118.115 0.416 . . . . 65.120000000000005 111.565 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 58' ' ' SER . 25.2 Cg_endo -64.96 -33.65 50.84 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.713 1.609 . . . . 64.230000000000004 112.164 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.5 mt-30 -66.12 -27.56 68.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.566 -0.454 . . . . 75.209999999999994 110.554 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 90.1 mt -76.84 -36.35 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.496 -0.557 . . . . 74.140000000000001 109.496 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 39.2 mt-10 -60.83 -36.96 80.44 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.134 -0.484 . . . . 65.510000000000005 109.706 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 58.5 tttm -57.53 -57.0 14.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.107 -0.497 . . . . 74.540000000000006 110.309 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD11 HD11 ' A' ' 123' ' ' ILE . 48.1 mt -63.07 -32.17 73.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.989 -0.551 . . . . 74.510000000000005 110.319 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.85 -42.53 94.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 43.32 110.839 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.54 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 52.9 mm-40 -74.61 -39.1 62.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.159 0.504 . . . . 74.129999999999995 110.841 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.33 -39.04 85.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.678 -0.692 . . . . 75.409999999999997 110.801 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -105.05 5.29 32.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.475 -0.784 . . . . 75.219999999999999 112.047 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.88 -19.12 2.31 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.761 0.652 . . . . 72.120000000000005 112.761 -171.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -71.08 -27.46 63.63 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.647 0.24 . . . . 74.019999999999996 111.647 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -134.81 10.25 3.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.34 0.256 . . . . 60.25 111.329 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 43' ' ' LEU . 50.9 t -135.86 142.13 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.052 0.453 . . . . 74.219999999999999 111.153 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.0 119.78 9.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.911 -0.774 . . . . 72.219999999999999 108.911 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.461 HG23 ' HB2' ' A' ' 45' ' ' LEU . 34.3 mt -102.45 129.31 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.612 0.244 . . . . 73.140000000000001 110.542 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -115.98 173.86 6.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.439 -0.578 . . . . 73.109999999999999 109.439 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -155.37 136.02 13.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.978 -0.379 . . . . 62.329999999999998 109.978 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.9 mt -79.71 79.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.073 -0.714 . . . . 75.129999999999995 109.073 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -81.23 56.18 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.385 0.612 . . . . 60.109999999999999 110.405 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -123.52 92.85 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.764 -0.653 . . . . 65.230000000000004 109.765 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -59.91 -17.66 39.03 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.84 -0.618 . . . . 64.209999999999994 111.211 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.66 -25.94 62.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.608 -0.724 . . . . 63.520000000000003 111.012 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -109.59 104.88 13.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.88 0.372 . . . . 73.530000000000001 110.324 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -99.13 -30.43 12.3 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.016 -0.538 . . . . 73.430000000000007 110.414 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 36.0 t70 -47.25 -47.13 24.91 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.611 -0.722 . . . . 63.32 111.883 -171.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.95 -41.05 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.237 -0.438 . . . . 71.010000000000005 111.128 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.37 95.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.222 0.534 . . . . 74.239999999999995 110.168 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 m -67.87 -33.24 74.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 72.420000000000002 110.697 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.9 mm-40 -66.27 -51.46 57.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 74.510000000000005 110.597 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -75.1 -17.33 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 73.109999999999999 110.461 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.26 45.07 20.63 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.011 -0.614 . . . . 65.549999999999997 112.533 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG11 ' OG1' ' A' ' 98' ' ' THR . 98.8 t -58.27 110.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.033 0.444 . . . . 75.310000000000002 110.175 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.7 m -85.94 -34.84 20.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.789 -0.642 . . . . 72.219999999999999 110.956 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.79 156.6 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 52.439999999999998 109.97 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.688 ' H ' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.31 144.92 33.2 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 110.043 -177.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 4.9 Cg_exo -78.01 173.41 57.08 Favored 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.074 -1.219 . . . . 64.140000000000001 112.637 -0.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.498 HG22 HG12 ' A' ' 112' ' ' ILE . 27.8 m -138.39 127.05 23.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.706 . . . . 74.0 109.979 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' HG21 ' A' ' 111' ' ' VAL . 48.6 mm -110.14 110.81 33.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.072 0.463 . . . . 71.439999999999998 110.984 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 100' ' ' LEU . 2.8 mm? -90.63 123.69 34.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.403 -0.817 . . . . 72.510000000000005 109.519 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.601 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -92.49 135.99 33.59 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.689 -0.486 . . . . 65.120000000000005 109.689 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 85.2 m-85 -141.58 142.66 33.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.249 -1.019 . . . . 74.140000000000001 108.249 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 26.7 ttpp -147.23 126.95 13.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.236 -0.586 . . . . 74.239999999999995 110.89 -175.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t30 63.32 25.55 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.625 0.726 . . . . 72.219999999999999 109.603 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.69 19.37 74.84 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.317 -0.856 . . . . 43.109999999999999 111.926 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -117.85 153.94 32.67 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 122.216 0.206 . . . . 63.039999999999999 110.58 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.49 ' O ' HD23 ' A' ' 108' ' ' LEU . 16.6 tppt? -56.48 139.75 48.26 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 124.121 0.888 . . . . 71.430000000000007 111.668 -176.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -149.99 168.37 24.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.8 -1.091 . . . . 72.319999999999993 108.707 -171.295 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 101' ' ' MET . 39.6 m -70.64 -177.07 1.43 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.921 0.712 . . . . 72.409999999999997 112.921 -166.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.466 ' HG3' HD11 ' A' ' 100' ' ' LEU . 47.4 tt0 -146.07 148.38 32.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.154 -0.341 . . . . 74.540000000000006 111.085 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.522 HG21 ' HB ' ' A' ' 99' ' ' ILE . 15.3 m -137.15 128.23 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.244 -0.434 . . . . 73.030000000000001 109.882 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.498 HG12 HG22 ' A' ' 98' ' ' THR . 67.5 mt -114.92 138.08 46.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.29 -0.414 . . . . 62.140000000000001 110.331 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.86 161.42 21.0 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.147 -0.549 . . . . 60.32 112.227 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.84 86.28 6.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.854 0.359 . . . . 75.109999999999999 110.553 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.6 t0 -139.15 93.78 2.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.159 0.504 . . . . 64.239999999999995 110.251 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.1 tp -60.3 -32.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.596 -0.729 . . . . 62.149999999999999 111.018 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 t -68.95 -46.87 67.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.021 -0.536 . . . . 72.200000000000003 109.976 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -67.46 -43.31 81.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 55.140000000000001 110.217 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 115' ' ' ASP . 79.6 mt -58.75 -52.4 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.4 . . . . 72.120000000000005 110.956 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -39.09 83.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 120.87 0.367 . . . . 74.510000000000005 110.034 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.541 ' HA ' HD22 ' A' ' 124' ' ' ASN . 58.7 m -54.56 -50.6 67.55 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.122 -0.49 . . . . 52.409999999999997 110.448 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.505 ' HB3' ' HE2' ' A' ' 101' ' ' MET . 33.3 mm-40 -64.17 -39.06 93.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.62 -0.264 . . . . 73.040000000000006 111.193 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.451 HD11 HD11 ' A' ' 66' ' ' LEU . 97.7 mt -55.79 -55.81 15.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.643 -0.423 . . . . 73.409999999999997 110.314 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.541 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.3 p30 -69.79 -27.36 64.84 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.428 -0.509 . . . . 70.219999999999999 110.393 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -70.69 -33.87 71.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.254 -0.43 . . . . 72.200000000000003 110.837 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.513 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.8 OUTLIER -86.07 -29.94 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 71.200000000000003 110.565 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.86 -49.68 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 74.310000000000002 110.904 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.696 -0.669 . . . . 71.430000000000007 110.124 -175.352 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.507 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 91.9 mmm . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.036 0.446 . . . . 71.319999999999993 110.43 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.68 107.35 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 73.430000000000007 110.079 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.5 126.54 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.17 -0.468 . . . . 70.140000000000001 110.59 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.17 124.38 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.846 -0.798 . . . . 71.409999999999997 108.846 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 34' ' ' LYS . 28.8 pt -129.32 158.02 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 73.540000000000006 110.859 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.18 165.14 53.91 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.845 -0.616 . . . . 75.430000000000007 112.253 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.87 -50.11 61.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 65.030000000000001 111.057 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.5 m -71.87 -10.52 59.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.218 -0.446 . . . . 74.420000000000002 111.51 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -89.21 -4.96 58.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.689 -0.232 . . . . 75.540000000000006 111.233 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' HD2' HD12 ' A' ' 79' ' ' ILE . 83.1 t80 -58.11 -62.49 1.79 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.789 0.328 . . . . 70.519999999999996 110.9 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.54 -39.35 93.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 73.420000000000002 109.994 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.0 -57.37 10.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.402 -0.817 . . . . 43.219999999999999 110.634 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HG3' HG21 ' A' ' 26' ' ' ILE . 43.9 mmtm -79.22 -18.37 53.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.991 -0.55 . . . . 63.340000000000003 112.137 -172.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 31' ' ' PHE . 55.0 t -74.03 -36.16 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.801 0.334 . . . . 74.140000000000001 110.334 171.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.4 p -85.98 -20.07 29.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.774 0.321 . . . . 53.409999999999997 111.02 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -68.5 4.45 1.37 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 111.936 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.848 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.4 p -58.13 137.95 56.54 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.219 -0.289 . . . . 71.299999999999997 110.219 175.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.25 -67.21 0.43 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 110.247 -0.279 . . . . 72.420000000000002 110.247 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.409 ' H ' HG12 ' A' ' 42' ' ' ILE . 5.3 p-10 -162.06 128.7 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.171 -0.307 . . . . 63.420000000000002 110.171 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.84 18.17 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.042 0.537 . . . . 72.450000000000003 112.248 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 40' ' ' ASP . 49.2 mm -71.51 136.26 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 116.524 -0.307 . . . . 70.510000000000005 110.497 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 74' ' ' VAL . 57.2 tp -80.06 126.26 30.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 72.329999999999998 110.158 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.87 119.24 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 72.450000000000003 110.381 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.52 ' HB2' HG12 ' A' ' 76' ' ' ILE . 3.3 mp -107.09 115.31 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 73.209999999999994 109.529 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.74 105.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.223 -0.658 . . . . 72.450000000000003 109.223 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 98' ' ' THR . 21.9 t0 -85.92 153.11 22.43 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.722 -0.217 . . . . 62.130000000000003 110.642 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.68 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 17.4 p90 -50.73 152.64 1.97 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.054 -0.521 . . . . 65.219999999999999 111.64 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -128.77 98.48 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.836 -0.62 . . . . 74.340000000000003 109.707 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.98 149.19 10.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 54.329999999999998 110.244 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.52 39.48 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.902 2.402 . . . . 64.329999999999998 112.209 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -145.03 131.49 19.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 73.150000000000006 110.375 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.413 ' HA ' HG12 ' A' ' 96' ' ' ILE . 25.9 p -166.18 154.55 10.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 63.299999999999997 109.912 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.77 -82.82 1.67 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 112.018 -0.433 . . . . 43.399999999999999 112.018 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.584 ' HB2' HD22 ' A' ' 59' ' ' LEU . 3.6 Cg_exo -77.66 50.32 3.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.295 2.663 . . . . 54.219999999999999 111.576 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.68 -51.61 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.643 -0.708 . . . . 71.349999999999994 110.837 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -54.32 -38.13 65.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.763 -0.653 . . . . 74.439999999999998 111.903 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.583 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.7 m -75.57 -59.19 2.86 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.706 0.765 . . . . 74.230000000000004 112.144 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.584 HD22 ' HB2' ' A' ' 55' ' ' PRO . 4.5 mm? -66.28 -34.44 78.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.716 -0.675 . . . . 64.099999999999994 112.762 -168.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.428 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 48.9 mt-10 -56.61 -60.18 10.04 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 120.602 -0.439 . . . . 65.120000000000005 110.634 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.7 Cg_endo -63.19 -34.63 67.71 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.003 1.802 . . . . 64.230000000000004 112.199 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 58' ' ' SER . 41.8 mt-30 -59.89 -41.84 92.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.421 -0.512 . . . . 75.209999999999994 110.947 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.25 -42.69 79.27 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.479 -0.328 . . . . 74.140000000000001 110.432 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 44.3 mt-10 -57.75 -37.2 73.19 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.057 -0.52 . . . . 65.510000000000005 110.539 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -66.82 -53.0 37.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.239 -0.437 . . . . 74.540000000000006 111.156 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.439 HD12 HD13 ' A' ' 123' ' ' ILE . 55.4 mt -60.09 -34.98 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.039 0.447 . . . . 74.510000000000005 110.174 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.14 -53.37 50.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.753 -0.658 . . . . 43.32 110.151 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.507 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 15.6 mm-40 -57.08 -31.91 65.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.532 -0.304 . . . . 74.129999999999995 111.683 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -78.06 -47.15 18.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 111.162 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -104.59 4.79 33.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.586 . . . . 75.219999999999999 112.437 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.3 t -52.9 -19.69 2.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.411 0.523 . . . . 72.120000000000005 112.411 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.77 -39.98 78.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.8 0.333 . . . . 74.019999999999996 110.497 176.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -125.45 9.72 7.85 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.26 -0.427 . . . . 60.25 111.236 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 71' ' ' THR . 41.0 t -132.17 138.91 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.885 0.374 . . . . 74.219999999999999 111.587 -176.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -144.87 133.67 22.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.942 -0.572 . . . . 72.219999999999999 109.492 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.52 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -113.98 143.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.498 0.19 . . . . 73.140000000000001 110.747 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -131.61 162.61 29.95 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.175 0.512 . . . . 73.109999999999999 111.129 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -137.1 142.71 42.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.013 -0.994 . . . . 62.329999999999998 108.606 170.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.565 HD12 ' HD2' ' A' ' 31' ' ' PHE . 43.8 mm -90.91 152.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.668 -0.493 . . . . 75.129999999999995 109.668 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -94.8 -169.31 1.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.205 -0.294 . . . . 60.109999999999999 110.205 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 mt 61.61 60.88 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 122.143 0.973 . . . . 65.230000000000004 109.699 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -59.74 -18.81 45.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.528 -1.215 . . . . 64.209999999999994 110.75 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.15 -17.9 62.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.593 -0.731 . . . . 63.520000000000003 111.435 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.8 67.72 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.405 0.621 . . . . 73.530000000000001 111.143 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -61.05 -30.5 70.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.27 -0.877 . . . . 73.430000000000007 110.811 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.65 -42.23 33.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.925 -0.579 . . . . 63.32 110.736 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.58 -36.56 60.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 71.010000000000005 110.717 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.013 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 m -60.13 -40.69 90.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.882 -0.599 . . . . 72.420000000000002 110.922 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -65.59 -41.06 93.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.918 -0.583 . . . . 74.510000000000005 111.426 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -90.65 -7.48 52.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 73.109999999999999 111.428 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.28 21.6 58.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.24 -0.505 . . . . 65.549999999999997 113.072 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 98' ' ' THR . 46.9 t -73.13 124.44 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.949 -0.389 . . . . 75.310000000000002 109.949 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 t -151.42 -42.26 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 72.219999999999999 110.324 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.66 137.83 40.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.304 -0.407 . . . . 52.439999999999998 110.096 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 96' ' ' ILE . 2.4 pp -110.09 154.51 42.72 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.387 -0.369 . . . . 75.510000000000005 111.592 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.07 171.9 63.12 Favored 'Cis proline' 0 C--N 1.352 0.753 0 C-N-CA 123.421 -1.491 . . . . 64.140000000000001 111.894 -5.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.68 ' HB ' ' HB3' ' A' ' 48' ' ' PHE . 83.8 m -130.21 110.93 11.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.355 -0.609 . . . . 74.0 109.355 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.422 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.6 mm -115.37 112.78 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 71.439999999999998 110.626 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 100' ' ' LEU . 6.6 mp -94.96 123.27 38.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.44 -0.578 . . . . 72.510000000000005 109.44 174.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.493 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 15.0 mmt -95.27 139.11 32.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.81 0.338 . . . . 65.120000000000005 110.499 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -141.04 149.33 41.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.075 -0.713 . . . . 74.140000000000001 109.075 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 103' ' ' LYS . 4.2 ttmp? -133.85 116.31 15.51 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.595 -0.521 . . . . 74.239999999999995 109.595 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.848 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.8 p-10 48.15 32.51 3.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.316 0.646 . . . . 72.219999999999999 112.202 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.87 -14.8 60.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.395 -0.431 . . . . 43.109999999999999 112.609 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -75.43 140.08 42.69 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.192 0.597 . . . . 63.039999999999999 110.176 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 108' ' ' LEU . 3.3 tmmm? -69.37 132.32 46.2 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.812 -0.631 . . . . 71.430000000000007 110.897 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.8 mm? -133.52 167.8 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.838 -1.074 . . . . 72.319999999999993 110.176 -175.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.71 179.45 2.61 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.476 0.655 . . . . 72.409999999999997 112.342 -169.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -137.85 151.4 48.03 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.657 -0.701 . . . . 74.540000000000006 110.221 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -121.9 131.2 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 114.879 -1.055 . . . . 73.030000000000001 109.996 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.5 mm -129.85 125.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 62.140000000000001 109.992 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.06 153.31 19.2 Favored Glycine 0 C--N 1.323 -0.15 0 CA-C-N 115.834 -0.621 . . . . 60.32 112.234 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.479 ' HB2' HD21 ' A' ' 59' ' ' LEU . . . -79.66 80.03 6.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.062 0.458 . . . . 75.109999999999999 111.019 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.68 94.51 3.3 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.545 -0.752 . . . . 64.239999999999995 109.075 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.35 -26.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 62.149999999999999 110.567 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.7 t -66.55 -42.12 87.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.865 -0.607 . . . . 72.200000000000003 109.647 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.83 -44.43 77.25 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 55.140000000000001 109.916 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.2 mt -56.12 -56.2 14.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.14 -0.482 . . . . 72.120000000000005 110.824 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.475 ' O ' HD12 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.61 -35.34 69.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.189 -0.46 . . . . 74.510000000000005 109.881 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.542 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 23.0 t -57.49 -46.35 83.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.003 -0.369 . . . . 52.409999999999997 110.003 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.56 -43.54 93.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.326 -0.397 . . . . 73.040000000000006 110.497 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.439 HD13 HD12 ' A' ' 66' ' ' LEU . 96.6 mt -53.45 -55.64 12.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.818 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 121' ' ' SER . 8.4 p30 -70.95 -27.91 64.09 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.946 -0.302 . . . . 70.219999999999999 110.3 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -63.36 -33.23 75.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.036 0.446 . . . . 72.200000000000003 110.125 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -79.71 -40.48 28.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.882 -0.599 . . . . 71.200000000000003 111.16 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.24 -42.21 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.085 0.469 . . . . 74.310000000000002 110.733 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.307 -0.854 . . . . 71.430000000000007 109.911 179.005 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.488 0.185 . . . . 75.420000000000002 110.516 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.39 123.46 0.8 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.517 -0.31 . . . . 51.25 110.522 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -91.41 61.6 4.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.516 0.674 . . . . 65.040000000000006 110.411 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -99.64 101.15 12.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.715 -0.675 . . . . 71.219999999999999 110.59 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -169.31 116.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 71.299999999999997 110.172 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -161.77 146.08 12.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.896 -0.593 . . . . 75.120000000000005 109.522 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -85.5 -78.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.848 0.356 . . . . 65.209999999999994 110.445 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -115.56 -158.8 0.69 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.979 -0.749 . . . . 74.329999999999998 108.979 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -135.62 120.27 18.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.951 0.405 . . . . 73.109999999999999 109.915 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.54 -161.84 11.75 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.165 -0.774 . . . . 70.450000000000003 111.165 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -72.53 78.51 1.06 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.756 0.789 . . . . 75.420000000000002 110.501 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.17 127.49 50.1 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.314 -0.995 . . . . 74.230000000000004 108.314 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.577 ' HG2' ' H ' ' A' ' 14' ' ' ALA . 30.4 tt0 -144.49 177.46 8.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.833 -0.432 . . . . 75.420000000000002 109.833 -174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.577 ' H ' ' HG2' ' A' ' 13' ' ' GLU . . . -160.62 29.7 0.16 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.313 -0.625 . . . . 74.349999999999994 109.313 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.504 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 22.4 mm-40 57.81 18.72 5.09 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.303 -0.862 . . . . 71.239999999999995 110.72 -171.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.3 t -83.48 -171.58 3.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.377 -0.828 . . . . 70.150000000000006 109.338 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -146.28 -80.45 0.16 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.708 0.289 . . . . 71.400000000000006 110.298 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.27 163.66 39.2 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.263 -0.494 . . . . 74.209999999999994 112.313 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -73.18 122.97 8.45 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.638 2.225 . . . . 75.329999999999998 111.501 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.81 39.83 0.04 OUTLIER Glycine 0 C--O 1.236 0.229 0 N-CA-C 111.937 -0.465 . . . . 31.0 111.937 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 m -62.33 131.97 51.09 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.33 0.252 . . . . 73.120000000000005 111.213 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.3 mmm -102.34 -21.53 14.28 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.341 -0.39 . . . . 71.319999999999993 110.638 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.58 96.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.953 0.406 . . . . 73.430000000000007 110.019 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 7.3 tp10 -67.09 125.87 27.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.759 -0.655 . . . . 70.140000000000001 110.862 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -85.8 128.12 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 71.409999999999997 109.423 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 31' ' ' PHE . 39.7 pt -134.62 146.37 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.728 0.299 . . . . 73.540000000000006 110.989 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.32 173.65 37.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.97 -0.559 . . . . 75.430000000000007 112.035 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.49 -47.21 27.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.074 0.549 . . . . 65.030000000000001 112.21 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -74.81 -20.97 59.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.107 -0.497 . . . . 74.420000000000002 111.513 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.8 -13.44 45.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 75.540000000000006 111.379 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.5 ' HA ' HD11 ' A' ' 26' ' ' ILE . 72.4 t80 -56.03 -62.25 1.83 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.952 0.353 . . . . 70.519999999999996 111.952 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -39.25 94.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.157 0.503 . . . . 73.420000000000002 110.112 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -55.7 -53.71 53.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.81 . . . . 43.219999999999999 110.395 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG3' HG23 ' A' ' 26' ' ' ILE . 74.6 mmtt -69.07 -32.9 72.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.444 -0.798 . . . . 63.340000000000003 111.375 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 31' ' ' PHE . 77.7 t -66.93 -36.18 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.967 0.413 . . . . 74.140000000000001 110.652 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 p -86.06 -19.63 29.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.381 -0.372 . . . . 53.409999999999997 111.525 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -63.29 -11.15 19.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 112.103 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.661 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 21.6 p -61.11 139.9 57.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.224 0.21 . . . . 71.299999999999997 111.482 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -72.15 -88.78 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.558 -0.292 . . . . 72.420000000000002 110.732 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.5 136.07 24.25 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.088 -0.338 . . . . 63.420000000000002 110.088 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 m120 58.22 16.43 3.95 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.627 -0.715 . . . . 72.450000000000003 111.897 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 41.5 mm -76.22 105.24 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.533 -0.543 . . . . 70.510000000000005 109.533 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 74' ' ' VAL . 53.5 tp -73.52 117.7 15.6 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.548 0.69 . . . . 72.329999999999998 109.974 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.504 HD13 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -102.0 113.0 37.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.959 . . . . 72.450000000000003 110.679 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.583 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.5 mp -97.28 118.75 34.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.313 -0.625 . . . . 73.209999999999994 109.313 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.83 107.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.935 -0.395 . . . . 72.450000000000003 109.935 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.67 136.69 36.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.983 -0.553 . . . . 62.130000000000003 111.246 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 100' ' ' LEU . 34.3 m-85 -111.13 81.9 1.51 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.435 0.636 . . . . 65.219999999999999 109.819 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.407 ' CZ2' ' SG ' ' A' ' 53' ' ' CYS . 23.0 t-105 -68.18 92.75 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.963 -1.017 . . . . 74.340000000000003 110.501 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 96' ' ' ILE . . . -77.09 137.94 65.15 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.324 -0.398 . . . . 54.329999999999998 110.074 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.34 -8.44 8.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.374 2.716 . . . . 64.329999999999998 113.763 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.71 ' HB3' HG22 ' A' ' 96' ' ' ILE . 67.5 t-105 -65.6 -52.42 52.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.632 -0.507 . . . . 73.150000000000006 109.632 177.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.407 ' SG ' ' CZ2' ' A' ' 49' ' ' TRP . 4.7 t 54.99 90.73 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.316 -0.856 . . . . 63.299999999999997 112.17 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.29 -100.88 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.138 -0.553 . . . . 43.399999999999999 111.949 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.93 6.29 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.017 2.478 . . . . 54.219999999999999 112.292 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.404 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 4.8 p -50.82 -29.74 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 71.349999999999994 111.449 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.417 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.07 -51.74 63.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.504 -177.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.2 m -75.33 -45.12 41.47 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.411 0.624 . . . . 74.230000000000004 111.286 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -63.35 -31.59 72.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 64.099999999999994 112.571 -172.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 1.9 tm-20 -61.55 -58.21 19.95 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.82 -0.352 . . . . 65.120000000000005 110.426 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 26.4 Cg_endo -63.39 -28.44 71.49 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.514 1.476 . . . . 64.230000000000004 112.039 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.578 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 42.8 mt-30 -69.53 -34.8 74.76 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 75.209999999999994 110.991 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 77.5 mt -68.89 -43.54 75.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.471 -0.566 . . . . 74.140000000000001 109.471 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 6.2 mm-40 -59.32 -35.8 74.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 65.510000000000005 110.218 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 11.6 ttmm -54.51 -57.69 10.4 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.386 0.612 . . . . 74.540000000000006 110.225 174.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.457 HD12 HD11 ' A' ' 123' ' ' ILE . 43.1 mt -69.47 -28.74 66.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.393 -0.821 . . . . 74.510000000000005 110.18 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.17 -44.6 79.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 43.32 110.273 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 85.9 mt-30 -73.69 -37.34 65.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 74.129999999999995 110.724 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -66.03 -45.26 82.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.028 0.442 . . . . 75.409999999999997 111.051 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -100.18 5.04 44.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.612 0.597 . . . . 75.219999999999999 112.612 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -53.64 -19.69 4.32 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.806 0.669 . . . . 72.120000000000005 112.806 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.6 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 10.5 pt-20 -66.98 -28.43 68.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.646 0.26 . . . . 74.019999999999996 111.13 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.6 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 44.7 m-80 -131.06 9.49 4.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.536 -0.302 . . . . 60.25 111.22 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 43' ' ' LEU . 39.7 t -136.39 141.2 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.989 0.423 . . . . 74.219999999999999 111.574 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -142.1 119.79 11.82 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.838 -0.801 . . . . 72.219999999999999 108.838 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.583 HG12 ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -99.61 138.89 22.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.761 0.315 . . . . 73.140000000000001 110.388 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 87.6 m-85 -124.55 160.27 28.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.872 -0.604 . . . . 73.109999999999999 109.457 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -137.33 120.66 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.252 -1.018 . . . . 62.329999999999998 108.252 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.77 132.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.742 -0.663 . . . . 75.129999999999995 111.561 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.01 96.32 7.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.613 -0.721 . . . . 60.109999999999999 109.471 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.462 HG13 ' HB3' ' A' ' 84' ' ' ASN . 10.6 tp -154.21 34.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 122.057 0.932 . . . . 65.230000000000004 108.921 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -18.82 1.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.473 -1.24 . . . . 64.209999999999994 113.751 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.67 -36.11 38.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.861 0.363 . . . . 63.520000000000003 111.167 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' HB3' HG13 ' A' ' 81' ' ' ILE . 4.6 t-20 -95.97 103.23 15.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 73.530000000000001 110.814 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.17 -22.44 55.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 73.430000000000007 110.387 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.9 m-20 -51.73 -36.1 45.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.034 -0.53 . . . . 63.32 111.089 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.0 t -52.85 -37.23 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 71.010000000000005 110.712 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.402 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . . . -64.63 -50.95 65.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.002 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -62.56 -33.09 74.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.633 -0.712 . . . . 72.420000000000002 111.171 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -74.49 -47.22 34.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 74.510000000000005 111.229 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.44 ' HB3' HD22 ' A' ' 100' ' ' LEU . 58.8 m-85 -87.07 -7.86 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.354 -0.385 . . . . 73.109999999999999 111.59 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 44.26 6.24 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.833 -0.699 . . . . 65.549999999999997 113.053 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 88' ' ' ALA . 61.6 t -84.12 123.54 39.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.392 -0.596 . . . . 75.310000000000002 109.392 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -136.03 6.69 3.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.441 -0.345 . . . . 72.219999999999999 111.041 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.24 176.26 11.02 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.641 0.258 . . . . 52.439999999999998 110.631 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.71 HG22 ' HB3' ' A' ' 52' ' ' TRP . 1.3 pp -128.13 108.2 19.79 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.179 -0.464 . . . . 75.510000000000005 110.997 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -89.47 -162.49 1.88 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.001 -1.25 . . . . 64.140000000000001 112.519 -0.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.3 m -146.95 126.29 13.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.578 -0.527 . . . . 74.0 109.578 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.575 ' HB ' HG22 ' A' ' 111' ' ' VAL . 48.3 mm -113.25 119.56 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.912 -0.586 . . . . 71.439999999999998 111.217 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.463 HD12 ' CE1' ' A' ' 48' ' ' PHE . 9.1 mp -100.85 149.85 23.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 72.510000000000005 109.328 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.498 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 24.6 mtt -115.69 146.67 41.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 65.120000000000005 110.631 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -143.93 150.73 38.8 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.253 -1.017 . . . . 74.140000000000001 108.253 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -149.28 120.65 7.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.613 -0.435 . . . . 74.239999999999995 110.942 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.661 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 5.7 t30 61.85 27.09 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.486 0.66 . . . . 72.219999999999999 109.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.89 -3.39 70.38 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.45 -0.796 . . . . 43.109999999999999 112.27 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -90.73 147.35 23.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.884 -0.413 . . . . 63.039999999999999 109.884 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.48 135.49 51.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.487 0.66 . . . . 71.430000000000007 110.845 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -135.76 168.19 19.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.719 -1.128 . . . . 72.319999999999993 108.947 -172.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.17 166.95 18.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.624 0.726 . . . . 72.409999999999997 111.964 -165.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.68 128.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.209 -0.905 . . . . 74.540000000000006 110.042 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 99' ' ' ILE . 15.7 m -113.14 109.41 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.633 0.73 . . . . 73.030000000000001 109.728 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.18 122.93 49.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.888 . . . . 62.140000000000001 110.198 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.75 -163.72 14.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.173 -0.537 . . . . 60.32 111.792 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.26 72.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.007 0.432 . . . . 75.109999999999999 110.697 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.6 t70 -125.03 92.37 3.63 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.745 -0.661 . . . . 64.239999999999995 109.348 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.84 -28.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 62.149999999999999 110.758 -173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.5 t -64.7 -45.8 85.07 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.041 -0.527 . . . . 72.200000000000003 109.93 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -67.96 -38.51 82.86 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.872 -0.603 . . . . 55.140000000000001 109.946 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.5 mt -60.25 -56.21 19.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.848 -0.615 . . . . 72.120000000000005 110.514 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.406 ' HA ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.46 -39.46 82.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 120.762 0.315 . . . . 74.510000000000005 110.165 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -54.41 -52.16 62.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.928 -0.578 . . . . 52.409999999999997 110.252 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.88 -32.5 70.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.357 -0.383 . . . . 73.040000000000006 111.278 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 119' ' ' ILE . 96.7 mt -57.64 -56.2 16.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 120.59 -0.444 . . . . 73.409999999999997 110.112 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -68.42 -32.94 73.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.499 -0.481 . . . . 70.219999999999999 110.039 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.73 -29.25 69.19 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.696 -0.684 . . . . 72.200000000000003 110.991 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.498 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.2 m-20 -98.11 -20.83 17.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.436 -0.347 . . . . 71.200000000000003 111.82 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.9 mt -74.48 -47.64 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.768 -0.456 . . . . 74.310000000000002 109.768 172.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.697 -0.683 . . . . 71.430000000000007 109.579 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.958 0.409 . . . . 75.420000000000002 110.313 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.44 138.91 55.66 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.302 -0.408 . . . . 51.25 110.923 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -164.03 132.91 3.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.354 -0.385 . . . . 65.040000000000006 110.334 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.02 -55.87 2.3 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.043 0.449 . . . . 71.219999999999999 109.969 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -170.75 88.97 0.13 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.811 -0.631 . . . . 71.299999999999997 109.978 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -68.95 111.47 4.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.329 -0.619 . . . . 75.120000000000005 109.329 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -125.39 170.83 10.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.859 0.362 . . . . 65.209999999999994 110.705 -174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -94.49 152.12 18.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.49 -0.559 . . . . 74.329999999999998 109.49 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.4 mtm -77.6 78.59 4.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.045 0.45 . . . . 73.109999999999999 110.349 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.29 108.8 3.46 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.417 -0.673 . . . . 70.450000000000003 111.417 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.7 m -89.82 91.95 8.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.844 0.354 . . . . 75.420000000000002 111.145 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.95 66.64 9.69 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.47 -0.567 . . . . 74.230000000000004 109.47 175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 38.7 tt0 50.82 76.55 0.15 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.573 -0.739 . . . . 75.420000000000002 110.479 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.13 77.26 4.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.864 -0.607 . . . . 74.349999999999994 111.173 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.468 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 15.7 mm100 -92.82 133.78 35.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.96 -0.564 . . . . 71.239999999999995 109.521 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.6 t -159.18 -179.62 8.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.521 -0.309 . . . . 70.150000000000006 110.604 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 62.39 15.99 8.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.422 0.629 . . . . 71.400000000000006 110.764 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.17 114.2 3.35 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 111.409 -0.677 . . . . 74.209999999999994 111.409 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.54 173.81 12.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.546 2.164 . . . . 75.329999999999998 112.216 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.49 -145.25 4.44 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.859 -0.496 . . . . 31.0 111.859 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -76.28 169.67 17.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.291 0.236 . . . . 73.120000000000005 110.395 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.416 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 81.8 mmm -74.85 -9.01 58.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.651 0.262 . . . . 71.319999999999993 111.444 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.45 HG23 ' HE2' ' A' ' 78' ' ' LYS . 13.2 mm -93.96 119.94 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.476 . . . . 73.430000000000007 109.716 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 31.0 tt0 -86.82 118.45 26.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.904 0.383 . . . . 70.140000000000001 110.601 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -80.72 137.77 36.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.222 -0.445 . . . . 71.409999999999997 110.339 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.453 HG23 ' HG3' ' A' ' 34' ' ' LYS . 42.0 pt -139.53 154.51 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.562 0.22 . . . . 73.540000000000006 110.991 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.66 176.53 28.72 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.3 -0.476 . . . . 75.430000000000007 112.716 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.06 -55.1 5.92 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.367 0.667 . . . . 65.030000000000001 112.177 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 t -70.39 -34.54 72.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.941 0.401 . . . . 74.420000000000002 110.673 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.22 -24.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 75.540000000000006 111.326 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' O ' HG21 ' A' ' 35' ' ' VAL . 87.9 t80 -49.61 -56.96 8.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 70.519999999999996 110.473 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.25 -55.2 30.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.136 -0.484 . . . . 73.420000000000002 110.507 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -52.54 -46.37 66.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.431 -0.804 . . . . 43.219999999999999 111.405 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HG3' HG23 ' A' ' 26' ' ' ILE . 72.2 mmtt -77.17 -24.28 51.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.394 -0.821 . . . . 63.340000000000003 111.56 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.51 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 90.7 t -79.18 -33.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.841 -0.429 . . . . 74.140000000000001 109.841 174.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.2 p -79.58 -19.64 48.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.974 0.416 . . . . 53.409999999999997 110.479 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -61.7 -23.38 66.08 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.863 -0.608 . . . . 74.540000000000006 111.722 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.4 p -74.78 91.46 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 71.299999999999997 110.572 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -69.98 -61.71 1.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 72.420000000000002 111.511 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' ILE . 5.8 m-20 -123.62 120.87 34.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.483 0.182 . . . . 63.420000000000002 110.511 -172.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 51.04 3.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.1 1.519 . . . . 72.450000000000003 115.1 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.5 mm -63.92 124.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 118.134 0.424 . . . . 70.510000000000005 110.824 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -88.65 110.45 20.96 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.876 -0.787 . . . . 72.329999999999998 108.876 177.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 101' ' ' MET . 70.8 mt -90.82 118.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 72.450000000000003 110.734 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.457 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -107.56 109.08 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.41 -0.589 . . . . 73.209999999999994 109.41 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 57.3 t -92.59 106.86 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.046 -0.353 . . . . 72.450000000000003 110.046 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.501 ' HA ' HD11 ' A' ' 99' ' ' ILE . 11.7 t70 -85.74 133.05 34.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.919 -0.582 . . . . 62.130000000000003 111.894 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -94.51 95.23 8.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.71 -0.677 . . . . 65.219999999999999 109.659 172.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.409 ' HZ3' ' HG3' ' A' ' 82' ' ' GLU . 52.4 t90 -66.32 136.26 55.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.48 -0.782 . . . . 74.340000000000003 111.634 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.52 127.25 25.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.547 -0.752 . . . . 54.329999999999998 109.192 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.85 -64.8 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.736 2.291 . . . . 64.329999999999998 112.498 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -95.94 116.8 29.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.222 -0.445 . . . . 73.150000000000006 110.128 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.9 t -158.36 158.65 34.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.284 -0.416 . . . . 63.299999999999997 110.58 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -91.57 -83.56 1.45 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 116.01 -0.541 . . . . 43.399999999999999 112.279 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.49 -25.45 74.03 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.9 2.4 . . . . 54.219999999999999 112.768 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 67.5 m -51.01 -37.26 44.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 71.349999999999994 111.49 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 5.0 ptp180 -62.89 -33.41 75.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.703 0.287 . . . . 74.439999999999998 110.914 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 10.6 m -74.96 -40.53 60.71 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.865 0.84 . . . . 74.230000000000004 110.112 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.81 -29.58 70.08 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.169 -0.923 . . . . 64.099999999999994 111.457 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 46.1 mt-10 -56.78 -60.92 7.96 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.737 -0.385 . . . . 65.120000000000005 110.692 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.423 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.4 Cg_endo -64.33 -33.16 59.91 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.662 1.575 . . . . 64.230000000000004 111.898 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.6 mt-30 -62.62 -38.43 90.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.335 -0.546 . . . . 75.209999999999994 110.63 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 119' ' ' ILE . 77.5 mt -72.5 -43.34 63.77 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.127 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.8 mt-10 -60.56 -32.43 71.51 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.127 -0.488 . . . . 65.510000000000005 110.395 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -66.78 -56.82 8.77 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.025 -0.534 . . . . 74.540000000000006 110.599 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.469 HD12 HD13 ' A' ' 116' ' ' ILE . 63.6 mt -58.19 -32.05 67.88 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.917 -0.583 . . . . 74.510000000000005 109.451 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.22 -52.62 53.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.669 -0.696 . . . . 43.32 110.127 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.2 mt-30 -53.37 -41.56 65.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.78 0.324 . . . . 74.129999999999995 110.806 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.94 -44.41 48.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 111.63 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -101.49 4.82 41.56 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.602 0.593 . . . . 75.219999999999999 112.602 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.0 t -53.31 -23.96 10.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.898 0.703 . . . . 72.120000000000005 112.898 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.04 -18.88 60.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 74.019999999999996 111.141 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -130.94 7.7 4.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.975 -0.557 . . . . 60.25 110.567 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 43' ' ' LEU . 21.5 t -141.15 139.95 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.81 0.338 . . . . 74.219999999999999 111.329 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.478 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 4.7 tppp? -142.29 128.12 19.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.85 -0.614 . . . . 72.219999999999999 109.587 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.457 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.7 mt -107.89 137.78 37.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.788 -0.449 . . . . 73.140000000000001 109.788 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.478 ' CZ ' ' HG2' ' A' ' 75' ' ' LYS . 51.1 m-85 -120.77 147.03 45.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.782 0.325 . . . . 73.109999999999999 111.371 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 23' ' ' ILE . 59.7 mttm -120.69 105.45 10.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.893 -0.78 . . . . 62.329999999999998 108.893 169.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mt -71.29 107.56 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.769 -0.456 . . . . 75.129999999999995 109.769 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.22 68.78 5.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.653 0.739 . . . . 60.109999999999999 111.846 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.7 pt -120.84 55.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.197 -1.408 . . . . 65.230000000000004 107.197 167.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' HZ3' ' A' ' 49' ' ' TRP . 36.5 tt0 -49.74 -32.67 14.16 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.137 -1.847 . . . . 64.209999999999994 113.202 -168.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 -2.9 58.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.209 0.448 . . . . 63.520000000000003 112.209 -174.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.47 78.86 1.4 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 73.530000000000001 111.046 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.74 -24.34 62.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.988 -0.551 . . . . 73.430000000000007 110.388 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.33 -35.04 25.96 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.411 -0.813 . . . . 63.32 111.447 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.54 -39.16 44.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.828 -0.624 . . . . 71.010000000000005 110.828 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.14 77.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.8 -0.636 . . . . 74.239999999999995 110.49 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.1 m -67.52 -34.17 76.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.596 . . . . 72.420000000000002 110.962 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.59 -38.93 92.69 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.79 0.329 . . . . 74.510000000000005 111.137 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -95.39 -6.63 40.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.554 -0.294 . . . . 73.109999999999999 111.624 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.85 59.56 2.07 Favored Glycine 0 C--O 1.236 0.235 0 C-N-CA 120.96 -0.638 . . . . 65.549999999999997 113.215 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.537 HG11 ' OG1' ' A' ' 98' ' ' THR . 81.4 t -89.22 117.75 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.843 0.354 . . . . 75.310000000000002 110.116 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.8 m -95.58 -38.14 10.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 110.91 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 155.23 50.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 52.439999999999998 110.46 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.86 132.28 24.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.209 -0.451 . . . . 75.510000000000005 111.08 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -91.15 -165.32 2.27 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 123.964 -1.265 . . . . 64.140000000000001 111.923 -4.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.537 ' OG1' HG11 ' A' ' 93' ' ' VAL . 54.9 m -143.3 141.2 30.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.23 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 47' ' ' ASP . 46.2 mm -120.76 113.98 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.971 -0.559 . . . . 71.439999999999998 110.794 -175.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.474 HD23 ' HG3' ' A' ' 110' ' ' GLN . 47.4 mt -90.95 123.41 34.42 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.357 -0.609 . . . . 72.510000000000005 109.357 171.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 38.7 mtt -96.73 143.78 27.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.662 -0.415 . . . . 65.120000000000005 110.922 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.65 154.83 45.61 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.412 -0.588 . . . . 74.140000000000001 109.412 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -156.68 120.59 4.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.261 -0.176 . . . . 74.239999999999995 110.972 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.492 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 60.56 25.91 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.832 0.825 . . . . 72.219999999999999 110.182 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.66 -8.21 73.26 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.396 -0.82 . . . . 43.109999999999999 112.514 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -86.86 147.78 25.65 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.973 -0.38 . . . . 63.039999999999999 109.973 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -72.68 127.98 34.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.629 0.728 . . . . 71.430000000000007 110.844 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.405 HD12 ' OD1' ' A' ' 126' ' ' ASN . 3.9 mm? -119.72 168.71 10.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.48 -1.236 . . . . 72.319999999999993 109.315 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -178.91 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.254 0.55 . . . . 72.409999999999997 112.257 -162.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.474 ' HG3' HD23 ' A' ' 100' ' ' LEU . 47.0 tt0 -138.3 143.8 40.15 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 122.014 0.911 . . . . 74.540000000000006 111.205 -172.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 74.0 t -126.26 118.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.566 -1.652 . . . . 73.030000000000001 109.67 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.48 123.28 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.127 -0.323 . . . . 62.140000000000001 110.127 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.39 139.81 10.22 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.71 -0.556 . . . . 60.32 111.71 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.97 80.22 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 75.109999999999999 111.429 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 119' ' ' ILE . 22.2 t0 -123.37 102.45 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 64.239999999999995 110.162 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.469 HD13 HD12 ' A' ' 66' ' ' LEU . 9.1 tp -60.06 -31.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 62.149999999999999 110.634 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.9 t -61.64 -56.63 17.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.395 -0.366 . . . . 72.200000000000003 110.181 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.29 -45.26 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 55.140000000000001 110.699 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.1 mt -61.2 -56.37 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 111.35 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.75 85.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.091 0.472 . . . . 74.510000000000005 110.222 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 t -60.65 -48.16 83.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 52.409999999999997 109.591 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.436 ' HB3' ' HE1' ' A' ' 101' ' ' MET . 73.5 mm-40 -67.69 -35.46 78.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.81 -0.632 . . . . 73.040000000000006 111.111 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.503 ' O ' HG13 ' A' ' 127' ' ' ILE . 93.4 mt -56.46 -55.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.199 -0.667 . . . . 73.409999999999997 109.199 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -63.86 -35.69 81.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 70.219999999999999 110.919 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.85 -46.61 88.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.873 0.368 . . . . 72.200000000000003 111.041 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.458 ' HB2' HD12 ' A' ' 43' ' ' LEU . 56.1 m-80 -91.21 -5.19 55.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 71.200000000000003 111.507 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 123' ' ' ILE . 60.5 mt -78.82 -47.22 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.757 -0.46 . . . . 74.310000000000002 109.757 167.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.464 -0.779 . . . . 71.430000000000007 110.539 -177.141 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.999 0.428 . . . . 75.420000000000002 110.605 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.72 152.72 24.46 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.208 -0.451 . . . . 51.25 111.102 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.72 109.55 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 65.040000000000006 109.278 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -59.95 -55.95 27.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.095 -0.502 . . . . 71.219999999999999 111.308 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -167.68 94.07 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.591 . . . . 71.299999999999997 110.482 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -65.85 85.17 0.08 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.329 0.585 . . . . 75.120000000000005 110.105 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -75.4 153.37 37.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 65.209999999999994 111.017 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -94.04 158.48 15.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.163 -0.472 . . . . 74.329999999999998 110.388 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.9 mtm -76.57 160.05 29.78 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.018 -0.537 . . . . 73.109999999999999 110.443 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.67 159.64 9.48 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.044 -0.598 . . . . 70.450000000000003 112.269 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.0 m -135.07 115.12 13.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.866 0.365 . . . . 75.420000000000002 110.076 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 12' ' ' LEU . 3.0 mm? -88.98 24.21 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 74.230000000000004 110.745 -174.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 60.08 86.09 0.1 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.483 0.659 . . . . 75.420000000000002 110.692 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.52 92.83 0.9 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.154 -0.93 . . . . 74.349999999999994 109.121 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -74.39 99.58 3.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 71.239999999999995 110.326 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -65.25 159.77 23.01 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.739 -0.664 . . . . 70.150000000000006 110.97 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 52.6 tt0 71.32 10.87 6.72 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.696 -0.684 . . . . 71.400000000000006 110.746 -175.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.9 112.37 4.96 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.671 -0.572 . . . . 74.209999999999994 111.671 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.21 154.42 19.02 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.666 2.244 . . . . 75.329999999999998 112.242 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.43 -139.84 4.06 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.01 -0.614 . . . . 31.0 112.358 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.5 m -83.7 170.15 14.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.5 0.32 . . . . 73.120000000000005 110.932 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 89.5 mmm -75.57 -16.95 60.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 111.016 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mm -85.39 111.47 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 73.430000000000007 109.491 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -85.24 112.02 20.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.9 -0.591 . . . . 70.140000000000001 110.806 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -83.61 134.86 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.698 -0.482 . . . . 71.409999999999997 109.698 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.4 pt -132.4 167.72 25.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 120.994 0.426 . . . . 73.540000000000006 111.492 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 178.96 32.45 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.579 -0.737 . . . . 75.430000000000007 112.464 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.86 -55.43 35.03 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.059 0.543 . . . . 65.030000000000001 112.026 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 t -68.82 -2.7 10.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 111.888 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.11 -9.88 25.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.565 0.209 . . . . 75.540000000000006 111.565 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.73 -62.08 1.93 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.82 0.343 . . . . 70.519999999999996 110.761 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.55 -49.27 70.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.927 -0.579 . . . . 73.420000000000002 110.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.2 -53.68 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.361 -0.836 . . . . 43.219999999999999 111.05 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -63.77 -40.11 95.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.035 -0.529 . . . . 63.340000000000003 111.127 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 44' ' ' ILE . 80.0 t -71.29 -40.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.104 0.409 . . . . 74.140000000000001 112.104 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 p -86.06 -29.39 23.44 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.295 0.48 . . . . 53.409999999999997 112.295 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.7 t -82.37 10.39 7.15 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.341 0.497 . . . . 74.540000000000006 112.341 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.776 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.6 p -66.57 142.69 57.41 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.252 -0.28 . . . . 71.299999999999997 110.351 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.08 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.339 0.399 . . . . 72.420000000000002 112.06 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.29 128.85 17.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.37 -0.233 . . . . 63.420000000000002 110.37 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 55.92 11.41 0.71 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.477 0.547 . . . . 72.450000000000003 112.477 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 37.6 mm -62.87 131.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.671 0.272 . . . . 70.510000000000005 110.787 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.52 110.95 21.74 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.335 0.588 . . . . 72.329999999999998 109.544 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 38' ' ' CYS . 73.0 mt -100.32 114.19 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 72.450000000000003 110.659 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.589 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -99.68 128.45 45.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.394 -0.595 . . . . 73.209999999999994 109.394 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 85.6 t -107.42 110.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.738 0.304 . . . . 72.450000000000003 110.366 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.481 ' HA ' HD13 ' A' ' 99' ' ' ILE . 4.2 t70 -85.58 134.49 34.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.847 -0.615 . . . . 62.130000000000003 110.985 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -97.96 119.81 37.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.172 -0.467 . . . . 65.219999999999999 109.862 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.462 ' HB2' ' ND2' ' A' ' 80' ' ' ASN . 51.2 t90 -54.57 108.87 0.43 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.453 -0.794 . . . . 74.340000000000003 111.786 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.6 112.41 39.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.785 -0.643 . . . . 54.329999999999998 109.902 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.41 -68.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.765 2.31 . . . . 64.329999999999998 112.556 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -114.14 110.16 19.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.0 -0.37 . . . . 73.150000000000006 110.0 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.6 t -163.55 135.96 5.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.19 -0.459 . . . . 63.299999999999997 110.142 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.09 -76.78 0.59 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.227 -0.511 . . . . 43.399999999999999 112.599 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.23 -29.31 56.32 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.983 2.455 . . . . 54.219999999999999 112.928 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.629 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 78.8 m -55.48 -31.37 61.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 112.173 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 7.0 ptp85 -69.06 -30.42 68.75 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.997 -0.281 . . . . 74.439999999999998 110.404 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.5 m -74.94 -29.34 60.91 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.295 0.569 . . . . 74.230000000000004 109.798 174.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.64 -29.09 69.03 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.871 -0.604 . . . . 64.099999999999994 111.126 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -57.99 -57.74 23.67 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.93 -0.308 . . . . 65.120000000000005 110.588 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.57 -31.41 41.31 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.113 1.875 . . . . 64.230000000000004 112.641 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.9 mt-30 -62.99 -41.67 99.64 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 120.428 -0.509 . . . . 75.209999999999994 110.286 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.9 mt -65.62 -34.96 79.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 74.140000000000001 109.66 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 31.5 mt-10 -63.56 -37.22 86.47 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.128 -0.487 . . . . 65.510000000000005 110.505 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 1.4 tpmt? -58.35 -56.4 22.63 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.213 0.53 . . . . 74.540000000000006 109.809 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.438 HD12 HD12 ' A' ' 123' ' ' ILE . 19.1 mt -63.51 -36.43 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.467 -0.788 . . . . 74.510000000000005 110.079 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.28 -53.74 44.22 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.125 -0.489 . . . . 43.32 110.176 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 98.2 mt-30 -55.35 -42.41 73.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.746 0.308 . . . . 74.129999999999995 110.909 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.84 -41.51 64.76 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 111.398 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -104.87 4.8 32.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.193 0.812 . . . . 75.219999999999999 113.193 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.0 t -53.5 -20.02 4.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.997 1.11 . . . . 72.120000000000005 113.997 -168.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.97 -18.77 61.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.323 . . . . 74.019999999999996 111.052 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -123.16 -25.77 4.45 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.954 -0.567 . . . . 60.25 110.5 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.472 HG12 HD11 ' A' ' 45' ' ' LEU . 49.5 t -109.02 134.77 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.033 0.444 . . . . 74.219999999999999 111.766 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -138.21 127.36 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 72.219999999999999 109.284 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.589 HG12 ' HB2' ' A' ' 45' ' ' LEU . 41.1 mt -108.71 123.47 64.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.263 -0.273 . . . . 73.140000000000001 110.263 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 88.1 m-85 -107.54 131.9 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.371 -0.377 . . . . 73.109999999999999 111.025 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 58.9 mttm -97.22 99.86 11.33 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.327 -0.62 . . . . 62.329999999999998 109.327 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.3 mt -81.75 83.18 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.452 0.644 . . . . 75.129999999999995 109.338 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 49' ' ' TRP . 12.9 m120 -86.64 78.02 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.759 -0.655 . . . . 60.109999999999999 110.712 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' HD21 ' A' ' 84' ' ' ASN . 18.4 pt -112.68 64.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.405 -0.816 . . . . 65.230000000000004 109.337 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.39 -32.46 38.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.41 -1.268 . . . . 64.209999999999994 112.542 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.54 -15.58 62.29 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.976 0.417 . . . . 63.520000000000003 111.367 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.43 HD21 ' HB ' ' A' ' 81' ' ' ILE . 30.1 m-80 -105.53 76.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 73.530000000000001 110.573 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -62.94 -33.17 74.78 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.933 -0.576 . . . . 73.430000000000007 110.7 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.8 m-20 -51.55 -32.14 27.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.825 -0.625 . . . . 63.32 111.651 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -55.89 -39.64 58.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.37 . . . . 71.010000000000005 110.679 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.64 96.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 74.239999999999995 109.918 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.7 m -64.57 -39.24 93.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.551 -0.75 . . . . 72.420000000000002 110.744 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.5 mm100 -63.27 -52.21 62.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.176 -0.466 . . . . 74.510000000000005 110.727 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -81.52 -11.78 59.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.989 -0.55 . . . . 73.109999999999999 111.16 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.71 44.81 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.271 -0.49 . . . . 65.549999999999997 112.507 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.466 HG13 ' OG1' ' A' ' 98' ' ' THR . 87.9 t -60.14 112.83 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.137 0.494 . . . . 75.310000000000002 110.09 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 m -87.06 -44.9 11.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.495 -0.775 . . . . 72.219999999999999 111.561 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.93 163.5 32.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.438 -0.346 . . . . 52.439999999999998 110.445 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.7 pt -101.45 133.06 21.1 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 75.510000000000005 110.64 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.629 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 66.4 Cg_endo -90.21 -178.02 11.13 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.77 -1.346 . . . . 64.140000000000001 111.967 -3.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.466 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.2 m -136.24 130.9 33.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.328 -0.397 . . . . 74.0 110.008 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 47' ' ' ASP . 44.2 mm -119.46 115.88 49.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.604 -0.725 . . . . 71.439999999999998 110.264 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 19.8 mt -88.14 158.66 18.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.345 -0.613 . . . . 72.510000000000005 109.345 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 31.7 mtt -123.55 141.76 51.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 65.120000000000005 109.728 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -140.95 154.36 46.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.074 -0.713 . . . . 74.140000000000001 109.074 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.5 ttmm -150.47 110.52 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.042 -0.263 . . . . 74.239999999999995 110.542 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.776 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.7 t30 64.03 25.27 13.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.598 0.714 . . . . 72.219999999999999 110.3 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.76 -16.47 41.19 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.767 -0.651 . . . . 43.109999999999999 111.925 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 34.5 ttpt -75.12 145.29 42.35 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.805 0.442 . . . . 63.039999999999999 110.092 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -64.07 148.33 50.08 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.317 0.579 . . . . 71.430000000000007 110.849 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.49 168.18 26.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.872 -1.158 . . . . 72.319999999999993 107.872 -170.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 m -69.86 -177.99 1.43 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.0 0.741 . . . . 72.409999999999997 113.0 -164.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -149.15 146.29 27.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.767 0.794 . . . . 74.540000000000006 110.7 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.19 119.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 113.93 -1.487 . . . . 73.030000000000001 109.542 -173.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.1 mt -113.34 123.96 69.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.144 -0.317 . . . . 62.140000000000001 110.144 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.31 152.36 24.39 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.605 -0.598 . . . . 60.32 111.605 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 72.38 4.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 111.185 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 119' ' ' ILE . 8.5 t70 -115.59 88.1 2.81 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.293 0.568 . . . . 64.239999999999995 109.516 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.14 -33.09 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.502 -0.772 . . . . 62.149999999999999 111.289 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.3 m -61.2 -49.52 76.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.011 0.434 . . . . 72.200000000000003 110.518 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -60.32 -44.13 95.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.038 -0.528 . . . . 55.140000000000001 110.077 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 115' ' ' ASP . 66.7 mt -58.21 -56.54 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 72.120000000000005 111.317 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.03 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.001 0.429 . . . . 74.510000000000005 110.583 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 t -59.09 -52.14 67.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.773 -0.649 . . . . 52.409999999999997 110.362 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.94 -34.66 77.02 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.52 -0.309 . . . . 73.040000000000006 111.136 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 127' ' ' ILE . 81.7 mt -55.75 -56.57 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.514 -0.55 . . . . 73.409999999999997 109.514 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -63.37 -37.05 85.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.05 -0.523 . . . . 70.219999999999999 110.526 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.74 -36.15 78.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 72.200000000000003 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -103.26 -1.13 29.33 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.43 0.53 . . . . 71.200000000000003 112.43 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 123' ' ' ILE . 82.5 mt -84.8 -60.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.419 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.577 -0.738 . . . . 71.430000000000007 110.705 -172.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.984 -0.376 . . . . 75.420000000000002 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.03 145.15 22.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 51.25 110.783 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -88.86 98.25 11.62 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.49 -0.559 . . . . 65.040000000000006 109.49 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -70.61 -65.28 0.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.401 -0.592 . . . . 71.219999999999999 109.401 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 73.25 -52.2 0.7 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.69 0.796 . . . . 71.299999999999997 112.59 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -66.31 134.12 51.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.533 0.206 . . . . 75.120000000000005 111.109 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -152.93 149.04 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.155 -0.313 . . . . 65.209999999999994 110.155 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -89.88 137.03 32.68 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.546 -0.297 . . . . 74.329999999999998 110.541 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 mmt -76.48 -35.07 58.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.681 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.31 58.18 6.24 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.915 -0.66 . . . . 70.450000000000003 112.056 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.4 p -86.82 91.55 8.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.871 0.367 . . . . 75.420000000000002 111.422 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.97 97.02 6.94 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.348 -0.387 . . . . 74.230000000000004 109.959 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.25 154.49 18.98 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.787 -0.449 . . . . 75.420000000000002 109.787 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -143.42 176.01 9.5 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.976 0.417 . . . . 74.349999999999994 112.109 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -151.83 148.59 28.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.235 -0.893 . . . . 71.239999999999995 109.418 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.6 p -120.62 168.73 11.07 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 110.454 -0.202 . . . . 70.150000000000006 110.454 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -135.16 140.13 45.14 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.126 0.488 . . . . 71.400000000000006 111.137 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.43 131.65 5.61 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.032 -0.827 . . . . 74.209999999999994 111.032 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.6 -17.43 54.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.615 2.21 . . . . 75.329999999999998 112.479 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.99 -64.31 4.16 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.009 -0.541 . . . . 31.0 111.868 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 p -135.62 125.95 26.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.748 -0.464 . . . . 73.120000000000005 109.748 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 75.9 mmm -79.77 -29.33 40.38 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 116.194 -0.457 . . . . 71.319999999999993 110.249 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' A' ' 78' ' ' LYS . 5.6 mm -66.83 108.86 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.824 -0.625 . . . . 73.430000000000007 110.094 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 10.4 tp10 -88.9 134.96 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.234 -0.284 . . . . 70.140000000000001 110.234 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -96.18 119.06 33.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 71.409999999999997 110.464 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.471 HG22 ' HG3' ' A' ' 34' ' ' LYS . 38.8 pt -134.58 160.97 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.294 -0.412 . . . . 73.540000000000006 111.305 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.51 -170.68 27.98 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 116.095 -0.502 . . . . 75.430000000000007 112.301 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.9 -50.37 73.68 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.002 0.43 . . . . 65.030000000000001 111.281 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -61.0 -21.21 63.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.979 -0.555 . . . . 74.420000000000002 111.319 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' CB ' ' HB ' ' A' ' 26' ' ' ILE . 5.8 mm-40 -88.8 -14.08 37.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 75.540000000000006 111.657 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -57.34 -62.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 70.519999999999996 110.837 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.92 -50.57 72.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.089 0.471 . . . . 73.420000000000002 110.263 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -50.74 -57.44 8.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.284 -0.871 . . . . 43.219999999999999 111.593 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HG3' HG22 ' A' ' 26' ' ' ILE . 49.1 mmtm -75.39 -28.9 59.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.98 -0.554 . . . . 63.340000000000003 111.757 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HA ' HD12 ' A' ' 44' ' ' ILE . 51.5 t -70.6 -37.51 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 121.1 -0.24 . . . . 74.140000000000001 111.292 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -86.44 -30.41 22.08 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.085 0.402 . . . . 53.409999999999997 112.085 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -74.33 7.44 2.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.043 0.386 . . . . 74.540000000000006 112.043 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.694 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 29.4 p -67.78 162.51 23.76 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.161 -0.311 . . . . 71.299999999999997 110.161 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -73.66 -82.71 0.05 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.637 0.256 . . . . 72.420000000000002 111.052 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -160.87 138.48 9.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.882 -0.414 . . . . 63.420000000000002 109.882 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 59.2 t30 62.09 1.99 0.75 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.97 0.508 . . . . 72.450000000000003 111.606 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -63.82 110.15 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.377 -0.374 . . . . 70.510000000000005 111.116 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB3' HG23 ' A' ' 74' ' ' VAL . 55.4 tp -76.27 114.41 14.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.174 -0.676 . . . . 72.329999999999998 109.174 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 38' ' ' CYS . 77.8 mt -99.86 110.46 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.989 -1.005 . . . . 72.450000000000003 110.492 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.664 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.9 mp -93.45 121.51 34.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 73.209999999999994 109.436 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 60.2 t -103.31 105.48 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.401 -0.592 . . . . 72.450000000000003 109.401 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HA ' HD12 ' A' ' 99' ' ' ILE . 27.2 t70 -83.63 129.37 34.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.872 0.368 . . . . 62.130000000000003 111.446 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.95 114.09 25.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.142 -1.059 . . . . 65.219999999999999 108.142 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.627 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 3.1 t90 -77.75 -42.26 34.76 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.486 0.491 . . . . 74.340000000000003 111.883 -164.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HB3' HG23 ' A' ' 96' ' ' ILE . . . 69.92 134.61 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.805 0.691 . . . . 54.329999999999998 110.964 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.75 -31.35 94.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.508 2.139 . . . . 64.329999999999998 111.4 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -127.82 136.32 51.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.543 -0.753 . . . . 73.150000000000006 109.014 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 5.2 p -146.64 -82.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.348 -0.141 . . . . 63.299999999999997 111.245 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . 108.86 -85.83 0.42 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.072 -0.585 . . . . 43.399999999999999 111.662 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 53' ' ' CYS . 19.4 Cg_endo -58.13 -9.83 7.05 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.916 2.411 . . . . 54.219999999999999 112.259 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.73 -37.52 63.42 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.004 -0.544 . . . . 71.349999999999994 110.676 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 14.2 ptm180 -56.88 -34.25 67.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 111.151 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.52 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.5 m -75.84 -54.86 6.27 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.8 0.81 . . . . 74.230000000000004 111.04 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -64.51 -41.99 96.08 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.188 -0.915 . . . . 64.099999999999994 113.222 -169.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.77 -53.92 60.67 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 117.962 0.346 . . . . 65.120000000000005 111.301 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.86 -27.88 58.98 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.678 1.585 . . . . 64.230000000000004 112.3 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.0 mt-30 -65.07 -38.82 92.04 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.426 -0.51 . . . . 75.209999999999994 110.069 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 95.8 mt -69.01 -40.04 78.92 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 74.140000000000001 109.499 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 5.7 mm-40 -53.85 -49.18 69.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.493 -0.776 . . . . 65.510000000000005 110.18 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -54.59 -52.39 62.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.711 -0.677 . . . . 74.540000000000006 110.775 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 123' ' ' ILE . 52.0 mt -65.02 -33.38 75.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 74.510000000000005 110.103 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.53 -14.91 61.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.46 . . . . 43.32 110.969 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.4 mt-30 -93.69 -39.22 10.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.882 0.373 . . . . 74.129999999999995 110.666 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -69.59 -34.01 73.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.542 0.687 . . . . 75.409999999999997 110.301 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.87 6.29 33.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.039 -0.982 . . . . 75.219999999999999 111.533 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 t -52.97 -22.15 5.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.634 0.975 . . . . 72.120000000000005 113.634 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -78.66 -23.04 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 74.019999999999996 111.166 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.19 5.59 6.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.132 -0.486 . . . . 60.25 111.483 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 43' ' ' LEU . 65.6 t -139.81 145.1 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.695 0.283 . . . . 74.219999999999999 111.578 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 28.5 tptp -148.77 127.86 12.8 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.649 -0.5 . . . . 72.219999999999999 109.649 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.9 mt -103.14 145.17 12.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.006 0.432 . . . . 73.140000000000001 111.052 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.452 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 98.4 m-85 -126.87 167.84 15.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.73 -0.668 . . . . 73.109999999999999 110.147 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.627 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 9.7 tppt? -136.49 108.52 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.273 -1.01 . . . . 62.329999999999998 108.273 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -75.65 128.29 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 75.129999999999995 110.347 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.6 21.31 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.443 0.64 . . . . 60.109999999999999 110.503 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 pt -94.55 32.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.427 0.632 . . . . 65.230000000000004 109.834 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.31 -18.58 50.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.822 -1.081 . . . . 64.209999999999994 111.59 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -89.29 5.99 42.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 63.520000000000003 111.623 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.406 ' ND2' HG22 ' A' ' 87' ' ' VAL . 49.9 t30 -116.43 89.06 3.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.963 0.411 . . . . 73.530000000000001 110.307 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -67.88 -21.77 65.13 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 73.430000000000007 111.521 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -50.13 -45.8 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.398 . . . . 63.32 110.547 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.406 HG22 ' ND2' ' A' ' 84' ' ' ASN . 74.0 t -60.35 -34.48 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.795 -0.639 . . . . 71.010000000000005 110.525 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.28 -51.5 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.041 0.448 . . . . 74.239999999999995 110.058 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -61.87 -42.23 98.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 72.420000000000002 110.914 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.89 -50.31 71.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.121 -0.491 . . . . 74.510000000000005 111.07 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.06 -4.69 58.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.398 -0.365 . . . . 73.109999999999999 111.493 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.72 34.86 37.7 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.202 -0.523 . . . . 65.549999999999997 113.53 170.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.519 HG11 ' OG1' ' A' ' 98' ' ' THR . 83.9 t -68.29 130.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 75.310000000000002 110.361 176.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.4 m -129.82 -71.3 0.61 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 72.219999999999999 110.083 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.64 136.18 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 110.027 -0.36 . . . . 52.439999999999998 110.027 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.51 HG23 ' HB3' ' A' ' 50' ' ' ALA . 2.2 pp -113.71 151.22 44.45 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.421 -0.354 . . . . 75.510000000000005 111.335 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.08 160.81 91.24 Favored 'Cis proline' 0 C--N 1.353 0.815 0 C-N-CA 124.079 -1.217 . . . . 64.140000000000001 112.365 -0.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.519 ' OG1' HG11 ' A' ' 93' ' ' VAL . 92.3 m -119.74 129.91 54.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 74.0 109.871 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.492 ' HB ' HG22 ' A' ' 111' ' ' VAL . 45.8 mm -110.16 113.48 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 71.439999999999998 110.899 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 38.0 mt -91.04 152.46 20.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.553 -0.906 . . . . 72.510000000000005 108.553 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 122' ' ' GLU . 36.9 mtt -124.12 141.38 52.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.883 0.31 . . . . 65.120000000000005 110.309 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 99.4 m-85 -143.94 154.94 43.83 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.851 -0.796 . . . . 74.140000000000001 108.851 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -144.19 104.86 4.16 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.683 -0.407 . . . . 74.239999999999995 111.04 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.694 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 7.9 t30 55.41 32.82 19.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.561 0.696 . . . . 72.219999999999999 110.627 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.0 -16.48 59.42 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.736 -0.666 . . . . 43.109999999999999 112.587 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -71.79 140.74 49.57 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 110.157 -0.312 . . . . 63.039999999999999 110.157 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.508 ' O ' HD21 ' A' ' 108' ' ' LEU . 12.2 mmmm -68.42 134.42 50.17 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.281 0.562 . . . . 71.430000000000007 110.961 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 2.3 mm? -139.0 168.84 18.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.44 -1.254 . . . . 72.319999999999993 109.057 -170.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -69.81 -178.62 1.57 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.252 0.834 . . . . 72.409999999999997 113.252 -163.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.415 ' HG3' HD21 ' A' ' 100' ' ' LEU . 48.4 tt0 -148.76 122.46 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.092 -0.958 . . . . 74.540000000000006 109.689 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.492 HG22 ' HB ' ' A' ' 99' ' ' ILE . 19.4 m -113.9 130.16 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.177 0.513 . . . . 73.030000000000001 110.028 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 98' ' ' THR . 58.0 mt -116.08 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 62.140000000000001 109.711 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.2 148.08 14.4 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.896 -0.482 . . . . 60.32 111.896 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.61 72.12 6.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.825 0.345 . . . . 75.109999999999999 111.174 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.4 t70 -122.76 91.94 3.6 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.349 -0.612 . . . . 64.239999999999995 109.349 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -59.33 -30.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 62.149999999999999 111.207 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.0 t -63.49 -49.22 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 72.200000000000003 110.071 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.47 -43.05 99.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.801 -0.444 . . . . 55.140000000000001 109.801 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . 70.9 mt -57.73 -56.27 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.718 -0.674 . . . . 72.120000000000005 111.104 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.425 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.19 -39.4 82.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 120.675 0.274 . . . . 74.510000000000005 110.436 -177.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.9 m -54.78 -52.0 63.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.794 -0.447 . . . . 52.409999999999997 109.794 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.505 ' HB3' ' HE1' ' A' ' 101' ' ' MET . 25.1 mm-40 -67.64 -32.19 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 73.040000000000006 111.478 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.517 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.7 mt -60.2 -56.18 19.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.383 -0.527 . . . . 73.409999999999997 109.918 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -68.01 -28.3 67.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.52 -0.472 . . . . 70.219999999999999 109.89 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 6.6 t30 -65.09 -44.49 88.68 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.664 -0.698 . . . . 72.200000000000003 111.403 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -91.32 -8.78 47.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.548 -0.296 . . . . 71.200000000000003 111.628 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.8 mt -76.44 -50.36 22.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.159 0.504 . . . . 74.310000000000002 109.645 167.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.401 -0.809 . . . . 71.430000000000007 109.667 -176.482 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.73 0.3 . . . . 75.420000000000002 110.453 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.53 78.55 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.25 0.547 . . . . 51.25 109.699 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -70.14 121.4 17.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.476 -0.784 . . . . 65.040000000000006 110.701 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.8 m170 67.48 90.78 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.227 0.611 . . . . 71.219999999999999 111.337 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -153.06 93.82 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.893 -0.594 . . . . 71.299999999999997 110.357 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -72.11 87.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.688 -0.486 . . . . 75.120000000000005 109.688 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -59.75 129.92 44.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.778 -0.646 . . . . 65.209999999999994 110.339 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -84.96 148.92 25.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.39 -0.368 . . . . 74.329999999999998 110.493 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.1 ptp -102.19 140.25 36.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 73.109999999999999 110.086 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.46 165.96 39.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.035 -0.602 . . . . 70.450000000000003 111.739 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 t -84.63 126.17 33.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 75.420000000000002 110.412 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.3 mt -82.97 -6.31 59.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.903 -0.59 . . . . 74.230000000000004 109.751 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -81.93 77.26 8.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.841 -0.618 . . . . 75.420000000000002 110.778 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.68 -66.53 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.703 -0.851 . . . . 74.349999999999994 108.703 172.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 46.66 78.47 0.07 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.297 -0.865 . . . . 71.239999999999995 111.656 174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 t -168.96 145.72 3.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.904 -0.589 . . . . 70.150000000000006 110.304 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -86.06 -178.66 6.59 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.137 -0.483 . . . . 71.400000000000006 110.072 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.38 92.26 0.78 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.933 -0.467 . . . . 74.209999999999994 111.933 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.87 147.8 27.6 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.489 2.126 . . . . 75.329999999999998 111.937 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 22' ' ' MET . . . 128.34 -27.74 4.42 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.227 -0.749 . . . . 31.0 111.227 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 p -57.83 114.49 2.33 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.776 0.339 . . . . 73.120000000000005 110.836 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 20' ' ' GLY . 94.3 mmm -124.04 -41.56 2.21 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.983 -0.553 . . . . 71.319999999999993 110.507 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.707 HG23 ' HG3' ' A' ' 78' ' ' LYS . 3.3 mm -68.76 101.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.234 -0.654 . . . . 73.430000000000007 109.234 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 40.5 tt0 -90.65 127.2 36.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.888 -0.596 . . . . 70.140000000000001 111.532 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -85.51 128.53 34.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.799 0.333 . . . . 71.409999999999997 110.436 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.34 164.79 32.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.492 -0.322 . . . . 73.540000000000006 111.031 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 -178.56 38.96 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.825 -0.625 . . . . 75.430000000000007 112.404 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.36 -43.4 94.66 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.004 0.43 . . . . 65.030000000000001 110.995 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -64.99 -36.16 83.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 74.420000000000002 110.539 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -74.09 -17.45 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 75.540000000000006 111.859 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -52.93 -62.31 1.73 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.633 0.254 . . . . 70.519999999999996 111.22 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.447 ' O ' HG21 ' A' ' 36' ' ' THR . 24.7 t70 -64.38 -45.99 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.02 0.438 . . . . 73.420000000000002 110.686 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -56.63 -57.16 13.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.331 -0.85 . . . . 43.219999999999999 110.701 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HE3' ' CE2' ' A' ' 77' ' ' TYR . 24.1 mmmt -65.28 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.698 -0.683 . . . . 63.340000000000003 110.885 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.63 -51.72 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.667 0.27 . . . . 74.140000000000001 111.143 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 32' ' ' ASP . 8.9 t -86.01 -10.71 54.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.829 0.307 . . . . 53.409999999999997 111.829 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -72.81 -12.59 61.05 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.923 0.342 . . . . 74.540000000000006 111.923 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 15.5 p -55.13 143.59 26.79 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.591 0.234 . . . . 71.299999999999997 111.488 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -54.56 -79.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.067 -0.515 . . . . 72.420000000000002 111.588 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -159.33 125.8 4.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.473 0.178 . . . . 63.420000000000002 110.793 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 59.21 15.33 4.13 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.885 0.474 . . . . 72.450000000000003 111.418 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -76.32 118.71 23.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.191 -0.459 . . . . 70.510000000000005 110.309 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.466 ' HB3' HG23 ' A' ' 74' ' ' VAL . 63.7 tp -74.46 122.03 22.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.945 -0.57 . . . . 72.329999999999998 110.424 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 38' ' ' CYS . 37.6 mt -110.77 121.91 64.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.661 -0.7 . . . . 72.450000000000003 110.295 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.53 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 4.4 mp -104.79 112.59 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.243 -0.651 . . . . 73.209999999999994 109.243 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -93.95 104.67 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.944 -0.391 . . . . 72.450000000000003 109.944 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.21 146.65 30.37 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.982 -0.554 . . . . 62.130000000000003 110.916 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -107.89 129.04 55.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 65.219999999999999 109.819 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.41 140.52 45.39 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 74.340000000000003 111.576 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' HD12 ' A' ' 96' ' ' ILE . . . -99.33 107.94 47.54 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 54.329999999999998 110.922 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -52.46 -52.46 8.84 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.746 2.297 . . . . 64.329999999999998 111.471 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.561 ' HB2' HD13 ' A' ' 96' ' ' ILE . 45.3 m95 -80.15 75.85 6.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.407 -0.96 . . . . 73.150000000000006 108.407 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.445 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 7.6 t -75.65 79.19 2.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.502 -0.772 . . . . 63.299999999999997 110.27 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -108.57 -74.04 0.82 Allowed Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.5 -0.773 . . . . 43.399999999999999 111.432 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.88 -18.95 59.83 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.732 2.288 . . . . 54.219999999999999 111.612 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 27.8 p -52.13 -34.43 44.41 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.516 -0.765 . . . . 71.349999999999994 110.379 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -53.8 -49.37 68.47 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.948 -0.569 . . . . 74.439999999999998 111.083 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.626 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 48.0 m -75.24 -42.8 54.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.072 0.463 . . . . 74.230000000000004 111.526 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.7 -37.83 88.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.815 0.672 . . . . 64.099999999999994 112.815 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 58.5 mm-40 -55.81 -58.84 13.67 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 117.967 0.349 . . . . 65.120000000000005 110.736 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.29 -27.53 55.71 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.938 1.759 . . . . 64.230000000000004 112.372 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.626 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.2 mt-30 -68.32 -40.62 81.61 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.698 -0.401 . . . . 75.209999999999994 110.71 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.99 -43.03 84.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.633 -0.506 . . . . 74.140000000000001 109.633 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 2.9 mm-40 -52.73 -47.14 67.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.722 -0.672 . . . . 65.510000000000005 110.131 174.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -52.29 -57.08 10.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.824 -0.626 . . . . 74.540000000000006 110.837 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.437 HD12 HD12 ' A' ' 123' ' ' ILE . 31.4 mt -65.78 -31.36 72.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.676 -0.693 . . . . 74.510000000000005 110.379 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.513 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -68.46 -44.2 75.36 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.873 -0.603 . . . . 43.32 110.223 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.0 mt-30 -71.38 -37.52 71.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.271 0.558 . . . . 74.129999999999995 110.581 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -73.4 -37.34 65.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.719 -0.673 . . . . 75.409999999999997 111.122 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.96 5.25 32.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.121 -0.491 . . . . 75.219999999999999 112.166 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.7 t -52.86 -21.17 3.92 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.135 0.791 . . . . 72.120000000000005 113.135 -171.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.66 -28.27 69.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 74.019999999999996 110.472 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.14 8.37 3.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.2 -0.454 . . . . 60.25 111.765 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 43' ' ' LEU . 64.9 t -134.41 141.9 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.053 0.454 . . . . 74.219999999999999 112.068 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 57.0 tptt -145.17 126.09 14.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.429 -0.805 . . . . 72.219999999999999 109.31 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.428 HG12 ' HB2' ' A' ' 45' ' ' LEU . 36.0 mt -108.31 140.25 27.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.742 0.306 . . . . 73.140000000000001 110.542 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 86.2 m-85 -121.39 170.5 9.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 73.109999999999999 109.712 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.707 ' HG3' HG23 ' A' ' 23' ' ' ILE . 28.8 mtpp -136.12 128.5 30.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.63 -0.507 . . . . 62.329999999999998 109.63 173.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.67 67.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.661 -1.237 . . . . 75.129999999999995 107.661 168.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -85.24 66.09 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.241 -0.891 . . . . 60.109999999999999 110.656 -170.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.5 mt -100.81 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.182 -1.044 . . . . 65.230000000000004 108.182 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -23.23 2.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.35 -1.296 . . . . 64.209999999999994 113.069 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.77 -36.47 23.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.689 0.255 . . . . 63.520000000000003 111.689 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -96.9 82.24 3.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 111.258 -170.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -68.43 -20.59 64.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.628 . . . . 73.430000000000007 109.991 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.9 m-20 -47.97 -39.51 19.67 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.476 -0.784 . . . . 63.32 111.427 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.8 -36.98 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.903 -0.59 . . . . 71.010000000000005 110.935 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.07 79.02 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 74.239999999999995 110.44 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.6 m -67.56 -37.77 83.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.78 -0.645 . . . . 72.420000000000002 111.02 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.6 mm100 -63.62 -46.08 87.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 74.510000000000005 110.788 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -87.28 -15.07 39.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.345 -0.389 . . . . 73.109999999999999 111.631 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 41.94 9.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.165 -0.54 . . . . 65.549999999999997 112.911 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 98' ' ' THR . 93.4 t -65.23 103.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.888 -0.412 . . . . 75.310000000000002 109.888 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -77.76 -37.86 48.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 72.219999999999999 111.526 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.493 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -140.68 138.47 34.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.359 -0.382 . . . . 52.439999999999998 110.186 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 52' ' ' TRP . 18.6 pt -106.51 140.77 21.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.075 -0.512 . . . . 75.510000000000005 110.777 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.22 -179.57 26.22 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.774 -1.344 . . . . 64.140000000000001 112.408 -0.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.455 HG21 HG12 ' A' ' 112' ' ' ILE . 93.8 m -138.61 132.58 31.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 74.0 110.121 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 44.2 mm -115.86 110.84 33.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.956 -0.566 . . . . 71.439999999999998 111.001 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.437 ' N ' HD13 ' A' ' 100' ' ' LEU . 5.7 mp -93.22 123.3 36.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.436 -0.579 . . . . 72.510000000000005 109.436 174.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' SER . 12.1 mmt -91.56 140.61 29.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.308 . . . . 65.120000000000005 110.328 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -143.77 148.35 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.151 -1.055 . . . . 74.140000000000001 108.151 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -145.61 112.06 5.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.076 -0.65 . . . . 74.239999999999995 111.384 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.653 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.6 t-20 62.19 25.95 15.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.552 0.691 . . . . 72.219999999999999 110.434 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.34 -16.55 58.65 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.576 -0.738 . . . . 43.109999999999999 112.084 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -73.5 142.4 46.77 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.041 -0.355 . . . . 63.039999999999999 110.041 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.32 127.48 33.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.430000000000007 110.725 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 108' ' ' LEU . 2.8 mm? -126.93 168.5 14.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.095 . . . . 72.319999999999993 110.576 -172.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.24 163.25 26.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.608 -0.723 . . . . 72.409999999999997 111.913 -167.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -127.25 124.34 38.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 74.540000000000006 110.044 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 32.2 m -102.8 140.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 109.814 -0.439 . . . . 73.030000000000001 109.814 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.493 HG21 ' HB1' ' A' ' 95' ' ' ALA . 63.2 mt -127.92 134.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 62.140000000000001 110.03 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.21 145.24 13.4 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.093 -0.575 . . . . 60.32 111.672 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.8 79.77 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 75.109999999999999 111.101 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -132.19 98.32 4.38 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.57 -0.53 . . . . 64.239999999999995 109.57 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.96 -28.78 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 62.149999999999999 110.799 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 t -64.89 -43.68 92.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.764 -0.458 . . . . 72.200000000000003 109.764 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -67.02 -44.77 79.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.125 -0.489 . . . . 55.140000000000001 109.958 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.9 mt -56.66 -54.01 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.996 -0.547 . . . . 72.120000000000005 110.958 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.52 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.25 -37.33 79.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 116.318 -0.401 . . . . 74.510000000000005 110.199 -177.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.435 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 21.5 t -56.44 -48.81 76.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.451 -0.574 . . . . 52.409999999999997 109.451 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 49.4 mm-40 -66.47 -37.16 84.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.384 -0.371 . . . . 73.040000000000006 111.046 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.5 mt -53.27 -55.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 120.833 -0.347 . . . . 73.409999999999997 110.133 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 121' ' ' SER . 7.7 p30 -69.12 -29.56 67.64 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.561 -0.456 . . . . 70.219999999999999 110.111 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 44.2 t30 -66.68 -32.81 74.36 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.411 . . . . 72.200000000000003 111.017 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -86.91 -31.07 20.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.811 -0.177 . . . . 71.200000000000003 111.152 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.5 mt -69.25 -39.8 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.112 0.482 . . . . 74.310000000000002 110.108 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.474 -0.774 . . . . 71.430000000000007 110.032 -179.022 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.168 -0.308 . . . . 75.420000000000002 110.168 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.35 131.17 46.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.168 -0.469 . . . . 51.25 110.715 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -89.13 103.15 15.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.972 0.415 . . . . 65.040000000000006 110.373 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -112.5 114.66 27.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 71.219999999999999 110.332 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -116.86 111.13 19.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.502 -0.317 . . . . 71.299999999999997 110.439 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -157.69 152.58 25.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.266 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -123.97 117.7 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 65.209999999999994 110.106 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -131.94 129.27 40.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 74.329999999999998 110.13 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.6 mtm -119.62 8.84 11.32 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.399 -0.364 . . . . 73.109999999999999 110.77 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.73 -147.29 41.56 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.511 -0.852 . . . . 70.450000000000003 111.149 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.5 p 51.54 22.18 1.47 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.074 0.55 . . . . 75.420000000000002 112.011 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.7 mt -120.28 95.62 4.82 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.728 -0.471 . . . . 74.230000000000004 109.728 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 58' ' ' SER . 40.5 tt0 -179.26 90.86 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.064 -0.516 . . . . 75.420000000000002 110.517 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.17 66.05 7.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.001 -0.74 . . . . 74.349999999999994 109.001 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.15 95.92 0.19 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.498 -0.774 . . . . 71.239999999999995 111.659 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.604 ' H ' ' HG3' ' A' ' 61' ' ' PRO . 37.7 p -137.31 158.44 44.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.361 -0.836 . . . . 70.150000000000006 109.859 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -138.45 136.15 35.92 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.299 -0.26 . . . . 71.400000000000006 110.299 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.78 129.69 1.63 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.819 -0.512 . . . . 74.209999999999994 111.819 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.8 85.12 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.427 2.085 . . . . 75.329999999999998 112.022 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.42 41.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.755 -0.657 . . . . 31.0 111.624 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 m -78.88 162.67 25.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.269 . . . . 73.120000000000005 111.5 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.9 mmm -55.28 -30.35 59.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.21 -0.45 . . . . 71.319999999999993 110.553 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.651 HG22 ' HB2' ' A' ' 78' ' ' LYS . 11.8 mm -63.28 103.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.628 -0.714 . . . . 73.430000000000007 109.284 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.85 125.13 27.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 70.140000000000001 111.558 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.1 120.68 24.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.238 -0.437 . . . . 71.409999999999997 110.007 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 31' ' ' PHE . 37.4 pt -130.32 151.76 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.872 0.368 . . . . 73.540000000000006 111.607 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.77 -160.59 29.77 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.707 -0.678 . . . . 75.430000000000007 112.685 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -56.87 12.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.564 0.346 . . . . 65.030000000000001 111.769 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -65.16 -37.33 87.05 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.1 0.476 . . . . 74.420000000000002 110.23 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.87 -30.23 70.34 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.805 -0.634 . . . . 75.540000000000006 110.824 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.5 ' HA ' HD11 ' A' ' 26' ' ' ILE . 88.1 t80 -54.65 -58.01 9.22 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.335 -0.246 . . . . 70.519999999999996 110.335 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -53.48 -54.69 33.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.782 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.5 -56.85 16.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.793 -0.64 . . . . 43.219999999999999 111.054 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.1 mmtt -58.13 -35.71 71.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.203 -0.908 . . . . 63.340000000000003 111.655 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.85 -40.04 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.795 0.331 . . . . 74.140000000000001 110.933 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.8 p -78.18 -9.49 59.22 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.909 0.385 . . . . 53.409999999999997 110.933 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -61.71 -13.49 23.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.859 -0.609 . . . . 74.540000000000006 111.666 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 44' ' ' ILE . 75.7 m -49.79 113.79 0.92 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.681 0.277 . . . . 71.299999999999997 111.061 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -63.58 -69.37 0.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.238 -0.653 . . . . 72.420000000000002 109.238 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -161.88 133.2 5.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.943 -0.571 . . . . 63.420000000000002 110.59 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 58.4 15.61 3.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.971 0.508 . . . . 72.450000000000003 111.661 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 mm -75.83 124.51 34.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.84 0.352 . . . . 70.510000000000005 110.758 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HB3' HG23 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -82.78 118.34 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.777 -0.647 . . . . 72.329999999999998 109.438 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.613 HD12 ' SG ' ' A' ' 38' ' ' CYS . 21.3 mt -114.02 117.49 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 72.450000000000003 110.39 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.9 mp -104.31 131.15 51.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.684 -0.858 . . . . 73.209999999999994 108.684 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.2 108.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.204 -0.295 . . . . 72.450000000000003 110.204 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 22.2 t0 -81.86 138.25 35.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 62.130000000000003 110.02 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -78.51 177.65 8.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 65.219999999999999 111.128 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.592 ' HB2' ' HA ' ' A' ' 80' ' ' ASN . 20.1 t90 -85.81 129.1 34.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 74.340000000000003 110.653 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.07 86.62 7.57 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.846 -0.616 . . . . 54.329999999999998 109.912 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.37 -22.44 21.73 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.296 1.997 . . . . 64.329999999999998 111.982 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -117.77 111.17 18.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 73.150000000000006 110.339 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -175.86 135.88 0.3 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.114 -0.494 . . . . 63.299999999999997 110.387 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -74.91 0.95 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.355 -0.45 . . . . 43.399999999999999 112.418 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.19 -23.03 72.54 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 54.219999999999999 113.057 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 71.8 m -55.83 -30.71 61.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.595 -0.275 . . . . 71.349999999999994 111.446 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -59.45 -32.42 70.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.852 0.358 . . . . 74.439999999999998 110.774 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.5 m -74.67 -38.17 62.49 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.809 0.814 . . . . 74.230000000000004 110.138 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.5 mm? -67.33 -34.71 77.92 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.359 -0.837 . . . . 64.099999999999994 111.975 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 45.5 mt-10 -55.05 -58.43 14.82 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 120.994 -0.282 . . . . 65.120000000000005 110.817 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.604 ' HG3' ' H ' ' A' ' 16' ' ' THR . 38.2 Cg_endo -66.62 -31.11 41.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.106 1.87 . . . . 64.230000000000004 112.332 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.1 mt-30 -62.79 -40.75 98.3 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.296 -0.562 . . . . 75.209999999999994 110.18 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.8 mt -68.73 -33.77 74.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.871 -0.604 . . . . 74.140000000000001 109.991 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 40.8 mt-10 -62.49 -44.55 96.12 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.324 -0.398 . . . . 65.510000000000005 110.271 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -54.79 -52.48 62.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.127 -0.488 . . . . 74.540000000000006 110.474 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.445 HD13 HD13 ' A' ' 123' ' ' ILE . 47.5 mt -65.33 -37.19 86.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.519 . . . . 74.510000000000005 110.205 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.58 -36.46 83.87 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.86 -0.609 . . . . 43.32 110.879 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -74.43 -50.35 18.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 74.129999999999995 110.544 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -63.54 -34.66 78.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 75.409999999999997 110.914 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -104.97 5.07 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 75.219999999999999 112.203 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.4 t -53.34 -20.0 3.95 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.37 0.507 . . . . 72.120000000000005 112.37 -172.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.19 -39.22 92.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 74.019999999999996 110.739 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.46 -9.88 12.03 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.051 -0.522 . . . . 60.25 110.848 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 43' ' ' LEU . 68.2 t -125.85 145.63 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.037 0.446 . . . . 74.219999999999999 111.635 -171.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.721 ' HZ1' ' HB2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.11 128.64 13.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.324 -0.621 . . . . 72.219999999999999 109.324 171.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.6 mt -111.5 129.13 67.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.078 0.466 . . . . 73.140000000000001 110.964 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.492 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.5 m-85 -114.81 177.84 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 73.109999999999999 109.18 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.651 ' HB2' HG22 ' A' ' 23' ' ' ILE . 59.0 tttp -148.17 123.5 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 62.329999999999998 110.532 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.56 HG21 HG23 ' A' ' 81' ' ' ILE . 29.2 mm -86.49 108.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 75.129999999999995 109.857 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 49' ' ' TRP . 30.4 p-10 -114.98 4.9 14.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.451 -0.341 . . . . 60.109999999999999 111.116 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.56 HG23 HG21 ' A' ' 79' ' ' ILE . 6.1 tt -65.47 105.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.34 0.59 . . . . 65.230000000000004 109.782 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -54.99 -31.0 60.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.046 -0.979 . . . . 64.209999999999994 112.756 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.85 -19.39 61.97 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.787 0.291 . . . . 63.520000000000003 111.787 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.435 HD21 HG23 ' A' ' 79' ' ' ILE . 45.1 t30 -87.9 88.11 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.062 0.458 . . . . 73.530000000000001 111.786 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -107.14 -30.49 8.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 73.430000000000007 109.324 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.55 -55.98 5.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.041 -0.981 . . . . 63.32 111.411 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.99 -34.22 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.734 -0.666 . . . . 71.010000000000005 111.071 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.39 62.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.076 0.465 . . . . 74.239999999999995 110.162 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -67.1 -31.53 72.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.611 -0.722 . . . . 72.420000000000002 111.096 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -75.17 -38.52 60.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.228 -0.442 . . . . 74.510000000000005 111.666 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -91.95 -11.66 35.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.757 0.281 . . . . 73.109999999999999 111.757 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.87 53.21 2.76 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.908 -0.663 . . . . 65.549999999999997 113.394 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG21 HG21 ' A' ' 98' ' ' THR . 98.4 t -79.69 106.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.677 -0.49 . . . . 75.310000000000002 109.677 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -82.88 -43.27 16.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.875 -0.602 . . . . 72.219999999999999 111.402 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.24 12.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.594 -0.276 . . . . 52.439999999999998 110.59 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.701 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -109.3 150.68 41.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.262 -0.426 . . . . 75.510000000000005 110.426 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 95.9 Cg_endo -77.84 174.81 50.29 Favored 'Cis proline' 0 C--N 1.353 0.803 0 C-N-CA 123.696 -1.377 . . . . 64.140000000000001 112.244 -1.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.471 HG21 HG21 ' A' ' 93' ' ' VAL . 92.3 m -142.36 115.28 8.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.291 -0.413 . . . . 74.0 110.439 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 111' ' ' VAL . 32.3 mm -109.81 111.42 36.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.723 -0.671 . . . . 71.439999999999998 110.373 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 100' ' ' LEU . 2.2 mm? -88.42 125.81 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.194 -0.912 . . . . 72.510000000000005 109.835 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.617 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -94.76 138.28 32.77 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.749 -0.463 . . . . 65.120000000000005 109.749 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -135.88 144.14 45.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.69 -0.485 . . . . 74.140000000000001 109.69 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.7 tptp -132.59 106.38 7.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.927 -0.309 . . . . 74.239999999999995 110.216 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.86 26.23 15.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.119 0.485 . . . . 72.219999999999999 110.709 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.53 -6.36 82.51 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.707 -0.679 . . . . 43.109999999999999 112.299 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -87.9 152.1 22.33 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 120.581 0.229 . . . . 63.039999999999999 110.647 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 7.8 tmtm? -56.86 134.8 55.62 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 124.262 0.976 . . . . 71.430000000000007 110.809 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.529 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -145.09 169.08 18.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.534 -1.212 . . . . 72.319999999999993 108.539 -175.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 101' ' ' MET . 40.7 m -70.01 -177.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.211 0.529 . . . . 72.409999999999997 111.927 -164.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.486 ' HG3' HD11 ' A' ' 100' ' ' LEU . 49.2 tt0 -147.14 142.77 27.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.132 -0.486 . . . . 74.540000000000006 110.141 -173.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 99' ' ' ILE . 16.2 m -128.22 132.35 68.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.945 0.402 . . . . 73.030000000000001 110.247 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.31 135.69 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.802 -0.636 . . . . 62.140000000000001 109.424 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.92 154.53 21.27 Favored Glycine 0 C--O 1.235 0.156 0 C-N-CA 121.003 -0.618 . . . . 60.32 111.816 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.6 74.87 9.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.724 0.297 . . . . 75.109999999999999 111.377 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -123.96 93.61 3.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.292 0.568 . . . . 64.239999999999995 109.483 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.435 HD12 HD12 ' A' ' 66' ' ' LEU . 9.3 tp -59.11 -30.6 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.524 -0.762 . . . . 62.149999999999999 111.047 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.0 t -67.82 -41.23 83.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.442 -0.345 . . . . 72.200000000000003 110.25 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -70.74 -40.96 72.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 110.08 -0.341 . . . . 55.140000000000001 110.08 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.71 -55.77 20.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.123 -0.49 . . . . 72.120000000000005 110.635 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.483 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.58 -35.57 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.514 -0.55 . . . . 74.510000000000005 109.514 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.1 t -53.69 -52.28 60.54 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.913 -0.585 . . . . 52.409999999999997 109.901 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 33.6 mm-40 -67.1 -38.38 85.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.23 -0.441 . . . . 73.040000000000006 111.371 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.445 HD13 HD13 ' A' ' 66' ' ' LEU . 98.4 mt -54.19 -55.77 12.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 120.571 -0.452 . . . . 73.409999999999997 110.303 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -71.47 -27.3 63.15 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.751 -0.379 . . . . 70.219999999999999 110.525 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 54.5 t30 -73.16 -28.51 62.27 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.131 -0.486 . . . . 72.200000000000003 110.864 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.447 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.9 OUTLIER -85.73 -36.86 19.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 71.200000000000003 110.192 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 123' ' ' ILE . 70.6 mt -67.67 -44.88 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.136 0.493 . . . . 74.310000000000002 110.201 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.711 -0.661 . . . . 71.430000000000007 109.967 -178.73 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.886 0.374 . . . . 75.420000000000002 110.622 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.17 -170.21 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.927 -0.579 . . . . 51.25 112.139 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -156.67 -39.97 0.07 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.572 -0.74 . . . . 65.040000000000006 109.488 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 71.75 -43.71 0.57 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.817 0.847 . . . . 71.219999999999999 111.346 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -57.06 95.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.111 0.481 . . . . 71.299999999999997 109.98 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -160.27 136.91 8.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.739 -0.664 . . . . 75.120000000000005 109.269 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.01 173.88 11.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.961 -0.385 . . . . 65.209999999999994 109.961 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.606 ' HB2' HG22 ' A' ' 89' ' ' THR . 19.0 p-80 -122.31 136.17 54.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 74.329999999999998 109.896 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tpt -92.76 -69.51 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 73.109999999999999 111.079 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 89' ' ' THR . . . -146.48 143.1 11.09 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.155 -0.545 . . . . 70.450000000000003 111.997 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -93.81 139.76 30.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.31 . . . . 75.420000000000002 111.094 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.17 179.53 7.16 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.806 -0.633 . . . . 74.230000000000004 109.356 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.7 172.6 13.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.765 0.316 . . . . 75.420000000000002 110.68 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.22 166.72 16.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 74.349999999999994 110.478 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.645 ' HG2' ' HB3' ' A' ' 51' ' ' PRO . 58.1 tp60 -154.78 149.06 26.06 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.436 -0.579 . . . . 71.239999999999995 109.436 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.831 HG23 ' HB3' ' A' ' 82' ' ' GLU . 3.1 p -141.75 99.2 3.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.085 0.469 . . . . 70.150000000000006 111.286 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.479 ' HG3' HE21 ' A' ' 15' ' ' GLN . 99.1 mt-30 -138.68 152.14 47.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.531 -0.759 . . . . 71.400000000000006 109.15 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 136.6 131.74 3.02 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.71 -0.556 . . . . 74.209999999999994 111.71 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -86.06 177.22 4.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.876 2.384 . . . . 75.329999999999998 112.133 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.51 81.37 0.08 OUTLIER Glycine 0 C--N 1.332 0.355 0 N-CA-C 111.529 -0.628 . . . . 31.0 111.529 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -99.48 -179.71 4.3 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.672 0.389 . . . . 73.120000000000005 110.391 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.3 ptm -68.13 -17.5 64.37 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.738 -0.838 . . . . 71.319999999999993 108.738 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.446 HG23 HG23 ' A' ' 76' ' ' ILE . 22.0 mm -67.34 93.37 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.811 -1.181 . . . . 73.430000000000007 107.811 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.77 111.83 6.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 70.140000000000001 111.759 -167.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 5.0 pm0 -69.97 129.38 39.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 71.409999999999997 110.202 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 36.8 pt -137.89 147.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.540000000000006 111.257 -174.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.53 -179.22 42.33 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.843 -0.617 . . . . 75.430000000000007 111.899 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.08 -48.4 67.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.745 0.418 . . . . 65.030000000000001 111.492 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 p -62.43 -35.35 78.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.039 -0.528 . . . . 74.420000000000002 111.158 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 44.8 mt-10 -77.49 -27.77 51.97 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.992 -0.549 . . . . 75.540000000000006 110.708 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.499 ' HA ' HD12 ' A' ' 26' ' ' ILE . 82.1 t80 -53.14 -61.02 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.165 0.291 . . . . 70.519999999999996 111.059 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.57 -52.61 61.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.159 0.504 . . . . 73.420000000000002 110.514 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -51.55 -57.24 9.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.086 -0.961 . . . . 43.219999999999999 111.035 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HG3' HG22 ' A' ' 26' ' ' ILE . 72.6 mmtt -61.92 -46.56 88.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.201 -0.909 . . . . 63.340000000000003 111.234 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 31' ' ' PHE . 73.8 t -59.44 -38.75 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.686 0.279 . . . . 74.140000000000001 111.107 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -84.89 -16.7 40.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.702 0.286 . . . . 53.409999999999997 111.435 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -68.33 -13.39 62.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.381 -0.372 . . . . 74.540000000000006 111.471 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -55.16 122.17 10.44 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.707 -0.224 . . . . 71.299999999999997 110.7 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.12 -75.18 0.05 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.37 -0.377 . . . . 72.420000000000002 110.811 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -161.93 124.62 2.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.45 -0.341 . . . . 63.420000000000002 110.096 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.87 17.37 9.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.69 0.618 . . . . 72.450000000000003 111.347 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -78.22 104.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.435 -0.58 . . . . 70.510000000000005 109.435 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.5 ' HB3' HG22 ' A' ' 74' ' ' VAL . 62.5 tp -68.9 108.18 3.38 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.509 0.671 . . . . 72.329999999999998 110.39 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mt -96.13 112.62 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.145 -0.934 . . . . 72.450000000000003 110.531 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -96.22 141.02 30.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.437 -0.949 . . . . 73.209999999999994 108.437 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.09 114.2 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 110.315 -0.254 . . . . 72.450000000000003 110.315 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -82.89 129.22 34.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.009 0.433 . . . . 62.130000000000003 110.117 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 100' ' ' LEU . 5.2 m-85 -90.05 -39.57 12.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.816 -0.629 . . . . 65.219999999999999 110.134 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.601 ' HZ2' HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -164.28 94.34 0.72 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.534 -0.303 . . . . 74.340000000000003 111.62 -176.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.666 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . . . -96.02 109.57 47.45 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.24 -0.436 . . . . 54.329999999999998 110.469 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.645 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 76.1 Cg_endo -92.07 130.08 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.996 2.464 . . . . 64.329999999999998 111.633 173.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -63.95 82.66 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.268 0.556 . . . . 73.150000000000006 111.164 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.654 ' H ' ' HB2' ' A' ' 56' ' ' CYS . 10.5 p -88.41 -169.21 2.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.472 -0.786 . . . . 63.299999999999997 109.567 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.11 -71.0 0.81 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.91 -0.662 . . . . 43.399999999999999 112.111 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 53' ' ' CYS . 31.3 Cg_exo -60.3 -35.56 91.01 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.742 2.295 . . . . 54.219999999999999 112.468 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.654 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 14.2 m -60.24 -29.79 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.046 0.45 . . . . 71.349999999999994 110.595 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -53.42 -52.69 58.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.827 -0.624 . . . . 74.439999999999998 110.275 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.653 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.1 m -75.76 -30.53 59.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.056 -0.52 . . . . 74.230000000000004 111.521 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -59.23 -59.14 5.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.231 0.456 . . . . 64.099999999999994 112.231 -170.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.27 -51.24 51.56 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 111.798 0.295 . . . . 65.120000000000005 111.798 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.38 -48.37 22.35 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.701 1.601 . . . . 64.230000000000004 111.586 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.3 mt-30 -60.02 -29.85 68.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.944 -0.571 . . . . 75.209999999999994 111.147 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.33 -44.24 88.41 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.716 -0.476 . . . . 74.140000000000001 109.716 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 33.2 mt-10 -62.02 -37.38 84.69 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.046 -0.524 . . . . 65.510000000000005 110.062 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 22.0 ttmm -55.79 -53.81 52.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.005 0.431 . . . . 74.540000000000006 110.828 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 62' ' ' GLN . 35.5 mt -63.79 -35.7 81.48 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.026 -0.534 . . . . 74.510000000000005 109.635 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.19 -44.31 95.72 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.445 -0.798 . . . . 43.32 110.16 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.9 mt-30 -60.61 -49.46 77.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.971 0.415 . . . . 74.129999999999995 110.265 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -62.17 -42.23 99.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.519 -0.764 . . . . 75.409999999999997 111.326 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -104.7 4.58 32.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.776 0.658 . . . . 75.219999999999999 112.776 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.55 -20.04 4.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.641 0.608 . . . . 72.120000000000005 112.641 -172.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.614 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 8.3 pt-20 -65.05 -33.69 76.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.606 0.241 . . . . 74.019999999999996 111.129 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.614 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 23.2 m-80 -124.19 5.12 8.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.509 -0.314 . . . . 60.25 110.909 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 43' ' ' LEU . 51.2 t -137.17 141.36 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.906 0.384 . . . . 74.219999999999999 111.556 -173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.89 130.07 16.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.389 -0.597 . . . . 72.219999999999999 109.389 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' HB2' ' A' ' 45' ' ' LEU . 23.7 mt -109.39 138.47 36.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 120.951 0.405 . . . . 73.140000000000001 110.411 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 93.7 m-85 -119.27 170.4 9.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.676 . . . . 73.109999999999999 110.47 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -140.74 96.51 3.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.403 -0.962 . . . . 62.329999999999998 108.403 -179.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 12.7 tt -72.84 116.44 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.207 0.527 . . . . 75.129999999999995 111.239 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -90.83 68.94 6.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.753 0.787 . . . . 60.109999999999999 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.701 HG12 HG21 ' A' ' 87' ' ' VAL . 11.0 tp -94.91 29.82 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.964 0.888 . . . . 65.230000000000004 109.897 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.831 ' HB3' HG23 ' A' ' 16' ' ' THR . 9.8 pt-20 -52.23 -18.24 1.45 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.752 -1.113 . . . . 64.209999999999994 113.451 -174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.49 -23.75 61.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.887 0.328 . . . . 63.520000000000003 111.887 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -147.09 156.53 43.08 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.964 0.412 . . . . 73.530000000000001 111.255 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -3.9 23.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.941 -0.572 . . . . 73.430000000000007 110.163 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 6.0 m-20 -50.71 -40.41 54.11 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.094 -0.503 . . . . 63.32 111.027 -176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.701 HG21 HG12 ' A' ' 81' ' ' ILE . 85.5 t -54.27 -38.04 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 115.865 -0.607 . . . . 71.010000000000005 111.208 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.92 97.63 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.108 0.48 . . . . 74.239999999999995 109.963 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.606 HG22 ' HB2' ' A' ' 8' ' ' HIS . 17.7 m -62.63 -37.86 87.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 72.420000000000002 110.514 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 77.3 mm-40 -63.86 -54.92 27.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.797 -0.638 . . . . 74.510000000000005 110.706 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.09 -14.04 58.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.323 -0.399 . . . . 73.109999999999999 111.72 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.41 59.13 5.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.037 -0.602 . . . . 65.549999999999997 112.127 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.601 HG21 ' HZ2' ' A' ' 49' ' ' TRP . 78.6 t -67.56 109.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 75.310000000000002 110.8 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.0 t -67.7 -50.52 57.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.903 -0.59 . . . . 72.219999999999999 110.71 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.69 172.57 16.46 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.346 -0.388 . . . . 52.439999999999998 110.683 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 49' ' ' TRP . 23.8 pt -113.6 148.37 39.58 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.923 -0.581 . . . . 75.510000000000005 109.835 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.666 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 72.1 Cg_endo -73.36 168.49 75.95 Favored 'Cis proline' 0 C--N 1.355 0.902 0 C-N-CA 124.21 -1.162 . . . . 64.140000000000001 112.788 -0.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.2 m -128.27 110.96 12.88 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.956 -0.566 . . . . 74.0 110.406 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.4 mm -114.85 110.9 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.165 -0.47 . . . . 71.439999999999998 110.435 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 48' ' ' PHE . 8.5 mp -96.17 155.02 16.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.304 -0.258 . . . . 72.510000000000005 110.304 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.519 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 35.2 mtt -119.0 150.4 40.01 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 110.196 -0.298 . . . . 65.120000000000005 110.196 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -144.27 152.29 40.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.089 0.556 . . . . 74.140000000000001 109.609 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -148.03 122.5 9.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.513 -0.181 . . . . 74.239999999999995 110.513 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.9 m-20 57.67 32.53 22.0 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.292 0.568 . . . . 72.219999999999999 110.665 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.44 75.88 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.689 -0.687 . . . . 43.109999999999999 112.479 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -117.4 152.67 34.49 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.068 -0.345 . . . . 63.039999999999999 110.068 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 8.8 tmtt? -69.46 126.41 29.65 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.938 0.774 . . . . 71.430000000000007 111.286 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.494 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.6 mm? -126.44 168.99 13.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.225 1.41 . . . . 72.319999999999993 109.19 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -179.82 1.9 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.274 0.559 . . . . 72.409999999999997 111.879 -164.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -148.85 143.37 26.24 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.853 0.835 . . . . 74.540000000000006 111.009 -172.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 t -123.43 130.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 113.843 -1.526 . . . . 73.030000000000001 109.753 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.1 124.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.483 . . . . 62.140000000000001 109.697 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.94 149.21 21.2 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.544 -0.622 . . . . 60.32 111.544 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.64 87.52 7.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.777 0.323 . . . . 75.109999999999999 110.972 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -130.28 100.11 5.27 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.432 -0.581 . . . . 64.239999999999995 109.432 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.7 tp -61.01 -33.22 54.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.58 . . . . 62.149999999999999 111.084 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.412 ' O ' HG21 ' A' ' 120' ' ' ILE . 34.2 t -63.85 -50.08 70.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 72.200000000000003 110.482 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.53 -45.03 92.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.5 -0.318 . . . . 55.140000000000001 110.302 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.475 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -58.13 -53.39 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.358 . . . . 72.120000000000005 110.719 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.506 HD11 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -61.5 -39.49 83.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 110.062 -0.347 . . . . 74.510000000000005 110.062 -178.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.605 ' HA ' HD22 ' A' ' 124' ' ' ASN . 67.2 m -59.44 -49.94 75.87 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.542 -0.299 . . . . 52.409999999999997 110.528 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -61.27 -37.75 84.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.407 -0.36 . . . . 73.040000000000006 110.483 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.1 mt -59.43 -56.22 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.518 0.199 . . . . 73.409999999999997 110.938 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.605 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.5 p30 -70.25 -25.6 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.757 -0.377 . . . . 70.219999999999999 110.386 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -69.4 -38.05 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 72.200000000000003 110.284 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 93.1 m-20 -87.88 -18.6 28.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.697 -0.683 . . . . 71.200000000000003 111.519 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 123' ' ' ILE . 78.9 mt -78.3 -45.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 74.310000000000002 110.126 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.634 -0.698 . . . . 71.430000000000007 109.921 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.465 -0.569 . . . . 75.420000000000002 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.55 159.22 16.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.136 0.493 . . . . 51.25 111.065 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -144.77 30.97 1.17 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.158 -1.053 . . . . 65.040000000000006 108.158 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -82.52 80.3 8.71 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.492 -1.231 . . . . 71.219999999999999 109.982 -175.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -124.14 103.81 8.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.048 -0.524 . . . . 71.299999999999997 110.064 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.7 148.07 22.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.211 -0.45 . . . . 75.120000000000005 109.986 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -141.61 126.67 18.38 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.641 0.258 . . . . 65.209999999999994 110.382 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -175.14 137.75 0.41 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.038 -0.528 . . . . 74.329999999999998 109.906 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -146.57 170.38 17.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.559 0.219 . . . . 73.109999999999999 110.436 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.78 172.42 43.9 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.23 -0.509 . . . . 70.450000000000003 112.757 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.5 t -121.46 163.16 19.23 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.516 0.327 . . . . 75.420000000000002 110.205 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 12' ' ' LEU . 2.8 mm? -83.67 -26.66 29.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 110.632 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -140.44 138.64 34.86 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.388 -0.369 . . . . 75.420000000000002 110.568 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.76 86.56 3.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.867 -0.606 . . . . 74.349999999999994 110.083 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -95.82 -178.5 4.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.532 -0.758 . . . . 71.239999999999995 110.254 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 90.5 m -141.44 126.27 18.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.164 -0.471 . . . . 70.150000000000006 110.272 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -83.65 -36.23 23.98 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.434 -0.348 . . . . 71.400000000000006 111.068 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.07 101.38 0.16 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.124 -0.56 . . . . 74.209999999999994 112.088 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -88.84 -169.23 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.0 2.467 . . . . 75.329999999999998 112.143 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.62 126.2 18.05 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.335 -1.106 . . . . 31.0 110.335 171.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.418 ' HA ' ' OE2' ' A' ' 64' ' ' GLU . 49.5 m -43.53 103.94 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.257 0.466 . . . . 73.120000000000005 112.257 -172.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.8 mmm -75.17 -26.27 58.94 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.794 -0.639 . . . . 71.319999999999993 109.333 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -65.34 88.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.1 -0.704 . . . . 73.430000000000007 109.1 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 17.0 tt0 -67.8 111.81 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.599 -0.728 . . . . 70.140000000000001 109.679 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.2 135.75 33.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 110.88 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.4 pt -139.39 175.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.888 -0.596 . . . . 73.540000000000006 110.29 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.86 -167.83 13.2 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.267 -0.424 . . . . 75.430000000000007 112.177 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.23 -54.28 38.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.727 0.411 . . . . 65.030000000000001 112.007 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -66.68 -29.34 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.392 -0.367 . . . . 74.420000000000002 110.925 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.18 -21.31 31.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 75.540000000000006 112.005 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.486 ' HA ' HD12 ' A' ' 26' ' ' ILE . 86.8 t80 -55.74 -61.9 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.623 0.249 . . . . 70.519999999999996 111.461 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.09 -43.49 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 73.420000000000002 110.506 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -52.58 -57.46 9.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.78 -0.645 . . . . 43.219999999999999 111.063 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HG3' HG22 ' A' ' 26' ' ' ILE . 47.8 mmtm -70.95 -38.14 72.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 63.340000000000003 111.473 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.58 -37.89 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.632 0.254 . . . . 74.140000000000001 110.94 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.5 p -83.04 -22.49 33.54 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.728 0.299 . . . . 53.409999999999997 110.99 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t -64.86 -5.14 5.36 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.328 -0.397 . . . . 74.540000000000006 111.71 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 104' ' ' ASN . 85.8 m -62.66 106.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.536 0.208 . . . . 71.299999999999997 110.514 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -61.24 -68.23 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.286 -0.415 . . . . 72.420000000000002 111.269 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -147.05 128.96 15.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.659 0.266 . . . . 63.420000000000002 111.551 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.66 24.54 5.59 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.644 0.778 . . . . 72.450000000000003 112.046 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 50.2 mm -78.61 113.61 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.591 -0.277 . . . . 70.510000000000005 110.262 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 74' ' ' VAL . 2.5 tm? -90.21 112.3 23.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.422 0.629 . . . . 72.329999999999998 109.583 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 49.3 mt -101.76 135.23 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.504 -0.771 . . . . 72.450000000000003 111.003 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.466 ' N ' HD13 ' A' ' 45' ' ' LEU . 4.4 mp -111.07 116.99 32.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.773 -0.825 . . . . 73.209999999999994 108.773 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.4 t -99.12 105.03 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.978 -0.378 . . . . 72.450000000000003 109.978 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.49 ' HA ' HD11 ' A' ' 99' ' ' ILE . 7.7 t70 -77.04 139.55 40.07 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.826 -0.624 . . . . 62.130000000000003 111.335 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -107.51 87.21 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.641 -0.874 . . . . 65.219999999999999 108.641 170.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.726 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 27.1 t-105 -43.34 130.38 4.9 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.671 -1.149 . . . . 74.340000000000003 112.974 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.09 103.85 51.56 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.638 -0.71 . . . . 54.329999999999998 109.642 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.18 -26.19 75.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.761 2.307 . . . . 64.329999999999998 112.684 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -121.36 105.45 10.54 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.204 -0.453 . . . . 73.150000000000006 110.388 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -174.15 146.73 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 63.299999999999997 110.544 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.67 -66.83 1.28 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.229 -0.441 . . . . 43.399999999999999 112.828 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.78 -28.69 59.49 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.587 2.191 . . . . 54.219999999999999 112.308 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 59.1 m -56.59 -31.92 64.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.076 -0.511 . . . . 71.349999999999994 111.159 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -54.35 -60.86 2.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.358 0.599 . . . . 74.439999999999998 109.858 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.531 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 50.3 m -55.43 -38.26 68.75 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 114.448 -1.251 . . . . 74.230000000000004 111.695 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 3.6 mm? -57.77 -34.95 70.12 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.335 -0.393 . . . . 64.099999999999994 110.941 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.4 mt-10 -55.94 -64.07 2.65 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.228 -0.415 . . . . 65.120000000000005 111.052 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 57' ' ' ARG . 33.4 Cg_endo -64.77 -24.75 61.39 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.788 1.658 . . . . 64.230000000000004 112.18 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.0 mt-30 -63.26 -44.17 95.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.306 -0.558 . . . . 75.209999999999994 110.077 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.0 mt -68.4 -39.62 81.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.903 -0.589 . . . . 74.140000000000001 110.099 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 46.5 mt-10 -60.93 -35.82 77.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.002 -0.544 . . . . 65.510000000000005 110.281 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.51 -56.21 24.84 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.031 0.443 . . . . 74.540000000000006 110.264 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.3 mt -56.26 -39.06 72.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.659 -0.701 . . . . 74.510000000000005 109.572 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -61.8 -48.24 81.49 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.115 -0.948 . . . . 43.32 110.251 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -55.93 -42.42 76.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 74.129999999999995 110.805 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -66.65 -45.09 80.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.003 -0.544 . . . . 75.409999999999997 111.303 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -101.71 5.47 41.4 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.996 0.739 . . . . 75.219999999999999 112.996 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.44 -19.61 3.77 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.334 0.865 . . . . 72.120000000000005 113.334 -169.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.8 -29.59 66.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 74.019999999999996 111.211 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -119.28 -11.03 9.62 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.896 -0.593 . . . . 60.25 111.275 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 43' ' ' LEU . 57.2 t -125.62 142.7 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.056 0.455 . . . . 74.219999999999999 111.656 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 5.2 tppp? -145.63 131.73 19.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 72.219999999999999 109.578 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.5 mt -103.72 120.69 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.0 -0.37 . . . . 73.140000000000001 110.0 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 50.2 m-85 -107.37 153.75 22.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 73.109999999999999 110.667 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.726 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 24.9 ttpt -131.32 120.18 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.274 -0.639 . . . . 62.329999999999998 109.274 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.484 HG23 HG12 ' A' ' 81' ' ' ILE . 39.9 mt -73.1 106.82 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.23 -1.026 . . . . 75.129999999999995 108.23 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.13 73.0 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.044 0.45 . . . . 60.109999999999999 111.394 -171.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 79' ' ' ILE . 26.5 pt -147.0 31.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.385 -0.825 . . . . 65.230000000000004 109.165 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -20.31 64.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.639 -0.709 . . . . 64.209999999999994 111.474 -175.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.1 -27.85 62.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.21 0.529 . . . . 63.520000000000003 109.907 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.45 76.87 9.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.555 -0.748 . . . . 73.530000000000001 109.078 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -62.62 -27.87 69.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.188 -0.915 . . . . 73.430000000000007 110.624 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 27.2 t70 -50.11 -41.74 49.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.847 -0.615 . . . . 63.32 110.56 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 81' ' ' ILE . 92.3 t -54.24 -40.36 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 71.010000000000005 110.788 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . . . -62.3 -47.3 84.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.424 0.631 . . . . 74.239999999999995 109.823 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.9 m -64.7 -33.41 75.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.444 -0.798 . . . . 72.420000000000002 110.867 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.6 mm-40 -68.43 -44.54 74.75 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 110.862 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.16 0.31 57.14 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.239 -0.437 . . . . 73.109999999999999 111.619 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.21 43.72 20.06 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.031 -0.604 . . . . 65.549999999999997 113.401 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 88' ' ' ALA . 95.9 t -74.82 106.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.297 -0.631 . . . . 75.310000000000002 109.297 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.0 m -61.76 -39.32 91.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.316 . . . . 72.219999999999999 111.738 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.61 145.65 24.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.472 -0.331 . . . . 52.439999999999998 110.606 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.5 pt -104.32 141.43 22.51 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.219 -0.446 . . . . 75.510000000000005 110.098 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -85.21 169.86 47.46 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.712 -1.37 . . . . 64.140000000000001 112.116 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -145.53 155.57 43.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.969 -0.56 . . . . 74.0 109.554 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 47' ' ' ASP . 47.7 mm -118.67 110.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.395 -0.82 . . . . 71.439999999999998 109.926 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' N ' HD11 ' A' ' 100' ' ' LEU . 5.1 mp -97.75 123.01 41.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.064 -0.717 . . . . 72.510000000000005 109.064 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.6 mtt -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 65.120000000000005 110.397 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -144.87 145.79 31.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.614 -0.513 . . . . 74.140000000000001 109.614 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -142.11 119.79 11.81 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.925 -0.398 . . . . 74.239999999999995 109.925 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.603 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 13.7 p30 51.21 25.61 2.53 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.997 0.919 . . . . 72.219999999999999 112.099 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.59 64.96 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.835 -0.62 . . . . 43.109999999999999 113.166 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.456 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 47.9 tptt -73.12 142.14 47.5 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 117.067 0.433 . . . . 63.039999999999999 110.37 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 2.5 tmtp? -68.88 122.52 18.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.824 -0.626 . . . . 71.430000000000007 110.009 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -118.1 168.8 10.22 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.273 1.029 . . . . 72.319999999999993 109.749 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 101' ' ' MET . 0.3 OUTLIER -69.73 166.94 18.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.485 0.659 . . . . 72.409999999999997 112.566 -159.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 57.2 tt0 -129.25 136.84 50.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.211 1.005 . . . . 74.540000000000006 111.326 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.47 121.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.256 -1.793 . . . . 73.030000000000001 109.608 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.2 mt -107.02 133.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 110.269 -0.271 . . . . 62.140000000000001 110.269 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.54 168.24 36.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.322 -0.466 . . . . 60.32 112.465 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.43 98.99 11.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.641 0.258 . . . . 75.109999999999999 110.884 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.2 t70 -143.55 100.61 3.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.548 -0.538 . . . . 64.239999999999995 109.548 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.3 tp -62.96 -38.45 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.895 -0.593 . . . . 62.149999999999999 111.577 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -66.54 -43.65 84.58 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.095 0.474 . . . . 72.200000000000003 110.147 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -61.41 -48.06 82.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 55.140000000000001 110.295 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 115' ' ' ASP . 73.8 mt -61.78 -47.15 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 72.120000000000005 111.519 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.519 ' HA ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.24 -41.76 92.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.211 0.529 . . . . 74.510000000000005 110.233 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.4 t -56.22 -45.73 79.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.795 -0.639 . . . . 52.409999999999997 109.465 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 39.5 mm-40 -70.2 -32.39 70.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 73.040000000000006 111.491 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 120' ' ' ILE . 80.1 mt -54.55 -55.01 17.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 N-CA-C 108.936 -0.764 . . . . 73.409999999999997 108.936 173.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -66.82 -36.07 81.5 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.391 . . . . 70.219999999999999 111.093 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.8 t30 -63.37 -42.06 98.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.216 -0.447 . . . . 72.200000000000003 111.294 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.408 ' OD1' HD13 ' A' ' 108' ' ' LEU . 57.8 m-80 -93.66 -15.3 25.44 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.448 -0.342 . . . . 71.200000000000003 111.671 -174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 123' ' ' ILE . 38.7 mt -61.45 -43.59 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.231 -1.025 . . . . 74.310000000000002 108.231 166.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.869 -1.06 . . . . 71.430000000000007 109.982 172.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 110.408 -0.219 . . . . 75.420000000000002 110.408 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.13 103.28 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 51.25 110.336 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -68.98 142.0 54.78 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.216 -0.447 . . . . 65.040000000000006 110.572 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -55.99 135.22 52.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.242 -0.436 . . . . 71.219999999999999 111.126 -177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -157.82 129.15 6.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.05 -0.523 . . . . 71.299999999999997 110.592 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -152.18 147.18 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.326 -0.62 . . . . 75.120000000000005 109.326 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -95.82 166.66 11.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.873 0.368 . . . . 65.209999999999994 110.864 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -125.79 63.14 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.445 -0.946 . . . . 74.329999999999998 108.445 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.0 ptm -136.44 151.08 49.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.524 -0.762 . . . . 73.109999999999999 110.162 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.11 140.0 2.85 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.899 -0.667 . . . . 70.450000000000003 112.074 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 m -89.81 64.99 6.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.264 0.554 . . . . 75.420000000000002 110.151 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.32 99.33 12.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.03 -0.532 . . . . 74.230000000000004 110.336 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.27 90.05 6.6 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.989 -0.745 . . . . 75.420000000000002 108.989 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.51 111.37 19.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.817 -0.629 . . . . 74.349999999999994 111.165 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -95.46 171.59 8.6 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.026 -0.534 . . . . 71.239999999999995 109.972 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.3 m -69.83 94.36 0.82 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.493 -0.321 . . . . 70.150000000000006 110.78 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -77.23 -28.13 53.6 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.36 -0.608 . . . . 71.400000000000006 109.36 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.0 -164.35 30.65 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.055 -0.818 . . . . 74.209999999999994 111.055 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -83.62 148.89 12.69 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.724 2.282 . . . . 75.329999999999998 111.662 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.51 51.52 3.33 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.289 -0.482 . . . . 31.0 112.002 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -147.65 32.39 0.87 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.451 -0.574 . . . . 73.120000000000005 109.451 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.445 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 96.0 mmm -72.64 -24.63 61.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.795 -0.639 . . . . 71.319999999999993 111.221 -174.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.4 HG22 ' HE2' ' A' ' 78' ' ' LYS . 20.8 mm -77.33 93.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.114 -0.698 . . . . 73.430000000000007 109.114 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.2 tp10 -68.4 122.76 19.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 70.140000000000001 111.152 -175.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -90.93 122.13 33.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.436 -0.347 . . . . 71.409999999999997 110.353 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.8 pt -126.94 165.08 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.299 -0.409 . . . . 73.540000000000006 111.258 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.34 -167.56 40.99 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.87 -0.604 . . . . 75.430000000000007 113.479 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.48 -54.3 30.33 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 65.030000000000001 111.448 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 t -74.67 -28.19 60.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.225 0.536 . . . . 74.420000000000002 110.359 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.23 -17.55 64.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 75.540000000000006 111.636 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.418 ' O ' HG22 ' A' ' 35' ' ' VAL . 91.4 t80 -58.4 -62.04 2.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.8 0.333 . . . . 70.519999999999996 110.16 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.16 -45.72 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.156 0.503 . . . . 73.420000000000002 110.207 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -56.15 -57.47 12.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.381 -0.827 . . . . 43.219999999999999 111.484 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.67 -29.61 65.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.223 -0.444 . . . . 63.340000000000003 111.456 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 31' ' ' PHE . 49.4 t -68.33 -41.59 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.648 0.261 . . . . 74.140000000000001 110.758 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 p -81.25 -18.88 44.44 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.872 0.367 . . . . 53.409999999999997 111.028 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 t -61.67 -21.75 64.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.136 -0.484 . . . . 74.540000000000006 111.529 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 22.9 p -59.62 122.09 13.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.606 0.241 . . . . 71.299999999999997 110.601 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.77 -69.18 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.148 -0.478 . . . . 72.420000000000002 111.844 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -161.42 135.76 7.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 63.420000000000002 110.934 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 16.6 m-80 59.36 17.1 5.58 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.704 0.628 . . . . 72.450000000000003 112.156 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.2 mm -87.85 114.01 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 70.510000000000005 110.292 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.545 HD22 ' SD ' ' A' ' 101' ' ' MET . 0.3 OUTLIER -78.82 109.19 12.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 72.329999999999998 109.387 178.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 38' ' ' CYS . 43.6 mt -97.68 121.64 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.951 -0.568 . . . . 72.450000000000003 110.482 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.662 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.9 mp -106.37 116.0 31.18 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.526 -0.546 . . . . 73.209999999999994 109.526 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.4 t -99.64 105.86 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 110.269 -0.271 . . . . 72.450000000000003 110.269 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 18.0 t70 -81.58 132.87 35.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.085 -0.507 . . . . 62.130000000000003 110.427 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -89.19 137.86 31.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.642 -0.503 . . . . 65.219999999999999 109.642 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -46.24 -51.06 15.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.594 0.559 . . . . 74.340000000000003 111.944 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 67.58 153.03 0.13 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.636 0.585 . . . . 54.329999999999998 111.828 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.2 173.92 9.77 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.426 2.084 . . . . 64.329999999999998 112.092 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -49.89 120.45 4.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.089 -0.505 . . . . 73.150000000000006 110.958 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.65 147.33 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 63.299999999999997 111.103 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -64.09 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.182 -0.463 . . . . 43.399999999999999 112.642 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.18 -30.55 32.93 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.208 2.605 . . . . 54.219999999999999 113.191 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 19.9 p -57.75 -29.01 64.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 71.349999999999994 111.285 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -54.3 -39.55 67.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.538 0.209 . . . . 74.439999999999998 111.276 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.645 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 45.1 m -75.11 -42.21 56.97 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.651 0.739 . . . . 74.230000000000004 110.48 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -61.61 -31.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.311 -0.859 . . . . 64.099999999999994 112.07 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 43.1 mt-10 -59.28 -60.93 8.94 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 117.803 0.274 . . . . 65.120000000000005 110.749 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 28.8 Cg_endo -62.98 -29.38 75.65 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.846 1.697 . . . . 64.230000000000004 112.174 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.645 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.0 mt-30 -64.51 -44.7 90.09 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.058 -0.657 . . . . 75.209999999999994 110.161 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 119' ' ' ILE . 85.7 mt -64.43 -45.68 86.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 74.140000000000001 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.6 mt-10 -63.16 -34.08 76.85 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.031 -0.531 . . . . 65.510000000000005 110.563 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.79 -47.29 87.01 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.827 0.346 . . . . 74.540000000000006 110.21 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.49 -35.64 79.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.907 -0.588 . . . . 74.510000000000005 109.731 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.39 -42.68 98.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.785 -0.643 . . . . 43.32 110.234 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.1 mt-30 -67.16 -44.3 80.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 74.129999999999995 110.082 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -67.27 -38.74 85.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.482 -0.781 . . . . 75.409999999999997 111.352 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -105.14 4.63 31.57 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.756 0.65 . . . . 75.219999999999999 112.756 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.43 -19.93 4.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.424 0.527 . . . . 72.120000000000005 112.424 -172.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.03 -29.03 70.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.793 0.33 . . . . 74.019999999999996 110.875 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -130.62 4.65 4.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.3 -0.409 . . . . 60.25 111.021 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 43' ' ' LEU . 62.4 t -133.49 149.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.941 0.4 . . . . 74.219999999999999 111.242 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HB2' ' HZ2' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -156.16 127.96 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.345 -0.613 . . . . 72.219999999999999 109.345 174.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.662 HG12 ' HB2' ' A' ' 45' ' ' LEU . 42.2 mt -106.12 141.27 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.738 0.304 . . . . 73.140000000000001 111.01 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.7 m-85 -123.51 171.72 9.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 73.109999999999999 109.821 176.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 21.1 ttmm -146.6 139.06 25.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 62.329999999999998 109.94 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.7 mm -96.6 99.14 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.23 -0.656 . . . . 75.129999999999995 109.23 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.7 -19.14 61.46 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.093 -0.503 . . . . 60.109999999999999 110.943 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.71 87.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 65.230000000000004 110.462 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.34 -18.52 63.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 64.209999999999994 111.385 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.85 -15.77 60.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.124 -0.489 . . . . 63.520000000000003 111.406 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -86.04 93.73 9.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.056 0.455 . . . . 73.530000000000001 109.972 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -87.59 -20.6 26.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 73.430000000000007 110.212 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.01 -58.54 2.39 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.959 -0.564 . . . . 63.32 111.149 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.53 -34.09 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.731 -0.668 . . . . 71.010000000000005 111.001 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.22 69.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.518 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.8 m -67.42 -40.95 85.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 72.420000000000002 110.627 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.16 -44.56 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 74.510000000000005 111.789 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -99.12 -4.19 32.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.833 0.308 . . . . 73.109999999999999 111.833 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.47 83.41 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.214 -0.517 . . . . 65.549999999999997 113.271 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.05 144.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.371 -0.603 . . . . 75.310000000000002 109.371 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.402 ' HB2' HG23 ' A' ' 112' ' ' ILE . 31.2 m -138.62 -63.72 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.691 0.281 . . . . 72.219999999999999 111.489 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.92 178.01 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 52.439999999999998 111.354 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 10.3 pt -112.35 116.2 48.95 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.46 -0.791 . . . . 75.510000000000005 110.87 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -92.02 -162.54 1.43 Allowed 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 124.219 -1.159 . . . . 64.140000000000001 111.947 -3.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.6 m -138.08 118.17 13.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.231 -0.441 . . . . 74.0 109.935 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mm -110.14 130.46 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.735 -0.666 . . . . 71.439999999999998 110.584 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' A' ' 110' ' ' GLN . 40.9 mt -107.18 143.98 34.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.926 -0.768 . . . . 72.510000000000005 108.926 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.545 ' SD ' HD22 ' A' ' 43' ' ' LEU . 3.2 mtt -109.92 149.48 29.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.117 0.417 . . . . 65.120000000000005 110.666 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.0 m-85 -146.82 162.03 39.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.789 -0.641 . . . . 74.140000000000001 109.472 175.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.583 ' HZ1' ' HB2' ' A' ' 103' ' ' LYS . 4.9 ttmp? -160.49 131.27 5.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.277 -0.268 . . . . 74.239999999999995 110.277 176.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.498 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 3.5 m-20 58.19 27.17 14.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.149 0.5 . . . . 72.219999999999999 110.58 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.43 27.93 71.95 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.836 -0.62 . . . . 43.109999999999999 112.266 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -126.83 149.6 49.63 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.491 -0.559 . . . . 63.039999999999999 109.491 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.56 ' O ' HD22 ' A' ' 108' ' ' LEU . 26.9 ttpt -68.75 143.91 54.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.747 0.784 . . . . 71.430000000000007 112.438 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 107' ' ' LYS . 1.4 mm? -144.68 169.3 18.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.841 -1.527 . . . . 72.319999999999993 108.379 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.62 173.71 5.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.773 0.797 . . . . 72.409999999999997 112.51 -162.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.1 tt0 -127.66 150.57 49.69 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.027 -0.988 . . . . 74.540000000000006 110.793 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.69 111.63 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 114.514 -1.221 . . . . 73.030000000000001 109.418 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.402 HG23 ' HB2' ' A' ' 94' ' ' SER . 60.1 mt -114.23 121.83 67.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.483 -0.326 . . . . 62.140000000000001 110.183 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.39 145.17 9.19 Favored Glycine 0 C--N 1.328 0.134 0 N-CA-C 111.76 -0.536 . . . . 60.32 111.76 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.14 72.19 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.13 0.491 . . . . 75.109999999999999 110.906 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -125.88 93.34 3.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.025 -0.731 . . . . 64.239999999999995 109.025 175.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.95 -25.09 34.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.334 -0.848 . . . . 62.149999999999999 111.511 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 t -67.67 -46.14 73.21 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.292 -0.633 . . . . 72.200000000000003 109.292 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.3 tptt -61.41 -45.88 92.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.619 -0.719 . . . . 55.140000000000001 109.744 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.588 HD12 HD21 ' A' ' 63' ' ' LEU . 69.9 mt -56.71 -56.09 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.062 -0.517 . . . . 72.120000000000005 111.292 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.0 -37.51 78.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 116.5 -0.318 . . . . 74.510000000000005 110.272 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.466 ' HA ' HD22 ' A' ' 124' ' ' ASN . 36.8 t -56.63 -51.53 68.33 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.164 -0.471 . . . . 52.409999999999997 109.898 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 20.9 mm-40 -58.58 -44.39 89.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.054 -0.521 . . . . 73.040000000000006 110.135 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.8 mt -54.4 -56.14 11.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.489 -0.323 . . . . 73.409999999999997 111.011 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.5 p30 -68.51 -33.05 73.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.486 -0.486 . . . . 70.219999999999999 110.56 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -68.48 -31.92 71.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.287 -0.415 . . . . 72.200000000000003 110.854 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.43 ' OD1' HD11 ' A' ' 108' ' ' LEU . 23.6 m-80 -90.86 -14.09 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.35 -0.386 . . . . 71.200000000000003 111.565 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.0 mt -81.52 -60.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.553 -0.536 . . . . 74.310000000000002 109.553 168.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.448 -0.787 . . . . 71.430000000000007 110.8 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.858 -0.423 . . . . 75.420000000000002 109.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.49 128.79 44.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.368 -0.378 . . . . 51.25 110.664 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -61.47 117.36 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 65.040000000000006 109.887 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -69.42 102.69 1.83 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.902 -0.777 . . . . 71.219999999999999 108.902 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -53.81 -27.5 29.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.105 -0.498 . . . . 71.299999999999997 111.924 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 t60 69.59 -67.48 0.22 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.445 0.466 . . . . 75.120000000000005 111.621 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -50.18 119.97 4.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.271 0.628 . . . . 65.209999999999994 111.067 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -140.6 145.73 37.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 110.003 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.8 tpt -69.68 102.53 1.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.759 -0.46 . . . . 73.109999999999999 109.759 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.94 48.91 0.41 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.357 -0.697 . . . . 70.450000000000003 111.357 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.3 m -81.68 97.67 8.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.603 -0.298 . . . . 75.420000000000002 110.381 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.31 140.64 31.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.132 -0.485 . . . . 74.230000000000004 110.203 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -63.16 -61.75 2.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 75.420000000000002 110.023 177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.28 7.14 2.12 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.863 -0.608 . . . . 74.349999999999994 112.442 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.92 89.09 7.16 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.304 -0.628 . . . . 71.239999999999995 109.304 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 p -125.01 148.43 48.47 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.737 -0.665 . . . . 70.150000000000006 110.992 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -69.66 98.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.838 0.351 . . . . 71.400000000000006 110.829 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.44 139.75 14.8 Favored Glycine 0 N--CA 1.453 -0.211 0 N-CA-C 111.575 -0.61 . . . . 74.209999999999994 111.575 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.06 -179.18 4.75 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 75.329999999999998 112.125 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.74 -159.75 8.56 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.56 -0.616 . . . . 31.0 111.56 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.6 t -63.61 97.94 0.16 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.524 -0.547 . . . . 73.120000000000005 109.524 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.2 mmm -86.42 -17.17 35.01 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.928 -0.578 . . . . 71.319999999999993 110.943 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.442 HG23 ' HE2' ' A' ' 78' ' ' LYS . 26.7 mm -87.89 101.03 11.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.241 -0.651 . . . . 73.430000000000007 109.241 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 8.8 tp10 -64.47 122.68 17.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.296 0.569 . . . . 70.140000000000001 110.534 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -100.53 109.61 21.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 71.409999999999997 110.22 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.3 pt -119.51 166.78 13.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.733 -0.667 . . . . 73.540000000000006 111.275 -174.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.65 -158.59 33.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.687 -0.688 . . . . 75.430000000000007 112.111 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.11 -51.17 41.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.052 0.454 . . . . 65.030000000000001 111.55 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.4 t -69.5 -36.77 76.81 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.924 -0.58 . . . . 74.420000000000002 111.646 -172.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 1.9 mp0 -65.16 -14.99 61.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 75.540000000000006 111.97 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CD2' HD12 ' A' ' 79' ' ' ILE . 81.5 t80 -51.85 -61.27 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.717 0.294 . . . . 70.519999999999996 110.926 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.11 -44.97 83.78 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.421 . . . . 73.420000000000002 110.394 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -53.69 -57.76 9.65 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.725 0.774 . . . . 43.219999999999999 110.662 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG3' HG23 ' A' ' 26' ' ' ILE . 75.3 mmtt -64.75 -38.1 89.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.083 -0.962 . . . . 63.340000000000003 111.354 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.8 t -70.62 -35.54 61.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.44 -0.345 . . . . 74.140000000000001 110.823 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -81.88 -14.99 55.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.653 0.263 . . . . 53.409999999999997 111.126 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -66.07 2.52 1.1 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.208 0.448 . . . . 74.540000000000006 112.208 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.513 ' SG ' HD11 ' A' ' 44' ' ' ILE . 89.9 m -60.54 169.37 1.78 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.294 0.569 . . . . 71.299999999999997 112.041 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.03 -82.01 0.61 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.401 -0.818 . . . . 72.420000000000002 109.138 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -162.05 137.92 7.61 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.45 -0.574 . . . . 63.420000000000002 109.45 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 61.92 10.47 3.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.645 0.378 . . . . 72.450000000000003 111.408 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.76 108.18 17.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.263 -0.643 . . . . 70.510000000000005 109.263 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 68.0 tp -83.46 121.67 27.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.177 0.513 . . . . 72.329999999999998 110.699 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.513 HD11 ' SG ' ' A' ' 38' ' ' CYS . 27.9 mt -105.83 118.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 72.450000000000003 110.084 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.616 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 3.6 mp -104.28 114.29 28.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.885 -0.783 . . . . 73.209999999999994 108.885 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.2 t -102.86 104.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.374 -0.232 . . . . 72.450000000000003 110.374 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.448 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 18.8 t0 -76.6 129.04 35.86 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.179 -0.674 . . . . 62.130000000000003 109.179 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -83.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 65.219999999999999 111.047 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -167.6 151.21 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 74.340000000000003 110.9 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.57 97.13 6.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.624 -0.717 . . . . 54.329999999999998 109.513 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.68 -50.42 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.581 2.187 . . . . 64.329999999999998 112.17 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -130.98 123.36 28.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.332 -0.618 . . . . 73.150000000000006 109.332 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.2 t -163.26 136.74 5.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 63.299999999999997 110.873 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -86.76 -66.52 1.37 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.955 -0.566 . . . . 43.399999999999999 112.249 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.13 -26.79 52.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.165 2.577 . . . . 54.219999999999999 113.066 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 79.0 m -55.7 -23.55 29.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.482 -0.326 . . . . 71.349999999999994 111.866 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 12.2 ptm180 -54.34 -44.36 72.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.694 0.283 . . . . 74.439999999999998 110.504 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 18.6 m -75.5 -35.61 60.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.239 0.542 . . . . 74.230000000000004 110.79 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -64.83 -36.46 84.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.45 0.537 . . . . 64.099999999999994 112.45 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.8 tt0 -58.18 -58.9 15.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 120.351 -0.54 . . . . 65.120000000000005 110.363 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.25 -32.99 95.01 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.819 1.68 . . . . 64.230000000000004 112.435 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 58' ' ' SER . 46.4 mt-30 -63.4 -44.19 95.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.028 0.442 . . . . 75.209999999999994 110.377 176.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.77 -37.82 82.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.963 -0.562 . . . . 74.140000000000001 110.222 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 52.9 mt-10 -65.51 -36.17 83.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.281 -0.418 . . . . 65.510000000000005 110.26 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -56.53 -52.07 66.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.016 0.436 . . . . 74.540000000000006 109.848 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 HD13 ' A' ' 116' ' ' ILE . 27.0 mt -68.33 -31.32 70.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 74.510000000000005 109.634 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.57 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -70.85 -13.37 62.01 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.643 -0.708 . . . . 43.32 110.982 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -96.06 -50.83 4.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.295 -0.411 . . . . 74.129999999999995 110.861 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.24 -43.05 99.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.36 0.6 . . . . 75.409999999999997 110.793 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.53 5.35 47.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.303 -0.862 . . . . 75.219999999999999 111.494 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.3 t -52.83 -25.88 12.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.258 0.836 . . . . 72.120000000000005 113.258 -168.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.75 -19.0 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.615 0.245 . . . . 74.019999999999996 111.403 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.7 2.0 7.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.521 -0.309 . . . . 60.25 110.991 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.71 144.48 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.784 0.326 . . . . 74.219999999999999 111.324 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -147.05 119.89 8.67 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.275 -0.639 . . . . 72.219999999999999 109.275 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.02 132.11 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.803 0.335 . . . . 73.140000000000001 110.558 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 74.3 m-85 -122.08 166.02 15.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 73.109999999999999 109.475 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HZ3' ' CB ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -148.72 142.58 25.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.411 -0.359 . . . . 62.329999999999998 110.371 172.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' A' ' 31' ' ' PHE . 61.3 mt -102.02 103.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 75.129999999999995 109.231 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -84.1 12.72 5.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 60.109999999999999 111.306 -174.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm -78.3 78.87 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.021 -0.733 . . . . 65.230000000000004 109.021 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -18.48 43.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 64.209999999999994 112.622 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.5 -11.66 60.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.756 0.312 . . . . 63.520000000000003 111.537 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.76 51.21 1.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.194 0.521 . . . . 73.530000000000001 110.281 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -61.42 -61.86 2.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.56 -0.746 . . . . 73.430000000000007 110.841 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 7.7 m-20 -52.83 -36.98 59.47 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.421 -0.809 . . . . 63.32 111.031 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.01 -42.16 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 71.010000000000005 110.202 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.85 -51.57 64.03 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.954 -0.566 . . . . 74.239999999999995 110.269 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.6 m -62.09 -31.48 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 72.420000000000002 111.01 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 25.3 mm-40 -68.81 -51.78 37.15 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.495 -0.32 . . . . 74.510000000000005 110.872 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -76.22 -10.91 59.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.494 -0.321 . . . . 73.109999999999999 111.415 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.42 44.34 2.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.814 -0.708 . . . . 65.549999999999997 113.694 167.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 98' ' ' THR . 72.4 t -77.83 106.13 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.557 -0.534 . . . . 75.310000000000002 109.557 173.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.531 ' HB3' HG22 ' A' ' 112' ' ' ILE . 22.8 t -92.91 -40.24 10.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 72.219999999999999 110.536 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.85 158.19 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 52.439999999999998 110.233 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.698 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.61 140.95 22.15 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.45 . . . . 75.510000000000005 110.406 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.43 -179.35 24.48 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.06 -1.225 . . . . 64.140000000000001 111.529 -3.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 93' ' ' VAL . 93.7 m -139.78 116.42 10.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.926 0.393 . . . . 74.0 110.206 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.1 mm -109.8 110.82 33.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 71.439999999999998 110.8 -173.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 123.44 33.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.737 -0.468 . . . . 72.510000000000005 109.737 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.616 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 17.7 mmt -90.19 140.14 29.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.221 -0.445 . . . . 65.120000000000005 110.078 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.4 144.44 36.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.219 -0.66 . . . . 74.140000000000001 109.219 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -138.42 112.43 8.51 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.587 -0.445 . . . . 74.239999999999995 110.671 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.51 32.33 22.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.615 0.722 . . . . 72.219999999999999 110.453 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.51 68.25 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 115.684 -0.689 . . . . 43.109999999999999 112.649 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -83.12 143.59 30.44 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.777 -0.453 . . . . 63.039999999999999 109.777 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.436 ' O ' HD23 ' A' ' 108' ' ' LEU . 21.5 tptm -65.88 130.62 43.9 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.83 0.706 . . . . 71.430000000000007 111.013 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -131.39 168.94 16.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.581 -1.191 . . . . 72.319999999999993 109.19 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' MET . 1.3 m -69.55 176.19 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.309 0.576 . . . . 72.409999999999997 111.937 -163.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.49 131.53 29.82 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.856 0.836 . . . . 74.540000000000006 110.992 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.83 107.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.926 -1.488 . . . . 73.030000000000001 109.752 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 94' ' ' SER . 64.0 mt -102.77 121.87 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.046 -0.524 . . . . 62.140000000000001 110.108 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.01 149.97 18.04 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.954 -0.458 . . . . 60.32 111.954 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.76 85.97 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.682 0.277 . . . . 75.109999999999999 111.129 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.8 t70 -132.64 92.11 3.01 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.349 0.595 . . . . 64.239999999999995 109.822 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 66' ' ' LEU . 9.2 tp -59.31 -32.89 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.265 -0.88 . . . . 62.149999999999999 111.651 -174.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.8 t -64.17 -48.49 75.77 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.898 0.38 . . . . 72.200000000000003 110.055 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -62.09 -43.37 98.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.013 -0.54 . . . . 55.140000000000001 109.711 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 71.2 mt -58.4 -56.27 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.036 -0.529 . . . . 72.120000000000005 111.117 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.506 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.34 -35.04 67.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 120.758 0.313 . . . . 74.510000000000005 110.187 -177.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.451 ' HA ' HD22 ' A' ' 124' ' ' ASN . 23.2 t -58.04 -51.9 67.77 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.109 -0.496 . . . . 52.409999999999997 109.791 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -61.64 -37.57 84.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.116 -0.493 . . . . 73.040000000000006 110.876 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.8 mt -58.51 -55.95 19.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.3 -0.409 . . . . 73.409999999999997 110.92 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.1 p30 -67.94 -31.42 71.15 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.651 -0.419 . . . . 70.219999999999999 110.011 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -58.06 -43.6 87.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.756 -0.656 . . . . 72.200000000000003 110.566 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -78.26 -38.94 41.54 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.254 0.465 . . . . 71.200000000000003 112.254 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.6 mt -58.07 -47.75 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.372 . . . . 74.310000000000002 110.939 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.926 -0.559 . . . . 71.430000000000007 110.657 -176.519 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HA ' ' OD1' ' A' ' 128' ' ' ASN . 16.5 tpt . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.249 -0.278 . . . . 75.420000000000002 110.249 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.14 29.18 7.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.16 -0.473 . . . . 51.25 111.843 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -109.59 131.6 54.91 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.643 -0.253 . . . . 65.040000000000006 110.892 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -132.43 146.4 51.92 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.207 -0.451 . . . . 71.219999999999999 111.432 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -165.69 154.77 11.92 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.097 -0.705 . . . . 71.299999999999997 109.097 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -99.12 151.86 20.5 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.799 0.333 . . . . 75.120000000000005 110.939 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 78.1 t60 -170.62 -175.77 1.93 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.743 -0.836 . . . . 65.209999999999994 108.743 -175.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -168.36 150.48 5.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.97 -0.381 . . . . 74.329999999999998 109.97 169.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.2 mtp -132.23 169.92 15.76 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.823 0.449 . . . . 73.109999999999999 109.969 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.36 142.8 8.04 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.649 -0.786 . . . . 70.450000000000003 112.871 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.5 m -137.7 139.34 40.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.541 -0.911 . . . . 75.420000000000002 108.541 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.7 mt -104.64 22.18 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.039 0.385 . . . . 74.230000000000004 112.039 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -170.29 142.04 2.13 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.725 0.298 . . . . 75.420000000000002 111.162 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' A' ' 57' ' ' ARG . . . -104.66 101.99 11.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.974 -0.557 . . . . 74.349999999999994 110.076 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -130.7 21.98 5.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.541 . . . . 71.239999999999995 110.736 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -150.42 98.96 2.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.744 -0.207 . . . . 70.150000000000006 110.791 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.05 170.48 15.64 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.143 -0.317 . . . . 71.400000000000006 110.143 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.49 112.66 0.53 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.835 -0.506 . . . . 74.209999999999994 111.835 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.0 90.89 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.636 2.224 . . . . 75.329999999999998 111.148 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.43 53.93 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.161 -1.176 . . . . 31.0 110.161 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.36 171.55 8.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.269 -0.465 . . . . 73.120000000000005 111.123 -170.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.7 mmm -60.4 -31.41 70.34 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.831 -0.803 . . . . 71.319999999999993 108.831 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.621 HG22 ' HD2' ' A' ' 78' ' ' LYS . 17.9 mm -64.99 93.69 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.368 -0.975 . . . . 73.430000000000007 108.368 171.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 9.7 tp10 -52.27 144.31 12.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.469 0.652 . . . . 70.140000000000001 111.98 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -101.67 115.61 30.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.157 -0.929 . . . . 71.409999999999997 110.276 -176.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.475 HG23 ' HG3' ' A' ' 34' ' ' LYS . 50.6 pt -133.96 179.94 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.956 0.408 . . . . 73.540000000000006 110.911 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.34 -153.52 7.93 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.896 -0.593 . . . . 75.430000000000007 111.852 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.97 -53.18 22.1 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.404 0.282 . . . . 65.030000000000001 111.487 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -70.82 -29.96 66.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.828 0.347 . . . . 74.420000000000002 111.565 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 mp0 -72.36 -27.3 62.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.438 . . . . 75.540000000000006 111.009 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -51.89 -61.83 2.01 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.13 0.269 . . . . 70.519999999999996 111.192 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 36' ' ' THR . 9.2 t70 -51.09 -53.59 32.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.986 -0.552 . . . . 73.420000000000002 110.549 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -54.07 -57.28 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.131 -0.941 . . . . 43.219999999999999 111.31 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 77' ' ' TYR . 75.9 mmtt -62.28 -33.37 74.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 63.340000000000003 111.014 -175.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' HD11 ' A' ' 44' ' ' ILE . 21.7 t -69.09 -55.66 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 112.16 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 32' ' ' ASP . 10.2 t -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.383 0.512 . . . . 53.409999999999997 112.383 -170.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 t -75.81 2.57 11.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.135 0.42 . . . . 74.540000000000006 112.135 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.778 ' SG ' HD13 ' A' ' 44' ' ' ILE . 92.0 m -82.8 128.62 34.57 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.666 0.27 . . . . 71.299999999999997 110.49 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.29 -72.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.769 0.655 . . . . 72.420000000000002 112.769 -172.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.43 121.93 35.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 63.420000000000002 111.361 -166.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 58.21 11.19 1.47 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.625 -1.171 . . . . 72.450000000000003 113.395 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 47.9 mm -73.04 95.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.971 0.415 . . . . 70.510000000000005 110.072 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HB3' HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -71.0 110.38 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.857 -0.794 . . . . 72.329999999999998 108.857 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.778 HD13 ' SG ' ' A' ' 38' ' ' CYS . 86.4 mt -94.38 123.24 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.393 -0.822 . . . . 72.450000000000003 110.526 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.668 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.3 mp -110.11 109.75 20.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.242 -0.651 . . . . 73.209999999999994 109.242 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.06 105.16 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.028 -0.36 . . . . 72.450000000000003 110.028 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -81.01 147.66 30.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.382 -0.372 . . . . 62.130000000000003 110.215 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -87.91 115.65 25.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.36 . . . . 65.219999999999999 110.624 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.545 ' HE1' ' HA ' ' A' ' 82' ' ' GLU . 51.6 t-105 -56.35 115.37 2.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.813 -0.631 . . . . 74.340000000000003 110.844 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -111.86 107.88 56.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 54.329999999999998 110.089 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 18.9 Cg_endo -59.81 -21.59 64.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.537 2.158 . . . . 64.329999999999998 111.79 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -131.95 128.63 38.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.531 -0.758 . . . . 73.150000000000006 109.383 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 47.6 t -164.37 175.13 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.889 0.376 . . . . 63.299999999999997 110.694 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -136.58 -61.17 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.553 -0.748 . . . . 43.399999999999999 111.435 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' O ' HD23 ' A' ' 59' ' ' LEU . 52.7 Cg_exo -55.0 -26.03 47.51 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.005 2.47 . . . . 54.219999999999999 112.684 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 56.6 m -57.29 -28.57 63.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.978 -0.555 . . . . 71.349999999999994 111.476 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 2.9 tmt_? -53.59 -49.12 68.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.935 0.398 . . . . 74.439999999999998 111.594 -172.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.4 m -75.3 -38.17 60.46 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.765 0.793 . . . . 74.230000000000004 110.95 177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 55' ' ' PRO . 4.4 mm? -73.71 -24.24 59.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.607 -0.724 . . . . 64.099999999999994 112.043 -172.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.5 mt-10 -59.56 -59.06 15.08 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.786 -0.449 . . . . 65.120000000000005 109.786 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.73 -34.46 31.51 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.819 1.679 . . . . 64.230000000000004 112.376 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.2 mt-30 -62.61 -42.7 99.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.145 -0.622 . . . . 75.209999999999994 110.97 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.604 HD23 HD13 ' A' ' 119' ' ' ILE . 67.6 mt -64.76 -38.62 91.6 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.48 -0.327 . . . . 74.140000000000001 110.132 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.0 mt-10 -58.11 -43.53 87.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 116.419 -0.355 . . . . 65.510000000000005 110.087 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -56.07 -53.43 57.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.093 -0.503 . . . . 74.540000000000006 111.09 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' A' ' 116' ' ' ILE . 34.8 mt -63.26 -37.29 86.67 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.639 -0.504 . . . . 74.510000000000005 109.639 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.18 -26.9 68.35 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.588 -0.733 . . . . 43.32 110.906 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.5 mt-30 -80.15 -48.83 12.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.819 0.342 . . . . 74.129999999999995 110.599 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -47.62 83.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.436 0.636 . . . . 75.409999999999997 109.806 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -90.54 4.47 51.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.294 -0.866 . . . . 75.219999999999999 112.416 -175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -53.16 -21.28 4.8 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.848 0.356 . . . . 72.120000000000005 111.664 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.35 -35.26 78.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 74.019999999999996 110.962 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -133.9 15.71 3.91 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.494 -0.321 . . . . 60.25 111.19 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 43' ' ' LEU . 41.9 t -135.29 139.69 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.071 0.462 . . . . 74.219999999999999 111.351 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 24' ' ' GLU . 61.0 tptt -145.25 119.81 9.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 72.219999999999999 109.14 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.668 HG12 ' HB2' ' A' ' 45' ' ' LEU . 29.2 mt -101.79 141.65 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.227 -0.286 . . . . 73.140000000000001 110.227 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 91.4 m-85 -130.22 161.25 31.59 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.55 0.34 . . . . 73.109999999999999 110.518 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.621 ' HD2' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -163.54 154.86 16.73 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 62.329999999999998 109.147 168.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 28.1 pt -79.53 152.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.394 -0.225 . . . . 75.129999999999995 110.394 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -107.26 6.62 28.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.626 0.25 . . . . 60.109999999999999 111.342 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.503 HD11 ' N ' ' A' ' 81' ' ' ILE . 3.0 mp -78.5 96.58 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 65.230000000000004 110.167 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.545 ' HA ' ' HE1' ' A' ' 49' ' ' TRP . 7.5 tm-20 -61.62 -26.8 68.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.946 -0.57 . . . . 64.209999999999994 110.333 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.72 -9.01 57.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.686 -0.688 . . . . 63.520000000000003 111.28 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -91.4 105.83 18.05 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.093 0.473 . . . . 73.530000000000001 111.155 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -121.54 -32.91 3.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 73.430000000000007 109.776 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.3 m-20 -49.51 -43.18 45.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.011 -0.995 . . . . 63.32 111.939 -173.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.2 -34.05 26.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.283 -0.417 . . . . 71.010000000000005 111.403 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.19 -49.23 78.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.15 0.5 . . . . 74.239999999999995 109.978 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 m -66.73 -35.49 80.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.437 -0.801 . . . . 72.420000000000002 110.642 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 72.8 mm-40 -61.34 -55.41 32.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.691 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.97 -11.87 51.91 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.462 -0.335 . . . . 73.109999999999999 111.815 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.59 42.28 14.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.75 -0.738 . . . . 65.549999999999997 112.354 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t -75.3 114.43 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.55 -0.537 . . . . 75.310000000000002 109.55 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -98.03 -74.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 72.219999999999999 111.05 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.74 136.44 33.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.76 0.314 . . . . 52.439999999999998 110.899 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.684 ' H ' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.67 151.98 46.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 75.510000000000005 109.845 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.86 169.35 64.19 Favored 'Cis proline' 0 C--N 1.354 0.836 0 C-N-CA 124.157 -1.184 . . . . 64.140000000000001 112.921 1.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 112' ' ' ILE . 89.0 m -139.02 114.13 9.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.715 -0.675 . . . . 74.0 109.879 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 32.4 mm -109.79 110.7 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 71.439999999999998 111.012 -173.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -97.83 123.36 41.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.745 -0.835 . . . . 72.510000000000005 108.745 171.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.446 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 37.9 mtt -93.43 150.83 20.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.965 0.412 . . . . 65.120000000000005 110.923 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.7 m-85 -143.33 153.82 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.416 -0.957 . . . . 74.140000000000001 108.416 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -150.91 115.3 5.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 74.239999999999995 110.62 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.76 25.38 15.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.663 0.744 . . . . 72.219999999999999 110.171 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.29 -0.42 87.2 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.636 -0.711 . . . . 43.109999999999999 112.276 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -91.68 145.21 24.77 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 122.812 -0.228 . . . . 63.039999999999999 110.819 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -63.31 132.51 51.83 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.916 0.76 . . . . 71.430000000000007 110.765 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 1.2 mm? -137.19 169.43 17.79 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 125.036 1.334 . . . . 72.319999999999993 108.788 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.25 172.18 7.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.459 0.54 . . . . 72.409999999999997 112.459 -162.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -140.14 126.04 19.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.081 -0.508 . . . . 74.540000000000006 110.605 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.1 m -115.3 122.47 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.191 0.519 . . . . 73.030000000000001 110.422 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 98' ' ' THR . 51.3 mt -108.18 140.56 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.718 -0.674 . . . . 62.140000000000001 109.485 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.12 157.49 32.45 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.991 -0.623 . . . . 60.32 112.13 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.46 97.3 9.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.927 0.343 . . . . 75.109999999999999 111.927 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.9 t0 -146.1 104.27 3.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.317 0.579 . . . . 64.239999999999995 110.677 169.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 62' ' ' GLN . 8.7 tp -59.13 -32.97 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.148 -0.933 . . . . 62.149999999999999 110.809 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 7' ' ' HIS . 41.0 m -67.91 -48.56 65.66 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.196 -0.456 . . . . 72.200000000000003 111.14 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -60.51 -47.66 85.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.374 -0.375 . . . . 55.140000000000001 110.301 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.604 HD13 HD23 ' A' ' 63' ' ' LEU . 78.5 mt -57.9 -55.56 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 72.120000000000005 111.081 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.427 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.86 -36.97 75.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.907 -0.405 . . . . 74.510000000000005 109.907 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -57.16 -52.02 66.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.847 -0.615 . . . . 52.409999999999997 110.082 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.86 -40.31 96.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.314 -0.403 . . . . 73.040000000000006 110.383 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.7 mt -55.32 -56.05 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.556 -0.293 . . . . 73.409999999999997 110.691 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.2 -30.65 66.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.624 -0.431 . . . . 70.219999999999999 110.007 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.53 -34.43 76.9 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.907 -0.588 . . . . 72.200000000000003 111.214 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.437 ' HB2' HD13 ' A' ' 43' ' ' LEU . 89.4 m-20 -92.62 -30.36 15.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 71.200000000000003 112.006 -175.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.431 HD12 ' CG2' ' A' ' 74' ' ' VAL . 79.0 mt -67.81 -51.6 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 74.310000000000002 110.253 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.534 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 9.9 m120 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.527 -0.76 . . . . 71.430000000000007 110.515 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.728 -0.471 . . . . 75.420000000000002 109.728 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.06 128.92 7.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.534 -0.303 . . . . 51.25 110.468 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -119.95 141.94 49.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 65.040000000000006 109.904 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -122.76 112.73 18.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.827 -0.435 . . . . 71.219999999999999 109.827 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -96.72 -33.27 11.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.482 -0.326 . . . . 71.299999999999997 111.682 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -137.76 136.26 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.073 0.464 . . . . 75.120000000000005 111.673 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -148.71 88.33 1.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.265 -0.879 . . . . 65.209999999999994 109.14 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -86.89 106.17 17.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.914 -0.585 . . . . 74.329999999999998 110.92 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.7 ttm -167.15 92.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.979 0.419 . . . . 73.109999999999999 109.982 174.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.79 131.46 1.91 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.725 -0.67 . . . . 70.450000000000003 111.592 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.2 m -151.38 122.74 7.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.546 -0.538 . . . . 75.420000000000002 109.546 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.577 HD11 ' HD2' ' A' ' 65' ' ' LYS . 68.8 mt -56.68 99.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 74.230000000000004 111.789 -174.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -33.04 25.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.073 -0.714 . . . . 75.420000000000002 109.073 173.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.31 85.18 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.519 -0.764 . . . . 74.349999999999994 109.994 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.35 140.09 55.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 71.239999999999995 110.782 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -153.85 133.88 13.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 70.150000000000006 109.841 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -60.74 144.82 51.52 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 123.538 0.524 . . . . 71.400000000000006 110.638 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.49 68.18 0.52 Allowed Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.199 -0.524 . . . . 74.209999999999994 112.028 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -96.51 13.7 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.339 2.693 . . . . 75.329999999999998 111.776 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.67 84.97 0.24 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.342 -0.703 . . . . 31.0 111.342 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.42 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 50.0 m -58.76 101.89 0.1 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.336 0.589 . . . . 73.120000000000005 111.562 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 85.1 mmm -72.68 -12.0 60.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.255 -0.884 . . . . 71.319999999999993 109.929 174.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.14 113.27 10.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.705 -0.679 . . . . 73.430000000000007 109.862 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.456 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 3.5 tp10 -81.72 126.41 31.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.036 0.446 . . . . 70.140000000000001 111.166 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -80.35 119.37 22.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.804 -0.635 . . . . 71.409999999999997 109.697 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.3 pt -126.69 146.47 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.158 0.504 . . . . 73.540000000000006 111.726 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.44 -162.61 26.26 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.221 -0.899 . . . . 75.430000000000007 111.522 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.94 -55.46 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.717 0.294 . . . . 65.030000000000001 110.98 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 m -61.58 -37.73 84.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.265 0.555 . . . . 74.420000000000002 110.644 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -65.33 -36.65 84.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.518 -0.765 . . . . 75.540000000000006 111.573 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.421 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.9 t80 -51.97 -61.69 2.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.732 0.271 . . . . 70.519999999999996 111.732 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -55.66 -46.67 77.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.099 0.476 . . . . 73.420000000000002 110.853 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.97 -57.22 13.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.611 -0.722 . . . . 43.219999999999999 110.88 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 33.7 mmtp -61.8 -32.48 72.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 63.340000000000003 111.369 -175.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 31' ' ' PHE . 76.8 t -72.51 -48.11 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.716 0.293 . . . . 74.140000000000001 110.808 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.0 p -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 53.409999999999997 110.97 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.4 t -65.84 -4.1 6.16 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.17 -0.468 . . . . 74.540000000000006 112.06 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.5 p -65.29 112.77 3.63 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.298 -0.251 . . . . 71.299999999999997 110.788 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.37 -77.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 72.420000000000002 111.059 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -147.63 129.06 14.89 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.627 0.251 . . . . 63.420000000000002 110.851 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 52.33 21.48 1.71 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.84 -0.618 . . . . 72.450000000000003 112.045 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.0 111.09 14.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.349 -0.387 . . . . 70.510000000000005 109.989 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.4 tp -77.26 107.0 9.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.323 0.582 . . . . 72.329999999999998 110.113 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 101' ' ' MET . 27.4 mt -95.05 120.7 44.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.529 -0.76 . . . . 72.450000000000003 110.672 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.548 HD11 HG12 ' A' ' 74' ' ' VAL . 5.8 mp -105.83 123.59 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.327 -0.62 . . . . 73.209999999999994 109.327 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.58 106.8 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.228 -0.286 . . . . 72.450000000000003 110.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.69 132.53 41.75 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.845 0.355 . . . . 62.130000000000003 110.21 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -89.12 62.78 6.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.487 . . . . 65.219999999999999 110.9 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.437 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 11.9 t90 70.68 -70.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.575 -0.739 . . . . 74.340000000000003 112.173 171.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 64.59 74.21 0.42 Allowed Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 123.13 0.572 . . . . 54.329999999999998 111.495 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HG2' ' H ' ' A' ' 52' ' ' TRP . 83.2 Cg_endo -88.5 -66.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.85 2.367 . . . . 64.329999999999998 113.833 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' H ' ' HG2' ' A' ' 51' ' ' PRO . 83.7 m95 -85.56 79.43 9.39 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.826 0.346 . . . . 73.150000000000006 110.96 -174.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.5 p -171.38 139.08 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.571 . . . . 63.299999999999997 110.276 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -75.7 -66.22 1.92 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 116.008 -0.542 . . . . 43.399999999999999 112.556 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.82 -28.6 4.95 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.337 2.691 . . . . 54.219999999999999 113.686 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.472 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 81.5 m -52.96 -34.92 58.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.571 -0.286 . . . . 71.349999999999994 111.668 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 17.5 ptm180 -59.63 -38.01 80.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.585 -0.279 . . . . 74.439999999999998 110.56 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.5 t -75.21 -37.94 60.93 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.423 0.63 . . . . 74.230000000000004 110.319 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.3 mm? -61.24 -34.85 75.81 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 64.099999999999994 111.877 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.72 -58.3 20.47 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.313 -0.375 . . . . 65.120000000000005 111.262 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.67 -30.67 85.71 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.859 1.706 . . . . 64.230000000000004 111.909 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -63.32 -39.95 95.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.596 -0.442 . . . . 75.209999999999994 109.896 174.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 119' ' ' ILE . 82.7 mt -69.85 -35.81 75.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.977 -0.556 . . . . 74.140000000000001 110.093 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 75.8 mt-10 -59.24 -42.59 91.46 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.118 -0.492 . . . . 65.510000000000005 109.97 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.577 ' HD2' HD11 ' A' ' 12' ' ' LEU . 18.4 ttmm -58.11 -54.28 48.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.226 -0.443 . . . . 74.540000000000006 110.461 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 123' ' ' ILE . 56.6 mt -62.17 -30.56 71.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.883 0.373 . . . . 74.510000000000005 110.038 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -69.67 -41.82 74.98 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.89 -0.596 . . . . 43.32 110.628 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.3 mt-30 -70.59 -40.46 73.22 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.04 0.447 . . . . 74.129999999999995 110.72 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -75.66 -35.82 60.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.805 -0.634 . . . . 75.409999999999997 111.012 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.7 5.35 36.21 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.018 -0.537 . . . . 75.219999999999999 112.006 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.8 t -52.44 -18.99 1.9 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.994 0.517 . . . . 72.120000000000005 112.167 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.97 -35.84 64.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.312 -0.404 . . . . 74.019999999999996 111.13 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -133.87 -11.16 2.66 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.717 0.266 . . . . 60.25 111.717 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.548 HG12 HD11 ' A' ' 45' ' ' LEU . 55.2 t -105.35 141.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.032 0.444 . . . . 74.219999999999999 112.047 -172.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -144.56 121.93 11.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 72.219999999999999 109.02 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.7 mt -109.93 143.36 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.012 0.434 . . . . 73.140000000000001 111.51 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 90.7 m-85 -126.73 172.87 9.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.629 -0.714 . . . . 73.109999999999999 110.438 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 49' ' ' TRP . 14.2 tppt? -138.73 115.85 10.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 62.329999999999998 110.418 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.65 99.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.051 -0.722 . . . . 75.129999999999995 109.051 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -108.37 30.81 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 60.109999999999999 111.023 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.71 74.25 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.443 -0.577 . . . . 65.230000000000004 109.443 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -35.58 25.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.137 -0.938 . . . . 64.209999999999994 112.54 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.58 -35.89 70.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 63.520000000000003 111.144 -176.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -93.86 42.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.697 0.761 . . . . 73.530000000000001 110.446 -171.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.38 -15.45 60.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.246 -0.888 . . . . 73.430000000000007 110.491 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.09 -33.91 58.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.757 -0.656 . . . . 63.32 111.086 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.6 t -56.21 -34.41 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.795 -0.639 . . . . 71.010000000000005 110.874 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.01 75.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.09 -0.505 . . . . 74.239999999999995 110.648 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -64.35 -41.76 96.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.963 -0.562 . . . . 72.420000000000002 110.562 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -63.69 -53.19 55.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.143 -0.48 . . . . 74.510000000000005 111.371 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.42 -18.06 60.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 73.109999999999999 111.106 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.74 55.67 3.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.988 -0.625 . . . . 65.549999999999997 112.507 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -69.53 106.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.559 -0.534 . . . . 75.310000000000002 109.559 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.42 ' HB3' HG23 ' A' ' 112' ' ' ILE . 23.3 t -65.72 -56.93 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.984 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.94 27.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.679 0.276 . . . . 52.439999999999998 110.682 -177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 pt -95.16 149.31 36.03 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.873 -0.603 . . . . 75.510000000000005 110.602 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.472 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.2 Cg_exo -71.01 170.46 63.79 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.147 -1.189 . . . . 64.140000000000001 112.516 -1.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.3 m -139.55 125.75 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.649 -0.5 . . . . 74.0 109.649 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.37 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 71.439999999999998 110.796 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -88.81 123.12 32.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.423 -0.584 . . . . 72.510000000000005 109.423 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 43.2 mtt -102.08 142.24 33.65 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.305 0.502 . . . . 65.120000000000005 111.32 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.57 144.96 33.11 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.478 -0.934 . . . . 74.140000000000001 108.478 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -146.42 115.97 7.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.457 -0.497 . . . . 74.239999999999995 111.342 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 62.58 25.72 15.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.823 -0.626 . . . . 72.219999999999999 110.54 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.83 -7.97 80.72 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.804 -0.635 . . . . 43.109999999999999 112.658 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -85.46 151.26 24.11 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 122.3 0.24 . . . . 63.039999999999999 110.952 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -77.56 116.95 18.53 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.558 0.694 . . . . 71.430000000000007 109.972 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.05 168.85 9.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.534 -1.212 . . . . 72.319999999999993 110.377 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.3 OUTLIER -70.08 -177.21 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 72.409999999999997 111.863 -162.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -147.49 147.12 29.83 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.681 0.753 . . . . 74.540000000000006 111.019 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.5 t -122.8 135.43 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 114.066 -1.424 . . . . 73.030000000000001 109.698 -174.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 94' ' ' SER . 65.5 mt -123.68 127.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.559 -0.291 . . . . 62.140000000000001 110.414 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.76 162.31 38.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.216 -0.516 . . . . 60.32 112.415 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.56 78.58 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.931 0.396 . . . . 75.109999999999999 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 119' ' ' ILE . 43.3 t0 -126.38 91.41 3.36 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.048 0.451 . . . . 64.239999999999995 109.799 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.412 HD11 HD11 ' A' ' 66' ' ' LEU . 9.0 tp -61.89 -27.5 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.605 -0.725 . . . . 62.149999999999999 110.654 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -69.87 -44.62 69.44 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.197 -0.456 . . . . 72.200000000000003 109.828 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -67.24 -38.96 86.07 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.69 -0.485 . . . . 55.140000000000001 109.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 115' ' ' ASP . 76.3 mt -60.32 -56.1 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.067 -0.515 . . . . 72.120000000000005 110.954 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -39.83 86.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.774 0.321 . . . . 74.510000000000005 110.197 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.443 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 32.9 t -56.74 -47.58 79.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.151 -0.477 . . . . 52.409999999999997 109.862 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -66.43 -40.83 89.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 73.040000000000006 110.793 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.9 mt -54.41 -56.18 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.79 -0.364 . . . . 73.409999999999997 110.125 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 121' ' ' SER . 8.6 p30 -67.42 -39.19 85.45 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.49 -0.484 . . . . 70.219999999999999 110.388 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.29 -38.4 90.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 72.200000000000003 111.86 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -83.15 -21.25 33.62 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.713 -0.221 . . . . 71.200000000000003 110.798 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.4 mt -72.4 -48.43 47.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.831 -0.433 . . . . 74.310000000000002 109.831 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.508 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.659 -0.686 . . . . 71.430000000000007 110.901 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.083 -0.34 . . . . 75.420000000000002 110.083 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.31 130.97 37.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.512 -0.313 . . . . 51.25 110.736 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -88.15 81.64 7.33 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.47 0.652 . . . . 65.040000000000006 109.84 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -133.6 135.76 44.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.324 -0.853 . . . . 71.219999999999999 110.904 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -141.06 -65.64 0.44 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.792 -0.447 . . . . 71.299999999999997 109.792 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -160.66 149.34 16.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.395 -0.594 . . . . 75.120000000000005 109.395 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -103.02 171.99 7.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.869 0.366 . . . . 65.209999999999994 110.883 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.518 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 44.6 t-80 -161.33 110.75 1.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.734 -0.666 . . . . 74.329999999999998 109.411 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 72.1 mtm -53.67 119.57 5.1 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 123.402 0.439 . . . . 73.109999999999999 110.875 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.7 154.65 52.45 Favored Glycine 0 C--N 1.33 0.208 0 CA-C-N 115.672 -0.695 . . . . 70.450000000000003 112.565 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.1 m -81.84 -72.63 0.42 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.441 0.162 . . . . 75.420000000000002 110.969 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -154.7 114.79 3.82 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.443 0.297 . . . . 74.230000000000004 111.251 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.653 ' HG2' ' HG2' ' A' ' 85' ' ' GLN . 12.3 pt-20 -109.53 106.87 16.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.154 -1.054 . . . . 75.420000000000002 108.154 168.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.518 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . . . -162.92 173.73 13.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.415 -0.357 . . . . 74.349999999999994 111.21 -173.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 74.72 97.33 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.117 0.886 . . . . 71.239999999999995 109.36 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.489 ' HA ' ' HZ2' ' A' ' 49' ' ' TRP . 45.0 p -56.71 120.14 7.33 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.324 -0.853 . . . . 70.150000000000006 112.559 -172.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.411 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 99.3 mt-30 -79.13 168.62 19.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.738 -0.665 . . . . 71.400000000000006 109.491 172.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.33 88.98 0.54 Allowed Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.865 -0.494 . . . . 74.209999999999994 111.865 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 93.8 Cg_endo -86.19 40.41 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.985 2.457 . . . . 75.329999999999998 112.482 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.66 49.68 3.42 Favored Glycine 0 C--N 1.328 0.107 0 N-CA-C 111.224 -0.75 . . . . 31.0 111.224 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' ' OE1' ' A' ' 64' ' ' GLU . 31.2 m -146.82 -161.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.938 -0.393 . . . . 73.120000000000005 109.938 -172.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.411 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 83.4 mmm -57.5 -25.39 59.75 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.704 0.288 . . . . 71.319999999999993 111.279 177.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -75.17 112.26 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 73.430000000000007 110.108 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 7.6 tp10 -71.07 150.27 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 70.140000000000001 110.74 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -118.06 126.63 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 71.409999999999997 110.567 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 31' ' ' PHE . 24.9 pt -143.13 166.63 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 111.16 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.87 -164.38 27.93 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.909 -0.587 . . . . 75.430000000000007 112.561 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' N ' HD13 ' A' ' 81' ' ' ILE . 12.3 t70 -69.12 -57.04 5.93 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.821 0.344 . . . . 65.030000000000001 111.361 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.35 -0.386 . . . . 74.420000000000002 110.236 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.86 -31.39 70.3 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.540000000000006 110.569 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.505 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.7 t80 -52.85 -60.12 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.074 0.464 . . . . 70.519999999999996 110.009 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.46 -45.91 73.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 73.420000000000002 110.848 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -66.39 -57.36 7.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 43.219999999999999 111.613 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG3' HG21 ' A' ' 26' ' ' ILE . 46.8 mmtm -60.52 -31.14 70.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.683 . . . . 63.340000000000003 111.214 -176.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 31' ' ' PHE . 68.1 t -73.43 -44.75 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.687 -0.233 . . . . 74.140000000000001 110.663 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.9 p -72.11 -14.62 61.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.995 0.426 . . . . 53.409999999999997 110.966 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.9 t -71.24 0.53 7.72 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.834 -0.621 . . . . 74.540000000000006 111.351 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.0 p -58.65 120.3 8.66 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.698 0.285 . . . . 71.299999999999997 110.739 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -67.65 -73.35 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.402 -0.363 . . . . 72.420000000000002 111.152 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -156.77 125.62 5.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.361 -0.381 . . . . 63.420000000000002 110.449 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 59.49 5.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.623 0.601 . . . . 72.450000000000003 112.623 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 73' ' ' ASN . 40.0 mm -68.13 112.72 3.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 70.510000000000005 110.73 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.1 tt -80.34 120.87 24.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.831 -0.803 . . . . 72.329999999999998 108.831 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.96 114.16 46.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.459 -0.791 . . . . 72.450000000000003 110.472 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.604 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.0 mp -101.93 137.36 40.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.587 -0.894 . . . . 73.209999999999994 108.587 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -124.74 110.44 25.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 110.21 -0.293 . . . . 72.450000000000003 110.21 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.51 122.16 22.64 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.53 -0.544 . . . . 62.130000000000003 109.53 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.429 ' HE2' HG12 ' A' ' 87' ' ' VAL . 37.4 t80 -69.11 -74.7 0.12 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.573 -0.528 . . . . 65.219999999999999 109.573 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.635 ' HZ3' ' HA ' ' A' ' 80' ' ' ASN . 8.5 t-105 -171.89 160.53 5.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.15 -0.477 . . . . 74.340000000000003 109.861 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.612 ' HB1' ' SG ' ' A' ' 53' ' ' CYS . . . -164.37 96.3 0.94 Allowed Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.276 0.36 . . . . 54.329999999999998 110.538 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.74 -77.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.936 2.424 . . . . 64.329999999999998 112.063 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -98.69 90.88 4.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.783 -0.451 . . . . 73.150000000000006 109.783 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' ' HB1' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -134.53 -58.75 0.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.652 -0.703 . . . . 63.299999999999997 110.78 -178.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.52 -85.83 0.4 Allowed Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.028 -0.606 . . . . 43.399999999999999 112.574 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.68 -22.04 42.23 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.999 2.466 . . . . 54.219999999999999 111.876 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.5 p -52.72 -33.27 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.621 -0.718 . . . . 71.349999999999994 110.986 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -60.65 -36.2 78.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.375 0.607 . . . . 74.439999999999998 110.041 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.8 m -74.56 -35.87 63.08 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.824 0.821 . . . . 74.230000000000004 110.042 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.5 mm? -65.59 -22.1 66.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.232 -0.895 . . . . 64.099999999999994 111.464 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 44.0 mt-10 -57.92 -62.23 5.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.969 -0.382 . . . . 65.120000000000005 109.969 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.506 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 40.0 Cg_endo -67.08 -31.55 36.49 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 121.891 1.727 . . . . 64.230000000000004 112.079 176.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.551 ' OE1' ' HB ' ' A' ' 116' ' ' ILE . 79.5 mt-30 -60.3 -45.79 92.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.054 0.455 . . . . 75.209999999999994 110.824 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.464 HD22 HD11 ' A' ' 119' ' ' ILE . 73.4 mt -64.75 -40.78 95.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.127 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' OE1' ' HB3' ' A' ' 21' ' ' SER . 30.0 mt-10 -57.57 -43.78 84.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.433 -0.349 . . . . 65.510000000000005 110.323 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.735 ' HB2' ' HZ3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -51.71 -57.22 9.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.008 -0.542 . . . . 74.540000000000006 110.688 178.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 HD12 HD12 ' A' ' 116' ' ' ILE . 19.7 mt -64.88 -34.92 79.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.941 -0.572 . . . . 74.510000000000005 109.654 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.545 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -66.58 -27.96 68.14 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.694 -0.684 . . . . 43.32 111.355 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.3 mt-30 -85.22 -37.11 20.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.832 0.349 . . . . 74.129999999999995 110.847 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.85 -37.99 70.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 75.409999999999997 110.953 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -104.89 5.89 33.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.577 -0.738 . . . . 75.219999999999999 111.925 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -22.66 5.5 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.578 0.955 . . . . 72.120000000000005 113.578 -169.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -77.42 -18.81 56.92 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.288 -0.258 . . . . 74.019999999999996 111.362 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.459 ' HA ' HD12 ' A' ' 42' ' ' ILE . 6.3 t30 -134.34 6.68 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.499 -0.319 . . . . 60.25 110.826 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 43' ' ' LEU . 54.6 t -139.13 139.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.71 0.29 . . . . 74.219999999999999 110.879 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 20.6 tptm -142.46 123.0 14.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 109.757 173.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' A' ' 45' ' ' LEU . 54.7 mt -98.08 125.39 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 73.140000000000001 110.508 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 62.3 m-85 -111.27 174.39 5.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.395 -0.594 . . . . 73.109999999999999 109.395 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.881 ' HZ2' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -156.08 152.71 28.34 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.295 -0.631 . . . . 62.329999999999998 109.295 167.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 34.4 pt -106.26 172.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.765 0.317 . . . . 75.129999999999995 111.016 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.635 ' HA ' ' HZ3' ' A' ' 49' ' ' TRP . 12.8 m120 -113.04 -90.19 0.52 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.961 -0.563 . . . . 60.109999999999999 109.523 171.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 81' ' ' ILE . 19.8 mm 52.69 23.26 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.075 0.464 . . . . 65.230000000000004 111.488 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HG3' ' HA ' ' A' ' 14' ' ' ALA . 36.6 tt0 -47.83 -28.48 2.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.401 0.68 . . . . 64.209999999999994 111.951 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -72.25 -35.66 68.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.783 -0.644 . . . . 63.520000000000003 111.592 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.21 99.16 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 73.530000000000001 110.681 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.653 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 78.9 mt-30 -73.33 6.56 2.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.971 -0.559 . . . . 73.430000000000007 111.68 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -45.19 -40.07 6.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.117 -0.492 . . . . 63.32 110.744 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG12 ' HE2' ' A' ' 48' ' ' PHE . 37.0 t -61.51 -39.9 84.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.679 -0.692 . . . . 71.010000000000005 110.703 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.37 -46.2 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.259 0.552 . . . . 74.239999999999995 110.076 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 74.5 m -67.38 -39.47 85.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.142 -0.935 . . . . 72.420000000000002 111.22 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -67.09 -43.04 83.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.351 -0.386 . . . . 74.510000000000005 111.625 -177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -92.58 -12.27 32.18 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.703 0.26 . . . . 73.109999999999999 111.703 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 8' ' ' HIS . . . 83.3 45.52 6.52 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.951 -0.642 . . . . 65.549999999999997 113.562 171.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.33 128.52 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.063 -0.347 . . . . 75.310000000000002 110.063 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 -16.66 7.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.489 -0.323 . . . . 72.219999999999999 111.071 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.4 168.44 25.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.421 -0.354 . . . . 52.439999999999998 110.104 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.1 pp -127.84 140.14 37.3 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.514 -0.312 . . . . 75.510000000000005 110.672 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 96.4 Cg_endo -78.78 -176.02 17.85 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 123.875 -1.302 . . . . 64.140000000000001 112.919 -0.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 m -147.6 124.5 11.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.686 -0.688 . . . . 74.0 109.638 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.7 mm -109.82 111.08 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.557 -0.292 . . . . 71.439999999999998 110.54 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 110' ' ' GLN . 1.9 mm? -88.12 123.5 32.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 72.510000000000005 109.283 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' A' ' 122' ' ' GLU . 26.3 mtt -103.36 142.12 34.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.729 0.299 . . . . 65.120000000000005 110.662 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -140.06 142.78 36.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.214 -0.662 . . . . 74.140000000000001 109.214 172.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 23.6 tptm -124.08 104.06 8.65 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.08 -0.248 . . . . 74.239999999999995 110.94 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.756 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.3 t30 40.8 40.69 1.02 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.967 0.507 . . . . 72.219999999999999 112.28 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.99 53.03 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.169 -0.539 . . . . 43.109999999999999 113.214 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -120.79 148.94 43.32 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 122.935 0.494 . . . . 63.039999999999999 109.846 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.602 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.4 tmtt? -64.48 130.36 43.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.292 0.568 . . . . 71.430000000000007 109.752 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.602 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -136.29 167.79 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.148 -0.933 . . . . 72.319999999999993 109.244 -173.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' MET . 8.9 m -70.69 179.44 2.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.714 0.768 . . . . 72.409999999999997 112.731 -165.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.497 ' HG3' HD13 ' A' ' 100' ' ' LEU . 50.2 tt0 -148.78 131.97 16.41 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.233 -0.894 . . . . 74.540000000000006 109.963 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.57 113.87 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.55 -1.204 . . . . 73.030000000000001 109.995 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.0 mm -97.8 120.65 47.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.081 -0.508 . . . . 62.140000000000001 109.979 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.12 -173.19 30.09 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.657 -0.577 . . . . 60.32 111.657 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.45 98.41 7.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.647 0.26 . . . . 75.109999999999999 111.059 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -142.32 101.68 3.95 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.067 0.461 . . . . 64.239999999999995 110.482 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.551 ' HB ' ' OE1' ' A' ' 62' ' ' GLN . 11.4 tp -66.0 -30.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 62.149999999999999 110.853 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.1 t -58.67 -50.63 73.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.16 0.505 . . . . 72.200000000000003 110.009 176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -63.77 -46.78 83.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.65 -0.704 . . . . 55.140000000000001 110.515 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.464 HD11 HD22 ' A' ' 63' ' ' LEU . 77.0 mt -57.17 -56.3 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.288 -0.415 . . . . 72.120000000000005 111.19 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.438 HD11 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.16 -38.91 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.893 -0.41 . . . . 74.510000000000005 109.893 -177.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.405 ' HA ' HD22 ' A' ' 124' ' ' ASN . 22.2 t -57.21 -51.25 70.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.174 -0.466 . . . . 52.409999999999997 110.047 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.563 ' HB2' ' HE1' ' A' ' 101' ' ' MET . 65.8 mm-40 -63.0 -40.53 98.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 73.040000000000006 110.772 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.441 HD12 HD13 ' A' ' 66' ' ' LEU . 96.8 mt -56.98 -56.68 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.992 -0.283 . . . . 73.409999999999997 111.001 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 121' ' ' SER . 8.1 p30 -69.36 -35.98 76.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.872 0.368 . . . . 70.219999999999999 110.232 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.95 -36.61 84.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 72.200000000000003 110.961 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -95.73 -9.18 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 71.200000000000003 111.54 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.425 HD11 ' CG2' ' A' ' 74' ' ' VAL . 78.1 mt -82.83 -44.27 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.311 0.577 . . . . 74.310000000000002 109.773 165.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.547 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-N 115.502 -0.772 . . . . 71.430000000000007 110.424 -177.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mtp . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.118 -0.327 . . . . 75.420000000000002 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.0 126.97 29.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 51.25 110.077 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -157.47 99.01 1.73 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.218 0.533 . . . . 65.040000000000006 111.132 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -164.43 112.94 1.12 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.623 -0.717 . . . . 71.219999999999999 109.18 173.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -100.31 146.84 26.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.526 . . . . 71.299999999999997 110.929 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -140.23 149.51 42.98 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.645 -0.502 . . . . 75.120000000000005 109.645 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -146.81 101.5 3.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.876 -0.416 . . . . 65.209999999999994 109.876 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 125' ' ' ASN . 19.9 t-160 -109.27 87.81 2.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.945 -0.571 . . . . 74.329999999999998 110.772 -175.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -79.15 133.95 36.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.779 -0.452 . . . . 73.109999999999999 109.779 175.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.24 86.46 0.22 Allowed Glycine 0 C--N 1.329 0.177 0 N-CA-C 111.697 -0.561 . . . . 70.450000000000003 111.697 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 p -82.75 92.25 7.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.996 0.427 . . . . 75.420000000000002 111.476 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -131.91 172.64 12.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.339 -0.615 . . . . 74.230000000000004 109.339 175.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.42 136.99 52.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.646 0.26 . . . . 75.420000000000002 110.635 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.99 161.0 13.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.293 -0.412 . . . . 74.349999999999994 110.619 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.631 ' HB2' ' HE3' ' A' ' 65' ' ' LYS . 11.7 mm100 -90.34 143.02 27.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.525 -0.307 . . . . 71.239999999999995 110.281 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 p -76.79 -4.68 44.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 70.150000000000006 111.422 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.38 90.41 1.29 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.098 -0.501 . . . . 71.400000000000006 110.852 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.08 79.47 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 CA-C-N 116.0 -0.545 . . . . 74.209999999999994 111.751 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -84.92 7.46 5.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.895 2.396 . . . . 75.329999999999998 113.071 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.44 122.98 5.43 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.385 -0.436 . . . . 31.0 112.491 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 p -67.35 143.64 56.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.839 0.352 . . . . 73.120000000000005 111.115 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.518 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.1 mmm -137.57 -39.28 0.58 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.249 -0.432 . . . . 71.319999999999993 112.002 -175.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.527 HG23 ' HG2' ' A' ' 78' ' ' LYS . 10.8 mm -67.04 130.93 32.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 120.679 0.276 . . . . 73.430000000000007 110.771 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 78' ' ' LYS . 2.6 pt-20 -105.39 161.28 14.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.848 -0.427 . . . . 70.140000000000001 109.848 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -118.35 147.01 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.457 0.17 . . . . 71.409999999999997 110.772 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 pt -139.41 156.38 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.784 0.326 . . . . 73.540000000000006 110.823 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.1 179.01 48.31 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.908 -0.587 . . . . 75.430000000000007 112.492 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.58 -44.97 96.03 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.957 0.408 . . . . 65.030000000000001 111.342 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -65.08 -30.15 71.09 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.295 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -80.96 -20.31 42.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.836 -0.62 . . . . 75.540000000000006 111.474 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 35' ' ' VAL . 87.1 t80 -57.63 -61.91 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.482 0.182 . . . . 70.519999999999996 111.138 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.78 -44.6 96.58 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.071 0.462 . . . . 73.420000000000002 110.237 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -53.62 -57.53 10.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.262 -0.881 . . . . 43.219999999999999 110.998 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -62.01 -43.64 98.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.223 -0.444 . . . . 63.340000000000003 111.162 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.658 HG11 ' HA2' ' A' ' 105' ' ' GLY . 73.9 t -62.67 -36.93 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.34 -0.391 . . . . 74.140000000000001 111.524 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -86.43 -29.2 23.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.047 0.388 . . . . 53.409999999999997 112.047 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -83.76 11.06 8.03 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.363 0.505 . . . . 74.540000000000006 112.363 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.2 p -59.4 143.89 48.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.244 -0.28 . . . . 71.299999999999997 110.244 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.4 -74.12 0.06 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.634 0.254 . . . . 72.420000000000002 110.715 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -161.74 126.22 3.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 63.420000000000002 110.159 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 57.05 12.27 1.21 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.672 0.619 . . . . 72.450000000000003 112.672 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 51.1 mm -64.09 117.89 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.519 -0.549 . . . . 70.510000000000005 109.519 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.1 112.2 13.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 72.329999999999998 110.105 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 38' ' ' CYS . 72.4 mt -98.7 105.64 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.001 -0.545 . . . . 72.450000000000003 110.634 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.552 HD11 HG11 ' A' ' 74' ' ' VAL . 5.1 mp -90.51 116.29 28.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.082 -0.71 . . . . 73.209999999999994 109.082 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.72 105.26 18.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.768 -0.456 . . . . 72.450000000000003 109.768 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 56.5 t0 -84.28 123.24 29.93 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.854 -0.612 . . . . 62.130000000000003 110.381 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 100' ' ' LEU . 76.8 m-85 -102.9 125.3 49.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 65.219999999999999 110.592 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -117.35 148.32 41.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.03 -0.532 . . . . 74.340000000000003 111.103 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . -109.25 -178.19 0.54 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.093 -0.958 . . . . 54.329999999999998 109.245 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.638 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 85.6 Cg_exo -46.15 -26.6 3.83 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.515 2.143 . . . . 64.329999999999998 112.628 173.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -142.81 178.9 7.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.715 . . . . 73.150000000000006 109.648 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.611 ' HA ' HG12 ' A' ' 96' ' ' ILE . 14.1 p -157.8 165.4 35.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.426 -0.213 . . . . 63.299999999999997 110.426 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.52 -108.15 1.05 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.217 -0.516 . . . . 43.399999999999999 113.374 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' O ' HD22 ' A' ' 59' ' ' LEU . 95.1 Cg_endo -80.65 45.52 2.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.257 2.638 . . . . 54.219999999999999 113.514 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.457 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 95.9 m -65.33 -22.63 66.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.464 -0.334 . . . . 71.349999999999994 111.85 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 57' ' ' ARG . 35.0 ttt180 -54.06 -60.92 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.61 0.243 . . . . 74.439999999999998 111.458 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.4 m -75.58 -41.6 54.2 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.408 0.623 . . . . 74.230000000000004 111.615 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.463 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -67.84 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.881 0.697 . . . . 64.099999999999994 112.881 -169.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 42.5 mt-10 -59.54 -60.48 10.43 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 120.225 -0.59 . . . . 65.120000000000005 110.286 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.82 -36.53 96.87 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.615 1.543 . . . . 64.230000000000004 112.007 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -60.73 -47.01 88.24 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.805 -0.358 . . . . 75.209999999999994 110.86 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 119' ' ' ILE . 91.9 mt -67.4 -41.01 85.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 74.140000000000001 110.618 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 31.5 mt-10 -69.5 -24.18 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 65.510000000000005 110.712 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.631 ' HE3' ' HB2' ' A' ' 15' ' ' GLN . 17.3 ttmm -68.43 -49.83 57.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.239 -0.282 . . . . 74.540000000000006 110.239 171.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.434 HD12 HD13 ' A' ' 123' ' ' ILE . 51.5 mt -62.54 -30.98 71.7 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.685 -0.487 . . . . 74.510000000000005 109.685 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.76 -51.55 64.34 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.927 -0.579 . . . . 43.32 109.772 173.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.518 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 35.7 mm-40 -51.97 -48.77 64.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 111.259 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -76.15 -36.8 58.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.744 -0.662 . . . . 75.409999999999997 111.577 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -104.53 3.88 32.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.989 0.737 . . . . 75.219999999999999 112.989 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.6 t -53.82 -19.43 4.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.934 0.397 . . . . 72.120000000000005 112.019 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.39 -24.18 64.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 74.019999999999996 111.168 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -134.48 1.19 3.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.347 -0.388 . . . . 60.25 110.781 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.552 HG11 HD11 ' A' ' 45' ' ' LEU . 5.2 t -127.32 138.75 53.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.851 0.357 . . . . 74.219999999999999 111.381 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -134.57 129.71 35.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.404 -0.961 . . . . 72.219999999999999 108.404 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 45' ' ' LEU . 17.1 mt -119.67 115.89 48.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.14 0.495 . . . . 73.140000000000001 110.778 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 87.3 m-85 -106.17 151.64 24.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 73.109999999999999 110.871 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HG2' HG23 ' A' ' 23' ' ' ILE . 61.0 mmtt -109.43 125.78 52.78 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.331 -0.849 . . . . 62.329999999999998 109.742 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -93.98 67.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.989 -1.486 . . . . 75.129999999999995 106.989 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.54 89.52 6.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.227 -0.897 . . . . 60.109999999999999 110.854 -171.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.44 112.94 20.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.542 -0.91 . . . . 65.230000000000004 108.542 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -18.15 58.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 64.209999999999994 110.948 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -83.68 17.02 2.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.566 -0.288 . . . . 63.520000000000003 111.753 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -76.25 52.37 0.75 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.856 0.687 . . . . 73.530000000000001 112.856 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -82.73 -61.14 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.765 -0.828 . . . . 73.430000000000007 108.765 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.2 m-20 -48.66 -49.18 38.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.988 -1.005 . . . . 63.32 110.985 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.49 -36.85 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 71.010000000000005 110.628 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.22 75.39 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.864 -0.421 . . . . 74.239999999999995 109.864 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 72.420000000000002 110.669 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.4 mm100 -75.03 -48.49 23.75 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.963 -0.562 . . . . 74.510000000000005 111.167 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.56 -10.27 52.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.381 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.34 56.11 11.0 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.109 -0.567 . . . . 65.549999999999997 111.887 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.4 t -77.25 109.37 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 75.310000000000002 110.468 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.445 ' HB2' HG21 ' A' ' 112' ' ' ILE . 12.1 m -63.27 -54.08 42.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.277 -0.419 . . . . 72.219999999999999 111.186 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.31 138.92 18.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 52.439999999999998 110.488 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.756 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.31 147.43 33.11 Favored Pre-proline 0 C--O 1.236 0.377 0 O-C-N 123.364 0.415 . . . . 75.510000000000005 110.504 -178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.3 Cg_exo -70.57 166.03 77.31 Favored 'Cis proline' 0 C--N 1.357 1.021 0 C-N-CA 124.24 -1.15 . . . . 64.140000000000001 113.12 3.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.477 HG23 HG12 ' A' ' 112' ' ' ILE . 88.6 m -145.8 130.75 18.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.642 . . . . 74.0 109.839 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.458 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 42.8 mm -109.8 110.79 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 71.439999999999998 111.193 -173.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.475 HD12 ' CD1' ' A' ' 48' ' ' PHE . 8.4 mp -101.13 123.41 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.501 -0.555 . . . . 72.510000000000005 109.501 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.539 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 22.2 mtt -92.26 145.6 24.36 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.138 -0.319 . . . . 65.120000000000005 110.138 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.4 m-85 -142.12 152.56 43.37 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.747 -0.464 . . . . 74.140000000000001 109.747 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -145.24 114.88 7.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.444 0.164 . . . . 74.239999999999995 110.814 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.521 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 32.0 t-20 57.4 41.04 26.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.371 0.605 . . . . 72.219999999999999 110.396 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.658 ' HA2' HG11 ' A' ' 35' ' ' VAL . . . 71.04 2.81 49.35 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 115.942 -0.572 . . . . 43.109999999999999 112.843 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -101.19 147.3 26.42 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 120.732 0.301 . . . . 63.039999999999999 110.797 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -56.62 129.57 41.55 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.638 1.212 . . . . 71.430000000000007 112.161 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -136.61 167.95 20.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.138 -1.392 . . . . 72.319999999999993 108.287 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.21 172.01 8.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.823 0.675 . . . . 72.409999999999997 112.823 -163.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -138.34 138.19 38.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.65 -0.704 . . . . 74.540000000000006 110.558 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.458 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.0 m -126.47 139.92 50.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.197 -0.456 . . . . 73.030000000000001 109.876 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.477 HG12 HG23 ' A' ' 98' ' ' THR . 38.7 mt -127.16 142.99 41.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.946 -0.57 . . . . 62.140000000000001 109.88 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.27 -152.16 21.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.036 -0.602 . . . . 60.32 112.417 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -125.98 93.18 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 75.109999999999999 111.741 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.5 t70 -145.03 91.21 2.12 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 64.239999999999995 108.655 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 tp -64.54 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.614 -0.721 . . . . 62.149999999999999 110.752 -171.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -66.93 -45.35 78.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.076 -0.511 . . . . 72.200000000000003 110.082 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -69.19 -39.82 78.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 55.140000000000001 110.277 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 63' ' ' LEU . 78.1 mt -58.66 -56.08 18.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.383 -0.371 . . . . 72.120000000000005 110.509 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.498 ' HA ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.4 -37.37 77.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.726 -0.472 . . . . 74.510000000000005 109.726 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.451 ' HA ' HD22 ' A' ' 124' ' ' ASN . 37.5 t -54.04 -52.01 62.21 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.102 -0.499 . . . . 52.409999999999997 110.491 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -72.17 -28.33 63.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 73.040000000000006 110.917 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 120' ' ' ILE . 97.6 mt -59.49 -56.21 18.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 120.634 -0.427 . . . . 73.409999999999997 110.143 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 121' ' ' SER . 9.1 p30 -71.19 -25.37 62.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.727 0.298 . . . . 70.219999999999999 110.325 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 8' ' ' HIS . 30.4 t30 -62.31 -48.21 80.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.618 -0.719 . . . . 72.200000000000003 110.598 175.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.539 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.3 m-20 -80.88 -26.81 36.61 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.526 -0.761 . . . . 71.200000000000003 111.671 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.523 HD13 HG23 ' A' ' 74' ' ' VAL . 71.1 mt -74.86 -49.84 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.689 0.28 . . . . 74.310000000000002 110.814 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.578 -0.725 . . . . 71.430000000000007 110.673 -174.368 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.999 -0.371 . . . . 75.420000000000002 109.999 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.93 88.0 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.182 0.515 . . . . 51.25 112.081 -174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -118.42 26.03 9.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.101 -1.074 . . . . 65.040000000000006 108.101 169.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -82.59 112.09 19.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.436 -1.257 . . . . 71.219999999999999 111.106 -171.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -144.14 151.51 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 71.299999999999997 109.65 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -111.14 138.95 46.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 75.120000000000005 110.347 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -127.45 11.45 6.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 65.209999999999994 110.543 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -73.0 73.12 1.16 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.207 -0.664 . . . . 74.329999999999998 109.207 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.4 ttm -110.35 84.72 1.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.271 -0.877 . . . . 73.109999999999999 109.484 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.0 -175.07 44.67 Favored Glycine 0 C--O 1.238 0.376 0 CA-C-N 115.925 -0.58 . . . . 70.450000000000003 111.658 -175.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 p -78.47 87.17 4.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.086 0.469 . . . . 75.420000000000002 110.869 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.51 HD23 ' H ' ' A' ' 12' ' ' LEU . 2.5 pt? -79.1 5.81 11.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.855 -0.611 . . . . 74.230000000000004 111.265 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -124.69 115.78 21.31 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.322 -0.399 . . . . 75.420000000000002 110.413 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.91 139.46 0.29 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.3 -0.409 . . . . 74.349999999999994 111.034 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -137.06 152.57 50.21 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.408 -0.589 . . . . 71.239999999999995 109.408 173.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 p -129.36 170.76 13.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.62 -0.264 . . . . 70.150000000000006 110.811 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -86.47 18.27 3.37 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.313 0.578 . . . . 71.400000000000006 110.637 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.04 -61.14 3.58 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.594 -1.002 . . . . 74.209999999999994 110.594 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 20' ' ' GLY . 74.2 Cg_endo -75.18 -149.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.619 2.212 . . . . 75.329999999999998 110.678 169.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 19' ' ' PRO . . . -168.14 104.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.37 -0.919 . . . . 31.0 112.739 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.4 t -68.15 141.64 55.97 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.097 -0.705 . . . . 73.120000000000005 109.097 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.9 mmm -110.84 6.58 21.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 71.319999999999993 111.058 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -91.03 100.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.023 -0.732 . . . . 73.430000000000007 109.023 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 28.9 tt0 -94.06 112.26 24.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 70.140000000000001 110.641 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.527 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 2.1 mp0 -72.36 132.0 43.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 71.409999999999997 110.089 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.2 pt -130.85 152.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 73.540000000000006 110.208 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.69 165.31 45.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.131 -0.557 . . . . 75.430000000000007 112.421 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -50.87 -39.05 52.86 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.843 0.457 . . . . 65.030000000000001 111.465 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -71.15 -36.84 72.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 74.420000000000002 110.546 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.44 -13.59 60.4 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 115.837 -0.62 . . . . 75.540000000000006 111.265 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' O ' HG21 ' A' ' 35' ' ' VAL . 75.8 t80 -56.36 -62.15 1.92 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.594 0.235 . . . . 70.519999999999996 110.714 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.79 -47.49 80.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 73.420000000000002 110.484 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.13 -57.57 10.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.619 -0.719 . . . . 43.219999999999999 111.094 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.6 mmtt -64.95 -36.98 86.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 63.340000000000003 111.236 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 31' ' ' PHE . 74.7 t -64.07 -41.72 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.96 0.41 . . . . 74.140000000000001 110.735 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.2 p -86.24 -9.96 55.52 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.31 -0.405 . . . . 53.409999999999997 111.702 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.3 t -74.42 -2.96 27.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.281 0.233 . . . . 74.540000000000006 111.556 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 44' ' ' ILE . 59.3 m -70.05 134.21 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.612 -0.267 . . . . 71.299999999999997 111.157 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -65.97 -78.03 0.06 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.833 -0.803 . . . . 72.420000000000002 108.833 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -162.49 156.43 21.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.316 -0.624 . . . . 63.420000000000002 109.316 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.633 ' HA ' ' HE2' ' A' ' 103' ' ' LYS . 53.2 m-20 62.06 13.08 5.42 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.1 0.56 . . . . 72.450000000000003 111.915 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 49.6 mm -86.85 106.65 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.897 -0.409 . . . . 70.510000000000005 109.897 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.51 109.13 16.45 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.804 -0.635 . . . . 72.329999999999998 109.437 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.607 HD12 ' SG ' ' A' ' 38' ' ' CYS . 46.3 mt -92.0 121.93 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.576 . . . . 72.450000000000003 110.836 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.55 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.7 mp -103.66 110.92 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.226 -0.657 . . . . 73.209999999999994 109.226 173.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 59.3 t -96.95 107.21 19.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.067 -0.345 . . . . 72.450000000000003 110.067 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.29 96.49 1.43 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.993 -0.743 . . . . 62.130000000000003 108.993 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.408 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 35.7 t80 -60.84 99.35 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.175 -0.92 . . . . 65.219999999999999 111.579 -172.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.46 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 59.05 -82.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.632 -0.713 . . . . 74.340000000000003 111.863 173.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.587 ' N ' ' HD3' ' A' ' 51' ' ' PRO . . . 53.69 48.3 4.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.185 0.594 . . . . 54.329999999999998 111.856 -175.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 50' ' ' ALA . 2.8 Cg_exo -75.29 -19.88 16.83 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.541 2.16 . . . . 64.329999999999998 112.345 -173.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -75.3 -38.58 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 110.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 8.3 t 54.95 82.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.441 -0.799 . . . . 63.299999999999997 111.084 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.93 -78.81 1.12 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.582 -0.607 . . . . 43.399999999999999 111.582 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.445 ' O ' HD22 ' A' ' 59' ' ' LEU . 6.0 Cg_exo -76.51 11.77 1.79 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.212 2.608 . . . . 54.219999999999999 111.81 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 5.6 p -63.73 -23.6 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.598 -0.728 . . . . 71.349999999999994 111.325 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -54.43 -52.48 61.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.313 -0.403 . . . . 74.439999999999998 110.492 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.9 m -75.29 -48.14 24.62 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.87 0.843 . . . . 74.230000000000004 111.806 178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 114' ' ' ALA . 4.1 mm? -68.09 -28.1 67.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 64.099999999999994 112.516 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.2 tt0 -58.56 -59.88 12.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.98 -0.378 . . . . 65.120000000000005 109.98 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.443 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 37.1 Cg_endo -66.04 -37.1 27.25 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.67 1.58 . . . . 64.230000000000004 112.107 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.87 -45.32 86.49 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.273 -0.571 . . . . 75.209999999999994 110.823 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 119' ' ' ILE . 84.8 mt -66.04 -41.18 91.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.416 -0.356 . . . . 74.140000000000001 110.678 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 51.9 mt-10 -57.41 -41.42 80.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.727 0.299 . . . . 65.510000000000005 110.344 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.04 -56.07 22.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.304 -0.407 . . . . 74.540000000000006 111.264 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.55 -34.71 71.32 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 74.510000000000005 109.902 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.11 -49.15 71.05 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.509 -0.769 . . . . 43.32 110.571 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.8 mt-30 -62.27 -41.56 98.58 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.004 0.43 . . . . 74.129999999999995 110.725 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -68.25 -38.49 81.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 75.409999999999997 110.937 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -104.49 4.18 32.84 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.347 0.499 . . . . 75.219999999999999 112.347 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.4 t -54.03 -19.66 5.17 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.785 0.661 . . . . 72.120000000000005 112.785 -172.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -61.3 -36.64 80.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.043 0.449 . . . . 74.019999999999996 110.094 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -120.57 -4.49 9.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.877 -0.601 . . . . 60.25 111.281 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.451 HG11 HD12 ' A' ' 45' ' ' LEU . 43.8 t -123.02 148.15 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.016 0.436 . . . . 74.219999999999999 111.569 -174.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.2 tptm -149.44 133.15 16.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.773 -0.649 . . . . 72.219999999999999 109.41 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 45' ' ' LEU . 52.6 mt -108.99 135.76 46.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.888 0.375 . . . . 73.140000000000001 111.082 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 49.3 m-85 -130.77 168.04 17.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.734 -0.666 . . . . 73.109999999999999 110.176 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.533 ' HZ2' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -174.18 153.46 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 62.329999999999998 109.997 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tp -121.02 119.68 60.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.51 -0.922 . . . . 75.129999999999995 108.51 170.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -94.96 44.31 1.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.23 -0.441 . . . . 60.109999999999999 111.689 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.0 pt -71.05 78.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 122.105 0.955 . . . . 65.230000000000004 109.409 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -47.48 -44.69 25.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 113.9 -1.5 . . . . 64.209999999999994 114.092 -167.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.726 0.298 . . . . 63.520000000000003 111.393 -173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.41 51.61 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 73.530000000000001 110.136 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -85.53 3.17 41.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.97 -0.559 . . . . 73.430000000000007 111.986 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.49 -39.0 64.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.19 0.519 . . . . 63.32 110.055 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.03 -34.45 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.195 -0.912 . . . . 71.010000000000005 110.495 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 48' ' ' PHE . . . -64.46 -52.08 59.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 110.301 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.8 m -62.25 -32.72 73.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 72.420000000000002 111.034 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -53.89 16.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.466 -0.334 . . . . 74.510000000000005 111.346 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -79.51 -10.24 59.76 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.507 -0.315 . . . . 73.109999999999999 111.732 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.23 43.01 5.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.926 -0.654 . . . . 65.549999999999997 113.558 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.98 135.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.52 -0.548 . . . . 75.310000000000002 109.52 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.8 m -133.04 1.42 3.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.057 0.391 . . . . 72.219999999999999 112.057 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.98 156.57 47.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.016 0.436 . . . . 52.439999999999998 111.635 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 pt -125.98 122.02 24.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.749 -0.659 . . . . 75.510000000000005 110.074 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.31 -172.62 9.13 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.737 -1.36 . . . . 64.140000000000001 112.647 -0.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.498 HG22 HD13 ' A' ' 112' ' ' ILE . 47.2 m -145.06 128.29 16.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.501 -0.772 . . . . 74.0 109.177 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 47.6 mm -110.13 116.08 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.578 0.228 . . . . 71.439999999999998 111.018 -174.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.3 mt -99.02 123.48 43.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.312 -0.625 . . . . 72.510000000000005 109.312 174.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.3 mtt -97.96 144.38 27.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.203 -0.295 . . . . 65.120000000000005 110.203 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.422 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -143.6 144.83 32.09 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.003 -0.369 . . . . 74.140000000000001 110.003 175.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.633 ' HE2' ' HA ' ' A' ' 41' ' ' ASN . 52.9 tttm -131.82 105.2 7.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.092 -0.243 . . . . 74.239999999999995 110.57 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 59.1 t30 58.9 30.67 20.46 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.717 0.77 . . . . 72.219999999999999 110.199 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.4 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 88.74 -16.37 54.62 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.614 -0.721 . . . . 43.109999999999999 112.517 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.612 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 2.4 tmmm? -76.1 140.19 41.71 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 109.608 -0.515 . . . . 63.039999999999999 109.608 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 106' ' ' LYS . 2.3 tmtp? -57.68 139.09 54.6 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.196 0.935 . . . . 71.430000000000007 110.742 -176.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.565 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -146.51 168.36 21.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.967 -1.015 . . . . 72.319999999999993 108.636 -171.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 m -70.32 175.45 4.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.601 0.963 . . . . 72.409999999999997 113.601 -161.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -141.01 142.03 34.28 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.956 -1.02 . . . . 74.540000000000006 110.769 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.561 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 15.3 t -123.55 114.56 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.995 -1.457 . . . . 73.030000000000001 109.946 -174.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 98' ' ' THR . 46.2 mm -106.71 121.1 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.763 -0.653 . . . . 62.140000000000001 109.972 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.03 163.96 33.69 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.433 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.48 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -85.6 79.99 9.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.288 . . . . 75.109999999999999 111.021 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.434 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.7 t70 -124.52 91.9 3.54 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.398 -0.593 . . . . 64.239999999999995 109.398 175.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.57 -31.94 52.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.883 -0.599 . . . . 62.149999999999999 111.205 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.6 t -62.7 -44.08 97.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.16 -0.473 . . . . 72.200000000000003 109.978 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -70.52 -37.47 74.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 55.140000000000001 109.952 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.472 HG12 HG13 ' A' ' 111' ' ' VAL . 72.8 mt -56.74 -56.27 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.257 -0.429 . . . . 72.120000000000005 110.674 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.515 ' HA ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.54 -37.91 81.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 110.22 -0.289 . . . . 74.510000000000005 110.22 -177.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.479 ' HA ' HD22 ' A' ' 124' ' ' ASN . 22.9 t -56.99 -51.97 67.13 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.937 -0.394 . . . . 52.409999999999997 109.937 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.49 -41.83 97.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.121 -0.49 . . . . 73.040000000000006 110.755 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.1 mt -53.06 -56.18 9.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.625 0.25 . . . . 73.409999999999997 110.412 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.0 p30 -71.57 -35.46 70.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.718 -0.393 . . . . 70.219999999999999 110.727 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -63.97 -35.18 79.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 72.200000000000003 111.208 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB3' HD12 ' A' ' 108' ' ' LEU . 84.8 m-20 -91.21 -31.15 16.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 71.200000000000003 111.707 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 123' ' ' ILE . 71.9 mt -58.55 -53.26 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 74.310000000000002 110.599 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 . . . . . 0 C--O 1.25 1.11 0 CA-C-N 115.79 -0.641 . . . . 71.430000000000007 110.358 -175.556 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.937 -0.394 . . . . 75.420000000000002 109.937 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.81 149.61 20.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.347 -0.388 . . . . 51.25 110.613 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -157.11 132.07 8.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.997 -0.742 . . . . 65.040000000000006 108.997 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -129.76 147.33 51.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.033 0.444 . . . . 71.219999999999999 111.53 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -106.97 171.46 7.36 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.499 -0.926 . . . . 71.299999999999997 108.499 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.423 ' HB3' ' NE2' ' A' ' 85' ' ' GLN . 28.6 t-80 -148.03 89.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.307 0.575 . . . . 75.120000000000005 110.869 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -70.86 125.57 27.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.596 -0.729 . . . . 65.209999999999994 109.358 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.82 174.21 11.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.8 -0.182 . . . . 74.329999999999998 110.966 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.0 tpt -156.1 101.02 2.06 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.579 0.55 . . . . 73.109999999999999 110.031 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.78 9.78 14.26 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 116.069 -0.514 . . . . 70.450000000000003 112.409 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.499 ' HA ' ' NE1' ' A' ' 49' ' ' TRP . 73.7 m -70.41 80.34 0.55 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.391 0.615 . . . . 75.420000000000002 111.584 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.443 HD12 ' HZ2' ' A' ' 49' ' ' TRP . 1.0 OUTLIER -90.34 57.55 3.73 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.718 -0.845 . . . . 74.230000000000004 108.718 170.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -48.33 133.96 15.33 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.44 -1.254 . . . . 75.420000000000002 112.252 -173.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.33 160.32 24.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.46 -0.791 . . . . 74.349999999999994 110.034 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -132.05 160.22 36.55 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.796 -0.446 . . . . 71.239999999999995 109.796 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -117.42 95.39 4.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.933 0.397 . . . . 70.150000000000006 110.058 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -50.82 126.4 15.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.376 -0.829 . . . . 71.400000000000006 110.956 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.7 -164.77 12.08 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.777 -0.647 . . . . 74.209999999999994 111.616 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.48 32.75 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.853 2.369 . . . . 75.329999999999998 112.503 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.09 -46.31 3.12 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.245 -0.502 . . . . 31.0 111.934 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.7 m -66.61 79.38 0.11 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.184 0.516 . . . . 73.120000000000005 111.319 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.493 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.7 mmm -87.48 -16.03 35.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.714 -0.676 . . . . 71.319999999999993 109.832 175.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -78.92 133.69 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.404 -0.816 . . . . 73.430000000000007 110.3 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -94.18 155.36 17.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 70.140000000000001 110.111 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -119.0 139.45 51.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.028 -0.73 . . . . 71.409999999999997 109.028 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 31' ' ' PHE . 32.6 pt -141.75 159.72 21.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.031 0.444 . . . . 73.540000000000006 111.558 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.72 -168.52 33.78 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.475 -0.784 . . . . 75.430000000000007 112.203 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.12 -48.87 72.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.657 0.383 . . . . 65.030000000000001 111.451 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 t -72.0 -40.83 68.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.420000000000002 110.371 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.31 -23.92 64.58 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.267 -0.424 . . . . 75.540000000000006 111.08 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.502 ' HA ' HD11 ' A' ' 26' ' ' ILE . 89.5 t80 -49.97 -58.2 5.95 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.851 0.357 . . . . 70.519999999999996 110.288 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -56.4 -57.52 11.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.89 -0.596 . . . . 73.420000000000002 110.599 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.87 -50.44 63.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.719 -0.673 . . . . 43.219999999999999 111.453 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG3' HG23 ' A' ' 26' ' ' ILE . 74.3 mmtt -68.32 -41.82 80.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 63.340000000000003 111.561 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HA ' HD11 ' A' ' 44' ' ' ILE . 76.1 t -70.46 -36.26 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 111.791 0.293 . . . . 74.140000000000001 111.791 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.3 p -85.96 -37.32 19.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.833 0.309 . . . . 53.409999999999997 111.833 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.5 t -83.82 10.83 8.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.033 0.383 . . . . 74.540000000000006 112.033 -173.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.81 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 19.9 p -59.99 146.99 40.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 110.32 -0.252 . . . . 71.299999999999997 110.32 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -45.98 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.406 0.682 . . . . 72.420000000000002 111.996 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.75 122.62 3.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.419 -0.215 . . . . 63.420000000000002 110.419 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.529 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.8 OUTLIER 62.56 7.25 2.34 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.787 0.435 . . . . 72.450000000000003 112.024 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.26 137.46 22.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.872 0.367 . . . . 70.510000000000005 111.247 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -81.12 123.61 28.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.534 -0.913 . . . . 72.329999999999998 108.534 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 82.1 mt -115.44 121.57 67.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.266 -0.425 . . . . 72.450000000000003 110.207 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -109.86 113.08 25.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.111 -0.7 . . . . 73.209999999999994 109.111 175.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.25 105.0 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.946 -0.39 . . . . 72.450000000000003 109.946 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.92 127.89 32.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.81 -0.632 . . . . 62.130000000000003 110.692 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -94.59 125.82 39.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.528 -0.916 . . . . 65.219999999999999 108.528 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.499 ' NE1' ' HA ' ' A' ' 11' ' ' THR . 74.4 t-105 -53.49 139.8 30.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.17 0.509 . . . . 74.340000000000003 111.622 -174.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -95.33 108.49 39.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.446 -0.797 . . . . 54.329999999999998 111.102 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 21.0 Cg_endo -60.74 -32.27 92.82 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.402 2.068 . . . . 64.329999999999998 111.061 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -101.16 93.08 5.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.485 -0.931 . . . . 73.150000000000006 108.485 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.468 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 10.4 t -91.82 89.23 6.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 63.299999999999997 110.32 -174.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.49 -86.25 1.62 Allowed Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.735 -0.666 . . . . 43.399999999999999 111.449 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.72 -11.92 16.22 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.139 2.559 . . . . 54.219999999999999 112.153 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 15.4 p -50.62 -43.59 56.93 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.534 -0.757 . . . . 71.349999999999994 110.948 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -54.89 -41.02 70.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.513 -0.767 . . . . 74.439999999999998 111.524 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.576 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.3 m -75.88 -53.39 8.51 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.991 0.9 . . . . 74.230000000000004 111.701 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.436 HD11 HD12 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -61.28 -44.42 97.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.853 -1.067 . . . . 64.099999999999994 111.914 -168.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.3 -52.63 73.07 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 119.516 -0.278 . . . . 65.120000000000005 111.336 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HG2' ' O ' ' A' ' 58' ' ' SER . 17.7 Cg_endo -61.67 -31.66 86.58 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.512 1.475 . . . . 64.230000000000004 112.137 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.1 mt-30 -62.88 -35.98 81.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.185 -0.606 . . . . 75.209999999999994 109.75 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.79 -39.08 76.8 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.792 -0.64 . . . . 74.140000000000001 109.937 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 mt-10 -53.69 -47.74 70.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.801 -0.444 . . . . 65.510000000000005 109.801 175.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -58.79 -52.45 65.65 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.942 -0.572 . . . . 74.540000000000006 111.251 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.479 HD12 HD12 ' A' ' 116' ' ' ILE . 48.9 mt -62.26 -34.89 77.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.912 0.387 . . . . 74.510000000000005 110.093 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.07 -43.41 95.55 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.946 -0.57 . . . . 43.32 109.99 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 51.3 mt-30 -64.86 -46.49 81.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.129999999999995 111.05 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -72.87 -34.41 66.71 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.996 0.427 . . . . 75.409999999999997 111.21 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -104.7 4.04 32.09 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.328 0.492 . . . . 75.219999999999999 112.328 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -53.32 -19.55 3.43 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.957 0.408 . . . . 72.120000000000005 111.536 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.63 -38.08 69.04 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.981 -0.554 . . . . 74.019999999999996 110.836 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -135.21 12.08 3.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.075 -0.511 . . . . 60.25 111.331 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.55 139.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.617 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -143.63 119.93 10.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.419 -0.81 . . . . 72.219999999999999 109.187 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 45' ' ' LEU . 40.5 mt -104.8 137.25 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.715 0.293 . . . . 73.140000000000001 110.706 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.45 151.15 40.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.935 -0.575 . . . . 73.109999999999999 109.895 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -120.8 102.74 8.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.624 -0.88 . . . . 62.329999999999998 108.624 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 79' ' ' ILE . 14.7 tt -80.47 102.2 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.613 0.72 . . . . 75.129999999999995 110.134 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.82 75.46 10.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 60.109999999999999 111.172 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.415 HD11 HG12 ' A' ' 87' ' ' VAL . 29.5 pt -124.03 24.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.011 -0.737 . . . . 65.230000000000004 109.011 171.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -58.02 -18.64 25.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.552 -1.204 . . . . 64.209999999999994 111.561 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.16 -23.23 62.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.317 0.58 . . . . 63.520000000000003 109.661 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.35 95.25 7.94 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.508 -0.923 . . . . 73.530000000000001 108.508 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 6' ' ' HIS . 25.6 tt0 -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.211 -0.45 . . . . 73.430000000000007 111.667 -172.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 14.5 m-20 -56.61 -32.96 65.79 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.471 -0.331 . . . . 63.32 111.286 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 81' ' ' ILE . 75.0 t -53.06 -38.63 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.467 -0.333 . . . . 71.010000000000005 110.537 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.7 -48.81 75.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.17 0.509 . . . . 74.239999999999995 109.827 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -59.34 -36.99 76.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.486 -0.779 . . . . 72.420000000000002 110.726 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 11.6 mm-40 -71.7 -51.27 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.006 -0.543 . . . . 74.510000000000005 110.492 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -73.98 -13.32 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 111.548 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.8 21.44 36.57 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.904 -0.665 . . . . 65.549999999999997 112.777 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.467 HG11 ' OG1' ' A' ' 98' ' ' THR . 64.5 t -70.42 117.28 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.156 -0.312 . . . . 75.310000000000002 110.156 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 t -136.45 8.03 3.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 72.219999999999999 110.985 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.477 ' HB3' HG21 ' A' ' 112' ' ' ILE . . . -147.18 164.06 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.794 -0.447 . . . . 52.439999999999998 109.794 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 96' ' ' ILE . 2.5 pp -122.51 122.0 27.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.439 -0.346 . . . . 75.510000000000005 111.207 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -87.06 -166.78 3.92 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.825 -1.323 . . . . 64.140000000000001 112.022 -3.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.486 HG21 HG12 ' A' ' 112' ' ' ILE . 81.5 m -138.92 120.35 14.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.535 -0.302 . . . . 74.0 110.202 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.636 ' HB ' HG23 ' A' ' 111' ' ' VAL . 47.5 mm -110.35 117.34 54.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.86 -0.609 . . . . 71.439999999999998 110.881 -174.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 100' ' ' LEU . 5.3 mp -100.59 123.22 44.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.535 -0.543 . . . . 72.510000000000005 109.535 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 109' ' ' SER . 11.6 mmt -87.65 148.08 24.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.686 0.279 . . . . 65.120000000000005 110.42 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.6 m-85 -145.45 160.99 40.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.956 -0.757 . . . . 74.140000000000001 108.956 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -148.79 109.46 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.621 0.248 . . . . 74.239999999999995 110.88 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.81 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER 59.9 31.84 20.91 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.746 -0.661 . . . . 72.219999999999999 110.352 177.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.462 ' HA2' HG11 ' A' ' 35' ' ' VAL . . . 87.52 -14.43 58.06 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.918 -0.583 . . . . 43.109999999999999 112.411 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.635 ' HZ2' ' HB3' ' A' ' 106' ' ' LYS . 7.7 ttpm? -81.76 139.56 34.76 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 110.301 -0.259 . . . . 63.039999999999999 110.301 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -58.88 149.6 26.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.812 -0.631 . . . . 71.430000000000007 111.511 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -154.39 168.01 28.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.127 0.971 . . . . 72.319999999999993 108.845 -170.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 101' ' ' MET . 3.1 m -70.35 148.17 48.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.571 0.7 . . . . 72.409999999999997 112.875 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -110.14 118.52 36.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 74.540000000000006 110.204 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.636 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.5 m -101.62 116.0 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 73.030000000000001 109.527 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 98' ' ' THR . 47.4 mt -107.59 120.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 62.140000000000001 110.577 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.11 160.84 12.44 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.246 -0.502 . . . . 60.32 112.238 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.76 83.42 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 75.109999999999999 111.017 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.5 t70 -133.75 92.22 2.94 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.344 -0.613 . . . . 64.239999999999995 109.344 174.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.479 HD12 HD12 ' A' ' 66' ' ' LEU . 8.8 tp -62.3 -32.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 62.149999999999999 111.413 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -65.29 -43.62 90.54 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.151 0.501 . . . . 72.200000000000003 110.065 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 14.8 tppt? -68.38 -43.13 78.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.935 -0.575 . . . . 55.140000000000001 110.19 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.436 HD12 HD11 ' A' ' 59' ' ' LEU . 70.8 mt -57.25 -51.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.709 -0.223 . . . . 72.120000000000005 110.676 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.509 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.02 -35.63 75.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.957 -0.386 . . . . 74.510000000000005 109.957 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.5 t -54.11 -51.23 64.86 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.147 0.498 . . . . 52.409999999999997 110.094 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 12.7 mm-40 -71.09 -31.84 68.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 73.040000000000006 110.766 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 120' ' ' ILE . 88.7 mt -58.15 -56.26 17.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.902 0.382 . . . . 73.409999999999997 110.037 176.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -65.8 -36.58 83.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.76 -0.459 . . . . 70.219999999999999 109.76 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -58.71 -41.57 86.65 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.097 -0.501 . . . . 72.200000000000003 110.966 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.417 ' HB2' HD11 ' A' ' 43' ' ' LEU . 81.5 m-20 -87.2 -12.75 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 71.200000000000003 111.371 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 123' ' ' ILE . 74.3 mt -80.88 -48.36 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.032 -0.359 . . . . 74.310000000000002 110.032 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.563 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.464 -0.779 . . . . 71.430000000000007 110.739 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.944 0.402 . . . . 75.420000000000002 110.622 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.63 110.54 22.94 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.1 -0.5 . . . . 51.25 110.274 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -140.23 121.16 14.56 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.898 0.38 . . . . 65.040000000000006 110.561 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 68.23 74.38 0.28 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.144 -0.934 . . . . 71.219999999999999 111.959 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -131.48 94.99 3.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.324 -0.991 . . . . 71.299999999999997 108.324 171.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -61.44 105.72 0.55 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.092 -0.504 . . . . 75.120000000000005 112.217 -171.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -92.07 88.81 6.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.4 -0.592 . . . . 65.209999999999994 109.4 172.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -158.17 107.73 2.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.616 . . . . 74.329999999999998 110.742 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.458 ' C ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -105.54 165.88 10.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.216 -0.661 . . . . 73.109999999999999 109.216 172.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.69 115.75 1.13 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.112 -0.566 . . . . 70.450000000000003 112.079 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.9 p -96.05 9.35 41.08 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.071 0.463 . . . . 75.420000000000002 111.121 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.581 HD21 ' H ' ' A' ' 12' ' ' LEU . 2.5 pt? -82.91 27.65 0.53 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.244 0.545 . . . . 74.230000000000004 110.794 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -64.96 -21.14 66.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.82 -0.627 . . . . 75.420000000000002 111.593 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.02 134.76 54.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.376 . . . . 74.349999999999994 111.204 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.619 HE21 ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -98.24 -2.5 39.51 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.124 -0.695 . . . . 71.239999999999995 109.124 173.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.1 m -60.49 102.58 0.19 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.23 -0.896 . . . . 70.150000000000006 111.478 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -120.79 173.58 7.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.075 -0.511 . . . . 71.400000000000006 109.902 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.92 -163.47 33.99 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.299 -0.477 . . . . 74.209999999999994 112.482 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.72 19.5 1.2 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.95 2.433 . . . . 75.329999999999998 112.782 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.36 9.83 84.4 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.096 -0.573 . . . . 31.0 112.304 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.4 t -149.34 156.76 42.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.008 -0.367 . . . . 73.120000000000005 110.008 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.424 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 92.5 mmm -73.66 -20.63 60.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.26 -0.427 . . . . 71.319999999999993 110.725 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 78' ' ' LYS . 18.3 mm -78.13 87.98 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.744 -0.835 . . . . 73.430000000000007 108.744 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.06 112.12 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.635 -0.711 . . . . 70.140000000000001 111.341 -171.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -72.83 132.36 43.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.692 -0.485 . . . . 71.409999999999997 109.692 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.495 HG22 ' HG3' ' A' ' 34' ' ' LYS . 39.0 pt -133.12 160.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.794 0.33 . . . . 73.540000000000006 110.952 -176.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.22 -177.36 40.45 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.921 -0.581 . . . . 75.430000000000007 112.95 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.01 -43.24 99.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.96 0.504 . . . . 65.030000000000001 111.622 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -74.09 -37.17 64.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.074 0.464 . . . . 74.420000000000002 110.67 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.85 -26.74 68.75 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.783 -0.644 . . . . 75.540000000000006 110.762 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.444 ' HD2' HG21 ' A' ' 79' ' ' ILE . 88.8 t80 -46.14 -61.66 1.67 Allowed 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.33 0.394 . . . . 70.519999999999996 111.122 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -50.31 69.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.914 -0.585 . . . . 73.420000000000002 110.891 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.75 -57.39 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.74 . . . . 43.219999999999999 110.75 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HG3' HG22 ' A' ' 26' ' ' ILE . 74.4 mmtt -58.01 -44.19 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.12 -0.945 . . . . 63.340000000000003 111.181 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.04 -48.13 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.714 0.292 . . . . 74.140000000000001 111.313 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.4 p -77.43 -15.28 59.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.701 0.286 . . . . 53.409999999999997 111.595 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 t -69.55 -5.38 23.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.322 -0.399 . . . . 74.540000000000006 111.983 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 13.4 p -62.41 108.63 1.15 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.621 0.248 . . . . 71.299999999999997 110.501 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -58.43 -73.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.185 -0.462 . . . . 72.420000000000002 111.625 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -153.97 121.89 6.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.7 0.286 . . . . 63.420000000000002 110.913 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 61.3 8.3 2.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.6 0.76 . . . . 72.450000000000003 111.968 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -73.89 113.85 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.245 -0.434 . . . . 70.510000000000005 110.123 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HB3' HG23 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -82.21 119.26 23.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.103 -0.499 . . . . 72.329999999999998 109.656 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.45 119.98 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.596 -0.729 . . . . 72.450000000000003 110.483 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -103.95 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.052 -0.721 . . . . 73.209999999999994 109.052 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 98.3 t -115.71 109.57 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.07 -0.344 . . . . 72.450000000000003 110.07 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.3 t70 -87.0 127.86 35.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 62.130000000000003 111.949 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -101.46 87.31 3.16 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.393 -0.595 . . . . 65.219999999999999 109.393 170.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.508 ' HB2' ' HZ2' ' A' ' 78' ' ' LYS . 84.3 t90 -65.37 119.84 11.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.408 -0.815 . . . . 74.340000000000003 110.508 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 144.4 29.61 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.446 . . . . 54.329999999999998 110.397 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.51 -34.38 85.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.701 2.267 . . . . 64.329999999999998 112.523 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -119.76 119.16 32.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 73.150000000000006 110.087 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.588 ' SG ' ' HB ' ' A' ' 96' ' ' ILE . 47.9 t -163.88 140.79 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.299999999999997 110.567 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.03 -72.14 1.21 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.216 -0.447 . . . . 43.399999999999999 112.652 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.35 -22.36 20.5 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.056 2.504 . . . . 54.219999999999999 113.29 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 98.3 m -54.17 -24.91 19.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.57 -0.286 . . . . 71.349999999999994 111.375 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -53.95 -49.95 67.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.38 0.61 . . . . 74.439999999999998 110.165 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.609 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 12.6 m -75.0 -40.72 60.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.399 -0.819 . . . . 74.230000000000004 111.079 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.4 mm? -62.42 -41.6 98.82 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.774 0.657 . . . . 64.099999999999994 112.774 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 44.5 mt-10 -55.43 -54.64 48.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 117.873 0.306 . . . . 65.120000000000005 111.272 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HG2' ' O ' ' A' ' 58' ' ' SER . 21.1 Cg_endo -63.15 -35.73 62.36 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.524 1.483 . . . . 64.230000000000004 112.005 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.609 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.9 mt-30 -64.01 -31.12 72.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.643 -0.423 . . . . 75.209999999999994 110.584 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 76.0 mt -70.0 -42.02 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 74.140000000000001 109.982 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -63.53 -34.02 76.87 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 120.866 -0.334 . . . . 65.510000000000005 110.337 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 36.7 ttmt -55.6 -57.18 13.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.784 0.326 . . . . 74.540000000000006 110.298 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.411 HD13 HD11 ' A' ' 123' ' ' ILE . 33.0 mt -66.61 -38.42 86.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 74.510000000000005 110.367 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.32 -45.86 90.17 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.733 -0.667 . . . . 43.32 110.515 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.424 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 16.8 mm-40 -69.85 -46.08 66.34 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.393 -0.367 . . . . 74.129999999999995 110.956 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.75 -41.95 82.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.856 -0.611 . . . . 75.409999999999997 110.953 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -104.66 4.3 32.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.687 -0.688 . . . . 75.219999999999999 112.235 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.1 t -53.16 -21.69 5.38 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.612 0.967 . . . . 72.120000000000005 113.612 -170.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -73.53 -18.7 61.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.797 0.332 . . . . 74.019999999999996 110.925 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.409 HD21 HG12 ' A' ' 127' ' ' ILE . 5.9 t30 -135.1 5.05 3.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.262 -0.426 . . . . 60.25 110.896 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 43' ' ' LEU . 43.5 t -139.34 145.26 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.913 0.387 . . . . 74.219999999999999 111.33 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -148.69 128.29 13.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 72.219999999999999 109.541 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.0 mt -106.56 128.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 120.852 0.358 . . . . 73.140000000000001 110.479 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -110.63 168.22 9.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.836 -0.62 . . . . 73.109999999999999 109.934 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HZ2' ' HB2' ' A' ' 49' ' ' TRP . 22.6 ttmm -135.05 99.27 4.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.219 -0.66 . . . . 62.329999999999998 109.219 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -119.31 97.04 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.861 0.838 . . . . 75.129999999999995 108.942 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -150.49 94.9 2.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.193 -0.912 . . . . 60.109999999999999 110.089 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.476 HD11 ' N ' ' A' ' 81' ' ' ILE . 2.7 mp -72.98 109.93 5.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.595 -0.891 . . . . 65.230000000000004 108.595 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.89 -31.09 68.28 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.059 0.457 . . . . 64.209999999999994 110.464 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.69 -19.08 49.83 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.946 -0.57 . . . . 63.520000000000003 111.608 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -119.7 79.84 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.4 0.619 . . . . 73.530000000000001 110.132 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.78 -21.84 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.444 -0.798 . . . . 73.430000000000007 111.06 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 26.2 t70 -45.77 -47.62 15.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.011 -0.54 . . . . 63.32 111.809 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.66 -42.02 49.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.314 -0.403 . . . . 71.010000000000005 110.988 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.84 -45.02 87.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 74.239999999999995 110.551 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -68.39 -29.86 68.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 72.420000000000002 110.587 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.1 mm100 -70.49 -46.47 63.67 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.356 -0.384 . . . . 74.510000000000005 111.089 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -79.91 -17.19 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.109999999999999 111.092 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.06 64.46 0.95 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.772 -0.728 . . . . 65.549999999999997 113.091 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' OG1' ' A' ' 98' ' ' THR . 91.5 t -97.04 133.15 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.399 -0.593 . . . . 75.310000000000002 109.399 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.2 m -138.71 -64.68 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.472 -0.331 . . . . 72.219999999999999 110.833 -175.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 112' ' ' ILE . . . -85.49 170.57 12.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.343 -0.39 . . . . 52.439999999999998 110.488 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.588 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -110.97 118.63 47.76 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.08 -0.509 . . . . 75.510000000000005 111.718 -175.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -92.62 -160.25 0.99 Allowed 'Cis proline' 0 C--N 1.352 0.738 0 C-N-CA 123.957 -1.268 . . . . 64.140000000000001 111.3 -6.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 112' ' ' ILE . 87.9 m -137.27 129.33 29.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.145 -0.317 . . . . 74.0 110.145 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.97 120.34 62.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.944 -0.571 . . . . 71.439999999999998 110.729 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 27.3 mt -88.23 146.55 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.208 -0.664 . . . . 72.510000000000005 109.208 172.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.54 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 14.6 mmt -112.37 143.24 43.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.54 -0.541 . . . . 65.120000000000005 109.54 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 89.2 m-85 -144.36 151.2 38.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.044 -0.724 . . . . 74.140000000000001 109.044 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.79 125.17 5.7 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.363 -0.535 . . . . 74.239999999999995 111.086 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 60.94 29.26 18.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.308 0.575 . . . . 72.219999999999999 110.836 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 38' ' ' CYS . . . 71.32 11.59 71.61 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.833 -0.621 . . . . 43.109999999999999 112.023 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -98.69 144.95 27.39 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.157 -0.682 . . . . 63.039999999999999 109.157 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -74.1 118.61 17.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.716 0.769 . . . . 71.430000000000007 109.768 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 3.5 mm? -113.57 169.59 8.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.19 -1.368 . . . . 72.319999999999993 110.204 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 101' ' ' MET . 8.0 m -69.49 -177.39 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.487 0.715 . . . . 72.409999999999997 112.432 -163.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -141.63 136.27 30.81 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.301 1.048 . . . . 74.540000000000006 111.366 -172.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.86 107.27 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 113.335 -1.757 . . . . 73.030000000000001 109.332 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.471 HG23 ' HB1' ' A' ' 95' ' ' ALA . 50.4 mt -105.66 118.73 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.051 -0.352 . . . . 62.140000000000001 110.051 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.09 151.71 11.01 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.164 -0.471 . . . . 60.32 112.102 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.93 80.17 1.17 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.145 0.498 . . . . 75.109999999999999 111.134 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.459 ' O ' HG13 ' A' ' 119' ' ' ILE . 63.5 t0 -126.41 89.85 3.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 64.239999999999995 109.849 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.19 -33.37 50.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.838 -0.619 . . . . 62.149999999999999 110.831 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.3 t -63.64 -46.29 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.91 -0.586 . . . . 72.200000000000003 109.905 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.728 ' HZ1' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -66.37 -38.56 87.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 55.140000000000001 110.003 -179.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 115' ' ' ASP . 78.0 mt -61.88 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.104 -0.498 . . . . 72.120000000000005 111.119 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -40.04 85.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.819 0.342 . . . . 74.510000000000005 110.089 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.512 ' HA ' HD22 ' A' ' 124' ' ' ASN . 30.7 t -54.92 -50.95 67.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.639 -0.709 . . . . 52.409999999999997 109.825 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.409 ' HB3' ' HE2' ' A' ' 101' ' ' MET . 20.2 mm-40 -66.43 -33.06 74.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 73.040000000000006 111.528 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 119' ' ' ILE . 98.0 mt -61.23 -56.17 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 120.308 -0.557 . . . . 73.409999999999997 109.857 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.512 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.0 p30 -70.41 -25.26 63.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.842 -0.343 . . . . 70.219999999999999 110.801 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -69.99 -53.63 16.83 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.061 -0.518 . . . . 72.200000000000003 110.685 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -80.72 -18.51 47.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.008 0.373 . . . . 71.200000000000003 112.008 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 123' ' ' ILE . 49.9 mt -63.18 -49.98 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.084 0.469 . . . . 74.310000000000002 109.917 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.448 -0.787 . . . . 71.430000000000007 110.091 -178.606 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.161 -0.311 . . . . 75.420000000000002 110.161 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.13 94.49 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.024 0.44 . . . . 51.25 111.455 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.11 16.62 2.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.938 -0.574 . . . . 65.040000000000006 110.277 173.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -71.59 132.27 44.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.104 -0.498 . . . . 71.219999999999999 110.272 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -69.54 165.27 21.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.958 -0.565 . . . . 71.299999999999997 111.555 -175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -139.43 153.5 47.6 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.853 -0.612 . . . . 75.120000000000005 110.166 -176.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.549 ' HB2' ' HE2' ' A' ' 9' ' ' MET . 39.6 p-80 -62.05 97.94 0.09 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.812 -0.81 . . . . 65.209999999999994 108.812 172.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.42 ' HD2' ' HB3' ' A' ' 95' ' ' ALA . 33.4 p-80 -107.75 13.72 26.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.582 -0.736 . . . . 74.329999999999998 112.83 -164.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.549 ' HE2' ' HB2' ' A' ' 7' ' ' HIS . 0.0 OUTLIER -79.1 64.37 4.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.736 0.779 . . . . 73.109999999999999 110.222 177.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.82 57.37 0.57 Allowed Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.347 -0.842 . . . . 70.450000000000003 111.748 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.696 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 8.8 t -129.1 151.45 49.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.65 -0.5 . . . . 75.420000000000002 109.65 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -129.17 -92.58 0.45 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.488 0.185 . . . . 74.230000000000004 111.294 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -152.87 134.2 14.31 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.789 0.328 . . . . 75.420000000000002 110.727 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.44 172.23 18.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.891 -0.595 . . . . 74.349999999999994 109.521 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -169.67 126.3 0.87 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.098 -0.334 . . . . 71.239999999999995 110.098 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 p 46.08 29.2 0.74 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.741 0.651 . . . . 70.150000000000006 111.281 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -101.58 119.42 38.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.73 -0.668 . . . . 71.400000000000006 111.209 -171.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.06 59.51 0.01 OUTLIER Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.732 -0.667 . . . . 74.209999999999994 111.651 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.47 -174.54 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.19 2.593 . . . . 75.329999999999998 113.148 -173.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.82 124.47 35.65 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.761 -0.654 . . . . 31.0 112.135 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 p -156.89 -173.2 4.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.111 -0.329 . . . . 73.120000000000005 110.111 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.632 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 62.4 mmm -57.95 -20.53 38.4 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.603 0.24 . . . . 71.319999999999993 110.847 175.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -68.7 84.52 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.497 -0.927 . . . . 73.430000000000007 108.497 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.19 112.23 2.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.085 -0.961 . . . . 70.140000000000001 110.682 -169.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.93 131.35 35.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.005 -0.543 . . . . 71.409999999999997 110.732 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.0 pt -136.87 162.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 73.540000000000006 110.534 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.39 174.64 36.89 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.145 -0.55 . . . . 75.430000000000007 111.868 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.9 -47.8 73.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.007 0.432 . . . . 65.030000000000001 110.176 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 m -59.45 -25.19 64.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.649 -0.705 . . . . 74.420000000000002 111.252 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 24.3 mm-40 -88.58 -20.03 25.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 75.540000000000006 111.56 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -55.89 -61.7 2.2 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.727 0.298 . . . . 70.519999999999996 110.978 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.77 -48.97 79.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 109.945 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -49.87 -57.3 7.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.068 -0.969 . . . . 43.219999999999999 111.48 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -66.94 -43.97 81.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.066 -0.515 . . . . 63.340000000000003 111.278 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.85 -38.85 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.296 -0.411 . . . . 74.140000000000001 111.715 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.5 p -86.37 -31.07 21.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.222 0.453 . . . . 53.409999999999997 112.222 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 t -82.01 -8.64 59.68 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.407 0.521 . . . . 74.540000000000006 112.407 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 10.9 p -58.48 129.52 42.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.001 -0.279 . . . . 71.299999999999997 110.251 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -49.94 -74.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.68 0.622 . . . . 72.420000000000002 112.68 -168.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -161.7 131.71 4.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.919 -0.128 . . . . 63.420000000000002 110.716 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 51.86 25.67 3.15 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.659 0.6 . . . . 72.450000000000003 112.421 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.6 mm -83.41 99.18 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.462 -0.57 . . . . 70.510000000000005 109.462 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' A' ' 74' ' ' VAL . 59.2 tp -67.72 107.4 2.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.669 . . . . 72.329999999999998 110.205 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -94.18 118.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 72.450000000000003 110.517 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.516 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.2 mp -100.26 108.27 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.5 -0.555 . . . . 73.209999999999994 109.5 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.29 104.98 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.312 -0.625 . . . . 72.450000000000003 109.312 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 98' ' ' THR . 37.3 t0 -91.6 145.16 24.82 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.162 -0.472 . . . . 62.130000000000003 110.069 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.446 ' CE1' HD12 ' A' ' 100' ' ' LEU . 10.1 m-85 -103.2 92.17 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.016 -0.538 . . . . 65.219999999999999 110.202 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -86.48 168.63 13.57 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.615 -0.72 . . . . 74.340000000000003 111.004 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.03 154.95 10.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.331 -0.849 . . . . 54.329999999999998 108.778 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.74 -38.02 21.95 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.841 2.361 . . . . 64.329999999999998 111.795 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -123.92 84.13 2.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.565 -0.902 . . . . 73.150000000000006 108.565 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -52.31 5.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.424 -0.353 . . . . 63.299999999999997 111.469 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.558 ' N ' ' SG ' ' A' ' 56' ' ' CYS . . . 151.66 -116.86 0.78 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.703 -0.76 . . . . 43.399999999999999 112.717 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.696 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.9 Cg_exo -79.54 37.01 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.365 2.71 . . . . 54.219999999999999 111.384 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 1.8 m -59.94 -35.54 75.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.095 -0.957 . . . . 71.349999999999994 111.156 -171.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -54.18 -44.2 71.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.959 -0.564 . . . . 74.439999999999998 111.378 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.639 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.2 m -74.75 -42.98 57.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.635 0.731 . . . . 74.230000000000004 110.5 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.3 mm? -72.24 -17.57 61.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 64.099999999999994 111.982 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 44.9 mt-10 -56.93 -63.94 3.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.529 -0.545 . . . . 65.120000000000005 109.529 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 53.4 Cg_endo -68.66 -35.4 16.8 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.595 1.53 . . . . 64.230000000000004 112.179 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.6 mt-30 -63.33 -46.73 85.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.335 -0.546 . . . . 75.209999999999994 111.465 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.5 mt -70.32 -43.25 70.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.874 -0.148 . . . . 74.140000000000001 110.666 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.632 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 35.4 mt-10 -59.07 -35.78 73.95 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.16 -0.311 . . . . 65.510000000000005 110.16 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.19 -57.21 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 74.540000000000006 110.458 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 123' ' ' ILE . 41.6 mt -62.44 -32.58 73.46 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.306 -0.406 . . . . 74.510000000000005 109.947 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.65 -51.71 57.38 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.866 -0.606 . . . . 43.32 110.547 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -67.23 -30.32 70.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.747 0.308 . . . . 74.129999999999995 111.296 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -81.32 -38.31 26.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.101 -0.5 . . . . 75.409999999999997 110.818 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -104.87 5.39 32.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.959 -0.564 . . . . 75.219999999999999 112.142 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 9.8 t -53.47 -19.8 4.06 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.424 0.527 . . . . 72.120000000000005 112.424 -173.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.4 -32.66 73.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.808 0.337 . . . . 74.019999999999996 111.101 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -133.56 14.04 4.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.277 -0.419 . . . . 60.25 110.748 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 71' ' ' THR . 50.5 t -140.84 142.57 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.965 0.412 . . . . 74.219999999999999 111.76 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -149.89 127.75 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.8 -0.637 . . . . 72.219999999999999 109.501 170.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.516 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.0 mt -99.14 122.21 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.099 -0.334 . . . . 73.140000000000001 110.099 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -110.81 155.42 22.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.322 -0.399 . . . . 73.109999999999999 110.137 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HZ1' ' CD ' ' A' ' 82' ' ' GLU . 50.2 pttt -137.83 130.87 30.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.006 -0.738 . . . . 62.329999999999998 109.006 168.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 81' ' ' ILE . 14.0 pt -79.07 149.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 75.129999999999995 110.025 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -74.8 30.18 0.09 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.929 0.395 . . . . 60.109999999999999 111.871 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 81' ' ' ILE . 29.7 mm -99.01 19.19 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.481 0.657 . . . . 65.230000000000004 109.691 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.429 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 38.3 mt-10 -57.74 -19.03 24.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.677 -0.692 . . . . 64.209999999999994 112.231 -176.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.14 -6.79 54.99 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.614 0.245 . . . . 63.520000000000003 111.547 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.425 ' HB2' HG23 ' A' ' 81' ' ' ILE . 30.5 m-80 -119.58 88.32 2.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.797 0.332 . . . . 73.530000000000001 110.717 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -64.72 -30.87 71.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.609 -0.515 . . . . 73.430000000000007 109.609 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.1 m-20 -43.55 -51.44 6.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.33 -0.85 . . . . 63.32 110.999 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.33 -36.16 51.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.46 -0.791 . . . . 71.010000000000005 111.054 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . . . -63.93 -50.95 66.65 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.309 0.576 . . . . 74.239999999999995 109.674 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -60.38 -34.4 73.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.341 -0.845 . . . . 72.420000000000002 110.808 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -60.71 -55.15 36.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.958 0.409 . . . . 74.510000000000005 110.369 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -73.57 -15.24 61.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 112.21 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.44 0.69 18.38 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.506 -0.854 . . . . 65.549999999999997 112.99 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 88' ' ' ALA . 88.4 t -67.78 109.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.047 0.451 . . . . 75.310000000000002 109.947 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 t -97.04 -7.12 33.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.856 -0.611 . . . . 72.219999999999999 111.404 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.42 ' HB3' ' HD2' ' A' ' 8' ' ' HIS . . . -152.44 158.66 42.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.973 -0.38 . . . . 52.439999999999998 109.973 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.12 144.56 52.08 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 110.186 -0.301 . . . . 75.510000000000005 110.186 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 114' ' ' ALA . 8.1 Cg_exo -73.32 -179.71 25.95 Favored 'Cis proline' 0 C--N 1.354 0.847 0 C-N-CA 124.33 -1.113 . . . . 64.140000000000001 112.323 -3.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 47' ' ' ASP . 18.5 m -160.36 137.24 9.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 74.0 110.717 -178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.572 ' HB ' HG21 ' A' ' 111' ' ' VAL . 36.1 mm -109.92 110.87 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.533 -0.758 . . . . 71.439999999999998 111.307 -174.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.446 HD12 ' CE1' ' A' ' 48' ' ' PHE . 7.3 mp -96.39 123.26 39.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.106 -1.072 . . . . 72.510000000000005 108.106 168.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.437 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 44.4 mtt -98.76 143.29 29.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.501 . . . . 65.120000000000005 110.995 -175.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -142.81 146.13 33.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.394 -0.965 . . . . 74.140000000000001 108.394 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 107.21 4.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.482 -0.487 . . . . 74.239999999999995 110.859 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.621 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 58.96 28.32 17.48 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.746 0.784 . . . . 72.219999999999999 110.469 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.85 -16.22 59.89 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.612 -0.722 . . . . 43.109999999999999 112.596 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.517 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 13.4 tmtt? -75.33 141.32 43.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.997 -0.742 . . . . 63.039999999999999 108.997 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.59 124.35 25.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.437 0.637 . . . . 71.430000000000007 111.529 -175.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -120.46 168.08 11.69 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.393 1.077 . . . . 72.319999999999993 109.981 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.63 176.68 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.224 0.535 . . . . 72.409999999999997 111.913 -164.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -141.11 126.86 19.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 74.540000000000006 110.524 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.572 HG21 ' HB ' ' A' ' 99' ' ' ILE . 35.5 m -114.21 130.06 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.695 -0.483 . . . . 73.030000000000001 109.695 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.1 117.8 56.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.748 -0.66 . . . . 62.140000000000001 109.679 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.72 144.92 9.0 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.289 -0.724 . . . . 60.32 111.289 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.557 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . . . -83.21 72.34 10.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 111.334 -176.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 119' ' ' ILE . 30.2 t70 -113.07 104.66 12.59 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.185 -0.461 . . . . 64.239999999999995 109.833 175.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.3 tp -60.94 -34.07 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 62.149999999999999 111.422 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.419 ' O ' HG23 ' A' ' 120' ' ' ILE . 21.1 t -64.45 -50.11 68.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 72.200000000000003 110.105 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.9 tptt -61.74 -46.69 88.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 55.140000000000001 110.174 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 115' ' ' ASP . 77.4 mt -57.67 -51.08 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.489 . . . . 72.120000000000005 111.146 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.45 ' O ' HD12 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.51 -39.99 87.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 110.1 -0.333 . . . . 74.510000000000005 110.1 -177.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.7 m -55.81 -50.69 69.82 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.924 -0.399 . . . . 52.409999999999997 109.924 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 61.5 mm-40 -62.62 -44.29 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 73.040000000000006 110.711 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.513 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.7 mt -53.44 -56.39 8.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.603 0.239 . . . . 73.409999999999997 110.777 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -70.18 -32.0 69.74 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.624 -0.431 . . . . 70.219999999999999 110.322 -175.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -64.55 -33.8 76.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.906 -0.588 . . . . 72.200000000000003 111.361 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.99 -20.7 19.14 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 111.984 0.365 . . . . 71.200000000000003 111.984 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.0 mt -71.49 -58.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.027 0.441 . . . . 74.310000000000002 110.028 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.247 -0.883 . . . . 71.430000000000007 110.249 -175.562 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.565 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.743 0.306 . . . . 75.420000000000002 110.551 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.13 62.92 5.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.262 0.553 . . . . 51.25 110.146 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -83.22 -9.19 59.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.617 -0.72 . . . . 65.040000000000006 110.775 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -75.72 87.64 2.77 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.988 0.423 . . . . 71.219999999999999 110.384 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -74.12 96.49 2.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.738 -0.838 . . . . 71.299999999999997 108.738 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -77.92 132.74 38.04 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.851 0.685 . . . . 75.120000000000005 112.851 -166.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -153.98 163.21 40.44 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.213 -0.903 . . . . 65.209999999999994 108.945 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -127.75 147.14 50.4 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.683 -0.488 . . . . 74.329999999999998 109.683 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.1 mtt -97.92 -67.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.982 0.42 . . . . 73.109999999999999 110.504 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.55 -176.02 38.52 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.121 -0.792 . . . . 70.450000000000003 111.121 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 t -158.39 159.28 35.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.991 0.396 . . . . 75.420000000000002 110.807 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 13' ' ' GLU . 2.5 tm? -154.02 151.23 29.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.695 -0.854 . . . . 74.230000000000004 108.695 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.615 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -133.54 91.99 2.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.41 0.624 . . . . 75.420000000000002 110.312 178.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.24 -87.71 0.04 OUTLIER 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.171 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 174.11 158.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.389 -0.597 . . . . 71.239999999999995 109.389 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -158.91 162.74 36.92 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.852 -0.425 . . . . 70.150000000000006 109.852 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 51.6 tp60 -148.4 23.43 1.03 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.263 -0.643 . . . . 71.400000000000006 109.263 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.1 97.28 1.17 Allowed Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.575 -0.738 . . . . 74.209999999999994 112.232 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 17' ' ' GLN . 55.8 Cg_endo -89.92 37.53 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.22 2.614 . . . . 75.329999999999998 111.931 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.58 164.51 15.61 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.766 -0.652 . . . . 31.0 112.062 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p 169.68 163.88 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.313 0.645 . . . . 73.120000000000005 109.531 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 54.7 mmm -57.17 -27.63 62.08 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.418 -0.586 . . . . 71.319999999999993 109.418 170.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.437 HG22 HG21 ' A' ' 76' ' ' ILE . 12.1 mm -71.95 89.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.55 -1.278 . . . . 73.430000000000007 107.55 169.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.63 112.15 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.465 -0.789 . . . . 70.140000000000001 111.442 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.68 117.11 18.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.701 -0.681 . . . . 71.409999999999997 109.983 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.9 pt -110.55 159.18 10.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.842 -0.617 . . . . 73.540000000000006 111.254 -172.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.88 -177.72 36.48 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.681 -0.691 . . . . 75.430000000000007 112.975 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.96 -56.92 10.08 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.734 0.814 . . . . 65.030000000000001 111.947 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -73.19 -18.59 61.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.944 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -83.9 -12.41 55.5 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.125 0.417 . . . . 75.540000000000006 112.125 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.499 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.3 t80 -58.19 -61.45 2.55 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.688 -0.486 . . . . 70.519999999999996 109.688 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.82 -52.82 61.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.689 -0.687 . . . . 73.420000000000002 110.745 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -55.98 -57.34 12.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.605 -0.725 . . . . 43.219999999999999 111.717 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -65.41 -34.13 77.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.027 -0.533 . . . . 63.340000000000003 111.552 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.8 t -70.26 -36.32 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.604 0.24 . . . . 74.140000000000001 110.96 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.87 -13.32 48.29 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.671 0.272 . . . . 53.409999999999997 111.172 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -62.83 -10.08 11.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.424 0.528 . . . . 74.540000000000006 112.424 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 17.4 p -76.7 116.97 17.86 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.927 -0.483 . . . . 71.299999999999997 110.695 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.12 -78.04 0.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.035 -0.53 . . . . 72.420000000000002 111.359 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.68 127.62 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.519 0.2 . . . . 63.420000000000002 110.844 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.5 14.0 5.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.781 -0.645 . . . . 72.450000000000003 111.378 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.7 mm -81.72 120.39 33.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.197 -0.456 . . . . 70.510000000000005 109.854 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HG21 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.38 123.85 28.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 109.963 -178.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 38' ' ' CYS . 44.2 mt -113.94 117.55 55.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 72.450000000000003 110.077 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.601 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.4 mp -105.37 126.15 51.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.03 -0.73 . . . . 73.209999999999994 109.03 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 67.0 t -104.93 105.08 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.698 -0.482 . . . . 72.450000000000003 109.698 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.16 145.33 32.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 62.130000000000003 111.995 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.42 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 23.6 m-85 -108.57 98.57 8.06 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.402 -0.817 . . . . 65.219999999999999 109.181 169.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -42.96 139.06 1.83 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.901 -1.045 . . . . 74.340000000000003 112.484 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.54 112.7 56.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 54.329999999999998 111.083 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.39 -40.14 11.34 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.616 2.211 . . . . 64.329999999999998 111.256 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -164.75 139.89 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.149 -0.932 . . . . 73.150000000000006 109.399 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.8 p -166.33 -67.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 63.299999999999997 110.395 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.06 -94.87 0.16 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.992 -0.623 . . . . 43.399999999999999 112.927 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.91 -7.19 20.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.986 2.457 . . . . 54.219999999999999 113.249 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.581 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 5.3 m -55.11 -30.48 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.458 -0.337 . . . . 71.349999999999994 111.537 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -53.75 -30.59 44.98 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.231 -0.44 . . . . 74.439999999999998 111.574 -172.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 42.5 m -75.3 -37.26 60.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.349 0.595 . . . . 74.230000000000004 110.998 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.1 mm? -66.68 -47.56 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.937 -0.574 . . . . 64.099999999999994 112.434 -172.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -47.75 -55.28 17.89 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 118.115 0.416 . . . . 65.120000000000005 111.565 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 58' ' ' SER . 25.2 Cg_endo -64.96 -33.65 50.84 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.713 1.609 . . . . 64.230000000000004 112.164 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.5 mt-30 -66.12 -27.56 68.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.566 -0.454 . . . . 75.209999999999994 110.554 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 90.1 mt -76.84 -36.35 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.496 -0.557 . . . . 74.140000000000001 109.496 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 39.2 mt-10 -60.83 -36.96 80.44 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.134 -0.484 . . . . 65.510000000000005 109.706 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 58.5 tttm -57.53 -57.0 14.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.107 -0.497 . . . . 74.540000000000006 110.309 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD11 HD11 ' A' ' 123' ' ' ILE . 48.1 mt -63.07 -32.17 73.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.989 -0.551 . . . . 74.510000000000005 110.319 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.85 -42.53 94.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 43.32 110.839 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.54 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 52.9 mm-40 -74.61 -39.1 62.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.159 0.504 . . . . 74.129999999999995 110.841 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.33 -39.04 85.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.678 -0.692 . . . . 75.409999999999997 110.801 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -105.05 5.29 32.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.475 -0.784 . . . . 75.219999999999999 112.047 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.88 -19.12 2.31 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.761 0.652 . . . . 72.120000000000005 112.761 -171.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -71.08 -27.46 63.63 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.647 0.24 . . . . 74.019999999999996 111.647 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -134.81 10.25 3.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.34 0.256 . . . . 60.25 111.329 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 43' ' ' LEU . 50.9 t -135.86 142.13 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.052 0.453 . . . . 74.219999999999999 111.153 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.0 119.78 9.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.911 -0.774 . . . . 72.219999999999999 108.911 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.461 HG23 ' HB2' ' A' ' 45' ' ' LEU . 34.3 mt -102.45 129.31 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.612 0.244 . . . . 73.140000000000001 110.542 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -115.98 173.86 6.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.439 -0.578 . . . . 73.109999999999999 109.439 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -155.37 136.02 13.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.978 -0.379 . . . . 62.329999999999998 109.978 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.9 mt -79.71 79.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.073 -0.714 . . . . 75.129999999999995 109.073 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -81.23 56.18 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.385 0.612 . . . . 60.109999999999999 110.405 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -123.52 92.85 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.764 -0.653 . . . . 65.230000000000004 109.765 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -59.91 -17.66 39.03 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.84 -0.618 . . . . 64.209999999999994 111.211 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 33.3 t70 -71.66 -25.94 62.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.608 -0.724 . . . . 63.520000000000003 111.012 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -109.59 104.88 13.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.88 0.372 . . . . 73.530000000000001 110.324 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -99.13 -30.43 12.3 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.016 -0.538 . . . . 73.430000000000007 110.414 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 36.0 t70 -47.25 -47.13 24.91 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.611 -0.722 . . . . 63.32 111.883 -171.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.95 -41.05 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.237 -0.438 . . . . 71.010000000000005 111.128 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.37 95.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.222 0.534 . . . . 74.239999999999995 110.168 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 m -67.87 -33.24 74.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 72.420000000000002 110.697 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.9 mm-40 -66.27 -51.46 57.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 74.510000000000005 110.597 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -75.1 -17.33 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 73.109999999999999 110.461 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.26 45.07 20.63 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.011 -0.614 . . . . 65.549999999999997 112.533 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG11 ' OG1' ' A' ' 98' ' ' THR . 98.8 t -58.27 110.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.033 0.444 . . . . 75.310000000000002 110.175 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.7 m -85.94 -34.84 20.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.789 -0.642 . . . . 72.219999999999999 110.956 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.79 156.6 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 52.439999999999998 109.97 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.688 ' H ' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.31 144.92 33.2 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 110.043 -177.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 4.9 Cg_exo -78.01 173.41 57.08 Favored 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.074 -1.219 . . . . 64.140000000000001 112.637 -0.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.498 HG22 HG12 ' A' ' 112' ' ' ILE . 27.8 m -138.39 127.05 23.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.706 . . . . 74.0 109.979 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' HG21 ' A' ' 111' ' ' VAL . 48.6 mm -110.14 110.81 33.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.072 0.463 . . . . 71.439999999999998 110.984 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 100' ' ' LEU . 2.8 mm? -90.63 123.69 34.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.403 -0.817 . . . . 72.510000000000005 109.519 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.601 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -92.49 135.99 33.59 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.689 -0.486 . . . . 65.120000000000005 109.689 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 85.2 m-85 -141.58 142.66 33.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.249 -1.019 . . . . 74.140000000000001 108.249 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 26.7 ttpp -147.23 126.95 13.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.236 -0.586 . . . . 74.239999999999995 110.89 -175.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t30 63.32 25.55 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.625 0.726 . . . . 72.219999999999999 109.603 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.69 19.37 74.84 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.317 -0.856 . . . . 43.109999999999999 111.926 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -117.85 153.94 32.67 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 122.216 0.206 . . . . 63.039999999999999 110.58 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.49 ' O ' HD23 ' A' ' 108' ' ' LEU . 16.6 tppt? -56.48 139.75 48.26 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 124.121 0.888 . . . . 71.430000000000007 111.668 -176.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -149.99 168.37 24.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.8 -1.091 . . . . 72.319999999999993 108.707 -171.295 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 101' ' ' MET . 39.6 m -70.64 -177.07 1.43 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.921 0.712 . . . . 72.409999999999997 112.921 -166.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.466 ' HG3' HD11 ' A' ' 100' ' ' LEU . 47.4 tt0 -146.07 148.38 32.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.154 -0.341 . . . . 74.540000000000006 111.085 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.522 HG21 ' HB ' ' A' ' 99' ' ' ILE . 15.3 m -137.15 128.23 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.244 -0.434 . . . . 73.030000000000001 109.882 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.498 HG12 HG22 ' A' ' 98' ' ' THR . 67.5 mt -114.92 138.08 46.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.29 -0.414 . . . . 62.140000000000001 110.331 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.86 161.42 21.0 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.147 -0.549 . . . . 60.32 112.227 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.84 86.28 6.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.854 0.359 . . . . 75.109999999999999 110.553 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.6 t0 -139.15 93.78 2.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.159 0.504 . . . . 64.239999999999995 110.251 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.1 tp -60.3 -32.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.596 -0.729 . . . . 62.149999999999999 111.018 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 t -68.95 -46.87 67.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.021 -0.536 . . . . 72.200000000000003 109.976 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -67.46 -43.31 81.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 55.140000000000001 110.217 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 115' ' ' ASP . 79.6 mt -58.75 -52.4 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.4 . . . . 72.120000000000005 110.956 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -39.09 83.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 120.87 0.367 . . . . 74.510000000000005 110.034 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.541 ' HA ' HD22 ' A' ' 124' ' ' ASN . 58.7 m -54.56 -50.6 67.55 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.122 -0.49 . . . . 52.409999999999997 110.448 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.505 ' HB3' ' HE2' ' A' ' 101' ' ' MET . 33.3 mm-40 -64.17 -39.06 93.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.62 -0.264 . . . . 73.040000000000006 111.193 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.451 HD11 HD11 ' A' ' 66' ' ' LEU . 97.7 mt -55.79 -55.81 15.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.643 -0.423 . . . . 73.409999999999997 110.314 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.541 HD22 ' HA ' ' A' ' 121' ' ' SER . 10.3 p30 -69.79 -27.36 64.84 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.428 -0.509 . . . . 70.219999999999999 110.393 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -70.69 -33.87 71.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.254 -0.43 . . . . 72.200000000000003 110.837 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.513 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.8 OUTLIER -86.07 -29.94 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 71.200000000000003 110.565 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.86 -49.68 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 74.310000000000002 110.904 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.696 -0.669 . . . . 71.430000000000007 110.124 -175.352 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.664 0.269 . . . . 75.420000000000002 110.632 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.54 -173.68 2.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.602 -0.272 . . . . 51.25 110.675 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -136.05 -177.59 4.76 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.845 -0.428 . . . . 65.040000000000006 109.845 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -73.48 88.46 1.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 71.219999999999999 109.975 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -93.29 -4.83 51.03 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 110.552 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -63.83 91.14 0.06 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.817 -0.629 . . . . 75.120000000000005 109.462 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -111.44 -42.39 3.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 65.209999999999994 111.225 -171.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -122.24 129.64 52.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.449 -0.341 . . . . 74.329999999999998 110.411 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.7 mtp -96.37 169.6 9.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 73.109999999999999 110.519 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.583 ' O ' HG23 ' A' ' 11' ' ' THR . . . -79.75 -47.81 7.01 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.747 -0.941 . . . . 70.450000000000003 110.747 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 10' ' ' GLY . 3.1 t 64.92 -49.61 0.34 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.79 1.636 . . . . 75.420000000000002 113.522 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.687 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 93.1 mt -72.51 103.12 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.993 0.425 . . . . 74.230000000000004 109.983 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.04 117.85 7.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.866 -0.606 . . . . 75.420000000000002 110.749 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.54 16.01 10.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.173 -0.467 . . . . 74.349999999999994 111.638 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.687 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 78.8 mt-30 -124.28 -173.55 2.8 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.896 -0.409 . . . . 71.239999999999995 109.896 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -150.81 -172.63 4.25 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.733 -0.469 . . . . 70.150000000000006 109.733 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -57.06 136.11 56.33 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.169 -0.308 . . . . 71.400000000000006 110.169 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.74 115.43 7.79 Favored Glycine 0 CA--C 1.521 0.415 0 O-C-N 123.372 0.42 . . . . 74.209999999999994 112.753 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.8 101.9 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.438 2.092 . . . . 75.329999999999998 111.551 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.5 -63.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.646 -0.582 . . . . 31.0 111.646 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -67.73 80.7 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 73.120000000000005 110.508 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.507 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 91.9 mmm -85.72 -1.79 57.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 71.319999999999993 110.43 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.68 107.35 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 73.430000000000007 110.079 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.5 126.54 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.17 -0.468 . . . . 70.140000000000001 110.59 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.17 124.38 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.846 -0.798 . . . . 71.409999999999997 108.846 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 34' ' ' LYS . 28.8 pt -129.32 158.02 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 73.540000000000006 110.859 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.18 165.14 53.91 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.845 -0.616 . . . . 75.430000000000007 112.253 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.87 -50.11 61.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 65.030000000000001 111.057 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.5 m -71.87 -10.52 59.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.218 -0.446 . . . . 74.420000000000002 111.51 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -89.21 -4.96 58.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.689 -0.232 . . . . 75.540000000000006 111.233 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' HD2' HD12 ' A' ' 79' ' ' ILE . 83.1 t80 -58.11 -62.49 1.79 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.789 0.328 . . . . 70.519999999999996 110.9 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.54 -39.35 93.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 73.420000000000002 109.994 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.0 -57.37 10.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.402 -0.817 . . . . 43.219999999999999 110.634 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HG3' HG21 ' A' ' 26' ' ' ILE . 43.9 mmtm -79.22 -18.37 53.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.991 -0.55 . . . . 63.340000000000003 112.137 -172.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 31' ' ' PHE . 55.0 t -74.03 -36.16 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.801 0.334 . . . . 74.140000000000001 110.334 171.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.4 p -85.98 -20.07 29.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.774 0.321 . . . . 53.409999999999997 111.02 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -68.5 4.45 1.37 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 111.936 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.848 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.4 p -58.13 137.95 56.54 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.219 -0.289 . . . . 71.299999999999997 110.219 175.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.25 -67.21 0.43 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 110.247 -0.279 . . . . 72.420000000000002 110.247 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' H ' HG12 ' A' ' 42' ' ' ILE . 5.3 p-10 -162.06 128.7 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.171 -0.307 . . . . 63.420000000000002 110.171 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.84 18.17 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.042 0.537 . . . . 72.450000000000003 112.248 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 40' ' ' ASP . 49.2 mm -71.51 136.26 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 116.524 -0.307 . . . . 70.510000000000005 110.497 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 74' ' ' VAL . 57.2 tp -80.06 126.26 30.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 72.329999999999998 110.158 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.87 119.24 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 72.450000000000003 110.381 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.52 ' HB2' HG12 ' A' ' 76' ' ' ILE . 3.3 mp -107.09 115.31 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 73.209999999999994 109.529 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.74 105.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.223 -0.658 . . . . 72.450000000000003 109.223 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 98' ' ' THR . 21.9 t0 -85.92 153.11 22.43 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.722 -0.217 . . . . 62.130000000000003 110.642 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.68 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 17.4 p90 -50.73 152.64 1.97 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.054 -0.521 . . . . 65.219999999999999 111.64 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -128.77 98.48 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.836 -0.62 . . . . 74.340000000000003 109.707 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.98 149.19 10.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 54.329999999999998 110.244 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.52 39.48 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.902 2.402 . . . . 64.329999999999998 112.209 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -145.03 131.49 19.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 73.150000000000006 110.375 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.413 ' HA ' HG12 ' A' ' 96' ' ' ILE . 25.9 p -166.18 154.55 10.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 63.299999999999997 109.912 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.77 -82.82 1.67 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 112.018 -0.433 . . . . 43.399999999999999 112.018 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.584 ' HB2' HD22 ' A' ' 59' ' ' LEU . 3.6 Cg_exo -77.66 50.32 3.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.295 2.663 . . . . 54.219999999999999 111.576 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.68 -51.61 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.643 -0.708 . . . . 71.349999999999994 110.837 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -54.32 -38.13 65.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.763 -0.653 . . . . 74.439999999999998 111.903 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.583 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.7 m -75.57 -59.19 2.86 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.706 0.765 . . . . 74.230000000000004 112.144 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.584 HD22 ' HB2' ' A' ' 55' ' ' PRO . 4.5 mm? -66.28 -34.44 78.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.716 -0.675 . . . . 64.099999999999994 112.762 -168.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 48.9 mt-10 -56.61 -60.18 10.04 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 120.602 -0.439 . . . . 65.120000000000005 110.634 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.7 Cg_endo -63.19 -34.63 67.71 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.003 1.802 . . . . 64.230000000000004 112.199 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 58' ' ' SER . 41.8 mt-30 -59.89 -41.84 92.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.421 -0.512 . . . . 75.209999999999994 110.947 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.25 -42.69 79.27 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.479 -0.328 . . . . 74.140000000000001 110.432 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 44.3 mt-10 -57.75 -37.2 73.19 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.057 -0.52 . . . . 65.510000000000005 110.539 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -66.82 -53.0 37.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.239 -0.437 . . . . 74.540000000000006 111.156 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.439 HD12 HD13 ' A' ' 123' ' ' ILE . 55.4 mt -60.09 -34.98 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.039 0.447 . . . . 74.510000000000005 110.174 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.14 -53.37 50.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.753 -0.658 . . . . 43.32 110.151 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.507 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 15.6 mm-40 -57.08 -31.91 65.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.532 -0.304 . . . . 74.129999999999995 111.683 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -78.06 -47.15 18.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 111.162 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -104.59 4.79 33.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.586 . . . . 75.219999999999999 112.437 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.3 t -52.9 -19.69 2.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.411 0.523 . . . . 72.120000000000005 112.411 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.77 -39.98 78.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.8 0.333 . . . . 74.019999999999996 110.497 176.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -125.45 9.72 7.85 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.26 -0.427 . . . . 60.25 111.236 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 71' ' ' THR . 41.0 t -132.17 138.91 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.885 0.374 . . . . 74.219999999999999 111.587 -176.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -144.87 133.67 22.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.942 -0.572 . . . . 72.219999999999999 109.492 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.52 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -113.98 143.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.498 0.19 . . . . 73.140000000000001 110.747 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -131.61 162.61 29.95 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.175 0.512 . . . . 73.109999999999999 111.129 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -137.1 142.71 42.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.013 -0.994 . . . . 62.329999999999998 108.606 170.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.565 HD12 ' HD2' ' A' ' 31' ' ' PHE . 43.8 mm -90.91 152.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.668 -0.493 . . . . 75.129999999999995 109.668 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -94.8 -169.31 1.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.205 -0.294 . . . . 60.109999999999999 110.205 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 mt 61.61 60.88 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 122.143 0.973 . . . . 65.230000000000004 109.699 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -59.74 -18.81 45.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.528 -1.215 . . . . 64.209999999999994 110.75 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.15 -17.9 62.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.593 -0.731 . . . . 63.520000000000003 111.435 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.8 67.72 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.405 0.621 . . . . 73.530000000000001 111.143 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -61.05 -30.5 70.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.27 -0.877 . . . . 73.430000000000007 110.811 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.65 -42.23 33.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.925 -0.579 . . . . 63.32 110.736 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.58 -36.56 60.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 71.010000000000005 110.717 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.013 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 m -60.13 -40.69 90.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.882 -0.599 . . . . 72.420000000000002 110.922 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -65.59 -41.06 93.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.918 -0.583 . . . . 74.510000000000005 111.426 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -90.65 -7.48 52.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 73.109999999999999 111.428 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.28 21.6 58.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.24 -0.505 . . . . 65.549999999999997 113.072 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 98' ' ' THR . 46.9 t -73.13 124.44 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.949 -0.389 . . . . 75.310000000000002 109.949 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 t -151.42 -42.26 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 72.219999999999999 110.324 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.66 137.83 40.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.304 -0.407 . . . . 52.439999999999998 110.096 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 96' ' ' ILE . 2.4 pp -110.09 154.51 42.72 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.387 -0.369 . . . . 75.510000000000005 111.592 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.07 171.9 63.12 Favored 'Cis proline' 0 C--N 1.352 0.753 0 C-N-CA 123.421 -1.491 . . . . 64.140000000000001 111.894 -5.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.68 ' HB ' ' HB3' ' A' ' 48' ' ' PHE . 83.8 m -130.21 110.93 11.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.355 -0.609 . . . . 74.0 109.355 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.422 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.6 mm -115.37 112.78 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 71.439999999999998 110.626 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 100' ' ' LEU . 6.6 mp -94.96 123.27 38.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.44 -0.578 . . . . 72.510000000000005 109.44 174.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.493 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 15.0 mmt -95.27 139.11 32.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.81 0.338 . . . . 65.120000000000005 110.499 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -141.04 149.33 41.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.075 -0.713 . . . . 74.140000000000001 109.075 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 103' ' ' LYS . 4.2 ttmp? -133.85 116.31 15.51 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.595 -0.521 . . . . 74.239999999999995 109.595 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.848 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.8 p-10 48.15 32.51 3.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.316 0.646 . . . . 72.219999999999999 112.202 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.87 -14.8 60.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.395 -0.431 . . . . 43.109999999999999 112.609 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -75.43 140.08 42.69 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.192 0.597 . . . . 63.039999999999999 110.176 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 108' ' ' LEU . 3.3 tmmm? -69.37 132.32 46.2 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.812 -0.631 . . . . 71.430000000000007 110.897 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.8 mm? -133.52 167.8 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.838 -1.074 . . . . 72.319999999999993 110.176 -175.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.71 179.45 2.61 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.476 0.655 . . . . 72.409999999999997 112.342 -169.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -137.85 151.4 48.03 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.657 -0.701 . . . . 74.540000000000006 110.221 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -121.9 131.2 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 114.879 -1.055 . . . . 73.030000000000001 109.996 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.5 mm -129.85 125.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 62.140000000000001 109.992 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.06 153.31 19.2 Favored Glycine 0 C--N 1.323 -0.15 0 CA-C-N 115.834 -0.621 . . . . 60.32 112.234 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.479 ' HB2' HD21 ' A' ' 59' ' ' LEU . . . -79.66 80.03 6.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.062 0.458 . . . . 75.109999999999999 111.019 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.68 94.51 3.3 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.545 -0.752 . . . . 64.239999999999995 109.075 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.35 -26.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 62.149999999999999 110.567 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.7 t -66.55 -42.12 87.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.865 -0.607 . . . . 72.200000000000003 109.647 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.83 -44.43 77.25 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 55.140000000000001 109.916 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.2 mt -56.12 -56.2 14.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.14 -0.482 . . . . 72.120000000000005 110.824 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.475 ' O ' HD12 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.61 -35.34 69.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.189 -0.46 . . . . 74.510000000000005 109.881 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.542 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 23.0 t -57.49 -46.35 83.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.003 -0.369 . . . . 52.409999999999997 110.003 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.56 -43.54 93.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.326 -0.397 . . . . 73.040000000000006 110.497 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.439 HD13 HD12 ' A' ' 66' ' ' LEU . 96.6 mt -53.45 -55.64 12.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.818 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 121' ' ' SER . 8.4 p30 -70.95 -27.91 64.09 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.946 -0.302 . . . . 70.219999999999999 110.3 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -63.36 -33.23 75.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.036 0.446 . . . . 72.200000000000003 110.125 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -79.71 -40.48 28.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.882 -0.599 . . . . 71.200000000000003 111.16 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.24 -42.21 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.085 0.469 . . . . 74.310000000000002 110.733 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.307 -0.854 . . . . 71.430000000000007 109.911 179.005 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.3 mmm . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.453 0.168 . . . . 71.32 110.638 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.58 96.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.953 0.406 . . . . 62.2 110.019 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 7.3 tp10 -67.09 125.87 27.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.759 -0.655 . . . . 70.14 110.862 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 25' ' ' GLN . 5.4 pm0 -85.8 128.12 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 71.41 109.423 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.7 pt -134.62 146.37 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.728 0.299 . . . . 73.54 110.989 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.32 173.65 37.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.97 -0.559 . . . . 75.43 112.035 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.49 -47.21 27.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.074 0.549 . . . . 65.03 112.21 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -74.81 -20.97 59.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.107 -0.497 . . . . 74.42 111.513 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.8 -13.44 45.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 75.54 111.379 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 26' ' ' ILE . 72.4 t80 -56.03 -62.25 1.83 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.952 0.353 . . . . 65.25 111.952 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -39.25 94.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.157 0.503 . . . . 73.42 110.112 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -55.7 -53.71 53.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.81 . . . . 43.22 110.395 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.6 mmtt -69.07 -32.9 72.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.444 -0.798 . . . . 63.34 111.375 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 31' ' ' PHE . 77.7 t -66.93 -36.18 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.967 0.413 . . . . 74.14 110.652 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 p -86.06 -19.63 29.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.381 -0.372 . . . . 53.41 111.525 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -63.29 -11.15 19.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.205 -0.452 . . . . 74.54 112.103 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 21.6 p -61.11 139.9 57.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.224 0.21 . . . . 55.23 111.482 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -72.15 -88.78 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.558 -0.292 . . . . 72.42 110.732 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.5 136.07 24.25 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.088 -0.338 . . . . 63.42 110.088 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.22 16.43 3.95 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.627 -0.715 . . . . 72.45 111.897 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 41.5 mm -76.22 105.24 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.533 -0.543 . . . . 70.51 109.533 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 74' ' ' VAL . 53.5 tp -73.52 117.7 15.6 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.548 0.69 . . . . 72.33 109.974 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -102.0 113.0 37.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.959 . . . . 72.45 110.679 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.594 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.5 mp -97.28 118.75 34.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.313 -0.625 . . . . 73.21 109.313 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.83 107.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.935 -0.395 . . . . 72.45 109.935 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.67 136.69 36.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.983 -0.553 . . . . 62.13 111.246 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 100' ' ' LEU . 34.3 m-85 -111.13 81.9 1.51 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.435 0.636 . . . . 65.22 109.819 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.407 ' CZ2' ' SG ' ' A' ' 53' ' ' CYS . 23.0 t-105 -68.18 92.75 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.963 -1.017 . . . . 74.34 110.501 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.567 ' HB3' HG22 ' A' ' 96' ' ' ILE . . . -77.09 137.94 65.15 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.324 -0.398 . . . . 54.33 110.074 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.34 -8.44 8.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.374 2.716 . . . . 64.33 113.763 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.736 ' HB3' HG21 ' A' ' 96' ' ' ILE . 67.5 t-105 -65.6 -52.42 52.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.632 -0.507 . . . . 73.15 109.632 177.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.407 ' SG ' ' CZ2' ' A' ' 49' ' ' TRP . 4.7 t 54.99 90.73 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.316 -0.856 . . . . 63.3 112.17 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.29 -100.88 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.138 -0.553 . . . . 43.4 111.949 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.93 6.29 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.017 2.478 . . . . 54.22 112.292 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.404 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 4.8 p -50.82 -29.74 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 71.35 111.449 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.07 -51.74 63.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.504 -177.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.2 m -75.33 -45.12 41.47 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.411 0.624 . . . . 70.35 111.286 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -63.35 -31.59 72.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 64.1 112.571 -172.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 1.9 tm-20 -61.55 -58.21 19.95 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.82 -0.352 . . . . 65.12 110.426 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 26.4 Cg_endo -63.39 -28.44 71.49 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.514 1.476 . . . . 64.23 112.039 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.587 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 42.8 mt-30 -69.53 -34.8 74.76 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 75.21 110.991 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 77.5 mt -68.89 -43.54 75.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.471 -0.566 . . . . 74.14 109.471 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 6.2 mm-40 -59.32 -35.8 74.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 65.51 110.218 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 11.6 ttmm -54.51 -57.69 10.4 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.386 0.612 . . . . 74.54 110.225 174.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.484 HD13 HD12 ' A' ' 123' ' ' ILE . 43.1 mt -69.47 -28.74 66.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.393 -0.821 . . . . 74.51 110.18 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.17 -44.6 79.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 43.32 110.273 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 85.9 mt-30 -73.69 -37.34 65.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.724 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -66.03 -45.26 82.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.028 0.442 . . . . 75.41 111.051 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -100.18 5.04 44.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.612 0.597 . . . . 75.22 112.612 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -53.64 -19.69 4.32 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.806 0.669 . . . . 63.31 112.806 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HG3' ' OD1' ' A' ' 73' ' ' ASN . 10.5 pt-20 -66.98 -28.43 68.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.646 0.26 . . . . 74.02 111.13 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.451 ' OD1' ' HG3' ' A' ' 72' ' ' GLU . 24.3 m120 -131.06 9.49 4.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.536 -0.302 . . . . 60.25 111.22 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 43' ' ' LEU . 39.7 t -136.39 141.2 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.989 0.423 . . . . 74.22 111.574 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -142.1 119.79 11.82 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.838 -0.801 . . . . 71.33 108.838 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -99.61 138.89 22.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.761 0.315 . . . . 73.14 110.388 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 87.6 m-85 -124.55 160.27 28.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.872 -0.604 . . . . 62.14 109.457 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -137.33 120.66 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.252 -1.018 . . . . 62.33 108.252 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.77 132.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.742 -0.663 . . . . 75.13 111.561 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.01 96.32 7.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.613 -0.721 . . . . 60.11 109.471 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 84' ' ' ASN . 10.6 tp -154.21 34.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 122.057 0.932 . . . . 65.23 108.921 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -18.82 1.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.473 -1.24 . . . . 64.21 113.751 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.67 -36.11 38.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.861 0.363 . . . . 63.52 111.167 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.497 ' HB3' HG13 ' A' ' 81' ' ' ILE . 4.6 t-20 -95.97 103.23 15.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 73.53 110.814 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.17 -22.44 55.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 73.43 110.387 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.9 m-20 -51.73 -36.1 45.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.034 -0.53 . . . . 63.32 111.089 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 81' ' ' ILE . 88.0 t -52.85 -37.23 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 71.01 110.712 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.63 -50.95 65.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.066 0.46 . . . . 74.24 110.002 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -62.56 -33.09 74.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.633 -0.712 . . . . 72.42 111.171 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -74.49 -47.22 34.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 52.44 111.229 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.467 ' HB3' HD21 ' A' ' 100' ' ' LEU . 58.8 m-85 -87.07 -7.86 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.354 -0.385 . . . . 63.04 111.59 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 44.26 6.24 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.833 -0.699 . . . . 65.55 113.053 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.12 123.54 39.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.392 -0.596 . . . . 75.31 109.392 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -136.03 6.69 3.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.441 -0.345 . . . . 63.12 111.041 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.24 176.26 11.02 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.641 0.258 . . . . 52.44 110.631 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.736 HG21 ' HB3' ' A' ' 52' ' ' TRP . 1.3 pp -128.13 108.2 19.79 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.179 -0.464 . . . . 75.51 110.997 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -89.47 -162.49 1.88 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.001 -1.25 . . . . 64.14 112.519 -0.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.3 m -146.95 126.29 13.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.578 -0.527 . . . . 74.0 109.578 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 111' ' ' VAL . 48.3 mm -113.25 119.56 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.912 -0.586 . . . . 62.41 111.217 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 48' ' ' PHE . 9.1 mp -100.85 149.85 23.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 72.51 109.328 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.51 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 24.6 mtt -115.69 146.67 41.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 65.12 110.631 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -143.93 150.73 38.8 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.253 -1.017 . . . . 73.14 108.253 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -149.28 120.65 7.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.613 -0.435 . . . . 74.24 110.942 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.642 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 5.7 t30 61.85 27.09 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.486 0.66 . . . . 72.22 109.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.89 -3.39 70.38 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.45 -0.796 . . . . 43.11 112.27 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -90.73 147.35 23.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.884 -0.413 . . . . 63.04 109.884 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.48 135.49 51.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.487 0.66 . . . . 71.43 110.845 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 0.7 OUTLIER -135.76 168.19 19.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.719 -1.128 . . . . 61.41 108.947 -172.474 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.17 166.95 18.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.624 0.726 . . . . 72.41 111.964 -165.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.68 128.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.209 -0.905 . . . . 74.54 110.042 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 99' ' ' ILE . 15.7 m -113.14 109.41 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.633 0.73 . . . . 70.11 109.728 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.18 122.93 49.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.888 . . . . 62.14 110.198 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.75 -163.72 14.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.173 -0.537 . . . . 60.32 111.792 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.26 72.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.007 0.432 . . . . 33.13 110.697 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.6 t70 -125.03 92.37 3.63 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.745 -0.661 . . . . 64.24 109.348 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.84 -28.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 62.15 110.758 -173.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.5 t -64.7 -45.8 85.07 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.041 -0.527 . . . . 72.2 109.93 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -67.96 -38.51 82.86 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.872 -0.603 . . . . 55.14 109.946 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.5 mt -60.25 -56.21 19.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.848 -0.615 . . . . 62.22 110.514 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.46 -39.46 82.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 120.762 0.315 . . . . 72.14 110.165 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -54.41 -52.16 62.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.928 -0.578 . . . . 43.12 110.252 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.88 -32.5 70.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.357 -0.383 . . . . 73.04 111.278 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 119' ' ' ILE . 96.7 mt -57.64 -56.2 16.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 120.59 -0.444 . . . . 73.41 110.112 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -68.42 -32.94 73.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.499 -0.481 . . . . 70.22 110.039 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.73 -29.25 69.19 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.696 -0.684 . . . . 72.2 110.991 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.498 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.2 m-20 -98.11 -20.83 17.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.436 -0.347 . . . . 71.2 111.82 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.9 mt -74.48 -47.64 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.768 -0.456 . . . . 54.51 109.768 172.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.697 -0.683 . . . . 71.43 109.579 177.828 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.443 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 81.8 mmm . . . . . 0 N--CA 1.469 0.476 0 CA-C-O 120.651 0.262 . . . . 71.32 111.444 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.464 HG21 ' HE2' ' A' ' 78' ' ' LYS . 13.2 mm -93.96 119.94 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.476 . . . . 62.2 109.716 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 31.0 tt0 -86.82 118.45 26.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.904 0.383 . . . . 70.14 110.601 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -80.72 137.77 36.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.222 -0.445 . . . . 71.41 110.339 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.507 HG21 ' HG3' ' A' ' 34' ' ' LYS . 42.0 pt -139.53 154.51 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.562 0.22 . . . . 73.54 110.991 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.66 176.53 28.72 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.3 -0.476 . . . . 75.43 112.716 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.06 -55.1 5.92 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.367 0.667 . . . . 65.03 112.177 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 t -70.39 -34.54 72.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.941 0.401 . . . . 74.42 110.673 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.22 -24.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 75.54 111.326 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.9 t80 -49.61 -56.96 8.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 65.25 110.473 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.25 -55.2 30.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.507 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -52.54 -46.37 66.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.431 -0.804 . . . . 43.22 111.405 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.2 mmtt -77.17 -24.28 51.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.394 -0.821 . . . . 63.34 111.56 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.7 t -79.18 -33.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.841 -0.429 . . . . 74.14 109.841 174.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.2 p -79.58 -19.64 48.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.974 0.416 . . . . 53.41 110.479 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -61.7 -23.38 66.08 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.863 -0.608 . . . . 74.54 111.722 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.4 p -74.78 91.46 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 55.23 110.572 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -69.98 -61.71 1.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 72.42 111.511 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' ILE . 5.8 m-20 -123.62 120.87 34.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.483 0.182 . . . . 63.42 110.511 -172.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 51.04 3.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.1 1.519 . . . . 72.45 115.1 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.5 mm -63.92 124.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 118.134 0.424 . . . . 70.51 110.824 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -88.65 110.45 20.96 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.876 -0.787 . . . . 72.33 108.876 177.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 101' ' ' MET . 70.8 mt -90.82 118.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 72.45 110.734 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.477 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -107.56 109.08 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.41 -0.589 . . . . 73.21 109.41 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 57.3 t -92.59 106.86 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.046 -0.353 . . . . 72.45 110.046 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.505 ' HA ' HD13 ' A' ' 99' ' ' ILE . 11.7 t70 -85.74 133.05 34.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.919 -0.582 . . . . 62.13 111.894 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -94.51 95.23 8.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.71 -0.677 . . . . 65.22 109.659 172.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.418 ' HZ3' ' HG3' ' A' ' 82' ' ' GLU . 52.4 t90 -66.32 136.26 55.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.48 -0.782 . . . . 74.34 111.634 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.52 127.25 25.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.547 -0.752 . . . . 54.33 109.192 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.85 -64.8 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.736 2.291 . . . . 64.33 112.498 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -95.94 116.8 29.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.128 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.9 t -158.36 158.65 34.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.284 -0.416 . . . . 63.3 110.58 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.57 -83.56 1.45 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 116.01 -0.541 . . . . 43.4 112.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.49 -25.45 74.03 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.9 2.4 . . . . 54.22 112.768 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 67.5 m -51.01 -37.26 44.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 71.35 111.49 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -62.89 -33.41 75.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.703 0.287 . . . . 74.44 110.914 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.536 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 10.6 m -74.96 -40.53 60.71 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.865 0.84 . . . . 70.35 110.112 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -65.81 -29.58 70.08 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.169 -0.923 . . . . 64.1 111.457 -176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.1 mt-10 -56.78 -60.92 7.96 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.737 -0.385 . . . . 65.12 110.692 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.4 Cg_endo -64.33 -33.16 59.91 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.662 1.575 . . . . 64.23 111.898 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 58' ' ' SER . 54.3 mt-30 -62.62 -38.43 90.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.335 -0.546 . . . . 75.21 110.63 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.448 HD21 HD13 ' A' ' 119' ' ' ILE . 77.5 mt -72.5 -43.34 63.77 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.127 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.8 mt-10 -60.56 -32.43 71.51 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.127 -0.488 . . . . 65.51 110.395 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 65' ' ' LYS . 33.4 ttmt -66.78 -56.82 8.77 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.025 -0.534 . . . . 74.54 110.599 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 116' ' ' ILE . 63.6 mt -58.19 -32.05 67.88 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.917 -0.583 . . . . 74.51 109.451 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.22 -52.62 53.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.669 -0.696 . . . . 43.32 110.127 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.2 mt-30 -53.37 -41.56 65.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.78 0.324 . . . . 74.13 110.806 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -74.94 -44.41 48.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.16 -0.473 . . . . 75.41 111.63 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -101.49 4.82 41.56 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.602 0.593 . . . . 75.22 112.602 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.0 t -53.31 -23.96 10.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.898 0.703 . . . . 63.31 112.898 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.04 -18.88 60.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 74.02 111.141 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -130.94 7.7 4.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.975 -0.557 . . . . 60.25 110.567 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 43' ' ' LEU . 21.5 t -141.15 139.95 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.81 0.338 . . . . 74.22 111.329 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 4.7 tppp? -142.29 128.12 19.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.85 -0.614 . . . . 71.33 109.587 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.7 mt -107.89 137.78 37.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.788 -0.449 . . . . 73.14 109.788 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CZ ' ' HG2' ' A' ' 75' ' ' LYS . 51.1 m-85 -120.77 147.03 45.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.782 0.325 . . . . 62.14 111.371 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE2' HG21 ' A' ' 23' ' ' ILE . 59.7 mttm -120.69 105.45 10.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.893 -0.78 . . . . 62.33 108.893 169.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mt -71.29 107.56 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.769 -0.456 . . . . 75.13 109.769 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.22 68.78 5.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.653 0.739 . . . . 60.11 111.846 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.7 pt -120.84 55.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.197 -1.408 . . . . 65.23 107.197 167.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' HZ3' ' A' ' 49' ' ' TRP . 36.5 tt0 -49.74 -32.67 14.16 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.137 -1.847 . . . . 64.21 113.202 -168.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 -2.9 58.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.209 0.448 . . . . 63.52 112.209 -174.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.47 78.86 1.4 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 73.53 111.046 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.74 -24.34 62.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.988 -0.551 . . . . 73.43 110.388 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.33 -35.04 25.96 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.411 -0.813 . . . . 63.32 111.447 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.54 -39.16 44.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.828 -0.624 . . . . 71.01 110.828 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.14 77.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.8 -0.636 . . . . 74.24 110.49 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.1 m -67.52 -34.17 76.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.596 . . . . 72.42 110.962 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.59 -38.93 92.69 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.79 0.329 . . . . 52.44 111.137 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -95.39 -6.63 40.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.554 -0.294 . . . . 63.04 111.624 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.85 59.56 2.07 Favored Glycine 0 C--O 1.236 0.235 0 C-N-CA 120.96 -0.638 . . . . 65.55 113.215 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.555 HG13 ' OG1' ' A' ' 98' ' ' THR . 81.4 t -89.22 117.75 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.843 0.354 . . . . 75.31 110.116 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.8 m -95.58 -38.14 10.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 63.12 110.91 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 155.23 50.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 52.44 110.46 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.86 132.28 24.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.209 -0.451 . . . . 75.51 111.08 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -91.15 -165.32 2.27 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 123.964 -1.265 . . . . 64.14 111.923 -4.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.555 ' OG1' HG13 ' A' ' 93' ' ' VAL . 54.9 m -143.3 141.2 30.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.23 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 47' ' ' ASP . 46.2 mm -120.76 113.98 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.971 -0.559 . . . . 62.41 110.794 -175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.493 HD23 ' HG3' ' A' ' 110' ' ' GLN . 47.4 mt -90.95 123.41 34.42 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.357 -0.609 . . . . 72.51 109.357 171.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 38.7 mtt -96.73 143.78 27.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.662 -0.415 . . . . 65.12 110.922 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.65 154.83 45.61 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.412 -0.588 . . . . 73.14 109.412 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -156.68 120.59 4.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.261 -0.176 . . . . 74.24 110.972 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.492 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 60.56 25.91 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.832 0.825 . . . . 72.22 110.182 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.66 -8.21 73.26 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.396 -0.82 . . . . 43.11 112.514 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -86.86 147.78 25.65 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.973 -0.38 . . . . 63.04 109.973 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -72.68 127.98 34.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.629 0.728 . . . . 71.43 110.844 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD12 ' OD1' ' A' ' 126' ' ' ASN . 3.9 mm? -119.72 168.71 10.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.48 -1.236 . . . . 61.41 109.315 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -178.91 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.254 0.55 . . . . 72.41 112.257 -162.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.493 ' HG3' HD23 ' A' ' 100' ' ' LEU . 47.0 tt0 -138.3 143.8 40.15 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 122.014 0.911 . . . . 74.54 111.205 -172.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 74.0 t -126.26 118.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.566 -1.652 . . . . 70.11 109.67 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.48 123.28 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.127 -0.323 . . . . 62.14 110.127 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.39 139.81 10.22 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.71 -0.556 . . . . 60.32 111.71 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.97 80.22 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 33.13 111.429 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 119' ' ' ILE . 22.2 t0 -123.37 102.45 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 64.24 110.162 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 66' ' ' LEU . 9.1 tp -60.06 -31.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 62.15 110.634 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.9 t -61.64 -56.63 17.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.395 -0.366 . . . . 72.2 110.181 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.29 -45.26 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 55.14 110.699 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.1 mt -61.2 -56.37 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.144 -0.48 . . . . 62.22 111.35 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.75 85.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.091 0.472 . . . . 72.14 110.222 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 t -60.65 -48.16 83.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 43.12 109.591 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.69 -35.46 78.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.81 -0.632 . . . . 73.04 111.111 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 127' ' ' ILE . 93.4 mt -56.46 -55.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.199 -0.667 . . . . 73.41 109.199 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -63.86 -35.69 81.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 70.22 110.919 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.85 -46.61 88.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.873 0.368 . . . . 72.2 111.041 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.496 ' HB2' HD11 ' A' ' 43' ' ' LEU . 56.1 m-80 -91.21 -5.19 55.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 71.2 111.507 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 123' ' ' ILE . 60.5 mt -78.82 -47.22 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.757 -0.46 . . . . 54.51 109.757 167.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.464 -0.779 . . . . 71.43 110.539 -177.141 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.469 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 89.5 mmm . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.724 0.297 . . . . 71.32 111.016 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 22.0 mm -85.39 111.47 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 62.2 109.491 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -85.24 112.02 20.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.9 -0.591 . . . . 70.14 110.806 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -83.61 134.86 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.698 -0.482 . . . . 71.41 109.698 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.4 pt -132.4 167.72 25.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 120.994 0.426 . . . . 73.54 111.492 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 178.96 32.45 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.579 -0.737 . . . . 75.43 112.464 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.86 -55.43 35.03 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.059 0.543 . . . . 65.03 112.026 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 t -68.82 -2.7 10.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.227 -0.442 . . . . 74.42 111.888 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.11 -9.88 25.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.565 0.209 . . . . 75.54 111.565 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.73 -62.08 1.93 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.82 0.343 . . . . 65.25 110.761 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.55 -49.27 70.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.927 -0.579 . . . . 73.42 110.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.2 -53.68 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.361 -0.836 . . . . 43.22 111.05 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -63.77 -40.11 95.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.035 -0.529 . . . . 63.34 111.127 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HA ' HD13 ' A' ' 44' ' ' ILE . 80.0 t -71.29 -40.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.104 0.409 . . . . 74.14 112.104 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 p -86.06 -29.39 23.44 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.295 0.48 . . . . 53.41 112.295 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.7 t -82.37 10.39 7.15 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.341 0.497 . . . . 74.54 112.341 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.761 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.6 p -66.57 142.69 57.41 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.252 -0.28 . . . . 55.23 110.351 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.08 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.339 0.399 . . . . 72.42 112.06 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.29 128.85 17.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.37 -0.233 . . . . 63.42 110.37 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 55.92 11.41 0.71 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.477 0.547 . . . . 72.45 112.477 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 37.6 mm -62.87 131.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.671 0.272 . . . . 70.51 110.787 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.52 110.95 21.74 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.335 0.588 . . . . 72.33 109.544 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 38' ' ' CYS . 73.0 mt -100.32 114.19 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 72.45 110.659 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.61 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -99.68 128.45 45.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.394 -0.595 . . . . 73.21 109.394 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 85.6 t -107.42 110.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.738 0.304 . . . . 72.45 110.366 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.489 ' HA ' HD13 ' A' ' 99' ' ' ILE . 4.2 t70 -85.58 134.49 34.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.847 -0.615 . . . . 62.13 110.985 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -97.96 119.81 37.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.172 -0.467 . . . . 65.22 109.862 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.2 t90 -54.57 108.87 0.43 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.453 -0.794 . . . . 74.34 111.786 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.6 112.41 39.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.785 -0.643 . . . . 54.33 109.902 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.41 -68.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.765 2.31 . . . . 64.33 112.556 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -114.14 110.16 19.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.0 -0.37 . . . . 73.15 110.0 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.6 t -163.55 135.96 5.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.19 -0.459 . . . . 63.3 110.142 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.09 -76.78 0.59 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.227 -0.511 . . . . 43.4 112.599 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.23 -29.31 56.32 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.983 2.455 . . . . 54.22 112.928 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 78.8 m -55.48 -31.37 61.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.152 -0.476 . . . . 71.35 112.173 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 7.0 ptp85 -69.06 -30.42 68.75 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.997 -0.281 . . . . 74.44 110.404 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.5 m -74.94 -29.34 60.91 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.295 0.569 . . . . 70.35 109.798 174.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -66.64 -29.09 69.03 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.871 -0.604 . . . . 64.1 111.126 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 48.3 mt-10 -57.99 -57.74 23.67 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.93 -0.308 . . . . 65.12 110.588 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 36.5 Cg_endo -66.57 -31.41 41.31 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.113 1.875 . . . . 64.23 112.641 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.9 mt-30 -62.99 -41.67 99.64 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 120.428 -0.509 . . . . 75.21 110.286 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 67.9 mt -65.62 -34.96 79.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 74.14 109.66 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.56 -37.22 86.47 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.128 -0.487 . . . . 65.51 110.505 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 1.4 tpmt? -58.35 -56.4 22.63 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.213 0.53 . . . . 74.54 109.809 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.468 HD13 HD12 ' A' ' 123' ' ' ILE . 19.1 mt -63.51 -36.43 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.467 -0.788 . . . . 74.51 110.079 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.28 -53.74 44.22 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.125 -0.489 . . . . 43.32 110.176 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 98.2 mt-30 -55.35 -42.41 73.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.746 0.308 . . . . 74.13 110.909 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -72.84 -41.51 64.76 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.398 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -104.87 4.8 32.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.193 0.812 . . . . 75.22 113.193 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.0 t -53.5 -20.02 4.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.997 1.11 . . . . 63.31 113.997 -168.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.97 -18.77 61.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.323 . . . . 74.02 111.052 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -123.16 -25.77 4.45 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.954 -0.567 . . . . 60.25 110.5 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 45' ' ' LEU . 49.5 t -109.02 134.77 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.033 0.444 . . . . 74.22 111.766 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -138.21 127.36 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 71.33 109.284 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.61 HG12 ' HB2' ' A' ' 45' ' ' LEU . 41.1 mt -108.71 123.47 64.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.263 -0.273 . . . . 73.14 110.263 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 88.1 m-85 -107.54 131.9 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.371 -0.377 . . . . 62.14 111.025 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 58.9 mttm -97.22 99.86 11.33 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.327 -0.62 . . . . 62.33 109.327 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.3 mt -81.75 83.18 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.452 0.644 . . . . 75.13 109.338 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.64 78.02 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.759 -0.655 . . . . 60.11 110.712 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.4 pt -112.68 64.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.405 -0.816 . . . . 65.23 109.337 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.39 -32.46 38.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.41 -1.268 . . . . 64.21 112.542 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.54 -15.58 62.29 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.976 0.417 . . . . 63.52 111.367 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -105.53 76.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 73.53 110.573 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -62.94 -33.17 74.78 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.933 -0.576 . . . . 73.43 110.7 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.8 m-20 -51.55 -32.14 27.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.825 -0.625 . . . . 63.32 111.651 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -55.89 -39.64 58.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.37 . . . . 71.01 110.679 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.64 96.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 74.24 109.918 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.7 m -64.57 -39.24 93.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.551 -0.75 . . . . 72.42 110.744 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.5 mm100 -63.27 -52.21 62.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.176 -0.466 . . . . 52.44 110.727 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -81.52 -11.78 59.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.989 -0.55 . . . . 63.04 111.16 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.71 44.81 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.271 -0.49 . . . . 65.55 112.507 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.478 HG13 ' OG1' ' A' ' 98' ' ' THR . 87.9 t -60.14 112.83 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.137 0.494 . . . . 75.31 110.09 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 m -87.06 -44.9 11.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.495 -0.775 . . . . 63.12 111.561 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.93 163.5 32.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.438 -0.346 . . . . 52.44 110.445 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 25.7 pt -101.45 133.06 21.1 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 75.51 110.64 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 66.4 Cg_endo -90.21 -178.02 11.13 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.77 -1.346 . . . . 64.14 111.967 -3.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.478 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.2 m -136.24 130.9 33.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.328 -0.397 . . . . 74.0 110.008 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 47' ' ' ASP . 44.2 mm -119.46 115.88 49.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.604 -0.725 . . . . 62.41 110.264 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 19.8 mt -88.14 158.66 18.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.345 -0.613 . . . . 72.51 109.345 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 31.7 mtt -123.55 141.76 51.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 65.12 109.728 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -140.95 154.36 46.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.074 -0.713 . . . . 73.14 109.074 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.5 ttmm -150.47 110.52 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.042 -0.263 . . . . 74.24 110.542 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.761 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.7 t30 64.03 25.27 13.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.598 0.714 . . . . 72.22 110.3 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.76 -16.47 41.19 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.767 -0.651 . . . . 43.11 111.925 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 34.5 ttpt -75.12 145.29 42.35 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.805 0.442 . . . . 63.04 110.092 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -64.07 148.33 50.08 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.317 0.579 . . . . 71.43 110.849 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.49 168.18 26.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.872 -1.158 . . . . 61.41 107.872 -170.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 m -69.86 -177.99 1.43 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.0 0.741 . . . . 72.41 113.0 -164.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 51.7 tt0 -149.15 146.29 27.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.767 0.794 . . . . 74.54 110.7 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.19 119.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 113.93 -1.487 . . . . 70.11 109.542 -173.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.1 mt -113.34 123.96 69.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.144 -0.317 . . . . 62.14 110.144 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.31 152.36 24.39 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.605 -0.598 . . . . 60.32 111.605 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 72.38 4.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.85 0.357 . . . . 33.13 111.185 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 119' ' ' ILE . 8.5 t70 -115.59 88.1 2.81 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.293 0.568 . . . . 64.24 109.516 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 66' ' ' LEU . 10.1 tp -59.14 -33.09 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.502 -0.772 . . . . 62.15 111.289 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.3 m -61.2 -49.52 76.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.011 0.434 . . . . 72.2 110.518 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -60.32 -44.13 95.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.038 -0.528 . . . . 55.14 110.077 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 115' ' ' ASP . 66.7 mt -58.21 -56.54 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 62.22 111.317 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.03 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.001 0.429 . . . . 72.14 110.583 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 t -59.09 -52.14 67.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.773 -0.649 . . . . 43.12 110.362 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.94 -34.66 77.02 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.52 -0.309 . . . . 73.04 111.136 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.562 ' O ' HG13 ' A' ' 127' ' ' ILE . 81.7 mt -55.75 -56.57 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.514 -0.55 . . . . 73.41 109.514 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -63.37 -37.05 85.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.05 -0.523 . . . . 70.22 110.526 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.74 -36.15 78.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 72.2 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -103.26 -1.13 29.33 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.43 0.53 . . . . 71.2 112.43 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 123' ' ' ILE . 82.5 mt -84.8 -60.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 54.51 110.419 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.577 -0.738 . . . . 71.43 110.705 -172.989 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 75.9 mmm . . . . . 0 C--O 1.24 0.571 0 CA-C-O 120.818 0.342 . . . . 71.32 110.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.55 HG21 ' HE2' ' A' ' 78' ' ' LYS . 5.6 mm -66.83 108.86 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.824 -0.625 . . . . 62.2 110.094 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 10.4 tp10 -88.9 134.96 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.234 -0.284 . . . . 70.14 110.234 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -96.18 119.06 33.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 71.41 110.464 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.475 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.8 pt -134.58 160.97 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.294 -0.412 . . . . 73.54 111.305 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.51 -170.68 27.98 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 116.095 -0.502 . . . . 75.43 112.301 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.9 -50.37 73.68 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.002 0.43 . . . . 65.03 111.281 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -61.0 -21.21 63.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.979 -0.555 . . . . 74.42 111.319 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.464 ' CB ' ' HB ' ' A' ' 26' ' ' ILE . 5.8 mm-40 -88.8 -14.08 37.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 75.54 111.657 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -57.34 -62.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 65.25 110.837 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.92 -50.57 72.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.089 0.471 . . . . 73.42 110.263 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -50.74 -57.44 8.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.284 -0.871 . . . . 43.22 111.593 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 26' ' ' ILE . 49.1 mmtm -75.39 -28.9 59.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.98 -0.554 . . . . 63.34 111.757 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.478 ' HA ' HD13 ' A' ' 44' ' ' ILE . 51.5 t -70.6 -37.51 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 121.1 -0.24 . . . . 74.14 111.292 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -86.44 -30.41 22.08 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.085 0.402 . . . . 53.41 112.085 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -74.33 7.44 2.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.043 0.386 . . . . 74.54 112.043 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 29.4 p -67.78 162.51 23.76 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.161 -0.311 . . . . 55.23 110.161 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -73.66 -82.71 0.05 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.637 0.256 . . . . 72.42 111.052 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -160.87 138.48 9.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.882 -0.414 . . . . 63.42 109.882 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 59.2 t30 62.09 1.99 0.75 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.97 0.508 . . . . 72.45 111.606 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -63.82 110.15 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.377 -0.374 . . . . 70.51 111.116 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HG22 ' A' ' 74' ' ' VAL . 55.4 tp -76.27 114.41 14.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.174 -0.676 . . . . 72.33 109.174 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 38' ' ' CYS . 77.8 mt -99.86 110.46 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.989 -1.005 . . . . 72.45 110.492 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.676 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.9 mp -93.45 121.51 34.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 73.21 109.436 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 60.2 t -103.31 105.48 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.401 -0.592 . . . . 72.45 109.401 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' HD13 ' A' ' 99' ' ' ILE . 27.2 t70 -83.63 129.37 34.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.872 0.368 . . . . 62.13 111.446 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.95 114.09 25.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.142 -1.059 . . . . 65.22 108.142 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.63 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 3.1 t90 -77.75 -42.26 34.76 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.486 0.491 . . . . 74.34 111.883 -164.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB2' HG21 ' A' ' 96' ' ' ILE . . . 69.92 134.61 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.805 0.691 . . . . 54.33 110.964 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.75 -31.35 94.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.508 2.139 . . . . 64.33 111.4 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -127.82 136.32 51.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.543 -0.753 . . . . 73.15 109.014 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 5.2 p -146.64 -82.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.348 -0.141 . . . . 63.3 111.245 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . 108.86 -85.83 0.42 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.072 -0.585 . . . . 43.4 111.662 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 53' ' ' CYS . 19.4 Cg_endo -58.13 -9.83 7.05 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.916 2.411 . . . . 54.22 112.259 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.73 -37.52 63.42 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.004 -0.544 . . . . 71.35 110.676 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 14.2 ptm180 -56.88 -34.25 67.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.145 -0.48 . . . . 74.44 111.151 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.5 m -75.84 -54.86 6.27 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.8 0.81 . . . . 70.35 111.04 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -64.51 -41.99 96.08 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.188 -0.915 . . . . 64.1 113.222 -169.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.77 -53.92 60.67 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 117.962 0.346 . . . . 65.12 111.301 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.86 -27.88 58.98 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.678 1.585 . . . . 64.23 112.3 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.0 mt-30 -65.07 -38.82 92.04 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.426 -0.51 . . . . 75.21 110.069 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 95.8 mt -69.01 -40.04 78.92 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 74.14 109.499 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 5.7 mm-40 -53.85 -49.18 69.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.493 -0.776 . . . . 65.51 110.18 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -54.59 -52.39 62.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.711 -0.677 . . . . 74.54 110.775 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.473 HD13 HD12 ' A' ' 123' ' ' ILE . 52.0 mt -65.02 -33.38 75.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 74.51 110.103 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -72.53 -14.91 61.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.46 . . . . 43.32 110.969 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.4 mt-30 -93.69 -39.22 10.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.882 0.373 . . . . 74.13 110.666 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -69.59 -34.01 73.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.542 0.687 . . . . 75.41 110.301 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.87 6.29 33.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.039 -0.982 . . . . 75.22 111.533 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.1 t -52.97 -22.15 5.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.634 0.975 . . . . 63.31 113.634 -168.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -78.66 -23.04 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 74.02 111.166 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.19 5.59 6.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.132 -0.486 . . . . 60.25 111.483 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.547 HG22 ' HB3' ' A' ' 43' ' ' LEU . 65.6 t -139.81 145.1 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.695 0.283 . . . . 74.22 111.578 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 28.5 tptp -148.77 127.86 12.8 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.649 -0.5 . . . . 71.33 109.649 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.9 mt -103.14 145.17 12.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.006 0.432 . . . . 73.14 111.052 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 98.4 m-85 -126.87 167.84 15.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.73 -0.668 . . . . 62.14 110.147 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 9.7 tppt? -136.49 108.52 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.273 -1.01 . . . . 62.33 108.273 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.754 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -75.65 128.29 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 75.13 110.347 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -90.6 21.31 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.443 0.64 . . . . 60.11 110.503 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 pt -94.55 32.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.427 0.632 . . . . 65.23 109.834 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.31 -18.58 50.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.822 -1.081 . . . . 64.21 111.59 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -89.29 5.99 42.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 63.52 111.623 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.413 ' ND2' HG23 ' A' ' 87' ' ' VAL . 49.9 t30 -116.43 89.06 3.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.963 0.411 . . . . 73.53 110.307 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -67.88 -21.77 65.13 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 73.43 111.521 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -50.13 -45.8 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.398 . . . . 63.32 110.547 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.413 HG23 ' ND2' ' A' ' 84' ' ' ASN . 74.0 t -60.35 -34.48 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.795 -0.639 . . . . 71.01 110.525 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.28 -51.5 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.041 0.448 . . . . 74.24 110.058 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -61.87 -42.23 98.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 72.42 110.914 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.89 -50.31 71.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.121 -0.491 . . . . 52.44 111.07 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.06 -4.69 58.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.398 -0.365 . . . . 63.04 111.493 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.72 34.86 37.7 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.202 -0.523 . . . . 65.55 113.53 170.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.526 HG13 ' OG1' ' A' ' 98' ' ' THR . 83.9 t -68.29 130.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 75.31 110.361 176.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.4 m -129.82 -71.3 0.61 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 63.12 110.083 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.64 136.18 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 110.027 -0.36 . . . . 52.44 110.027 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 50' ' ' ALA . 2.2 pp -113.71 151.22 44.45 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.421 -0.354 . . . . 75.51 111.335 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.08 160.81 91.24 Favored 'Cis proline' 0 C--N 1.353 0.815 0 C-N-CA 124.079 -1.217 . . . . 64.14 112.365 -0.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.529 HG23 HG12 ' A' ' 112' ' ' ILE . 92.3 m -119.74 129.91 54.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 74.0 109.871 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 111' ' ' VAL . 45.8 mm -110.16 113.48 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 62.41 110.899 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 38.0 mt -91.04 152.46 20.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.553 -0.906 . . . . 72.51 108.553 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.426 ' HB3' HD11 ' A' ' 43' ' ' LEU . 36.9 mtt -124.12 141.38 52.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.883 0.31 . . . . 65.12 110.309 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.524 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 99.4 m-85 -143.94 154.94 43.83 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.851 -0.796 . . . . 73.14 108.851 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -144.19 104.86 4.16 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.683 -0.407 . . . . 74.24 111.04 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.682 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 7.9 t30 55.41 32.82 19.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.561 0.696 . . . . 72.22 110.627 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.0 -16.48 59.42 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.736 -0.666 . . . . 43.11 112.587 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -71.79 140.74 49.57 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 110.157 -0.312 . . . . 63.04 110.157 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.556 ' O ' HD22 ' A' ' 108' ' ' LEU . 12.2 mmmm -68.42 134.42 50.17 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.281 0.562 . . . . 71.43 110.961 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.556 HD22 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -139.0 168.84 18.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.44 -1.254 . . . . 61.41 109.057 -170.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -69.81 -178.62 1.57 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.252 0.834 . . . . 72.41 113.252 -163.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.428 ' HG3' HD23 ' A' ' 100' ' ' LEU . 48.4 tt0 -148.76 122.46 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.092 -0.958 . . . . 74.54 109.689 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.505 HG23 ' HB ' ' A' ' 99' ' ' ILE . 19.4 m -113.9 130.16 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.177 0.513 . . . . 70.11 110.028 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.529 HG12 HG23 ' A' ' 98' ' ' THR . 58.0 mt -116.08 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 62.14 109.711 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.2 148.08 14.4 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.896 -0.482 . . . . 60.32 111.896 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.61 72.12 6.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.825 0.345 . . . . 33.13 111.174 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.4 t70 -122.76 91.94 3.6 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.349 -0.612 . . . . 64.24 109.349 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -59.33 -30.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 62.15 111.207 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.0 t -63.49 -49.22 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 72.2 110.071 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.47 -43.05 99.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.801 -0.444 . . . . 55.14 109.801 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 123' ' ' ILE . 70.9 mt -57.73 -56.27 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.718 -0.674 . . . . 62.22 111.104 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.19 -39.4 82.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 120.675 0.274 . . . . 72.14 110.436 -177.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.9 m -54.78 -52.0 63.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.794 -0.447 . . . . 43.12 109.794 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 25.1 mm-40 -67.64 -32.19 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 73.04 111.478 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.7 mt -60.2 -56.18 19.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.383 -0.527 . . . . 73.41 109.918 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -68.01 -28.3 67.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.52 -0.472 . . . . 70.22 109.89 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 23.7 t-20 -65.09 -44.49 88.68 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.664 -0.698 . . . . 72.2 111.403 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -91.32 -8.78 47.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.548 -0.296 . . . . 71.2 111.628 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.8 mt -76.44 -50.36 22.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.159 0.504 . . . . 54.51 109.645 167.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.401 -0.809 . . . . 71.43 109.667 -176.482 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.452 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 94.3 mmm . . . . . 0 C--O 1.238 0.474 0 CA-C-O 120.825 0.345 . . . . 71.32 110.507 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.751 HG22 ' HG3' ' A' ' 78' ' ' LYS . 3.3 mm -68.76 101.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.234 -0.654 . . . . 62.2 109.234 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 40.5 tt0 -90.65 127.2 36.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.888 -0.596 . . . . 70.14 111.532 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -85.51 128.53 34.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.799 0.333 . . . . 71.41 110.436 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.34 164.79 32.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.492 -0.322 . . . . 73.54 111.031 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 -178.56 38.96 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.825 -0.625 . . . . 75.43 112.404 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.36 -43.4 94.66 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.004 0.43 . . . . 65.03 110.995 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -64.99 -36.16 83.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 74.42 110.539 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -74.09 -17.45 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 75.54 111.859 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -52.93 -62.31 1.73 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.633 0.254 . . . . 65.25 111.22 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 36' ' ' THR . 24.7 t70 -64.38 -45.99 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.02 0.438 . . . . 73.42 110.686 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -56.63 -57.16 13.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.331 -0.85 . . . . 43.22 110.701 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HE3' ' CE2' ' A' ' 77' ' ' TYR . 24.1 mmmt -65.28 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.698 -0.683 . . . . 63.34 110.885 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.63 -51.72 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.667 0.27 . . . . 74.14 111.143 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 32' ' ' ASP . 8.9 t -86.01 -10.71 54.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.829 0.307 . . . . 53.41 111.829 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -72.81 -12.59 61.05 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.923 0.342 . . . . 74.54 111.923 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.693 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 15.5 p -55.13 143.59 26.79 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.591 0.234 . . . . 55.23 111.488 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -54.56 -79.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.067 -0.515 . . . . 72.42 111.588 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' H ' HG12 ' A' ' 42' ' ' ILE . 33.8 t70 -159.33 125.8 4.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.473 0.178 . . . . 63.42 110.793 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 59.21 15.33 4.13 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.885 0.474 . . . . 72.45 111.418 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.693 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -76.32 118.71 23.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.309 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 74' ' ' VAL . 63.7 tp -74.46 122.03 22.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.945 -0.57 . . . . 72.33 110.424 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 38' ' ' CYS . 37.6 mt -110.77 121.91 64.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.661 -0.7 . . . . 72.45 110.295 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 4.4 mp -104.79 112.59 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.243 -0.651 . . . . 73.21 109.243 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -93.95 104.67 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.944 -0.391 . . . . 72.45 109.944 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.21 146.65 30.37 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.982 -0.554 . . . . 62.13 110.916 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -107.89 129.04 55.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 65.22 109.819 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.41 140.52 45.39 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 74.34 111.576 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB1' HD12 ' A' ' 96' ' ' ILE . . . -99.33 107.94 47.54 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 54.33 110.922 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -52.46 -52.46 8.84 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.746 2.297 . . . . 64.33 111.471 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.576 ' HB2' HD11 ' A' ' 96' ' ' ILE . 45.3 m95 -80.15 75.85 6.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.407 -0.96 . . . . 73.15 108.407 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.445 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 7.6 t -75.65 79.19 2.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.502 -0.772 . . . . 63.3 110.27 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -108.57 -74.04 0.82 Allowed Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.5 -0.773 . . . . 43.4 111.432 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.88 -18.95 59.83 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.732 2.288 . . . . 54.22 111.612 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 27.8 p -52.13 -34.43 44.41 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.516 -0.765 . . . . 71.35 110.379 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -53.8 -49.37 68.47 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.948 -0.569 . . . . 74.44 111.083 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.623 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 48.0 m -75.24 -42.8 54.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.072 0.463 . . . . 70.35 111.526 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.7 -37.83 88.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.815 0.672 . . . . 64.1 112.815 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 58.5 mm-40 -55.81 -58.84 13.67 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 117.967 0.349 . . . . 65.12 110.736 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 36.4 Cg_endo -65.29 -27.53 55.71 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.938 1.759 . . . . 64.23 112.372 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.2 mt-30 -68.32 -40.62 81.61 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.698 -0.401 . . . . 75.21 110.71 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.99 -43.03 84.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.633 -0.506 . . . . 74.14 109.633 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 2.9 mm-40 -52.73 -47.14 67.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.722 -0.672 . . . . 65.51 110.131 174.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -52.29 -57.08 10.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.824 -0.626 . . . . 74.54 110.837 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.46 HD13 HD12 ' A' ' 123' ' ' ILE . 31.4 mt -65.78 -31.36 72.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.676 -0.693 . . . . 74.51 110.379 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.53 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -68.46 -44.2 75.36 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.873 -0.603 . . . . 43.32 110.223 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.0 mt-30 -71.38 -37.52 71.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.271 0.558 . . . . 74.13 110.581 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -73.4 -37.34 65.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.719 -0.673 . . . . 75.41 111.122 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.96 5.25 32.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.121 -0.491 . . . . 75.22 112.166 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.7 t -52.86 -21.17 3.92 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.135 0.791 . . . . 63.31 113.135 -171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.66 -28.27 69.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 74.02 110.472 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.14 8.37 3.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.2 -0.454 . . . . 60.25 111.765 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 43' ' ' LEU . 64.9 t -134.41 141.9 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.053 0.454 . . . . 74.22 112.068 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 57.0 tptt -145.17 126.09 14.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.429 -0.805 . . . . 71.33 109.31 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 45' ' ' LEU . 36.0 mt -108.31 140.25 27.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.742 0.306 . . . . 73.14 110.542 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 86.2 m-85 -121.39 170.5 9.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 62.14 109.712 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.751 ' HG3' HG22 ' A' ' 23' ' ' ILE . 28.8 mtpp -136.12 128.5 30.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.63 -0.507 . . . . 62.33 109.63 173.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.67 67.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.661 -1.237 . . . . 75.13 107.661 168.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -85.24 66.09 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.241 -0.891 . . . . 60.11 110.656 -170.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.5 mt -100.81 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.182 -1.044 . . . . 65.23 108.182 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -23.23 2.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.35 -1.296 . . . . 64.21 113.069 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.77 -36.47 23.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.689 0.255 . . . . 63.52 111.689 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -96.9 82.24 3.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.156 0.503 . . . . 73.53 111.258 -170.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -68.43 -20.59 64.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.628 . . . . 73.43 109.991 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.9 m-20 -47.97 -39.51 19.67 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.476 -0.784 . . . . 63.32 111.427 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.8 -36.98 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.903 -0.59 . . . . 71.01 110.935 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.07 79.02 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 74.24 110.44 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.6 m -67.56 -37.77 83.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.78 -0.645 . . . . 72.42 111.02 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 77.3 mm-40 -63.62 -46.08 87.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 52.44 110.788 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -87.28 -15.07 39.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.345 -0.389 . . . . 63.04 111.631 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 41.94 9.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.165 -0.54 . . . . 65.55 112.911 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.449 HG13 ' OG1' ' A' ' 98' ' ' THR . 93.4 t -65.23 103.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.888 -0.412 . . . . 75.31 109.888 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -77.76 -37.86 48.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 63.12 111.526 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.522 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -140.68 138.47 34.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.359 -0.382 . . . . 52.44 110.186 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 52' ' ' TRP . 18.6 pt -106.51 140.77 21.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.075 -0.512 . . . . 75.51 110.777 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.22 -179.57 26.22 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.774 -1.344 . . . . 64.14 112.408 -0.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HG12 ' A' ' 112' ' ' ILE . 93.8 m -138.61 132.58 31.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 74.0 110.121 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 44.2 mm -115.86 110.84 33.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.956 -0.566 . . . . 62.41 111.001 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -93.22 123.3 36.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.436 -0.579 . . . . 72.51 109.436 174.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.532 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 12.1 mmt -91.56 140.61 29.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.308 . . . . 65.12 110.328 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -143.77 148.35 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.151 -1.055 . . . . 73.14 108.151 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -145.61 112.06 5.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.076 -0.65 . . . . 74.24 111.384 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.64 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 64.4 t30 62.19 25.95 15.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.552 0.691 . . . . 72.22 110.434 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.34 -16.55 58.65 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.576 -0.738 . . . . 43.11 112.084 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -73.5 142.4 46.77 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.041 -0.355 . . . . 63.04 110.041 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.32 127.48 33.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.43 110.725 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 108' ' ' LEU . 2.8 mm? -126.93 168.5 14.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.095 . . . . 61.41 110.576 -172.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.24 163.25 26.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.608 -0.723 . . . . 72.41 111.913 -167.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -127.25 124.34 38.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 74.54 110.044 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 32.2 m -102.8 140.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 109.814 -0.439 . . . . 70.11 109.814 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' A' ' 95' ' ' ALA . 63.2 mt -127.92 134.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 62.14 110.03 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.21 145.24 13.4 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.093 -0.575 . . . . 60.32 111.672 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.8 79.77 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 33.13 111.101 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -132.19 98.32 4.38 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.57 -0.53 . . . . 64.24 109.57 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.96 -28.78 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 62.15 110.799 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 t -64.89 -43.68 92.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.764 -0.458 . . . . 72.2 109.764 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -67.02 -44.77 79.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.125 -0.489 . . . . 55.14 109.958 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.9 mt -56.66 -54.01 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.996 -0.547 . . . . 62.22 110.958 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.25 -37.33 79.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 116.318 -0.401 . . . . 72.14 110.199 -177.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.5 t -56.44 -48.81 76.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.451 -0.574 . . . . 43.12 109.451 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 49.4 mm-40 -66.47 -37.16 84.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.384 -0.371 . . . . 73.04 111.046 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.5 mt -53.27 -55.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 120.833 -0.347 . . . . 73.41 110.133 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.12 -29.56 67.64 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.561 -0.456 . . . . 70.22 110.111 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 44.2 t30 -66.68 -32.81 74.36 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.411 . . . . 72.2 111.017 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.407 ' OD1' HD12 ' A' ' 108' ' ' LEU . 64.7 m-80 -86.91 -31.07 20.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.811 -0.177 . . . . 71.2 111.152 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.5 mt -69.25 -39.8 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.112 0.482 . . . . 54.51 110.108 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.474 -0.774 . . . . 71.43 110.032 -179.022 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.9 mmm . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 120.809 0.338 . . . . 71.32 110.553 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.688 HG22 ' HB2' ' A' ' 78' ' ' LYS . 11.8 mm -63.28 103.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.628 -0.714 . . . . 62.2 109.284 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.85 125.13 27.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 70.14 111.558 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.1 120.68 24.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.238 -0.437 . . . . 71.41 110.007 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.4 pt -130.32 151.76 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.872 0.368 . . . . 73.54 111.607 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.77 -160.59 29.77 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.707 -0.678 . . . . 75.43 112.685 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -56.87 12.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.564 0.346 . . . . 65.03 111.769 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -65.16 -37.33 87.05 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.1 0.476 . . . . 74.42 110.23 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.87 -30.23 70.34 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.805 -0.634 . . . . 75.54 110.824 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.1 t80 -54.65 -58.01 9.22 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.335 -0.246 . . . . 65.25 110.335 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -53.48 -54.69 33.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.782 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.5 -56.85 16.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.793 -0.64 . . . . 43.22 111.054 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.1 mmtt -58.13 -35.71 71.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.203 -0.908 . . . . 63.34 111.655 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.85 -40.04 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.795 0.331 . . . . 74.14 110.933 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.8 p -78.18 -9.49 59.22 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.909 0.385 . . . . 53.41 110.933 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -61.71 -13.49 23.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.859 -0.609 . . . . 74.54 111.666 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.643 ' SG ' HD12 ' A' ' 44' ' ' ILE . 75.7 m -49.79 113.79 0.92 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.681 0.277 . . . . 55.23 111.061 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -63.58 -69.37 0.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.238 -0.653 . . . . 72.42 109.238 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -161.88 133.2 5.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.943 -0.571 . . . . 63.42 110.59 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 m120 58.4 15.61 3.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.971 0.508 . . . . 72.45 111.661 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 mm -75.83 124.51 34.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.84 0.352 . . . . 70.51 110.758 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -82.78 118.34 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.777 -0.647 . . . . 72.33 109.438 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.643 HD12 ' SG ' ' A' ' 38' ' ' CYS . 21.3 mt -114.02 117.49 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.39 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.618 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.9 mp -104.31 131.15 51.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.684 -0.858 . . . . 73.21 108.684 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.2 108.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.204 -0.295 . . . . 72.45 110.204 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 22.2 t0 -81.86 138.25 35.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 62.13 110.02 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -78.51 177.65 8.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 65.22 111.128 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 80' ' ' ASN . 20.1 t90 -85.81 129.1 34.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.653 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.07 86.62 7.57 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.846 -0.616 . . . . 54.33 109.912 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.37 -22.44 21.73 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.296 1.997 . . . . 64.33 111.982 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -117.77 111.17 18.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 73.15 110.339 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -175.86 135.88 0.3 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.114 -0.494 . . . . 63.3 110.387 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -74.91 0.95 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.355 -0.45 . . . . 43.4 112.418 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.19 -23.03 72.54 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 54.22 113.057 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.469 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 71.8 m -55.83 -30.71 61.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.595 -0.275 . . . . 71.35 111.446 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -59.45 -32.42 70.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.852 0.358 . . . . 74.44 110.774 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.559 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.5 m -74.67 -38.17 62.49 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.809 0.814 . . . . 70.35 110.138 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.5 mm? -67.33 -34.71 77.92 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.359 -0.837 . . . . 64.1 111.975 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 45.5 mt-10 -55.05 -58.43 14.82 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 120.994 -0.282 . . . . 65.12 110.817 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 38.2 Cg_endo -66.62 -31.11 41.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.106 1.87 . . . . 64.23 112.332 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.1 mt-30 -62.79 -40.75 98.3 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.296 -0.562 . . . . 75.21 110.18 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.8 mt -68.73 -33.77 74.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.871 -0.604 . . . . 74.14 109.991 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 40.8 mt-10 -62.49 -44.55 96.12 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.324 -0.398 . . . . 65.51 110.271 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -54.79 -52.48 62.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.127 -0.488 . . . . 74.54 110.474 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.471 HD13 HD12 ' A' ' 123' ' ' ILE . 47.5 mt -65.33 -37.19 86.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.519 . . . . 74.51 110.205 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.58 -36.46 83.87 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.86 -0.609 . . . . 43.32 110.879 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -74.43 -50.35 18.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 74.13 110.544 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -63.54 -34.66 78.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 75.41 110.914 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -104.97 5.07 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 75.22 112.203 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.4 t -53.34 -20.0 3.95 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.37 0.507 . . . . 63.31 112.37 -172.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.19 -39.22 92.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 74.02 110.739 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.46 -9.88 12.03 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.051 -0.522 . . . . 60.25 110.848 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 43' ' ' LEU . 68.2 t -125.85 145.63 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.037 0.446 . . . . 74.22 111.635 -171.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.11 128.64 13.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.324 -0.621 . . . . 71.33 109.324 171.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.6 mt -111.5 129.13 67.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.078 0.466 . . . . 73.14 110.964 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.5 m-85 -114.81 177.84 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 62.14 109.18 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HB2' HG22 ' A' ' 23' ' ' ILE . 59.0 tttp -148.17 123.5 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 62.33 110.532 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 81' ' ' ILE . 29.2 mm -86.49 108.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 75.13 109.857 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.596 ' HA ' ' HB2' ' A' ' 49' ' ' TRP . 30.4 p-10 -114.98 4.9 14.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.451 -0.341 . . . . 60.11 111.116 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.56 HG22 HG23 ' A' ' 79' ' ' ILE . 6.1 tt -65.47 105.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.34 0.59 . . . . 65.23 109.782 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -54.99 -31.0 60.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.046 -0.979 . . . . 64.21 112.756 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.85 -19.39 61.97 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.787 0.291 . . . . 63.52 111.787 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.487 HD22 HG21 ' A' ' 79' ' ' ILE . 45.1 t30 -87.9 88.11 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.062 0.458 . . . . 73.53 111.786 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -107.14 -30.49 8.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 73.43 109.324 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.55 -55.98 5.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.041 -0.981 . . . . 63.32 111.411 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.99 -34.22 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.734 -0.666 . . . . 71.01 111.071 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.39 62.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.076 0.465 . . . . 74.24 110.162 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -67.1 -31.53 72.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.611 -0.722 . . . . 72.42 111.096 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -75.17 -38.52 60.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.228 -0.442 . . . . 52.44 111.666 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -91.95 -11.66 35.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.757 0.281 . . . . 63.04 111.757 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.87 53.21 2.76 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.908 -0.663 . . . . 65.55 113.394 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 98' ' ' THR . 98.4 t -79.69 106.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.677 -0.49 . . . . 75.31 109.677 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -82.88 -43.27 16.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.875 -0.602 . . . . 63.12 111.402 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.24 12.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.594 -0.276 . . . . 52.44 110.59 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.808 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -109.3 150.68 41.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.262 -0.426 . . . . 75.51 110.426 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 95.9 Cg_endo -77.84 174.81 50.29 Favored 'Cis proline' 0 C--N 1.353 0.803 0 C-N-CA 123.696 -1.377 . . . . 64.14 112.244 -1.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.442 HG21 HG22 ' A' ' 93' ' ' VAL . 92.3 m -142.36 115.28 8.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.291 -0.413 . . . . 74.0 110.439 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' A' ' 111' ' ' VAL . 32.3 mm -109.81 111.42 36.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.723 -0.671 . . . . 62.41 110.373 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 100' ' ' LEU . 2.2 mm? -88.42 125.81 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.194 -0.912 . . . . 72.51 109.835 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.618 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -94.76 138.28 32.77 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.749 -0.463 . . . . 65.12 109.749 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -135.88 144.14 45.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.69 -0.485 . . . . 73.14 109.69 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.7 tptp -132.59 106.38 7.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.927 -0.309 . . . . 74.24 110.216 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.86 26.23 15.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.119 0.485 . . . . 72.22 110.709 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.53 -6.36 82.51 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.707 -0.679 . . . . 43.11 112.299 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -87.9 152.1 22.33 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 120.581 0.229 . . . . 63.04 110.647 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 7.8 tmtm? -56.86 134.8 55.62 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 124.262 0.976 . . . . 71.43 110.809 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.53 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -145.09 169.08 18.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.534 -1.212 . . . . 61.41 108.539 -175.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 101' ' ' MET . 40.7 m -70.01 -177.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.211 0.529 . . . . 72.41 111.927 -164.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.49 ' HG3' HD13 ' A' ' 100' ' ' LEU . 7.3 tt0 -147.14 142.77 27.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.132 -0.486 . . . . 74.54 110.141 -173.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.502 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.2 m -128.22 132.35 68.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.945 0.402 . . . . 70.11 110.247 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.31 135.69 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.802 -0.636 . . . . 62.14 109.424 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.92 154.53 21.27 Favored Glycine 0 C--O 1.235 0.156 0 C-N-CA 121.003 -0.618 . . . . 60.32 111.816 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.6 74.87 9.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.724 0.297 . . . . 33.13 111.377 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -123.96 93.61 3.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.292 0.568 . . . . 64.24 109.483 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -59.11 -30.6 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.524 -0.762 . . . . 62.15 111.047 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.0 t -67.82 -41.23 83.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.442 -0.345 . . . . 72.2 110.25 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -70.74 -40.96 72.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 110.08 -0.341 . . . . 55.14 110.08 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.71 -55.77 20.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.123 -0.49 . . . . 62.22 110.635 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.494 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.58 -35.57 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.514 -0.55 . . . . 72.14 109.514 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.1 t -53.69 -52.28 60.54 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.913 -0.585 . . . . 43.12 109.901 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 33.6 mm-40 -67.1 -38.38 85.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.23 -0.441 . . . . 73.04 111.371 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.471 HD12 HD13 ' A' ' 66' ' ' LEU . 98.4 mt -54.19 -55.77 12.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 120.571 -0.452 . . . . 73.41 110.303 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.47 -27.3 63.15 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.751 -0.379 . . . . 70.22 110.525 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.415 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 54.5 t30 -73.16 -28.51 62.27 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.131 -0.486 . . . . 72.2 110.864 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.523 ' ND2' HD12 ' A' ' 108' ' ' LEU . 3.7 m-20 -85.73 -36.86 19.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 71.2 110.192 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 123' ' ' ILE . 70.6 mt -67.67 -44.88 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.136 0.493 . . . . 54.51 110.201 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.711 -0.661 . . . . 71.43 109.967 -178.73 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 C--O 1.234 0.243 0 N-CA-C 108.738 -0.838 . . . . 71.32 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.45 HG23 HG22 ' A' ' 76' ' ' ILE . 22.0 mm -67.34 93.37 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.811 -1.181 . . . . 62.2 107.811 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.77 111.83 6.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 70.14 111.759 -167.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 5.0 pm0 -69.97 129.38 39.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 71.41 110.202 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 36.8 pt -137.89 147.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.54 111.257 -174.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.53 -179.22 42.33 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.843 -0.617 . . . . 75.43 111.899 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.08 -48.4 67.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.745 0.418 . . . . 65.03 111.492 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 p -62.43 -35.35 78.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.039 -0.528 . . . . 74.42 111.158 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 44.8 mt-10 -77.49 -27.77 51.97 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.992 -0.549 . . . . 75.54 110.708 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.531 ' HA ' HD12 ' A' ' 26' ' ' ILE . 82.1 t80 -53.14 -61.02 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.165 0.291 . . . . 65.25 111.059 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.57 -52.61 61.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.159 0.504 . . . . 73.42 110.514 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -51.55 -57.24 9.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.086 -0.961 . . . . 43.22 111.035 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.6 mmtt -61.92 -46.56 88.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.201 -0.909 . . . . 63.34 111.234 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 31' ' ' PHE . 73.8 t -59.44 -38.75 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.686 0.279 . . . . 74.14 111.107 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -84.89 -16.7 40.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.702 0.286 . . . . 53.41 111.435 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -68.33 -13.39 62.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.381 -0.372 . . . . 74.54 111.471 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -55.16 122.17 10.44 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.707 -0.224 . . . . 55.23 110.7 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.12 -75.18 0.05 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.37 -0.377 . . . . 72.42 110.811 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -161.93 124.62 2.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.45 -0.341 . . . . 63.42 110.096 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.87 17.37 9.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.69 0.618 . . . . 72.45 111.347 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -78.22 104.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.435 -0.58 . . . . 70.51 109.435 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HB3' HG22 ' A' ' 74' ' ' VAL . 62.5 tp -68.9 108.18 3.38 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.509 0.671 . . . . 72.33 110.39 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 77' ' ' TYR . 35.9 mt -96.13 112.62 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.145 -0.934 . . . . 72.45 110.531 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.547 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -96.22 141.02 30.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.437 -0.949 . . . . 73.21 108.437 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.09 114.2 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 110.315 -0.254 . . . . 72.45 110.315 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -82.89 129.22 34.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.009 0.433 . . . . 62.13 110.117 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.493 ' CE1' HD13 ' A' ' 100' ' ' LEU . 5.2 m-85 -90.05 -39.57 12.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.816 -0.629 . . . . 65.22 110.134 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.632 ' HZ2' HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -164.28 94.34 0.72 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.534 -0.303 . . . . 74.34 111.62 -176.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.694 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . . . -96.02 109.57 47.45 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.24 -0.436 . . . . 54.33 110.469 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HG3' HD12 ' A' ' 96' ' ' ILE . 76.1 Cg_endo -92.07 130.08 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.996 2.464 . . . . 64.33 111.633 173.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -63.95 82.66 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.268 0.556 . . . . 73.15 111.164 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.665 ' H ' ' HB2' ' A' ' 56' ' ' CYS . 10.5 p -88.41 -169.21 2.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.472 -0.786 . . . . 63.3 109.567 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.11 -71.0 0.81 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.91 -0.662 . . . . 43.4 112.111 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.627 ' HD2' ' SG ' ' A' ' 53' ' ' CYS . 31.3 Cg_exo -60.3 -35.56 91.01 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.742 2.295 . . . . 54.22 112.468 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.665 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 14.2 m -60.24 -29.79 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.046 0.45 . . . . 71.35 110.595 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -53.42 -52.69 58.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.827 -0.624 . . . . 74.44 110.275 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.651 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.1 m -75.76 -30.53 59.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.056 -0.52 . . . . 70.35 111.521 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -59.23 -59.14 5.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.231 0.456 . . . . 64.1 112.231 -170.219 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.27 -51.24 51.56 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 111.798 0.295 . . . . 65.12 111.798 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.38 -48.37 22.35 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.701 1.601 . . . . 64.23 111.586 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.3 mt-30 -60.02 -29.85 68.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.944 -0.571 . . . . 75.21 111.147 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.33 -44.24 88.41 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.716 -0.476 . . . . 74.14 109.716 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 33.2 mt-10 -62.02 -37.38 84.69 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.046 -0.524 . . . . 65.51 110.062 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 22.0 ttmm -55.79 -53.81 52.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.005 0.431 . . . . 74.54 110.828 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.471 HD11 HD11 ' A' ' 116' ' ' ILE . 35.5 mt -63.79 -35.7 81.48 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.026 -0.534 . . . . 74.51 109.635 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.19 -44.31 95.72 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.445 -0.798 . . . . 43.32 110.16 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.9 mt-30 -60.61 -49.46 77.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.971 0.415 . . . . 74.13 110.265 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -62.17 -42.23 99.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.519 -0.764 . . . . 75.41 111.326 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -104.7 4.58 32.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.776 0.658 . . . . 75.22 112.776 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.55 -20.04 4.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.641 0.608 . . . . 63.31 112.641 -172.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.473 ' HG3' ' OD1' ' A' ' 73' ' ' ASN . 8.3 pt-20 -65.05 -33.69 76.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.606 0.241 . . . . 74.02 111.129 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 72' ' ' GLU . 15.5 m120 -124.19 5.12 8.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.509 -0.314 . . . . 60.25 110.909 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 43' ' ' LEU . 51.2 t -137.17 141.36 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.906 0.384 . . . . 74.22 111.556 -173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.89 130.07 16.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.389 -0.597 . . . . 71.33 109.389 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 45' ' ' LEU . 23.7 mt -109.39 138.47 36.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 120.951 0.405 . . . . 73.14 110.411 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 93.7 m-85 -119.27 170.4 9.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.676 . . . . 62.14 110.47 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -140.74 96.51 3.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.403 -0.962 . . . . 62.33 108.403 -179.644 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 12.7 tt -72.84 116.44 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.207 0.527 . . . . 75.13 111.239 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -90.83 68.94 6.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.753 0.787 . . . . 60.11 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.726 HG12 HG21 ' A' ' 87' ' ' VAL . 11.0 tp -94.91 29.82 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.964 0.888 . . . . 65.23 109.897 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.23 -18.24 1.45 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.752 -1.113 . . . . 64.21 113.451 -174.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.49 -23.75 61.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.887 0.328 . . . . 63.52 111.887 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -147.09 156.53 43.08 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.964 0.412 . . . . 73.53 111.255 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -3.9 23.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.941 -0.572 . . . . 73.43 110.163 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 6.0 m-20 -50.71 -40.41 54.11 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.094 -0.503 . . . . 63.32 111.027 -176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 81' ' ' ILE . 85.5 t -54.27 -38.04 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 115.865 -0.607 . . . . 71.01 111.208 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.92 97.63 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.108 0.48 . . . . 74.24 109.963 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 m -62.63 -37.86 87.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 72.42 110.514 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 77.3 mm-40 -63.86 -54.92 27.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.797 -0.638 . . . . 52.44 110.706 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.09 -14.04 58.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.323 -0.399 . . . . 63.04 111.72 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.41 59.13 5.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.037 -0.602 . . . . 65.55 112.127 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.632 HG21 ' HZ2' ' A' ' 49' ' ' TRP . 78.6 t -67.56 109.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 75.31 110.8 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.0 t -67.7 -50.52 57.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.903 -0.59 . . . . 63.12 110.71 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.69 172.57 16.46 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.346 -0.388 . . . . 52.44 110.683 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.5 HG22 ' CD1' ' A' ' 49' ' ' TRP . 23.8 pt -113.6 148.37 39.58 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.923 -0.581 . . . . 75.51 109.835 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.694 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 72.1 Cg_endo -73.36 168.49 75.95 Favored 'Cis proline' 0 C--N 1.355 0.902 0 C-N-CA 124.21 -1.162 . . . . 64.14 112.788 -0.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.2 m -128.27 110.96 12.88 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.956 -0.566 . . . . 74.0 110.406 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.4 mm -114.85 110.9 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.165 -0.47 . . . . 62.41 110.435 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.493 HD13 ' CE1' ' A' ' 48' ' ' PHE . 8.5 mp -96.17 155.02 16.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.304 -0.258 . . . . 72.51 110.304 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.519 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 35.2 mtt -119.0 150.4 40.01 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 110.196 -0.298 . . . . 65.12 110.196 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -144.27 152.29 40.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.089 0.556 . . . . 73.14 109.609 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -148.03 122.5 9.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.513 -0.181 . . . . 74.24 110.513 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.56 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.9 m-20 57.67 32.53 22.0 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.292 0.568 . . . . 72.22 110.665 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.44 75.88 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.689 -0.687 . . . . 43.11 112.479 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -117.4 152.67 34.49 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.068 -0.345 . . . . 63.04 110.068 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 8.8 tmtt? -69.46 126.41 29.65 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.938 0.774 . . . . 71.43 111.286 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.506 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.6 mm? -126.44 168.99 13.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.225 1.41 . . . . 61.41 109.19 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -179.82 1.9 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.274 0.559 . . . . 72.41 111.879 -164.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -148.85 143.37 26.24 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.853 0.835 . . . . 74.54 111.009 -172.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 t -123.43 130.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 113.843 -1.526 . . . . 70.11 109.753 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.1 124.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.483 . . . . 62.14 109.697 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.94 149.21 21.2 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.544 -0.622 . . . . 60.32 111.544 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.64 87.52 7.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.777 0.323 . . . . 33.13 110.972 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -130.28 100.11 5.27 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.432 -0.581 . . . . 64.24 109.432 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 66' ' ' LEU . 9.7 tp -61.01 -33.22 54.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.58 . . . . 62.15 111.084 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 120' ' ' ILE . 34.2 t -63.85 -50.08 70.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 72.2 110.482 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.53 -45.03 92.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.5 -0.318 . . . . 55.14 110.302 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.476 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -58.13 -53.39 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.358 . . . . 62.22 110.719 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -61.5 -39.49 83.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 110.062 -0.347 . . . . 72.14 110.062 -178.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.2 m -59.44 -49.94 75.87 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.542 -0.299 . . . . 43.12 110.528 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -61.27 -37.75 84.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.407 -0.36 . . . . 73.04 110.483 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.1 mt -59.43 -56.22 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.518 0.199 . . . . 73.41 110.938 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -70.25 -25.6 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.757 -0.377 . . . . 70.22 110.386 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -69.4 -38.05 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 72.2 110.284 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.519 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 93.1 m-20 -87.88 -18.6 28.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.697 -0.683 . . . . 71.2 111.519 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 123' ' ' ILE . 78.9 mt -78.3 -45.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 54.51 110.126 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.634 -0.698 . . . . 71.43 109.921 -178.088 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.8 mmm . . . . . 0 C--O 1.233 0.198 0 N-CA-C 109.333 -0.617 . . . . 71.32 109.333 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -65.34 88.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.1 -0.704 . . . . 62.2 109.1 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 17.0 tt0 -67.8 111.81 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.599 -0.728 . . . . 70.14 109.679 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.2 135.75 33.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 71.41 110.88 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.4 pt -139.39 175.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.888 -0.596 . . . . 73.54 110.29 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -121.86 -167.83 13.2 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.267 -0.424 . . . . 75.43 112.177 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.23 -54.28 38.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.727 0.411 . . . . 65.03 112.007 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -66.68 -29.34 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.392 -0.367 . . . . 74.42 110.925 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.416 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 4.8 mm-40 -84.18 -21.31 31.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 75.54 112.005 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 26' ' ' ILE . 86.8 t80 -55.74 -61.9 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.623 0.249 . . . . 65.25 111.461 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.09 -43.49 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 73.42 110.506 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -52.58 -57.46 9.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.78 -0.645 . . . . 43.22 111.063 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 26' ' ' ILE . 47.8 mmtm -70.95 -38.14 72.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 63.34 111.473 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.58 -37.89 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.632 0.254 . . . . 74.14 110.94 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.5 p -83.04 -22.49 33.54 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.728 0.299 . . . . 53.41 110.99 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t -64.86 -5.14 5.36 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.328 -0.397 . . . . 74.54 111.71 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 104' ' ' ASN . 85.8 m -62.66 106.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.536 0.208 . . . . 55.23 110.514 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -61.24 -68.23 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.286 -0.415 . . . . 72.42 111.269 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -147.05 128.96 15.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.659 0.266 . . . . 63.42 111.551 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 54.66 24.54 5.59 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.644 0.778 . . . . 72.45 112.046 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 50.2 mm -78.61 113.61 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.591 -0.277 . . . . 70.51 110.262 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB3' HG22 ' A' ' 74' ' ' VAL . 2.5 tm? -90.21 112.3 23.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.422 0.629 . . . . 72.33 109.583 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 49.3 mt -101.76 135.23 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.504 -0.771 . . . . 72.45 111.003 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.4 mp -111.07 116.99 32.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.773 -0.825 . . . . 73.21 108.773 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.4 t -99.12 105.03 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.978 -0.378 . . . . 72.45 109.978 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.508 ' HA ' HD13 ' A' ' 99' ' ' ILE . 7.7 t70 -77.04 139.55 40.07 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.826 -0.624 . . . . 62.13 111.335 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -107.51 87.21 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.641 -0.874 . . . . 65.22 108.641 170.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 27.1 t-105 -43.34 130.38 4.9 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.671 -1.149 . . . . 74.34 112.974 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.09 103.85 51.56 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.638 -0.71 . . . . 54.33 109.642 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.18 -26.19 75.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.761 2.307 . . . . 64.33 112.684 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -121.36 105.45 10.54 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.388 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -174.15 146.73 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 63.3 110.544 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.67 -66.83 1.28 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.229 -0.441 . . . . 43.4 112.828 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.78 -28.69 59.49 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.587 2.191 . . . . 54.22 112.308 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 59.1 m -56.59 -31.92 64.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.076 -0.511 . . . . 71.35 111.159 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.603 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -54.35 -60.86 2.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.358 0.599 . . . . 74.44 109.858 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.532 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 50.3 m -55.43 -38.26 68.75 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 114.448 -1.251 . . . . 70.35 111.695 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 3.6 mm? -57.77 -34.95 70.12 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.335 -0.393 . . . . 64.1 110.941 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.4 mt-10 -55.94 -64.07 2.65 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.228 -0.415 . . . . 65.12 111.052 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 57' ' ' ARG . 33.4 Cg_endo -64.77 -24.75 61.39 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.788 1.658 . . . . 64.23 112.18 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 58' ' ' SER . 52.2 mt-30 -63.26 -44.17 95.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.306 -0.558 . . . . 75.21 110.077 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.0 mt -68.4 -39.62 81.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.903 -0.589 . . . . 74.14 110.099 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 46.5 mt-10 -60.93 -35.82 77.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.002 -0.544 . . . . 65.51 110.281 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.51 -56.21 24.84 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.031 0.443 . . . . 74.54 110.264 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 116' ' ' ILE . 59.3 mt -56.26 -39.06 72.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.659 -0.701 . . . . 74.51 109.572 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -61.8 -48.24 81.49 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.115 -0.948 . . . . 43.32 110.251 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -55.93 -42.42 76.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 74.13 110.805 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.65 -45.09 80.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.003 -0.544 . . . . 75.41 111.303 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -101.71 5.47 41.4 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.996 0.739 . . . . 75.22 112.996 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.44 -19.61 3.77 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.334 0.865 . . . . 63.31 113.334 -169.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.8 -29.59 66.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 74.02 111.211 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -119.28 -11.03 9.62 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.896 -0.593 . . . . 60.25 111.275 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 43' ' ' LEU . 57.2 t -125.62 142.7 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.056 0.455 . . . . 74.22 111.656 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 5.2 tppp? -145.63 131.73 19.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 71.33 109.578 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.5 mt -103.72 120.69 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.0 -0.37 . . . . 73.14 110.0 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 50.2 m-85 -107.37 153.75 22.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.667 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.766 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 24.9 ttpt -131.32 120.18 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.274 -0.639 . . . . 62.33 109.274 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 81' ' ' ILE . 39.9 mt -73.1 106.82 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.23 -1.026 . . . . 75.13 108.23 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.13 73.0 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.044 0.45 . . . . 60.11 111.394 -171.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 87' ' ' VAL . 26.5 pt -147.0 31.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.385 -0.825 . . . . 65.23 109.165 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -62.65 -20.31 64.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.639 -0.709 . . . . 64.21 111.474 -175.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.1 -27.85 62.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.21 0.529 . . . . 63.52 109.907 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.45 76.87 9.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.555 -0.748 . . . . 73.53 109.078 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -62.62 -27.87 69.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.188 -0.915 . . . . 73.43 110.624 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 27.2 t70 -50.11 -41.74 49.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.847 -0.615 . . . . 63.32 110.56 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.528 HG21 HD12 ' A' ' 81' ' ' ILE . 92.3 t -54.24 -40.36 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 71.01 110.788 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -62.3 -47.3 84.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.424 0.631 . . . . 74.24 109.823 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.9 m -64.7 -33.41 75.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.444 -0.798 . . . . 72.42 110.867 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.6 mm-40 -68.43 -44.54 74.75 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.192 -0.458 . . . . 52.44 110.862 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.16 0.31 57.14 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.239 -0.437 . . . . 63.04 111.619 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.21 43.72 20.06 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.031 -0.604 . . . . 65.55 113.401 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.461 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 95.9 t -74.82 106.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.297 -0.631 . . . . 75.31 109.297 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.0 m -61.76 -39.32 91.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.316 . . . . 63.12 111.738 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.61 145.65 24.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.472 -0.331 . . . . 52.44 110.606 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.5 pt -104.32 141.43 22.51 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.219 -0.446 . . . . 75.51 110.098 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -85.21 169.86 47.46 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.712 -1.37 . . . . 64.14 112.116 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -145.53 155.57 43.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.969 -0.56 . . . . 74.0 109.554 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 47' ' ' ASP . 47.7 mm -118.67 110.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.395 -0.82 . . . . 62.41 109.926 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.75 123.01 41.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.064 -0.717 . . . . 72.51 109.064 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.6 mtt -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 65.12 110.397 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -144.87 145.79 31.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.614 -0.513 . . . . 73.14 109.614 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -142.11 119.79 11.81 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.925 -0.398 . . . . 74.24 109.925 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.623 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 13.7 p30 51.21 25.61 2.53 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.997 0.919 . . . . 72.22 112.099 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.59 64.96 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.835 -0.62 . . . . 43.11 113.166 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 47.9 tptt -73.12 142.14 47.5 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 117.067 0.433 . . . . 63.04 110.37 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 2.5 tmtp? -68.88 122.52 18.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.824 -0.626 . . . . 71.43 110.009 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -118.1 168.8 10.22 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.273 1.029 . . . . 61.41 109.749 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 101' ' ' MET . 0.3 OUTLIER -69.73 166.94 18.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.485 0.659 . . . . 72.41 112.566 -159.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 57.2 tt0 -129.25 136.84 50.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.211 1.005 . . . . 74.54 111.326 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.47 121.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.256 -1.793 . . . . 70.11 109.608 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.2 mt -107.02 133.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 110.269 -0.271 . . . . 62.14 110.269 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.54 168.24 36.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.322 -0.466 . . . . 60.32 112.465 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.43 98.99 11.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.641 0.258 . . . . 33.13 110.884 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.2 t70 -143.55 100.61 3.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.548 -0.538 . . . . 64.24 109.548 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.466 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -62.96 -38.45 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.895 -0.593 . . . . 62.15 111.577 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -66.54 -43.65 84.58 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.095 0.474 . . . . 72.2 110.147 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -61.41 -48.06 82.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 55.14 110.295 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 115' ' ' ASP . 73.8 mt -61.78 -47.15 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 62.22 111.519 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.24 -41.76 92.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.211 0.529 . . . . 72.14 110.233 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.4 t -56.22 -45.73 79.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.795 -0.639 . . . . 43.12 109.465 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 39.5 mm-40 -70.2 -32.39 70.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 73.04 111.491 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 120' ' ' ILE . 80.1 mt -54.55 -55.01 17.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 N-CA-C 108.936 -0.764 . . . . 73.41 108.936 173.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -66.82 -36.07 81.5 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.391 . . . . 70.22 111.093 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 3.4 t-20 -63.37 -42.06 98.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.216 -0.447 . . . . 72.2 111.294 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -93.66 -15.3 25.44 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.448 -0.342 . . . . 71.2 111.671 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 123' ' ' ILE . 38.7 mt -61.45 -43.59 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.231 -1.025 . . . . 54.51 108.231 166.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.982 172.437 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.478 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 96.0 mmm . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.548 0.214 . . . . 71.32 111.221 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.419 HG21 ' HE2' ' A' ' 78' ' ' LYS . 20.8 mm -77.33 93.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.114 -0.698 . . . . 62.2 109.114 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.2 tp10 -68.4 122.76 19.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 70.14 111.152 -175.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -90.93 122.13 33.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.436 -0.347 . . . . 71.41 110.353 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.8 pt -126.94 165.08 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.299 -0.409 . . . . 73.54 111.258 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.34 -167.56 40.99 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.87 -0.604 . . . . 75.43 113.479 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.48 -54.3 30.33 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 65.03 111.448 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 t -74.67 -28.19 60.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.225 0.536 . . . . 74.42 110.359 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.23 -17.55 64.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 75.54 111.636 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.4 t80 -58.4 -62.04 2.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.8 0.333 . . . . 65.25 110.16 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.16 -45.72 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.156 0.503 . . . . 73.42 110.207 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -56.15 -57.47 12.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.381 -0.827 . . . . 43.22 111.484 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.67 -29.61 65.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.223 -0.444 . . . . 63.34 111.456 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 31' ' ' PHE . 49.4 t -68.33 -41.59 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.648 0.261 . . . . 74.14 110.758 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 p -81.25 -18.88 44.44 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.872 0.367 . . . . 53.41 111.028 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 t -61.67 -21.75 64.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.136 -0.484 . . . . 74.54 111.529 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.703 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 22.9 p -59.62 122.09 13.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.606 0.241 . . . . 55.23 110.601 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.77 -69.18 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.148 -0.478 . . . . 72.42 111.844 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -161.42 135.76 7.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 63.42 110.934 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 16.6 m-80 59.36 17.1 5.58 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.704 0.628 . . . . 72.45 112.156 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.2 mm -87.85 114.01 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 70.51 110.292 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.537 HD21 ' SD ' ' A' ' 101' ' ' MET . 0.3 OUTLIER -78.82 109.19 12.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 72.33 109.387 178.056 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 38' ' ' CYS . 43.6 mt -97.68 121.64 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.951 -0.568 . . . . 72.45 110.482 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.673 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.9 mp -106.37 116.0 31.18 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.526 -0.546 . . . . 73.21 109.526 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.4 t -99.64 105.86 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 110.269 -0.271 . . . . 72.45 110.269 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -81.58 132.87 35.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.085 -0.507 . . . . 62.13 110.427 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -89.19 137.86 31.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.642 -0.503 . . . . 65.22 109.642 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -46.24 -51.06 15.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.594 0.559 . . . . 74.34 111.944 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 67.58 153.03 0.13 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.636 0.585 . . . . 54.33 111.828 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.2 173.92 9.77 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.426 2.084 . . . . 64.33 112.092 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -49.89 120.45 4.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.089 -0.505 . . . . 73.15 110.958 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.65 147.33 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 63.3 111.103 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -64.09 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.182 -0.463 . . . . 43.4 112.642 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.18 -30.55 32.93 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.208 2.605 . . . . 54.22 113.191 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 19.9 p -57.75 -29.01 64.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 71.35 111.285 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -54.3 -39.55 67.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.538 0.209 . . . . 74.44 111.276 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.649 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 45.1 m -75.11 -42.21 56.97 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.651 0.739 . . . . 70.35 110.48 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -61.61 -31.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.311 -0.859 . . . . 64.1 112.07 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 43.1 mt-10 -59.28 -60.93 8.94 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 117.803 0.274 . . . . 65.12 110.749 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 28.8 Cg_endo -62.98 -29.38 75.65 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.846 1.697 . . . . 64.23 112.174 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.0 mt-30 -64.51 -44.7 90.09 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.058 -0.657 . . . . 75.21 110.161 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.605 HD21 HD13 ' A' ' 119' ' ' ILE . 85.7 mt -64.43 -45.68 86.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 74.14 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.6 mt-10 -63.16 -34.08 76.85 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.031 -0.531 . . . . 65.51 110.563 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.79 -47.29 87.01 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.827 0.346 . . . . 74.54 110.21 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.49 -35.64 79.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.907 -0.588 . . . . 74.51 109.731 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.39 -42.68 98.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.785 -0.643 . . . . 43.32 110.234 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.1 mt-30 -67.16 -44.3 80.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 74.13 110.082 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -67.27 -38.74 85.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.482 -0.781 . . . . 75.41 111.352 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -105.14 4.63 31.57 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.756 0.65 . . . . 75.22 112.756 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.43 -19.93 4.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.424 0.527 . . . . 63.31 112.424 -172.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.03 -29.03 70.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.793 0.33 . . . . 74.02 110.875 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -130.62 4.65 4.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.3 -0.409 . . . . 60.25 111.021 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 43' ' ' LEU . 62.4 t -133.49 149.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.941 0.4 . . . . 74.22 111.242 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.16 127.96 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.345 -0.613 . . . . 71.33 109.345 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.673 HG12 ' HB2' ' A' ' 45' ' ' LEU . 42.2 mt -106.12 141.27 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.738 0.304 . . . . 73.14 111.01 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.7 m-85 -123.51 171.72 9.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 62.14 109.821 176.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' HG21 ' A' ' 23' ' ' ILE . 21.1 ttmm -146.6 139.06 25.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 62.33 109.94 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.7 mm -96.6 99.14 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.23 -0.656 . . . . 75.13 109.23 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.7 -19.14 61.46 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.093 -0.503 . . . . 60.11 110.943 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.71 87.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 65.23 110.462 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.34 -18.52 63.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 64.21 111.385 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.85 -15.77 60.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.124 -0.489 . . . . 63.52 111.406 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -86.04 93.73 9.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.056 0.455 . . . . 73.53 109.972 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -87.59 -20.6 26.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 73.43 110.212 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.01 -58.54 2.39 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.959 -0.564 . . . . 63.32 111.149 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.53 -34.09 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.731 -0.668 . . . . 71.01 111.001 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -67.91 -47.22 69.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.066 0.46 . . . . 74.24 110.518 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.8 m -67.42 -40.95 85.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 72.42 110.627 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.16 -44.56 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 52.44 111.789 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -99.12 -4.19 32.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.833 0.308 . . . . 63.04 111.833 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.47 83.41 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.214 -0.517 . . . . 65.55 113.271 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 88' ' ' ALA . 85.7 t -81.05 144.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.371 -0.603 . . . . 75.31 109.371 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.42 ' HB2' HG21 ' A' ' 112' ' ' ILE . 31.2 m -138.62 -63.72 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.691 0.281 . . . . 63.12 111.489 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.92 178.01 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 52.44 111.354 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 10.3 pt -112.35 116.2 48.95 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.46 -0.791 . . . . 75.51 110.87 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -92.02 -162.54 1.43 Allowed 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 124.219 -1.159 . . . . 64.14 111.947 -3.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.414 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.6 m -138.08 118.17 13.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.231 -0.441 . . . . 74.0 109.935 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mm -110.14 130.46 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.735 -0.666 . . . . 62.41 110.584 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 110' ' ' GLN . 40.9 mt -107.18 143.98 34.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.926 -0.768 . . . . 72.51 108.926 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.537 ' SD ' HD21 ' A' ' 43' ' ' LEU . 3.2 mtt -109.92 149.48 29.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.117 0.417 . . . . 65.12 110.666 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.0 m-85 -146.82 162.03 39.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.789 -0.641 . . . . 73.14 109.472 175.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 4.9 ttmp? -160.49 131.27 5.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.277 -0.268 . . . . 74.24 110.277 176.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.498 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 3.5 m-20 58.19 27.17 14.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.149 0.5 . . . . 72.22 110.58 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.43 27.93 71.95 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.836 -0.62 . . . . 43.11 112.266 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -126.83 149.6 49.63 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.491 -0.559 . . . . 63.04 109.491 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.589 ' O ' HD22 ' A' ' 108' ' ' LEU . 26.9 ttpt -68.75 143.91 54.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.747 0.784 . . . . 71.43 112.438 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 107' ' ' LYS . 1.4 mm? -144.68 169.3 18.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.841 -1.527 . . . . 61.41 108.379 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.62 173.71 5.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.773 0.797 . . . . 72.41 112.51 -162.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.471 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.1 tt0 -127.66 150.57 49.69 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.027 -0.988 . . . . 74.54 110.793 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 119' ' ' ILE . 2.3 t -127.69 111.63 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 114.514 -1.221 . . . . 70.11 109.418 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 94' ' ' SER . 60.1 mt -114.23 121.83 67.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.483 -0.326 . . . . 62.14 110.183 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.39 145.17 9.19 Favored Glycine 0 C--N 1.328 0.134 0 N-CA-C 111.76 -0.536 . . . . 60.32 111.76 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.14 72.19 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.13 0.491 . . . . 33.13 110.906 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -125.88 93.34 3.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.025 -0.731 . . . . 64.24 109.025 175.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.95 -25.09 34.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.334 -0.848 . . . . 62.15 111.511 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 t -67.67 -46.14 73.21 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.292 -0.633 . . . . 72.2 109.292 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.3 tptt -61.41 -45.88 92.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.619 -0.719 . . . . 55.14 109.744 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.605 HD13 HD21 ' A' ' 63' ' ' LEU . 69.9 mt -56.71 -56.09 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.062 -0.517 . . . . 62.22 111.292 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.503 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.0 -37.51 78.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 116.5 -0.318 . . . . 72.14 110.272 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.8 t -56.63 -51.53 68.33 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.164 -0.471 . . . . 43.12 109.898 176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 20.9 mm-40 -58.58 -44.39 89.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.054 -0.521 . . . . 73.04 110.135 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.8 mt -54.4 -56.14 11.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.489 -0.323 . . . . 73.41 111.011 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -68.51 -33.05 73.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.486 -0.486 . . . . 70.22 110.56 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -68.48 -31.92 71.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.287 -0.415 . . . . 72.2 110.854 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.484 ' OD1' HD12 ' A' ' 108' ' ' LEU . 23.6 m-80 -90.86 -14.09 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.35 -0.386 . . . . 71.2 111.565 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.0 mt -81.52 -60.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.553 -0.536 . . . . 54.51 109.553 168.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.448 -0.787 . . . . 71.43 110.8 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.2 mmm . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.741 0.305 . . . . 71.32 110.943 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.481 HG21 ' HE2' ' A' ' 78' ' ' LYS . 26.7 mm -87.89 101.03 11.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.241 -0.651 . . . . 62.2 109.241 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 8.8 tp10 -64.47 122.68 17.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.296 0.569 . . . . 70.14 110.534 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -100.53 109.61 21.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 71.41 110.22 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.3 pt -119.51 166.78 13.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.733 -0.667 . . . . 73.54 111.275 -174.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.65 -158.59 33.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.687 -0.688 . . . . 75.43 112.111 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.11 -51.17 41.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.052 0.454 . . . . 65.03 111.55 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.4 t -69.5 -36.77 76.81 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.924 -0.58 . . . . 74.42 111.646 -172.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 1.9 mp0 -65.16 -14.99 61.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 75.54 111.97 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.426 ' O ' HG23 ' A' ' 35' ' ' VAL . 81.5 t80 -51.85 -61.27 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.717 0.294 . . . . 65.25 110.926 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.11 -44.97 83.78 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.421 . . . . 73.42 110.394 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -53.69 -57.76 9.65 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.725 0.774 . . . . 43.22 110.662 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.3 mmtt -64.75 -38.1 89.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.083 -0.962 . . . . 63.34 111.354 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.8 t -70.62 -35.54 61.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.44 -0.345 . . . . 74.14 110.823 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -81.88 -14.99 55.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.653 0.263 . . . . 53.41 111.126 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -66.07 2.52 1.1 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.208 0.448 . . . . 74.54 112.208 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' SG ' HD12 ' A' ' 44' ' ' ILE . 89.9 m -60.54 169.37 1.78 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.294 0.569 . . . . 55.23 112.041 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.03 -82.01 0.61 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.401 -0.818 . . . . 72.42 109.138 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -162.05 137.92 7.61 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.45 -0.574 . . . . 63.42 109.45 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 61.92 10.47 3.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.645 0.378 . . . . 72.45 111.408 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.76 108.18 17.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.263 -0.643 . . . . 70.51 109.263 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 126' ' ' ASN . 68.0 tp -83.46 121.67 27.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.177 0.513 . . . . 72.33 110.699 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.517 HD12 ' SG ' ' A' ' 38' ' ' CYS . 27.9 mt -105.83 118.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 72.45 110.084 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 3.6 mp -104.28 114.29 28.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.885 -0.783 . . . . 73.21 108.885 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.2 t -102.86 104.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.374 -0.232 . . . . 72.45 110.374 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.448 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 18.8 t0 -76.6 129.04 35.86 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.179 -0.674 . . . . 62.13 109.179 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -83.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 65.22 111.047 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -167.6 151.21 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 74.34 110.9 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.57 97.13 6.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.624 -0.717 . . . . 54.33 109.513 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.68 -50.42 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.581 2.187 . . . . 64.33 112.17 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -130.98 123.36 28.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.332 -0.618 . . . . 73.15 109.332 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.2 t -163.26 136.74 5.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 63.3 110.873 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -86.76 -66.52 1.37 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.955 -0.566 . . . . 43.4 112.249 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' A' ' 54' ' ' GLY . 15.3 Cg_endo -55.13 -26.79 52.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.165 2.577 . . . . 54.22 113.066 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 79.0 m -55.7 -23.55 29.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.482 -0.326 . . . . 71.35 111.866 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 12.2 ptm180 -54.34 -44.36 72.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.694 0.283 . . . . 74.44 110.504 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 18.6 m -75.5 -35.61 60.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.239 0.542 . . . . 70.35 110.79 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -64.83 -36.46 84.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.45 0.537 . . . . 64.1 112.45 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.8 tt0 -58.18 -58.9 15.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 120.351 -0.54 . . . . 65.12 110.363 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.25 -32.99 95.01 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.819 1.68 . . . . 64.23 112.435 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 58' ' ' SER . 46.4 mt-30 -63.4 -44.19 95.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.028 0.442 . . . . 75.21 110.377 176.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.77 -37.82 82.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.963 -0.562 . . . . 74.14 110.222 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 52.9 mt-10 -65.51 -36.17 83.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.281 -0.418 . . . . 65.51 110.26 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -56.53 -52.07 66.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.016 0.436 . . . . 74.54 109.848 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 116' ' ' ILE . 27.0 mt -68.33 -31.32 70.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 74.51 109.634 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.578 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -70.85 -13.37 62.01 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.643 -0.708 . . . . 43.32 110.982 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -96.06 -50.83 4.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.295 -0.411 . . . . 74.13 110.861 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -63.24 -43.05 99.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.36 0.6 . . . . 75.41 110.793 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.53 5.35 47.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.303 -0.862 . . . . 75.22 111.494 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.3 t -52.83 -25.88 12.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.258 0.836 . . . . 63.31 113.258 -168.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.75 -19.0 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.615 0.245 . . . . 74.02 111.403 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.7 2.0 7.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.521 -0.309 . . . . 60.25 110.991 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.71 144.48 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.784 0.326 . . . . 74.22 111.324 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -147.05 119.89 8.67 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.275 -0.639 . . . . 71.33 109.275 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.02 132.11 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.803 0.335 . . . . 73.14 110.558 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 74.3 m-85 -122.08 166.02 15.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 62.14 109.475 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HE2' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -148.72 142.58 25.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.411 -0.359 . . . . 62.33 110.371 172.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 31' ' ' PHE . 61.3 mt -102.02 103.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 75.13 109.231 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -84.1 12.72 5.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 60.11 111.306 -174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm -78.3 78.87 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.021 -0.733 . . . . 65.23 109.021 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -18.48 43.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 64.21 112.622 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.5 -11.66 60.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.756 0.312 . . . . 63.52 111.537 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.76 51.21 1.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.194 0.521 . . . . 73.53 110.281 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -61.42 -61.86 2.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.56 -0.746 . . . . 73.43 110.841 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 7.7 m-20 -52.83 -36.98 59.47 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.421 -0.809 . . . . 63.32 111.031 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.01 -42.16 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 71.01 110.202 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.85 -51.57 64.03 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.269 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.6 m -62.09 -31.48 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 72.42 111.01 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 25.3 mm-40 -68.81 -51.78 37.15 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.495 -0.32 . . . . 52.44 110.872 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -76.22 -10.91 59.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.494 -0.321 . . . . 63.04 111.415 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.42 44.34 2.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.814 -0.708 . . . . 65.55 113.694 167.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 98' ' ' THR . 72.4 t -77.83 106.13 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.557 -0.534 . . . . 75.31 109.557 173.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.549 ' HB3' HG21 ' A' ' 112' ' ' ILE . 22.8 t -92.91 -40.24 10.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 63.12 110.536 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.85 158.19 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 52.44 110.233 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.782 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.61 140.95 22.15 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.45 . . . . 75.51 110.406 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.43 -179.35 24.48 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.06 -1.225 . . . . 64.14 111.529 -3.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.51 HG21 HG22 ' A' ' 93' ' ' VAL . 93.7 m -139.78 116.42 10.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.926 0.393 . . . . 74.0 110.206 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.446 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.1 mm -109.8 110.82 33.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 62.41 110.8 -173.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 123.44 33.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.737 -0.468 . . . . 72.51 109.737 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.622 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 17.7 mmt -90.19 140.14 29.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.221 -0.445 . . . . 65.12 110.078 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.4 144.44 36.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.219 -0.66 . . . . 73.14 109.219 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -138.42 112.43 8.51 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.587 -0.445 . . . . 74.24 110.671 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.51 32.33 22.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.615 0.722 . . . . 72.22 110.453 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.51 68.25 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 115.684 -0.689 . . . . 43.11 112.649 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -83.12 143.59 30.44 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.777 -0.453 . . . . 63.04 109.777 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' HD22 ' A' ' 108' ' ' LEU . 21.5 tptm -65.88 130.62 43.9 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.83 0.706 . . . . 71.43 111.013 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -131.39 168.94 16.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.581 -1.191 . . . . 61.41 109.19 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 101' ' ' MET . 1.3 m -69.55 176.19 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.309 0.576 . . . . 72.41 111.937 -163.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.49 131.53 29.82 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.856 0.836 . . . . 74.54 110.992 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.83 107.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.926 -1.488 . . . . 70.11 109.752 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 94' ' ' SER . 64.0 mt -102.77 121.87 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.046 -0.524 . . . . 62.14 110.108 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.01 149.97 18.04 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.954 -0.458 . . . . 60.32 111.954 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.76 85.97 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.682 0.277 . . . . 33.13 111.129 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.8 t70 -132.64 92.11 3.01 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.349 0.595 . . . . 64.24 109.822 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 66' ' ' LEU . 9.2 tp -59.31 -32.89 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.265 -0.88 . . . . 62.15 111.651 -174.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.8 t -64.17 -48.49 75.77 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.898 0.38 . . . . 72.2 110.055 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -62.09 -43.37 98.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.013 -0.54 . . . . 55.14 109.711 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 71.2 mt -58.4 -56.27 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.036 -0.529 . . . . 62.22 111.117 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.517 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.34 -35.04 67.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 120.758 0.313 . . . . 72.14 110.187 -177.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -58.04 -51.9 67.77 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.109 -0.496 . . . . 43.12 109.791 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -61.64 -37.57 84.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.876 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.8 mt -58.51 -55.95 19.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.3 -0.409 . . . . 73.41 110.92 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -67.94 -31.42 71.15 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.651 -0.419 . . . . 70.22 110.011 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -58.06 -43.6 87.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.756 -0.656 . . . . 72.2 110.566 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.449 ' HB2' HD22 ' A' ' 43' ' ' LEU . 26.7 m-80 -78.26 -38.94 41.54 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.254 0.465 . . . . 71.2 112.254 -177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.6 mt -58.07 -47.75 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.372 . . . . 54.51 110.939 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.926 -0.559 . . . . 71.43 110.657 -176.519 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.7 mmm . . . . . 0 C--O 1.234 0.238 0 N-CA-C 108.831 -0.803 . . . . 71.32 108.831 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 ' HD2' ' A' ' 78' ' ' LYS . 17.9 mm -64.99 93.69 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.368 -0.975 . . . . 62.2 108.368 171.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 9.7 tp10 -52.27 144.31 12.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.469 0.652 . . . . 70.14 111.98 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -101.67 115.61 30.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.157 -0.929 . . . . 71.41 110.276 -176.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.479 HG21 ' HG3' ' A' ' 34' ' ' LYS . 50.6 pt -133.96 179.94 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.956 0.408 . . . . 73.54 110.911 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.34 -153.52 7.93 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.896 -0.593 . . . . 75.43 111.852 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.97 -53.18 22.1 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.404 0.282 . . . . 65.03 111.487 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -70.82 -29.96 66.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.828 0.347 . . . . 74.42 111.565 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 mp0 -72.36 -27.3 62.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.438 . . . . 75.54 111.009 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -51.89 -61.83 2.01 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.13 0.269 . . . . 65.25 111.192 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 36' ' ' THR . 9.2 t70 -51.09 -53.59 32.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.986 -0.552 . . . . 73.42 110.549 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -54.07 -57.28 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.131 -0.941 . . . . 43.22 111.31 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 77' ' ' TYR . 75.9 mmtt -62.28 -33.37 74.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 63.34 111.014 -175.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.455 ' HA ' HD13 ' A' ' 44' ' ' ILE . 21.7 t -69.09 -55.66 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.185 -0.461 . . . . 74.14 112.16 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 32' ' ' ASP . 10.2 t -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.383 0.512 . . . . 53.41 112.383 -170.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 t -75.81 2.57 11.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.135 0.42 . . . . 74.54 112.135 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.81 ' SG ' HD11 ' A' ' 44' ' ' ILE . 92.0 m -82.8 128.62 34.57 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.666 0.27 . . . . 55.23 110.49 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.29 -72.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.769 0.655 . . . . 72.42 112.769 -172.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.43 121.93 35.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 63.42 111.361 -166.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 58.21 11.19 1.47 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.625 -1.171 . . . . 72.45 113.395 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 47.9 mm -73.04 95.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.971 0.415 . . . . 70.51 110.072 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -71.0 110.38 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.857 -0.794 . . . . 72.33 108.857 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.81 HD11 ' SG ' ' A' ' 38' ' ' CYS . 86.4 mt -94.38 123.24 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.393 -0.822 . . . . 72.45 110.526 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.681 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.3 mp -110.11 109.75 20.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.242 -0.651 . . . . 73.21 109.242 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.06 105.16 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.028 -0.36 . . . . 72.45 110.028 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -81.01 147.66 30.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.382 -0.372 . . . . 62.13 110.215 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 88' ' ' ALA . 88.2 t80 -87.91 115.65 25.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.36 . . . . 65.22 110.624 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.573 ' HE1' ' HA ' ' A' ' 82' ' ' GLU . 51.6 t-105 -56.35 115.37 2.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.813 -0.631 . . . . 74.34 110.844 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -111.86 107.88 56.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 54.33 110.089 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 18.9 Cg_endo -59.81 -21.59 64.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.537 2.158 . . . . 64.33 111.79 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -131.95 128.63 38.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.531 -0.758 . . . . 73.15 109.383 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 47.6 t -164.37 175.13 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.889 0.376 . . . . 63.3 110.694 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -136.58 -61.17 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.553 -0.748 . . . . 43.4 111.435 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.463 ' O ' HD23 ' A' ' 59' ' ' LEU . 52.7 Cg_exo -55.0 -26.03 47.51 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.005 2.47 . . . . 54.22 112.684 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 56.6 m -57.29 -28.57 63.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.978 -0.555 . . . . 71.35 111.476 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -53.59 -49.12 68.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.935 0.398 . . . . 74.44 111.594 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.4 m -75.3 -38.17 60.46 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.765 0.793 . . . . 70.35 110.95 177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 55' ' ' PRO . 4.4 mm? -73.71 -24.24 59.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.607 -0.724 . . . . 64.1 112.043 -172.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.5 mt-10 -59.56 -59.06 15.08 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.786 -0.449 . . . . 65.12 109.786 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.73 -34.46 31.51 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.819 1.679 . . . . 64.23 112.376 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.63 ' HB3' HD13 ' A' ' 116' ' ' ILE . 40.2 mt-30 -62.61 -42.7 99.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.145 -0.622 . . . . 75.21 110.97 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.638 HD21 HD13 ' A' ' 119' ' ' ILE . 67.6 mt -64.76 -38.62 91.6 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.48 -0.327 . . . . 74.14 110.132 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.0 mt-10 -58.11 -43.53 87.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 116.419 -0.355 . . . . 65.51 110.087 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -56.07 -53.43 57.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.093 -0.503 . . . . 74.54 111.09 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 123' ' ' ILE . 34.8 mt -63.26 -37.29 86.67 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.639 -0.504 . . . . 74.51 109.639 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.18 -26.9 68.35 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.588 -0.733 . . . . 43.32 110.906 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.5 mt-30 -80.15 -48.83 12.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.819 0.342 . . . . 74.13 110.599 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -47.62 83.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.436 0.636 . . . . 75.41 109.806 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -90.54 4.47 51.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.294 -0.866 . . . . 75.22 112.416 -175.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -53.16 -21.28 4.8 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.848 0.356 . . . . 63.31 111.664 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.35 -35.26 78.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 74.02 110.962 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -133.9 15.71 3.91 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.494 -0.321 . . . . 60.25 111.19 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 43' ' ' LEU . 41.9 t -135.29 139.69 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.071 0.462 . . . . 74.22 111.351 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 24' ' ' GLU . 61.0 tptt -145.25 119.81 9.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 71.33 109.14 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.681 HG12 ' HB2' ' A' ' 45' ' ' LEU . 29.2 mt -101.79 141.65 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.227 -0.286 . . . . 73.14 110.227 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 91.4 m-85 -130.22 161.25 31.59 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.55 0.34 . . . . 62.14 110.518 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.642 ' HD2' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -163.54 154.86 16.73 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 62.33 109.147 168.242 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 28.1 pt -79.53 152.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.394 -0.225 . . . . 75.13 110.394 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -107.26 6.62 28.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.626 0.25 . . . . 60.11 111.342 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 81' ' ' ILE . 3.0 mp -78.5 96.58 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 65.23 110.167 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HA ' ' HE1' ' A' ' 49' ' ' TRP . 7.5 tm-20 -61.62 -26.8 68.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.946 -0.57 . . . . 64.21 110.333 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.72 -9.01 57.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.686 -0.688 . . . . 63.52 111.28 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -91.4 105.83 18.05 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.093 0.473 . . . . 73.53 111.155 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -121.54 -32.91 3.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 73.43 109.776 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.3 m-20 -49.51 -43.18 45.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.011 -0.995 . . . . 63.32 111.939 -173.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.2 -34.05 26.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.283 -0.417 . . . . 71.01 111.403 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . . . -60.19 -49.23 78.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.15 0.5 . . . . 74.24 109.978 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 m -66.73 -35.49 80.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.437 -0.801 . . . . 72.42 110.642 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 72.8 mm-40 -61.34 -55.41 32.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.128 -0.487 . . . . 52.44 110.691 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.97 -11.87 51.91 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.462 -0.335 . . . . 63.04 111.815 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.59 42.28 14.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.75 -0.738 . . . . 65.55 112.354 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t -75.3 114.43 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -98.03 -74.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 63.12 111.05 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.74 136.44 33.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.76 0.314 . . . . 52.44 110.899 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.67 151.98 46.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 75.51 109.845 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.86 169.35 64.19 Favored 'Cis proline' 0 C--N 1.354 0.836 0 C-N-CA 124.157 -1.184 . . . . 64.14 112.921 1.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 112' ' ' ILE . 89.0 m -139.02 114.13 9.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.715 -0.675 . . . . 74.0 109.879 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.459 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 32.4 mm -109.79 110.7 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 62.41 111.012 -173.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -97.83 123.36 41.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.745 -0.835 . . . . 72.51 108.745 171.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.482 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 37.9 mtt -93.43 150.83 20.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.965 0.412 . . . . 65.12 110.923 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.7 m-85 -143.33 153.82 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.416 -0.957 . . . . 73.14 108.416 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -150.91 115.3 5.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 74.24 110.62 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.76 25.38 15.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.663 0.744 . . . . 72.22 110.171 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.29 -0.42 87.2 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.636 -0.711 . . . . 43.11 112.276 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -91.68 145.21 24.77 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 122.812 -0.228 . . . . 63.04 110.819 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' HD22 ' A' ' 108' ' ' LEU . 3.7 tppp? -63.31 132.51 51.83 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.916 0.76 . . . . 71.43 110.765 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 1.2 mm? -137.19 169.43 17.79 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 125.036 1.334 . . . . 61.41 108.788 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.25 172.18 7.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.459 0.54 . . . . 72.41 112.459 -162.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -140.14 126.04 19.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.081 -0.508 . . . . 74.54 110.605 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.1 m -115.3 122.47 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.191 0.519 . . . . 70.11 110.422 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 98' ' ' THR . 51.3 mt -108.18 140.56 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.718 -0.674 . . . . 62.14 109.485 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.12 157.49 32.45 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.991 -0.623 . . . . 60.32 112.13 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.46 97.3 9.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.927 0.343 . . . . 33.13 111.927 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.9 t0 -146.1 104.27 3.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.317 0.579 . . . . 64.24 110.677 169.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 62' ' ' GLN . 8.7 tp -59.13 -32.97 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.148 -0.933 . . . . 62.15 110.809 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.0 m -67.91 -48.56 65.66 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.196 -0.456 . . . . 72.2 111.14 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -60.51 -47.66 85.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.374 -0.375 . . . . 55.14 110.301 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.638 HD13 HD21 ' A' ' 63' ' ' LEU . 78.5 mt -57.9 -55.56 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 62.22 111.081 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.436 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.86 -36.97 75.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.907 -0.405 . . . . 72.14 109.907 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -57.16 -52.02 66.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.847 -0.615 . . . . 43.12 110.082 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.86 -40.31 96.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.314 -0.403 . . . . 73.04 110.383 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.7 mt -55.32 -56.05 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.556 -0.293 . . . . 73.41 110.691 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.2 -30.65 66.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.624 -0.431 . . . . 70.22 110.007 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.53 -34.43 76.9 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.907 -0.588 . . . . 72.2 111.214 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -92.62 -30.36 15.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 71.2 112.006 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.464 HD11 ' CG2' ' A' ' 74' ' ' VAL . 79.0 mt -67.81 -51.6 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 54.51 110.253 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.527 -0.76 . . . . 71.43 110.515 -175.816 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 85.1 mmm . . . . . 0 C--O 1.232 0.153 0 N-CA-C 109.929 -0.397 . . . . 71.32 109.929 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.14 113.27 10.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.705 -0.679 . . . . 62.2 109.862 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 3.5 tp10 -81.72 126.41 31.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.036 0.446 . . . . 70.14 111.166 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -80.35 119.37 22.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.804 -0.635 . . . . 71.41 109.697 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.3 pt -126.69 146.47 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.158 0.504 . . . . 73.54 111.726 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.44 -162.61 26.26 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.221 -0.899 . . . . 75.43 111.522 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.94 -55.46 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.717 0.294 . . . . 65.03 110.98 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 m -61.58 -37.73 84.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.265 0.555 . . . . 74.42 110.644 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -65.33 -36.65 84.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.518 -0.765 . . . . 75.54 111.573 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.9 t80 -51.97 -61.69 2.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.732 0.271 . . . . 65.25 111.732 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -55.66 -46.67 77.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.099 0.476 . . . . 73.42 110.853 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.97 -57.22 13.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.611 -0.722 . . . . 43.22 110.88 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 33.7 mmtp -61.8 -32.48 72.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 63.34 111.369 -175.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 31' ' ' PHE . 76.8 t -72.51 -48.11 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.716 0.293 . . . . 74.14 110.808 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.0 p -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 53.41 110.97 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.4 t -65.84 -4.1 6.16 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.17 -0.468 . . . . 74.54 112.06 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.5 p -65.29 112.77 3.63 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.298 -0.251 . . . . 55.23 110.788 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.37 -77.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 72.42 111.059 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -147.63 129.06 14.89 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.627 0.251 . . . . 63.42 110.851 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 52.33 21.48 1.71 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.84 -0.618 . . . . 72.45 112.045 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.0 111.09 14.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.349 -0.387 . . . . 70.51 109.989 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.4 tp -77.26 107.0 9.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.323 0.582 . . . . 72.33 110.113 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 101' ' ' MET . 27.4 mt -95.05 120.7 44.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.529 -0.76 . . . . 72.45 110.672 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 74' ' ' VAL . 5.8 mp -105.83 123.59 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.327 -0.62 . . . . 73.21 109.327 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.58 106.8 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.228 -0.286 . . . . 72.45 110.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.69 132.53 41.75 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.845 0.355 . . . . 62.13 110.21 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -89.12 62.78 6.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.487 . . . . 65.22 110.9 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.475 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 11.9 t90 70.68 -70.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.575 -0.739 . . . . 74.34 112.173 171.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 64.59 74.21 0.42 Allowed Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 123.13 0.572 . . . . 54.33 111.495 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -88.5 -66.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.85 2.367 . . . . 64.33 113.833 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -85.56 79.43 9.39 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.826 0.346 . . . . 73.15 110.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.5 p -171.38 139.08 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.571 . . . . 63.3 110.276 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.573 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -75.7 -66.22 1.92 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 116.008 -0.542 . . . . 43.4 112.556 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.82 -28.6 4.95 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.337 2.691 . . . . 54.22 113.686 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 81.5 m -52.96 -34.92 58.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.571 -0.286 . . . . 71.35 111.668 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 17.5 ptm180 -59.63 -38.01 80.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.585 -0.279 . . . . 74.44 110.56 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.5 t -75.21 -37.94 60.93 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.423 0.63 . . . . 70.35 110.319 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.3 mm? -61.24 -34.85 75.81 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 64.1 111.877 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.72 -58.3 20.47 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.313 -0.375 . . . . 65.12 111.262 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.67 -30.67 85.71 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.859 1.706 . . . . 64.23 111.909 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -63.32 -39.95 95.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.596 -0.442 . . . . 75.21 109.896 174.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.503 HD21 HD13 ' A' ' 119' ' ' ILE . 82.7 mt -69.85 -35.81 75.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.977 -0.556 . . . . 74.14 110.093 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 75.8 mt-10 -59.24 -42.59 91.46 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.118 -0.492 . . . . 65.51 109.97 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -58.11 -54.28 48.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.461 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 123' ' ' ILE . 56.6 mt -62.17 -30.56 71.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.883 0.373 . . . . 74.51 110.038 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.539 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -69.67 -41.82 74.98 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.89 -0.596 . . . . 43.32 110.628 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.3 mt-30 -70.59 -40.46 73.22 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.04 0.447 . . . . 74.13 110.72 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -75.66 -35.82 60.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.805 -0.634 . . . . 75.41 111.012 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.7 5.35 36.21 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.018 -0.537 . . . . 75.22 112.006 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.8 t -52.44 -18.99 1.9 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.994 0.517 . . . . 63.31 112.167 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.97 -35.84 64.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.312 -0.404 . . . . 74.02 111.13 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -133.87 -11.16 2.66 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.717 0.266 . . . . 60.25 111.717 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.567 HG13 HD13 ' A' ' 45' ' ' LEU . 55.2 t -105.35 141.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.032 0.444 . . . . 74.22 112.047 -172.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -144.56 121.93 11.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 71.33 109.02 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.7 mt -109.93 143.36 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.012 0.434 . . . . 73.14 111.51 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 90.7 m-85 -126.73 172.87 9.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.629 -0.714 . . . . 62.14 110.438 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 49' ' ' TRP . 14.2 tppt? -138.73 115.85 10.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 62.33 110.418 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.65 99.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.051 -0.722 . . . . 75.13 109.051 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -108.37 30.81 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 60.11 111.023 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.71 74.25 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.443 -0.577 . . . . 65.23 109.443 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -35.58 25.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.137 -0.938 . . . . 64.21 112.54 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.58 -35.89 70.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 63.52 111.144 -176.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -93.86 42.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.697 0.761 . . . . 73.53 110.446 -171.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.38 -15.45 60.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.246 -0.888 . . . . 73.43 110.491 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.09 -33.91 58.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.757 -0.656 . . . . 63.32 111.086 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.6 t -56.21 -34.41 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.795 -0.639 . . . . 71.01 110.874 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.01 75.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.09 -0.505 . . . . 74.24 110.648 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -64.35 -41.76 96.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.963 -0.562 . . . . 72.42 110.562 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -63.69 -53.19 55.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.143 -0.48 . . . . 52.44 111.371 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.42 -18.06 60.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 63.04 111.106 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.74 55.67 3.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.988 -0.625 . . . . 65.55 112.507 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -69.53 106.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.559 -0.534 . . . . 75.31 109.559 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' ' 112' ' ' ILE . 23.3 t -65.72 -56.93 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 63.12 110.984 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.94 27.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.679 0.276 . . . . 52.44 110.682 -177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 pt -95.16 149.31 36.03 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.873 -0.603 . . . . 75.51 110.602 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.47 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.2 Cg_exo -71.01 170.46 63.79 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.147 -1.189 . . . . 64.14 112.516 -1.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.3 m -139.55 125.75 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.649 -0.5 . . . . 74.0 109.649 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 49.9 mm -110.37 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 62.41 110.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -88.81 123.12 32.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.423 -0.584 . . . . 72.51 109.423 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 43.2 mtt -102.08 142.24 33.65 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.305 0.502 . . . . 65.12 111.32 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.57 144.96 33.11 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.478 -0.934 . . . . 73.14 108.478 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 40.1 ttpt -146.42 115.97 7.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.457 -0.497 . . . . 74.24 111.342 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 62.58 25.72 15.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.823 -0.626 . . . . 72.22 110.54 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.83 -7.97 80.72 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.804 -0.635 . . . . 43.11 112.658 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -85.46 151.26 24.11 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 122.3 0.24 . . . . 63.04 110.952 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.5 tmtt? -77.56 116.95 18.53 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.558 0.694 . . . . 71.43 109.972 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.415 ' CD2' ' HB3' ' A' ' 103' ' ' LYS . 4.2 mm? -112.05 168.85 9.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.534 -1.212 . . . . 61.41 110.377 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -177.21 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 72.41 111.863 -162.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -147.49 147.12 29.83 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.681 0.753 . . . . 74.54 111.019 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 13.5 t -122.8 135.43 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 114.066 -1.424 . . . . 70.11 109.698 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.458 HG21 ' HB3' ' A' ' 94' ' ' SER . 65.5 mt -123.68 127.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.559 -0.291 . . . . 62.14 110.414 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.76 162.31 38.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.216 -0.516 . . . . 60.32 112.415 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.56 78.58 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.931 0.396 . . . . 33.13 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.474 ' O ' HG13 ' A' ' 119' ' ' ILE . 43.3 t0 -126.38 91.41 3.36 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.048 0.451 . . . . 64.24 109.799 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 66' ' ' LEU . 9.0 tp -61.89 -27.5 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.605 -0.725 . . . . 62.15 110.654 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -69.87 -44.62 69.44 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.197 -0.456 . . . . 72.2 109.828 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -67.24 -38.96 86.07 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.69 -0.485 . . . . 55.14 109.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.503 HD13 HD21 ' A' ' 63' ' ' LEU . 76.3 mt -60.32 -56.1 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.067 -0.515 . . . . 62.22 110.954 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -39.83 86.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.774 0.321 . . . . 72.14 110.197 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.9 t -56.74 -47.58 79.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.151 -0.477 . . . . 43.12 109.862 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -66.43 -40.83 89.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 73.04 110.793 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 66' ' ' LEU . 96.9 mt -54.41 -56.18 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.79 -0.364 . . . . 73.41 110.125 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -67.42 -39.19 85.45 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.49 -0.484 . . . . 70.22 110.388 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.29 -38.4 90.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 72.2 111.86 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -83.15 -21.25 33.62 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.713 -0.221 . . . . 71.2 110.798 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.4 mt -72.4 -48.43 47.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.831 -0.433 . . . . 54.51 109.831 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.659 -0.686 . . . . 71.43 110.901 -179.846 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.407 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 83.4 mmm . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 120.704 0.288 . . . . 71.32 111.279 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -75.17 112.26 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 62.2 110.108 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.573 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 7.6 tp10 -71.07 150.27 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 70.14 110.74 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -118.06 126.63 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.567 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 31' ' ' PHE . 24.9 pt -143.13 166.63 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.236 -0.438 . . . . 73.54 111.16 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -100.87 -164.38 27.93 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.909 -0.587 . . . . 75.43 112.561 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.426 ' N ' HD11 ' A' ' 81' ' ' ILE . 12.3 t70 -69.12 -57.04 5.93 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.821 0.344 . . . . 65.03 111.361 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.35 -0.386 . . . . 74.42 110.236 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 45.5 mt-10 -68.86 -31.39 70.3 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.54 110.569 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.7 t80 -52.85 -60.12 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.074 0.464 . . . . 65.25 110.009 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.46 -45.91 73.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 73.42 110.848 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -66.39 -57.36 7.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 43.22 111.613 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG3' HG21 ' A' ' 26' ' ' ILE . 46.8 mmtm -60.52 -31.14 70.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.683 . . . . 63.34 111.214 -176.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 31' ' ' PHE . 68.1 t -73.43 -44.75 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.687 -0.233 . . . . 74.14 110.663 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.9 p -72.11 -14.62 61.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.995 0.426 . . . . 53.41 110.966 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.9 t -71.24 0.53 7.72 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.834 -0.621 . . . . 74.54 111.351 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.78 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.0 p -58.65 120.3 8.66 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.698 0.285 . . . . 55.23 110.739 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -67.65 -73.35 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.402 -0.363 . . . . 72.42 111.152 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -156.77 125.62 5.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.361 -0.381 . . . . 63.42 110.449 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 59.49 5.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.623 0.601 . . . . 72.45 112.623 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 73' ' ' ASN . 40.0 mm -68.13 112.72 3.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 70.51 110.73 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.478 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.1 tt -80.34 120.87 24.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.831 -0.803 . . . . 72.33 108.831 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.96 114.16 46.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.459 -0.791 . . . . 72.45 110.472 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.0 mp -101.93 137.36 40.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.587 -0.894 . . . . 73.21 108.587 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -124.74 110.44 25.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 110.21 -0.293 . . . . 72.45 110.21 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.51 122.16 22.64 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.53 -0.544 . . . . 62.13 109.53 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -69.11 -74.7 0.12 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.573 -0.528 . . . . 65.22 109.573 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.655 ' HZ3' ' HA ' ' A' ' 80' ' ' ASN . 8.5 t-105 -171.89 160.53 5.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.15 -0.477 . . . . 74.34 109.861 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.636 ' HB1' ' SG ' ' A' ' 53' ' ' CYS . . . -164.37 96.3 0.94 Allowed Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.276 0.36 . . . . 54.33 110.538 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.74 -77.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.936 2.424 . . . . 64.33 112.063 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -98.69 90.88 4.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.783 -0.451 . . . . 73.15 109.783 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.636 ' SG ' ' HB1' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -134.53 -58.75 0.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.652 -0.703 . . . . 63.3 110.78 -178.021 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.52 -85.83 0.4 Allowed Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.028 -0.606 . . . . 43.4 112.574 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.68 -22.04 42.23 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.999 2.466 . . . . 54.22 111.876 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.5 p -52.72 -33.27 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.621 -0.718 . . . . 71.35 110.986 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -60.65 -36.2 78.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.375 0.607 . . . . 74.44 110.041 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.8 m -74.56 -35.87 63.08 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.824 0.821 . . . . 70.35 110.042 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.5 mm? -65.59 -22.1 66.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.232 -0.895 . . . . 64.1 111.464 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 -57.92 -62.23 5.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.969 -0.382 . . . . 65.12 109.969 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 40.0 Cg_endo -67.08 -31.55 36.49 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 121.891 1.727 . . . . 64.23 112.079 176.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.561 ' HB2' ' HA ' ' A' ' 59' ' ' LEU . 79.5 mt-30 -60.3 -45.79 92.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.054 0.455 . . . . 75.21 110.824 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 119' ' ' ILE . 73.4 mt -64.75 -40.78 95.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.127 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 30.0 mt-10 -57.57 -43.78 84.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.433 -0.349 . . . . 65.51 110.323 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.71 -57.22 9.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.008 -0.542 . . . . 74.54 110.688 178.429 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.479 HD13 HD12 ' A' ' 123' ' ' ILE . 19.7 mt -64.88 -34.92 79.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.941 -0.572 . . . . 74.51 109.654 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.566 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -66.58 -27.96 68.14 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.694 -0.684 . . . . 43.32 111.355 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.3 mt-30 -85.22 -37.11 20.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.832 0.349 . . . . 74.13 110.847 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.85 -37.99 70.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 75.41 110.953 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -104.89 5.89 33.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.577 -0.738 . . . . 75.22 111.925 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -22.66 5.5 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.578 0.955 . . . . 63.31 113.578 -169.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -77.42 -18.81 56.92 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.288 -0.258 . . . . 74.02 111.362 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.471 ' HA ' HD13 ' A' ' 42' ' ' ILE . 6.3 t30 -134.34 6.68 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.499 -0.319 . . . . 60.25 110.826 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 43' ' ' LEU . 54.6 t -139.13 139.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.71 0.29 . . . . 74.22 110.879 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 20.6 tptm -142.46 123.0 14.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 71.33 109.757 173.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 45' ' ' LEU . 54.7 mt -98.08 125.39 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 73.14 110.508 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.552 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 62.3 m-85 -111.27 174.39 5.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.395 -0.594 . . . . 62.14 109.395 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HB2' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -156.08 152.71 28.34 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.295 -0.631 . . . . 62.33 109.295 167.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 34.4 pt -106.26 172.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.765 0.317 . . . . 75.13 111.016 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.655 ' HA ' ' HZ3' ' A' ' 49' ' ' TRP . 91.0 m-20 -113.04 -90.19 0.52 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.961 -0.563 . . . . 60.11 109.523 171.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 81' ' ' ILE . 19.8 mm 52.69 23.26 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.075 0.464 . . . . 65.23 111.488 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -47.83 -28.48 2.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.401 0.68 . . . . 64.21 111.951 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -72.25 -35.66 68.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.783 -0.644 . . . . 63.52 111.592 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.21 99.16 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 73.53 110.681 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -73.33 6.56 2.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.971 -0.559 . . . . 73.43 111.68 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -45.19 -40.07 6.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.117 -0.492 . . . . 63.32 110.744 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.0 t -61.51 -39.9 84.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.679 -0.692 . . . . 71.01 110.703 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.37 -46.2 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.259 0.552 . . . . 74.24 110.076 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.5 m -67.38 -39.47 85.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.142 -0.935 . . . . 72.42 111.22 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -67.09 -43.04 83.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.351 -0.386 . . . . 52.44 111.625 -177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -92.58 -12.27 32.18 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.703 0.26 . . . . 63.04 111.703 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.3 45.52 6.52 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.951 -0.642 . . . . 65.55 113.562 171.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.33 128.52 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.063 -0.347 . . . . 75.31 110.063 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 -16.66 7.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.489 -0.323 . . . . 63.12 111.071 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.4 168.44 25.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.421 -0.354 . . . . 52.44 110.104 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.1 pp -127.84 140.14 37.3 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.514 -0.312 . . . . 75.51 110.672 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 96.4 Cg_endo -78.78 -176.02 17.85 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 123.875 -1.302 . . . . 64.14 112.919 -0.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 m -147.6 124.5 11.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.686 -0.688 . . . . 74.0 109.638 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 48.7 mm -109.82 111.08 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.557 -0.292 . . . . 62.41 110.54 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 100' ' ' LEU . 1.9 mm? -88.12 123.5 32.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 72.51 109.283 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 109' ' ' SER . 26.3 mtt -103.36 142.12 34.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.729 0.299 . . . . 65.12 110.662 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -140.06 142.78 36.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.214 -0.662 . . . . 73.14 109.214 172.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 23.6 tptm -124.08 104.06 8.65 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.08 -0.248 . . . . 74.24 110.94 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.78 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.3 t30 40.8 40.69 1.02 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.967 0.507 . . . . 72.22 112.28 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.99 53.03 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.169 -0.539 . . . . 43.11 113.214 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -120.79 148.94 43.32 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 122.935 0.494 . . . . 63.04 109.846 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.617 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.4 tmtt? -64.48 130.36 43.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.292 0.568 . . . . 71.43 109.752 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.617 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -136.29 167.79 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.148 -0.933 . . . . 61.41 109.244 -173.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.511 ' H ' HD13 ' A' ' 108' ' ' LEU . 8.9 m -70.69 179.44 2.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.714 0.768 . . . . 72.41 112.731 -165.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.505 ' HG3' HD13 ' A' ' 100' ' ' LEU . 7.3 tt0 -148.78 131.97 16.41 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.233 -0.894 . . . . 74.54 109.963 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 6.5 t -110.57 113.87 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.55 -1.204 . . . . 70.11 109.995 -172.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.0 mm -97.8 120.65 47.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.081 -0.508 . . . . 62.14 109.979 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.12 -173.19 30.09 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.657 -0.577 . . . . 60.32 111.657 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.45 98.41 7.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.647 0.26 . . . . 33.13 111.059 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -142.32 101.68 3.95 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.067 0.461 . . . . 64.24 110.482 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.561 ' HB ' ' OE1' ' A' ' 62' ' ' GLN . 11.4 tp -66.0 -30.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 62.15 110.853 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.1 t -58.67 -50.63 73.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.16 0.505 . . . . 72.2 110.009 176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -63.77 -46.78 83.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.65 -0.704 . . . . 55.14 110.515 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 63' ' ' LEU . 77.0 mt -57.17 -56.3 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.19 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.16 -38.91 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.893 -0.41 . . . . 72.14 109.893 -177.344 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.2 t -57.21 -51.25 70.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.174 -0.466 . . . . 43.12 110.047 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.0 -40.53 98.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 73.04 110.772 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 66' ' ' LEU . 96.8 mt -56.98 -56.68 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.992 -0.283 . . . . 73.41 111.001 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.36 -35.98 76.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.872 0.368 . . . . 70.22 110.232 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.95 -36.61 84.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 72.2 110.961 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -95.73 -9.18 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 71.2 111.54 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 74' ' ' VAL . 78.1 mt -82.83 -44.27 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.311 0.577 . . . . 54.51 109.773 165.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.248 0.989 0 CA-C-N 115.502 -0.772 . . . . 71.43 110.424 -177.402 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.542 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.1 mmm . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 112.002 0.371 . . . . 71.32 112.002 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.536 HG22 ' HG2' ' A' ' 78' ' ' LYS . 10.8 mm -67.04 130.93 32.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 120.679 0.276 . . . . 62.2 110.771 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 77' ' ' TYR . 2.6 pt-20 -105.39 161.28 14.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.848 -0.427 . . . . 70.14 109.848 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 3.9 pp0? -118.35 147.01 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.457 0.17 . . . . 71.41 110.772 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 pt -139.41 156.38 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.784 0.326 . . . . 73.54 110.823 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.1 179.01 48.31 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.908 -0.587 . . . . 75.43 112.492 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.58 -44.97 96.03 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.957 0.408 . . . . 65.03 111.342 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -65.08 -30.15 71.09 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.295 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -80.96 -20.31 42.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.836 -0.62 . . . . 75.54 111.474 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.1 t80 -57.63 -61.91 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.482 0.182 . . . . 65.25 111.138 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.78 -44.6 96.58 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.071 0.462 . . . . 73.42 110.237 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -53.62 -57.53 10.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.262 -0.881 . . . . 43.22 110.998 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -62.01 -43.64 98.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.223 -0.444 . . . . 63.34 111.162 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.658 HG12 ' HA2' ' A' ' 105' ' ' GLY . 73.9 t -62.67 -36.93 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.34 -0.391 . . . . 74.14 111.524 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -86.43 -29.2 23.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.047 0.388 . . . . 53.41 112.047 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -83.76 11.06 8.03 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.363 0.505 . . . . 74.54 112.363 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.2 p -59.4 143.89 48.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.244 -0.28 . . . . 55.23 110.244 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.4 -74.12 0.06 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.634 0.254 . . . . 72.42 110.715 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -161.74 126.22 3.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.159 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 57.05 12.27 1.21 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.672 0.619 . . . . 72.45 112.672 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 51.1 mm -64.09 117.89 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.519 -0.549 . . . . 70.51 109.519 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.1 112.2 13.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 72.33 110.105 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 38' ' ' CYS . 72.4 mt -98.7 105.64 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.001 -0.545 . . . . 72.45 110.634 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 74' ' ' VAL . 5.1 mp -90.51 116.29 28.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.082 -0.71 . . . . 73.21 109.082 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.72 105.26 18.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.768 -0.456 . . . . 72.45 109.768 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.454 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 56.5 t0 -84.28 123.24 29.93 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.854 -0.612 . . . . 62.13 110.381 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 100' ' ' LEU . 76.8 m-85 -102.9 125.3 49.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 65.22 110.592 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -117.35 148.32 41.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.03 -0.532 . . . . 74.34 111.103 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . -109.25 -178.19 0.54 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.093 -0.958 . . . . 54.33 109.245 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 85.6 Cg_exo -46.15 -26.6 3.83 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.515 2.143 . . . . 64.33 112.628 173.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -142.81 178.9 7.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.715 . . . . 73.15 109.648 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.641 ' HA ' HG12 ' A' ' 96' ' ' ILE . 14.1 p -157.8 165.4 35.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.426 -0.213 . . . . 63.3 110.426 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.52 -108.15 1.05 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.217 -0.516 . . . . 43.4 113.374 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.442 ' O ' HD23 ' A' ' 59' ' ' LEU . 95.1 Cg_endo -80.65 45.52 2.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.257 2.638 . . . . 54.22 113.514 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 95.9 m -65.33 -22.63 66.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.464 -0.334 . . . . 71.35 111.85 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 57' ' ' ARG . 35.0 ttt180 -54.06 -60.92 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.61 0.243 . . . . 74.44 111.458 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.4 m -75.58 -41.6 54.2 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.408 0.623 . . . . 70.35 111.615 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.552 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -67.84 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.881 0.697 . . . . 64.1 112.881 -169.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 42.5 mt-10 -59.54 -60.48 10.43 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 120.225 -0.59 . . . . 65.12 110.286 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.82 -36.53 96.87 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.615 1.543 . . . . 64.23 112.007 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -60.73 -47.01 88.24 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.805 -0.358 . . . . 75.21 110.86 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 119' ' ' ILE . 91.9 mt -67.4 -41.01 85.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 74.14 110.618 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 31.5 mt-10 -69.5 -24.18 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 65.51 110.712 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -68.43 -49.83 57.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.239 -0.282 . . . . 74.54 110.239 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.452 HD13 HD12 ' A' ' 123' ' ' ILE . 51.5 mt -62.54 -30.98 71.7 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.685 -0.487 . . . . 74.51 109.685 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.76 -51.55 64.34 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.927 -0.579 . . . . 43.32 109.772 173.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.542 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 35.7 mm-40 -51.97 -48.77 64.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.12 -0.491 . . . . 74.13 111.259 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -76.15 -36.8 58.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.744 -0.662 . . . . 75.41 111.577 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -104.53 3.88 32.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.989 0.737 . . . . 75.22 112.989 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.6 t -53.82 -19.43 4.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.934 0.397 . . . . 63.31 112.019 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.39 -24.18 64.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 74.02 111.168 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -134.48 1.19 3.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.347 -0.388 . . . . 60.25 110.781 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 45' ' ' LEU . 5.2 t -127.32 138.75 53.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.851 0.357 . . . . 74.22 111.381 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -134.57 129.71 35.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.404 -0.961 . . . . 71.33 108.404 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 45' ' ' LEU . 17.1 mt -119.67 115.89 48.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.14 0.495 . . . . 73.14 110.778 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.43 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 87.3 m-85 -106.17 151.64 24.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 62.14 110.871 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.536 ' HG2' HG22 ' A' ' 23' ' ' ILE . 61.0 mmtt -109.43 125.78 52.78 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.331 -0.849 . . . . 62.33 109.742 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -93.98 67.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.989 -1.486 . . . . 75.13 106.989 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.54 89.52 6.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.227 -0.897 . . . . 60.11 110.854 -171.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.5 mt -132.44 112.94 20.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.542 -0.91 . . . . 65.23 108.542 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -18.15 58.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 64.21 110.948 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' H ' HG22 ' A' ' 81' ' ' ILE . 65.3 m-20 -83.68 17.02 2.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.566 -0.288 . . . . 63.52 111.753 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -76.25 52.37 0.75 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.856 0.687 . . . . 73.53 112.856 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -82.73 -61.14 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.765 -0.828 . . . . 73.43 108.765 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.2 m-20 -48.66 -49.18 38.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.988 -1.005 . . . . 63.32 110.985 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.49 -36.85 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 71.01 110.628 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.22 75.39 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.864 -0.421 . . . . 74.24 109.864 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 72.42 110.669 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.4 mm100 -75.03 -48.49 23.75 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.963 -0.562 . . . . 52.44 111.167 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.56 -10.27 52.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 63.04 111.381 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.34 56.11 11.0 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.109 -0.567 . . . . 65.55 111.887 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.4 t -77.25 109.37 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 75.31 110.468 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.447 ' HB2' HG21 ' A' ' 112' ' ' ILE . 12.1 m -63.27 -54.08 42.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.277 -0.419 . . . . 63.12 111.186 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.31 138.92 18.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 52.44 110.488 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.835 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.31 147.43 33.11 Favored Pre-proline 0 C--O 1.236 0.377 0 O-C-N 123.364 0.415 . . . . 75.51 110.504 -178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.479 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.3 Cg_exo -70.57 166.03 77.31 Favored 'Cis proline' 0 C--N 1.357 1.021 0 C-N-CA 124.24 -1.15 . . . . 64.14 113.12 3.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.546 HG23 HG12 ' A' ' 112' ' ' ILE . 88.6 m -145.8 130.75 18.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.642 . . . . 74.0 109.839 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.463 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 42.8 mm -109.8 110.79 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 62.41 111.193 -173.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' A' ' 48' ' ' PHE . 8.4 mp -101.13 123.41 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.501 -0.555 . . . . 72.51 109.501 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.539 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 22.2 mtt -92.26 145.6 24.36 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.138 -0.319 . . . . 65.12 110.138 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.4 m-85 -142.12 152.56 43.37 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.747 -0.464 . . . . 73.14 109.747 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -145.24 114.88 7.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.444 0.164 . . . . 74.24 110.814 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.517 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 32.0 t-20 57.4 41.04 26.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.371 0.605 . . . . 72.22 110.396 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.658 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 71.04 2.81 49.35 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 115.942 -0.572 . . . . 43.11 112.843 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -101.19 147.3 26.42 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 120.732 0.301 . . . . 63.04 110.797 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -56.62 129.57 41.55 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.638 1.212 . . . . 71.43 112.161 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -136.61 167.95 20.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.138 -1.392 . . . . 61.41 108.287 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.21 172.01 8.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.823 0.675 . . . . 72.41 112.823 -163.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -138.34 138.19 38.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.65 -0.704 . . . . 74.54 110.558 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.0 m -126.47 139.92 50.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.197 -0.456 . . . . 70.11 109.876 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.546 HG12 HG23 ' A' ' 98' ' ' THR . 38.7 mt -127.16 142.99 41.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.946 -0.57 . . . . 62.14 109.88 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.27 -152.16 21.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.036 -0.602 . . . . 60.32 112.417 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -125.98 93.18 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 33.13 111.741 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.5 t70 -145.03 91.21 2.12 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 64.24 108.655 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 tp -64.54 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.614 -0.721 . . . . 62.15 110.752 -171.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -66.93 -45.35 78.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.076 -0.511 . . . . 72.2 110.082 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' HD3' ' HG2' ' A' ' 122' ' ' GLU . 14.9 tppt? -69.19 -39.82 78.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 55.14 110.277 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 63' ' ' LEU . 78.1 mt -58.66 -56.08 18.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.383 -0.371 . . . . 62.22 110.509 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.4 -37.37 77.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.726 -0.472 . . . . 72.14 109.726 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -54.04 -52.01 62.21 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.102 -0.499 . . . . 43.12 110.491 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -72.17 -28.33 63.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 73.04 110.917 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 120' ' ' ILE . 97.6 mt -59.49 -56.21 18.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 120.634 -0.427 . . . . 73.41 110.143 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.19 -25.37 62.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.727 0.298 . . . . 70.22 110.325 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.469 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 30.4 t30 -62.31 -48.21 80.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.618 -0.719 . . . . 72.2 110.598 175.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.539 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.3 m-20 -80.88 -26.81 36.61 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.526 -0.761 . . . . 71.2 111.671 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 74' ' ' VAL . 71.1 mt -74.86 -49.84 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.689 0.28 . . . . 54.51 110.814 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.578 -0.725 . . . . 71.43 110.673 -174.368 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.9 mmm . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.761 0.315 . . . . 71.32 111.058 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -91.03 100.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.023 -0.732 . . . . 62.2 109.023 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 28.9 tt0 -94.06 112.26 24.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 70.14 110.641 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -72.36 132.0 43.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 71.41 110.089 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.513 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.2 pt -130.85 152.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 73.54 110.208 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.69 165.31 45.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.131 -0.557 . . . . 75.43 112.421 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -50.87 -39.05 52.86 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.843 0.457 . . . . 65.03 111.465 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -71.15 -36.84 72.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 74.42 110.546 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.44 -13.59 60.4 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 115.837 -0.62 . . . . 75.54 111.265 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 35' ' ' VAL . 75.8 t80 -56.36 -62.15 1.92 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.594 0.235 . . . . 65.25 110.714 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.79 -47.49 80.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 73.42 110.484 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.13 -57.57 10.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.619 -0.719 . . . . 43.22 111.094 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.6 mmtt -64.95 -36.98 86.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 63.34 111.236 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 31' ' ' PHE . 74.7 t -64.07 -41.72 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.96 0.41 . . . . 74.14 110.735 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.2 p -86.24 -9.96 55.52 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.31 -0.405 . . . . 53.41 111.702 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.3 t -74.42 -2.96 27.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.281 0.233 . . . . 74.54 111.556 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.612 ' SG ' HD11 ' A' ' 44' ' ' ILE . 59.3 m -70.05 134.21 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.612 -0.267 . . . . 55.23 111.157 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -65.97 -78.03 0.06 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.833 -0.803 . . . . 72.42 108.833 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -162.49 156.43 21.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.316 -0.624 . . . . 63.42 109.316 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.659 ' HA ' ' HE2' ' A' ' 103' ' ' LYS . 53.2 m-20 62.06 13.08 5.42 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.1 0.56 . . . . 72.45 111.915 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 49.6 mm -86.85 106.65 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.897 -0.409 . . . . 70.51 109.897 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.51 109.13 16.45 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.804 -0.635 . . . . 72.33 109.437 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.612 HD11 ' SG ' ' A' ' 38' ' ' CYS . 46.3 mt -92.0 121.93 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.576 . . . . 72.45 110.836 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.564 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.7 mp -103.66 110.92 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.226 -0.657 . . . . 73.21 109.226 173.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.95 107.21 19.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.067 -0.345 . . . . 72.45 110.067 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.29 96.49 1.43 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.993 -0.743 . . . . 62.13 108.993 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 35.7 t80 -60.84 99.35 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.175 -0.92 . . . . 65.22 111.579 -172.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.454 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 59.05 -82.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.632 -0.713 . . . . 74.34 111.863 173.05 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 51' ' ' PRO . . . 53.69 48.3 4.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.185 0.594 . . . . 54.33 111.856 -175.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 50' ' ' ALA . 2.8 Cg_exo -75.29 -19.88 16.83 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.541 2.16 . . . . 64.33 112.345 -173.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -75.3 -38.58 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 73.15 110.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 8.3 t 54.95 82.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.441 -0.799 . . . . 63.3 111.084 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.93 -78.81 1.12 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.582 -0.607 . . . . 43.4 111.582 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.471 ' O ' HD23 ' A' ' 59' ' ' LEU . 6.0 Cg_exo -76.51 11.77 1.79 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.212 2.608 . . . . 54.22 111.81 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 5.6 p -63.73 -23.6 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.598 -0.728 . . . . 71.35 111.325 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -54.43 -52.48 61.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.492 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.553 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.9 m -75.29 -48.14 24.62 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.87 0.843 . . . . 70.35 111.806 178.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.1 mm? -68.09 -28.1 67.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 64.1 112.516 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.2 tt0 -58.56 -59.88 12.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.98 -0.378 . . . . 65.12 109.98 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 37.1 Cg_endo -66.04 -37.1 27.25 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.67 1.58 . . . . 64.23 112.107 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.87 -45.32 86.49 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.273 -0.571 . . . . 75.21 110.823 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 119' ' ' ILE . 84.8 mt -66.04 -41.18 91.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.416 -0.356 . . . . 74.14 110.678 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 51.9 mt-10 -57.41 -41.42 80.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.727 0.299 . . . . 65.51 110.344 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.04 -56.07 22.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.304 -0.407 . . . . 74.54 111.264 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.55 -34.71 71.32 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 74.51 109.902 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.11 -49.15 71.05 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.509 -0.769 . . . . 43.32 110.571 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.8 mt-30 -62.27 -41.56 98.58 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.004 0.43 . . . . 74.13 110.725 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -68.25 -38.49 81.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 75.41 110.937 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -104.49 4.18 32.84 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.347 0.499 . . . . 75.22 112.347 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.4 t -54.03 -19.66 5.17 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.785 0.661 . . . . 63.31 112.785 -172.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -61.3 -36.64 80.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.043 0.449 . . . . 74.02 110.094 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -120.57 -4.49 9.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.877 -0.601 . . . . 60.25 111.281 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.472 HG13 HD13 ' A' ' 45' ' ' LEU . 43.8 t -123.02 148.15 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.016 0.436 . . . . 74.22 111.569 -174.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.2 tptm -149.44 133.15 16.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.773 -0.649 . . . . 71.33 109.41 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 45' ' ' LEU . 52.6 mt -108.99 135.76 46.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.888 0.375 . . . . 73.14 111.082 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 49.3 m-85 -130.77 168.04 17.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.734 -0.666 . . . . 62.14 110.176 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB2' ' HZ2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -174.18 153.46 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 62.33 109.997 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tp -121.02 119.68 60.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.51 -0.922 . . . . 75.13 108.51 170.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -94.96 44.31 1.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.23 -0.441 . . . . 60.11 111.689 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.0 pt -71.05 78.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 122.105 0.955 . . . . 65.23 109.409 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -47.48 -44.69 25.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 113.9 -1.5 . . . . 64.21 114.092 -167.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.726 0.298 . . . . 63.52 111.393 -173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.41 51.61 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 73.53 110.136 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -85.53 3.17 41.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.97 -0.559 . . . . 73.43 111.986 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.49 -39.0 64.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.19 0.519 . . . . 63.32 110.055 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.03 -34.45 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.195 -0.912 . . . . 71.01 110.495 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HB2' ' HE2' ' A' ' 48' ' ' PHE . . . -64.46 -52.08 59.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.212 -0.449 . . . . 74.24 110.301 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.8 m -62.25 -32.72 73.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 72.42 111.034 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -53.89 16.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.466 -0.334 . . . . 52.44 111.346 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -79.51 -10.24 59.76 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.507 -0.315 . . . . 63.04 111.732 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.23 43.01 5.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.926 -0.654 . . . . 65.55 113.558 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.98 135.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.52 -0.548 . . . . 75.31 109.52 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.8 m -133.04 1.42 3.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.057 0.391 . . . . 63.12 112.057 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.98 156.57 47.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.016 0.436 . . . . 52.44 111.635 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 pt -125.98 122.02 24.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.749 -0.659 . . . . 75.51 110.074 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.31 -172.62 9.13 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.737 -1.36 . . . . 64.14 112.647 -0.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.51 HG23 HD13 ' A' ' 112' ' ' ILE . 47.2 m -145.06 128.29 16.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.501 -0.772 . . . . 74.0 109.177 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 47.6 mm -110.13 116.08 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.578 0.228 . . . . 62.41 111.018 -174.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.3 mt -99.02 123.48 43.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.312 -0.625 . . . . 72.51 109.312 174.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.3 mtt -97.96 144.38 27.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.203 -0.295 . . . . 65.12 110.203 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.43 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -143.6 144.83 32.09 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.003 -0.369 . . . . 73.14 110.003 175.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 41' ' ' ASN . 52.9 tttm -131.82 105.2 7.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.092 -0.243 . . . . 74.24 110.57 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 59.1 t30 58.9 30.67 20.46 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.717 0.77 . . . . 72.22 110.199 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.74 -16.37 54.62 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.614 -0.721 . . . . 43.11 112.517 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 2.4 tmmm? -76.1 140.19 41.71 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 109.608 -0.515 . . . . 63.04 109.608 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 106' ' ' LYS . 2.3 tmtp? -57.68 139.09 54.6 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.196 0.935 . . . . 71.43 110.742 -176.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -146.51 168.36 21.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.967 -1.015 . . . . 61.41 108.636 -171.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 m -70.32 175.45 4.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.601 0.963 . . . . 72.41 113.601 -161.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -141.01 142.03 34.28 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.956 -1.02 . . . . 74.54 110.769 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 15.3 t -123.55 114.56 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.995 -1.457 . . . . 70.11 109.946 -174.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.51 HD13 HG23 ' A' ' 98' ' ' THR . 46.2 mm -106.71 121.1 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.763 -0.653 . . . . 62.14 109.972 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.03 163.96 33.69 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.433 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.513 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -85.6 79.99 9.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.288 . . . . 33.13 111.021 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.7 t70 -124.52 91.9 3.54 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.398 -0.593 . . . . 64.24 109.398 175.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.57 -31.94 52.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.883 -0.599 . . . . 62.15 111.205 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.6 t -62.7 -44.08 97.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.16 -0.473 . . . . 72.2 109.978 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -70.52 -37.47 74.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 55.14 109.952 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.506 HG12 HG11 ' A' ' 111' ' ' VAL . 72.8 mt -56.74 -56.27 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.257 -0.429 . . . . 62.22 110.674 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.523 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.54 -37.91 81.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 110.22 -0.289 . . . . 72.14 110.22 -177.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -56.99 -51.97 67.13 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.937 -0.394 . . . . 43.12 109.937 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.49 -41.83 97.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.121 -0.49 . . . . 73.04 110.755 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.1 mt -53.06 -56.18 9.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.625 0.25 . . . . 73.41 110.412 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -71.57 -35.46 70.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.718 -0.393 . . . . 70.22 110.727 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -63.97 -35.18 79.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 72.2 111.208 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.421 ' HB3' HD11 ' A' ' 108' ' ' LEU . 84.8 m-20 -91.21 -31.15 16.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 71.2 111.707 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 123' ' ' ILE . 71.9 mt -58.55 -53.26 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 54.51 110.599 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 . . . . . 0 C--O 1.25 1.11 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.358 -175.556 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.533 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.7 mmm . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.202 0.525 . . . . 71.32 109.832 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -78.92 133.69 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.404 -0.816 . . . . 62.2 110.3 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -94.18 155.36 17.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 70.14 110.111 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -119.0 139.45 51.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.028 -0.73 . . . . 71.41 109.028 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 31' ' ' PHE . 32.6 pt -141.75 159.72 21.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.031 0.444 . . . . 73.54 111.558 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.72 -168.52 33.78 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.475 -0.784 . . . . 75.43 112.203 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.12 -48.87 72.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.657 0.383 . . . . 65.03 111.451 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 t -72.0 -40.83 68.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.42 110.371 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.31 -23.92 64.58 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.267 -0.424 . . . . 75.54 111.08 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.5 t80 -49.97 -58.2 5.95 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.851 0.357 . . . . 65.25 110.288 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -56.4 -57.52 11.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.89 -0.596 . . . . 73.42 110.599 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.87 -50.44 63.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.719 -0.673 . . . . 43.22 111.453 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.3 mmtt -68.32 -41.82 80.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 63.34 111.561 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 44' ' ' ILE . 76.1 t -70.46 -36.26 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 111.791 0.293 . . . . 74.14 111.791 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.3 p -85.96 -37.32 19.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.833 0.309 . . . . 53.41 111.833 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.5 t -83.82 10.83 8.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.033 0.383 . . . . 74.54 112.033 -173.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.812 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 19.9 p -59.99 146.99 40.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 110.32 -0.252 . . . . 55.23 110.32 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -45.98 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.406 0.682 . . . . 72.42 111.996 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.75 122.62 3.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.419 -0.215 . . . . 63.42 110.419 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.56 7.25 2.34 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.787 0.435 . . . . 72.45 112.024 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.26 137.46 22.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.872 0.367 . . . . 70.51 111.247 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -81.12 123.61 28.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.534 -0.913 . . . . 72.33 108.534 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 82.1 mt -115.44 121.57 67.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.266 -0.425 . . . . 72.45 110.207 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -109.86 113.08 25.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.111 -0.7 . . . . 73.21 109.111 175.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.25 105.0 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.946 -0.39 . . . . 72.45 109.946 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.92 127.89 32.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.81 -0.632 . . . . 62.13 110.692 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -94.59 125.82 39.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.528 -0.916 . . . . 65.22 108.528 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -53.49 139.8 30.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.17 0.509 . . . . 74.34 111.622 -174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -95.33 108.49 39.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.446 -0.797 . . . . 54.33 111.102 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 21.0 Cg_endo -60.74 -32.27 92.82 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.402 2.068 . . . . 64.33 111.061 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -101.16 93.08 5.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.485 -0.931 . . . . 73.15 108.485 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.468 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 10.4 t -91.82 89.23 6.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 63.3 110.32 -174.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.49 -86.25 1.62 Allowed Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.735 -0.666 . . . . 43.4 111.449 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.72 -11.92 16.22 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.139 2.559 . . . . 54.22 112.153 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 15.4 p -50.62 -43.59 56.93 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.534 -0.757 . . . . 71.35 110.948 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -54.89 -41.02 70.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.513 -0.767 . . . . 74.44 111.524 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.3 m -75.88 -53.39 8.51 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.991 0.9 . . . . 70.35 111.701 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -61.28 -44.42 97.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.853 -1.067 . . . . 64.1 111.914 -168.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.3 -52.63 73.07 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 119.516 -0.278 . . . . 65.12 111.336 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 58' ' ' SER . 17.7 Cg_endo -61.67 -31.66 86.58 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.512 1.475 . . . . 64.23 112.137 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.1 mt-30 -62.88 -35.98 81.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.185 -0.606 . . . . 75.21 109.75 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.79 -39.08 76.8 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.792 -0.64 . . . . 74.14 109.937 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 mt-10 -53.69 -47.74 70.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.801 -0.444 . . . . 65.51 109.801 175.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -58.79 -52.45 65.65 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.942 -0.572 . . . . 74.54 111.251 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 116' ' ' ILE . 48.9 mt -62.26 -34.89 77.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.912 0.387 . . . . 74.51 110.093 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.07 -43.41 95.55 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.946 -0.57 . . . . 43.32 109.99 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 51.3 mt-30 -64.86 -46.49 81.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.05 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -72.87 -34.41 66.71 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.996 0.427 . . . . 75.41 111.21 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -104.7 4.04 32.09 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.328 0.492 . . . . 75.22 112.328 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -53.32 -19.55 3.43 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.957 0.408 . . . . 63.31 111.536 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.63 -38.08 69.04 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.981 -0.554 . . . . 74.02 110.836 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -135.21 12.08 3.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.075 -0.511 . . . . 60.25 111.331 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.55 139.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.064 0.459 . . . . 74.22 111.617 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -143.63 119.93 10.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.419 -0.81 . . . . 71.33 109.187 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 45' ' ' LEU . 40.5 mt -104.8 137.25 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.715 0.293 . . . . 73.14 110.706 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.45 151.15 40.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.935 -0.575 . . . . 62.14 109.895 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -120.8 102.74 8.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.624 -0.88 . . . . 62.33 108.624 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.7 tt -80.47 102.2 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.613 0.72 . . . . 75.13 110.134 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -84.82 75.46 10.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 60.11 111.172 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.403 HD11 HG11 ' A' ' 87' ' ' VAL . 29.5 pt -124.03 24.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.011 -0.737 . . . . 65.23 109.011 171.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -58.02 -18.64 25.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.552 -1.204 . . . . 64.21 111.561 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.16 -23.23 62.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.317 0.58 . . . . 63.52 109.661 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.35 95.25 7.94 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.508 -0.923 . . . . 73.53 108.508 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.211 -0.45 . . . . 73.43 111.667 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 14.5 m-20 -56.61 -32.96 65.79 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.471 -0.331 . . . . 63.32 111.286 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 81' ' ' ILE . 75.0 t -53.06 -38.63 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.467 -0.333 . . . . 71.01 110.537 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.7 -48.81 75.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.17 0.509 . . . . 74.24 109.827 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -59.34 -36.99 76.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.486 -0.779 . . . . 72.42 110.726 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 11.6 mm-40 -71.7 -51.27 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.006 -0.543 . . . . 52.44 110.492 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -73.98 -13.32 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.221 -0.445 . . . . 63.04 111.548 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.8 21.44 36.57 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.904 -0.665 . . . . 65.55 112.777 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.478 HG13 ' OG1' ' A' ' 98' ' ' THR . 64.5 t -70.42 117.28 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.156 -0.312 . . . . 75.31 110.156 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 t -136.45 8.03 3.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 63.12 110.985 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.597 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -147.18 164.06 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.794 -0.447 . . . . 52.44 109.794 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.618 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -122.51 122.0 27.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.439 -0.346 . . . . 75.51 111.207 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 66.5 Cg_endo -87.06 -166.78 3.92 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.825 -1.323 . . . . 64.14 112.022 -3.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 112' ' ' ILE . 81.5 m -138.92 120.35 14.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.535 -0.302 . . . . 74.0 110.202 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 111' ' ' VAL . 47.5 mm -110.35 117.34 54.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.86 -0.609 . . . . 62.41 110.881 -174.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -100.59 123.22 44.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.535 -0.543 . . . . 72.51 109.535 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 109' ' ' SER . 11.6 mmt -87.65 148.08 24.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.686 0.279 . . . . 65.12 110.42 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.6 m-85 -145.45 160.99 40.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.956 -0.757 . . . . 73.14 108.956 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -148.79 109.46 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.621 0.248 . . . . 74.24 110.88 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.812 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER 59.9 31.84 20.91 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.746 -0.661 . . . . 72.22 110.352 177.154 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.494 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 87.52 -14.43 58.06 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.918 -0.583 . . . . 43.11 112.411 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -81.76 139.56 34.76 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 110.301 -0.259 . . . . 63.04 110.301 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -58.88 149.6 26.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.812 -0.631 . . . . 71.43 111.511 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -154.39 168.01 28.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.127 0.971 . . . . 61.41 108.845 -170.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 101' ' ' MET . 3.1 m -70.35 148.17 48.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.571 0.7 . . . . 72.41 112.875 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -110.14 118.52 36.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 74.54 110.204 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.647 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.5 m -101.62 116.0 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 70.11 109.527 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.597 HG22 ' HB3' ' A' ' 95' ' ' ALA . 47.4 mt -107.59 120.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 62.14 110.577 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.11 160.84 12.44 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.246 -0.502 . . . . 60.32 112.238 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.76 83.42 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 33.13 111.017 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.5 t70 -133.75 92.22 2.94 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.344 -0.613 . . . . 64.24 109.344 174.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.536 HD11 HD11 ' A' ' 66' ' ' LEU . 8.8 tp -62.3 -32.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 62.15 111.413 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -65.29 -43.62 90.54 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.151 0.501 . . . . 72.2 110.065 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 14.8 tppt? -68.38 -43.13 78.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.935 -0.575 . . . . 55.14 110.19 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 59' ' ' LEU . 70.8 mt -57.25 -51.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.709 -0.223 . . . . 62.22 110.676 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.522 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.02 -35.63 75.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.957 -0.386 . . . . 72.14 109.957 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.5 t -54.11 -51.23 64.86 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.147 0.498 . . . . 43.12 110.094 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 12.7 mm-40 -71.09 -31.84 68.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 73.04 110.766 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 120' ' ' ILE . 88.7 mt -58.15 -56.26 17.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.902 0.382 . . . . 73.41 110.037 176.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -65.8 -36.58 83.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.76 -0.459 . . . . 70.22 109.76 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -58.71 -41.57 86.65 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.097 -0.501 . . . . 72.2 110.966 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.403 ' HB2' HD11 ' A' ' 43' ' ' LEU . 81.5 m-20 -87.2 -12.75 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 71.2 111.371 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 123' ' ' ILE . 74.3 mt -80.88 -48.36 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.032 -0.359 . . . . 54.51 110.032 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.464 -0.779 . . . . 71.43 110.739 -179.119 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.436 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 92.5 mmm . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.882 0.372 . . . . 71.32 110.725 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' A' ' 78' ' ' LYS . 18.3 mm -78.13 87.98 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.744 -0.835 . . . . 62.2 108.744 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.06 112.12 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.635 -0.711 . . . . 70.14 111.341 -171.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -72.83 132.36 43.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.692 -0.485 . . . . 71.41 109.692 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.53 HG21 ' HG3' ' A' ' 34' ' ' LYS . 39.0 pt -133.12 160.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.794 0.33 . . . . 73.54 110.952 -176.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.22 -177.36 40.45 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.921 -0.581 . . . . 75.43 112.95 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.01 -43.24 99.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.96 0.504 . . . . 65.03 111.622 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -74.09 -37.17 64.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.074 0.464 . . . . 74.42 110.67 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.85 -26.74 68.75 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.783 -0.644 . . . . 75.54 110.762 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.456 ' HD2' HG21 ' A' ' 79' ' ' ILE . 88.8 t80 -46.14 -61.66 1.67 Allowed 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.33 0.394 . . . . 65.25 111.122 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -50.31 69.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.914 -0.585 . . . . 73.42 110.891 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.75 -57.39 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.74 . . . . 43.22 110.75 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.4 mmtt -58.01 -44.19 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.12 -0.945 . . . . 63.34 111.181 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.04 -48.13 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.714 0.292 . . . . 74.14 111.313 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.4 p -77.43 -15.28 59.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.701 0.286 . . . . 53.41 111.595 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 t -69.55 -5.38 23.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.322 -0.399 . . . . 74.54 111.983 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 13.4 p -62.41 108.63 1.15 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.621 0.248 . . . . 55.23 110.501 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -58.43 -73.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.185 -0.462 . . . . 72.42 111.625 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -153.97 121.89 6.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.7 0.286 . . . . 63.42 110.913 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 61.3 8.3 2.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.6 0.76 . . . . 72.45 111.968 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -73.89 113.85 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.245 -0.434 . . . . 70.51 110.123 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -82.21 119.26 23.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.103 -0.499 . . . . 72.33 109.656 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.45 119.98 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.596 -0.729 . . . . 72.45 110.483 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -103.95 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.052 -0.721 . . . . 73.21 109.052 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 98.3 t -115.71 109.57 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.07 -0.344 . . . . 72.45 110.07 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.3 t70 -87.0 127.86 35.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 62.13 111.949 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -101.46 87.31 3.16 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.393 -0.595 . . . . 65.22 109.393 170.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.37 119.84 11.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.408 -0.815 . . . . 74.34 110.508 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 144.4 29.61 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.446 . . . . 54.33 110.397 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.51 -34.38 85.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.701 2.267 . . . . 64.33 112.523 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -119.76 119.16 32.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 73.15 110.087 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' ' HB ' ' A' ' 96' ' ' ILE . 47.9 t -163.88 140.79 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.3 110.567 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.03 -72.14 1.21 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.216 -0.447 . . . . 43.4 112.652 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.35 -22.36 20.5 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.056 2.504 . . . . 54.22 113.29 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 98.3 m -54.17 -24.91 19.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.57 -0.286 . . . . 71.35 111.375 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -53.95 -49.95 67.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.38 0.61 . . . . 74.44 110.165 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 12.6 m -75.0 -40.72 60.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.399 -0.819 . . . . 70.35 111.079 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.4 mm? -62.42 -41.6 98.82 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.774 0.657 . . . . 64.1 112.774 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -55.43 -54.64 48.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 117.873 0.306 . . . . 65.12 111.272 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HG2' ' O ' ' A' ' 58' ' ' SER . 21.1 Cg_endo -63.15 -35.73 62.36 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.524 1.483 . . . . 64.23 112.005 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.9 mt-30 -64.01 -31.12 72.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.643 -0.423 . . . . 75.21 110.584 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 76.0 mt -70.0 -42.02 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 74.14 109.982 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -63.53 -34.02 76.87 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 120.866 -0.334 . . . . 65.51 110.337 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 36.7 ttmt -55.6 -57.18 13.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.784 0.326 . . . . 74.54 110.298 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD12 ' A' ' 123' ' ' ILE . 33.0 mt -66.61 -38.42 86.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 74.51 110.367 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.32 -45.86 90.17 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.733 -0.667 . . . . 43.32 110.515 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.436 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 16.8 mm-40 -69.85 -46.08 66.34 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.393 -0.367 . . . . 74.13 110.956 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -57.75 -41.95 82.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.856 -0.611 . . . . 75.41 110.953 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -104.66 4.3 32.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.687 -0.688 . . . . 75.22 112.235 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.1 t -53.16 -21.69 5.38 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.612 0.967 . . . . 63.31 113.612 -170.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -73.53 -18.7 61.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.797 0.332 . . . . 74.02 110.925 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.1 5.05 3.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.262 -0.426 . . . . 60.25 110.896 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 43' ' ' LEU . 43.5 t -139.34 145.26 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.913 0.387 . . . . 74.22 111.33 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -148.69 128.29 13.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 71.33 109.541 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.569 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.0 mt -106.56 128.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 120.852 0.358 . . . . 73.14 110.479 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -110.63 168.22 9.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.836 -0.62 . . . . 62.14 109.934 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 23' ' ' ILE . 22.6 ttmm -135.05 99.27 4.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.219 -0.66 . . . . 62.33 109.219 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -119.31 97.04 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.861 0.838 . . . . 75.13 108.942 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -150.49 94.9 2.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.193 -0.912 . . . . 60.11 110.089 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.7 mp -72.98 109.93 5.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.595 -0.891 . . . . 65.23 108.595 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.89 -31.09 68.28 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.059 0.457 . . . . 64.21 110.464 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.69 -19.08 49.83 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.946 -0.57 . . . . 63.52 111.608 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' H ' HG22 ' A' ' 81' ' ' ILE . 32.8 t30 -119.7 79.84 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.4 0.619 . . . . 73.53 110.132 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.78 -21.84 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.444 -0.798 . . . . 73.43 111.06 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 26.2 t70 -45.77 -47.62 15.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.011 -0.54 . . . . 63.32 111.809 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.66 -42.02 49.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.314 -0.403 . . . . 71.01 110.988 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.84 -45.02 87.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 74.24 110.551 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -68.39 -29.86 68.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 72.42 110.587 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.1 mm100 -70.49 -46.47 63.67 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.356 -0.384 . . . . 52.44 111.089 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -79.91 -17.19 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 63.04 111.092 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.06 64.46 0.95 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.772 -0.728 . . . . 65.55 113.091 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.427 HG13 ' OG1' ' A' ' 98' ' ' THR . 91.5 t -97.04 133.15 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.399 -0.593 . . . . 75.31 109.399 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.2 m -138.71 -64.68 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.472 -0.331 . . . . 63.12 110.833 -175.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -85.49 170.57 12.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.343 -0.39 . . . . 52.44 110.488 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -110.97 118.63 47.76 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.08 -0.509 . . . . 75.51 111.718 -175.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -92.62 -160.25 0.99 Allowed 'Cis proline' 0 C--N 1.352 0.738 0 C-N-CA 123.957 -1.268 . . . . 64.14 111.3 -6.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 112' ' ' ILE . 87.9 m -137.27 129.33 29.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.145 -0.317 . . . . 74.0 110.145 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.97 120.34 62.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.944 -0.571 . . . . 62.41 110.729 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 27.3 mt -88.23 146.55 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.208 -0.664 . . . . 72.51 109.208 172.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.537 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 14.6 mmt -112.37 143.24 43.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.54 -0.541 . . . . 65.12 109.54 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 89.2 m-85 -144.36 151.2 38.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.044 -0.724 . . . . 73.14 109.044 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.79 125.17 5.7 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.363 -0.535 . . . . 74.24 111.086 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 60.94 29.26 18.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.308 0.575 . . . . 72.22 110.836 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 38' ' ' CYS . . . 71.32 11.59 71.61 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.833 -0.621 . . . . 43.11 112.023 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -98.69 144.95 27.39 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.157 -0.682 . . . . 63.04 109.157 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -74.1 118.61 17.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.716 0.769 . . . . 71.43 109.768 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 3.5 mm? -113.57 169.59 8.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.19 -1.368 . . . . 61.41 110.204 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 101' ' ' MET . 8.0 m -69.49 -177.39 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.487 0.715 . . . . 72.41 112.432 -163.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 51.1 tt0 -141.63 136.27 30.81 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.301 1.048 . . . . 74.54 111.366 -172.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.86 107.27 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 113.335 -1.757 . . . . 70.11 109.332 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 95' ' ' ALA . 50.4 mt -105.66 118.73 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.051 -0.352 . . . . 62.14 110.051 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.09 151.71 11.01 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.164 -0.471 . . . . 60.32 112.102 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.93 80.17 1.17 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.145 0.498 . . . . 33.13 111.134 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 119' ' ' ILE . 63.5 t0 -126.41 89.85 3.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 64.24 109.849 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.19 -33.37 50.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.838 -0.619 . . . . 62.15 110.831 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.3 t -63.64 -46.29 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.91 -0.586 . . . . 72.2 109.905 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.442 ' NZ ' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -66.37 -38.56 87.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 55.14 110.003 -179.166 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 115' ' ' ASP . 78.0 mt -61.88 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.104 -0.498 . . . . 62.22 111.119 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -40.04 85.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.819 0.342 . . . . 72.14 110.089 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.7 t -54.92 -50.95 67.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.639 -0.709 . . . . 43.12 109.825 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.43 -33.06 74.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 73.04 111.528 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 119' ' ' ILE . 98.0 mt -61.23 -56.17 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 120.308 -0.557 . . . . 73.41 109.857 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -70.41 -25.26 63.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.842 -0.343 . . . . 70.22 110.801 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -69.99 -53.63 16.83 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.061 -0.518 . . . . 72.2 110.685 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -80.72 -18.51 47.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.008 0.373 . . . . 71.2 112.008 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 123' ' ' ILE . 49.9 mt -63.18 -49.98 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.084 0.469 . . . . 54.51 109.917 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.448 -0.787 . . . . 71.43 110.091 -178.606 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.63 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 62.4 mmm . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.603 0.24 . . . . 71.32 110.847 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -68.7 84.52 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.497 -0.927 . . . . 62.2 108.497 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.19 112.23 2.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.085 -0.961 . . . . 70.14 110.682 -169.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.93 131.35 35.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.005 -0.543 . . . . 71.41 110.732 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.0 pt -136.87 162.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.534 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.39 174.64 36.89 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.145 -0.55 . . . . 75.43 111.868 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.9 -47.8 73.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.007 0.432 . . . . 65.03 110.176 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 m -59.45 -25.19 64.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.649 -0.705 . . . . 74.42 111.252 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 24.3 mm-40 -88.58 -20.03 25.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 75.54 111.56 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -55.89 -61.7 2.2 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.727 0.298 . . . . 65.25 110.978 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.77 -48.97 79.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 73.42 109.945 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -49.87 -57.3 7.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.068 -0.969 . . . . 43.22 111.48 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -66.94 -43.97 81.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.066 -0.515 . . . . 63.34 111.278 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.85 -38.85 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.715 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.5 p -86.37 -31.07 21.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.222 0.453 . . . . 53.41 112.222 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 t -82.01 -8.64 59.68 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.407 0.521 . . . . 74.54 112.407 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 10.9 p -58.48 129.52 42.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.001 -0.279 . . . . 55.23 110.251 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -49.94 -74.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.68 0.622 . . . . 72.42 112.68 -168.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -161.7 131.71 4.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.919 -0.128 . . . . 63.42 110.716 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 51.86 25.67 3.15 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.659 0.6 . . . . 72.45 112.421 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.6 mm -83.41 99.18 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.462 -0.57 . . . . 70.51 109.462 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HB3' HG22 ' A' ' 74' ' ' VAL . 59.2 tp -67.72 107.4 2.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.669 . . . . 72.33 110.205 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -94.18 118.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 72.45 110.517 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.2 mp -100.26 108.27 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.5 -0.555 . . . . 73.21 109.5 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.29 104.98 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.312 -0.625 . . . . 72.45 109.312 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' THR . 37.3 t0 -91.6 145.16 24.82 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.162 -0.472 . . . . 62.13 110.069 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 100' ' ' LEU . 10.1 m-85 -103.2 92.17 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.016 -0.538 . . . . 65.22 110.202 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -86.48 168.63 13.57 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.615 -0.72 . . . . 74.34 111.004 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.03 154.95 10.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.331 -0.849 . . . . 54.33 108.778 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.74 -38.02 21.95 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.841 2.361 . . . . 64.33 111.795 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -123.92 84.13 2.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.565 -0.902 . . . . 73.15 108.565 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -52.31 5.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.424 -0.353 . . . . 63.3 111.469 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.558 ' N ' ' SG ' ' A' ' 56' ' ' CYS . . . 151.66 -116.86 0.78 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.703 -0.76 . . . . 43.4 112.717 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD3' ' HA3' ' A' ' 54' ' ' GLY . 5.9 Cg_exo -79.54 37.01 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.365 2.71 . . . . 54.22 111.384 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 1.8 m -59.94 -35.54 75.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.095 -0.957 . . . . 71.35 111.156 -171.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -54.18 -44.2 71.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.959 -0.564 . . . . 74.44 111.378 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.637 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.2 m -74.75 -42.98 57.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.635 0.731 . . . . 70.35 110.5 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.3 mm? -72.24 -17.57 61.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 64.1 111.982 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 44.9 mt-10 -56.93 -63.94 3.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.529 -0.545 . . . . 65.12 109.529 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 53.4 Cg_endo -68.66 -35.4 16.8 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.595 1.53 . . . . 64.23 112.179 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.6 mt-30 -63.33 -46.73 85.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.335 -0.546 . . . . 75.21 111.465 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.5 mt -70.32 -43.25 70.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.874 -0.148 . . . . 74.14 110.666 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.63 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 35.4 mt-10 -59.07 -35.78 73.95 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.16 -0.311 . . . . 65.51 110.16 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.19 -57.21 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 74.54 110.458 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 123' ' ' ILE . 41.6 mt -62.44 -32.58 73.46 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.306 -0.406 . . . . 74.51 109.947 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.65 -51.71 57.38 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.866 -0.606 . . . . 43.32 110.547 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -67.23 -30.32 70.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.747 0.308 . . . . 74.13 111.296 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -81.32 -38.31 26.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.101 -0.5 . . . . 75.41 110.818 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -104.87 5.39 32.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.959 -0.564 . . . . 75.22 112.142 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 9.8 t -53.47 -19.8 4.06 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.424 0.527 . . . . 63.31 112.424 -173.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.4 -32.66 73.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.808 0.337 . . . . 74.02 111.101 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -133.56 14.04 4.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.277 -0.419 . . . . 60.25 110.748 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' THR . 50.5 t -140.84 142.57 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.965 0.412 . . . . 74.22 111.76 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -149.89 127.75 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.8 -0.637 . . . . 71.33 109.501 170.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.0 mt -99.14 122.21 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.099 -0.334 . . . . 73.14 110.099 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -110.81 155.42 22.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.322 -0.399 . . . . 62.14 110.137 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -137.83 130.87 30.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 81' ' ' ILE . 14.0 pt -79.07 149.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.025 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -74.8 30.18 0.09 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.929 0.395 . . . . 60.11 111.871 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.7 mm -99.01 19.19 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.481 0.657 . . . . 65.23 109.691 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.74 -19.03 24.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.677 -0.692 . . . . 64.21 112.231 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.14 -6.79 54.99 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.614 0.245 . . . . 63.52 111.547 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.455 ' HB2' HG22 ' A' ' 81' ' ' ILE . 30.5 m-80 -119.58 88.32 2.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.797 0.332 . . . . 73.53 110.717 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -64.72 -30.87 71.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.609 -0.515 . . . . 73.43 109.609 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.1 m-20 -43.55 -51.44 6.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.33 -0.85 . . . . 63.32 110.999 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.33 -36.16 51.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.46 -0.791 . . . . 71.01 111.054 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -63.93 -50.95 66.65 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.309 0.576 . . . . 74.24 109.674 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -60.38 -34.4 73.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.341 -0.845 . . . . 72.42 110.808 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -60.71 -55.15 36.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.958 0.409 . . . . 52.44 110.369 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -73.57 -15.24 61.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.199 -0.455 . . . . 63.04 112.21 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.44 0.69 18.38 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.506 -0.854 . . . . 65.55 112.99 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 88.4 t -67.78 109.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.047 0.451 . . . . 75.31 109.947 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 t -97.04 -7.12 33.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.856 -0.611 . . . . 63.12 111.404 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.44 158.66 42.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.973 -0.38 . . . . 52.44 109.973 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.12 144.56 52.08 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 110.186 -0.301 . . . . 75.51 110.186 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 114' ' ' ALA . 8.1 Cg_exo -73.32 -179.71 25.95 Favored 'Cis proline' 0 C--N 1.354 0.847 0 C-N-CA 124.33 -1.113 . . . . 64.14 112.323 -3.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' ASP . 18.5 m -160.36 137.24 9.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 74.0 110.717 -178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.585 ' HB ' HG22 ' A' ' 111' ' ' VAL . 36.1 mm -109.92 110.87 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.533 -0.758 . . . . 62.41 111.307 -174.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' A' ' 48' ' ' PHE . 7.3 mp -96.39 123.26 39.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.106 -1.072 . . . . 72.51 108.106 168.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.477 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 44.4 mtt -98.76 143.29 29.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.501 . . . . 65.12 110.995 -175.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -142.81 146.13 33.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.394 -0.965 . . . . 73.14 108.394 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 107.21 4.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.482 -0.487 . . . . 74.24 110.859 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.596 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 58.96 28.32 17.48 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.746 0.784 . . . . 72.22 110.469 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.85 -16.22 59.89 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.612 -0.722 . . . . 43.11 112.596 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 13.4 tmtt? -75.33 141.32 43.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.997 -0.742 . . . . 63.04 108.997 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.518 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.59 124.35 25.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.437 0.637 . . . . 71.43 111.529 -175.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -120.46 168.08 11.69 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.393 1.077 . . . . 61.41 109.981 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.63 176.68 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.224 0.535 . . . . 72.41 111.913 -164.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -141.11 126.86 19.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 74.54 110.524 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 99' ' ' ILE . 35.5 m -114.21 130.06 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.695 -0.483 . . . . 70.11 109.695 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.1 117.8 56.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.748 -0.66 . . . . 62.14 109.679 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.72 144.92 9.0 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.289 -0.724 . . . . 60.32 111.289 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.568 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . . . -83.21 72.34 10.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.852 0.358 . . . . 33.13 111.334 -176.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 119' ' ' ILE . 30.2 t70 -113.07 104.66 12.59 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.185 -0.461 . . . . 64.24 109.833 175.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -60.94 -34.07 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 62.15 111.422 -173.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 120' ' ' ILE . 21.1 t -64.45 -50.11 68.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 72.2 110.105 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.9 tptt -61.74 -46.69 88.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 55.14 110.174 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 111' ' ' VAL . 77.4 mt -57.67 -51.08 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.489 . . . . 62.22 111.146 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.51 -39.99 87.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 110.1 -0.333 . . . . 72.14 110.1 -177.189 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.7 m -55.81 -50.69 69.82 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.924 -0.399 . . . . 43.12 109.924 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 61.5 mm-40 -62.62 -44.29 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 73.04 110.711 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.7 mt -53.44 -56.39 8.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.603 0.239 . . . . 73.41 110.777 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -70.18 -32.0 69.74 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.624 -0.431 . . . . 70.22 110.322 -175.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -64.55 -33.8 76.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.906 -0.588 . . . . 72.2 111.361 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.99 -20.7 19.14 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 111.984 0.365 . . . . 71.2 111.984 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.0 mt -71.49 -58.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.027 0.441 . . . . 54.51 110.028 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.247 -0.883 . . . . 71.43 110.249 -175.562 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 54.7 mmm . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 109.418 -0.586 . . . . 71.32 109.418 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.511 HG23 HG22 ' A' ' 76' ' ' ILE . 12.1 mm -71.95 89.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.55 -1.278 . . . . 62.2 107.55 169.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.63 112.15 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.465 -0.789 . . . . 70.14 111.442 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.68 117.11 18.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.701 -0.681 . . . . 71.41 109.983 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.9 pt -110.55 159.18 10.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.842 -0.617 . . . . 73.54 111.254 -172.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.88 -177.72 36.48 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.681 -0.691 . . . . 75.43 112.975 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.96 -56.92 10.08 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.734 0.814 . . . . 65.03 111.947 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -73.19 -18.59 61.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.944 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -83.9 -12.41 55.5 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.125 0.417 . . . . 75.54 112.125 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.3 t80 -58.19 -61.45 2.55 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.688 -0.486 . . . . 65.25 109.688 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.82 -52.82 61.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.689 -0.687 . . . . 73.42 110.745 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -55.98 -57.34 12.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.605 -0.725 . . . . 43.22 111.717 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -65.41 -34.13 77.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.027 -0.533 . . . . 63.34 111.552 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 31' ' ' PHE . 69.8 t -70.26 -36.32 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.604 0.24 . . . . 74.14 110.96 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.87 -13.32 48.29 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.671 0.272 . . . . 53.41 111.172 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -62.83 -10.08 11.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.424 0.528 . . . . 74.54 112.424 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 17.4 p -76.7 116.97 17.86 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.927 -0.483 . . . . 55.23 110.695 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.12 -78.04 0.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.035 -0.53 . . . . 72.42 111.359 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.68 127.62 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.519 0.2 . . . . 63.42 110.844 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.5 14.0 5.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.781 -0.645 . . . . 72.45 111.378 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.7 mm -81.72 120.39 33.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.197 -0.456 . . . . 70.51 109.854 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.38 123.85 28.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 72.33 109.963 -178.487 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 38' ' ' CYS . 44.2 mt -113.94 117.55 55.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 72.45 110.077 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.4 mp -105.37 126.15 51.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 67.0 t -104.93 105.08 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.698 -0.482 . . . . 72.45 109.698 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.16 145.33 32.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 62.13 111.995 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 23.6 m-85 -108.57 98.57 8.06 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.402 -0.817 . . . . 65.22 109.181 169.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -42.96 139.06 1.83 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.901 -1.045 . . . . 74.34 112.484 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.54 112.7 56.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 54.33 111.083 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.39 -40.14 11.34 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.616 2.211 . . . . 64.33 111.256 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -164.75 139.89 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.149 -0.932 . . . . 73.15 109.399 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.8 p -166.33 -67.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 63.3 110.395 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.06 -94.87 0.16 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.992 -0.623 . . . . 43.4 112.927 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.91 -7.19 20.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.986 2.457 . . . . 54.22 113.249 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.584 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 5.3 m -55.11 -30.48 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.458 -0.337 . . . . 71.35 111.537 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -53.75 -30.59 44.98 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.231 -0.44 . . . . 74.44 111.574 -172.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 42.5 m -75.3 -37.26 60.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.349 0.595 . . . . 70.35 110.998 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.1 mm? -66.68 -47.56 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.937 -0.574 . . . . 64.1 112.434 -172.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -47.75 -55.28 17.89 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 118.115 0.416 . . . . 65.12 111.565 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -33.65 50.84 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.713 1.609 . . . . 64.23 112.164 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.5 mt-30 -66.12 -27.56 68.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.566 -0.454 . . . . 75.21 110.554 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 90.1 mt -76.84 -36.35 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.496 -0.557 . . . . 74.14 109.496 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 39.2 mt-10 -60.83 -36.96 80.44 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.134 -0.484 . . . . 65.51 109.706 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 58.5 tttm -57.53 -57.0 14.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.107 -0.497 . . . . 74.54 110.309 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.491 HD13 HD12 ' A' ' 123' ' ' ILE . 48.1 mt -63.07 -32.17 73.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.989 -0.551 . . . . 74.51 110.319 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.85 -42.53 94.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 43.32 110.839 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.54 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 52.9 mm-40 -74.61 -39.1 62.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.159 0.504 . . . . 74.13 110.841 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.33 -39.04 85.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.678 -0.692 . . . . 75.41 110.801 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.412 ' CD1' HG21 ' A' ' 123' ' ' ILE . 43.5 m-85 -105.05 5.29 32.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.475 -0.784 . . . . 75.22 112.047 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.88 -19.12 2.31 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.761 0.652 . . . . 63.31 112.761 -171.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -71.08 -27.46 63.63 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.647 0.24 . . . . 74.02 111.647 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -134.81 10.25 3.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.34 0.256 . . . . 60.25 111.329 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 43' ' ' LEU . 50.9 t -135.86 142.13 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.052 0.453 . . . . 74.22 111.153 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.0 119.78 9.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 23' ' ' ILE . 34.3 mt -102.45 129.31 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.612 0.244 . . . . 73.14 110.542 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -115.98 173.86 6.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.439 -0.578 . . . . 62.14 109.439 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -155.37 136.02 13.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.978 -0.379 . . . . 62.33 109.978 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.9 mt -79.71 79.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.073 -0.714 . . . . 75.13 109.073 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -81.23 56.18 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.385 0.612 . . . . 60.11 110.405 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -123.52 92.85 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.764 -0.653 . . . . 65.23 109.765 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -59.91 -17.66 39.03 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.84 -0.618 . . . . 64.21 111.211 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.66 -25.94 62.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.608 -0.724 . . . . 63.52 111.012 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -109.59 104.88 13.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.88 0.372 . . . . 73.53 110.324 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -99.13 -30.43 12.3 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.016 -0.538 . . . . 73.43 110.414 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 36.0 t70 -47.25 -47.13 24.91 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.611 -0.722 . . . . 63.32 111.883 -171.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.95 -41.05 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.237 -0.438 . . . . 71.01 111.128 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.37 95.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.222 0.534 . . . . 74.24 110.168 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 m -67.87 -33.24 74.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 72.42 110.697 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.9 mm-40 -66.27 -51.46 57.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 52.44 110.597 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -75.1 -17.33 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 63.04 110.461 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.26 45.07 20.63 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.011 -0.614 . . . . 65.55 112.533 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.418 HG13 ' OG1' ' A' ' 98' ' ' THR . 98.8 t -58.27 110.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.033 0.444 . . . . 75.31 110.175 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.7 m -85.94 -34.84 20.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.789 -0.642 . . . . 63.12 110.956 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.79 156.6 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 52.44 109.97 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.747 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.31 144.92 33.2 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.043 -177.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.584 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 4.9 Cg_exo -78.01 173.41 57.08 Favored 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.074 -1.219 . . . . 64.14 112.637 -0.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.554 HG23 HG12 ' A' ' 112' ' ' ILE . 27.8 m -138.39 127.05 23.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.706 . . . . 74.0 109.979 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 111' ' ' VAL . 48.6 mm -110.14 110.81 33.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.072 0.463 . . . . 62.41 110.984 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 2.8 mm? -90.63 123.69 34.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.403 -0.817 . . . . 72.51 109.519 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -92.49 135.99 33.59 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.689 -0.486 . . . . 65.12 109.689 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.522 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 85.2 m-85 -141.58 142.66 33.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.249 -1.019 . . . . 73.14 108.249 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 26.7 ttpp -147.23 126.95 13.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.236 -0.586 . . . . 74.24 110.89 -175.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t30 63.32 25.55 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.625 0.726 . . . . 72.22 109.603 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.69 19.37 74.84 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.317 -0.856 . . . . 43.11 111.926 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -117.85 153.94 32.67 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 122.216 0.206 . . . . 63.04 110.58 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.507 ' O ' HD22 ' A' ' 108' ' ' LEU . 16.6 tppt? -56.48 139.75 48.26 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 124.121 0.888 . . . . 71.43 111.668 -176.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.651 HD12 ' ND2' ' A' ' 126' ' ' ASN . 0.4 OUTLIER -149.99 168.37 24.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.8 -1.091 . . . . 61.41 108.707 -171.295 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 101' ' ' MET . 39.6 m -70.64 -177.07 1.43 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.921 0.712 . . . . 72.41 112.921 -166.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.467 ' HG3' HD13 ' A' ' 100' ' ' LEU . 47.4 tt0 -146.07 148.38 32.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.154 -0.341 . . . . 74.54 111.085 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 99' ' ' ILE . 15.3 m -137.15 128.23 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.244 -0.434 . . . . 70.11 109.882 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 98' ' ' THR . 67.5 mt -114.92 138.08 46.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.29 -0.414 . . . . 62.14 110.331 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.86 161.42 21.0 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.147 -0.549 . . . . 60.32 112.227 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.84 86.28 6.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.854 0.359 . . . . 33.13 110.553 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.6 t0 -139.15 93.78 2.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.159 0.504 . . . . 64.24 110.251 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.1 tp -60.3 -32.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.596 -0.729 . . . . 62.15 111.018 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 t -68.95 -46.87 67.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.021 -0.536 . . . . 72.2 109.976 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -67.46 -43.31 81.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 55.14 110.217 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 115' ' ' ASP . 79.6 mt -58.75 -52.4 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.4 . . . . 62.22 110.956 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.98 -39.09 83.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 120.87 0.367 . . . . 72.14 110.034 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.7 m -54.56 -50.6 67.55 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.122 -0.49 . . . . 43.12 110.448 176.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.17 -39.06 93.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.62 -0.264 . . . . 73.04 111.193 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.491 HD12 HD13 ' A' ' 66' ' ' LEU . 97.7 mt -55.79 -55.81 15.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.643 -0.423 . . . . 73.41 110.314 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.79 -27.36 64.84 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.428 -0.509 . . . . 70.22 110.393 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -70.69 -33.87 71.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.254 -0.43 . . . . 72.2 110.837 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.651 ' ND2' HD12 ' A' ' 108' ' ' LEU . 3.1 m-20 -86.07 -29.94 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 71.2 110.565 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.86 -49.68 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 54.51 110.904 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.696 -0.669 . . . . 71.43 110.124 -175.352 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.507 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 91.9 mmm . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.036 0.446 . . . . 71.32 110.43 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.68 107.35 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 62.2 110.079 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.5 126.54 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.59 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.17 124.38 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.846 -0.798 . . . . 71.41 108.846 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 34' ' ' LYS . 28.8 pt -129.32 158.02 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 73.54 110.859 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.18 165.14 53.91 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.845 -0.616 . . . . 75.43 112.253 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.87 -50.11 61.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 65.03 111.057 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.5 m -71.87 -10.52 59.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 111.51 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -89.21 -4.96 58.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.689 -0.232 . . . . 75.54 111.233 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.576 ' HD2' HD11 ' A' ' 79' ' ' ILE . 83.1 t80 -58.11 -62.49 1.79 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.789 0.328 . . . . 65.25 110.9 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.54 -39.35 93.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 73.42 109.994 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.0 -57.37 10.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.402 -0.817 . . . . 43.22 110.634 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HG3' HG21 ' A' ' 26' ' ' ILE . 43.9 mmtm -79.22 -18.37 53.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.991 -0.55 . . . . 63.34 112.137 -172.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 31' ' ' PHE . 55.0 t -74.03 -36.16 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.801 0.334 . . . . 74.14 110.334 171.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.4 p -85.98 -20.07 29.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.774 0.321 . . . . 53.41 111.02 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -68.5 4.45 1.37 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.936 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.86 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.4 p -58.13 137.95 56.54 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.219 -0.289 . . . . 55.23 110.219 175.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.25 -67.21 0.43 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 110.247 -0.279 . . . . 72.42 110.247 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.488 ' H ' HG12 ' A' ' 42' ' ' ILE . 5.3 p-10 -162.06 128.7 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.171 -0.307 . . . . 63.42 110.171 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.84 18.17 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.042 0.537 . . . . 72.45 112.248 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.488 HG12 ' H ' ' A' ' 40' ' ' ASP . 49.2 mm -71.51 136.26 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 116.524 -0.307 . . . . 70.51 110.497 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 126' ' ' ASN . 57.2 tp -80.06 126.26 30.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 72.33 110.158 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.87 119.24 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 72.45 110.381 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 76' ' ' ILE . 3.3 mp -107.09 115.31 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 73.21 109.529 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.74 105.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.223 -0.658 . . . . 72.45 109.223 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' THR . 21.9 t0 -85.92 153.11 22.43 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.722 -0.217 . . . . 62.13 110.642 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.693 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 17.4 p90 -50.73 152.64 1.97 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.054 -0.521 . . . . 65.22 111.64 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -128.77 98.48 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.836 -0.62 . . . . 74.34 109.707 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.98 149.19 10.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 54.33 110.244 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.52 39.48 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.902 2.402 . . . . 64.33 112.209 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -145.03 131.49 19.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 73.15 110.375 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.41 ' HA ' HG12 ' A' ' 96' ' ' ILE . 25.9 p -166.18 154.55 10.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 63.3 109.912 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.77 -82.82 1.67 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 112.018 -0.433 . . . . 43.4 112.018 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.61 ' HB2' HD23 ' A' ' 59' ' ' LEU . 3.6 Cg_exo -77.66 50.32 3.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.295 2.663 . . . . 54.22 111.576 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.68 -51.61 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.643 -0.708 . . . . 71.35 110.837 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -54.32 -38.13 65.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.763 -0.653 . . . . 74.44 111.903 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.7 m -75.57 -59.19 2.86 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.706 0.765 . . . . 70.35 112.144 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 55' ' ' PRO . 4.5 mm? -66.28 -34.44 78.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.716 -0.675 . . . . 64.1 112.762 -168.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 48.9 mt-10 -56.61 -60.18 10.04 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 120.602 -0.439 . . . . 65.12 110.634 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.7 Cg_endo -63.19 -34.63 67.71 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.003 1.802 . . . . 64.23 112.199 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 58' ' ' SER . 41.8 mt-30 -59.89 -41.84 92.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.421 -0.512 . . . . 75.21 110.947 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.25 -42.69 79.27 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.479 -0.328 . . . . 74.14 110.432 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 44.3 mt-10 -57.75 -37.2 73.19 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.057 -0.52 . . . . 65.51 110.539 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -66.82 -53.0 37.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.239 -0.437 . . . . 74.54 111.156 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD12 ' A' ' 123' ' ' ILE . 55.4 mt -60.09 -34.98 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.039 0.447 . . . . 74.51 110.174 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.14 -53.37 50.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.753 -0.658 . . . . 43.32 110.151 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.507 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 15.6 mm-40 -57.08 -31.91 65.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.532 -0.304 . . . . 74.13 111.683 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -78.06 -47.15 18.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.162 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -104.59 4.79 33.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.586 . . . . 75.22 112.437 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.3 t -52.9 -19.69 2.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.411 0.523 . . . . 63.31 112.411 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.77 -39.98 78.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.8 0.333 . . . . 74.02 110.497 176.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -125.45 9.72 7.85 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.26 -0.427 . . . . 60.25 111.236 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' THR . 41.0 t -132.17 138.91 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.885 0.374 . . . . 74.22 111.587 -176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -144.87 133.67 22.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.942 -0.572 . . . . 71.33 109.492 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -113.98 143.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.498 0.19 . . . . 73.14 110.747 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -131.61 162.61 29.95 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.175 0.512 . . . . 62.14 111.129 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -137.1 142.71 42.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.013 -0.994 . . . . 62.33 108.606 170.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' A' ' 31' ' ' PHE . 43.8 mm -90.91 152.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.668 -0.493 . . . . 75.13 109.668 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -94.8 -169.31 1.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.205 -0.294 . . . . 60.11 110.205 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 mt 61.61 60.88 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 122.143 0.973 . . . . 65.23 109.699 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 28.2 mp0 -59.74 -18.81 45.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.528 -1.215 . . . . 64.21 110.75 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.15 -17.9 62.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.593 -0.731 . . . . 63.52 111.435 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.8 67.72 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.405 0.621 . . . . 73.53 111.143 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -61.05 -30.5 70.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.27 -0.877 . . . . 73.43 110.811 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.65 -42.23 33.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.925 -0.579 . . . . 63.32 110.736 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.58 -36.56 60.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 71.01 110.717 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.013 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 m -60.13 -40.69 90.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.882 -0.599 . . . . 72.42 110.922 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -65.59 -41.06 93.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.918 -0.583 . . . . 52.44 111.426 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -90.65 -7.48 52.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 63.04 111.428 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.28 21.6 58.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.24 -0.505 . . . . 65.55 113.072 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.501 HG22 HG21 ' A' ' 98' ' ' THR . 46.9 t -73.13 124.44 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.949 -0.389 . . . . 75.31 109.949 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 t -151.42 -42.26 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 63.12 110.324 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.4 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . . . -102.66 137.83 40.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.304 -0.407 . . . . 52.44 110.096 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.4 pp -110.09 154.51 42.72 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.387 -0.369 . . . . 75.51 111.592 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.07 171.9 63.12 Favored 'Cis proline' 0 C--N 1.352 0.753 0 C-N-CA 123.421 -1.491 . . . . 64.14 111.894 -5.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 48' ' ' PHE . 83.8 m -130.21 110.93 11.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.355 -0.609 . . . . 74.0 109.355 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.6 mm -115.37 112.78 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 62.41 110.626 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.6 mp -94.96 123.27 38.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.44 -0.578 . . . . 72.51 109.44 174.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.491 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 15.0 mmt -95.27 139.11 32.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.81 0.338 . . . . 65.12 110.499 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -141.04 149.33 41.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.075 -0.713 . . . . 73.14 109.075 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -133.85 116.31 15.51 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.595 -0.521 . . . . 74.24 109.595 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.86 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.8 p-10 48.15 32.51 3.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.316 0.646 . . . . 72.22 112.202 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.87 -14.8 60.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.395 -0.431 . . . . 43.11 112.609 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -75.43 140.08 42.69 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.192 0.597 . . . . 63.04 110.176 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' A' ' 108' ' ' LEU . 3.3 tmmm? -69.37 132.32 46.2 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.812 -0.631 . . . . 71.43 110.897 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.495 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.8 mm? -133.52 167.8 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.838 -1.074 . . . . 61.41 110.176 -175.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.71 179.45 2.61 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.476 0.655 . . . . 72.41 112.342 -169.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -137.85 151.4 48.03 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.657 -0.701 . . . . 74.54 110.221 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -121.9 131.2 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 114.879 -1.055 . . . . 70.11 109.996 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 95' ' ' ALA . 27.5 mm -129.85 125.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 62.14 109.992 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.06 153.31 19.2 Favored Glycine 0 C--N 1.323 -0.15 0 CA-C-N 115.834 -0.621 . . . . 60.32 112.234 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -79.66 80.03 6.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.062 0.458 . . . . 33.13 111.019 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.68 94.51 3.3 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.545 -0.752 . . . . 64.24 109.075 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.35 -26.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 62.15 110.567 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.7 t -66.55 -42.12 87.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.865 -0.607 . . . . 72.2 109.647 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.83 -44.43 77.25 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 55.14 109.916 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.2 mt -56.12 -56.2 14.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.14 -0.482 . . . . 62.22 110.824 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.61 -35.34 69.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.189 -0.46 . . . . 72.14 109.881 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.0 t -57.49 -46.35 83.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.003 -0.369 . . . . 43.12 110.003 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.56 -43.54 93.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.326 -0.397 . . . . 73.04 110.497 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.435 HD12 HD13 ' A' ' 66' ' ' LEU . 96.6 mt -53.45 -55.64 12.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.818 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -70.95 -27.91 64.09 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.946 -0.302 . . . . 70.22 110.3 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -63.36 -33.23 75.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.036 0.446 . . . . 72.2 110.125 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.44 ' HB2' HD22 ' A' ' 43' ' ' LEU . 27.5 m-80 -79.71 -40.48 28.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.882 -0.599 . . . . 71.2 111.16 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.24 -42.21 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.085 0.469 . . . . 54.51 110.733 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.307 -0.854 . . . . 71.43 109.911 179.005 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.488 0.185 . . . . 75.42 110.516 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.39 123.46 0.8 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.517 -0.31 . . . . 34.04 110.522 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -91.41 61.6 4.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.516 0.674 . . . . 65.04 110.411 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -99.64 101.15 12.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.715 -0.675 . . . . 71.22 110.59 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -169.31 116.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 65.22 110.172 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -161.77 146.08 12.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.896 -0.593 . . . . 75.12 109.522 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -85.5 -78.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.848 0.356 . . . . 65.21 110.445 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -115.56 -158.8 0.69 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.979 -0.749 . . . . 74.33 108.979 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -135.62 120.27 18.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.951 0.405 . . . . 73.11 109.915 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.54 -161.84 11.75 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.165 -0.774 . . . . 70.45 111.165 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -72.53 78.51 1.06 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.756 0.789 . . . . 73.25 110.501 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.17 127.49 50.1 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.314 -0.995 . . . . 74.23 108.314 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.59 ' HG2' ' H ' ' A' ' 14' ' ' ALA . 30.4 tt0 -144.49 177.46 8.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.833 -0.432 . . . . 75.42 109.833 -174.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.59 ' H ' ' HG2' ' A' ' 13' ' ' GLU . . . -160.62 29.7 0.16 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.313 -0.625 . . . . 52.13 109.313 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.551 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 22.4 mm-40 57.81 18.72 5.09 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.303 -0.862 . . . . 70.34 110.72 -171.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.3 t -83.48 -171.58 3.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.377 -0.828 . . . . 70.15 109.338 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -146.28 -80.45 0.16 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.708 0.289 . . . . 71.4 110.298 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.27 163.66 39.2 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.263 -0.494 . . . . 74.21 112.313 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -73.18 122.97 8.45 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.638 2.225 . . . . 75.33 111.501 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.81 39.83 0.04 OUTLIER Glycine 0 C--O 1.236 0.229 0 N-CA-C 111.937 -0.465 . . . . 31.0 111.937 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 m -62.33 131.97 51.09 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.33 0.252 . . . . 70.35 111.213 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.3 mmm -102.34 -21.53 14.28 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.341 -0.39 . . . . 71.32 110.638 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.58 96.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.953 0.406 . . . . 62.2 110.019 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 7.3 tp10 -67.09 125.87 27.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.759 -0.655 . . . . 70.14 110.862 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 25' ' ' GLN . 5.4 pm0 -85.8 128.12 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 71.41 109.423 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.7 pt -134.62 146.37 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.728 0.299 . . . . 73.54 110.989 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.32 173.65 37.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.97 -0.559 . . . . 75.43 112.035 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.49 -47.21 27.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.074 0.549 . . . . 65.03 112.21 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -74.81 -20.97 59.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.107 -0.497 . . . . 74.42 111.513 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.8 -13.44 45.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 75.54 111.379 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 26' ' ' ILE . 72.4 t80 -56.03 -62.25 1.83 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.952 0.353 . . . . 65.25 111.952 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -39.25 94.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.157 0.503 . . . . 73.42 110.112 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -55.7 -53.71 53.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.81 . . . . 43.22 110.395 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.6 mmtt -69.07 -32.9 72.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.444 -0.798 . . . . 63.34 111.375 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 31' ' ' PHE . 77.7 t -66.93 -36.18 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.967 0.413 . . . . 74.14 110.652 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 p -86.06 -19.63 29.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.381 -0.372 . . . . 53.41 111.525 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -63.29 -11.15 19.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.205 -0.452 . . . . 74.54 112.103 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 21.6 p -61.11 139.9 57.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.224 0.21 . . . . 55.23 111.482 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -72.15 -88.78 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.558 -0.292 . . . . 72.42 110.732 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.5 136.07 24.25 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.088 -0.338 . . . . 63.42 110.088 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.22 16.43 3.95 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.627 -0.715 . . . . 72.45 111.897 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 41.5 mm -76.22 105.24 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.533 -0.543 . . . . 70.51 109.533 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 74' ' ' VAL . 53.5 tp -73.52 117.7 15.6 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.548 0.69 . . . . 72.33 109.974 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -102.0 113.0 37.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.959 . . . . 72.45 110.679 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.594 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.5 mp -97.28 118.75 34.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.313 -0.625 . . . . 73.21 109.313 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.83 107.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.935 -0.395 . . . . 72.45 109.935 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.67 136.69 36.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.983 -0.553 . . . . 62.13 111.246 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 100' ' ' LEU . 34.3 m-85 -111.13 81.9 1.51 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.435 0.636 . . . . 65.22 109.819 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.407 ' CZ2' ' SG ' ' A' ' 53' ' ' CYS . 23.0 t-105 -68.18 92.75 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.963 -1.017 . . . . 74.34 110.501 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.567 ' HB3' HG22 ' A' ' 96' ' ' ILE . . . -77.09 137.94 65.15 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.324 -0.398 . . . . 54.33 110.074 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.34 -8.44 8.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.374 2.716 . . . . 64.33 113.763 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.736 ' HB3' HG21 ' A' ' 96' ' ' ILE . 67.5 t-105 -65.6 -52.42 52.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.632 -0.507 . . . . 73.15 109.632 177.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.407 ' SG ' ' CZ2' ' A' ' 49' ' ' TRP . 4.7 t 54.99 90.73 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.316 -0.856 . . . . 63.3 112.17 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.29 -100.88 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.138 -0.553 . . . . 43.4 111.949 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.93 6.29 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.017 2.478 . . . . 54.22 112.292 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.404 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 4.8 p -50.82 -29.74 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 71.35 111.449 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.07 -51.74 63.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.504 -177.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.2 m -75.33 -45.12 41.47 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.411 0.624 . . . . 70.35 111.286 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -63.35 -31.59 72.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 64.1 112.571 -172.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 1.9 tm-20 -61.55 -58.21 19.95 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.82 -0.352 . . . . 65.12 110.426 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 26.4 Cg_endo -63.39 -28.44 71.49 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.514 1.476 . . . . 64.23 112.039 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.587 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 42.8 mt-30 -69.53 -34.8 74.76 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 75.21 110.991 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 77.5 mt -68.89 -43.54 75.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.471 -0.566 . . . . 74.14 109.471 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 6.2 mm-40 -59.32 -35.8 74.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 65.51 110.218 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 11.6 ttmm -54.51 -57.69 10.4 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.386 0.612 . . . . 74.54 110.225 174.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.484 HD13 HD12 ' A' ' 123' ' ' ILE . 43.1 mt -69.47 -28.74 66.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.393 -0.821 . . . . 74.51 110.18 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.17 -44.6 79.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 43.32 110.273 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 85.9 mt-30 -73.69 -37.34 65.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.724 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -66.03 -45.26 82.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.028 0.442 . . . . 75.41 111.051 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -100.18 5.04 44.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.612 0.597 . . . . 75.22 112.612 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -53.64 -19.69 4.32 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.806 0.669 . . . . 63.31 112.806 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HG3' ' OD1' ' A' ' 73' ' ' ASN . 10.5 pt-20 -66.98 -28.43 68.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.646 0.26 . . . . 74.02 111.13 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.451 ' OD1' ' HG3' ' A' ' 72' ' ' GLU . 24.3 m120 -131.06 9.49 4.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.536 -0.302 . . . . 60.25 111.22 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 43' ' ' LEU . 39.7 t -136.39 141.2 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.989 0.423 . . . . 74.22 111.574 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -142.1 119.79 11.82 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.838 -0.801 . . . . 71.33 108.838 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -99.61 138.89 22.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.761 0.315 . . . . 73.14 110.388 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 87.6 m-85 -124.55 160.27 28.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.872 -0.604 . . . . 62.14 109.457 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -137.33 120.66 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.252 -1.018 . . . . 62.33 108.252 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.77 132.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.742 -0.663 . . . . 75.13 111.561 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.01 96.32 7.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.613 -0.721 . . . . 60.11 109.471 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 84' ' ' ASN . 10.6 tp -154.21 34.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 122.057 0.932 . . . . 65.23 108.921 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -18.82 1.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.473 -1.24 . . . . 64.21 113.751 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.67 -36.11 38.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.861 0.363 . . . . 63.52 111.167 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.497 ' HB3' HG13 ' A' ' 81' ' ' ILE . 4.6 t-20 -95.97 103.23 15.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 73.53 110.814 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.17 -22.44 55.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 73.43 110.387 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.9 m-20 -51.73 -36.1 45.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.034 -0.53 . . . . 63.32 111.089 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 81' ' ' ILE . 88.0 t -52.85 -37.23 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 71.01 110.712 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.63 -50.95 65.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.066 0.46 . . . . 74.24 110.002 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -62.56 -33.09 74.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.633 -0.712 . . . . 72.42 111.171 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -74.49 -47.22 34.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 52.44 111.229 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.467 ' HB3' HD21 ' A' ' 100' ' ' LEU . 58.8 m-85 -87.07 -7.86 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.354 -0.385 . . . . 63.04 111.59 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 44.26 6.24 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.833 -0.699 . . . . 65.55 113.053 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.12 123.54 39.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.392 -0.596 . . . . 75.31 109.392 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -136.03 6.69 3.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.441 -0.345 . . . . 63.12 111.041 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.24 176.26 11.02 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.641 0.258 . . . . 52.44 110.631 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.736 HG21 ' HB3' ' A' ' 52' ' ' TRP . 1.3 pp -128.13 108.2 19.79 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.179 -0.464 . . . . 75.51 110.997 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -89.47 -162.49 1.88 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.001 -1.25 . . . . 64.14 112.519 -0.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.3 m -146.95 126.29 13.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.578 -0.527 . . . . 74.0 109.578 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 111' ' ' VAL . 48.3 mm -113.25 119.56 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.912 -0.586 . . . . 62.41 111.217 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 48' ' ' PHE . 9.1 mp -100.85 149.85 23.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 72.51 109.328 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.51 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 24.6 mtt -115.69 146.67 41.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 65.12 110.631 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -143.93 150.73 38.8 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.253 -1.017 . . . . 73.14 108.253 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -149.28 120.65 7.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.613 -0.435 . . . . 74.24 110.942 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.642 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 5.7 t30 61.85 27.09 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.486 0.66 . . . . 72.22 109.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.89 -3.39 70.38 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.45 -0.796 . . . . 43.11 112.27 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -90.73 147.35 23.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.884 -0.413 . . . . 63.04 109.884 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.48 135.49 51.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.487 0.66 . . . . 71.43 110.845 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 0.7 OUTLIER -135.76 168.19 19.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.719 -1.128 . . . . 61.41 108.947 -172.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.17 166.95 18.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.624 0.726 . . . . 72.41 111.964 -165.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.68 128.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.209 -0.905 . . . . 74.54 110.042 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 99' ' ' ILE . 15.7 m -113.14 109.41 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.633 0.73 . . . . 70.11 109.728 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.18 122.93 49.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.888 . . . . 62.14 110.198 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.75 -163.72 14.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.173 -0.537 . . . . 60.32 111.792 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.26 72.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.007 0.432 . . . . 33.13 110.697 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.6 t70 -125.03 92.37 3.63 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.745 -0.661 . . . . 64.24 109.348 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.84 -28.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 62.15 110.758 -173.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.5 t -64.7 -45.8 85.07 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.041 -0.527 . . . . 72.2 109.93 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -67.96 -38.51 82.86 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.872 -0.603 . . . . 55.14 109.946 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.5 mt -60.25 -56.21 19.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.848 -0.615 . . . . 62.22 110.514 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.46 -39.46 82.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 120.762 0.315 . . . . 72.14 110.165 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -54.41 -52.16 62.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.928 -0.578 . . . . 43.12 110.252 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.88 -32.5 70.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.357 -0.383 . . . . 73.04 111.278 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 119' ' ' ILE . 96.7 mt -57.64 -56.2 16.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 120.59 -0.444 . . . . 73.41 110.112 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -68.42 -32.94 73.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.499 -0.481 . . . . 70.22 110.039 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.73 -29.25 69.19 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.696 -0.684 . . . . 72.2 110.991 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.498 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.2 m-20 -98.11 -20.83 17.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.436 -0.347 . . . . 71.2 111.82 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.9 mt -74.48 -47.64 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.768 -0.456 . . . . 54.51 109.768 172.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.697 -0.683 . . . . 71.43 109.579 177.828 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.958 0.409 . . . . 75.42 110.313 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.44 138.91 55.66 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.302 -0.408 . . . . 34.04 110.923 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -164.03 132.91 3.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.354 -0.385 . . . . 65.04 110.334 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.02 -55.87 2.3 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.043 0.449 . . . . 71.22 109.969 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -170.75 88.97 0.13 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.811 -0.631 . . . . 65.22 109.978 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -68.95 111.47 4.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.329 -0.619 . . . . 75.12 109.329 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -125.39 170.83 10.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.859 0.362 . . . . 65.21 110.705 -174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -94.49 152.12 18.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.49 -0.559 . . . . 74.33 109.49 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.4 mtm -77.6 78.59 4.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.045 0.45 . . . . 73.11 110.349 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.29 108.8 3.46 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.417 -0.673 . . . . 70.45 111.417 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.7 m -89.82 91.95 8.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.844 0.354 . . . . 73.25 111.145 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.2 mm? -85.95 66.64 9.69 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.47 -0.567 . . . . 74.23 109.47 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.504 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 38.7 tt0 50.82 76.55 0.15 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.573 -0.739 . . . . 75.42 110.479 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.13 77.26 4.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.864 -0.607 . . . . 52.13 111.173 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.504 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 15.7 mm100 -92.82 133.78 35.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.96 -0.564 . . . . 70.34 109.521 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.6 t -159.18 -179.62 8.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.521 -0.309 . . . . 70.15 110.604 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 62.39 15.99 8.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.422 0.629 . . . . 71.4 110.764 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.17 114.2 3.35 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 111.409 -0.677 . . . . 74.21 111.409 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.54 173.81 12.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.546 2.164 . . . . 75.33 112.216 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.49 -145.25 4.44 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.859 -0.496 . . . . 31.0 111.859 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -76.28 169.67 17.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.291 0.236 . . . . 70.35 110.395 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.443 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 81.8 mmm -74.85 -9.01 58.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.651 0.262 . . . . 71.32 111.444 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.464 HG21 ' HE2' ' A' ' 78' ' ' LYS . 13.2 mm -93.96 119.94 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.476 . . . . 62.2 109.716 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 31.0 tt0 -86.82 118.45 26.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.904 0.383 . . . . 70.14 110.601 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -80.72 137.77 36.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.222 -0.445 . . . . 71.41 110.339 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.507 HG21 ' HG3' ' A' ' 34' ' ' LYS . 42.0 pt -139.53 154.51 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.562 0.22 . . . . 73.54 110.991 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.66 176.53 28.72 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.3 -0.476 . . . . 75.43 112.716 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.06 -55.1 5.92 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.367 0.667 . . . . 65.03 112.177 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 t -70.39 -34.54 72.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.941 0.401 . . . . 74.42 110.673 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.22 -24.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 75.54 111.326 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.9 t80 -49.61 -56.96 8.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 65.25 110.473 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.25 -55.2 30.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.507 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -52.54 -46.37 66.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.431 -0.804 . . . . 43.22 111.405 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.2 mmtt -77.17 -24.28 51.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.394 -0.821 . . . . 63.34 111.56 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.7 t -79.18 -33.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.841 -0.429 . . . . 74.14 109.841 174.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.2 p -79.58 -19.64 48.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.974 0.416 . . . . 53.41 110.479 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -61.7 -23.38 66.08 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.863 -0.608 . . . . 74.54 111.722 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.4 p -74.78 91.46 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 55.23 110.572 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -69.98 -61.71 1.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 72.42 111.511 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' ILE . 5.8 m-20 -123.62 120.87 34.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.483 0.182 . . . . 63.42 110.511 -172.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 51.04 3.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.1 1.519 . . . . 72.45 115.1 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.5 mm -63.92 124.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 118.134 0.424 . . . . 70.51 110.824 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -88.65 110.45 20.96 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.876 -0.787 . . . . 72.33 108.876 177.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 101' ' ' MET . 70.8 mt -90.82 118.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 72.45 110.734 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.477 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -107.56 109.08 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.41 -0.589 . . . . 73.21 109.41 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 57.3 t -92.59 106.86 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.046 -0.353 . . . . 72.45 110.046 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.505 ' HA ' HD13 ' A' ' 99' ' ' ILE . 11.7 t70 -85.74 133.05 34.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.919 -0.582 . . . . 62.13 111.894 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -94.51 95.23 8.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.71 -0.677 . . . . 65.22 109.659 172.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.418 ' HZ3' ' HG3' ' A' ' 82' ' ' GLU . 52.4 t90 -66.32 136.26 55.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.48 -0.782 . . . . 74.34 111.634 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.52 127.25 25.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.547 -0.752 . . . . 54.33 109.192 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.85 -64.8 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.736 2.291 . . . . 64.33 112.498 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -95.94 116.8 29.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.128 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.9 t -158.36 158.65 34.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.284 -0.416 . . . . 63.3 110.58 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.57 -83.56 1.45 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 116.01 -0.541 . . . . 43.4 112.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.49 -25.45 74.03 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.9 2.4 . . . . 54.22 112.768 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 67.5 m -51.01 -37.26 44.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 71.35 111.49 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -62.89 -33.41 75.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.703 0.287 . . . . 74.44 110.914 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.536 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 10.6 m -74.96 -40.53 60.71 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.865 0.84 . . . . 70.35 110.112 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -65.81 -29.58 70.08 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.169 -0.923 . . . . 64.1 111.457 -176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.1 mt-10 -56.78 -60.92 7.96 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.737 -0.385 . . . . 65.12 110.692 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.4 Cg_endo -64.33 -33.16 59.91 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.662 1.575 . . . . 64.23 111.898 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 58' ' ' SER . 54.3 mt-30 -62.62 -38.43 90.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.335 -0.546 . . . . 75.21 110.63 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.448 HD21 HD13 ' A' ' 119' ' ' ILE . 77.5 mt -72.5 -43.34 63.77 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.127 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.8 mt-10 -60.56 -32.43 71.51 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.127 -0.488 . . . . 65.51 110.395 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 65' ' ' LYS . 33.4 ttmt -66.78 -56.82 8.77 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.025 -0.534 . . . . 74.54 110.599 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 116' ' ' ILE . 63.6 mt -58.19 -32.05 67.88 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.917 -0.583 . . . . 74.51 109.451 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.22 -52.62 53.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.669 -0.696 . . . . 43.32 110.127 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.2 mt-30 -53.37 -41.56 65.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.78 0.324 . . . . 74.13 110.806 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -74.94 -44.41 48.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.16 -0.473 . . . . 75.41 111.63 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -101.49 4.82 41.56 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.602 0.593 . . . . 75.22 112.602 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.0 t -53.31 -23.96 10.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.898 0.703 . . . . 63.31 112.898 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.04 -18.88 60.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 74.02 111.141 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -130.94 7.7 4.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.975 -0.557 . . . . 60.25 110.567 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 43' ' ' LEU . 21.5 t -141.15 139.95 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.81 0.338 . . . . 74.22 111.329 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 4.7 tppp? -142.29 128.12 19.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.85 -0.614 . . . . 71.33 109.587 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.7 mt -107.89 137.78 37.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.788 -0.449 . . . . 73.14 109.788 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CZ ' ' HG2' ' A' ' 75' ' ' LYS . 51.1 m-85 -120.77 147.03 45.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.782 0.325 . . . . 62.14 111.371 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE2' HG21 ' A' ' 23' ' ' ILE . 59.7 mttm -120.69 105.45 10.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.893 -0.78 . . . . 62.33 108.893 169.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mt -71.29 107.56 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.769 -0.456 . . . . 75.13 109.769 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.22 68.78 5.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.653 0.739 . . . . 60.11 111.846 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.7 pt -120.84 55.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.197 -1.408 . . . . 65.23 107.197 167.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' HZ3' ' A' ' 49' ' ' TRP . 36.5 tt0 -49.74 -32.67 14.16 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.137 -1.847 . . . . 64.21 113.202 -168.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 -2.9 58.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.209 0.448 . . . . 63.52 112.209 -174.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.47 78.86 1.4 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 73.53 111.046 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.74 -24.34 62.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.988 -0.551 . . . . 73.43 110.388 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.33 -35.04 25.96 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.411 -0.813 . . . . 63.32 111.447 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.54 -39.16 44.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.828 -0.624 . . . . 71.01 110.828 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.14 77.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.8 -0.636 . . . . 74.24 110.49 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.1 m -67.52 -34.17 76.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.596 . . . . 72.42 110.962 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.59 -38.93 92.69 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.79 0.329 . . . . 52.44 111.137 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -95.39 -6.63 40.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.554 -0.294 . . . . 63.04 111.624 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.85 59.56 2.07 Favored Glycine 0 C--O 1.236 0.235 0 C-N-CA 120.96 -0.638 . . . . 65.55 113.215 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.555 HG13 ' OG1' ' A' ' 98' ' ' THR . 81.4 t -89.22 117.75 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.843 0.354 . . . . 75.31 110.116 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.8 m -95.58 -38.14 10.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 63.12 110.91 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 155.23 50.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 52.44 110.46 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.86 132.28 24.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.209 -0.451 . . . . 75.51 111.08 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -91.15 -165.32 2.27 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 123.964 -1.265 . . . . 64.14 111.923 -4.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.555 ' OG1' HG13 ' A' ' 93' ' ' VAL . 54.9 m -143.3 141.2 30.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.23 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 47' ' ' ASP . 46.2 mm -120.76 113.98 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.971 -0.559 . . . . 62.41 110.794 -175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.493 HD23 ' HG3' ' A' ' 110' ' ' GLN . 47.4 mt -90.95 123.41 34.42 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.357 -0.609 . . . . 72.51 109.357 171.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 38.7 mtt -96.73 143.78 27.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.662 -0.415 . . . . 65.12 110.922 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.65 154.83 45.61 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.412 -0.588 . . . . 73.14 109.412 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -156.68 120.59 4.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.261 -0.176 . . . . 74.24 110.972 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.492 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 60.56 25.91 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.832 0.825 . . . . 72.22 110.182 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.66 -8.21 73.26 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.396 -0.82 . . . . 43.11 112.514 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -86.86 147.78 25.65 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.973 -0.38 . . . . 63.04 109.973 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -72.68 127.98 34.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.629 0.728 . . . . 71.43 110.844 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD12 ' OD1' ' A' ' 126' ' ' ASN . 3.9 mm? -119.72 168.71 10.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.48 -1.236 . . . . 61.41 109.315 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -178.91 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.254 0.55 . . . . 72.41 112.257 -162.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.493 ' HG3' HD23 ' A' ' 100' ' ' LEU . 47.0 tt0 -138.3 143.8 40.15 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 122.014 0.911 . . . . 74.54 111.205 -172.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 74.0 t -126.26 118.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.566 -1.652 . . . . 70.11 109.67 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.48 123.28 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.127 -0.323 . . . . 62.14 110.127 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.39 139.81 10.22 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.71 -0.556 . . . . 60.32 111.71 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.97 80.22 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 33.13 111.429 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 119' ' ' ILE . 22.2 t0 -123.37 102.45 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 64.24 110.162 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 66' ' ' LEU . 9.1 tp -60.06 -31.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 62.15 110.634 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.9 t -61.64 -56.63 17.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.395 -0.366 . . . . 72.2 110.181 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.29 -45.26 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 55.14 110.699 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.1 mt -61.2 -56.37 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.144 -0.48 . . . . 62.22 111.35 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.75 85.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.091 0.472 . . . . 72.14 110.222 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 t -60.65 -48.16 83.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 43.12 109.591 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.69 -35.46 78.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.81 -0.632 . . . . 73.04 111.111 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 127' ' ' ILE . 93.4 mt -56.46 -55.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.199 -0.667 . . . . 73.41 109.199 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -63.86 -35.69 81.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 70.22 110.919 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.85 -46.61 88.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.873 0.368 . . . . 72.2 111.041 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.496 ' HB2' HD11 ' A' ' 43' ' ' LEU . 56.1 m-80 -91.21 -5.19 55.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 71.2 111.507 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 123' ' ' ILE . 60.5 mt -78.82 -47.22 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.757 -0.46 . . . . 54.51 109.757 167.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.464 -0.779 . . . . 71.43 110.539 -177.141 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.999 0.428 . . . . 75.42 110.605 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.72 152.72 24.46 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.208 -0.451 . . . . 34.04 111.102 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.72 109.55 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 65.04 109.278 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -59.95 -55.95 27.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.095 -0.502 . . . . 71.22 111.308 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -167.68 94.07 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.591 . . . . 65.22 110.482 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -65.85 85.17 0.08 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.329 0.585 . . . . 75.12 110.105 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -75.4 153.37 37.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 65.21 111.017 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -94.04 158.48 15.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.163 -0.472 . . . . 74.33 110.388 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.9 mtm -76.57 160.05 29.78 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.018 -0.537 . . . . 73.11 110.443 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.67 159.64 9.48 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.044 -0.598 . . . . 70.45 112.269 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 13' ' ' GLU . 90.0 m -135.07 115.12 13.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.866 0.365 . . . . 73.25 110.076 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.0 mm? -88.98 24.21 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 74.23 110.745 -174.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' H ' HG22 ' A' ' 11' ' ' THR . 43.5 tt0 60.08 86.09 0.1 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.483 0.659 . . . . 75.42 110.692 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.52 92.83 0.9 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.154 -0.93 . . . . 52.13 109.121 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -74.39 99.58 3.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 70.34 110.326 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -65.25 159.77 23.01 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.739 -0.664 . . . . 70.15 110.97 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 17' ' ' GLN . 52.6 tt0 71.32 10.87 6.72 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.696 -0.684 . . . . 71.4 110.746 -175.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.9 112.37 4.96 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.671 -0.572 . . . . 74.21 111.671 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.21 154.42 19.02 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.666 2.244 . . . . 75.33 112.242 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.43 -139.84 4.06 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.01 -0.614 . . . . 31.0 112.358 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.5 m -83.7 170.15 14.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.5 0.32 . . . . 70.35 110.932 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.469 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 89.5 mmm -75.57 -16.95 60.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.159 -0.473 . . . . 71.32 111.016 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 22.0 mm -85.39 111.47 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 62.2 109.491 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -85.24 112.02 20.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.9 -0.591 . . . . 70.14 110.806 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -83.61 134.86 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.698 -0.482 . . . . 71.41 109.698 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.4 pt -132.4 167.72 25.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 120.994 0.426 . . . . 73.54 111.492 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 178.96 32.45 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.579 -0.737 . . . . 75.43 112.464 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.86 -55.43 35.03 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.059 0.543 . . . . 65.03 112.026 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 t -68.82 -2.7 10.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.227 -0.442 . . . . 74.42 111.888 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.11 -9.88 25.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.565 0.209 . . . . 75.54 111.565 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.73 -62.08 1.93 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.82 0.343 . . . . 65.25 110.761 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.55 -49.27 70.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.927 -0.579 . . . . 73.42 110.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.2 -53.68 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.361 -0.836 . . . . 43.22 111.05 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -63.77 -40.11 95.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.035 -0.529 . . . . 63.34 111.127 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HA ' HD13 ' A' ' 44' ' ' ILE . 80.0 t -71.29 -40.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.104 0.409 . . . . 74.14 112.104 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 p -86.06 -29.39 23.44 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.295 0.48 . . . . 53.41 112.295 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.7 t -82.37 10.39 7.15 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.341 0.497 . . . . 74.54 112.341 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.761 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.6 p -66.57 142.69 57.41 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.252 -0.28 . . . . 55.23 110.351 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.08 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.339 0.399 . . . . 72.42 112.06 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.29 128.85 17.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.37 -0.233 . . . . 63.42 110.37 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 55.92 11.41 0.71 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.477 0.547 . . . . 72.45 112.477 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 37.6 mm -62.87 131.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.671 0.272 . . . . 70.51 110.787 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.52 110.95 21.74 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.335 0.588 . . . . 72.33 109.544 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 38' ' ' CYS . 73.0 mt -100.32 114.19 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 72.45 110.659 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.61 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -99.68 128.45 45.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.394 -0.595 . . . . 73.21 109.394 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 85.6 t -107.42 110.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.738 0.304 . . . . 72.45 110.366 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' HA ' HD13 ' A' ' 99' ' ' ILE . 4.2 t70 -85.58 134.49 34.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.847 -0.615 . . . . 62.13 110.985 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -97.96 119.81 37.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.172 -0.467 . . . . 65.22 109.862 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.2 t90 -54.57 108.87 0.43 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.453 -0.794 . . . . 74.34 111.786 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.6 112.41 39.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.785 -0.643 . . . . 54.33 109.902 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.41 -68.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.765 2.31 . . . . 64.33 112.556 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -114.14 110.16 19.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.0 -0.37 . . . . 73.15 110.0 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.6 t -163.55 135.96 5.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.19 -0.459 . . . . 63.3 110.142 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.09 -76.78 0.59 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.227 -0.511 . . . . 43.4 112.599 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.23 -29.31 56.32 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.983 2.455 . . . . 54.22 112.928 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 78.8 m -55.48 -31.37 61.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.152 -0.476 . . . . 71.35 112.173 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 7.0 ptp85 -69.06 -30.42 68.75 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.997 -0.281 . . . . 74.44 110.404 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.5 m -74.94 -29.34 60.91 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.295 0.569 . . . . 70.35 109.798 174.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -66.64 -29.09 69.03 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.871 -0.604 . . . . 64.1 111.126 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 48.3 mt-10 -57.99 -57.74 23.67 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.93 -0.308 . . . . 65.12 110.588 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 36.5 Cg_endo -66.57 -31.41 41.31 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.113 1.875 . . . . 64.23 112.641 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.9 mt-30 -62.99 -41.67 99.64 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 120.428 -0.509 . . . . 75.21 110.286 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 67.9 mt -65.62 -34.96 79.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 74.14 109.66 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.56 -37.22 86.47 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.128 -0.487 . . . . 65.51 110.505 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 1.4 tpmt? -58.35 -56.4 22.63 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.213 0.53 . . . . 74.54 109.809 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.468 HD13 HD12 ' A' ' 123' ' ' ILE . 19.1 mt -63.51 -36.43 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.467 -0.788 . . . . 74.51 110.079 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.28 -53.74 44.22 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.125 -0.489 . . . . 43.32 110.176 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 98.2 mt-30 -55.35 -42.41 73.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.746 0.308 . . . . 74.13 110.909 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -72.84 -41.51 64.76 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.398 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -104.87 4.8 32.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.193 0.812 . . . . 75.22 113.193 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.0 t -53.5 -20.02 4.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.997 1.11 . . . . 63.31 113.997 -168.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.97 -18.77 61.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.323 . . . . 74.02 111.052 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -123.16 -25.77 4.45 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.954 -0.567 . . . . 60.25 110.5 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 45' ' ' LEU . 49.5 t -109.02 134.77 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.033 0.444 . . . . 74.22 111.766 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -138.21 127.36 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 71.33 109.284 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.61 HG12 ' HB2' ' A' ' 45' ' ' LEU . 41.1 mt -108.71 123.47 64.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.263 -0.273 . . . . 73.14 110.263 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 88.1 m-85 -107.54 131.9 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.371 -0.377 . . . . 62.14 111.025 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 58.9 mttm -97.22 99.86 11.33 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.327 -0.62 . . . . 62.33 109.327 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.3 mt -81.75 83.18 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.452 0.644 . . . . 75.13 109.338 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.64 78.02 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.759 -0.655 . . . . 60.11 110.712 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.4 pt -112.68 64.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.405 -0.816 . . . . 65.23 109.337 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.39 -32.46 38.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.41 -1.268 . . . . 64.21 112.542 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.54 -15.58 62.29 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.976 0.417 . . . . 63.52 111.367 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -105.53 76.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 73.53 110.573 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -62.94 -33.17 74.78 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.933 -0.576 . . . . 73.43 110.7 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.8 m-20 -51.55 -32.14 27.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.825 -0.625 . . . . 63.32 111.651 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -55.89 -39.64 58.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.37 . . . . 71.01 110.679 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.64 96.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 74.24 109.918 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.7 m -64.57 -39.24 93.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.551 -0.75 . . . . 72.42 110.744 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.5 mm100 -63.27 -52.21 62.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.176 -0.466 . . . . 52.44 110.727 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -81.52 -11.78 59.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.989 -0.55 . . . . 63.04 111.16 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.71 44.81 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.271 -0.49 . . . . 65.55 112.507 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.478 HG13 ' OG1' ' A' ' 98' ' ' THR . 87.9 t -60.14 112.83 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.137 0.494 . . . . 75.31 110.09 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 m -87.06 -44.9 11.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.495 -0.775 . . . . 63.12 111.561 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.93 163.5 32.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.438 -0.346 . . . . 52.44 110.445 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 25.7 pt -101.45 133.06 21.1 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 75.51 110.64 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 66.4 Cg_endo -90.21 -178.02 11.13 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.77 -1.346 . . . . 64.14 111.967 -3.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.478 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.2 m -136.24 130.9 33.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.328 -0.397 . . . . 74.0 110.008 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 47' ' ' ASP . 44.2 mm -119.46 115.88 49.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.604 -0.725 . . . . 62.41 110.264 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 19.8 mt -88.14 158.66 18.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.345 -0.613 . . . . 72.51 109.345 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 31.7 mtt -123.55 141.76 51.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 65.12 109.728 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -140.95 154.36 46.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.074 -0.713 . . . . 73.14 109.074 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.5 ttmm -150.47 110.52 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.042 -0.263 . . . . 74.24 110.542 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.761 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.7 t30 64.03 25.27 13.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.598 0.714 . . . . 72.22 110.3 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.76 -16.47 41.19 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.767 -0.651 . . . . 43.11 111.925 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 34.5 ttpt -75.12 145.29 42.35 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.805 0.442 . . . . 63.04 110.092 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -64.07 148.33 50.08 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.317 0.579 . . . . 71.43 110.849 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.49 168.18 26.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.872 -1.158 . . . . 61.41 107.872 -170.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 m -69.86 -177.99 1.43 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.0 0.741 . . . . 72.41 113.0 -164.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 51.7 tt0 -149.15 146.29 27.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.767 0.794 . . . . 74.54 110.7 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.19 119.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 113.93 -1.487 . . . . 70.11 109.542 -173.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.1 mt -113.34 123.96 69.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.144 -0.317 . . . . 62.14 110.144 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.31 152.36 24.39 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.605 -0.598 . . . . 60.32 111.605 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 72.38 4.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.85 0.357 . . . . 33.13 111.185 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 119' ' ' ILE . 8.5 t70 -115.59 88.1 2.81 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.293 0.568 . . . . 64.24 109.516 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 66' ' ' LEU . 10.1 tp -59.14 -33.09 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.502 -0.772 . . . . 62.15 111.289 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.3 m -61.2 -49.52 76.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.011 0.434 . . . . 72.2 110.518 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -60.32 -44.13 95.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.038 -0.528 . . . . 55.14 110.077 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 115' ' ' ASP . 66.7 mt -58.21 -56.54 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 62.22 111.317 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.03 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.001 0.429 . . . . 72.14 110.583 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 t -59.09 -52.14 67.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.773 -0.649 . . . . 43.12 110.362 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.94 -34.66 77.02 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.52 -0.309 . . . . 73.04 111.136 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.562 ' O ' HG13 ' A' ' 127' ' ' ILE . 81.7 mt -55.75 -56.57 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.514 -0.55 . . . . 73.41 109.514 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -63.37 -37.05 85.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.05 -0.523 . . . . 70.22 110.526 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.74 -36.15 78.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 72.2 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -103.26 -1.13 29.33 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.43 0.53 . . . . 71.2 112.43 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 123' ' ' ILE . 82.5 mt -84.8 -60.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 54.51 110.419 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.577 -0.738 . . . . 71.43 110.705 -172.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.984 -0.376 . . . . 75.42 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.03 145.15 22.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 34.04 110.783 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -88.86 98.25 11.62 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.49 -0.559 . . . . 65.04 109.49 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -70.61 -65.28 0.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.401 -0.592 . . . . 71.22 109.401 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 73.25 -52.2 0.7 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.69 0.796 . . . . 65.22 112.59 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -66.31 134.12 51.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.533 0.206 . . . . 75.12 111.109 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -152.93 149.04 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.155 -0.313 . . . . 65.21 110.155 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -89.88 137.03 32.68 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.546 -0.297 . . . . 74.33 110.541 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 mmt -76.48 -35.07 58.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.681 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.31 58.18 6.24 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.915 -0.66 . . . . 70.45 112.056 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.4 p -86.82 91.55 8.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.871 0.367 . . . . 73.25 111.422 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.97 97.02 6.94 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.348 -0.387 . . . . 74.23 109.959 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.25 154.49 18.98 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.787 -0.449 . . . . 75.42 109.787 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -143.42 176.01 9.5 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.976 0.417 . . . . 52.13 112.109 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -151.83 148.59 28.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.235 -0.893 . . . . 70.34 109.418 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.6 p -120.62 168.73 11.07 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 110.454 -0.202 . . . . 70.15 110.454 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -135.16 140.13 45.14 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.126 0.488 . . . . 71.4 111.137 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.43 131.65 5.61 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.032 -0.827 . . . . 74.21 111.032 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.6 -17.43 54.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.615 2.21 . . . . 75.33 112.479 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.99 -64.31 4.16 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.009 -0.541 . . . . 31.0 111.868 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 p -135.62 125.95 26.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.748 -0.464 . . . . 70.35 109.748 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 75.9 mmm -79.77 -29.33 40.38 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.249 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.55 HG21 ' HE2' ' A' ' 78' ' ' LYS . 5.6 mm -66.83 108.86 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.824 -0.625 . . . . 62.2 110.094 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 10.4 tp10 -88.9 134.96 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.234 -0.284 . . . . 70.14 110.234 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -96.18 119.06 33.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 71.41 110.464 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.475 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.8 pt -134.58 160.97 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.294 -0.412 . . . . 73.54 111.305 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.51 -170.68 27.98 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 116.095 -0.502 . . . . 75.43 112.301 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.9 -50.37 73.68 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.002 0.43 . . . . 65.03 111.281 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -61.0 -21.21 63.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.979 -0.555 . . . . 74.42 111.319 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.464 ' CB ' ' HB ' ' A' ' 26' ' ' ILE . 5.8 mm-40 -88.8 -14.08 37.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 75.54 111.657 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -57.34 -62.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 65.25 110.837 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.92 -50.57 72.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.089 0.471 . . . . 73.42 110.263 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -50.74 -57.44 8.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.284 -0.871 . . . . 43.22 111.593 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 26' ' ' ILE . 49.1 mmtm -75.39 -28.9 59.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.98 -0.554 . . . . 63.34 111.757 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.478 ' HA ' HD13 ' A' ' 44' ' ' ILE . 51.5 t -70.6 -37.51 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 121.1 -0.24 . . . . 74.14 111.292 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -86.44 -30.41 22.08 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.085 0.402 . . . . 53.41 112.085 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -74.33 7.44 2.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.043 0.386 . . . . 74.54 112.043 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 29.4 p -67.78 162.51 23.76 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.161 -0.311 . . . . 55.23 110.161 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -73.66 -82.71 0.05 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.637 0.256 . . . . 72.42 111.052 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -160.87 138.48 9.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.882 -0.414 . . . . 63.42 109.882 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 59.2 t30 62.09 1.99 0.75 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.97 0.508 . . . . 72.45 111.606 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -63.82 110.15 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.377 -0.374 . . . . 70.51 111.116 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HG22 ' A' ' 74' ' ' VAL . 55.4 tp -76.27 114.41 14.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.174 -0.676 . . . . 72.33 109.174 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 38' ' ' CYS . 77.8 mt -99.86 110.46 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.989 -1.005 . . . . 72.45 110.492 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.676 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.9 mp -93.45 121.51 34.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 73.21 109.436 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 60.2 t -103.31 105.48 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.401 -0.592 . . . . 72.45 109.401 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' HD13 ' A' ' 99' ' ' ILE . 27.2 t70 -83.63 129.37 34.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.872 0.368 . . . . 62.13 111.446 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.95 114.09 25.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.142 -1.059 . . . . 65.22 108.142 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.63 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 3.1 t90 -77.75 -42.26 34.76 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.486 0.491 . . . . 74.34 111.883 -164.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB2' HG21 ' A' ' 96' ' ' ILE . . . 69.92 134.61 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.805 0.691 . . . . 54.33 110.964 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.75 -31.35 94.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.508 2.139 . . . . 64.33 111.4 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -127.82 136.32 51.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.543 -0.753 . . . . 73.15 109.014 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 5.2 p -146.64 -82.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.348 -0.141 . . . . 63.3 111.245 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . 108.86 -85.83 0.42 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.072 -0.585 . . . . 43.4 111.662 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 53' ' ' CYS . 19.4 Cg_endo -58.13 -9.83 7.05 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.916 2.411 . . . . 54.22 112.259 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.73 -37.52 63.42 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.004 -0.544 . . . . 71.35 110.676 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 14.2 ptm180 -56.88 -34.25 67.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.145 -0.48 . . . . 74.44 111.151 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.5 m -75.84 -54.86 6.27 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.8 0.81 . . . . 70.35 111.04 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -64.51 -41.99 96.08 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.188 -0.915 . . . . 64.1 113.222 -169.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.77 -53.92 60.67 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 117.962 0.346 . . . . 65.12 111.301 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.86 -27.88 58.98 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.678 1.585 . . . . 64.23 112.3 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.0 mt-30 -65.07 -38.82 92.04 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.426 -0.51 . . . . 75.21 110.069 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 95.8 mt -69.01 -40.04 78.92 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 74.14 109.499 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 5.7 mm-40 -53.85 -49.18 69.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.493 -0.776 . . . . 65.51 110.18 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -54.59 -52.39 62.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.711 -0.677 . . . . 74.54 110.775 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.473 HD13 HD12 ' A' ' 123' ' ' ILE . 52.0 mt -65.02 -33.38 75.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 74.51 110.103 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -72.53 -14.91 61.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.46 . . . . 43.32 110.969 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.4 mt-30 -93.69 -39.22 10.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.882 0.373 . . . . 74.13 110.666 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -69.59 -34.01 73.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.542 0.687 . . . . 75.41 110.301 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.87 6.29 33.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.039 -0.982 . . . . 75.22 111.533 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.1 t -52.97 -22.15 5.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.634 0.975 . . . . 63.31 113.634 -168.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -78.66 -23.04 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 74.02 111.166 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.19 5.59 6.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.132 -0.486 . . . . 60.25 111.483 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.547 HG22 ' HB3' ' A' ' 43' ' ' LEU . 65.6 t -139.81 145.1 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.695 0.283 . . . . 74.22 111.578 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 28.5 tptp -148.77 127.86 12.8 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.649 -0.5 . . . . 71.33 109.649 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.9 mt -103.14 145.17 12.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.006 0.432 . . . . 73.14 111.052 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 98.4 m-85 -126.87 167.84 15.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.73 -0.668 . . . . 62.14 110.147 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 9.7 tppt? -136.49 108.52 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.273 -1.01 . . . . 62.33 108.273 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.754 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -75.65 128.29 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 75.13 110.347 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -90.6 21.31 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.443 0.64 . . . . 60.11 110.503 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 pt -94.55 32.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.427 0.632 . . . . 65.23 109.834 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.31 -18.58 50.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.822 -1.081 . . . . 64.21 111.59 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -89.29 5.99 42.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 63.52 111.623 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.413 ' ND2' HG23 ' A' ' 87' ' ' VAL . 49.9 t30 -116.43 89.06 3.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.963 0.411 . . . . 73.53 110.307 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -67.88 -21.77 65.13 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 73.43 111.521 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -50.13 -45.8 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.398 . . . . 63.32 110.547 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.413 HG23 ' ND2' ' A' ' 84' ' ' ASN . 74.0 t -60.35 -34.48 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.795 -0.639 . . . . 71.01 110.525 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.28 -51.5 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.041 0.448 . . . . 74.24 110.058 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -61.87 -42.23 98.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 72.42 110.914 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.89 -50.31 71.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.121 -0.491 . . . . 52.44 111.07 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.06 -4.69 58.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.398 -0.365 . . . . 63.04 111.493 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.72 34.86 37.7 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.202 -0.523 . . . . 65.55 113.53 170.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.526 HG13 ' OG1' ' A' ' 98' ' ' THR . 83.9 t -68.29 130.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 75.31 110.361 176.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.4 m -129.82 -71.3 0.61 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 63.12 110.083 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.64 136.18 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 110.027 -0.36 . . . . 52.44 110.027 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 50' ' ' ALA . 2.2 pp -113.71 151.22 44.45 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.421 -0.354 . . . . 75.51 111.335 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.08 160.81 91.24 Favored 'Cis proline' 0 C--N 1.353 0.815 0 C-N-CA 124.079 -1.217 . . . . 64.14 112.365 -0.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.529 HG23 HG12 ' A' ' 112' ' ' ILE . 92.3 m -119.74 129.91 54.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 74.0 109.871 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 111' ' ' VAL . 45.8 mm -110.16 113.48 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 62.41 110.899 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 38.0 mt -91.04 152.46 20.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.553 -0.906 . . . . 72.51 108.553 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.426 ' HB3' HD11 ' A' ' 43' ' ' LEU . 36.9 mtt -124.12 141.38 52.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.883 0.31 . . . . 65.12 110.309 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.524 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 99.4 m-85 -143.94 154.94 43.83 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.851 -0.796 . . . . 73.14 108.851 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -144.19 104.86 4.16 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.683 -0.407 . . . . 74.24 111.04 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.682 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 7.9 t30 55.41 32.82 19.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.561 0.696 . . . . 72.22 110.627 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.0 -16.48 59.42 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.736 -0.666 . . . . 43.11 112.587 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -71.79 140.74 49.57 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 110.157 -0.312 . . . . 63.04 110.157 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.556 ' O ' HD22 ' A' ' 108' ' ' LEU . 12.2 mmmm -68.42 134.42 50.17 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.281 0.562 . . . . 71.43 110.961 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.556 HD22 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -139.0 168.84 18.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.44 -1.254 . . . . 61.41 109.057 -170.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -69.81 -178.62 1.57 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.252 0.834 . . . . 72.41 113.252 -163.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.428 ' HG3' HD23 ' A' ' 100' ' ' LEU . 48.4 tt0 -148.76 122.46 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.092 -0.958 . . . . 74.54 109.689 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.505 HG23 ' HB ' ' A' ' 99' ' ' ILE . 19.4 m -113.9 130.16 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.177 0.513 . . . . 70.11 110.028 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.529 HG12 HG23 ' A' ' 98' ' ' THR . 58.0 mt -116.08 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 62.14 109.711 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.2 148.08 14.4 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.896 -0.482 . . . . 60.32 111.896 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.61 72.12 6.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.825 0.345 . . . . 33.13 111.174 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.4 t70 -122.76 91.94 3.6 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.349 -0.612 . . . . 64.24 109.349 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -59.33 -30.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 62.15 111.207 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.0 t -63.49 -49.22 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 72.2 110.071 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.47 -43.05 99.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.801 -0.444 . . . . 55.14 109.801 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 123' ' ' ILE . 70.9 mt -57.73 -56.27 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.718 -0.674 . . . . 62.22 111.104 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.19 -39.4 82.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 120.675 0.274 . . . . 72.14 110.436 -177.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.9 m -54.78 -52.0 63.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.794 -0.447 . . . . 43.12 109.794 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 25.1 mm-40 -67.64 -32.19 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 73.04 111.478 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.7 mt -60.2 -56.18 19.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.383 -0.527 . . . . 73.41 109.918 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -68.01 -28.3 67.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.52 -0.472 . . . . 70.22 109.89 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 23.7 t-20 -65.09 -44.49 88.68 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.664 -0.698 . . . . 72.2 111.403 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -91.32 -8.78 47.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.548 -0.296 . . . . 71.2 111.628 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.8 mt -76.44 -50.36 22.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.159 0.504 . . . . 54.51 109.645 167.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.401 -0.809 . . . . 71.43 109.667 -176.482 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.73 0.3 . . . . 75.42 110.453 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.53 78.55 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.25 0.547 . . . . 34.04 109.699 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -70.14 121.4 17.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.476 -0.784 . . . . 65.04 110.701 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.8 m170 67.48 90.78 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.227 0.611 . . . . 71.22 111.337 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -153.06 93.82 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.893 -0.594 . . . . 65.22 110.357 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -72.11 87.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.688 -0.486 . . . . 75.12 109.688 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -59.75 129.92 44.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.778 -0.646 . . . . 65.21 110.339 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -84.96 148.92 25.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.39 -0.368 . . . . 74.33 110.493 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.1 ptp -102.19 140.25 36.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 73.11 110.086 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.46 165.96 39.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.035 -0.602 . . . . 70.45 111.739 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 t -84.63 126.17 33.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 73.25 110.412 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.3 mt -82.97 -6.31 59.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.903 -0.59 . . . . 74.23 109.751 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -81.93 77.26 8.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.841 -0.618 . . . . 75.42 110.778 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.68 -66.53 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.703 -0.851 . . . . 52.13 108.703 172.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 46.66 78.47 0.07 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.297 -0.865 . . . . 70.34 111.656 174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 t -168.96 145.72 3.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.904 -0.589 . . . . 70.15 110.304 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -86.06 -178.66 6.59 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.137 -0.483 . . . . 71.4 110.072 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.38 92.26 0.78 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.933 -0.467 . . . . 74.21 111.933 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.87 147.8 27.6 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.489 2.126 . . . . 75.33 111.937 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' HG2' ' A' ' 22' ' ' MET . . . 128.34 -27.74 4.42 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.227 -0.749 . . . . 31.0 111.227 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 p -57.83 114.49 2.33 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.776 0.339 . . . . 70.35 110.836 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 20' ' ' GLY . 94.3 mmm -124.04 -41.56 2.21 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.983 -0.553 . . . . 71.32 110.507 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.751 HG22 ' HG3' ' A' ' 78' ' ' LYS . 3.3 mm -68.76 101.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.234 -0.654 . . . . 62.2 109.234 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 40.5 tt0 -90.65 127.2 36.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.888 -0.596 . . . . 70.14 111.532 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -85.51 128.53 34.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.799 0.333 . . . . 71.41 110.436 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.34 164.79 32.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.492 -0.322 . . . . 73.54 111.031 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 -178.56 38.96 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.825 -0.625 . . . . 75.43 112.404 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.36 -43.4 94.66 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.004 0.43 . . . . 65.03 110.995 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -64.99 -36.16 83.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 74.42 110.539 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -74.09 -17.45 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 75.54 111.859 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -52.93 -62.31 1.73 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.633 0.254 . . . . 65.25 111.22 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 36' ' ' THR . 24.7 t70 -64.38 -45.99 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.02 0.438 . . . . 73.42 110.686 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -56.63 -57.16 13.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.331 -0.85 . . . . 43.22 110.701 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HE3' ' CE2' ' A' ' 77' ' ' TYR . 24.1 mmmt -65.28 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.698 -0.683 . . . . 63.34 110.885 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.63 -51.72 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.667 0.27 . . . . 74.14 111.143 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 32' ' ' ASP . 8.9 t -86.01 -10.71 54.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.829 0.307 . . . . 53.41 111.829 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -72.81 -12.59 61.05 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.923 0.342 . . . . 74.54 111.923 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.693 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 15.5 p -55.13 143.59 26.79 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.591 0.234 . . . . 55.23 111.488 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -54.56 -79.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.067 -0.515 . . . . 72.42 111.588 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' H ' HG12 ' A' ' 42' ' ' ILE . 33.8 t70 -159.33 125.8 4.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.473 0.178 . . . . 63.42 110.793 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 59.21 15.33 4.13 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.885 0.474 . . . . 72.45 111.418 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.693 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -76.32 118.71 23.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.309 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 74' ' ' VAL . 63.7 tp -74.46 122.03 22.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.945 -0.57 . . . . 72.33 110.424 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 38' ' ' CYS . 37.6 mt -110.77 121.91 64.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.661 -0.7 . . . . 72.45 110.295 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 4.4 mp -104.79 112.59 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.243 -0.651 . . . . 73.21 109.243 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -93.95 104.67 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.944 -0.391 . . . . 72.45 109.944 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.21 146.65 30.37 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.982 -0.554 . . . . 62.13 110.916 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -107.89 129.04 55.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 65.22 109.819 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.41 140.52 45.39 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 74.34 111.576 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB1' HD12 ' A' ' 96' ' ' ILE . . . -99.33 107.94 47.54 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 54.33 110.922 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -52.46 -52.46 8.84 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.746 2.297 . . . . 64.33 111.471 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.576 ' HB2' HD11 ' A' ' 96' ' ' ILE . 45.3 m95 -80.15 75.85 6.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.407 -0.96 . . . . 73.15 108.407 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.445 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 7.6 t -75.65 79.19 2.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.502 -0.772 . . . . 63.3 110.27 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -108.57 -74.04 0.82 Allowed Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.5 -0.773 . . . . 43.4 111.432 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.88 -18.95 59.83 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.732 2.288 . . . . 54.22 111.612 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 27.8 p -52.13 -34.43 44.41 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.516 -0.765 . . . . 71.35 110.379 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -53.8 -49.37 68.47 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.948 -0.569 . . . . 74.44 111.083 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.623 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 48.0 m -75.24 -42.8 54.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.072 0.463 . . . . 70.35 111.526 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.7 -37.83 88.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.815 0.672 . . . . 64.1 112.815 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 58.5 mm-40 -55.81 -58.84 13.67 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 117.967 0.349 . . . . 65.12 110.736 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 36.4 Cg_endo -65.29 -27.53 55.71 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.938 1.759 . . . . 64.23 112.372 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.2 mt-30 -68.32 -40.62 81.61 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.698 -0.401 . . . . 75.21 110.71 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.99 -43.03 84.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.633 -0.506 . . . . 74.14 109.633 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 2.9 mm-40 -52.73 -47.14 67.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.722 -0.672 . . . . 65.51 110.131 174.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -52.29 -57.08 10.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.824 -0.626 . . . . 74.54 110.837 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.46 HD13 HD12 ' A' ' 123' ' ' ILE . 31.4 mt -65.78 -31.36 72.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.676 -0.693 . . . . 74.51 110.379 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -68.46 -44.2 75.36 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.873 -0.603 . . . . 43.32 110.223 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.0 mt-30 -71.38 -37.52 71.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.271 0.558 . . . . 74.13 110.581 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -73.4 -37.34 65.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.719 -0.673 . . . . 75.41 111.122 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.96 5.25 32.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.121 -0.491 . . . . 75.22 112.166 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.7 t -52.86 -21.17 3.92 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.135 0.791 . . . . 63.31 113.135 -171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.66 -28.27 69.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 74.02 110.472 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.14 8.37 3.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.2 -0.454 . . . . 60.25 111.765 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 43' ' ' LEU . 64.9 t -134.41 141.9 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.053 0.454 . . . . 74.22 112.068 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 57.0 tptt -145.17 126.09 14.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.429 -0.805 . . . . 71.33 109.31 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 45' ' ' LEU . 36.0 mt -108.31 140.25 27.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.742 0.306 . . . . 73.14 110.542 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 86.2 m-85 -121.39 170.5 9.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 62.14 109.712 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.751 ' HG3' HG22 ' A' ' 23' ' ' ILE . 28.8 mtpp -136.12 128.5 30.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.63 -0.507 . . . . 62.33 109.63 173.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.67 67.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.661 -1.237 . . . . 75.13 107.661 168.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -85.24 66.09 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.241 -0.891 . . . . 60.11 110.656 -170.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.5 mt -100.81 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.182 -1.044 . . . . 65.23 108.182 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -23.23 2.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.35 -1.296 . . . . 64.21 113.069 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.77 -36.47 23.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.689 0.255 . . . . 63.52 111.689 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -96.9 82.24 3.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.156 0.503 . . . . 73.53 111.258 -170.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -68.43 -20.59 64.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.628 . . . . 73.43 109.991 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.9 m-20 -47.97 -39.51 19.67 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.476 -0.784 . . . . 63.32 111.427 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.8 -36.98 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.903 -0.59 . . . . 71.01 110.935 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.07 79.02 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 74.24 110.44 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.6 m -67.56 -37.77 83.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.78 -0.645 . . . . 72.42 111.02 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 77.3 mm-40 -63.62 -46.08 87.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 52.44 110.788 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -87.28 -15.07 39.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.345 -0.389 . . . . 63.04 111.631 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 41.94 9.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.165 -0.54 . . . . 65.55 112.911 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.449 HG13 ' OG1' ' A' ' 98' ' ' THR . 93.4 t -65.23 103.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.888 -0.412 . . . . 75.31 109.888 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -77.76 -37.86 48.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 63.12 111.526 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.522 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -140.68 138.47 34.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.359 -0.382 . . . . 52.44 110.186 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 52' ' ' TRP . 18.6 pt -106.51 140.77 21.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.075 -0.512 . . . . 75.51 110.777 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.22 -179.57 26.22 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.774 -1.344 . . . . 64.14 112.408 -0.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HG12 ' A' ' 112' ' ' ILE . 93.8 m -138.61 132.58 31.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 74.0 110.121 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 44.2 mm -115.86 110.84 33.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.956 -0.566 . . . . 62.41 111.001 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -93.22 123.3 36.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.436 -0.579 . . . . 72.51 109.436 174.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.532 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 12.1 mmt -91.56 140.61 29.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.308 . . . . 65.12 110.328 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -143.77 148.35 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.151 -1.055 . . . . 73.14 108.151 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -145.61 112.06 5.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.076 -0.65 . . . . 74.24 111.384 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.64 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 64.4 t30 62.19 25.95 15.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.552 0.691 . . . . 72.22 110.434 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.34 -16.55 58.65 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.576 -0.738 . . . . 43.11 112.084 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -73.5 142.4 46.77 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.041 -0.355 . . . . 63.04 110.041 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.32 127.48 33.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.43 110.725 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 108' ' ' LEU . 2.8 mm? -126.93 168.5 14.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.095 . . . . 61.41 110.576 -172.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.24 163.25 26.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.608 -0.723 . . . . 72.41 111.913 -167.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -127.25 124.34 38.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 74.54 110.044 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 32.2 m -102.8 140.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 109.814 -0.439 . . . . 70.11 109.814 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' A' ' 95' ' ' ALA . 63.2 mt -127.92 134.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 62.14 110.03 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.21 145.24 13.4 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.093 -0.575 . . . . 60.32 111.672 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.8 79.77 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 33.13 111.101 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -132.19 98.32 4.38 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.57 -0.53 . . . . 64.24 109.57 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.96 -28.78 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 62.15 110.799 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 t -64.89 -43.68 92.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.764 -0.458 . . . . 72.2 109.764 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -67.02 -44.77 79.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.125 -0.489 . . . . 55.14 109.958 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.9 mt -56.66 -54.01 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.996 -0.547 . . . . 62.22 110.958 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.25 -37.33 79.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 116.318 -0.401 . . . . 72.14 110.199 -177.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.5 t -56.44 -48.81 76.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.451 -0.574 . . . . 43.12 109.451 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 49.4 mm-40 -66.47 -37.16 84.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.384 -0.371 . . . . 73.04 111.046 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.5 mt -53.27 -55.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 120.833 -0.347 . . . . 73.41 110.133 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.12 -29.56 67.64 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.561 -0.456 . . . . 70.22 110.111 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 44.2 t30 -66.68 -32.81 74.36 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.411 . . . . 72.2 111.017 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.407 ' OD1' HD12 ' A' ' 108' ' ' LEU . 64.7 m-80 -86.91 -31.07 20.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.811 -0.177 . . . . 71.2 111.152 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.5 mt -69.25 -39.8 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.112 0.482 . . . . 54.51 110.108 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.474 -0.774 . . . . 71.43 110.032 -179.022 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.168 -0.308 . . . . 75.42 110.168 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.35 131.17 46.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.168 -0.469 . . . . 34.04 110.715 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -89.13 103.15 15.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.972 0.415 . . . . 65.04 110.373 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -112.5 114.66 27.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.332 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -116.86 111.13 19.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.502 -0.317 . . . . 65.22 110.439 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -157.69 152.58 25.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.188 -0.46 . . . . 75.12 110.266 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -123.97 117.7 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 65.21 110.106 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -131.94 129.27 40.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 74.33 110.13 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.6 mtm -119.62 8.84 11.32 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.399 -0.364 . . . . 73.11 110.77 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.73 -147.29 41.56 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.511 -0.852 . . . . 70.45 111.149 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.5 p 51.54 22.18 1.47 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.074 0.55 . . . . 73.25 112.011 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.7 mt -120.28 95.62 4.82 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.728 -0.471 . . . . 74.23 109.728 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 58' ' ' SER . 40.5 tt0 -179.26 90.86 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.064 -0.516 . . . . 75.42 110.517 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.17 66.05 7.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.001 -0.74 . . . . 52.13 109.001 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.15 95.92 0.19 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.498 -0.774 . . . . 70.34 111.659 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.665 ' H ' ' HG3' ' A' ' 61' ' ' PRO . 37.7 p -137.31 158.44 44.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.361 -0.836 . . . . 70.15 109.859 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -138.45 136.15 35.92 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.299 -0.26 . . . . 71.4 110.299 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.78 129.69 1.63 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.819 -0.512 . . . . 74.21 111.819 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.8 85.12 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.427 2.085 . . . . 75.33 112.022 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.42 41.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.755 -0.657 . . . . 31.0 111.624 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 m -78.88 162.67 25.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.269 . . . . 70.35 111.5 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.9 mmm -55.28 -30.35 59.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.553 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.688 HG22 ' HB2' ' A' ' 78' ' ' LYS . 11.8 mm -63.28 103.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.628 -0.714 . . . . 62.2 109.284 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.85 125.13 27.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 70.14 111.558 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.1 120.68 24.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.238 -0.437 . . . . 71.41 110.007 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.4 pt -130.32 151.76 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.872 0.368 . . . . 73.54 111.607 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.77 -160.59 29.77 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.707 -0.678 . . . . 75.43 112.685 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -56.87 12.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.564 0.346 . . . . 65.03 111.769 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -65.16 -37.33 87.05 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.1 0.476 . . . . 74.42 110.23 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.87 -30.23 70.34 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.805 -0.634 . . . . 75.54 110.824 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.1 t80 -54.65 -58.01 9.22 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.335 -0.246 . . . . 65.25 110.335 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -53.48 -54.69 33.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.782 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.5 -56.85 16.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.793 -0.64 . . . . 43.22 111.054 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.1 mmtt -58.13 -35.71 71.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.203 -0.908 . . . . 63.34 111.655 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.85 -40.04 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.795 0.331 . . . . 74.14 110.933 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.8 p -78.18 -9.49 59.22 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.909 0.385 . . . . 53.41 110.933 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -61.71 -13.49 23.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.859 -0.609 . . . . 74.54 111.666 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.643 ' SG ' HD12 ' A' ' 44' ' ' ILE . 75.7 m -49.79 113.79 0.92 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.681 0.277 . . . . 55.23 111.061 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -63.58 -69.37 0.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.238 -0.653 . . . . 72.42 109.238 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -161.88 133.2 5.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.943 -0.571 . . . . 63.42 110.59 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 m120 58.4 15.61 3.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.971 0.508 . . . . 72.45 111.661 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 mm -75.83 124.51 34.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.84 0.352 . . . . 70.51 110.758 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -82.78 118.34 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.777 -0.647 . . . . 72.33 109.438 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.643 HD12 ' SG ' ' A' ' 38' ' ' CYS . 21.3 mt -114.02 117.49 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.39 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.618 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.9 mp -104.31 131.15 51.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.684 -0.858 . . . . 73.21 108.684 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.2 108.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.204 -0.295 . . . . 72.45 110.204 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 22.2 t0 -81.86 138.25 35.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 62.13 110.02 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -78.51 177.65 8.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 65.22 111.128 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 80' ' ' ASN . 20.1 t90 -85.81 129.1 34.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.653 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.07 86.62 7.57 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.846 -0.616 . . . . 54.33 109.912 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.37 -22.44 21.73 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.296 1.997 . . . . 64.33 111.982 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -117.77 111.17 18.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 73.15 110.339 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -175.86 135.88 0.3 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.114 -0.494 . . . . 63.3 110.387 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -74.91 0.95 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.355 -0.45 . . . . 43.4 112.418 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.19 -23.03 72.54 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 54.22 113.057 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.469 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 71.8 m -55.83 -30.71 61.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.595 -0.275 . . . . 71.35 111.446 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -59.45 -32.42 70.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.852 0.358 . . . . 74.44 110.774 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.559 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.5 m -74.67 -38.17 62.49 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.809 0.814 . . . . 70.35 110.138 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.5 mm? -67.33 -34.71 77.92 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.359 -0.837 . . . . 64.1 111.975 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 45.5 mt-10 -55.05 -58.43 14.82 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 120.994 -0.282 . . . . 65.12 110.817 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.665 ' HG3' ' H ' ' A' ' 16' ' ' THR . 38.2 Cg_endo -66.62 -31.11 41.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.106 1.87 . . . . 64.23 112.332 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.1 mt-30 -62.79 -40.75 98.3 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.296 -0.562 . . . . 75.21 110.18 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.8 mt -68.73 -33.77 74.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.871 -0.604 . . . . 74.14 109.991 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 40.8 mt-10 -62.49 -44.55 96.12 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.324 -0.398 . . . . 65.51 110.271 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -54.79 -52.48 62.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.127 -0.488 . . . . 74.54 110.474 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.471 HD13 HD12 ' A' ' 123' ' ' ILE . 47.5 mt -65.33 -37.19 86.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.519 . . . . 74.51 110.205 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.58 -36.46 83.87 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.86 -0.609 . . . . 43.32 110.879 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -74.43 -50.35 18.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 74.13 110.544 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -63.54 -34.66 78.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 75.41 110.914 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -104.97 5.07 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 75.22 112.203 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.4 t -53.34 -20.0 3.95 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.37 0.507 . . . . 63.31 112.37 -172.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.19 -39.22 92.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 74.02 110.739 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.46 -9.88 12.03 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.051 -0.522 . . . . 60.25 110.848 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 43' ' ' LEU . 68.2 t -125.85 145.63 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.037 0.446 . . . . 74.22 111.635 -171.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.11 128.64 13.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.324 -0.621 . . . . 71.33 109.324 171.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.6 mt -111.5 129.13 67.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.078 0.466 . . . . 73.14 110.964 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.5 m-85 -114.81 177.84 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 62.14 109.18 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HB2' HG22 ' A' ' 23' ' ' ILE . 59.0 tttp -148.17 123.5 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 62.33 110.532 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 81' ' ' ILE . 29.2 mm -86.49 108.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 75.13 109.857 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.596 ' HA ' ' HB2' ' A' ' 49' ' ' TRP . 30.4 p-10 -114.98 4.9 14.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.451 -0.341 . . . . 60.11 111.116 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.56 HG22 HG23 ' A' ' 79' ' ' ILE . 6.1 tt -65.47 105.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.34 0.59 . . . . 65.23 109.782 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -54.99 -31.0 60.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.046 -0.979 . . . . 64.21 112.756 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.85 -19.39 61.97 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.787 0.291 . . . . 63.52 111.787 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.487 HD22 HG21 ' A' ' 79' ' ' ILE . 45.1 t30 -87.9 88.11 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.062 0.458 . . . . 73.53 111.786 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -107.14 -30.49 8.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 73.43 109.324 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.55 -55.98 5.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.041 -0.981 . . . . 63.32 111.411 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.99 -34.22 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.734 -0.666 . . . . 71.01 111.071 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.39 62.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.076 0.465 . . . . 74.24 110.162 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -67.1 -31.53 72.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.611 -0.722 . . . . 72.42 111.096 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -75.17 -38.52 60.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.228 -0.442 . . . . 52.44 111.666 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -91.95 -11.66 35.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.757 0.281 . . . . 63.04 111.757 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.87 53.21 2.76 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.908 -0.663 . . . . 65.55 113.394 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 98' ' ' THR . 98.4 t -79.69 106.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.677 -0.49 . . . . 75.31 109.677 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -82.88 -43.27 16.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.875 -0.602 . . . . 63.12 111.402 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.24 12.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.594 -0.276 . . . . 52.44 110.59 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.808 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -109.3 150.68 41.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.262 -0.426 . . . . 75.51 110.426 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 95.9 Cg_endo -77.84 174.81 50.29 Favored 'Cis proline' 0 C--N 1.353 0.803 0 C-N-CA 123.696 -1.377 . . . . 64.14 112.244 -1.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.442 HG21 HG22 ' A' ' 93' ' ' VAL . 92.3 m -142.36 115.28 8.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.291 -0.413 . . . . 74.0 110.439 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' A' ' 111' ' ' VAL . 32.3 mm -109.81 111.42 36.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.723 -0.671 . . . . 62.41 110.373 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 100' ' ' LEU . 2.2 mm? -88.42 125.81 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.194 -0.912 . . . . 72.51 109.835 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.618 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -94.76 138.28 32.77 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.749 -0.463 . . . . 65.12 109.749 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -135.88 144.14 45.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.69 -0.485 . . . . 73.14 109.69 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.7 tptp -132.59 106.38 7.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.927 -0.309 . . . . 74.24 110.216 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.86 26.23 15.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.119 0.485 . . . . 72.22 110.709 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.53 -6.36 82.51 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.707 -0.679 . . . . 43.11 112.299 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -87.9 152.1 22.33 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 120.581 0.229 . . . . 63.04 110.647 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 7.8 tmtm? -56.86 134.8 55.62 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 124.262 0.976 . . . . 71.43 110.809 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.53 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -145.09 169.08 18.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.534 -1.212 . . . . 61.41 108.539 -175.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 101' ' ' MET . 40.7 m -70.01 -177.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.211 0.529 . . . . 72.41 111.927 -164.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.49 ' HG3' HD13 ' A' ' 100' ' ' LEU . 7.3 tt0 -147.14 142.77 27.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.132 -0.486 . . . . 74.54 110.141 -173.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.502 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.2 m -128.22 132.35 68.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.945 0.402 . . . . 70.11 110.247 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.31 135.69 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.802 -0.636 . . . . 62.14 109.424 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.92 154.53 21.27 Favored Glycine 0 C--O 1.235 0.156 0 C-N-CA 121.003 -0.618 . . . . 60.32 111.816 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.6 74.87 9.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.724 0.297 . . . . 33.13 111.377 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -123.96 93.61 3.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.292 0.568 . . . . 64.24 109.483 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -59.11 -30.6 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.524 -0.762 . . . . 62.15 111.047 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.0 t -67.82 -41.23 83.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.442 -0.345 . . . . 72.2 110.25 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -70.74 -40.96 72.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 110.08 -0.341 . . . . 55.14 110.08 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.71 -55.77 20.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.123 -0.49 . . . . 62.22 110.635 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.494 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.58 -35.57 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.514 -0.55 . . . . 72.14 109.514 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.1 t -53.69 -52.28 60.54 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.913 -0.585 . . . . 43.12 109.901 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 33.6 mm-40 -67.1 -38.38 85.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.23 -0.441 . . . . 73.04 111.371 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.471 HD12 HD13 ' A' ' 66' ' ' LEU . 98.4 mt -54.19 -55.77 12.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 120.571 -0.452 . . . . 73.41 110.303 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.47 -27.3 63.15 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.751 -0.379 . . . . 70.22 110.525 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.415 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 54.5 t30 -73.16 -28.51 62.27 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.131 -0.486 . . . . 72.2 110.864 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.523 ' ND2' HD12 ' A' ' 108' ' ' LEU . 3.7 m-20 -85.73 -36.86 19.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 71.2 110.192 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 123' ' ' ILE . 70.6 mt -67.67 -44.88 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.136 0.493 . . . . 54.51 110.201 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.711 -0.661 . . . . 71.43 109.967 -178.73 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.886 0.374 . . . . 75.42 110.622 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.17 -170.21 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.927 -0.579 . . . . 34.04 112.139 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -156.67 -39.97 0.07 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.572 -0.74 . . . . 65.04 109.488 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 71.75 -43.71 0.57 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.817 0.847 . . . . 71.22 111.346 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -57.06 95.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.111 0.481 . . . . 65.22 109.98 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -160.27 136.91 8.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.739 -0.664 . . . . 75.12 109.269 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.01 173.88 11.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.961 -0.385 . . . . 65.21 109.961 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.62 ' HB2' HG22 ' A' ' 89' ' ' THR . 19.0 p-80 -122.31 136.17 54.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 74.33 109.896 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tpt -92.76 -69.51 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 73.11 111.079 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 89' ' ' THR . . . -146.48 143.1 11.09 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.155 -0.545 . . . . 70.45 111.997 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -93.81 139.76 30.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.31 . . . . 73.25 111.094 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.17 179.53 7.16 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.806 -0.633 . . . . 74.23 109.356 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.7 172.6 13.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.765 0.316 . . . . 75.42 110.68 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.22 166.72 16.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 52.13 110.478 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.656 ' HG2' ' HB3' ' A' ' 51' ' ' PRO . 8.3 tp-100 -154.78 149.06 26.06 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.436 -0.579 . . . . 70.34 109.436 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.857 HG21 ' HB3' ' A' ' 82' ' ' GLU . 3.1 p -141.75 99.2 3.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.085 0.469 . . . . 70.15 111.286 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -138.68 152.14 47.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.531 -0.759 . . . . 71.4 109.15 175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 136.6 131.74 3.02 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.71 -0.556 . . . . 74.21 111.71 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -86.06 177.22 4.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.876 2.384 . . . . 75.33 112.133 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.51 81.37 0.08 OUTLIER Glycine 0 C--N 1.332 0.355 0 N-CA-C 111.529 -0.628 . . . . 31.0 111.529 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -99.48 -179.71 4.3 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.672 0.389 . . . . 70.35 110.391 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.3 ptm -68.13 -17.5 64.37 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.738 -0.838 . . . . 71.32 108.738 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.45 HG23 HG22 ' A' ' 76' ' ' ILE . 22.0 mm -67.34 93.37 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.811 -1.181 . . . . 62.2 107.811 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.77 111.83 6.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 70.14 111.759 -167.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 5.0 pm0 -69.97 129.38 39.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 71.41 110.202 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 36.8 pt -137.89 147.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.54 111.257 -174.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.53 -179.22 42.33 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.843 -0.617 . . . . 75.43 111.899 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.08 -48.4 67.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.745 0.418 . . . . 65.03 111.492 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 p -62.43 -35.35 78.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.039 -0.528 . . . . 74.42 111.158 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 44.8 mt-10 -77.49 -27.77 51.97 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.992 -0.549 . . . . 75.54 110.708 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.531 ' HA ' HD12 ' A' ' 26' ' ' ILE . 82.1 t80 -53.14 -61.02 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.165 0.291 . . . . 65.25 111.059 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.57 -52.61 61.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.159 0.504 . . . . 73.42 110.514 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -51.55 -57.24 9.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.086 -0.961 . . . . 43.22 111.035 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.6 mmtt -61.92 -46.56 88.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.201 -0.909 . . . . 63.34 111.234 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 31' ' ' PHE . 73.8 t -59.44 -38.75 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.686 0.279 . . . . 74.14 111.107 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -84.89 -16.7 40.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.702 0.286 . . . . 53.41 111.435 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -68.33 -13.39 62.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.381 -0.372 . . . . 74.54 111.471 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -55.16 122.17 10.44 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.707 -0.224 . . . . 55.23 110.7 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.12 -75.18 0.05 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.37 -0.377 . . . . 72.42 110.811 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -161.93 124.62 2.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.45 -0.341 . . . . 63.42 110.096 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.87 17.37 9.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.69 0.618 . . . . 72.45 111.347 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -78.22 104.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.435 -0.58 . . . . 70.51 109.435 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HB3' HG22 ' A' ' 74' ' ' VAL . 62.5 tp -68.9 108.18 3.38 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.509 0.671 . . . . 72.33 110.39 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 77' ' ' TYR . 35.9 mt -96.13 112.62 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.145 -0.934 . . . . 72.45 110.531 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.547 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -96.22 141.02 30.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.437 -0.949 . . . . 73.21 108.437 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.09 114.2 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 110.315 -0.254 . . . . 72.45 110.315 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -82.89 129.22 34.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.009 0.433 . . . . 62.13 110.117 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.493 ' CE1' HD13 ' A' ' 100' ' ' LEU . 5.2 m-85 -90.05 -39.57 12.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.816 -0.629 . . . . 65.22 110.134 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.632 ' HZ2' HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -164.28 94.34 0.72 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.534 -0.303 . . . . 74.34 111.62 -176.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.694 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . . . -96.02 109.57 47.45 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.24 -0.436 . . . . 54.33 110.469 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 76.1 Cg_endo -92.07 130.08 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.996 2.464 . . . . 64.33 111.633 173.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -63.95 82.66 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.268 0.556 . . . . 73.15 111.164 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.665 ' H ' ' HB2' ' A' ' 56' ' ' CYS . 10.5 p -88.41 -169.21 2.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.472 -0.786 . . . . 63.3 109.567 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.11 -71.0 0.81 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.91 -0.662 . . . . 43.4 112.111 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.627 ' HD2' ' SG ' ' A' ' 53' ' ' CYS . 31.3 Cg_exo -60.3 -35.56 91.01 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.742 2.295 . . . . 54.22 112.468 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.665 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 14.2 m -60.24 -29.79 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.046 0.45 . . . . 71.35 110.595 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -53.42 -52.69 58.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.827 -0.624 . . . . 74.44 110.275 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.651 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.1 m -75.76 -30.53 59.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.056 -0.52 . . . . 70.35 111.521 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -59.23 -59.14 5.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.231 0.456 . . . . 64.1 112.231 -170.219 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.27 -51.24 51.56 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 111.798 0.295 . . . . 65.12 111.798 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.38 -48.37 22.35 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.701 1.601 . . . . 64.23 111.586 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.3 mt-30 -60.02 -29.85 68.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.944 -0.571 . . . . 75.21 111.147 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.33 -44.24 88.41 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.716 -0.476 . . . . 74.14 109.716 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 33.2 mt-10 -62.02 -37.38 84.69 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.046 -0.524 . . . . 65.51 110.062 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 22.0 ttmm -55.79 -53.81 52.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.005 0.431 . . . . 74.54 110.828 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.471 HD11 HD11 ' A' ' 116' ' ' ILE . 35.5 mt -63.79 -35.7 81.48 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.026 -0.534 . . . . 74.51 109.635 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.19 -44.31 95.72 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.445 -0.798 . . . . 43.32 110.16 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.9 mt-30 -60.61 -49.46 77.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.971 0.415 . . . . 74.13 110.265 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -62.17 -42.23 99.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.519 -0.764 . . . . 75.41 111.326 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -104.7 4.58 32.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.776 0.658 . . . . 75.22 112.776 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.55 -20.04 4.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.641 0.608 . . . . 63.31 112.641 -172.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.473 ' HG3' ' OD1' ' A' ' 73' ' ' ASN . 8.3 pt-20 -65.05 -33.69 76.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.606 0.241 . . . . 74.02 111.129 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 72' ' ' GLU . 15.5 m120 -124.19 5.12 8.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.509 -0.314 . . . . 60.25 110.909 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 43' ' ' LEU . 51.2 t -137.17 141.36 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.906 0.384 . . . . 74.22 111.556 -173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.89 130.07 16.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.389 -0.597 . . . . 71.33 109.389 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 45' ' ' LEU . 23.7 mt -109.39 138.47 36.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 120.951 0.405 . . . . 73.14 110.411 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 93.7 m-85 -119.27 170.4 9.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.676 . . . . 62.14 110.47 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -140.74 96.51 3.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.403 -0.962 . . . . 62.33 108.403 -179.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 12.7 tt -72.84 116.44 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.207 0.527 . . . . 75.13 111.239 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -90.83 68.94 6.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.753 0.787 . . . . 60.11 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.726 HG12 HG21 ' A' ' 87' ' ' VAL . 11.0 tp -94.91 29.82 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.964 0.888 . . . . 65.23 109.897 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.857 ' HB3' HG21 ' A' ' 16' ' ' THR . 9.8 pt-20 -52.23 -18.24 1.45 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.752 -1.113 . . . . 64.21 113.451 -174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.49 -23.75 61.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.887 0.328 . . . . 63.52 111.887 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -147.09 156.53 43.08 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.964 0.412 . . . . 73.53 111.255 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -3.9 23.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.941 -0.572 . . . . 73.43 110.163 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 6.0 m-20 -50.71 -40.41 54.11 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.094 -0.503 . . . . 63.32 111.027 -176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 81' ' ' ILE . 85.5 t -54.27 -38.04 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 115.865 -0.607 . . . . 71.01 111.208 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.92 97.63 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.108 0.48 . . . . 74.24 109.963 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 8' ' ' HIS . 17.7 m -62.63 -37.86 87.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 72.42 110.514 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 77.3 mm-40 -63.86 -54.92 27.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.797 -0.638 . . . . 52.44 110.706 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.09 -14.04 58.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.323 -0.399 . . . . 63.04 111.72 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.41 59.13 5.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.037 -0.602 . . . . 65.55 112.127 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.632 HG21 ' HZ2' ' A' ' 49' ' ' TRP . 78.6 t -67.56 109.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 75.31 110.8 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.0 t -67.7 -50.52 57.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.903 -0.59 . . . . 63.12 110.71 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.69 172.57 16.46 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.346 -0.388 . . . . 52.44 110.683 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.5 HG22 ' CD1' ' A' ' 49' ' ' TRP . 23.8 pt -113.6 148.37 39.58 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.923 -0.581 . . . . 75.51 109.835 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.694 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 72.1 Cg_endo -73.36 168.49 75.95 Favored 'Cis proline' 0 C--N 1.355 0.902 0 C-N-CA 124.21 -1.162 . . . . 64.14 112.788 -0.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.2 m -128.27 110.96 12.88 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.956 -0.566 . . . . 74.0 110.406 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.4 mm -114.85 110.9 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.165 -0.47 . . . . 62.41 110.435 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.493 HD13 ' CE1' ' A' ' 48' ' ' PHE . 8.5 mp -96.17 155.02 16.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.304 -0.258 . . . . 72.51 110.304 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.519 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 35.2 mtt -119.0 150.4 40.01 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 110.196 -0.298 . . . . 65.12 110.196 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -144.27 152.29 40.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.089 0.556 . . . . 73.14 109.609 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -148.03 122.5 9.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.513 -0.181 . . . . 74.24 110.513 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.56 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.9 m-20 57.67 32.53 22.0 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.292 0.568 . . . . 72.22 110.665 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.44 75.88 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.689 -0.687 . . . . 43.11 112.479 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -117.4 152.67 34.49 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.068 -0.345 . . . . 63.04 110.068 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 8.8 tmtt? -69.46 126.41 29.65 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.938 0.774 . . . . 71.43 111.286 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.506 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.6 mm? -126.44 168.99 13.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.225 1.41 . . . . 61.41 109.19 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -179.82 1.9 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.274 0.559 . . . . 72.41 111.879 -164.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -148.85 143.37 26.24 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.853 0.835 . . . . 74.54 111.009 -172.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 t -123.43 130.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 113.843 -1.526 . . . . 70.11 109.753 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.1 124.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.483 . . . . 62.14 109.697 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.94 149.21 21.2 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.544 -0.622 . . . . 60.32 111.544 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.64 87.52 7.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.777 0.323 . . . . 33.13 110.972 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -130.28 100.11 5.27 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.432 -0.581 . . . . 64.24 109.432 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 66' ' ' LEU . 9.7 tp -61.01 -33.22 54.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.58 . . . . 62.15 111.084 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 120' ' ' ILE . 34.2 t -63.85 -50.08 70.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 72.2 110.482 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.53 -45.03 92.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.5 -0.318 . . . . 55.14 110.302 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.476 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -58.13 -53.39 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.358 . . . . 62.22 110.719 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -61.5 -39.49 83.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 110.062 -0.347 . . . . 72.14 110.062 -178.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.2 m -59.44 -49.94 75.87 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.542 -0.299 . . . . 43.12 110.528 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -61.27 -37.75 84.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.407 -0.36 . . . . 73.04 110.483 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.1 mt -59.43 -56.22 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.518 0.199 . . . . 73.41 110.938 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -70.25 -25.6 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.757 -0.377 . . . . 70.22 110.386 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -69.4 -38.05 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 72.2 110.284 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 93.1 m-20 -87.88 -18.6 28.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.697 -0.683 . . . . 71.2 111.519 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 123' ' ' ILE . 78.9 mt -78.3 -45.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 54.51 110.126 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.634 -0.698 . . . . 71.43 109.921 -178.088 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.465 -0.569 . . . . 75.42 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.55 159.22 16.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.136 0.493 . . . . 34.04 111.065 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -144.77 30.97 1.17 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.158 -1.053 . . . . 65.04 108.158 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -82.52 80.3 8.71 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.492 -1.231 . . . . 71.22 109.982 -175.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -124.14 103.81 8.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.048 -0.524 . . . . 65.22 110.064 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.7 148.07 22.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.211 -0.45 . . . . 75.12 109.986 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -141.61 126.67 18.38 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.641 0.258 . . . . 65.21 110.382 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -175.14 137.75 0.41 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.038 -0.528 . . . . 74.33 109.906 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -146.57 170.38 17.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.559 0.219 . . . . 73.11 110.436 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.78 172.42 43.9 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.23 -0.509 . . . . 70.45 112.757 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.5 t -121.46 163.16 19.23 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.516 0.327 . . . . 73.25 110.205 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 12' ' ' LEU . 2.8 mm? -83.67 -26.66 29.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 74.23 110.632 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -140.44 138.64 34.86 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.388 -0.369 . . . . 75.42 110.568 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.76 86.56 3.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.867 -0.606 . . . . 52.13 110.083 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -95.82 -178.5 4.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.532 -0.758 . . . . 70.34 110.254 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 90.5 m -141.44 126.27 18.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.164 -0.471 . . . . 70.15 110.272 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -83.65 -36.23 23.98 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.434 -0.348 . . . . 71.4 111.068 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.07 101.38 0.16 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.124 -0.56 . . . . 74.21 112.088 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -88.84 -169.23 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.0 2.467 . . . . 75.33 112.143 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.62 126.2 18.05 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.335 -1.106 . . . . 31.0 110.335 171.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.437 ' HA ' ' OE2' ' A' ' 64' ' ' GLU . 49.5 m -43.53 103.94 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.257 0.466 . . . . 70.35 112.257 -172.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.8 mmm -75.17 -26.27 58.94 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.794 -0.639 . . . . 71.32 109.333 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -65.34 88.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.1 -0.704 . . . . 62.2 109.1 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 17.0 tt0 -67.8 111.81 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.599 -0.728 . . . . 70.14 109.679 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.2 135.75 33.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 71.41 110.88 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.4 pt -139.39 175.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.888 -0.596 . . . . 73.54 110.29 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -121.86 -167.83 13.2 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.267 -0.424 . . . . 75.43 112.177 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.23 -54.28 38.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.727 0.411 . . . . 65.03 112.007 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -66.68 -29.34 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.392 -0.367 . . . . 74.42 110.925 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 4.8 mm-40 -84.18 -21.31 31.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 75.54 112.005 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 26' ' ' ILE . 86.8 t80 -55.74 -61.9 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.623 0.249 . . . . 65.25 111.461 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.09 -43.49 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 73.42 110.506 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -52.58 -57.46 9.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.78 -0.645 . . . . 43.22 111.063 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 26' ' ' ILE . 47.8 mmtm -70.95 -38.14 72.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 63.34 111.473 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.58 -37.89 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.632 0.254 . . . . 74.14 110.94 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.5 p -83.04 -22.49 33.54 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.728 0.299 . . . . 53.41 110.99 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t -64.86 -5.14 5.36 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.328 -0.397 . . . . 74.54 111.71 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 104' ' ' ASN . 85.8 m -62.66 106.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.536 0.208 . . . . 55.23 110.514 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -61.24 -68.23 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.286 -0.415 . . . . 72.42 111.269 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -147.05 128.96 15.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.659 0.266 . . . . 63.42 111.551 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 54.66 24.54 5.59 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.644 0.778 . . . . 72.45 112.046 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 50.2 mm -78.61 113.61 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.591 -0.277 . . . . 70.51 110.262 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB3' HG22 ' A' ' 74' ' ' VAL . 2.5 tm? -90.21 112.3 23.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.422 0.629 . . . . 72.33 109.583 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 49.3 mt -101.76 135.23 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.504 -0.771 . . . . 72.45 111.003 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.4 mp -111.07 116.99 32.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.773 -0.825 . . . . 73.21 108.773 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.4 t -99.12 105.03 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.978 -0.378 . . . . 72.45 109.978 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.508 ' HA ' HD13 ' A' ' 99' ' ' ILE . 7.7 t70 -77.04 139.55 40.07 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.826 -0.624 . . . . 62.13 111.335 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -107.51 87.21 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.641 -0.874 . . . . 65.22 108.641 170.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 27.1 t-105 -43.34 130.38 4.9 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.671 -1.149 . . . . 74.34 112.974 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.09 103.85 51.56 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.638 -0.71 . . . . 54.33 109.642 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.18 -26.19 75.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.761 2.307 . . . . 64.33 112.684 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -121.36 105.45 10.54 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.388 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -174.15 146.73 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 63.3 110.544 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.67 -66.83 1.28 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.229 -0.441 . . . . 43.4 112.828 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.78 -28.69 59.49 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.587 2.191 . . . . 54.22 112.308 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 59.1 m -56.59 -31.92 64.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.076 -0.511 . . . . 71.35 111.159 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.603 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -54.35 -60.86 2.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.358 0.599 . . . . 74.44 109.858 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.532 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 50.3 m -55.43 -38.26 68.75 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 114.448 -1.251 . . . . 70.35 111.695 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 3.6 mm? -57.77 -34.95 70.12 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.335 -0.393 . . . . 64.1 110.941 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.4 mt-10 -55.94 -64.07 2.65 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.228 -0.415 . . . . 65.12 111.052 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 57' ' ' ARG . 33.4 Cg_endo -64.77 -24.75 61.39 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.788 1.658 . . . . 64.23 112.18 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 58' ' ' SER . 52.2 mt-30 -63.26 -44.17 95.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.306 -0.558 . . . . 75.21 110.077 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.0 mt -68.4 -39.62 81.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.903 -0.589 . . . . 74.14 110.099 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 46.5 mt-10 -60.93 -35.82 77.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.002 -0.544 . . . . 65.51 110.281 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.51 -56.21 24.84 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.031 0.443 . . . . 74.54 110.264 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 116' ' ' ILE . 59.3 mt -56.26 -39.06 72.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.659 -0.701 . . . . 74.51 109.572 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -61.8 -48.24 81.49 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.115 -0.948 . . . . 43.32 110.251 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -55.93 -42.42 76.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 74.13 110.805 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.65 -45.09 80.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.003 -0.544 . . . . 75.41 111.303 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -101.71 5.47 41.4 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.996 0.739 . . . . 75.22 112.996 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.44 -19.61 3.77 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.334 0.865 . . . . 63.31 113.334 -169.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.8 -29.59 66.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 74.02 111.211 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -119.28 -11.03 9.62 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.896 -0.593 . . . . 60.25 111.275 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 43' ' ' LEU . 57.2 t -125.62 142.7 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.056 0.455 . . . . 74.22 111.656 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 5.2 tppp? -145.63 131.73 19.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 71.33 109.578 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.5 mt -103.72 120.69 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.0 -0.37 . . . . 73.14 110.0 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 50.2 m-85 -107.37 153.75 22.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.667 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.766 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 24.9 ttpt -131.32 120.18 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.274 -0.639 . . . . 62.33 109.274 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 81' ' ' ILE . 39.9 mt -73.1 106.82 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.23 -1.026 . . . . 75.13 108.23 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.13 73.0 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.044 0.45 . . . . 60.11 111.394 -171.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 87' ' ' VAL . 26.5 pt -147.0 31.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.385 -0.825 . . . . 65.23 109.165 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -62.65 -20.31 64.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.639 -0.709 . . . . 64.21 111.474 -175.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.1 -27.85 62.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.21 0.529 . . . . 63.52 109.907 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.45 76.87 9.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.555 -0.748 . . . . 73.53 109.078 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -62.62 -27.87 69.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.188 -0.915 . . . . 73.43 110.624 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 27.2 t70 -50.11 -41.74 49.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.847 -0.615 . . . . 63.32 110.56 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.528 HG21 HD12 ' A' ' 81' ' ' ILE . 92.3 t -54.24 -40.36 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 71.01 110.788 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -62.3 -47.3 84.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.424 0.631 . . . . 74.24 109.823 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.9 m -64.7 -33.41 75.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.444 -0.798 . . . . 72.42 110.867 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.6 mm-40 -68.43 -44.54 74.75 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.192 -0.458 . . . . 52.44 110.862 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.16 0.31 57.14 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.239 -0.437 . . . . 63.04 111.619 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.21 43.72 20.06 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.031 -0.604 . . . . 65.55 113.401 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.461 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 95.9 t -74.82 106.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.297 -0.631 . . . . 75.31 109.297 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.0 m -61.76 -39.32 91.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.316 . . . . 63.12 111.738 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.61 145.65 24.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.472 -0.331 . . . . 52.44 110.606 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.5 pt -104.32 141.43 22.51 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.219 -0.446 . . . . 75.51 110.098 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -85.21 169.86 47.46 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.712 -1.37 . . . . 64.14 112.116 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -145.53 155.57 43.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.969 -0.56 . . . . 74.0 109.554 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 47' ' ' ASP . 47.7 mm -118.67 110.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.395 -0.82 . . . . 62.41 109.926 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.75 123.01 41.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.064 -0.717 . . . . 72.51 109.064 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.6 mtt -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 65.12 110.397 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -144.87 145.79 31.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.614 -0.513 . . . . 73.14 109.614 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -142.11 119.79 11.81 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.925 -0.398 . . . . 74.24 109.925 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.623 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 13.7 p30 51.21 25.61 2.53 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.997 0.919 . . . . 72.22 112.099 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.59 64.96 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.835 -0.62 . . . . 43.11 113.166 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 47.9 tptt -73.12 142.14 47.5 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 117.067 0.433 . . . . 63.04 110.37 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 2.5 tmtp? -68.88 122.52 18.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.824 -0.626 . . . . 71.43 110.009 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -118.1 168.8 10.22 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.273 1.029 . . . . 61.41 109.749 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 101' ' ' MET . 0.3 OUTLIER -69.73 166.94 18.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.485 0.659 . . . . 72.41 112.566 -159.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 57.2 tt0 -129.25 136.84 50.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.211 1.005 . . . . 74.54 111.326 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.47 121.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.256 -1.793 . . . . 70.11 109.608 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.2 mt -107.02 133.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 110.269 -0.271 . . . . 62.14 110.269 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.54 168.24 36.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.322 -0.466 . . . . 60.32 112.465 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.43 98.99 11.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.641 0.258 . . . . 33.13 110.884 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.2 t70 -143.55 100.61 3.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.548 -0.538 . . . . 64.24 109.548 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.466 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -62.96 -38.45 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.895 -0.593 . . . . 62.15 111.577 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -66.54 -43.65 84.58 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.095 0.474 . . . . 72.2 110.147 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -61.41 -48.06 82.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 55.14 110.295 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 115' ' ' ASP . 73.8 mt -61.78 -47.15 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 62.22 111.519 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.24 -41.76 92.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.211 0.529 . . . . 72.14 110.233 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.4 t -56.22 -45.73 79.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.795 -0.639 . . . . 43.12 109.465 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 39.5 mm-40 -70.2 -32.39 70.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 73.04 111.491 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 120' ' ' ILE . 80.1 mt -54.55 -55.01 17.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 N-CA-C 108.936 -0.764 . . . . 73.41 108.936 173.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -66.82 -36.07 81.5 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.391 . . . . 70.22 111.093 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 3.4 t-20 -63.37 -42.06 98.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.216 -0.447 . . . . 72.2 111.294 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -93.66 -15.3 25.44 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.448 -0.342 . . . . 71.2 111.671 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 123' ' ' ILE . 38.7 mt -61.45 -43.59 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.231 -1.025 . . . . 54.51 108.231 166.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.982 172.437 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 110.408 -0.219 . . . . 75.42 110.408 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.13 103.28 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 34.04 110.336 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -68.98 142.0 54.78 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.216 -0.447 . . . . 65.04 110.572 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -55.99 135.22 52.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.242 -0.436 . . . . 71.22 111.126 -177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -157.82 129.15 6.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.05 -0.523 . . . . 65.22 110.592 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -152.18 147.18 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.326 -0.62 . . . . 75.12 109.326 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -95.82 166.66 11.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.873 0.368 . . . . 65.21 110.864 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -125.79 63.14 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.445 -0.946 . . . . 74.33 108.445 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.0 ptm -136.44 151.08 49.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.524 -0.762 . . . . 73.11 110.162 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.11 140.0 2.85 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.899 -0.667 . . . . 70.45 112.074 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 m -89.81 64.99 6.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.264 0.554 . . . . 73.25 110.151 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.32 99.33 12.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.03 -0.532 . . . . 74.23 110.336 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.27 90.05 6.6 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.989 -0.745 . . . . 75.42 108.989 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.51 111.37 19.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.817 -0.629 . . . . 52.13 111.165 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -95.46 171.59 8.6 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.026 -0.534 . . . . 70.34 109.972 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.3 m -69.83 94.36 0.82 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.493 -0.321 . . . . 70.15 110.78 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -77.23 -28.13 53.6 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.36 -0.608 . . . . 71.4 109.36 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.0 -164.35 30.65 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.055 -0.818 . . . . 74.21 111.055 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -83.62 148.89 12.69 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.724 2.282 . . . . 75.33 111.662 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.51 51.52 3.33 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.289 -0.482 . . . . 31.0 112.002 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -147.65 32.39 0.87 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.451 -0.574 . . . . 70.35 109.451 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.478 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 96.0 mmm -72.64 -24.63 61.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.795 -0.639 . . . . 71.32 111.221 -174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.419 HG21 ' HE2' ' A' ' 78' ' ' LYS . 20.8 mm -77.33 93.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.114 -0.698 . . . . 62.2 109.114 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.2 tp10 -68.4 122.76 19.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 70.14 111.152 -175.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -90.93 122.13 33.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.436 -0.347 . . . . 71.41 110.353 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.8 pt -126.94 165.08 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.299 -0.409 . . . . 73.54 111.258 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.34 -167.56 40.99 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.87 -0.604 . . . . 75.43 113.479 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.48 -54.3 30.33 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 65.03 111.448 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 t -74.67 -28.19 60.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.225 0.536 . . . . 74.42 110.359 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.23 -17.55 64.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 75.54 111.636 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.4 t80 -58.4 -62.04 2.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.8 0.333 . . . . 65.25 110.16 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.16 -45.72 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.156 0.503 . . . . 73.42 110.207 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -56.15 -57.47 12.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.381 -0.827 . . . . 43.22 111.484 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.67 -29.61 65.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.223 -0.444 . . . . 63.34 111.456 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 31' ' ' PHE . 49.4 t -68.33 -41.59 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.648 0.261 . . . . 74.14 110.758 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 p -81.25 -18.88 44.44 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.872 0.367 . . . . 53.41 111.028 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 t -61.67 -21.75 64.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.136 -0.484 . . . . 74.54 111.529 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.703 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 22.9 p -59.62 122.09 13.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.606 0.241 . . . . 55.23 110.601 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.77 -69.18 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.148 -0.478 . . . . 72.42 111.844 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -161.42 135.76 7.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 63.42 110.934 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 16.6 m-80 59.36 17.1 5.58 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.704 0.628 . . . . 72.45 112.156 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.2 mm -87.85 114.01 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 70.51 110.292 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.537 HD21 ' SD ' ' A' ' 101' ' ' MET . 0.3 OUTLIER -78.82 109.19 12.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 72.33 109.387 178.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 38' ' ' CYS . 43.6 mt -97.68 121.64 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.951 -0.568 . . . . 72.45 110.482 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.673 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.9 mp -106.37 116.0 31.18 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.526 -0.546 . . . . 73.21 109.526 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.4 t -99.64 105.86 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 110.269 -0.271 . . . . 72.45 110.269 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -81.58 132.87 35.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.085 -0.507 . . . . 62.13 110.427 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -89.19 137.86 31.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.642 -0.503 . . . . 65.22 109.642 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -46.24 -51.06 15.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.594 0.559 . . . . 74.34 111.944 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 67.58 153.03 0.13 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.636 0.585 . . . . 54.33 111.828 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.2 173.92 9.77 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.426 2.084 . . . . 64.33 112.092 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -49.89 120.45 4.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.089 -0.505 . . . . 73.15 110.958 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.65 147.33 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 63.3 111.103 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -64.09 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.182 -0.463 . . . . 43.4 112.642 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.18 -30.55 32.93 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.208 2.605 . . . . 54.22 113.191 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 19.9 p -57.75 -29.01 64.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 71.35 111.285 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -54.3 -39.55 67.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.538 0.209 . . . . 74.44 111.276 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.649 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 45.1 m -75.11 -42.21 56.97 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.651 0.739 . . . . 70.35 110.48 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -61.61 -31.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.311 -0.859 . . . . 64.1 112.07 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 43.1 mt-10 -59.28 -60.93 8.94 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 117.803 0.274 . . . . 65.12 110.749 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 28.8 Cg_endo -62.98 -29.38 75.65 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.846 1.697 . . . . 64.23 112.174 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.0 mt-30 -64.51 -44.7 90.09 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.058 -0.657 . . . . 75.21 110.161 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.605 HD21 HD13 ' A' ' 119' ' ' ILE . 85.7 mt -64.43 -45.68 86.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 74.14 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.6 mt-10 -63.16 -34.08 76.85 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.031 -0.531 . . . . 65.51 110.563 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.79 -47.29 87.01 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.827 0.346 . . . . 74.54 110.21 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.49 -35.64 79.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.907 -0.588 . . . . 74.51 109.731 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.39 -42.68 98.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.785 -0.643 . . . . 43.32 110.234 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 21.6 mt-30 -67.16 -44.3 80.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 74.13 110.082 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -67.27 -38.74 85.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.482 -0.781 . . . . 75.41 111.352 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -105.14 4.63 31.57 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.756 0.65 . . . . 75.22 112.756 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.43 -19.93 4.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.424 0.527 . . . . 63.31 112.424 -172.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.03 -29.03 70.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.793 0.33 . . . . 74.02 110.875 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -130.62 4.65 4.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.3 -0.409 . . . . 60.25 111.021 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 43' ' ' LEU . 62.4 t -133.49 149.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.941 0.4 . . . . 74.22 111.242 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.16 127.96 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.345 -0.613 . . . . 71.33 109.345 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.673 HG12 ' HB2' ' A' ' 45' ' ' LEU . 42.2 mt -106.12 141.27 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.738 0.304 . . . . 73.14 111.01 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.7 m-85 -123.51 171.72 9.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 62.14 109.821 176.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' HG21 ' A' ' 23' ' ' ILE . 21.1 ttmm -146.6 139.06 25.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 62.33 109.94 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.7 mm -96.6 99.14 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.23 -0.656 . . . . 75.13 109.23 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.7 -19.14 61.46 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.093 -0.503 . . . . 60.11 110.943 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.71 87.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 65.23 110.462 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.34 -18.52 63.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 64.21 111.385 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.85 -15.77 60.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.124 -0.489 . . . . 63.52 111.406 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -86.04 93.73 9.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.056 0.455 . . . . 73.53 109.972 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -87.59 -20.6 26.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 73.43 110.212 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.01 -58.54 2.39 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.959 -0.564 . . . . 63.32 111.149 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.53 -34.09 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.731 -0.668 . . . . 71.01 111.001 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -67.91 -47.22 69.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.066 0.46 . . . . 74.24 110.518 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.8 m -67.42 -40.95 85.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 72.42 110.627 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.16 -44.56 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 52.44 111.789 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -99.12 -4.19 32.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.833 0.308 . . . . 63.04 111.833 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.47 83.41 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.214 -0.517 . . . . 65.55 113.271 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 88' ' ' ALA . 85.7 t -81.05 144.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.371 -0.603 . . . . 75.31 109.371 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.42 ' HB2' HG21 ' A' ' 112' ' ' ILE . 31.2 m -138.62 -63.72 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.691 0.281 . . . . 63.12 111.489 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.92 178.01 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 52.44 111.354 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 10.3 pt -112.35 116.2 48.95 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.46 -0.791 . . . . 75.51 110.87 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -92.02 -162.54 1.43 Allowed 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 124.219 -1.159 . . . . 64.14 111.947 -3.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.414 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.6 m -138.08 118.17 13.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.231 -0.441 . . . . 74.0 109.935 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mm -110.14 130.46 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.735 -0.666 . . . . 62.41 110.584 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 110' ' ' GLN . 40.9 mt -107.18 143.98 34.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.926 -0.768 . . . . 72.51 108.926 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.537 ' SD ' HD21 ' A' ' 43' ' ' LEU . 3.2 mtt -109.92 149.48 29.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.117 0.417 . . . . 65.12 110.666 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.0 m-85 -146.82 162.03 39.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.789 -0.641 . . . . 73.14 109.472 175.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 4.9 ttmp? -160.49 131.27 5.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.277 -0.268 . . . . 74.24 110.277 176.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.498 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 3.5 m-20 58.19 27.17 14.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.149 0.5 . . . . 72.22 110.58 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.43 27.93 71.95 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.836 -0.62 . . . . 43.11 112.266 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -126.83 149.6 49.63 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.491 -0.559 . . . . 63.04 109.491 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.589 ' O ' HD22 ' A' ' 108' ' ' LEU . 26.9 ttpt -68.75 143.91 54.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.747 0.784 . . . . 71.43 112.438 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 107' ' ' LYS . 1.4 mm? -144.68 169.3 18.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.841 -1.527 . . . . 61.41 108.379 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.62 173.71 5.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.773 0.797 . . . . 72.41 112.51 -162.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.471 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.1 tt0 -127.66 150.57 49.69 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.027 -0.988 . . . . 74.54 110.793 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 119' ' ' ILE . 2.3 t -127.69 111.63 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 114.514 -1.221 . . . . 70.11 109.418 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 94' ' ' SER . 60.1 mt -114.23 121.83 67.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.483 -0.326 . . . . 62.14 110.183 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.39 145.17 9.19 Favored Glycine 0 C--N 1.328 0.134 0 N-CA-C 111.76 -0.536 . . . . 60.32 111.76 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.14 72.19 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.13 0.491 . . . . 33.13 110.906 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -125.88 93.34 3.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.025 -0.731 . . . . 64.24 109.025 175.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.95 -25.09 34.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.334 -0.848 . . . . 62.15 111.511 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 t -67.67 -46.14 73.21 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.292 -0.633 . . . . 72.2 109.292 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.3 tptt -61.41 -45.88 92.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.619 -0.719 . . . . 55.14 109.744 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.605 HD13 HD21 ' A' ' 63' ' ' LEU . 69.9 mt -56.71 -56.09 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.062 -0.517 . . . . 62.22 111.292 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.503 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.0 -37.51 78.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 116.5 -0.318 . . . . 72.14 110.272 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.8 t -56.63 -51.53 68.33 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.164 -0.471 . . . . 43.12 109.898 176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 20.9 mm-40 -58.58 -44.39 89.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.054 -0.521 . . . . 73.04 110.135 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.8 mt -54.4 -56.14 11.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.489 -0.323 . . . . 73.41 111.011 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -68.51 -33.05 73.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.486 -0.486 . . . . 70.22 110.56 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -68.48 -31.92 71.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.287 -0.415 . . . . 72.2 110.854 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.484 ' OD1' HD12 ' A' ' 108' ' ' LEU . 23.6 m-80 -90.86 -14.09 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.35 -0.386 . . . . 71.2 111.565 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.0 mt -81.52 -60.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.553 -0.536 . . . . 54.51 109.553 168.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.448 -0.787 . . . . 71.43 110.8 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.858 -0.423 . . . . 75.42 109.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.49 128.79 44.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.368 -0.378 . . . . 34.04 110.664 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -61.47 117.36 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 65.04 109.887 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -69.42 102.69 1.83 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.902 -0.777 . . . . 71.22 108.902 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -53.81 -27.5 29.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.105 -0.498 . . . . 65.22 111.924 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 t60 69.59 -67.48 0.22 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.445 0.466 . . . . 75.12 111.621 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -50.18 119.97 4.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.271 0.628 . . . . 65.21 111.067 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -140.6 145.73 37.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.003 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.8 tpt -69.68 102.53 1.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.759 -0.46 . . . . 73.11 109.759 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.94 48.91 0.41 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.357 -0.697 . . . . 70.45 111.357 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.3 m -81.68 97.67 8.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.603 -0.298 . . . . 73.25 110.381 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.31 140.64 31.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.203 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -63.16 -61.75 2.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 75.42 110.023 177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.28 7.14 2.12 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.863 -0.608 . . . . 52.13 112.442 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.92 89.09 7.16 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.304 -0.628 . . . . 70.34 109.304 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 p -125.01 148.43 48.47 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.737 -0.665 . . . . 70.15 110.992 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -69.66 98.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.838 0.351 . . . . 71.4 110.829 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.44 139.75 14.8 Favored Glycine 0 N--CA 1.453 -0.211 0 N-CA-C 111.575 -0.61 . . . . 74.21 111.575 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.06 -179.18 4.75 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 75.33 112.125 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.74 -159.75 8.56 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.56 -0.616 . . . . 31.0 111.56 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.6 t -63.61 97.94 0.16 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.524 -0.547 . . . . 70.35 109.524 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.2 mmm -86.42 -17.17 35.01 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.928 -0.578 . . . . 71.32 110.943 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.481 HG21 ' HE2' ' A' ' 78' ' ' LYS . 26.7 mm -87.89 101.03 11.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.241 -0.651 . . . . 62.2 109.241 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 8.8 tp10 -64.47 122.68 17.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.296 0.569 . . . . 70.14 110.534 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -100.53 109.61 21.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 71.41 110.22 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.3 pt -119.51 166.78 13.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.733 -0.667 . . . . 73.54 111.275 -174.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.65 -158.59 33.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.687 -0.688 . . . . 75.43 112.111 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.11 -51.17 41.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.052 0.454 . . . . 65.03 111.55 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.4 t -69.5 -36.77 76.81 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.924 -0.58 . . . . 74.42 111.646 -172.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 1.9 mp0 -65.16 -14.99 61.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 75.54 111.97 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.426 ' O ' HG23 ' A' ' 35' ' ' VAL . 81.5 t80 -51.85 -61.27 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.717 0.294 . . . . 65.25 110.926 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.11 -44.97 83.78 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.421 . . . . 73.42 110.394 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -53.69 -57.76 9.65 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.725 0.774 . . . . 43.22 110.662 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.3 mmtt -64.75 -38.1 89.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.083 -0.962 . . . . 63.34 111.354 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.8 t -70.62 -35.54 61.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.44 -0.345 . . . . 74.14 110.823 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -81.88 -14.99 55.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.653 0.263 . . . . 53.41 111.126 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -66.07 2.52 1.1 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.208 0.448 . . . . 74.54 112.208 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' SG ' HD12 ' A' ' 44' ' ' ILE . 89.9 m -60.54 169.37 1.78 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.294 0.569 . . . . 55.23 112.041 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.03 -82.01 0.61 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.401 -0.818 . . . . 72.42 109.138 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -162.05 137.92 7.61 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.45 -0.574 . . . . 63.42 109.45 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 61.92 10.47 3.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.645 0.378 . . . . 72.45 111.408 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.76 108.18 17.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.263 -0.643 . . . . 70.51 109.263 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 126' ' ' ASN . 68.0 tp -83.46 121.67 27.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.177 0.513 . . . . 72.33 110.699 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.517 HD12 ' SG ' ' A' ' 38' ' ' CYS . 27.9 mt -105.83 118.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 72.45 110.084 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 3.6 mp -104.28 114.29 28.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.885 -0.783 . . . . 73.21 108.885 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.2 t -102.86 104.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.374 -0.232 . . . . 72.45 110.374 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.448 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 18.8 t0 -76.6 129.04 35.86 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.179 -0.674 . . . . 62.13 109.179 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -83.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 65.22 111.047 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -167.6 151.21 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 74.34 110.9 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.57 97.13 6.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.624 -0.717 . . . . 54.33 109.513 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.68 -50.42 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.581 2.187 . . . . 64.33 112.17 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -130.98 123.36 28.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.332 -0.618 . . . . 73.15 109.332 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.2 t -163.26 136.74 5.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 63.3 110.873 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -86.76 -66.52 1.37 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.955 -0.566 . . . . 43.4 112.249 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' A' ' 54' ' ' GLY . 15.3 Cg_endo -55.13 -26.79 52.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.165 2.577 . . . . 54.22 113.066 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 79.0 m -55.7 -23.55 29.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.482 -0.326 . . . . 71.35 111.866 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 12.2 ptm180 -54.34 -44.36 72.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.694 0.283 . . . . 74.44 110.504 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 18.6 m -75.5 -35.61 60.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.239 0.542 . . . . 70.35 110.79 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -64.83 -36.46 84.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.45 0.537 . . . . 64.1 112.45 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.8 tt0 -58.18 -58.9 15.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 120.351 -0.54 . . . . 65.12 110.363 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.25 -32.99 95.01 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.819 1.68 . . . . 64.23 112.435 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 58' ' ' SER . 46.4 mt-30 -63.4 -44.19 95.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.028 0.442 . . . . 75.21 110.377 176.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.77 -37.82 82.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.963 -0.562 . . . . 74.14 110.222 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 52.9 mt-10 -65.51 -36.17 83.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.281 -0.418 . . . . 65.51 110.26 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -56.53 -52.07 66.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.016 0.436 . . . . 74.54 109.848 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 116' ' ' ILE . 27.0 mt -68.33 -31.32 70.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 74.51 109.634 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.578 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -70.85 -13.37 62.01 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.643 -0.708 . . . . 43.32 110.982 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -96.06 -50.83 4.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.295 -0.411 . . . . 74.13 110.861 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -63.24 -43.05 99.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.36 0.6 . . . . 75.41 110.793 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.53 5.35 47.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.303 -0.862 . . . . 75.22 111.494 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.3 t -52.83 -25.88 12.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.258 0.836 . . . . 63.31 113.258 -168.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.75 -19.0 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.615 0.245 . . . . 74.02 111.403 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.7 2.0 7.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.521 -0.309 . . . . 60.25 110.991 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.71 144.48 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.784 0.326 . . . . 74.22 111.324 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -147.05 119.89 8.67 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.275 -0.639 . . . . 71.33 109.275 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.02 132.11 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.803 0.335 . . . . 73.14 110.558 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 74.3 m-85 -122.08 166.02 15.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 62.14 109.475 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HE2' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -148.72 142.58 25.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.411 -0.359 . . . . 62.33 110.371 172.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 31' ' ' PHE . 61.3 mt -102.02 103.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 75.13 109.231 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -84.1 12.72 5.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 60.11 111.306 -174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm -78.3 78.87 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.021 -0.733 . . . . 65.23 109.021 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -18.48 43.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 64.21 112.622 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.5 -11.66 60.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.756 0.312 . . . . 63.52 111.537 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.76 51.21 1.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.194 0.521 . . . . 73.53 110.281 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -61.42 -61.86 2.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.56 -0.746 . . . . 73.43 110.841 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 7.7 m-20 -52.83 -36.98 59.47 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.421 -0.809 . . . . 63.32 111.031 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.01 -42.16 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 71.01 110.202 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.85 -51.57 64.03 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.269 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.6 m -62.09 -31.48 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 72.42 111.01 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 25.3 mm-40 -68.81 -51.78 37.15 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.495 -0.32 . . . . 52.44 110.872 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -76.22 -10.91 59.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.494 -0.321 . . . . 63.04 111.415 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.42 44.34 2.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.814 -0.708 . . . . 65.55 113.694 167.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 98' ' ' THR . 72.4 t -77.83 106.13 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.557 -0.534 . . . . 75.31 109.557 173.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.549 ' HB3' HG21 ' A' ' 112' ' ' ILE . 22.8 t -92.91 -40.24 10.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 63.12 110.536 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.85 158.19 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 52.44 110.233 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.782 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.61 140.95 22.15 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.45 . . . . 75.51 110.406 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.43 -179.35 24.48 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.06 -1.225 . . . . 64.14 111.529 -3.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.51 HG21 HG22 ' A' ' 93' ' ' VAL . 93.7 m -139.78 116.42 10.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.926 0.393 . . . . 74.0 110.206 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.446 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.1 mm -109.8 110.82 33.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 62.41 110.8 -173.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 123.44 33.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.737 -0.468 . . . . 72.51 109.737 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.622 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 17.7 mmt -90.19 140.14 29.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.221 -0.445 . . . . 65.12 110.078 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.4 144.44 36.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.219 -0.66 . . . . 73.14 109.219 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -138.42 112.43 8.51 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.587 -0.445 . . . . 74.24 110.671 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.51 32.33 22.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.615 0.722 . . . . 72.22 110.453 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.51 68.25 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 115.684 -0.689 . . . . 43.11 112.649 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -83.12 143.59 30.44 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.777 -0.453 . . . . 63.04 109.777 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' HD22 ' A' ' 108' ' ' LEU . 21.5 tptm -65.88 130.62 43.9 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.83 0.706 . . . . 71.43 111.013 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -131.39 168.94 16.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.581 -1.191 . . . . 61.41 109.19 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 101' ' ' MET . 1.3 m -69.55 176.19 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.309 0.576 . . . . 72.41 111.937 -163.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.49 131.53 29.82 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.856 0.836 . . . . 74.54 110.992 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.83 107.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.926 -1.488 . . . . 70.11 109.752 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 94' ' ' SER . 64.0 mt -102.77 121.87 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.046 -0.524 . . . . 62.14 110.108 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.01 149.97 18.04 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.954 -0.458 . . . . 60.32 111.954 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.76 85.97 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.682 0.277 . . . . 33.13 111.129 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.8 t70 -132.64 92.11 3.01 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.349 0.595 . . . . 64.24 109.822 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 66' ' ' LEU . 9.2 tp -59.31 -32.89 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.265 -0.88 . . . . 62.15 111.651 -174.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.8 t -64.17 -48.49 75.77 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.898 0.38 . . . . 72.2 110.055 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -62.09 -43.37 98.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.013 -0.54 . . . . 55.14 109.711 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 71.2 mt -58.4 -56.27 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.036 -0.529 . . . . 62.22 111.117 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.517 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.34 -35.04 67.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 120.758 0.313 . . . . 72.14 110.187 -177.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -58.04 -51.9 67.77 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.109 -0.496 . . . . 43.12 109.791 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -61.64 -37.57 84.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.876 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.8 mt -58.51 -55.95 19.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.3 -0.409 . . . . 73.41 110.92 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -67.94 -31.42 71.15 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.651 -0.419 . . . . 70.22 110.011 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -58.06 -43.6 87.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.756 -0.656 . . . . 72.2 110.566 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.449 ' HB2' HD22 ' A' ' 43' ' ' LEU . 26.7 m-80 -78.26 -38.94 41.54 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.254 0.465 . . . . 71.2 112.254 -177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.6 mt -58.07 -47.75 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.372 . . . . 54.51 110.939 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.926 -0.559 . . . . 71.43 110.657 -176.519 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.544 ' HA ' ' OD1' ' A' ' 128' ' ' ASN . 16.5 tpt . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.249 -0.278 . . . . 75.42 110.249 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.14 29.18 7.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.16 -0.473 . . . . 34.04 111.843 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -109.59 131.6 54.91 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.643 -0.253 . . . . 65.04 110.892 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -132.43 146.4 51.92 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.207 -0.451 . . . . 71.22 111.432 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -165.69 154.77 11.92 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.097 -0.705 . . . . 65.22 109.097 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -99.12 151.86 20.5 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.799 0.333 . . . . 75.12 110.939 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 50.9 t-80 -170.62 -175.77 1.93 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.743 -0.836 . . . . 65.21 108.743 -175.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -168.36 150.48 5.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.97 -0.381 . . . . 74.33 109.97 169.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.2 mtp -132.23 169.92 15.76 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.823 0.449 . . . . 73.11 109.969 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.36 142.8 8.04 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.649 -0.786 . . . . 70.45 112.871 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' A' ' 55' ' ' PRO . 29.5 m -137.7 139.34 40.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.541 -0.911 . . . . 73.25 108.541 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.7 mt -104.64 22.18 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.039 0.385 . . . . 74.23 112.039 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -170.29 142.04 2.13 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.725 0.298 . . . . 75.42 111.162 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' HB2' ' A' ' 57' ' ' ARG . . . -104.66 101.99 11.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.974 -0.557 . . . . 52.13 110.076 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -130.7 21.98 5.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.541 . . . . 70.34 110.736 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -150.42 98.96 2.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.744 -0.207 . . . . 70.15 110.791 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.05 170.48 15.64 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.143 -0.317 . . . . 71.4 110.143 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.49 112.66 0.53 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.835 -0.506 . . . . 74.21 111.835 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.0 90.89 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.636 2.224 . . . . 75.33 111.148 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.43 53.93 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.161 -1.176 . . . . 31.0 110.161 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.36 171.55 8.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.269 -0.465 . . . . 70.35 111.123 -170.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.7 mmm -60.4 -31.41 70.34 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.831 -0.803 . . . . 71.32 108.831 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 ' HD2' ' A' ' 78' ' ' LYS . 17.9 mm -64.99 93.69 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.368 -0.975 . . . . 62.2 108.368 171.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 9.7 tp10 -52.27 144.31 12.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.469 0.652 . . . . 70.14 111.98 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -101.67 115.61 30.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.157 -0.929 . . . . 71.41 110.276 -176.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.479 HG21 ' HG3' ' A' ' 34' ' ' LYS . 50.6 pt -133.96 179.94 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.956 0.408 . . . . 73.54 110.911 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.34 -153.52 7.93 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.896 -0.593 . . . . 75.43 111.852 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.97 -53.18 22.1 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.404 0.282 . . . . 65.03 111.487 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -70.82 -29.96 66.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.828 0.347 . . . . 74.42 111.565 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 mp0 -72.36 -27.3 62.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.438 . . . . 75.54 111.009 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -51.89 -61.83 2.01 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.13 0.269 . . . . 65.25 111.192 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 36' ' ' THR . 9.2 t70 -51.09 -53.59 32.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.986 -0.552 . . . . 73.42 110.549 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -54.07 -57.28 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.131 -0.941 . . . . 43.22 111.31 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 77' ' ' TYR . 75.9 mmtt -62.28 -33.37 74.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 63.34 111.014 -175.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.455 ' HA ' HD13 ' A' ' 44' ' ' ILE . 21.7 t -69.09 -55.66 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.185 -0.461 . . . . 74.14 112.16 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 32' ' ' ASP . 10.2 t -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.383 0.512 . . . . 53.41 112.383 -170.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 t -75.81 2.57 11.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.135 0.42 . . . . 74.54 112.135 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.81 ' SG ' HD11 ' A' ' 44' ' ' ILE . 92.0 m -82.8 128.62 34.57 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.666 0.27 . . . . 55.23 110.49 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.29 -72.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.769 0.655 . . . . 72.42 112.769 -172.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.43 121.93 35.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 63.42 111.361 -166.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 58.21 11.19 1.47 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.625 -1.171 . . . . 72.45 113.395 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 47.9 mm -73.04 95.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.971 0.415 . . . . 70.51 110.072 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -71.0 110.38 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.857 -0.794 . . . . 72.33 108.857 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.81 HD11 ' SG ' ' A' ' 38' ' ' CYS . 86.4 mt -94.38 123.24 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.393 -0.822 . . . . 72.45 110.526 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.681 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.3 mp -110.11 109.75 20.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.242 -0.651 . . . . 73.21 109.242 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.06 105.16 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.028 -0.36 . . . . 72.45 110.028 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -81.01 147.66 30.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.382 -0.372 . . . . 62.13 110.215 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 88' ' ' ALA . 88.2 t80 -87.91 115.65 25.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.36 . . . . 65.22 110.624 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.573 ' HE1' ' HA ' ' A' ' 82' ' ' GLU . 51.6 t-105 -56.35 115.37 2.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.813 -0.631 . . . . 74.34 110.844 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -111.86 107.88 56.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 54.33 110.089 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 18.9 Cg_endo -59.81 -21.59 64.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.537 2.158 . . . . 64.33 111.79 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -131.95 128.63 38.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.531 -0.758 . . . . 73.15 109.383 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 47.6 t -164.37 175.13 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.889 0.376 . . . . 63.3 110.694 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -136.58 -61.17 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.553 -0.748 . . . . 43.4 111.435 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.463 ' O ' HD23 ' A' ' 59' ' ' LEU . 52.7 Cg_exo -55.0 -26.03 47.51 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.005 2.47 . . . . 54.22 112.684 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 56.6 m -57.29 -28.57 63.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.978 -0.555 . . . . 71.35 111.476 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.601 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 2.9 tmt_? -53.59 -49.12 68.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.935 0.398 . . . . 74.44 111.594 -172.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.4 m -75.3 -38.17 60.46 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.765 0.793 . . . . 70.35 110.95 177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 55' ' ' PRO . 4.4 mm? -73.71 -24.24 59.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.607 -0.724 . . . . 64.1 112.043 -172.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.5 mt-10 -59.56 -59.06 15.08 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.786 -0.449 . . . . 65.12 109.786 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.73 -34.46 31.51 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.819 1.679 . . . . 64.23 112.376 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.63 ' HB3' HD13 ' A' ' 116' ' ' ILE . 40.2 mt-30 -62.61 -42.7 99.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.145 -0.622 . . . . 75.21 110.97 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.638 HD21 HD13 ' A' ' 119' ' ' ILE . 67.6 mt -64.76 -38.62 91.6 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.48 -0.327 . . . . 74.14 110.132 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.0 mt-10 -58.11 -43.53 87.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 116.419 -0.355 . . . . 65.51 110.087 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -56.07 -53.43 57.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.093 -0.503 . . . . 74.54 111.09 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 123' ' ' ILE . 34.8 mt -63.26 -37.29 86.67 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.639 -0.504 . . . . 74.51 109.639 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.18 -26.9 68.35 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.588 -0.733 . . . . 43.32 110.906 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.5 mt-30 -80.15 -48.83 12.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.819 0.342 . . . . 74.13 110.599 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -47.62 83.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.436 0.636 . . . . 75.41 109.806 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -90.54 4.47 51.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.294 -0.866 . . . . 75.22 112.416 -175.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -53.16 -21.28 4.8 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.848 0.356 . . . . 63.31 111.664 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.35 -35.26 78.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 74.02 110.962 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -133.9 15.71 3.91 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.494 -0.321 . . . . 60.25 111.19 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 43' ' ' LEU . 41.9 t -135.29 139.69 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.071 0.462 . . . . 74.22 111.351 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 24' ' ' GLU . 61.0 tptt -145.25 119.81 9.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 71.33 109.14 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.681 HG12 ' HB2' ' A' ' 45' ' ' LEU . 29.2 mt -101.79 141.65 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.227 -0.286 . . . . 73.14 110.227 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 91.4 m-85 -130.22 161.25 31.59 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.55 0.34 . . . . 62.14 110.518 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.642 ' HD2' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -163.54 154.86 16.73 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 62.33 109.147 168.242 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 28.1 pt -79.53 152.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.394 -0.225 . . . . 75.13 110.394 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -107.26 6.62 28.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.626 0.25 . . . . 60.11 111.342 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 81' ' ' ILE . 3.0 mp -78.5 96.58 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 65.23 110.167 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HA ' ' HE1' ' A' ' 49' ' ' TRP . 7.5 tm-20 -61.62 -26.8 68.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.946 -0.57 . . . . 64.21 110.333 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.72 -9.01 57.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.686 -0.688 . . . . 63.52 111.28 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -91.4 105.83 18.05 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.093 0.473 . . . . 73.53 111.155 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -121.54 -32.91 3.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 73.43 109.776 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.3 m-20 -49.51 -43.18 45.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.011 -0.995 . . . . 63.32 111.939 -173.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.2 -34.05 26.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.283 -0.417 . . . . 71.01 111.403 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . . . -60.19 -49.23 78.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.15 0.5 . . . . 74.24 109.978 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 m -66.73 -35.49 80.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.437 -0.801 . . . . 72.42 110.642 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 72.8 mm-40 -61.34 -55.41 32.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.128 -0.487 . . . . 52.44 110.691 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.97 -11.87 51.91 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.462 -0.335 . . . . 63.04 111.815 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.59 42.28 14.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.75 -0.738 . . . . 65.55 112.354 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t -75.3 114.43 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -98.03 -74.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 63.12 111.05 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.74 136.44 33.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.76 0.314 . . . . 52.44 110.899 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.67 151.98 46.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 75.51 109.845 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.86 169.35 64.19 Favored 'Cis proline' 0 C--N 1.354 0.836 0 C-N-CA 124.157 -1.184 . . . . 64.14 112.921 1.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 112' ' ' ILE . 89.0 m -139.02 114.13 9.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.715 -0.675 . . . . 74.0 109.879 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.459 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 32.4 mm -109.79 110.7 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 62.41 111.012 -173.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -97.83 123.36 41.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.745 -0.835 . . . . 72.51 108.745 171.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.482 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 37.9 mtt -93.43 150.83 20.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.965 0.412 . . . . 65.12 110.923 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.7 m-85 -143.33 153.82 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.416 -0.957 . . . . 73.14 108.416 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -150.91 115.3 5.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 74.24 110.62 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.76 25.38 15.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.663 0.744 . . . . 72.22 110.171 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.29 -0.42 87.2 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.636 -0.711 . . . . 43.11 112.276 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -91.68 145.21 24.77 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 122.812 -0.228 . . . . 63.04 110.819 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' HD22 ' A' ' 108' ' ' LEU . 3.7 tppp? -63.31 132.51 51.83 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.916 0.76 . . . . 71.43 110.765 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 1.2 mm? -137.19 169.43 17.79 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 125.036 1.334 . . . . 61.41 108.788 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.25 172.18 7.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.459 0.54 . . . . 72.41 112.459 -162.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -140.14 126.04 19.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.081 -0.508 . . . . 74.54 110.605 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.1 m -115.3 122.47 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.191 0.519 . . . . 70.11 110.422 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 98' ' ' THR . 51.3 mt -108.18 140.56 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.718 -0.674 . . . . 62.14 109.485 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.12 157.49 32.45 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.991 -0.623 . . . . 60.32 112.13 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.46 97.3 9.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.927 0.343 . . . . 33.13 111.927 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.9 t0 -146.1 104.27 3.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.317 0.579 . . . . 64.24 110.677 169.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 62' ' ' GLN . 8.7 tp -59.13 -32.97 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.148 -0.933 . . . . 62.15 110.809 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 7' ' ' HIS . 41.0 m -67.91 -48.56 65.66 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.196 -0.456 . . . . 72.2 111.14 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -60.51 -47.66 85.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.374 -0.375 . . . . 55.14 110.301 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.638 HD13 HD21 ' A' ' 63' ' ' LEU . 78.5 mt -57.9 -55.56 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 62.22 111.081 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.436 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.86 -36.97 75.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.907 -0.405 . . . . 72.14 109.907 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -57.16 -52.02 66.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.847 -0.615 . . . . 43.12 110.082 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.86 -40.31 96.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.314 -0.403 . . . . 73.04 110.383 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.7 mt -55.32 -56.05 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.556 -0.293 . . . . 73.41 110.691 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.2 -30.65 66.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.624 -0.431 . . . . 70.22 110.007 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.53 -34.43 76.9 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.907 -0.588 . . . . 72.2 111.214 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -92.62 -30.36 15.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 71.2 112.006 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.464 HD11 ' CG2' ' A' ' 74' ' ' VAL . 79.0 mt -67.81 -51.6 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 54.51 110.253 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.544 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 9.9 m120 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.527 -0.76 . . . . 71.43 110.515 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.728 -0.471 . . . . 75.42 109.728 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.06 128.92 7.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.534 -0.303 . . . . 34.04 110.468 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -119.95 141.94 49.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 65.04 109.904 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -122.76 112.73 18.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.827 -0.435 . . . . 71.22 109.827 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -96.72 -33.27 11.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.482 -0.326 . . . . 65.22 111.682 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -137.76 136.26 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.073 0.464 . . . . 75.12 111.673 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -148.71 88.33 1.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.265 -0.879 . . . . 65.21 109.14 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -86.89 106.17 17.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.914 -0.585 . . . . 74.33 110.92 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.7 ttm -167.15 92.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.979 0.419 . . . . 73.11 109.982 174.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.79 131.46 1.91 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.725 -0.67 . . . . 70.45 111.592 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.2 m -151.38 122.74 7.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.546 -0.538 . . . . 73.25 109.546 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD13 ' HD2' ' A' ' 65' ' ' LYS . 68.8 mt -56.68 99.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 74.23 111.789 -174.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -83.62 -33.04 25.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.073 -0.714 . . . . 75.42 109.073 173.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.31 85.18 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.519 -0.764 . . . . 52.13 109.994 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.35 140.09 55.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 70.34 110.782 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -153.85 133.88 13.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 70.15 109.841 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -60.74 144.82 51.52 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 123.538 0.524 . . . . 71.4 110.638 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.49 68.18 0.52 Allowed Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.199 -0.524 . . . . 74.21 112.028 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -96.51 13.7 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.339 2.693 . . . . 75.33 111.776 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.67 84.97 0.24 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.342 -0.703 . . . . 31.0 111.342 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.421 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 50.0 m -58.76 101.89 0.1 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.336 0.589 . . . . 70.35 111.562 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 85.1 mmm -72.68 -12.0 60.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.255 -0.884 . . . . 71.32 109.929 174.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.14 113.27 10.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.705 -0.679 . . . . 62.2 109.862 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 3.5 tp10 -81.72 126.41 31.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.036 0.446 . . . . 70.14 111.166 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -80.35 119.37 22.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.804 -0.635 . . . . 71.41 109.697 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.3 pt -126.69 146.47 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.158 0.504 . . . . 73.54 111.726 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.44 -162.61 26.26 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.221 -0.899 . . . . 75.43 111.522 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.94 -55.46 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.717 0.294 . . . . 65.03 110.98 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 m -61.58 -37.73 84.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.265 0.555 . . . . 74.42 110.644 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -65.33 -36.65 84.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.518 -0.765 . . . . 75.54 111.573 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.9 t80 -51.97 -61.69 2.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.732 0.271 . . . . 65.25 111.732 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -55.66 -46.67 77.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.099 0.476 . . . . 73.42 110.853 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.97 -57.22 13.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.611 -0.722 . . . . 43.22 110.88 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 33.7 mmtp -61.8 -32.48 72.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 63.34 111.369 -175.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 31' ' ' PHE . 76.8 t -72.51 -48.11 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.716 0.293 . . . . 74.14 110.808 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.0 p -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 53.41 110.97 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.4 t -65.84 -4.1 6.16 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.17 -0.468 . . . . 74.54 112.06 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.5 p -65.29 112.77 3.63 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.298 -0.251 . . . . 55.23 110.788 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.37 -77.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 72.42 111.059 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -147.63 129.06 14.89 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.627 0.251 . . . . 63.42 110.851 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 52.33 21.48 1.71 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.84 -0.618 . . . . 72.45 112.045 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.0 111.09 14.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.349 -0.387 . . . . 70.51 109.989 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.4 tp -77.26 107.0 9.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.323 0.582 . . . . 72.33 110.113 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 101' ' ' MET . 27.4 mt -95.05 120.7 44.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.529 -0.76 . . . . 72.45 110.672 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 74' ' ' VAL . 5.8 mp -105.83 123.59 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.327 -0.62 . . . . 73.21 109.327 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.58 106.8 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.228 -0.286 . . . . 72.45 110.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.69 132.53 41.75 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.845 0.355 . . . . 62.13 110.21 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -89.12 62.78 6.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.487 . . . . 65.22 110.9 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.475 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 11.9 t90 70.68 -70.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.575 -0.739 . . . . 74.34 112.173 171.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 64.59 74.21 0.42 Allowed Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 123.13 0.572 . . . . 54.33 111.495 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -88.5 -66.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.85 2.367 . . . . 64.33 113.833 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -85.56 79.43 9.39 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.826 0.346 . . . . 73.15 110.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.5 p -171.38 139.08 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.571 . . . . 63.3 110.276 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -75.7 -66.22 1.92 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 116.008 -0.542 . . . . 43.4 112.556 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.82 -28.6 4.95 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.337 2.691 . . . . 54.22 113.686 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 81.5 m -52.96 -34.92 58.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.571 -0.286 . . . . 71.35 111.668 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 17.5 ptm180 -59.63 -38.01 80.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.585 -0.279 . . . . 74.44 110.56 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.5 t -75.21 -37.94 60.93 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.423 0.63 . . . . 70.35 110.319 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.3 mm? -61.24 -34.85 75.81 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 64.1 111.877 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.72 -58.3 20.47 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.313 -0.375 . . . . 65.12 111.262 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.67 -30.67 85.71 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.859 1.706 . . . . 64.23 111.909 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -63.32 -39.95 95.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.596 -0.442 . . . . 75.21 109.896 174.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.503 HD21 HD13 ' A' ' 119' ' ' ILE . 82.7 mt -69.85 -35.81 75.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.977 -0.556 . . . . 74.14 110.093 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 75.8 mt-10 -59.24 -42.59 91.46 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.118 -0.492 . . . . 65.51 109.97 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.582 ' HD2' HD13 ' A' ' 12' ' ' LEU . 18.4 ttmm -58.11 -54.28 48.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.461 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 123' ' ' ILE . 56.6 mt -62.17 -30.56 71.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.883 0.373 . . . . 74.51 110.038 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.539 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -69.67 -41.82 74.98 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.89 -0.596 . . . . 43.32 110.628 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.3 mt-30 -70.59 -40.46 73.22 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.04 0.447 . . . . 74.13 110.72 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -75.66 -35.82 60.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.805 -0.634 . . . . 75.41 111.012 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.7 5.35 36.21 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.018 -0.537 . . . . 75.22 112.006 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.8 t -52.44 -18.99 1.9 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.994 0.517 . . . . 63.31 112.167 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.97 -35.84 64.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.312 -0.404 . . . . 74.02 111.13 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -133.87 -11.16 2.66 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.717 0.266 . . . . 60.25 111.717 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.567 HG13 HD13 ' A' ' 45' ' ' LEU . 55.2 t -105.35 141.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.032 0.444 . . . . 74.22 112.047 -172.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -144.56 121.93 11.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 71.33 109.02 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.7 mt -109.93 143.36 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.012 0.434 . . . . 73.14 111.51 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 90.7 m-85 -126.73 172.87 9.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.629 -0.714 . . . . 62.14 110.438 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 49' ' ' TRP . 14.2 tppt? -138.73 115.85 10.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 62.33 110.418 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.65 99.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.051 -0.722 . . . . 75.13 109.051 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -108.37 30.81 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 60.11 111.023 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.71 74.25 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.443 -0.577 . . . . 65.23 109.443 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -35.58 25.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.137 -0.938 . . . . 64.21 112.54 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.58 -35.89 70.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 63.52 111.144 -176.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -93.86 42.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.697 0.761 . . . . 73.53 110.446 -171.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.38 -15.45 60.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.246 -0.888 . . . . 73.43 110.491 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.09 -33.91 58.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.757 -0.656 . . . . 63.32 111.086 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.6 t -56.21 -34.41 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.795 -0.639 . . . . 71.01 110.874 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.01 75.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.09 -0.505 . . . . 74.24 110.648 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -64.35 -41.76 96.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.963 -0.562 . . . . 72.42 110.562 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -63.69 -53.19 55.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.143 -0.48 . . . . 52.44 111.371 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.42 -18.06 60.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 63.04 111.106 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.74 55.67 3.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.988 -0.625 . . . . 65.55 112.507 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -69.53 106.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.559 -0.534 . . . . 75.31 109.559 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' ' 112' ' ' ILE . 23.3 t -65.72 -56.93 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 63.12 110.984 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.94 27.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.679 0.276 . . . . 52.44 110.682 -177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 pt -95.16 149.31 36.03 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.873 -0.603 . . . . 75.51 110.602 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.47 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.2 Cg_exo -71.01 170.46 63.79 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.147 -1.189 . . . . 64.14 112.516 -1.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.3 m -139.55 125.75 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.649 -0.5 . . . . 74.0 109.649 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 49.9 mm -110.37 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 62.41 110.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -88.81 123.12 32.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.423 -0.584 . . . . 72.51 109.423 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 43.2 mtt -102.08 142.24 33.65 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.305 0.502 . . . . 65.12 111.32 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.57 144.96 33.11 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.478 -0.934 . . . . 73.14 108.478 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 40.1 ttpt -146.42 115.97 7.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.457 -0.497 . . . . 74.24 111.342 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 62.58 25.72 15.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.823 -0.626 . . . . 72.22 110.54 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.83 -7.97 80.72 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.804 -0.635 . . . . 43.11 112.658 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -85.46 151.26 24.11 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 122.3 0.24 . . . . 63.04 110.952 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.5 tmtt? -77.56 116.95 18.53 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.558 0.694 . . . . 71.43 109.972 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.415 ' CD2' ' HB3' ' A' ' 103' ' ' LYS . 4.2 mm? -112.05 168.85 9.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.534 -1.212 . . . . 61.41 110.377 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -177.21 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 72.41 111.863 -162.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -147.49 147.12 29.83 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.681 0.753 . . . . 74.54 111.019 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 13.5 t -122.8 135.43 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 114.066 -1.424 . . . . 70.11 109.698 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.458 HG21 ' HB3' ' A' ' 94' ' ' SER . 65.5 mt -123.68 127.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.559 -0.291 . . . . 62.14 110.414 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.76 162.31 38.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.216 -0.516 . . . . 60.32 112.415 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.56 78.58 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.931 0.396 . . . . 33.13 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.474 ' O ' HG13 ' A' ' 119' ' ' ILE . 43.3 t0 -126.38 91.41 3.36 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.048 0.451 . . . . 64.24 109.799 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 66' ' ' LEU . 9.0 tp -61.89 -27.5 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.605 -0.725 . . . . 62.15 110.654 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -69.87 -44.62 69.44 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.197 -0.456 . . . . 72.2 109.828 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -67.24 -38.96 86.07 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.69 -0.485 . . . . 55.14 109.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.503 HD13 HD21 ' A' ' 63' ' ' LEU . 76.3 mt -60.32 -56.1 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.067 -0.515 . . . . 62.22 110.954 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -39.83 86.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.774 0.321 . . . . 72.14 110.197 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.9 t -56.74 -47.58 79.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.151 -0.477 . . . . 43.12 109.862 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -66.43 -40.83 89.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 73.04 110.793 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 66' ' ' LEU . 96.9 mt -54.41 -56.18 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.79 -0.364 . . . . 73.41 110.125 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -67.42 -39.19 85.45 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.49 -0.484 . . . . 70.22 110.388 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.29 -38.4 90.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 72.2 111.86 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -83.15 -21.25 33.62 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.713 -0.221 . . . . 71.2 110.798 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.4 mt -72.4 -48.43 47.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.831 -0.433 . . . . 54.51 109.831 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.659 -0.686 . . . . 71.43 110.901 -179.846 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.083 -0.34 . . . . 75.42 110.083 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.31 130.97 37.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.512 -0.313 . . . . 34.04 110.736 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -88.15 81.64 7.33 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.47 0.652 . . . . 65.04 109.84 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -133.6 135.76 44.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.324 -0.853 . . . . 71.22 110.904 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -141.06 -65.64 0.44 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.792 -0.447 . . . . 65.22 109.792 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -160.66 149.34 16.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.395 -0.594 . . . . 75.12 109.395 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -103.02 171.99 7.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.869 0.366 . . . . 65.21 110.883 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.546 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 44.6 t-80 -161.33 110.75 1.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.734 -0.666 . . . . 74.33 109.411 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 72.1 mtm -53.67 119.57 5.1 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 123.402 0.439 . . . . 73.11 110.875 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.7 154.65 52.45 Favored Glycine 0 C--N 1.33 0.208 0 CA-C-N 115.672 -0.695 . . . . 70.45 112.565 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.1 m -81.84 -72.63 0.42 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.441 0.162 . . . . 73.25 110.969 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -154.7 114.79 3.82 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.443 0.297 . . . . 74.23 111.251 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.671 ' HG2' ' HG2' ' A' ' 85' ' ' GLN . 12.3 pt-20 -109.53 106.87 16.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.154 -1.054 . . . . 75.42 108.154 168.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.511 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . . . -162.92 173.73 13.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.415 -0.357 . . . . 52.13 111.21 -173.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 74.72 97.33 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.117 0.886 . . . . 70.34 109.36 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.515 ' HA ' ' HZ2' ' A' ' 49' ' ' TRP . 45.0 p -56.71 120.14 7.33 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.324 -0.853 . . . . 70.15 112.559 -172.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.434 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 99.3 mt-30 -79.13 168.62 19.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.738 -0.665 . . . . 71.4 109.491 172.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.33 88.98 0.54 Allowed Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.865 -0.494 . . . . 74.21 111.865 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.457 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 93.8 Cg_endo -86.19 40.41 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.985 2.457 . . . . 75.33 112.482 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.66 49.68 3.42 Favored Glycine 0 C--N 1.328 0.107 0 N-CA-C 111.224 -0.75 . . . . 31.0 111.224 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.49 ' HB3' ' OE1' ' A' ' 64' ' ' GLU . 31.2 m -146.82 -161.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.938 -0.393 . . . . 70.35 109.938 -172.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.407 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 83.4 mmm -57.5 -25.39 59.75 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.704 0.288 . . . . 71.32 111.279 177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -75.17 112.26 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 62.2 110.108 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.573 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 7.6 tp10 -71.07 150.27 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 70.14 110.74 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -118.06 126.63 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.567 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 31' ' ' PHE . 24.9 pt -143.13 166.63 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.236 -0.438 . . . . 73.54 111.16 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -100.87 -164.38 27.93 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.909 -0.587 . . . . 75.43 112.561 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.426 ' N ' HD11 ' A' ' 81' ' ' ILE . 12.3 t70 -69.12 -57.04 5.93 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.821 0.344 . . . . 65.03 111.361 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.35 -0.386 . . . . 74.42 110.236 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 45.5 mt-10 -68.86 -31.39 70.3 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.54 110.569 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.7 t80 -52.85 -60.12 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.074 0.464 . . . . 65.25 110.009 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.46 -45.91 73.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 73.42 110.848 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -66.39 -57.36 7.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 43.22 111.613 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG3' HG21 ' A' ' 26' ' ' ILE . 46.8 mmtm -60.52 -31.14 70.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.683 . . . . 63.34 111.214 -176.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 31' ' ' PHE . 68.1 t -73.43 -44.75 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.687 -0.233 . . . . 74.14 110.663 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.9 p -72.11 -14.62 61.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.995 0.426 . . . . 53.41 110.966 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.9 t -71.24 0.53 7.72 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.834 -0.621 . . . . 74.54 111.351 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.78 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.0 p -58.65 120.3 8.66 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.698 0.285 . . . . 55.23 110.739 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -67.65 -73.35 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.402 -0.363 . . . . 72.42 111.152 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -156.77 125.62 5.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.361 -0.381 . . . . 63.42 110.449 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 59.49 5.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.623 0.601 . . . . 72.45 112.623 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 73' ' ' ASN . 40.0 mm -68.13 112.72 3.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 70.51 110.73 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.478 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.1 tt -80.34 120.87 24.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.831 -0.803 . . . . 72.33 108.831 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.96 114.16 46.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.459 -0.791 . . . . 72.45 110.472 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.0 mp -101.93 137.36 40.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.587 -0.894 . . . . 73.21 108.587 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -124.74 110.44 25.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 110.21 -0.293 . . . . 72.45 110.21 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.51 122.16 22.64 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.53 -0.544 . . . . 62.13 109.53 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -69.11 -74.7 0.12 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.573 -0.528 . . . . 65.22 109.573 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.655 ' HZ3' ' HA ' ' A' ' 80' ' ' ASN . 8.5 t-105 -171.89 160.53 5.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.15 -0.477 . . . . 74.34 109.861 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.636 ' HB1' ' SG ' ' A' ' 53' ' ' CYS . . . -164.37 96.3 0.94 Allowed Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.276 0.36 . . . . 54.33 110.538 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.74 -77.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.936 2.424 . . . . 64.33 112.063 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -98.69 90.88 4.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.783 -0.451 . . . . 73.15 109.783 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.636 ' SG ' ' HB1' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -134.53 -58.75 0.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.652 -0.703 . . . . 63.3 110.78 -178.021 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.52 -85.83 0.4 Allowed Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.028 -0.606 . . . . 43.4 112.574 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.68 -22.04 42.23 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.999 2.466 . . . . 54.22 111.876 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.5 p -52.72 -33.27 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.621 -0.718 . . . . 71.35 110.986 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -60.65 -36.2 78.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.375 0.607 . . . . 74.44 110.041 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.8 m -74.56 -35.87 63.08 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.824 0.821 . . . . 70.35 110.042 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.5 mm? -65.59 -22.1 66.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.232 -0.895 . . . . 64.1 111.464 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 -57.92 -62.23 5.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.969 -0.382 . . . . 65.12 109.969 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 40.0 Cg_endo -67.08 -31.55 36.49 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 121.891 1.727 . . . . 64.23 112.079 176.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.561 ' HB2' ' HA ' ' A' ' 59' ' ' LEU . 79.5 mt-30 -60.3 -45.79 92.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.054 0.455 . . . . 75.21 110.824 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 119' ' ' ILE . 73.4 mt -64.75 -40.78 95.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.127 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 21' ' ' SER . 30.0 mt-10 -57.57 -43.78 84.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.433 -0.349 . . . . 65.51 110.323 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.71 -57.22 9.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.008 -0.542 . . . . 74.54 110.688 178.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.479 HD13 HD12 ' A' ' 123' ' ' ILE . 19.7 mt -64.88 -34.92 79.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.941 -0.572 . . . . 74.51 109.654 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.566 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -66.58 -27.96 68.14 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.694 -0.684 . . . . 43.32 111.355 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.3 mt-30 -85.22 -37.11 20.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.832 0.349 . . . . 74.13 110.847 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.85 -37.99 70.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 75.41 110.953 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -104.89 5.89 33.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.577 -0.738 . . . . 75.22 111.925 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -22.66 5.5 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.578 0.955 . . . . 63.31 113.578 -169.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -77.42 -18.81 56.92 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.288 -0.258 . . . . 74.02 111.362 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.471 ' HA ' HD13 ' A' ' 42' ' ' ILE . 6.3 t30 -134.34 6.68 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.499 -0.319 . . . . 60.25 110.826 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 43' ' ' LEU . 54.6 t -139.13 139.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.71 0.29 . . . . 74.22 110.879 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 20.6 tptm -142.46 123.0 14.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 71.33 109.757 173.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 45' ' ' LEU . 54.7 mt -98.08 125.39 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 73.14 110.508 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.552 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 62.3 m-85 -111.27 174.39 5.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.395 -0.594 . . . . 62.14 109.395 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HB2' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -156.08 152.71 28.34 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.295 -0.631 . . . . 62.33 109.295 167.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 34.4 pt -106.26 172.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.765 0.317 . . . . 75.13 111.016 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.655 ' HA ' ' HZ3' ' A' ' 49' ' ' TRP . 91.0 m-20 -113.04 -90.19 0.52 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.961 -0.563 . . . . 60.11 109.523 171.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 81' ' ' ILE . 19.8 mm 52.69 23.26 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.075 0.464 . . . . 65.23 111.488 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HG3' ' HA ' ' A' ' 14' ' ' ALA . 36.6 tt0 -47.83 -28.48 2.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.401 0.68 . . . . 64.21 111.951 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -72.25 -35.66 68.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.783 -0.644 . . . . 63.52 111.592 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.21 99.16 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 73.53 110.681 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.671 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 78.9 mt-30 -73.33 6.56 2.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.971 -0.559 . . . . 73.43 111.68 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -45.19 -40.07 6.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.117 -0.492 . . . . 63.32 110.744 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.0 t -61.51 -39.9 84.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.679 -0.692 . . . . 71.01 110.703 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.37 -46.2 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.259 0.552 . . . . 74.24 110.076 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 74.5 m -67.38 -39.47 85.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.142 -0.935 . . . . 72.42 111.22 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -67.09 -43.04 83.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.351 -0.386 . . . . 52.44 111.625 -177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -92.58 -12.27 32.18 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.703 0.26 . . . . 63.04 111.703 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 8' ' ' HIS . . . 83.3 45.52 6.52 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.951 -0.642 . . . . 65.55 113.562 171.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.33 128.52 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.063 -0.347 . . . . 75.31 110.063 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 -16.66 7.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.489 -0.323 . . . . 63.12 111.071 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.4 168.44 25.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.421 -0.354 . . . . 52.44 110.104 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.1 pp -127.84 140.14 37.3 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.514 -0.312 . . . . 75.51 110.672 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 96.4 Cg_endo -78.78 -176.02 17.85 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 123.875 -1.302 . . . . 64.14 112.919 -0.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 m -147.6 124.5 11.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.686 -0.688 . . . . 74.0 109.638 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 48.7 mm -109.82 111.08 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.557 -0.292 . . . . 62.41 110.54 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 100' ' ' LEU . 1.9 mm? -88.12 123.5 32.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 72.51 109.283 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 109' ' ' SER . 26.3 mtt -103.36 142.12 34.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.729 0.299 . . . . 65.12 110.662 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -140.06 142.78 36.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.214 -0.662 . . . . 73.14 109.214 172.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 23.6 tptm -124.08 104.06 8.65 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.08 -0.248 . . . . 74.24 110.94 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.78 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.3 t30 40.8 40.69 1.02 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.967 0.507 . . . . 72.22 112.28 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.99 53.03 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.169 -0.539 . . . . 43.11 113.214 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -120.79 148.94 43.32 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 122.935 0.494 . . . . 63.04 109.846 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.617 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.4 tmtt? -64.48 130.36 43.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.292 0.568 . . . . 71.43 109.752 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.617 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -136.29 167.79 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.148 -0.933 . . . . 61.41 109.244 -173.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.511 ' H ' HD13 ' A' ' 108' ' ' LEU . 8.9 m -70.69 179.44 2.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.714 0.768 . . . . 72.41 112.731 -165.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.505 ' HG3' HD13 ' A' ' 100' ' ' LEU . 7.3 tt0 -148.78 131.97 16.41 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.233 -0.894 . . . . 74.54 109.963 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 6.5 t -110.57 113.87 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.55 -1.204 . . . . 70.11 109.995 -172.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.0 mm -97.8 120.65 47.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.081 -0.508 . . . . 62.14 109.979 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.12 -173.19 30.09 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.657 -0.577 . . . . 60.32 111.657 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.45 98.41 7.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.647 0.26 . . . . 33.13 111.059 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -142.32 101.68 3.95 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.067 0.461 . . . . 64.24 110.482 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.561 ' HB ' ' OE1' ' A' ' 62' ' ' GLN . 11.4 tp -66.0 -30.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 62.15 110.853 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.1 t -58.67 -50.63 73.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.16 0.505 . . . . 72.2 110.009 176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -63.77 -46.78 83.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.65 -0.704 . . . . 55.14 110.515 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 63' ' ' LEU . 77.0 mt -57.17 -56.3 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.19 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.16 -38.91 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.893 -0.41 . . . . 72.14 109.893 -177.344 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.2 t -57.21 -51.25 70.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.174 -0.466 . . . . 43.12 110.047 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.0 -40.53 98.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 73.04 110.772 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 66' ' ' LEU . 96.8 mt -56.98 -56.68 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.992 -0.283 . . . . 73.41 111.001 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.36 -35.98 76.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.872 0.368 . . . . 70.22 110.232 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.95 -36.61 84.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 72.2 110.961 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -95.73 -9.18 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 71.2 111.54 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 74' ' ' VAL . 78.1 mt -82.83 -44.27 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.311 0.577 . . . . 54.51 109.773 165.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.248 0.989 0 CA-C-N 115.502 -0.772 . . . . 71.43 110.424 -177.402 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mtp . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.118 -0.327 . . . . 75.42 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.0 126.97 29.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 34.04 110.077 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -157.47 99.01 1.73 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.218 0.533 . . . . 65.04 111.132 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -164.43 112.94 1.12 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.623 -0.717 . . . . 71.22 109.18 173.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -100.31 146.84 26.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.526 . . . . 65.22 110.929 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -140.23 149.51 42.98 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.645 -0.502 . . . . 75.12 109.645 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -146.81 101.5 3.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.876 -0.416 . . . . 65.21 109.876 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 125' ' ' ASN . 19.9 t-160 -109.27 87.81 2.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.945 -0.571 . . . . 74.33 110.772 -175.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -79.15 133.95 36.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.779 -0.452 . . . . 73.11 109.779 175.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.24 86.46 0.22 Allowed Glycine 0 C--N 1.329 0.177 0 N-CA-C 111.697 -0.561 . . . . 70.45 111.697 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 p -82.75 92.25 7.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.996 0.427 . . . . 73.25 111.476 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -131.91 172.64 12.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.339 -0.615 . . . . 74.23 109.339 175.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.42 136.99 52.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.646 0.26 . . . . 75.42 110.635 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.99 161.0 13.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.293 -0.412 . . . . 52.13 110.619 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.648 ' HB2' ' HE3' ' A' ' 65' ' ' LYS . 11.7 mm100 -90.34 143.02 27.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.525 -0.307 . . . . 70.34 110.281 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 p -76.79 -4.68 44.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 70.15 111.422 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.38 90.41 1.29 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.098 -0.501 . . . . 71.4 110.852 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.08 79.47 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 CA-C-N 116.0 -0.545 . . . . 74.21 111.751 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -84.92 7.46 5.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.895 2.396 . . . . 75.33 113.071 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.44 122.98 5.43 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.385 -0.436 . . . . 31.0 112.491 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 p -67.35 143.64 56.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.839 0.352 . . . . 70.35 111.115 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.542 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.1 mmm -137.57 -39.28 0.58 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.249 -0.432 . . . . 71.32 112.002 -175.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.536 HG22 ' HG2' ' A' ' 78' ' ' LYS . 10.8 mm -67.04 130.93 32.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 120.679 0.276 . . . . 62.2 110.771 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 77' ' ' TYR . 2.6 pt-20 -105.39 161.28 14.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.848 -0.427 . . . . 70.14 109.848 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 3.9 pp0? -118.35 147.01 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.457 0.17 . . . . 71.41 110.772 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 pt -139.41 156.38 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.784 0.326 . . . . 73.54 110.823 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.1 179.01 48.31 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.908 -0.587 . . . . 75.43 112.492 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.58 -44.97 96.03 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.957 0.408 . . . . 65.03 111.342 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -65.08 -30.15 71.09 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.295 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -80.96 -20.31 42.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.836 -0.62 . . . . 75.54 111.474 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.1 t80 -57.63 -61.91 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.482 0.182 . . . . 65.25 111.138 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.78 -44.6 96.58 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.071 0.462 . . . . 73.42 110.237 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -53.62 -57.53 10.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.262 -0.881 . . . . 43.22 110.998 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -62.01 -43.64 98.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.223 -0.444 . . . . 63.34 111.162 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.658 HG12 ' HA2' ' A' ' 105' ' ' GLY . 73.9 t -62.67 -36.93 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.34 -0.391 . . . . 74.14 111.524 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -86.43 -29.2 23.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.047 0.388 . . . . 53.41 112.047 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -83.76 11.06 8.03 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.363 0.505 . . . . 74.54 112.363 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.2 p -59.4 143.89 48.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.244 -0.28 . . . . 55.23 110.244 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.4 -74.12 0.06 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.634 0.254 . . . . 72.42 110.715 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -161.74 126.22 3.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.159 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 57.05 12.27 1.21 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.672 0.619 . . . . 72.45 112.672 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 51.1 mm -64.09 117.89 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.519 -0.549 . . . . 70.51 109.519 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.1 112.2 13.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 72.33 110.105 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 38' ' ' CYS . 72.4 mt -98.7 105.64 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.001 -0.545 . . . . 72.45 110.634 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 74' ' ' VAL . 5.1 mp -90.51 116.29 28.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.082 -0.71 . . . . 73.21 109.082 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.72 105.26 18.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.768 -0.456 . . . . 72.45 109.768 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 56.5 t0 -84.28 123.24 29.93 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.854 -0.612 . . . . 62.13 110.381 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 100' ' ' LEU . 76.8 m-85 -102.9 125.3 49.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 65.22 110.592 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -117.35 148.32 41.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.03 -0.532 . . . . 74.34 111.103 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . -109.25 -178.19 0.54 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.093 -0.958 . . . . 54.33 109.245 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 85.6 Cg_exo -46.15 -26.6 3.83 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.515 2.143 . . . . 64.33 112.628 173.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -142.81 178.9 7.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.715 . . . . 73.15 109.648 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.641 ' HA ' HG12 ' A' ' 96' ' ' ILE . 14.1 p -157.8 165.4 35.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.426 -0.213 . . . . 63.3 110.426 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.52 -108.15 1.05 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.217 -0.516 . . . . 43.4 113.374 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' O ' HD23 ' A' ' 59' ' ' LEU . 95.1 Cg_endo -80.65 45.52 2.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.257 2.638 . . . . 54.22 113.514 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 95.9 m -65.33 -22.63 66.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.464 -0.334 . . . . 71.35 111.85 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 57' ' ' ARG . 35.0 ttt180 -54.06 -60.92 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.61 0.243 . . . . 74.44 111.458 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.4 m -75.58 -41.6 54.2 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.408 0.623 . . . . 70.35 111.615 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.552 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -67.84 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.881 0.697 . . . . 64.1 112.881 -169.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 42.5 mt-10 -59.54 -60.48 10.43 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 120.225 -0.59 . . . . 65.12 110.286 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.82 -36.53 96.87 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.615 1.543 . . . . 64.23 112.007 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -60.73 -47.01 88.24 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.805 -0.358 . . . . 75.21 110.86 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 119' ' ' ILE . 91.9 mt -67.4 -41.01 85.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 74.14 110.618 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 31.5 mt-10 -69.5 -24.18 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 65.51 110.712 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.648 ' HE3' ' HB2' ' A' ' 15' ' ' GLN . 17.3 ttmm -68.43 -49.83 57.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.239 -0.282 . . . . 74.54 110.239 171.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.452 HD13 HD12 ' A' ' 123' ' ' ILE . 51.5 mt -62.54 -30.98 71.7 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.685 -0.487 . . . . 74.51 109.685 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.76 -51.55 64.34 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.927 -0.579 . . . . 43.32 109.772 173.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.542 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 35.7 mm-40 -51.97 -48.77 64.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.12 -0.491 . . . . 74.13 111.259 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -76.15 -36.8 58.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.744 -0.662 . . . . 75.41 111.577 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -104.53 3.88 32.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.989 0.737 . . . . 75.22 112.989 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.6 t -53.82 -19.43 4.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.934 0.397 . . . . 63.31 112.019 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.39 -24.18 64.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 74.02 111.168 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -134.48 1.19 3.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.347 -0.388 . . . . 60.25 110.781 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 45' ' ' LEU . 5.2 t -127.32 138.75 53.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.851 0.357 . . . . 74.22 111.381 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -134.57 129.71 35.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.404 -0.961 . . . . 71.33 108.404 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 45' ' ' LEU . 17.1 mt -119.67 115.89 48.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.14 0.495 . . . . 73.14 110.778 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.43 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 87.3 m-85 -106.17 151.64 24.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 62.14 110.871 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.536 ' HG2' HG22 ' A' ' 23' ' ' ILE . 61.0 mmtt -109.43 125.78 52.78 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.331 -0.849 . . . . 62.33 109.742 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -93.98 67.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.989 -1.486 . . . . 75.13 106.989 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.54 89.52 6.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.227 -0.897 . . . . 60.11 110.854 -171.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.5 mt -132.44 112.94 20.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.542 -0.91 . . . . 65.23 108.542 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -18.15 58.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 64.21 110.948 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' H ' HG22 ' A' ' 81' ' ' ILE . 65.3 m-20 -83.68 17.02 2.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.566 -0.288 . . . . 63.52 111.753 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -76.25 52.37 0.75 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.856 0.687 . . . . 73.53 112.856 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -82.73 -61.14 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.765 -0.828 . . . . 73.43 108.765 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.2 m-20 -48.66 -49.18 38.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.988 -1.005 . . . . 63.32 110.985 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.49 -36.85 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 71.01 110.628 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.22 75.39 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.864 -0.421 . . . . 74.24 109.864 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 72.42 110.669 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.4 mm100 -75.03 -48.49 23.75 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.963 -0.562 . . . . 52.44 111.167 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.56 -10.27 52.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 63.04 111.381 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.34 56.11 11.0 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.109 -0.567 . . . . 65.55 111.887 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.4 t -77.25 109.37 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 75.31 110.468 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.447 ' HB2' HG21 ' A' ' 112' ' ' ILE . 12.1 m -63.27 -54.08 42.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.277 -0.419 . . . . 63.12 111.186 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.31 138.92 18.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 52.44 110.488 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.835 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.31 147.43 33.11 Favored Pre-proline 0 C--O 1.236 0.377 0 O-C-N 123.364 0.415 . . . . 75.51 110.504 -178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.479 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.3 Cg_exo -70.57 166.03 77.31 Favored 'Cis proline' 0 C--N 1.357 1.021 0 C-N-CA 124.24 -1.15 . . . . 64.14 113.12 3.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.546 HG23 HG12 ' A' ' 112' ' ' ILE . 88.6 m -145.8 130.75 18.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.642 . . . . 74.0 109.839 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.463 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 42.8 mm -109.8 110.79 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 62.41 111.193 -173.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' A' ' 48' ' ' PHE . 8.4 mp -101.13 123.41 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.501 -0.555 . . . . 72.51 109.501 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.539 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 22.2 mtt -92.26 145.6 24.36 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.138 -0.319 . . . . 65.12 110.138 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.4 m-85 -142.12 152.56 43.37 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.747 -0.464 . . . . 73.14 109.747 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -145.24 114.88 7.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.444 0.164 . . . . 74.24 110.814 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.517 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 32.0 t-20 57.4 41.04 26.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.371 0.605 . . . . 72.22 110.396 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.658 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 71.04 2.81 49.35 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 115.942 -0.572 . . . . 43.11 112.843 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -101.19 147.3 26.42 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 120.732 0.301 . . . . 63.04 110.797 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -56.62 129.57 41.55 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.638 1.212 . . . . 71.43 112.161 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -136.61 167.95 20.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.138 -1.392 . . . . 61.41 108.287 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.21 172.01 8.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.823 0.675 . . . . 72.41 112.823 -163.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -138.34 138.19 38.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.65 -0.704 . . . . 74.54 110.558 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.0 m -126.47 139.92 50.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.197 -0.456 . . . . 70.11 109.876 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.546 HG12 HG23 ' A' ' 98' ' ' THR . 38.7 mt -127.16 142.99 41.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.946 -0.57 . . . . 62.14 109.88 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.27 -152.16 21.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.036 -0.602 . . . . 60.32 112.417 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -125.98 93.18 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 33.13 111.741 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.5 t70 -145.03 91.21 2.12 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 64.24 108.655 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 tp -64.54 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.614 -0.721 . . . . 62.15 110.752 -171.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -66.93 -45.35 78.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.076 -0.511 . . . . 72.2 110.082 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' HD3' ' HG2' ' A' ' 122' ' ' GLU . 14.9 tppt? -69.19 -39.82 78.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 55.14 110.277 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 63' ' ' LEU . 78.1 mt -58.66 -56.08 18.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.383 -0.371 . . . . 62.22 110.509 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.4 -37.37 77.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.726 -0.472 . . . . 72.14 109.726 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.496 ' HA ' HD21 ' A' ' 124' ' ' ASN . 37.5 t -54.04 -52.01 62.21 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.102 -0.499 . . . . 43.12 110.491 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -72.17 -28.33 63.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 73.04 110.917 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 120' ' ' ILE . 97.6 mt -59.49 -56.21 18.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 120.634 -0.427 . . . . 73.41 110.143 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.496 HD21 ' HA ' ' A' ' 121' ' ' SER . 9.1 p30 -71.19 -25.37 62.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.727 0.298 . . . . 70.22 110.325 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 8' ' ' HIS . 30.4 t30 -62.31 -48.21 80.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.618 -0.719 . . . . 72.2 110.598 175.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.539 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.3 m-20 -80.88 -26.81 36.61 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.526 -0.761 . . . . 71.2 111.671 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 74' ' ' VAL . 71.1 mt -74.86 -49.84 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.689 0.28 . . . . 54.51 110.814 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.578 -0.725 . . . . 71.43 110.673 -174.368 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.999 -0.371 . . . . 75.42 109.999 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.93 88.0 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.182 0.515 . . . . 34.04 112.081 -174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -118.42 26.03 9.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.101 -1.074 . . . . 65.04 108.101 169.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -82.59 112.09 19.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.436 -1.257 . . . . 71.22 111.106 -171.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -144.14 151.51 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 65.22 109.65 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -111.14 138.95 46.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 75.12 110.347 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -127.45 11.45 6.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 65.21 110.543 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -73.0 73.12 1.16 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.207 -0.664 . . . . 74.33 109.207 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.4 ttm -110.35 84.72 1.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.271 -0.877 . . . . 73.11 109.484 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.0 -175.07 44.67 Favored Glycine 0 C--O 1.238 0.376 0 CA-C-N 115.925 -0.58 . . . . 70.45 111.658 -175.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 p -78.47 87.17 4.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.086 0.469 . . . . 73.25 110.869 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 12' ' ' LEU . 2.5 pt? -79.1 5.81 11.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.855 -0.611 . . . . 74.23 111.265 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -124.69 115.78 21.31 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.322 -0.399 . . . . 75.42 110.413 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.91 139.46 0.29 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.3 -0.409 . . . . 52.13 111.034 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -137.06 152.57 50.21 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.408 -0.589 . . . . 70.34 109.408 173.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 p -129.36 170.76 13.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.62 -0.264 . . . . 70.15 110.811 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -86.47 18.27 3.37 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.313 0.578 . . . . 71.4 110.637 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.04 -61.14 3.58 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.594 -1.002 . . . . 74.21 110.594 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.18 -149.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.619 2.212 . . . . 75.33 110.678 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -168.14 104.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.37 -0.919 . . . . 31.0 112.739 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.4 t -68.15 141.64 55.97 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.097 -0.705 . . . . 70.35 109.097 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.9 mmm -110.84 6.58 21.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 71.32 111.058 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -91.03 100.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.023 -0.732 . . . . 62.2 109.023 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 28.9 tt0 -94.06 112.26 24.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 70.14 110.641 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -72.36 132.0 43.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 71.41 110.089 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.513 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.2 pt -130.85 152.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 73.54 110.208 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.69 165.31 45.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.131 -0.557 . . . . 75.43 112.421 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -50.87 -39.05 52.86 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.843 0.457 . . . . 65.03 111.465 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -71.15 -36.84 72.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 74.42 110.546 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.44 -13.59 60.4 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 115.837 -0.62 . . . . 75.54 111.265 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 35' ' ' VAL . 75.8 t80 -56.36 -62.15 1.92 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.594 0.235 . . . . 65.25 110.714 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.79 -47.49 80.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 73.42 110.484 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.13 -57.57 10.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.619 -0.719 . . . . 43.22 111.094 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.6 mmtt -64.95 -36.98 86.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 63.34 111.236 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 31' ' ' PHE . 74.7 t -64.07 -41.72 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.96 0.41 . . . . 74.14 110.735 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.2 p -86.24 -9.96 55.52 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.31 -0.405 . . . . 53.41 111.702 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.3 t -74.42 -2.96 27.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.281 0.233 . . . . 74.54 111.556 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.612 ' SG ' HD11 ' A' ' 44' ' ' ILE . 59.3 m -70.05 134.21 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.612 -0.267 . . . . 55.23 111.157 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -65.97 -78.03 0.06 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.833 -0.803 . . . . 72.42 108.833 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -162.49 156.43 21.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.316 -0.624 . . . . 63.42 109.316 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.659 ' HA ' ' HE2' ' A' ' 103' ' ' LYS . 53.2 m-20 62.06 13.08 5.42 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.1 0.56 . . . . 72.45 111.915 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 49.6 mm -86.85 106.65 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.897 -0.409 . . . . 70.51 109.897 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.51 109.13 16.45 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.804 -0.635 . . . . 72.33 109.437 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.612 HD11 ' SG ' ' A' ' 38' ' ' CYS . 46.3 mt -92.0 121.93 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.576 . . . . 72.45 110.836 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.564 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.7 mp -103.66 110.92 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.226 -0.657 . . . . 73.21 109.226 173.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.95 107.21 19.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.067 -0.345 . . . . 72.45 110.067 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.29 96.49 1.43 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.993 -0.743 . . . . 62.13 108.993 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 35.7 t80 -60.84 99.35 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.175 -0.92 . . . . 65.22 111.579 -172.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.454 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 59.05 -82.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.632 -0.713 . . . . 74.34 111.863 173.05 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 51' ' ' PRO . . . 53.69 48.3 4.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.185 0.594 . . . . 54.33 111.856 -175.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 50' ' ' ALA . 2.8 Cg_exo -75.29 -19.88 16.83 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.541 2.16 . . . . 64.33 112.345 -173.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -75.3 -38.58 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 73.15 110.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 8.3 t 54.95 82.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.441 -0.799 . . . . 63.3 111.084 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.93 -78.81 1.12 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.582 -0.607 . . . . 43.4 111.582 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.471 ' O ' HD23 ' A' ' 59' ' ' LEU . 6.0 Cg_exo -76.51 11.77 1.79 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.212 2.608 . . . . 54.22 111.81 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 5.6 p -63.73 -23.6 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.598 -0.728 . . . . 71.35 111.325 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -54.43 -52.48 61.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.492 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.553 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.9 m -75.29 -48.14 24.62 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.87 0.843 . . . . 70.35 111.806 178.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.1 mm? -68.09 -28.1 67.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 64.1 112.516 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.2 tt0 -58.56 -59.88 12.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.98 -0.378 . . . . 65.12 109.98 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 37.1 Cg_endo -66.04 -37.1 27.25 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.67 1.58 . . . . 64.23 112.107 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.87 -45.32 86.49 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.273 -0.571 . . . . 75.21 110.823 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 119' ' ' ILE . 84.8 mt -66.04 -41.18 91.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.416 -0.356 . . . . 74.14 110.678 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 51.9 mt-10 -57.41 -41.42 80.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.727 0.299 . . . . 65.51 110.344 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.04 -56.07 22.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.304 -0.407 . . . . 74.54 111.264 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.55 -34.71 71.32 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 74.51 109.902 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.11 -49.15 71.05 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.509 -0.769 . . . . 43.32 110.571 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.8 mt-30 -62.27 -41.56 98.58 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.004 0.43 . . . . 74.13 110.725 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -68.25 -38.49 81.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 75.41 110.937 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -104.49 4.18 32.84 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.347 0.499 . . . . 75.22 112.347 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.4 t -54.03 -19.66 5.17 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.785 0.661 . . . . 63.31 112.785 -172.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -61.3 -36.64 80.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.043 0.449 . . . . 74.02 110.094 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -120.57 -4.49 9.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.877 -0.601 . . . . 60.25 111.281 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.472 HG13 HD13 ' A' ' 45' ' ' LEU . 43.8 t -123.02 148.15 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.016 0.436 . . . . 74.22 111.569 -174.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.2 tptm -149.44 133.15 16.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.773 -0.649 . . . . 71.33 109.41 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 45' ' ' LEU . 52.6 mt -108.99 135.76 46.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.888 0.375 . . . . 73.14 111.082 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 49.3 m-85 -130.77 168.04 17.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.734 -0.666 . . . . 62.14 110.176 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB2' ' HZ2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -174.18 153.46 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 62.33 109.997 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tp -121.02 119.68 60.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.51 -0.922 . . . . 75.13 108.51 170.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -94.96 44.31 1.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.23 -0.441 . . . . 60.11 111.689 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.0 pt -71.05 78.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 122.105 0.955 . . . . 65.23 109.409 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -47.48 -44.69 25.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 113.9 -1.5 . . . . 64.21 114.092 -167.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.726 0.298 . . . . 63.52 111.393 -173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.41 51.61 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 73.53 110.136 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -85.53 3.17 41.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.97 -0.559 . . . . 73.43 111.986 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.49 -39.0 64.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.19 0.519 . . . . 63.32 110.055 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.03 -34.45 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.195 -0.912 . . . . 71.01 110.495 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HB2' ' HE2' ' A' ' 48' ' ' PHE . . . -64.46 -52.08 59.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.212 -0.449 . . . . 74.24 110.301 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.8 m -62.25 -32.72 73.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 72.42 111.034 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -53.89 16.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.466 -0.334 . . . . 52.44 111.346 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -79.51 -10.24 59.76 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.507 -0.315 . . . . 63.04 111.732 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.23 43.01 5.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.926 -0.654 . . . . 65.55 113.558 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.98 135.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.52 -0.548 . . . . 75.31 109.52 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.8 m -133.04 1.42 3.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.057 0.391 . . . . 63.12 112.057 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.98 156.57 47.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.016 0.436 . . . . 52.44 111.635 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 pt -125.98 122.02 24.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.749 -0.659 . . . . 75.51 110.074 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.31 -172.62 9.13 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.737 -1.36 . . . . 64.14 112.647 -0.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.51 HG23 HD13 ' A' ' 112' ' ' ILE . 47.2 m -145.06 128.29 16.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.501 -0.772 . . . . 74.0 109.177 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 47.6 mm -110.13 116.08 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.578 0.228 . . . . 62.41 111.018 -174.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.3 mt -99.02 123.48 43.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.312 -0.625 . . . . 72.51 109.312 174.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.3 mtt -97.96 144.38 27.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.203 -0.295 . . . . 65.12 110.203 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.43 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -143.6 144.83 32.09 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.003 -0.369 . . . . 73.14 110.003 175.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 41' ' ' ASN . 52.9 tttm -131.82 105.2 7.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.092 -0.243 . . . . 74.24 110.57 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 59.1 t30 58.9 30.67 20.46 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.717 0.77 . . . . 72.22 110.199 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.74 -16.37 54.62 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.614 -0.721 . . . . 43.11 112.517 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 2.4 tmmm? -76.1 140.19 41.71 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 109.608 -0.515 . . . . 63.04 109.608 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 106' ' ' LYS . 2.3 tmtp? -57.68 139.09 54.6 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.196 0.935 . . . . 71.43 110.742 -176.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -146.51 168.36 21.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.967 -1.015 . . . . 61.41 108.636 -171.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 m -70.32 175.45 4.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.601 0.963 . . . . 72.41 113.601 -161.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -141.01 142.03 34.28 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.956 -1.02 . . . . 74.54 110.769 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 15.3 t -123.55 114.56 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.995 -1.457 . . . . 70.11 109.946 -174.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.51 HD13 HG23 ' A' ' 98' ' ' THR . 46.2 mm -106.71 121.1 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.763 -0.653 . . . . 62.14 109.972 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.03 163.96 33.69 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.433 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.513 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -85.6 79.99 9.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.288 . . . . 33.13 111.021 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.7 t70 -124.52 91.9 3.54 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.398 -0.593 . . . . 64.24 109.398 175.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.57 -31.94 52.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.883 -0.599 . . . . 62.15 111.205 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.6 t -62.7 -44.08 97.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.16 -0.473 . . . . 72.2 109.978 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -70.52 -37.47 74.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 55.14 109.952 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.506 HG12 HG11 ' A' ' 111' ' ' VAL . 72.8 mt -56.74 -56.27 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.257 -0.429 . . . . 62.22 110.674 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.523 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.54 -37.91 81.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 110.22 -0.289 . . . . 72.14 110.22 -177.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -56.99 -51.97 67.13 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.937 -0.394 . . . . 43.12 109.937 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.49 -41.83 97.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.121 -0.49 . . . . 73.04 110.755 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.1 mt -53.06 -56.18 9.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.625 0.25 . . . . 73.41 110.412 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -71.57 -35.46 70.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.718 -0.393 . . . . 70.22 110.727 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -63.97 -35.18 79.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 72.2 111.208 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.421 ' HB3' HD11 ' A' ' 108' ' ' LEU . 84.8 m-20 -91.21 -31.15 16.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 71.2 111.707 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 123' ' ' ILE . 71.9 mt -58.55 -53.26 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 54.51 110.599 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 . . . . . 0 C--O 1.25 1.11 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.358 -175.556 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.937 -0.394 . . . . 75.42 109.937 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.81 149.61 20.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.347 -0.388 . . . . 34.04 110.613 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -157.11 132.07 8.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.997 -0.742 . . . . 65.04 108.997 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -129.76 147.33 51.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.033 0.444 . . . . 71.22 111.53 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -106.97 171.46 7.36 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.499 -0.926 . . . . 65.22 108.499 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.434 ' HB3' ' NE2' ' A' ' 85' ' ' GLN . 28.6 t-80 -148.03 89.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.307 0.575 . . . . 75.12 110.869 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -70.86 125.57 27.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.596 -0.729 . . . . 65.21 109.358 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.82 174.21 11.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.8 -0.182 . . . . 74.33 110.966 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.0 tpt -156.1 101.02 2.06 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.579 0.55 . . . . 73.11 110.031 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.78 9.78 14.26 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 116.069 -0.514 . . . . 70.45 112.409 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.518 ' HA ' ' NE1' ' A' ' 49' ' ' TRP . 73.7 m -70.41 80.34 0.55 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.391 0.615 . . . . 73.25 111.584 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.434 HD12 ' HZ2' ' A' ' 49' ' ' TRP . 1.0 OUTLIER -90.34 57.55 3.73 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.718 -0.845 . . . . 74.23 108.718 170.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -48.33 133.96 15.33 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.44 -1.254 . . . . 75.42 112.252 -173.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.33 160.32 24.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.46 -0.791 . . . . 52.13 110.034 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -132.05 160.22 36.55 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.796 -0.446 . . . . 70.34 109.796 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -117.42 95.39 4.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.933 0.397 . . . . 70.15 110.058 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -50.82 126.4 15.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.376 -0.829 . . . . 71.4 110.956 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.7 -164.77 12.08 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.777 -0.647 . . . . 74.21 111.616 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.48 32.75 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.853 2.369 . . . . 75.33 112.503 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.09 -46.31 3.12 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.245 -0.502 . . . . 31.0 111.934 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.7 m -66.61 79.38 0.11 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.184 0.516 . . . . 70.35 111.319 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.533 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.7 mmm -87.48 -16.03 35.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.714 -0.676 . . . . 71.32 109.832 175.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -78.92 133.69 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.404 -0.816 . . . . 62.2 110.3 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -94.18 155.36 17.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 70.14 110.111 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -119.0 139.45 51.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.028 -0.73 . . . . 71.41 109.028 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 31' ' ' PHE . 32.6 pt -141.75 159.72 21.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.031 0.444 . . . . 73.54 111.558 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.72 -168.52 33.78 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.475 -0.784 . . . . 75.43 112.203 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.12 -48.87 72.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.657 0.383 . . . . 65.03 111.451 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 t -72.0 -40.83 68.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.42 110.371 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.31 -23.92 64.58 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.267 -0.424 . . . . 75.54 111.08 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.5 t80 -49.97 -58.2 5.95 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.851 0.357 . . . . 65.25 110.288 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -56.4 -57.52 11.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.89 -0.596 . . . . 73.42 110.599 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.87 -50.44 63.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.719 -0.673 . . . . 43.22 111.453 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.3 mmtt -68.32 -41.82 80.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 63.34 111.561 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 44' ' ' ILE . 76.1 t -70.46 -36.26 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 111.791 0.293 . . . . 74.14 111.791 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.3 p -85.96 -37.32 19.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.833 0.309 . . . . 53.41 111.833 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.5 t -83.82 10.83 8.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.033 0.383 . . . . 74.54 112.033 -173.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.812 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 19.9 p -59.99 146.99 40.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 110.32 -0.252 . . . . 55.23 110.32 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -45.98 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.406 0.682 . . . . 72.42 111.996 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.75 122.62 3.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.419 -0.215 . . . . 63.42 110.419 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.56 7.25 2.34 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.787 0.435 . . . . 72.45 112.024 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.26 137.46 22.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.872 0.367 . . . . 70.51 111.247 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -81.12 123.61 28.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.534 -0.913 . . . . 72.33 108.534 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 82.1 mt -115.44 121.57 67.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.266 -0.425 . . . . 72.45 110.207 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -109.86 113.08 25.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.111 -0.7 . . . . 73.21 109.111 175.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.25 105.0 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.946 -0.39 . . . . 72.45 109.946 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.92 127.89 32.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.81 -0.632 . . . . 62.13 110.692 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -94.59 125.82 39.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.528 -0.916 . . . . 65.22 108.528 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.518 ' NE1' ' HA ' ' A' ' 11' ' ' THR . 74.4 t-105 -53.49 139.8 30.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.17 0.509 . . . . 74.34 111.622 -174.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -95.33 108.49 39.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.446 -0.797 . . . . 54.33 111.102 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 21.0 Cg_endo -60.74 -32.27 92.82 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.402 2.068 . . . . 64.33 111.061 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -101.16 93.08 5.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.485 -0.931 . . . . 73.15 108.485 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.468 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 10.4 t -91.82 89.23 6.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 63.3 110.32 -174.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.49 -86.25 1.62 Allowed Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.735 -0.666 . . . . 43.4 111.449 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.72 -11.92 16.22 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.139 2.559 . . . . 54.22 112.153 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 15.4 p -50.62 -43.59 56.93 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.534 -0.757 . . . . 71.35 110.948 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -54.89 -41.02 70.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.513 -0.767 . . . . 74.44 111.524 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.3 m -75.88 -53.39 8.51 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.991 0.9 . . . . 70.35 111.701 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -61.28 -44.42 97.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.853 -1.067 . . . . 64.1 111.914 -168.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.3 -52.63 73.07 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 119.516 -0.278 . . . . 65.12 111.336 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 58' ' ' SER . 17.7 Cg_endo -61.67 -31.66 86.58 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.512 1.475 . . . . 64.23 112.137 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.1 mt-30 -62.88 -35.98 81.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.185 -0.606 . . . . 75.21 109.75 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.79 -39.08 76.8 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.792 -0.64 . . . . 74.14 109.937 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 mt-10 -53.69 -47.74 70.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.801 -0.444 . . . . 65.51 109.801 175.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -58.79 -52.45 65.65 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.942 -0.572 . . . . 74.54 111.251 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 116' ' ' ILE . 48.9 mt -62.26 -34.89 77.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.912 0.387 . . . . 74.51 110.093 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.07 -43.41 95.55 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.946 -0.57 . . . . 43.32 109.99 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 51.3 mt-30 -64.86 -46.49 81.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.05 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -72.87 -34.41 66.71 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.996 0.427 . . . . 75.41 111.21 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -104.7 4.04 32.09 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.328 0.492 . . . . 75.22 112.328 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -53.32 -19.55 3.43 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.957 0.408 . . . . 63.31 111.536 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.63 -38.08 69.04 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.981 -0.554 . . . . 74.02 110.836 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -135.21 12.08 3.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.075 -0.511 . . . . 60.25 111.331 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.55 139.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.064 0.459 . . . . 74.22 111.617 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -143.63 119.93 10.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.419 -0.81 . . . . 71.33 109.187 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 45' ' ' LEU . 40.5 mt -104.8 137.25 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.715 0.293 . . . . 73.14 110.706 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.45 151.15 40.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.935 -0.575 . . . . 62.14 109.895 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -120.8 102.74 8.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.624 -0.88 . . . . 62.33 108.624 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.7 tt -80.47 102.2 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.613 0.72 . . . . 75.13 110.134 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.82 75.46 10.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 60.11 111.172 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.403 HD11 HG11 ' A' ' 87' ' ' VAL . 29.5 pt -124.03 24.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.011 -0.737 . . . . 65.23 109.011 171.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -58.02 -18.64 25.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.552 -1.204 . . . . 64.21 111.561 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.16 -23.23 62.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.317 0.58 . . . . 63.52 109.661 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.35 95.25 7.94 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.508 -0.923 . . . . 73.53 108.508 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' NE2' ' HB3' ' A' ' 6' ' ' HIS . 25.6 tt0 -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.211 -0.45 . . . . 73.43 111.667 -172.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 14.5 m-20 -56.61 -32.96 65.79 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.471 -0.331 . . . . 63.32 111.286 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 81' ' ' ILE . 75.0 t -53.06 -38.63 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.467 -0.333 . . . . 71.01 110.537 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.7 -48.81 75.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.17 0.509 . . . . 74.24 109.827 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -59.34 -36.99 76.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.486 -0.779 . . . . 72.42 110.726 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 11.6 mm-40 -71.7 -51.27 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.006 -0.543 . . . . 52.44 110.492 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -73.98 -13.32 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.221 -0.445 . . . . 63.04 111.548 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.8 21.44 36.57 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.904 -0.665 . . . . 65.55 112.777 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.478 HG13 ' OG1' ' A' ' 98' ' ' THR . 64.5 t -70.42 117.28 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.156 -0.312 . . . . 75.31 110.156 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 t -136.45 8.03 3.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 63.12 110.985 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.597 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -147.18 164.06 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.794 -0.447 . . . . 52.44 109.794 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.618 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -122.51 122.0 27.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.439 -0.346 . . . . 75.51 111.207 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 66.5 Cg_endo -87.06 -166.78 3.92 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.825 -1.323 . . . . 64.14 112.022 -3.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 112' ' ' ILE . 81.5 m -138.92 120.35 14.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.535 -0.302 . . . . 74.0 110.202 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 111' ' ' VAL . 47.5 mm -110.35 117.34 54.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.86 -0.609 . . . . 62.41 110.881 -174.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -100.59 123.22 44.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.535 -0.543 . . . . 72.51 109.535 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 109' ' ' SER . 11.6 mmt -87.65 148.08 24.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.686 0.279 . . . . 65.12 110.42 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.6 m-85 -145.45 160.99 40.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.956 -0.757 . . . . 73.14 108.956 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -148.79 109.46 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.621 0.248 . . . . 74.24 110.88 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.812 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER 59.9 31.84 20.91 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.746 -0.661 . . . . 72.22 110.352 177.154 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.494 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 87.52 -14.43 58.06 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.918 -0.583 . . . . 43.11 112.411 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -81.76 139.56 34.76 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 110.301 -0.259 . . . . 63.04 110.301 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -58.88 149.6 26.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.812 -0.631 . . . . 71.43 111.511 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -154.39 168.01 28.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.127 0.971 . . . . 61.41 108.845 -170.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 101' ' ' MET . 3.1 m -70.35 148.17 48.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.571 0.7 . . . . 72.41 112.875 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -110.14 118.52 36.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 74.54 110.204 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.647 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.5 m -101.62 116.0 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 70.11 109.527 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.597 HG22 ' HB3' ' A' ' 95' ' ' ALA . 47.4 mt -107.59 120.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 62.14 110.577 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.11 160.84 12.44 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.246 -0.502 . . . . 60.32 112.238 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.76 83.42 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 33.13 111.017 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.5 t70 -133.75 92.22 2.94 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.344 -0.613 . . . . 64.24 109.344 174.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.536 HD11 HD11 ' A' ' 66' ' ' LEU . 8.8 tp -62.3 -32.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 62.15 111.413 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -65.29 -43.62 90.54 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.151 0.501 . . . . 72.2 110.065 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 14.8 tppt? -68.38 -43.13 78.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.935 -0.575 . . . . 55.14 110.19 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 59' ' ' LEU . 70.8 mt -57.25 -51.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.709 -0.223 . . . . 62.22 110.676 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.522 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.02 -35.63 75.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.957 -0.386 . . . . 72.14 109.957 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.5 t -54.11 -51.23 64.86 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.147 0.498 . . . . 43.12 110.094 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 12.7 mm-40 -71.09 -31.84 68.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 73.04 110.766 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 120' ' ' ILE . 88.7 mt -58.15 -56.26 17.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.902 0.382 . . . . 73.41 110.037 176.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -65.8 -36.58 83.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.76 -0.459 . . . . 70.22 109.76 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -58.71 -41.57 86.65 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.097 -0.501 . . . . 72.2 110.966 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.403 ' HB2' HD11 ' A' ' 43' ' ' LEU . 81.5 m-20 -87.2 -12.75 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 71.2 111.371 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 123' ' ' ILE . 74.3 mt -80.88 -48.36 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.032 -0.359 . . . . 54.51 110.032 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.464 -0.779 . . . . 71.43 110.739 -179.119 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.944 0.402 . . . . 75.42 110.622 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.63 110.54 22.94 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.1 -0.5 . . . . 34.04 110.274 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -140.23 121.16 14.56 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.898 0.38 . . . . 65.04 110.561 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 68.23 74.38 0.28 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.144 -0.934 . . . . 71.22 111.959 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -131.48 94.99 3.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.324 -0.991 . . . . 65.22 108.324 171.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -61.44 105.72 0.55 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.092 -0.504 . . . . 75.12 112.217 -171.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -92.07 88.81 6.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.4 -0.592 . . . . 65.21 109.4 172.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -158.17 107.73 2.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.616 . . . . 74.33 110.742 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.458 ' C ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -105.54 165.88 10.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.216 -0.661 . . . . 73.11 109.216 172.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.69 115.75 1.13 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.112 -0.566 . . . . 70.45 112.079 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.9 p -96.05 9.35 41.08 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.071 0.463 . . . . 73.25 111.121 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 12' ' ' LEU . 2.5 pt? -82.91 27.65 0.53 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.244 0.545 . . . . 74.23 110.794 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -64.96 -21.14 66.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.82 -0.627 . . . . 75.42 111.593 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.02 134.76 54.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.376 . . . . 52.13 111.204 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 7.7 tp60 -98.24 -2.5 39.51 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.124 -0.695 . . . . 70.34 109.124 173.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.1 m -60.49 102.58 0.19 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.23 -0.896 . . . . 70.15 111.478 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -120.79 173.58 7.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.075 -0.511 . . . . 71.4 109.902 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.92 -163.47 33.99 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.299 -0.477 . . . . 74.21 112.482 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.72 19.5 1.2 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.95 2.433 . . . . 75.33 112.782 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.36 9.83 84.4 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.096 -0.573 . . . . 31.0 112.304 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.4 t -149.34 156.76 42.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.008 -0.367 . . . . 70.35 110.008 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.436 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 92.5 mmm -73.66 -20.63 60.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.26 -0.427 . . . . 71.32 110.725 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' A' ' 78' ' ' LYS . 18.3 mm -78.13 87.98 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.744 -0.835 . . . . 62.2 108.744 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.06 112.12 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.635 -0.711 . . . . 70.14 111.341 -171.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -72.83 132.36 43.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.692 -0.485 . . . . 71.41 109.692 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.53 HG21 ' HG3' ' A' ' 34' ' ' LYS . 39.0 pt -133.12 160.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.794 0.33 . . . . 73.54 110.952 -176.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.22 -177.36 40.45 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.921 -0.581 . . . . 75.43 112.95 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.01 -43.24 99.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.96 0.504 . . . . 65.03 111.622 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -74.09 -37.17 64.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.074 0.464 . . . . 74.42 110.67 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.85 -26.74 68.75 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.783 -0.644 . . . . 75.54 110.762 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.456 ' HD2' HG21 ' A' ' 79' ' ' ILE . 88.8 t80 -46.14 -61.66 1.67 Allowed 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.33 0.394 . . . . 65.25 111.122 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -50.31 69.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.914 -0.585 . . . . 73.42 110.891 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.75 -57.39 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.74 . . . . 43.22 110.75 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.4 mmtt -58.01 -44.19 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.12 -0.945 . . . . 63.34 111.181 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.04 -48.13 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.714 0.292 . . . . 74.14 111.313 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.4 p -77.43 -15.28 59.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.701 0.286 . . . . 53.41 111.595 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 t -69.55 -5.38 23.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.322 -0.399 . . . . 74.54 111.983 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 13.4 p -62.41 108.63 1.15 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.621 0.248 . . . . 55.23 110.501 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -58.43 -73.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.185 -0.462 . . . . 72.42 111.625 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -153.97 121.89 6.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.7 0.286 . . . . 63.42 110.913 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 61.3 8.3 2.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.6 0.76 . . . . 72.45 111.968 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -73.89 113.85 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.245 -0.434 . . . . 70.51 110.123 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -82.21 119.26 23.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.103 -0.499 . . . . 72.33 109.656 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.45 119.98 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.596 -0.729 . . . . 72.45 110.483 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -103.95 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.052 -0.721 . . . . 73.21 109.052 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 98.3 t -115.71 109.57 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.07 -0.344 . . . . 72.45 110.07 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.3 t70 -87.0 127.86 35.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 62.13 111.949 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -101.46 87.31 3.16 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.393 -0.595 . . . . 65.22 109.393 170.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.37 119.84 11.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.408 -0.815 . . . . 74.34 110.508 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 144.4 29.61 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.446 . . . . 54.33 110.397 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.51 -34.38 85.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.701 2.267 . . . . 64.33 112.523 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -119.76 119.16 32.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 73.15 110.087 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' ' HB ' ' A' ' 96' ' ' ILE . 47.9 t -163.88 140.79 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.3 110.567 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.03 -72.14 1.21 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.216 -0.447 . . . . 43.4 112.652 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.35 -22.36 20.5 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.056 2.504 . . . . 54.22 113.29 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 98.3 m -54.17 -24.91 19.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.57 -0.286 . . . . 71.35 111.375 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -53.95 -49.95 67.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.38 0.61 . . . . 74.44 110.165 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 12.6 m -75.0 -40.72 60.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.399 -0.819 . . . . 70.35 111.079 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.4 mm? -62.42 -41.6 98.82 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.774 0.657 . . . . 64.1 112.774 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -55.43 -54.64 48.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 117.873 0.306 . . . . 65.12 111.272 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HG2' ' O ' ' A' ' 58' ' ' SER . 21.1 Cg_endo -63.15 -35.73 62.36 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.524 1.483 . . . . 64.23 112.005 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.9 mt-30 -64.01 -31.12 72.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.643 -0.423 . . . . 75.21 110.584 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 76.0 mt -70.0 -42.02 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 74.14 109.982 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -63.53 -34.02 76.87 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 120.866 -0.334 . . . . 65.51 110.337 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 36.7 ttmt -55.6 -57.18 13.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.784 0.326 . . . . 74.54 110.298 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD12 ' A' ' 123' ' ' ILE . 33.0 mt -66.61 -38.42 86.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 74.51 110.367 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.32 -45.86 90.17 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.733 -0.667 . . . . 43.32 110.515 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.436 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 16.8 mm-40 -69.85 -46.08 66.34 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.393 -0.367 . . . . 74.13 110.956 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -57.75 -41.95 82.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.856 -0.611 . . . . 75.41 110.953 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -104.66 4.3 32.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.687 -0.688 . . . . 75.22 112.235 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.1 t -53.16 -21.69 5.38 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.612 0.967 . . . . 63.31 113.612 -170.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -73.53 -18.7 61.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.797 0.332 . . . . 74.02 110.925 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.1 5.05 3.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.262 -0.426 . . . . 60.25 110.896 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 43' ' ' LEU . 43.5 t -139.34 145.26 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.913 0.387 . . . . 74.22 111.33 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -148.69 128.29 13.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 71.33 109.541 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.569 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.0 mt -106.56 128.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 120.852 0.358 . . . . 73.14 110.479 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -110.63 168.22 9.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.836 -0.62 . . . . 62.14 109.934 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 23' ' ' ILE . 22.6 ttmm -135.05 99.27 4.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.219 -0.66 . . . . 62.33 109.219 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -119.31 97.04 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.861 0.838 . . . . 75.13 108.942 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -150.49 94.9 2.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.193 -0.912 . . . . 60.11 110.089 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.7 mp -72.98 109.93 5.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.595 -0.891 . . . . 65.23 108.595 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.89 -31.09 68.28 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.059 0.457 . . . . 64.21 110.464 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.69 -19.08 49.83 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.946 -0.57 . . . . 63.52 111.608 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' H ' HG22 ' A' ' 81' ' ' ILE . 32.8 t30 -119.7 79.84 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.4 0.619 . . . . 73.53 110.132 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.78 -21.84 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.444 -0.798 . . . . 73.43 111.06 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 26.2 t70 -45.77 -47.62 15.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.011 -0.54 . . . . 63.32 111.809 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.66 -42.02 49.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.314 -0.403 . . . . 71.01 110.988 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.84 -45.02 87.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 74.24 110.551 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -68.39 -29.86 68.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 72.42 110.587 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.1 mm100 -70.49 -46.47 63.67 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.356 -0.384 . . . . 52.44 111.089 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -79.91 -17.19 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 63.04 111.092 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.06 64.46 0.95 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.772 -0.728 . . . . 65.55 113.091 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.427 HG13 ' OG1' ' A' ' 98' ' ' THR . 91.5 t -97.04 133.15 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.399 -0.593 . . . . 75.31 109.399 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.2 m -138.71 -64.68 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.472 -0.331 . . . . 63.12 110.833 -175.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -85.49 170.57 12.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.343 -0.39 . . . . 52.44 110.488 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -110.97 118.63 47.76 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.08 -0.509 . . . . 75.51 111.718 -175.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -92.62 -160.25 0.99 Allowed 'Cis proline' 0 C--N 1.352 0.738 0 C-N-CA 123.957 -1.268 . . . . 64.14 111.3 -6.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 112' ' ' ILE . 87.9 m -137.27 129.33 29.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.145 -0.317 . . . . 74.0 110.145 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.97 120.34 62.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.944 -0.571 . . . . 62.41 110.729 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 27.3 mt -88.23 146.55 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.208 -0.664 . . . . 72.51 109.208 172.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.537 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 14.6 mmt -112.37 143.24 43.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.54 -0.541 . . . . 65.12 109.54 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 89.2 m-85 -144.36 151.2 38.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.044 -0.724 . . . . 73.14 109.044 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.79 125.17 5.7 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.363 -0.535 . . . . 74.24 111.086 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 60.94 29.26 18.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.308 0.575 . . . . 72.22 110.836 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 38' ' ' CYS . . . 71.32 11.59 71.61 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.833 -0.621 . . . . 43.11 112.023 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -98.69 144.95 27.39 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.157 -0.682 . . . . 63.04 109.157 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -74.1 118.61 17.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.716 0.769 . . . . 71.43 109.768 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 3.5 mm? -113.57 169.59 8.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.19 -1.368 . . . . 61.41 110.204 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 101' ' ' MET . 8.0 m -69.49 -177.39 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.487 0.715 . . . . 72.41 112.432 -163.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 51.1 tt0 -141.63 136.27 30.81 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.301 1.048 . . . . 74.54 111.366 -172.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.86 107.27 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 113.335 -1.757 . . . . 70.11 109.332 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 95' ' ' ALA . 50.4 mt -105.66 118.73 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.051 -0.352 . . . . 62.14 110.051 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.09 151.71 11.01 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.164 -0.471 . . . . 60.32 112.102 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.93 80.17 1.17 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.145 0.498 . . . . 33.13 111.134 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 119' ' ' ILE . 63.5 t0 -126.41 89.85 3.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 64.24 109.849 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.19 -33.37 50.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.838 -0.619 . . . . 62.15 110.831 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.3 t -63.64 -46.29 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.91 -0.586 . . . . 72.2 109.905 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.442 ' NZ ' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -66.37 -38.56 87.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 55.14 110.003 -179.166 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 115' ' ' ASP . 78.0 mt -61.88 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.104 -0.498 . . . . 62.22 111.119 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -40.04 85.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.819 0.342 . . . . 72.14 110.089 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.7 t -54.92 -50.95 67.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.639 -0.709 . . . . 43.12 109.825 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.43 -33.06 74.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 73.04 111.528 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 119' ' ' ILE . 98.0 mt -61.23 -56.17 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 120.308 -0.557 . . . . 73.41 109.857 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -70.41 -25.26 63.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.842 -0.343 . . . . 70.22 110.801 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -69.99 -53.63 16.83 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.061 -0.518 . . . . 72.2 110.685 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -80.72 -18.51 47.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.008 0.373 . . . . 71.2 112.008 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 123' ' ' ILE . 49.9 mt -63.18 -49.98 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.084 0.469 . . . . 54.51 109.917 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.448 -0.787 . . . . 71.43 110.091 -178.606 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.161 -0.311 . . . . 75.42 110.161 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.13 94.49 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.024 0.44 . . . . 34.04 111.455 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.11 16.62 2.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.938 -0.574 . . . . 65.04 110.277 173.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -71.59 132.27 44.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.104 -0.498 . . . . 71.22 110.272 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -69.54 165.27 21.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.958 -0.565 . . . . 65.22 111.555 -175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -139.43 153.5 47.6 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.853 -0.612 . . . . 75.12 110.166 -176.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -62.05 97.94 0.09 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.812 -0.81 . . . . 65.21 108.812 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 95' ' ' ALA . 33.4 p-80 -107.75 13.72 26.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.582 -0.736 . . . . 74.33 112.83 -164.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.1 64.37 4.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.736 0.779 . . . . 73.11 110.222 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.82 57.37 0.57 Allowed Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.347 -0.842 . . . . 70.45 111.748 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.707 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 8.8 t -129.1 151.45 49.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.65 -0.5 . . . . 73.25 109.65 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -129.17 -92.58 0.45 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.488 0.185 . . . . 74.23 111.294 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -152.87 134.2 14.31 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.789 0.328 . . . . 75.42 110.727 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.44 172.23 18.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.891 -0.595 . . . . 52.13 109.521 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -169.67 126.3 0.87 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.098 -0.334 . . . . 70.34 110.098 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 p 46.08 29.2 0.74 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.741 0.651 . . . . 70.15 111.281 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -101.58 119.42 38.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.73 -0.668 . . . . 71.4 111.209 -171.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.434 ' H ' ' HD3' ' A' ' 19' ' ' PRO . . . 154.06 59.51 0.01 OUTLIER Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.732 -0.667 . . . . 74.21 111.651 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' ' H ' ' A' ' 18' ' ' GLY . 67.4 Cg_endo -83.47 -174.54 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.19 2.593 . . . . 75.33 113.148 -173.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.82 124.47 35.65 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.761 -0.654 . . . . 31.0 112.135 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 p -156.89 -173.2 4.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.111 -0.329 . . . . 70.35 110.111 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.63 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 62.4 mmm -57.95 -20.53 38.4 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.603 0.24 . . . . 71.32 110.847 175.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -68.7 84.52 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.497 -0.927 . . . . 62.2 108.497 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.19 112.23 2.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.085 -0.961 . . . . 70.14 110.682 -169.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.93 131.35 35.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.005 -0.543 . . . . 71.41 110.732 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.0 pt -136.87 162.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.534 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.39 174.64 36.89 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.145 -0.55 . . . . 75.43 111.868 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.9 -47.8 73.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.007 0.432 . . . . 65.03 110.176 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 m -59.45 -25.19 64.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.649 -0.705 . . . . 74.42 111.252 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 24.3 mm-40 -88.58 -20.03 25.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 75.54 111.56 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -55.89 -61.7 2.2 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.727 0.298 . . . . 65.25 110.978 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.77 -48.97 79.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 73.42 109.945 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -49.87 -57.3 7.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.068 -0.969 . . . . 43.22 111.48 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -66.94 -43.97 81.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.066 -0.515 . . . . 63.34 111.278 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.85 -38.85 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.715 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.5 p -86.37 -31.07 21.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.222 0.453 . . . . 53.41 112.222 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 t -82.01 -8.64 59.68 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.407 0.521 . . . . 74.54 112.407 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 10.9 p -58.48 129.52 42.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.001 -0.279 . . . . 55.23 110.251 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -49.94 -74.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.68 0.622 . . . . 72.42 112.68 -168.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -161.7 131.71 4.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.919 -0.128 . . . . 63.42 110.716 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 51.86 25.67 3.15 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.659 0.6 . . . . 72.45 112.421 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.6 mm -83.41 99.18 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.462 -0.57 . . . . 70.51 109.462 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HB3' HG22 ' A' ' 74' ' ' VAL . 59.2 tp -67.72 107.4 2.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.669 . . . . 72.33 110.205 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -94.18 118.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 72.45 110.517 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.2 mp -100.26 108.27 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.5 -0.555 . . . . 73.21 109.5 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.29 104.98 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.312 -0.625 . . . . 72.45 109.312 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' THR . 37.3 t0 -91.6 145.16 24.82 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.162 -0.472 . . . . 62.13 110.069 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 100' ' ' LEU . 10.1 m-85 -103.2 92.17 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.016 -0.538 . . . . 65.22 110.202 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -86.48 168.63 13.57 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.615 -0.72 . . . . 74.34 111.004 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.03 154.95 10.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.331 -0.849 . . . . 54.33 108.778 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.74 -38.02 21.95 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.841 2.361 . . . . 64.33 111.795 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -123.92 84.13 2.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.565 -0.902 . . . . 73.15 108.565 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -52.31 5.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.424 -0.353 . . . . 63.3 111.469 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.558 ' N ' ' SG ' ' A' ' 56' ' ' CYS . . . 151.66 -116.86 0.78 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.703 -0.76 . . . . 43.4 112.717 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.707 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.9 Cg_exo -79.54 37.01 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.365 2.71 . . . . 54.22 111.384 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 1.8 m -59.94 -35.54 75.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.095 -0.957 . . . . 71.35 111.156 -171.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -54.18 -44.2 71.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.959 -0.564 . . . . 74.44 111.378 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.637 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.2 m -74.75 -42.98 57.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.635 0.731 . . . . 70.35 110.5 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.3 mm? -72.24 -17.57 61.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 64.1 111.982 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 44.9 mt-10 -56.93 -63.94 3.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.529 -0.545 . . . . 65.12 109.529 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 53.4 Cg_endo -68.66 -35.4 16.8 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.595 1.53 . . . . 64.23 112.179 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.6 mt-30 -63.33 -46.73 85.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.335 -0.546 . . . . 75.21 111.465 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.5 mt -70.32 -43.25 70.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.874 -0.148 . . . . 74.14 110.666 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.63 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 35.4 mt-10 -59.07 -35.78 73.95 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.16 -0.311 . . . . 65.51 110.16 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.19 -57.21 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 74.54 110.458 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 123' ' ' ILE . 41.6 mt -62.44 -32.58 73.46 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.306 -0.406 . . . . 74.51 109.947 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.65 -51.71 57.38 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.866 -0.606 . . . . 43.32 110.547 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -67.23 -30.32 70.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.747 0.308 . . . . 74.13 111.296 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -81.32 -38.31 26.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.101 -0.5 . . . . 75.41 110.818 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -104.87 5.39 32.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.959 -0.564 . . . . 75.22 112.142 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 9.8 t -53.47 -19.8 4.06 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.424 0.527 . . . . 63.31 112.424 -173.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.4 -32.66 73.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.808 0.337 . . . . 74.02 111.101 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -133.56 14.04 4.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.277 -0.419 . . . . 60.25 110.748 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' THR . 50.5 t -140.84 142.57 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.965 0.412 . . . . 74.22 111.76 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -149.89 127.75 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.8 -0.637 . . . . 71.33 109.501 170.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.0 mt -99.14 122.21 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.099 -0.334 . . . . 73.14 110.099 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -110.81 155.42 22.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.322 -0.399 . . . . 62.14 110.137 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -137.83 130.87 30.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 81' ' ' ILE . 14.0 pt -79.07 149.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.025 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -74.8 30.18 0.09 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.929 0.395 . . . . 60.11 111.871 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.7 mm -99.01 19.19 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.481 0.657 . . . . 65.23 109.691 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.74 -19.03 24.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.677 -0.692 . . . . 64.21 112.231 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.14 -6.79 54.99 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.614 0.245 . . . . 63.52 111.547 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.455 ' HB2' HG22 ' A' ' 81' ' ' ILE . 30.5 m-80 -119.58 88.32 2.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.797 0.332 . . . . 73.53 110.717 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -64.72 -30.87 71.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.609 -0.515 . . . . 73.43 109.609 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.1 m-20 -43.55 -51.44 6.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.33 -0.85 . . . . 63.32 110.999 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.33 -36.16 51.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.46 -0.791 . . . . 71.01 111.054 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -63.93 -50.95 66.65 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.309 0.576 . . . . 74.24 109.674 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -60.38 -34.4 73.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.341 -0.845 . . . . 72.42 110.808 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -60.71 -55.15 36.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.958 0.409 . . . . 52.44 110.369 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -73.57 -15.24 61.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.199 -0.455 . . . . 63.04 112.21 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.44 0.69 18.38 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.506 -0.854 . . . . 65.55 112.99 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 88.4 t -67.78 109.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.047 0.451 . . . . 75.31 109.947 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 t -97.04 -7.12 33.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.856 -0.611 . . . . 63.12 111.404 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' HD2' ' A' ' 8' ' ' HIS . . . -152.44 158.66 42.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.973 -0.38 . . . . 52.44 109.973 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.12 144.56 52.08 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 110.186 -0.301 . . . . 75.51 110.186 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 114' ' ' ALA . 8.1 Cg_exo -73.32 -179.71 25.95 Favored 'Cis proline' 0 C--N 1.354 0.847 0 C-N-CA 124.33 -1.113 . . . . 64.14 112.323 -3.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' ASP . 18.5 m -160.36 137.24 9.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 74.0 110.717 -178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.585 ' HB ' HG22 ' A' ' 111' ' ' VAL . 36.1 mm -109.92 110.87 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.533 -0.758 . . . . 62.41 111.307 -174.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' A' ' 48' ' ' PHE . 7.3 mp -96.39 123.26 39.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.106 -1.072 . . . . 72.51 108.106 168.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.477 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 44.4 mtt -98.76 143.29 29.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.501 . . . . 65.12 110.995 -175.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -142.81 146.13 33.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.394 -0.965 . . . . 73.14 108.394 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 107.21 4.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.482 -0.487 . . . . 74.24 110.859 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.596 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 58.96 28.32 17.48 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.746 0.784 . . . . 72.22 110.469 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.85 -16.22 59.89 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.612 -0.722 . . . . 43.11 112.596 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 13.4 tmtt? -75.33 141.32 43.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.997 -0.742 . . . . 63.04 108.997 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.518 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.59 124.35 25.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.437 0.637 . . . . 71.43 111.529 -175.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -120.46 168.08 11.69 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.393 1.077 . . . . 61.41 109.981 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.63 176.68 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.224 0.535 . . . . 72.41 111.913 -164.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -141.11 126.86 19.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 74.54 110.524 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 99' ' ' ILE . 35.5 m -114.21 130.06 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.695 -0.483 . . . . 70.11 109.695 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.1 117.8 56.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.748 -0.66 . . . . 62.14 109.679 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.72 144.92 9.0 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.289 -0.724 . . . . 60.32 111.289 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.568 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . . . -83.21 72.34 10.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.852 0.358 . . . . 33.13 111.334 -176.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 119' ' ' ILE . 30.2 t70 -113.07 104.66 12.59 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.185 -0.461 . . . . 64.24 109.833 175.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -60.94 -34.07 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 62.15 111.422 -173.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 120' ' ' ILE . 21.1 t -64.45 -50.11 68.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 72.2 110.105 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.9 tptt -61.74 -46.69 88.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 55.14 110.174 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 111' ' ' VAL . 77.4 mt -57.67 -51.08 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.489 . . . . 62.22 111.146 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.51 -39.99 87.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 110.1 -0.333 . . . . 72.14 110.1 -177.189 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.7 m -55.81 -50.69 69.82 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.924 -0.399 . . . . 43.12 109.924 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 61.5 mm-40 -62.62 -44.29 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 73.04 110.711 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.7 mt -53.44 -56.39 8.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.603 0.239 . . . . 73.41 110.777 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -70.18 -32.0 69.74 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.624 -0.431 . . . . 70.22 110.322 -175.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -64.55 -33.8 76.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.906 -0.588 . . . . 72.2 111.361 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.99 -20.7 19.14 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 111.984 0.365 . . . . 71.2 111.984 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.0 mt -71.49 -58.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.027 0.441 . . . . 54.51 110.028 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.247 -0.883 . . . . 71.43 110.249 -175.562 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.743 0.306 . . . . 75.42 110.551 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.13 62.92 5.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.262 0.553 . . . . 34.04 110.146 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -83.22 -9.19 59.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.617 -0.72 . . . . 65.04 110.775 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -75.72 87.64 2.77 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.988 0.423 . . . . 71.22 110.384 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -74.12 96.49 2.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.738 -0.838 . . . . 65.22 108.738 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -77.92 132.74 38.04 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.851 0.685 . . . . 75.12 112.851 -166.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -153.98 163.21 40.44 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.213 -0.903 . . . . 65.21 108.945 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -127.75 147.14 50.4 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.683 -0.488 . . . . 74.33 109.683 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.1 mtt -97.92 -67.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.982 0.42 . . . . 73.11 110.504 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.55 -176.02 38.52 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.121 -0.792 . . . . 70.45 111.121 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 t -158.39 159.28 35.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.991 0.396 . . . . 73.25 110.807 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.633 HD13 ' N ' ' A' ' 13' ' ' GLU . 2.5 tm? -154.02 151.23 29.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.695 -0.854 . . . . 74.23 108.695 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.633 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -133.54 91.99 2.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.41 0.624 . . . . 75.42 110.312 178.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' GLU . . . -76.24 -87.71 0.04 OUTLIER 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.19 -0.459 . . . . 52.13 110.171 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 174.11 158.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.389 -0.597 . . . . 70.34 109.389 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -158.91 162.74 36.92 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.852 -0.425 . . . . 70.15 109.852 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.431 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 51.6 tp60 -148.4 23.43 1.03 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.263 -0.643 . . . . 71.4 109.263 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.1 97.28 1.17 Allowed Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.575 -0.738 . . . . 74.21 112.232 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 17' ' ' GLN . 55.8 Cg_endo -89.92 37.53 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.22 2.614 . . . . 75.33 111.931 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.58 164.51 15.61 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.766 -0.652 . . . . 31.0 112.062 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p 169.68 163.88 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.313 0.645 . . . . 70.35 109.531 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 54.7 mmm -57.17 -27.63 62.08 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.418 -0.586 . . . . 71.32 109.418 170.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.511 HG23 HG22 ' A' ' 76' ' ' ILE . 12.1 mm -71.95 89.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.55 -1.278 . . . . 62.2 107.55 169.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.63 112.15 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.465 -0.789 . . . . 70.14 111.442 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.68 117.11 18.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.701 -0.681 . . . . 71.41 109.983 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.9 pt -110.55 159.18 10.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.842 -0.617 . . . . 73.54 111.254 -172.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.88 -177.72 36.48 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.681 -0.691 . . . . 75.43 112.975 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.96 -56.92 10.08 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.734 0.814 . . . . 65.03 111.947 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -73.19 -18.59 61.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.944 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -83.9 -12.41 55.5 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.125 0.417 . . . . 75.54 112.125 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.3 t80 -58.19 -61.45 2.55 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.688 -0.486 . . . . 65.25 109.688 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.82 -52.82 61.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.689 -0.687 . . . . 73.42 110.745 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -55.98 -57.34 12.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.605 -0.725 . . . . 43.22 111.717 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -65.41 -34.13 77.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.027 -0.533 . . . . 63.34 111.552 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 31' ' ' PHE . 69.8 t -70.26 -36.32 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.604 0.24 . . . . 74.14 110.96 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.87 -13.32 48.29 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.671 0.272 . . . . 53.41 111.172 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -62.83 -10.08 11.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.424 0.528 . . . . 74.54 112.424 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 17.4 p -76.7 116.97 17.86 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.927 -0.483 . . . . 55.23 110.695 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.12 -78.04 0.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.035 -0.53 . . . . 72.42 111.359 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.68 127.62 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.519 0.2 . . . . 63.42 110.844 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.5 14.0 5.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.781 -0.645 . . . . 72.45 111.378 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.7 mm -81.72 120.39 33.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.197 -0.456 . . . . 70.51 109.854 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.38 123.85 28.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 72.33 109.963 -178.487 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 38' ' ' CYS . 44.2 mt -113.94 117.55 55.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 72.45 110.077 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.4 mp -105.37 126.15 51.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 67.0 t -104.93 105.08 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.698 -0.482 . . . . 72.45 109.698 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.16 145.33 32.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 62.13 111.995 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 23.6 m-85 -108.57 98.57 8.06 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.402 -0.817 . . . . 65.22 109.181 169.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -42.96 139.06 1.83 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.901 -1.045 . . . . 74.34 112.484 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.54 112.7 56.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 54.33 111.083 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.39 -40.14 11.34 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.616 2.211 . . . . 64.33 111.256 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -164.75 139.89 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.149 -0.932 . . . . 73.15 109.399 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.8 p -166.33 -67.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 63.3 110.395 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.06 -94.87 0.16 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.992 -0.623 . . . . 43.4 112.927 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.91 -7.19 20.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.986 2.457 . . . . 54.22 113.249 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.584 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 5.3 m -55.11 -30.48 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.458 -0.337 . . . . 71.35 111.537 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -53.75 -30.59 44.98 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.231 -0.44 . . . . 74.44 111.574 -172.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 42.5 m -75.3 -37.26 60.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.349 0.595 . . . . 70.35 110.998 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.1 mm? -66.68 -47.56 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.937 -0.574 . . . . 64.1 112.434 -172.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -47.75 -55.28 17.89 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 118.115 0.416 . . . . 65.12 111.565 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -33.65 50.84 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.713 1.609 . . . . 64.23 112.164 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.5 mt-30 -66.12 -27.56 68.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.566 -0.454 . . . . 75.21 110.554 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 90.1 mt -76.84 -36.35 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.496 -0.557 . . . . 74.14 109.496 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 39.2 mt-10 -60.83 -36.96 80.44 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.134 -0.484 . . . . 65.51 109.706 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 58.5 tttm -57.53 -57.0 14.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.107 -0.497 . . . . 74.54 110.309 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.491 HD13 HD12 ' A' ' 123' ' ' ILE . 48.1 mt -63.07 -32.17 73.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.989 -0.551 . . . . 74.51 110.319 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.85 -42.53 94.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 43.32 110.839 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.54 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 52.9 mm-40 -74.61 -39.1 62.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.159 0.504 . . . . 74.13 110.841 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.33 -39.04 85.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.678 -0.692 . . . . 75.41 110.801 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.412 ' CD1' HG21 ' A' ' 123' ' ' ILE . 43.5 m-85 -105.05 5.29 32.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.475 -0.784 . . . . 75.22 112.047 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.88 -19.12 2.31 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.761 0.652 . . . . 63.31 112.761 -171.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -71.08 -27.46 63.63 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.647 0.24 . . . . 74.02 111.647 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -134.81 10.25 3.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.34 0.256 . . . . 60.25 111.329 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 43' ' ' LEU . 50.9 t -135.86 142.13 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.052 0.453 . . . . 74.22 111.153 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.0 119.78 9.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 23' ' ' ILE . 34.3 mt -102.45 129.31 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.612 0.244 . . . . 73.14 110.542 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -115.98 173.86 6.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.439 -0.578 . . . . 62.14 109.439 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -155.37 136.02 13.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.978 -0.379 . . . . 62.33 109.978 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.9 mt -79.71 79.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.073 -0.714 . . . . 75.13 109.073 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -81.23 56.18 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.385 0.612 . . . . 60.11 110.405 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -123.52 92.85 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.764 -0.653 . . . . 65.23 109.765 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 12.3 pt-20 -59.91 -17.66 39.03 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.84 -0.618 . . . . 64.21 111.211 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 33.3 t70 -71.66 -25.94 62.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.608 -0.724 . . . . 63.52 111.012 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -109.59 104.88 13.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.88 0.372 . . . . 73.53 110.324 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -99.13 -30.43 12.3 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.016 -0.538 . . . . 73.43 110.414 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 36.0 t70 -47.25 -47.13 24.91 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.611 -0.722 . . . . 63.32 111.883 -171.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.95 -41.05 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.237 -0.438 . . . . 71.01 111.128 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.37 95.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.222 0.534 . . . . 74.24 110.168 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 m -67.87 -33.24 74.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 72.42 110.697 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.9 mm-40 -66.27 -51.46 57.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 52.44 110.597 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -75.1 -17.33 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 63.04 110.461 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.26 45.07 20.63 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.011 -0.614 . . . . 65.55 112.533 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.418 HG13 ' OG1' ' A' ' 98' ' ' THR . 98.8 t -58.27 110.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.033 0.444 . . . . 75.31 110.175 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.7 m -85.94 -34.84 20.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.789 -0.642 . . . . 63.12 110.956 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.79 156.6 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 52.44 109.97 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.747 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.31 144.92 33.2 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.043 -177.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.584 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 4.9 Cg_exo -78.01 173.41 57.08 Favored 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.074 -1.219 . . . . 64.14 112.637 -0.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.554 HG23 HG12 ' A' ' 112' ' ' ILE . 27.8 m -138.39 127.05 23.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.706 . . . . 74.0 109.979 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 111' ' ' VAL . 48.6 mm -110.14 110.81 33.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.072 0.463 . . . . 62.41 110.984 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 2.8 mm? -90.63 123.69 34.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.403 -0.817 . . . . 72.51 109.519 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -92.49 135.99 33.59 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.689 -0.486 . . . . 65.12 109.689 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.522 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 85.2 m-85 -141.58 142.66 33.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.249 -1.019 . . . . 73.14 108.249 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 26.7 ttpp -147.23 126.95 13.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.236 -0.586 . . . . 74.24 110.89 -175.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t30 63.32 25.55 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.625 0.726 . . . . 72.22 109.603 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.69 19.37 74.84 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.317 -0.856 . . . . 43.11 111.926 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -117.85 153.94 32.67 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 122.216 0.206 . . . . 63.04 110.58 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.507 ' O ' HD22 ' A' ' 108' ' ' LEU . 16.6 tppt? -56.48 139.75 48.26 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 124.121 0.888 . . . . 71.43 111.668 -176.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.651 HD12 ' ND2' ' A' ' 126' ' ' ASN . 0.4 OUTLIER -149.99 168.37 24.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.8 -1.091 . . . . 61.41 108.707 -171.295 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 101' ' ' MET . 39.6 m -70.64 -177.07 1.43 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.921 0.712 . . . . 72.41 112.921 -166.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.467 ' HG3' HD13 ' A' ' 100' ' ' LEU . 47.4 tt0 -146.07 148.38 32.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.154 -0.341 . . . . 74.54 111.085 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 99' ' ' ILE . 15.3 m -137.15 128.23 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.244 -0.434 . . . . 70.11 109.882 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 98' ' ' THR . 67.5 mt -114.92 138.08 46.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.29 -0.414 . . . . 62.14 110.331 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.86 161.42 21.0 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.147 -0.549 . . . . 60.32 112.227 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.84 86.28 6.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.854 0.359 . . . . 33.13 110.553 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.6 t0 -139.15 93.78 2.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.159 0.504 . . . . 64.24 110.251 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.1 tp -60.3 -32.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.596 -0.729 . . . . 62.15 111.018 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 t -68.95 -46.87 67.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.021 -0.536 . . . . 72.2 109.976 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -67.46 -43.31 81.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 55.14 110.217 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 115' ' ' ASP . 79.6 mt -58.75 -52.4 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.4 . . . . 62.22 110.956 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.98 -39.09 83.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 120.87 0.367 . . . . 72.14 110.034 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.7 m -54.56 -50.6 67.55 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.122 -0.49 . . . . 43.12 110.448 176.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.17 -39.06 93.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.62 -0.264 . . . . 73.04 111.193 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.491 HD12 HD13 ' A' ' 66' ' ' LEU . 97.7 mt -55.79 -55.81 15.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.643 -0.423 . . . . 73.41 110.314 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.79 -27.36 64.84 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.428 -0.509 . . . . 70.22 110.393 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -70.69 -33.87 71.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.254 -0.43 . . . . 72.2 110.837 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.651 ' ND2' HD12 ' A' ' 108' ' ' LEU . 3.1 m-20 -86.07 -29.94 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 71.2 110.565 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.86 -49.68 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 54.51 110.904 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.696 -0.669 . . . . 71.43 110.124 -175.352 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.664 0.269 . . . . 75.42 110.632 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.54 -173.68 2.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.602 -0.272 . . . . 34.04 110.675 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -136.05 -177.59 4.76 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.845 -0.428 . . . . 65.04 109.845 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -73.48 88.46 1.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 71.22 109.975 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -93.29 -4.83 51.03 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.177 -0.465 . . . . 65.22 110.552 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -63.83 91.14 0.06 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.817 -0.629 . . . . 75.12 109.462 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -111.44 -42.39 3.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 65.21 111.225 -171.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -122.24 129.64 52.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.449 -0.341 . . . . 74.33 110.411 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.7 mtp -96.37 169.6 9.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 73.11 110.519 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 11' ' ' THR . . . -79.75 -47.81 7.01 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.747 -0.941 . . . . 70.45 110.747 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 10' ' ' GLY . 3.1 t 64.92 -49.61 0.34 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.79 1.636 . . . . 73.25 113.522 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.718 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 93.1 mt -72.51 103.12 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.993 0.425 . . . . 74.23 109.983 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.04 117.85 7.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.866 -0.606 . . . . 75.42 110.749 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.54 16.01 10.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.173 -0.467 . . . . 52.13 111.638 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.718 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 78.8 mt-30 -124.28 -173.55 2.8 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.896 -0.409 . . . . 70.34 109.896 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -150.81 -172.63 4.25 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.733 -0.469 . . . . 70.15 109.733 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -57.06 136.11 56.33 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.169 -0.308 . . . . 71.4 110.169 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.74 115.43 7.79 Favored Glycine 0 CA--C 1.521 0.415 0 O-C-N 123.372 0.42 . . . . 74.21 112.753 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.8 101.9 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.438 2.092 . . . . 75.33 111.551 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.5 -63.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.646 -0.582 . . . . 31.0 111.646 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -67.73 80.7 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 70.35 110.508 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.507 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 91.9 mmm -85.72 -1.79 57.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 71.32 110.43 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.68 107.35 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 62.2 110.079 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.5 126.54 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.59 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.17 124.38 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.846 -0.798 . . . . 71.41 108.846 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 34' ' ' LYS . 28.8 pt -129.32 158.02 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 73.54 110.859 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.18 165.14 53.91 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.845 -0.616 . . . . 75.43 112.253 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.87 -50.11 61.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 65.03 111.057 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.5 m -71.87 -10.52 59.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 111.51 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -89.21 -4.96 58.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.689 -0.232 . . . . 75.54 111.233 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.576 ' HD2' HD11 ' A' ' 79' ' ' ILE . 83.1 t80 -58.11 -62.49 1.79 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.789 0.328 . . . . 65.25 110.9 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.54 -39.35 93.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 73.42 109.994 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.0 -57.37 10.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.402 -0.817 . . . . 43.22 110.634 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HG3' HG21 ' A' ' 26' ' ' ILE . 43.9 mmtm -79.22 -18.37 53.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.991 -0.55 . . . . 63.34 112.137 -172.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 31' ' ' PHE . 55.0 t -74.03 -36.16 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.801 0.334 . . . . 74.14 110.334 171.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.4 p -85.98 -20.07 29.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.774 0.321 . . . . 53.41 111.02 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -68.5 4.45 1.37 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.936 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.86 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.4 p -58.13 137.95 56.54 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.219 -0.289 . . . . 55.23 110.219 175.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.25 -67.21 0.43 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 110.247 -0.279 . . . . 72.42 110.247 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.488 ' H ' HG12 ' A' ' 42' ' ' ILE . 5.3 p-10 -162.06 128.7 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.171 -0.307 . . . . 63.42 110.171 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.84 18.17 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.042 0.537 . . . . 72.45 112.248 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.488 HG12 ' H ' ' A' ' 40' ' ' ASP . 49.2 mm -71.51 136.26 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 116.524 -0.307 . . . . 70.51 110.497 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 126' ' ' ASN . 57.2 tp -80.06 126.26 30.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 72.33 110.158 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.87 119.24 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 72.45 110.381 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 76' ' ' ILE . 3.3 mp -107.09 115.31 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 73.21 109.529 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.74 105.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.223 -0.658 . . . . 72.45 109.223 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' THR . 21.9 t0 -85.92 153.11 22.43 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.722 -0.217 . . . . 62.13 110.642 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.693 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 17.4 p90 -50.73 152.64 1.97 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.054 -0.521 . . . . 65.22 111.64 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -128.77 98.48 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.836 -0.62 . . . . 74.34 109.707 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.98 149.19 10.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 54.33 110.244 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.52 39.48 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.902 2.402 . . . . 64.33 112.209 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -145.03 131.49 19.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 73.15 110.375 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.41 ' HA ' HG12 ' A' ' 96' ' ' ILE . 25.9 p -166.18 154.55 10.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 63.3 109.912 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.77 -82.82 1.67 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 112.018 -0.433 . . . . 43.4 112.018 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.61 ' HB2' HD23 ' A' ' 59' ' ' LEU . 3.6 Cg_exo -77.66 50.32 3.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.295 2.663 . . . . 54.22 111.576 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.68 -51.61 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.643 -0.708 . . . . 71.35 110.837 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -54.32 -38.13 65.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.763 -0.653 . . . . 74.44 111.903 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.7 m -75.57 -59.19 2.86 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.706 0.765 . . . . 70.35 112.144 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 55' ' ' PRO . 4.5 mm? -66.28 -34.44 78.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.716 -0.675 . . . . 64.1 112.762 -168.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 48.9 mt-10 -56.61 -60.18 10.04 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 120.602 -0.439 . . . . 65.12 110.634 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.7 Cg_endo -63.19 -34.63 67.71 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.003 1.802 . . . . 64.23 112.199 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 58' ' ' SER . 41.8 mt-30 -59.89 -41.84 92.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.421 -0.512 . . . . 75.21 110.947 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.25 -42.69 79.27 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.479 -0.328 . . . . 74.14 110.432 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 44.3 mt-10 -57.75 -37.2 73.19 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.057 -0.52 . . . . 65.51 110.539 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -66.82 -53.0 37.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.239 -0.437 . . . . 74.54 111.156 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD12 ' A' ' 123' ' ' ILE . 55.4 mt -60.09 -34.98 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.039 0.447 . . . . 74.51 110.174 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.14 -53.37 50.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.753 -0.658 . . . . 43.32 110.151 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.507 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 15.6 mm-40 -57.08 -31.91 65.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.532 -0.304 . . . . 74.13 111.683 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -78.06 -47.15 18.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.162 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -104.59 4.79 33.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.586 . . . . 75.22 112.437 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.3 t -52.9 -19.69 2.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.411 0.523 . . . . 63.31 112.411 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.77 -39.98 78.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.8 0.333 . . . . 74.02 110.497 176.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -125.45 9.72 7.85 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.26 -0.427 . . . . 60.25 111.236 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' THR . 41.0 t -132.17 138.91 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.885 0.374 . . . . 74.22 111.587 -176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -144.87 133.67 22.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.942 -0.572 . . . . 71.33 109.492 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -113.98 143.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.498 0.19 . . . . 73.14 110.747 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -131.61 162.61 29.95 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.175 0.512 . . . . 62.14 111.129 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -137.1 142.71 42.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.013 -0.994 . . . . 62.33 108.606 170.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' A' ' 31' ' ' PHE . 43.8 mm -90.91 152.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.668 -0.493 . . . . 75.13 109.668 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -94.8 -169.31 1.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.205 -0.294 . . . . 60.11 110.205 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 mt 61.61 60.88 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 122.143 0.973 . . . . 65.23 109.699 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 28.2 mp0 -59.74 -18.81 45.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.528 -1.215 . . . . 64.21 110.75 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.15 -17.9 62.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.593 -0.731 . . . . 63.52 111.435 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.8 67.72 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.405 0.621 . . . . 73.53 111.143 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -61.05 -30.5 70.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.27 -0.877 . . . . 73.43 110.811 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.65 -42.23 33.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.925 -0.579 . . . . 63.32 110.736 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.58 -36.56 60.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 71.01 110.717 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.013 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 m -60.13 -40.69 90.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.882 -0.599 . . . . 72.42 110.922 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -65.59 -41.06 93.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.918 -0.583 . . . . 52.44 111.426 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -90.65 -7.48 52.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 63.04 111.428 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.28 21.6 58.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.24 -0.505 . . . . 65.55 113.072 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.501 HG22 HG21 ' A' ' 98' ' ' THR . 46.9 t -73.13 124.44 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.949 -0.389 . . . . 75.31 109.949 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 t -151.42 -42.26 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 63.12 110.324 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.4 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . . . -102.66 137.83 40.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.304 -0.407 . . . . 52.44 110.096 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.4 pp -110.09 154.51 42.72 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.387 -0.369 . . . . 75.51 111.592 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.07 171.9 63.12 Favored 'Cis proline' 0 C--N 1.352 0.753 0 C-N-CA 123.421 -1.491 . . . . 64.14 111.894 -5.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 48' ' ' PHE . 83.8 m -130.21 110.93 11.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.355 -0.609 . . . . 74.0 109.355 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.6 mm -115.37 112.78 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 62.41 110.626 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.6 mp -94.96 123.27 38.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.44 -0.578 . . . . 72.51 109.44 174.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.491 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 15.0 mmt -95.27 139.11 32.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.81 0.338 . . . . 65.12 110.499 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -141.04 149.33 41.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.075 -0.713 . . . . 73.14 109.075 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -133.85 116.31 15.51 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.595 -0.521 . . . . 74.24 109.595 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.86 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.8 p-10 48.15 32.51 3.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.316 0.646 . . . . 72.22 112.202 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.87 -14.8 60.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.395 -0.431 . . . . 43.11 112.609 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -75.43 140.08 42.69 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.192 0.597 . . . . 63.04 110.176 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' A' ' 108' ' ' LEU . 3.3 tmmm? -69.37 132.32 46.2 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.812 -0.631 . . . . 71.43 110.897 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.495 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.8 mm? -133.52 167.8 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.838 -1.074 . . . . 61.41 110.176 -175.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.71 179.45 2.61 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.476 0.655 . . . . 72.41 112.342 -169.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -137.85 151.4 48.03 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.657 -0.701 . . . . 74.54 110.221 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -121.9 131.2 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 114.879 -1.055 . . . . 70.11 109.996 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 95' ' ' ALA . 27.5 mm -129.85 125.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 62.14 109.992 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.06 153.31 19.2 Favored Glycine 0 C--N 1.323 -0.15 0 CA-C-N 115.834 -0.621 . . . . 60.32 112.234 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -79.66 80.03 6.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.062 0.458 . . . . 33.13 111.019 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.68 94.51 3.3 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.545 -0.752 . . . . 64.24 109.075 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.35 -26.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 62.15 110.567 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.7 t -66.55 -42.12 87.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.865 -0.607 . . . . 72.2 109.647 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.83 -44.43 77.25 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 55.14 109.916 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.2 mt -56.12 -56.2 14.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.14 -0.482 . . . . 62.22 110.824 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.61 -35.34 69.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.189 -0.46 . . . . 72.14 109.881 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.0 t -57.49 -46.35 83.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.003 -0.369 . . . . 43.12 110.003 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.56 -43.54 93.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.326 -0.397 . . . . 73.04 110.497 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.435 HD12 HD13 ' A' ' 66' ' ' LEU . 96.6 mt -53.45 -55.64 12.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.818 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -70.95 -27.91 64.09 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.946 -0.302 . . . . 70.22 110.3 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -63.36 -33.23 75.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.036 0.446 . . . . 72.2 110.125 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.44 ' HB2' HD22 ' A' ' 43' ' ' LEU . 27.5 m-80 -79.71 -40.48 28.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.882 -0.599 . . . . 71.2 111.16 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.24 -42.21 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.085 0.469 . . . . 54.51 110.733 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.307 -0.854 . . . . 71.43 109.911 179.005 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.3 mmm . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.453 0.168 . . . . 71.32 110.638 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.58 96.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.953 0.406 . . . . 62.2 110.019 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 7.3 tp10 -67.09 125.87 27.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.759 -0.655 . . . . 70.14 110.862 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 25' ' ' GLN . 5.4 pm0 -85.8 128.12 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 71.41 109.423 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.7 pt -134.62 146.37 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.728 0.299 . . . . 73.54 110.989 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.32 173.65 37.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.97 -0.559 . . . . 75.43 112.035 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.49 -47.21 27.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.074 0.549 . . . . 65.03 112.21 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -74.81 -20.97 59.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.107 -0.497 . . . . 74.42 111.513 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.8 -13.44 45.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 75.54 111.379 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 26' ' ' ILE . 72.4 t80 -56.03 -62.25 1.83 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.952 0.353 . . . . 65.25 111.952 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -39.25 94.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.157 0.503 . . . . 73.42 110.112 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -55.7 -53.71 53.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.81 . . . . 43.22 110.395 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.6 mmtt -69.07 -32.9 72.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.444 -0.798 . . . . 63.34 111.375 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 31' ' ' PHE . 77.7 t -66.93 -36.18 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.967 0.413 . . . . 74.14 110.652 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 p -86.06 -19.63 29.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.381 -0.372 . . . . 53.41 111.525 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -63.29 -11.15 19.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.205 -0.452 . . . . 74.54 112.103 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 21.6 p -61.11 139.9 57.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.224 0.21 . . . . 55.23 111.482 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -72.15 -88.78 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.558 -0.292 . . . . 72.42 110.732 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.5 136.07 24.25 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.088 -0.338 . . . . 63.42 110.088 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 m120 58.22 16.43 3.95 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.627 -0.715 . . . . 72.45 111.897 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 41.5 mm -76.22 105.24 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.533 -0.543 . . . . 70.51 109.533 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 74' ' ' VAL . 53.5 tp -73.52 117.7 15.6 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.548 0.69 . . . . 72.33 109.974 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -102.0 113.0 37.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.959 . . . . 72.45 110.679 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.594 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.5 mp -97.28 118.75 34.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.313 -0.625 . . . . 73.21 109.313 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.83 107.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.935 -0.395 . . . . 72.45 109.935 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.67 136.69 36.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.983 -0.553 . . . . 62.13 111.246 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 100' ' ' LEU . 34.3 m-85 -111.13 81.9 1.51 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.435 0.636 . . . . 65.22 109.819 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.407 ' CZ2' ' SG ' ' A' ' 53' ' ' CYS . 23.0 t-105 -68.18 92.75 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.963 -1.017 . . . . 74.34 110.501 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.567 ' HB3' HG22 ' A' ' 96' ' ' ILE . . . -77.09 137.94 65.15 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.324 -0.398 . . . . 54.33 110.074 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.34 -8.44 8.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.374 2.716 . . . . 64.33 113.763 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.736 ' HB3' HG21 ' A' ' 96' ' ' ILE . 67.5 t-105 -65.6 -52.42 52.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.632 -0.507 . . . . 73.15 109.632 177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.407 ' SG ' ' CZ2' ' A' ' 49' ' ' TRP . 4.7 t 54.99 90.73 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.316 -0.856 . . . . 63.3 112.17 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.29 -100.88 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.138 -0.553 . . . . 43.4 111.949 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.93 6.29 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.017 2.478 . . . . 54.22 112.292 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.404 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 4.8 p -50.82 -29.74 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 71.35 111.449 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.07 -51.74 63.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.504 -177.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.2 m -75.33 -45.12 41.47 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.411 0.624 . . . . 70.35 111.286 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -63.35 -31.59 72.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 64.1 112.571 -172.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 1.9 tm-20 -61.55 -58.21 19.95 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.82 -0.352 . . . . 65.12 110.426 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 26.4 Cg_endo -63.39 -28.44 71.49 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.514 1.476 . . . . 64.23 112.039 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.587 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 42.8 mt-30 -69.53 -34.8 74.76 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 75.21 110.991 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 77.5 mt -68.89 -43.54 75.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.471 -0.566 . . . . 74.14 109.471 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 6.2 mm-40 -59.32 -35.8 74.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 65.51 110.218 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 11.6 ttmm -54.51 -57.69 10.4 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.386 0.612 . . . . 74.54 110.225 174.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.484 HD13 HD12 ' A' ' 123' ' ' ILE . 43.1 mt -69.47 -28.74 66.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.393 -0.821 . . . . 74.51 110.18 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.17 -44.6 79.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 43.32 110.273 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 85.9 mt-30 -73.69 -37.34 65.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.724 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -66.03 -45.26 82.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.028 0.442 . . . . 75.41 111.051 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -100.18 5.04 44.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.612 0.597 . . . . 75.22 112.612 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -53.64 -19.69 4.32 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.806 0.669 . . . . 63.31 112.806 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.601 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 10.5 pt-20 -66.98 -28.43 68.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.646 0.26 . . . . 74.02 111.13 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.601 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 44.7 m-80 -131.06 9.49 4.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.536 -0.302 . . . . 60.25 111.22 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 43' ' ' LEU . 39.7 t -136.39 141.2 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.989 0.423 . . . . 74.22 111.574 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -142.1 119.79 11.82 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.838 -0.801 . . . . 71.33 108.838 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -99.61 138.89 22.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.761 0.315 . . . . 73.14 110.388 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 87.6 m-85 -124.55 160.27 28.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.872 -0.604 . . . . 62.14 109.457 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -137.33 120.66 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.252 -1.018 . . . . 62.33 108.252 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.77 132.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.742 -0.663 . . . . 75.13 111.561 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.01 96.32 7.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.613 -0.721 . . . . 60.11 109.471 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 84' ' ' ASN . 10.6 tp -154.21 34.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 122.057 0.932 . . . . 65.23 108.921 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -18.82 1.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.473 -1.24 . . . . 64.21 113.751 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.67 -36.11 38.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.861 0.363 . . . . 63.52 111.167 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.497 ' HB3' HG13 ' A' ' 81' ' ' ILE . 4.6 t-20 -95.97 103.23 15.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 73.53 110.814 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.17 -22.44 55.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 73.43 110.387 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.9 m-20 -51.73 -36.1 45.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.034 -0.53 . . . . 63.32 111.089 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 81' ' ' ILE . 88.0 t -52.85 -37.23 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 71.01 110.712 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.63 -50.95 65.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.066 0.46 . . . . 74.24 110.002 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -62.56 -33.09 74.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.633 -0.712 . . . . 72.42 111.171 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -74.49 -47.22 34.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 52.44 111.229 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.467 ' HB3' HD21 ' A' ' 100' ' ' LEU . 58.8 m-85 -87.07 -7.86 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.354 -0.385 . . . . 63.04 111.59 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 44.26 6.24 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.833 -0.699 . . . . 65.55 113.053 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.12 123.54 39.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.392 -0.596 . . . . 75.31 109.392 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -136.03 6.69 3.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.441 -0.345 . . . . 63.12 111.041 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.24 176.26 11.02 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.641 0.258 . . . . 52.44 110.631 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.736 HG21 ' HB3' ' A' ' 52' ' ' TRP . 1.3 pp -128.13 108.2 19.79 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.179 -0.464 . . . . 75.51 110.997 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -89.47 -162.49 1.88 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.001 -1.25 . . . . 64.14 112.519 -0.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.3 m -146.95 126.29 13.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.578 -0.527 . . . . 74.0 109.578 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 111' ' ' VAL . 48.3 mm -113.25 119.56 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.912 -0.586 . . . . 62.41 111.217 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 48' ' ' PHE . 9.1 mp -100.85 149.85 23.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 72.51 109.328 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.51 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 24.6 mtt -115.69 146.67 41.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 65.12 110.631 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -143.93 150.73 38.8 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.253 -1.017 . . . . 73.14 108.253 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -149.28 120.65 7.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.613 -0.435 . . . . 74.24 110.942 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.642 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 5.7 t30 61.85 27.09 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.486 0.66 . . . . 72.22 109.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.89 -3.39 70.38 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.45 -0.796 . . . . 43.11 112.27 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -90.73 147.35 23.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.884 -0.413 . . . . 63.04 109.884 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.48 135.49 51.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.487 0.66 . . . . 71.43 110.845 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 0.7 OUTLIER -135.76 168.19 19.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.719 -1.128 . . . . 61.41 108.947 -172.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.17 166.95 18.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.624 0.726 . . . . 72.41 111.964 -165.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.68 128.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.209 -0.905 . . . . 74.54 110.042 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 99' ' ' ILE . 15.7 m -113.14 109.41 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.633 0.73 . . . . 70.11 109.728 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.18 122.93 49.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.888 . . . . 62.14 110.198 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.75 -163.72 14.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.173 -0.537 . . . . 60.32 111.792 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.26 72.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.007 0.432 . . . . 33.13 110.697 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.6 t70 -125.03 92.37 3.63 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.745 -0.661 . . . . 64.24 109.348 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.84 -28.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 62.15 110.758 -173.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.5 t -64.7 -45.8 85.07 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.041 -0.527 . . . . 72.2 109.93 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -67.96 -38.51 82.86 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.872 -0.603 . . . . 55.14 109.946 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.5 mt -60.25 -56.21 19.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.848 -0.615 . . . . 62.22 110.514 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.46 -39.46 82.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 120.762 0.315 . . . . 72.14 110.165 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -54.41 -52.16 62.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.928 -0.578 . . . . 43.12 110.252 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.88 -32.5 70.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.357 -0.383 . . . . 73.04 111.278 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 119' ' ' ILE . 96.7 mt -57.64 -56.2 16.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 120.59 -0.444 . . . . 73.41 110.112 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -68.42 -32.94 73.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.499 -0.481 . . . . 70.22 110.039 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.73 -29.25 69.19 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.696 -0.684 . . . . 72.2 110.991 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.498 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.2 m-20 -98.11 -20.83 17.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.436 -0.347 . . . . 71.2 111.82 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.9 mt -74.48 -47.64 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.768 -0.456 . . . . 54.51 109.768 172.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.419 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.697 -0.683 . . . . 71.43 109.579 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.443 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 81.8 mmm . . . . . 0 N--CA 1.469 0.476 0 CA-C-O 120.651 0.262 . . . . 71.32 111.444 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.464 HG21 ' HE2' ' A' ' 78' ' ' LYS . 13.2 mm -93.96 119.94 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.476 . . . . 62.2 109.716 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 31.0 tt0 -86.82 118.45 26.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.904 0.383 . . . . 70.14 110.601 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -80.72 137.77 36.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.222 -0.445 . . . . 71.41 110.339 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.507 HG21 ' HG3' ' A' ' 34' ' ' LYS . 42.0 pt -139.53 154.51 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.562 0.22 . . . . 73.54 110.991 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.66 176.53 28.72 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.3 -0.476 . . . . 75.43 112.716 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.06 -55.1 5.92 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.367 0.667 . . . . 65.03 112.177 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 t -70.39 -34.54 72.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.941 0.401 . . . . 74.42 110.673 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.22 -24.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 75.54 111.326 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.9 t80 -49.61 -56.96 8.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 65.25 110.473 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.25 -55.2 30.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.507 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -52.54 -46.37 66.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.431 -0.804 . . . . 43.22 111.405 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.2 mmtt -77.17 -24.28 51.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.394 -0.821 . . . . 63.34 111.56 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.7 t -79.18 -33.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.841 -0.429 . . . . 74.14 109.841 174.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.2 p -79.58 -19.64 48.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.974 0.416 . . . . 53.41 110.479 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -61.7 -23.38 66.08 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.863 -0.608 . . . . 74.54 111.722 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.4 p -74.78 91.46 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 55.23 110.572 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -69.98 -61.71 1.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 72.42 111.511 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' ILE . 5.8 m-20 -123.62 120.87 34.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.483 0.182 . . . . 63.42 110.511 -172.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 51.04 3.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.1 1.519 . . . . 72.45 115.1 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.5 mm -63.92 124.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 118.134 0.424 . . . . 70.51 110.824 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -88.65 110.45 20.96 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.876 -0.787 . . . . 72.33 108.876 177.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 101' ' ' MET . 70.8 mt -90.82 118.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 72.45 110.734 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.477 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -107.56 109.08 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.41 -0.589 . . . . 73.21 109.41 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 57.3 t -92.59 106.86 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.046 -0.353 . . . . 72.45 110.046 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.505 ' HA ' HD13 ' A' ' 99' ' ' ILE . 11.7 t70 -85.74 133.05 34.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.919 -0.582 . . . . 62.13 111.894 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -94.51 95.23 8.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.71 -0.677 . . . . 65.22 109.659 172.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.418 ' HZ3' ' HG3' ' A' ' 82' ' ' GLU . 52.4 t90 -66.32 136.26 55.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.48 -0.782 . . . . 74.34 111.634 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.52 127.25 25.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.547 -0.752 . . . . 54.33 109.192 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.85 -64.8 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.736 2.291 . . . . 64.33 112.498 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -95.94 116.8 29.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.128 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.9 t -158.36 158.65 34.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.284 -0.416 . . . . 63.3 110.58 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.57 -83.56 1.45 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 116.01 -0.541 . . . . 43.4 112.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.49 -25.45 74.03 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.9 2.4 . . . . 54.22 112.768 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 67.5 m -51.01 -37.26 44.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 71.35 111.49 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -62.89 -33.41 75.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.703 0.287 . . . . 74.44 110.914 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.536 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 10.6 m -74.96 -40.53 60.71 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.865 0.84 . . . . 70.35 110.112 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -65.81 -29.58 70.08 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.169 -0.923 . . . . 64.1 111.457 -176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.1 mt-10 -56.78 -60.92 7.96 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.737 -0.385 . . . . 65.12 110.692 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.4 Cg_endo -64.33 -33.16 59.91 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.662 1.575 . . . . 64.23 111.898 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.6 mt-30 -62.62 -38.43 90.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.335 -0.546 . . . . 75.21 110.63 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.448 HD21 HD13 ' A' ' 119' ' ' ILE . 77.5 mt -72.5 -43.34 63.77 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.127 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.8 mt-10 -60.56 -32.43 71.51 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.127 -0.488 . . . . 65.51 110.395 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 65' ' ' LYS . 33.4 ttmt -66.78 -56.82 8.77 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.025 -0.534 . . . . 74.54 110.599 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 116' ' ' ILE . 63.6 mt -58.19 -32.05 67.88 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.917 -0.583 . . . . 74.51 109.451 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.22 -52.62 53.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.669 -0.696 . . . . 43.32 110.127 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.2 mt-30 -53.37 -41.56 65.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.78 0.324 . . . . 74.13 110.806 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.94 -44.41 48.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.16 -0.473 . . . . 75.41 111.63 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -101.49 4.82 41.56 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.602 0.593 . . . . 75.22 112.602 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.0 t -53.31 -23.96 10.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.898 0.703 . . . . 63.31 112.898 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.04 -18.88 60.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 74.02 111.141 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -130.94 7.7 4.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.975 -0.557 . . . . 60.25 110.567 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 43' ' ' LEU . 21.5 t -141.15 139.95 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.81 0.338 . . . . 74.22 111.329 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 4.7 tppp? -142.29 128.12 19.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.85 -0.614 . . . . 71.33 109.587 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.7 mt -107.89 137.78 37.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.788 -0.449 . . . . 73.14 109.788 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CZ ' ' HG2' ' A' ' 75' ' ' LYS . 51.1 m-85 -120.77 147.03 45.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.782 0.325 . . . . 62.14 111.371 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE2' HG21 ' A' ' 23' ' ' ILE . 59.7 mttm -120.69 105.45 10.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.893 -0.78 . . . . 62.33 108.893 169.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mt -71.29 107.56 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.769 -0.456 . . . . 75.13 109.769 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.22 68.78 5.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.653 0.739 . . . . 60.11 111.846 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.7 pt -120.84 55.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.197 -1.408 . . . . 65.23 107.197 167.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' HZ3' ' A' ' 49' ' ' TRP . 36.5 tt0 -49.74 -32.67 14.16 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.137 -1.847 . . . . 64.21 113.202 -168.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 -2.9 58.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.209 0.448 . . . . 63.52 112.209 -174.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.47 78.86 1.4 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 73.53 111.046 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.74 -24.34 62.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.988 -0.551 . . . . 73.43 110.388 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.33 -35.04 25.96 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.411 -0.813 . . . . 63.32 111.447 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.54 -39.16 44.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.828 -0.624 . . . . 71.01 110.828 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.14 77.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.8 -0.636 . . . . 74.24 110.49 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.1 m -67.52 -34.17 76.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.596 . . . . 72.42 110.962 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.59 -38.93 92.69 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.79 0.329 . . . . 52.44 111.137 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -95.39 -6.63 40.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.554 -0.294 . . . . 63.04 111.624 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.85 59.56 2.07 Favored Glycine 0 C--O 1.236 0.235 0 C-N-CA 120.96 -0.638 . . . . 65.55 113.215 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.555 HG13 ' OG1' ' A' ' 98' ' ' THR . 81.4 t -89.22 117.75 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.843 0.354 . . . . 75.31 110.116 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.8 m -95.58 -38.14 10.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 63.12 110.91 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 155.23 50.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 52.44 110.46 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.86 132.28 24.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.209 -0.451 . . . . 75.51 111.08 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -91.15 -165.32 2.27 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 123.964 -1.265 . . . . 64.14 111.923 -4.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.555 ' OG1' HG13 ' A' ' 93' ' ' VAL . 54.9 m -143.3 141.2 30.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.23 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 47' ' ' ASP . 46.2 mm -120.76 113.98 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.971 -0.559 . . . . 62.41 110.794 -175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.493 HD23 ' HG3' ' A' ' 110' ' ' GLN . 47.4 mt -90.95 123.41 34.42 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.357 -0.609 . . . . 72.51 109.357 171.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 38.7 mtt -96.73 143.78 27.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.662 -0.415 . . . . 65.12 110.922 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.65 154.83 45.61 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.412 -0.588 . . . . 73.14 109.412 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -156.68 120.59 4.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.261 -0.176 . . . . 74.24 110.972 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.492 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 60.56 25.91 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.832 0.825 . . . . 72.22 110.182 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.66 -8.21 73.26 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.396 -0.82 . . . . 43.11 112.514 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -86.86 147.78 25.65 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.973 -0.38 . . . . 63.04 109.973 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -72.68 127.98 34.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.629 0.728 . . . . 71.43 110.844 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD12 ' OD1' ' A' ' 126' ' ' ASN . 3.9 mm? -119.72 168.71 10.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.48 -1.236 . . . . 61.41 109.315 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -178.91 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.254 0.55 . . . . 72.41 112.257 -162.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.493 ' HG3' HD23 ' A' ' 100' ' ' LEU . 47.0 tt0 -138.3 143.8 40.15 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 122.014 0.911 . . . . 74.54 111.205 -172.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 74.0 t -126.26 118.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.566 -1.652 . . . . 70.11 109.67 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.48 123.28 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.127 -0.323 . . . . 62.14 110.127 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.39 139.81 10.22 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.71 -0.556 . . . . 60.32 111.71 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.97 80.22 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 33.13 111.429 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 119' ' ' ILE . 22.2 t0 -123.37 102.45 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 64.24 110.162 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 66' ' ' LEU . 9.1 tp -60.06 -31.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 62.15 110.634 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.9 t -61.64 -56.63 17.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.395 -0.366 . . . . 72.2 110.181 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.29 -45.26 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 55.14 110.699 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.1 mt -61.2 -56.37 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.144 -0.48 . . . . 62.22 111.35 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.41 HD13 HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -62.24 -39.75 85.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.091 0.472 . . . . 72.14 110.222 -176.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 t -60.65 -48.16 83.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 43.12 109.591 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.69 -35.46 78.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.81 -0.632 . . . . 73.04 111.111 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 127' ' ' ILE . 93.4 mt -56.46 -55.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.199 -0.667 . . . . 73.41 109.199 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.41 HD22 HD13 ' A' ' 120' ' ' ILE . 46.6 m-80 -63.86 -35.69 81.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 70.22 110.919 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.85 -46.61 88.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.873 0.368 . . . . 72.2 111.041 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.496 ' HB2' HD11 ' A' ' 43' ' ' LEU . 56.1 m-80 -91.21 -5.19 55.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 71.2 111.507 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 123' ' ' ILE . 60.5 mt -78.82 -47.22 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.757 -0.46 . . . . 54.51 109.757 167.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.464 -0.779 . . . . 71.43 110.539 -177.141 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.469 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 89.5 mmm . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.724 0.297 . . . . 71.32 111.016 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 22.0 mm -85.39 111.47 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 62.2 109.491 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -85.24 112.02 20.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.9 -0.591 . . . . 70.14 110.806 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -83.61 134.86 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.698 -0.482 . . . . 71.41 109.698 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.4 pt -132.4 167.72 25.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 120.994 0.426 . . . . 73.54 111.492 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 178.96 32.45 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.579 -0.737 . . . . 75.43 112.464 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.86 -55.43 35.03 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.059 0.543 . . . . 65.03 112.026 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 t -68.82 -2.7 10.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.227 -0.442 . . . . 74.42 111.888 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.11 -9.88 25.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.565 0.209 . . . . 75.54 111.565 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.73 -62.08 1.93 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.82 0.343 . . . . 65.25 110.761 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.55 -49.27 70.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.927 -0.579 . . . . 73.42 110.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.2 -53.68 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.361 -0.836 . . . . 43.22 111.05 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -63.77 -40.11 95.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.035 -0.529 . . . . 63.34 111.127 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HA ' HD13 ' A' ' 44' ' ' ILE . 80.0 t -71.29 -40.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.104 0.409 . . . . 74.14 112.104 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 p -86.06 -29.39 23.44 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.295 0.48 . . . . 53.41 112.295 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.7 t -82.37 10.39 7.15 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.341 0.497 . . . . 74.54 112.341 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.761 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.6 p -66.57 142.69 57.41 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.252 -0.28 . . . . 55.23 110.351 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.08 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.339 0.399 . . . . 72.42 112.06 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.29 128.85 17.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.37 -0.233 . . . . 63.42 110.37 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 55.92 11.41 0.71 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.477 0.547 . . . . 72.45 112.477 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 37.6 mm -62.87 131.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.671 0.272 . . . . 70.51 110.787 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.52 110.95 21.74 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.335 0.588 . . . . 72.33 109.544 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 38' ' ' CYS . 73.0 mt -100.32 114.19 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 72.45 110.659 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.61 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -99.68 128.45 45.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.394 -0.595 . . . . 73.21 109.394 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 85.6 t -107.42 110.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.738 0.304 . . . . 72.45 110.366 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.489 ' HA ' HD13 ' A' ' 99' ' ' ILE . 4.2 t70 -85.58 134.49 34.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.847 -0.615 . . . . 62.13 110.985 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -97.96 119.81 37.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.172 -0.467 . . . . 65.22 109.862 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.468 ' HB2' ' ND2' ' A' ' 80' ' ' ASN . 51.2 t90 -54.57 108.87 0.43 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.453 -0.794 . . . . 74.34 111.786 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.6 112.41 39.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.785 -0.643 . . . . 54.33 109.902 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.41 -68.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.765 2.31 . . . . 64.33 112.556 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -114.14 110.16 19.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.0 -0.37 . . . . 73.15 110.0 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.6 t -163.55 135.96 5.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.19 -0.459 . . . . 63.3 110.142 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.09 -76.78 0.59 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.227 -0.511 . . . . 43.4 112.599 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.23 -29.31 56.32 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.983 2.455 . . . . 54.22 112.928 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 78.8 m -55.48 -31.37 61.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.152 -0.476 . . . . 71.35 112.173 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 7.0 ptp85 -69.06 -30.42 68.75 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.997 -0.281 . . . . 74.44 110.404 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.5 m -74.94 -29.34 60.91 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.295 0.569 . . . . 70.35 109.798 174.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -66.64 -29.09 69.03 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.871 -0.604 . . . . 64.1 111.126 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 48.3 mt-10 -57.99 -57.74 23.67 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.93 -0.308 . . . . 65.12 110.588 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 36.5 Cg_endo -66.57 -31.41 41.31 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.113 1.875 . . . . 64.23 112.641 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.9 mt-30 -62.99 -41.67 99.64 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 120.428 -0.509 . . . . 75.21 110.286 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 67.9 mt -65.62 -34.96 79.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 74.14 109.66 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.56 -37.22 86.47 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.128 -0.487 . . . . 65.51 110.505 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 1.4 tpmt? -58.35 -56.4 22.63 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.213 0.53 . . . . 74.54 109.809 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.468 HD13 HD12 ' A' ' 123' ' ' ILE . 19.1 mt -63.51 -36.43 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.467 -0.788 . . . . 74.51 110.079 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.28 -53.74 44.22 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.125 -0.489 . . . . 43.32 110.176 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 98.2 mt-30 -55.35 -42.41 73.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.746 0.308 . . . . 74.13 110.909 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.84 -41.51 64.76 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.398 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -104.87 4.8 32.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.193 0.812 . . . . 75.22 113.193 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.0 t -53.5 -20.02 4.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.997 1.11 . . . . 63.31 113.997 -168.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.97 -18.77 61.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.323 . . . . 74.02 111.052 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -123.16 -25.77 4.45 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.954 -0.567 . . . . 60.25 110.5 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 45' ' ' LEU . 49.5 t -109.02 134.77 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.033 0.444 . . . . 74.22 111.766 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -138.21 127.36 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 71.33 109.284 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.61 HG12 ' HB2' ' A' ' 45' ' ' LEU . 41.1 mt -108.71 123.47 64.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.263 -0.273 . . . . 73.14 110.263 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 88.1 m-85 -107.54 131.9 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.371 -0.377 . . . . 62.14 111.025 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 58.9 mttm -97.22 99.86 11.33 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.327 -0.62 . . . . 62.33 109.327 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.3 mt -81.75 83.18 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.452 0.644 . . . . 75.13 109.338 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 49' ' ' TRP . 12.9 m120 -86.64 78.02 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.759 -0.655 . . . . 60.11 110.712 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.487 ' HB ' HD22 ' A' ' 84' ' ' ASN . 18.4 pt -112.68 64.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.405 -0.816 . . . . 65.23 109.337 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.39 -32.46 38.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.41 -1.268 . . . . 64.21 112.542 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.54 -15.58 62.29 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.976 0.417 . . . . 63.52 111.367 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.487 HD22 ' HB ' ' A' ' 81' ' ' ILE . 30.1 m-80 -105.53 76.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 73.53 110.573 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -62.94 -33.17 74.78 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.933 -0.576 . . . . 73.43 110.7 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.8 m-20 -51.55 -32.14 27.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.825 -0.625 . . . . 63.32 111.651 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -55.89 -39.64 58.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.37 . . . . 71.01 110.679 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.64 96.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 74.24 109.918 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.7 m -64.57 -39.24 93.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.551 -0.75 . . . . 72.42 110.744 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.5 mm100 -63.27 -52.21 62.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.176 -0.466 . . . . 52.44 110.727 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -81.52 -11.78 59.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.989 -0.55 . . . . 63.04 111.16 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.71 44.81 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.271 -0.49 . . . . 65.55 112.507 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.478 HG13 ' OG1' ' A' ' 98' ' ' THR . 87.9 t -60.14 112.83 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.137 0.494 . . . . 75.31 110.09 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 m -87.06 -44.9 11.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.495 -0.775 . . . . 63.12 111.561 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.93 163.5 32.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.438 -0.346 . . . . 52.44 110.445 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 25.7 pt -101.45 133.06 21.1 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 75.51 110.64 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 66.4 Cg_endo -90.21 -178.02 11.13 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.77 -1.346 . . . . 64.14 111.967 -3.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.478 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.2 m -136.24 130.9 33.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.328 -0.397 . . . . 74.0 110.008 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 47' ' ' ASP . 44.2 mm -119.46 115.88 49.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.604 -0.725 . . . . 62.41 110.264 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 19.8 mt -88.14 158.66 18.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.345 -0.613 . . . . 72.51 109.345 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 31.7 mtt -123.55 141.76 51.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 65.12 109.728 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -140.95 154.36 46.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.074 -0.713 . . . . 73.14 109.074 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.5 ttmm -150.47 110.52 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.042 -0.263 . . . . 74.24 110.542 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.761 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.7 t30 64.03 25.27 13.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.598 0.714 . . . . 72.22 110.3 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.76 -16.47 41.19 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.767 -0.651 . . . . 43.11 111.925 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 34.5 ttpt -75.12 145.29 42.35 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.805 0.442 . . . . 63.04 110.092 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -64.07 148.33 50.08 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.317 0.579 . . . . 71.43 110.849 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.49 168.18 26.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.872 -1.158 . . . . 61.41 107.872 -170.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 m -69.86 -177.99 1.43 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.0 0.741 . . . . 72.41 113.0 -164.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 51.7 tt0 -149.15 146.29 27.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.767 0.794 . . . . 74.54 110.7 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.19 119.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 113.93 -1.487 . . . . 70.11 109.542 -173.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.1 mt -113.34 123.96 69.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.144 -0.317 . . . . 62.14 110.144 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.31 152.36 24.39 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.605 -0.598 . . . . 60.32 111.605 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 72.38 4.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.85 0.357 . . . . 33.13 111.185 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 119' ' ' ILE . 8.5 t70 -115.59 88.1 2.81 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.293 0.568 . . . . 64.24 109.516 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 66' ' ' LEU . 10.1 tp -59.14 -33.09 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.502 -0.772 . . . . 62.15 111.289 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.3 m -61.2 -49.52 76.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.011 0.434 . . . . 72.2 110.518 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -60.32 -44.13 95.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.038 -0.528 . . . . 55.14 110.077 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 115' ' ' ASP . 66.7 mt -58.21 -56.54 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 62.22 111.317 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.03 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.001 0.429 . . . . 72.14 110.583 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 t -59.09 -52.14 67.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.773 -0.649 . . . . 43.12 110.362 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.94 -34.66 77.02 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.52 -0.309 . . . . 73.04 111.136 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.562 ' O ' HG13 ' A' ' 127' ' ' ILE . 81.7 mt -55.75 -56.57 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.514 -0.55 . . . . 73.41 109.514 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -63.37 -37.05 85.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.05 -0.523 . . . . 70.22 110.526 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.74 -36.15 78.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 72.2 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -103.26 -1.13 29.33 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.43 0.53 . . . . 71.2 112.43 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 123' ' ' ILE . 82.5 mt -84.8 -60.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 54.51 110.419 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.577 -0.738 . . . . 71.43 110.705 -172.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 75.9 mmm . . . . . 0 C--O 1.24 0.571 0 CA-C-O 120.818 0.342 . . . . 71.32 110.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.55 HG21 ' HE2' ' A' ' 78' ' ' LYS . 5.6 mm -66.83 108.86 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.824 -0.625 . . . . 62.2 110.094 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 10.4 tp10 -88.9 134.96 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.234 -0.284 . . . . 70.14 110.234 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -96.18 119.06 33.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 71.41 110.464 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.475 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.8 pt -134.58 160.97 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.294 -0.412 . . . . 73.54 111.305 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.51 -170.68 27.98 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 116.095 -0.502 . . . . 75.43 112.301 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.9 -50.37 73.68 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.002 0.43 . . . . 65.03 111.281 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -61.0 -21.21 63.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.979 -0.555 . . . . 74.42 111.319 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.464 ' CB ' ' HB ' ' A' ' 26' ' ' ILE . 5.8 mm-40 -88.8 -14.08 37.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 75.54 111.657 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -57.34 -62.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 65.25 110.837 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.92 -50.57 72.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.089 0.471 . . . . 73.42 110.263 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -50.74 -57.44 8.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.284 -0.871 . . . . 43.22 111.593 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 26' ' ' ILE . 49.1 mmtm -75.39 -28.9 59.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.98 -0.554 . . . . 63.34 111.757 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.478 ' HA ' HD13 ' A' ' 44' ' ' ILE . 51.5 t -70.6 -37.51 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 121.1 -0.24 . . . . 74.14 111.292 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -86.44 -30.41 22.08 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.085 0.402 . . . . 53.41 112.085 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -74.33 7.44 2.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.043 0.386 . . . . 74.54 112.043 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 29.4 p -67.78 162.51 23.76 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.161 -0.311 . . . . 55.23 110.161 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -73.66 -82.71 0.05 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.637 0.256 . . . . 72.42 111.052 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -160.87 138.48 9.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.882 -0.414 . . . . 63.42 109.882 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 59.2 t30 62.09 1.99 0.75 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.97 0.508 . . . . 72.45 111.606 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -63.82 110.15 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.377 -0.374 . . . . 70.51 111.116 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HG22 ' A' ' 74' ' ' VAL . 55.4 tp -76.27 114.41 14.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.174 -0.676 . . . . 72.33 109.174 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 38' ' ' CYS . 77.8 mt -99.86 110.46 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.989 -1.005 . . . . 72.45 110.492 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.676 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.9 mp -93.45 121.51 34.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 73.21 109.436 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 60.2 t -103.31 105.48 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.401 -0.592 . . . . 72.45 109.401 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' HD13 ' A' ' 99' ' ' ILE . 27.2 t70 -83.63 129.37 34.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.872 0.368 . . . . 62.13 111.446 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.95 114.09 25.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.142 -1.059 . . . . 65.22 108.142 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.63 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 3.1 t90 -77.75 -42.26 34.76 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.486 0.491 . . . . 74.34 111.883 -164.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB2' HG21 ' A' ' 96' ' ' ILE . . . 69.92 134.61 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.805 0.691 . . . . 54.33 110.964 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.75 -31.35 94.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.508 2.139 . . . . 64.33 111.4 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -127.82 136.32 51.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.543 -0.753 . . . . 73.15 109.014 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 5.2 p -146.64 -82.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.348 -0.141 . . . . 63.3 111.245 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . 108.86 -85.83 0.42 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.072 -0.585 . . . . 43.4 111.662 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 53' ' ' CYS . 19.4 Cg_endo -58.13 -9.83 7.05 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.916 2.411 . . . . 54.22 112.259 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.73 -37.52 63.42 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.004 -0.544 . . . . 71.35 110.676 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 14.2 ptm180 -56.88 -34.25 67.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.145 -0.48 . . . . 74.44 111.151 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.5 m -75.84 -54.86 6.27 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.8 0.81 . . . . 70.35 111.04 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -64.51 -41.99 96.08 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.188 -0.915 . . . . 64.1 113.222 -169.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.77 -53.92 60.67 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 117.962 0.346 . . . . 65.12 111.301 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.86 -27.88 58.98 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.678 1.585 . . . . 64.23 112.3 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.0 mt-30 -65.07 -38.82 92.04 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.426 -0.51 . . . . 75.21 110.069 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 95.8 mt -69.01 -40.04 78.92 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 74.14 109.499 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 5.7 mm-40 -53.85 -49.18 69.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.493 -0.776 . . . . 65.51 110.18 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -54.59 -52.39 62.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.711 -0.677 . . . . 74.54 110.775 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.473 HD13 HD12 ' A' ' 123' ' ' ILE . 52.0 mt -65.02 -33.38 75.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 74.51 110.103 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -72.53 -14.91 61.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.46 . . . . 43.32 110.969 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.4 mt-30 -93.69 -39.22 10.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.882 0.373 . . . . 74.13 110.666 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -69.59 -34.01 73.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.542 0.687 . . . . 75.41 110.301 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.87 6.29 33.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.039 -0.982 . . . . 75.22 111.533 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.1 t -52.97 -22.15 5.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.634 0.975 . . . . 63.31 113.634 -168.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -78.66 -23.04 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 74.02 111.166 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.19 5.59 6.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.132 -0.486 . . . . 60.25 111.483 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.547 HG22 ' HB3' ' A' ' 43' ' ' LEU . 65.6 t -139.81 145.1 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.695 0.283 . . . . 74.22 111.578 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 28.5 tptp -148.77 127.86 12.8 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.649 -0.5 . . . . 71.33 109.649 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.9 mt -103.14 145.17 12.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.006 0.432 . . . . 73.14 111.052 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 98.4 m-85 -126.87 167.84 15.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.73 -0.668 . . . . 62.14 110.147 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 9.7 tppt? -136.49 108.52 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.273 -1.01 . . . . 62.33 108.273 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.754 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -75.65 128.29 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 75.13 110.347 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.6 21.31 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.443 0.64 . . . . 60.11 110.503 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 pt -94.55 32.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.427 0.632 . . . . 65.23 109.834 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.31 -18.58 50.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.822 -1.081 . . . . 64.21 111.59 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -89.29 5.99 42.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 63.52 111.623 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.413 ' ND2' HG23 ' A' ' 87' ' ' VAL . 49.9 t30 -116.43 89.06 3.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.963 0.411 . . . . 73.53 110.307 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -67.88 -21.77 65.13 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 73.43 111.521 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -50.13 -45.8 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.398 . . . . 63.32 110.547 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.413 HG23 ' ND2' ' A' ' 84' ' ' ASN . 74.0 t -60.35 -34.48 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.795 -0.639 . . . . 71.01 110.525 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.28 -51.5 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.041 0.448 . . . . 74.24 110.058 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -61.87 -42.23 98.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 72.42 110.914 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.89 -50.31 71.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.121 -0.491 . . . . 52.44 111.07 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.06 -4.69 58.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.398 -0.365 . . . . 63.04 111.493 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.72 34.86 37.7 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.202 -0.523 . . . . 65.55 113.53 170.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.526 HG13 ' OG1' ' A' ' 98' ' ' THR . 83.9 t -68.29 130.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 75.31 110.361 176.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.4 m -129.82 -71.3 0.61 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 63.12 110.083 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.64 136.18 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 110.027 -0.36 . . . . 52.44 110.027 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 50' ' ' ALA . 2.2 pp -113.71 151.22 44.45 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.421 -0.354 . . . . 75.51 111.335 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.08 160.81 91.24 Favored 'Cis proline' 0 C--N 1.353 0.815 0 C-N-CA 124.079 -1.217 . . . . 64.14 112.365 -0.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.529 HG23 HG12 ' A' ' 112' ' ' ILE . 92.3 m -119.74 129.91 54.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 74.0 109.871 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 111' ' ' VAL . 45.8 mm -110.16 113.48 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 62.41 110.899 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 38.0 mt -91.04 152.46 20.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.553 -0.906 . . . . 72.51 108.553 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.426 ' HB3' HD11 ' A' ' 43' ' ' LEU . 36.9 mtt -124.12 141.38 52.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.883 0.31 . . . . 65.12 110.309 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.524 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 99.4 m-85 -143.94 154.94 43.83 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.851 -0.796 . . . . 73.14 108.851 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -144.19 104.86 4.16 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.683 -0.407 . . . . 74.24 111.04 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.682 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 7.9 t30 55.41 32.82 19.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.561 0.696 . . . . 72.22 110.627 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.0 -16.48 59.42 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.736 -0.666 . . . . 43.11 112.587 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -71.79 140.74 49.57 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 110.157 -0.312 . . . . 63.04 110.157 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.556 ' O ' HD22 ' A' ' 108' ' ' LEU . 12.2 mmmm -68.42 134.42 50.17 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.281 0.562 . . . . 71.43 110.961 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.556 HD22 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -139.0 168.84 18.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.44 -1.254 . . . . 61.41 109.057 -170.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -69.81 -178.62 1.57 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.252 0.834 . . . . 72.41 113.252 -163.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.428 ' HG3' HD23 ' A' ' 100' ' ' LEU . 48.4 tt0 -148.76 122.46 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.092 -0.958 . . . . 74.54 109.689 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.505 HG23 ' HB ' ' A' ' 99' ' ' ILE . 19.4 m -113.9 130.16 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.177 0.513 . . . . 70.11 110.028 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.529 HG12 HG23 ' A' ' 98' ' ' THR . 58.0 mt -116.08 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 62.14 109.711 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.2 148.08 14.4 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.896 -0.482 . . . . 60.32 111.896 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.61 72.12 6.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.825 0.345 . . . . 33.13 111.174 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.4 t70 -122.76 91.94 3.6 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.349 -0.612 . . . . 64.24 109.349 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -59.33 -30.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 62.15 111.207 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.0 t -63.49 -49.22 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 72.2 110.071 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.47 -43.05 99.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.801 -0.444 . . . . 55.14 109.801 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 123' ' ' ILE . 70.9 mt -57.73 -56.27 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.718 -0.674 . . . . 62.22 111.104 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.19 -39.4 82.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 120.675 0.274 . . . . 72.14 110.436 -177.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.44 ' HA ' HD21 ' A' ' 124' ' ' ASN . 66.9 m -54.78 -52.0 63.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.794 -0.447 . . . . 43.12 109.794 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 25.1 mm-40 -67.64 -32.19 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 73.04 111.478 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.7 mt -60.2 -56.18 19.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.383 -0.527 . . . . 73.41 109.918 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.44 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.2 p30 -68.01 -28.3 67.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.52 -0.472 . . . . 70.22 109.89 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 6.6 t30 -65.09 -44.49 88.68 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.664 -0.698 . . . . 72.2 111.403 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -91.32 -8.78 47.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.548 -0.296 . . . . 71.2 111.628 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.8 mt -76.44 -50.36 22.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.159 0.504 . . . . 54.51 109.645 167.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.401 -0.809 . . . . 71.43 109.667 -176.482 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.452 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 94.3 mmm . . . . . 0 C--O 1.238 0.474 0 CA-C-O 120.825 0.345 . . . . 71.32 110.507 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.751 HG22 ' HG3' ' A' ' 78' ' ' LYS . 3.3 mm -68.76 101.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.234 -0.654 . . . . 62.2 109.234 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 40.5 tt0 -90.65 127.2 36.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.888 -0.596 . . . . 70.14 111.532 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -85.51 128.53 34.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.799 0.333 . . . . 71.41 110.436 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.34 164.79 32.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.492 -0.322 . . . . 73.54 111.031 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 -178.56 38.96 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.825 -0.625 . . . . 75.43 112.404 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.36 -43.4 94.66 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.004 0.43 . . . . 65.03 110.995 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -64.99 -36.16 83.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 74.42 110.539 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -74.09 -17.45 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 75.54 111.859 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -52.93 -62.31 1.73 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.633 0.254 . . . . 65.25 111.22 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 36' ' ' THR . 24.7 t70 -64.38 -45.99 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.02 0.438 . . . . 73.42 110.686 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -56.63 -57.16 13.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.331 -0.85 . . . . 43.22 110.701 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HE3' ' CE2' ' A' ' 77' ' ' TYR . 24.1 mmmt -65.28 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.698 -0.683 . . . . 63.34 110.885 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.63 -51.72 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.667 0.27 . . . . 74.14 111.143 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 32' ' ' ASP . 8.9 t -86.01 -10.71 54.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.829 0.307 . . . . 53.41 111.829 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -72.81 -12.59 61.05 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.923 0.342 . . . . 74.54 111.923 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.693 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 15.5 p -55.13 143.59 26.79 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.591 0.234 . . . . 55.23 111.488 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -54.56 -79.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.067 -0.515 . . . . 72.42 111.588 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' H ' HG12 ' A' ' 42' ' ' ILE . 33.8 t70 -159.33 125.8 4.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.473 0.178 . . . . 63.42 110.793 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 59.21 15.33 4.13 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.885 0.474 . . . . 72.45 111.418 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.693 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -76.32 118.71 23.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.309 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 74' ' ' VAL . 63.7 tp -74.46 122.03 22.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.945 -0.57 . . . . 72.33 110.424 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 38' ' ' CYS . 37.6 mt -110.77 121.91 64.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.661 -0.7 . . . . 72.45 110.295 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 4.4 mp -104.79 112.59 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.243 -0.651 . . . . 73.21 109.243 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -93.95 104.67 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.944 -0.391 . . . . 72.45 109.944 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.21 146.65 30.37 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.982 -0.554 . . . . 62.13 110.916 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -107.89 129.04 55.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 65.22 109.819 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.41 140.52 45.39 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 74.34 111.576 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB1' HD12 ' A' ' 96' ' ' ILE . . . -99.33 107.94 47.54 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 54.33 110.922 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -52.46 -52.46 8.84 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.746 2.297 . . . . 64.33 111.471 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.576 ' HB2' HD11 ' A' ' 96' ' ' ILE . 45.3 m95 -80.15 75.85 6.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.407 -0.96 . . . . 73.15 108.407 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.445 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 7.6 t -75.65 79.19 2.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.502 -0.772 . . . . 63.3 110.27 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -108.57 -74.04 0.82 Allowed Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.5 -0.773 . . . . 43.4 111.432 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.88 -18.95 59.83 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.732 2.288 . . . . 54.22 111.612 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 27.8 p -52.13 -34.43 44.41 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.516 -0.765 . . . . 71.35 110.379 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -53.8 -49.37 68.47 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.948 -0.569 . . . . 74.44 111.083 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.623 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 48.0 m -75.24 -42.8 54.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.072 0.463 . . . . 70.35 111.526 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.7 -37.83 88.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.815 0.672 . . . . 64.1 112.815 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 58.5 mm-40 -55.81 -58.84 13.67 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 117.967 0.349 . . . . 65.12 110.736 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 36.4 Cg_endo -65.29 -27.53 55.71 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.938 1.759 . . . . 64.23 112.372 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.2 mt-30 -68.32 -40.62 81.61 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.698 -0.401 . . . . 75.21 110.71 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.99 -43.03 84.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.633 -0.506 . . . . 74.14 109.633 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 2.9 mm-40 -52.73 -47.14 67.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.722 -0.672 . . . . 65.51 110.131 174.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -52.29 -57.08 10.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.824 -0.626 . . . . 74.54 110.837 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.46 HD13 HD12 ' A' ' 123' ' ' ILE . 31.4 mt -65.78 -31.36 72.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.676 -0.693 . . . . 74.51 110.379 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.53 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -68.46 -44.2 75.36 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.873 -0.603 . . . . 43.32 110.223 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.0 mt-30 -71.38 -37.52 71.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.271 0.558 . . . . 74.13 110.581 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -73.4 -37.34 65.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.719 -0.673 . . . . 75.41 111.122 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.96 5.25 32.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.121 -0.491 . . . . 75.22 112.166 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.7 t -52.86 -21.17 3.92 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.135 0.791 . . . . 63.31 113.135 -171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.66 -28.27 69.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 74.02 110.472 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.14 8.37 3.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.2 -0.454 . . . . 60.25 111.765 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 43' ' ' LEU . 64.9 t -134.41 141.9 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.053 0.454 . . . . 74.22 112.068 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 57.0 tptt -145.17 126.09 14.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.429 -0.805 . . . . 71.33 109.31 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 45' ' ' LEU . 36.0 mt -108.31 140.25 27.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.742 0.306 . . . . 73.14 110.542 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 86.2 m-85 -121.39 170.5 9.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 62.14 109.712 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.751 ' HG3' HG22 ' A' ' 23' ' ' ILE . 28.8 mtpp -136.12 128.5 30.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.63 -0.507 . . . . 62.33 109.63 173.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.67 67.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.661 -1.237 . . . . 75.13 107.661 168.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -85.24 66.09 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.241 -0.891 . . . . 60.11 110.656 -170.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.5 mt -100.81 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.182 -1.044 . . . . 65.23 108.182 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -23.23 2.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.35 -1.296 . . . . 64.21 113.069 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.77 -36.47 23.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.689 0.255 . . . . 63.52 111.689 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -96.9 82.24 3.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.156 0.503 . . . . 73.53 111.258 -170.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -68.43 -20.59 64.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.628 . . . . 73.43 109.991 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.9 m-20 -47.97 -39.51 19.67 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.476 -0.784 . . . . 63.32 111.427 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.8 -36.98 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.903 -0.59 . . . . 71.01 110.935 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.07 79.02 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 74.24 110.44 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.6 m -67.56 -37.77 83.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.78 -0.645 . . . . 72.42 111.02 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.6 mm100 -63.62 -46.08 87.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 52.44 110.788 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -87.28 -15.07 39.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.345 -0.389 . . . . 63.04 111.631 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 41.94 9.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.165 -0.54 . . . . 65.55 112.911 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.449 HG13 ' OG1' ' A' ' 98' ' ' THR . 93.4 t -65.23 103.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.888 -0.412 . . . . 75.31 109.888 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -77.76 -37.86 48.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 63.12 111.526 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.522 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -140.68 138.47 34.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.359 -0.382 . . . . 52.44 110.186 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 52' ' ' TRP . 18.6 pt -106.51 140.77 21.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.075 -0.512 . . . . 75.51 110.777 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.22 -179.57 26.22 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.774 -1.344 . . . . 64.14 112.408 -0.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HG12 ' A' ' 112' ' ' ILE . 93.8 m -138.61 132.58 31.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 74.0 110.121 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 44.2 mm -115.86 110.84 33.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.956 -0.566 . . . . 62.41 111.001 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -93.22 123.3 36.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.436 -0.579 . . . . 72.51 109.436 174.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.532 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 12.1 mmt -91.56 140.61 29.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.308 . . . . 65.12 110.328 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -143.77 148.35 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.151 -1.055 . . . . 73.14 108.151 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -145.61 112.06 5.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.076 -0.65 . . . . 74.24 111.384 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.64 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.6 t-20 62.19 25.95 15.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.552 0.691 . . . . 72.22 110.434 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.34 -16.55 58.65 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.576 -0.738 . . . . 43.11 112.084 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -73.5 142.4 46.77 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.041 -0.355 . . . . 63.04 110.041 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.32 127.48 33.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.43 110.725 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 108' ' ' LEU . 2.8 mm? -126.93 168.5 14.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.095 . . . . 61.41 110.576 -172.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.24 163.25 26.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.608 -0.723 . . . . 72.41 111.913 -167.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -127.25 124.34 38.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 74.54 110.044 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 32.2 m -102.8 140.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 109.814 -0.439 . . . . 70.11 109.814 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' A' ' 95' ' ' ALA . 63.2 mt -127.92 134.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 62.14 110.03 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.21 145.24 13.4 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.093 -0.575 . . . . 60.32 111.672 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.8 79.77 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 33.13 111.101 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -132.19 98.32 4.38 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.57 -0.53 . . . . 64.24 109.57 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.96 -28.78 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 62.15 110.799 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 t -64.89 -43.68 92.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.764 -0.458 . . . . 72.2 109.764 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -67.02 -44.77 79.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.125 -0.489 . . . . 55.14 109.958 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.9 mt -56.66 -54.01 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.996 -0.547 . . . . 62.22 110.958 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.25 -37.33 79.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 116.318 -0.401 . . . . 72.14 110.199 -177.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.427 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 21.5 t -56.44 -48.81 76.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.451 -0.574 . . . . 43.12 109.451 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 49.4 mm-40 -66.47 -37.16 84.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.384 -0.371 . . . . 73.04 111.046 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.5 mt -53.27 -55.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 120.833 -0.347 . . . . 73.41 110.133 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' A' ' 121' ' ' SER . 7.7 p30 -69.12 -29.56 67.64 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.561 -0.456 . . . . 70.22 110.111 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 44.2 t30 -66.68 -32.81 74.36 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.411 . . . . 72.2 111.017 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.407 ' OD1' HD12 ' A' ' 108' ' ' LEU . 64.7 m-80 -86.91 -31.07 20.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.811 -0.177 . . . . 71.2 111.152 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.5 mt -69.25 -39.8 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.112 0.482 . . . . 54.51 110.108 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.474 -0.774 . . . . 71.43 110.032 -179.022 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.9 mmm . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 120.809 0.338 . . . . 71.32 110.553 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.688 HG22 ' HB2' ' A' ' 78' ' ' LYS . 11.8 mm -63.28 103.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.628 -0.714 . . . . 62.2 109.284 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.85 125.13 27.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 70.14 111.558 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.1 120.68 24.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.238 -0.437 . . . . 71.41 110.007 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.4 pt -130.32 151.76 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.872 0.368 . . . . 73.54 111.607 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.77 -160.59 29.77 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.707 -0.678 . . . . 75.43 112.685 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -56.87 12.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.564 0.346 . . . . 65.03 111.769 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -65.16 -37.33 87.05 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.1 0.476 . . . . 74.42 110.23 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.87 -30.23 70.34 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.805 -0.634 . . . . 75.54 110.824 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.1 t80 -54.65 -58.01 9.22 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.335 -0.246 . . . . 65.25 110.335 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -53.48 -54.69 33.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.782 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.5 -56.85 16.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.793 -0.64 . . . . 43.22 111.054 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.1 mmtt -58.13 -35.71 71.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.203 -0.908 . . . . 63.34 111.655 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.85 -40.04 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.795 0.331 . . . . 74.14 110.933 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.8 p -78.18 -9.49 59.22 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.909 0.385 . . . . 53.41 110.933 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -61.71 -13.49 23.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.859 -0.609 . . . . 74.54 111.666 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.643 ' SG ' HD12 ' A' ' 44' ' ' ILE . 75.7 m -49.79 113.79 0.92 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.681 0.277 . . . . 55.23 111.061 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -63.58 -69.37 0.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.238 -0.653 . . . . 72.42 109.238 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -161.88 133.2 5.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.943 -0.571 . . . . 63.42 110.59 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 58.4 15.61 3.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.971 0.508 . . . . 72.45 111.661 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 mm -75.83 124.51 34.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.84 0.352 . . . . 70.51 110.758 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -82.78 118.34 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.777 -0.647 . . . . 72.33 109.438 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.643 HD12 ' SG ' ' A' ' 38' ' ' CYS . 21.3 mt -114.02 117.49 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.39 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.618 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.9 mp -104.31 131.15 51.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.684 -0.858 . . . . 73.21 108.684 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.2 108.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.204 -0.295 . . . . 72.45 110.204 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 22.2 t0 -81.86 138.25 35.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 62.13 110.02 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -78.51 177.65 8.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 65.22 111.128 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 80' ' ' ASN . 20.1 t90 -85.81 129.1 34.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.653 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.07 86.62 7.57 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.846 -0.616 . . . . 54.33 109.912 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.37 -22.44 21.73 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.296 1.997 . . . . 64.33 111.982 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -117.77 111.17 18.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 73.15 110.339 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -175.86 135.88 0.3 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.114 -0.494 . . . . 63.3 110.387 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -74.91 0.95 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.355 -0.45 . . . . 43.4 112.418 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.19 -23.03 72.54 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 54.22 113.057 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.469 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 71.8 m -55.83 -30.71 61.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.595 -0.275 . . . . 71.35 111.446 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -59.45 -32.42 70.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.852 0.358 . . . . 74.44 110.774 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.559 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.5 m -74.67 -38.17 62.49 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.809 0.814 . . . . 70.35 110.138 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.5 mm? -67.33 -34.71 77.92 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.359 -0.837 . . . . 64.1 111.975 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 45.5 mt-10 -55.05 -58.43 14.82 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 120.994 -0.282 . . . . 65.12 110.817 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 38.2 Cg_endo -66.62 -31.11 41.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.106 1.87 . . . . 64.23 112.332 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.1 mt-30 -62.79 -40.75 98.3 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.296 -0.562 . . . . 75.21 110.18 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.8 mt -68.73 -33.77 74.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.871 -0.604 . . . . 74.14 109.991 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 40.8 mt-10 -62.49 -44.55 96.12 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.324 -0.398 . . . . 65.51 110.271 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -54.79 -52.48 62.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.127 -0.488 . . . . 74.54 110.474 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.471 HD13 HD12 ' A' ' 123' ' ' ILE . 47.5 mt -65.33 -37.19 86.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.519 . . . . 74.51 110.205 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.58 -36.46 83.87 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.86 -0.609 . . . . 43.32 110.879 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -74.43 -50.35 18.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 74.13 110.544 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -63.54 -34.66 78.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 75.41 110.914 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -104.97 5.07 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 75.22 112.203 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.4 t -53.34 -20.0 3.95 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.37 0.507 . . . . 63.31 112.37 -172.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.19 -39.22 92.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 74.02 110.739 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.46 -9.88 12.03 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.051 -0.522 . . . . 60.25 110.848 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 43' ' ' LEU . 68.2 t -125.85 145.63 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.037 0.446 . . . . 74.22 111.635 -171.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.11 128.64 13.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.324 -0.621 . . . . 71.33 109.324 171.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.6 mt -111.5 129.13 67.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.078 0.466 . . . . 73.14 110.964 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.5 m-85 -114.81 177.84 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 62.14 109.18 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HB2' HG22 ' A' ' 23' ' ' ILE . 59.0 tttp -148.17 123.5 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 62.33 110.532 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 81' ' ' ILE . 29.2 mm -86.49 108.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 75.13 109.857 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.596 ' HA ' ' HB2' ' A' ' 49' ' ' TRP . 30.4 p-10 -114.98 4.9 14.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.451 -0.341 . . . . 60.11 111.116 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.56 HG22 HG23 ' A' ' 79' ' ' ILE . 6.1 tt -65.47 105.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.34 0.59 . . . . 65.23 109.782 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -54.99 -31.0 60.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.046 -0.979 . . . . 64.21 112.756 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.85 -19.39 61.97 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.787 0.291 . . . . 63.52 111.787 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.487 HD22 HG21 ' A' ' 79' ' ' ILE . 45.1 t30 -87.9 88.11 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.062 0.458 . . . . 73.53 111.786 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -107.14 -30.49 8.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 73.43 109.324 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.55 -55.98 5.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.041 -0.981 . . . . 63.32 111.411 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.99 -34.22 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.734 -0.666 . . . . 71.01 111.071 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.39 62.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.076 0.465 . . . . 74.24 110.162 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -67.1 -31.53 72.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.611 -0.722 . . . . 72.42 111.096 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -75.17 -38.52 60.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.228 -0.442 . . . . 52.44 111.666 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -91.95 -11.66 35.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.757 0.281 . . . . 63.04 111.757 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.87 53.21 2.76 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.908 -0.663 . . . . 65.55 113.394 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 98' ' ' THR . 98.4 t -79.69 106.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.677 -0.49 . . . . 75.31 109.677 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -82.88 -43.27 16.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.875 -0.602 . . . . 63.12 111.402 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.24 12.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.594 -0.276 . . . . 52.44 110.59 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.808 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -109.3 150.68 41.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.262 -0.426 . . . . 75.51 110.426 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 95.9 Cg_endo -77.84 174.81 50.29 Favored 'Cis proline' 0 C--N 1.353 0.803 0 C-N-CA 123.696 -1.377 . . . . 64.14 112.244 -1.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.442 HG21 HG22 ' A' ' 93' ' ' VAL . 92.3 m -142.36 115.28 8.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.291 -0.413 . . . . 74.0 110.439 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' A' ' 111' ' ' VAL . 32.3 mm -109.81 111.42 36.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.723 -0.671 . . . . 62.41 110.373 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 100' ' ' LEU . 2.2 mm? -88.42 125.81 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.194 -0.912 . . . . 72.51 109.835 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.618 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -94.76 138.28 32.77 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.749 -0.463 . . . . 65.12 109.749 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -135.88 144.14 45.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.69 -0.485 . . . . 73.14 109.69 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.7 tptp -132.59 106.38 7.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.927 -0.309 . . . . 74.24 110.216 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.86 26.23 15.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.119 0.485 . . . . 72.22 110.709 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.53 -6.36 82.51 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.707 -0.679 . . . . 43.11 112.299 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -87.9 152.1 22.33 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 120.581 0.229 . . . . 63.04 110.647 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 7.8 tmtm? -56.86 134.8 55.62 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 124.262 0.976 . . . . 71.43 110.809 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.53 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -145.09 169.08 18.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.534 -1.212 . . . . 61.41 108.539 -175.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 101' ' ' MET . 40.7 m -70.01 -177.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.211 0.529 . . . . 72.41 111.927 -164.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.49 ' HG3' HD13 ' A' ' 100' ' ' LEU . 49.2 tt0 -147.14 142.77 27.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.132 -0.486 . . . . 74.54 110.141 -173.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.502 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.2 m -128.22 132.35 68.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.945 0.402 . . . . 70.11 110.247 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.31 135.69 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.802 -0.636 . . . . 62.14 109.424 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.92 154.53 21.27 Favored Glycine 0 C--O 1.235 0.156 0 C-N-CA 121.003 -0.618 . . . . 60.32 111.816 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.6 74.87 9.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.724 0.297 . . . . 33.13 111.377 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -123.96 93.61 3.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.292 0.568 . . . . 64.24 109.483 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -59.11 -30.6 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.524 -0.762 . . . . 62.15 111.047 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.0 t -67.82 -41.23 83.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.442 -0.345 . . . . 72.2 110.25 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -70.74 -40.96 72.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 110.08 -0.341 . . . . 55.14 110.08 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.71 -55.77 20.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.123 -0.49 . . . . 62.22 110.635 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.494 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.58 -35.57 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.514 -0.55 . . . . 72.14 109.514 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.434 ' HA ' HD21 ' A' ' 124' ' ' ASN . 48.1 t -53.69 -52.28 60.54 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.913 -0.585 . . . . 43.12 109.901 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 33.6 mm-40 -67.1 -38.38 85.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.23 -0.441 . . . . 73.04 111.371 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.471 HD12 HD13 ' A' ' 66' ' ' LEU . 98.4 mt -54.19 -55.77 12.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 120.571 -0.452 . . . . 73.41 110.303 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.434 HD21 ' HA ' ' A' ' 121' ' ' SER . 8.5 p30 -71.47 -27.3 63.15 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.751 -0.379 . . . . 70.22 110.525 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.415 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 54.5 t30 -73.16 -28.51 62.27 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.131 -0.486 . . . . 72.2 110.864 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.45 HD22 ' N ' ' A' ' 126' ' ' ASN . 0.9 OUTLIER -85.73 -36.86 19.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 71.2 110.192 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 123' ' ' ILE . 70.6 mt -67.67 -44.88 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.136 0.493 . . . . 54.51 110.201 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.711 -0.661 . . . . 71.43 109.967 -178.73 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 C--O 1.234 0.243 0 N-CA-C 108.738 -0.838 . . . . 71.32 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.45 HG23 HG22 ' A' ' 76' ' ' ILE . 22.0 mm -67.34 93.37 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.811 -1.181 . . . . 62.2 107.811 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.77 111.83 6.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 70.14 111.759 -167.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 5.0 pm0 -69.97 129.38 39.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 71.41 110.202 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 36.8 pt -137.89 147.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.54 111.257 -174.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.53 -179.22 42.33 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.843 -0.617 . . . . 75.43 111.899 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.08 -48.4 67.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.745 0.418 . . . . 65.03 111.492 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 p -62.43 -35.35 78.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.039 -0.528 . . . . 74.42 111.158 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 44.8 mt-10 -77.49 -27.77 51.97 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.992 -0.549 . . . . 75.54 110.708 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.531 ' HA ' HD12 ' A' ' 26' ' ' ILE . 82.1 t80 -53.14 -61.02 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.165 0.291 . . . . 65.25 111.059 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.57 -52.61 61.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.159 0.504 . . . . 73.42 110.514 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -51.55 -57.24 9.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.086 -0.961 . . . . 43.22 111.035 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.6 mmtt -61.92 -46.56 88.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.201 -0.909 . . . . 63.34 111.234 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 31' ' ' PHE . 73.8 t -59.44 -38.75 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.686 0.279 . . . . 74.14 111.107 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -84.89 -16.7 40.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.702 0.286 . . . . 53.41 111.435 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -68.33 -13.39 62.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.381 -0.372 . . . . 74.54 111.471 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -55.16 122.17 10.44 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.707 -0.224 . . . . 55.23 110.7 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.12 -75.18 0.05 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.37 -0.377 . . . . 72.42 110.811 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -161.93 124.62 2.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.45 -0.341 . . . . 63.42 110.096 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.87 17.37 9.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.69 0.618 . . . . 72.45 111.347 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -78.22 104.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.435 -0.58 . . . . 70.51 109.435 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HB3' HG22 ' A' ' 74' ' ' VAL . 62.5 tp -68.9 108.18 3.38 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.509 0.671 . . . . 72.33 110.39 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 77' ' ' TYR . 35.9 mt -96.13 112.62 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.145 -0.934 . . . . 72.45 110.531 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.547 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -96.22 141.02 30.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.437 -0.949 . . . . 73.21 108.437 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.09 114.2 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 110.315 -0.254 . . . . 72.45 110.315 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -82.89 129.22 34.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.009 0.433 . . . . 62.13 110.117 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.493 ' CE1' HD13 ' A' ' 100' ' ' LEU . 5.2 m-85 -90.05 -39.57 12.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.816 -0.629 . . . . 65.22 110.134 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.632 ' HZ2' HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -164.28 94.34 0.72 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.534 -0.303 . . . . 74.34 111.62 -176.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.694 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . . . -96.02 109.57 47.45 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.24 -0.436 . . . . 54.33 110.469 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HG3' HD12 ' A' ' 96' ' ' ILE . 76.1 Cg_endo -92.07 130.08 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.996 2.464 . . . . 64.33 111.633 173.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -63.95 82.66 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.268 0.556 . . . . 73.15 111.164 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.665 ' H ' ' HB2' ' A' ' 56' ' ' CYS . 10.5 p -88.41 -169.21 2.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.472 -0.786 . . . . 63.3 109.567 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.11 -71.0 0.81 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.91 -0.662 . . . . 43.4 112.111 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.627 ' HD2' ' SG ' ' A' ' 53' ' ' CYS . 31.3 Cg_exo -60.3 -35.56 91.01 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.742 2.295 . . . . 54.22 112.468 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.665 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 14.2 m -60.24 -29.79 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.046 0.45 . . . . 71.35 110.595 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -53.42 -52.69 58.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.827 -0.624 . . . . 74.44 110.275 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.651 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.1 m -75.76 -30.53 59.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.056 -0.52 . . . . 70.35 111.521 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -59.23 -59.14 5.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.231 0.456 . . . . 64.1 112.231 -170.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.27 -51.24 51.56 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 111.798 0.295 . . . . 65.12 111.798 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.38 -48.37 22.35 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.701 1.601 . . . . 64.23 111.586 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.3 mt-30 -60.02 -29.85 68.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.944 -0.571 . . . . 75.21 111.147 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.33 -44.24 88.41 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.716 -0.476 . . . . 74.14 109.716 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 33.2 mt-10 -62.02 -37.38 84.69 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.046 -0.524 . . . . 65.51 110.062 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 22.0 ttmm -55.79 -53.81 52.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.005 0.431 . . . . 74.54 110.828 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.471 HD11 HD11 ' A' ' 116' ' ' ILE . 35.5 mt -63.79 -35.7 81.48 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.026 -0.534 . . . . 74.51 109.635 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.19 -44.31 95.72 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.445 -0.798 . . . . 43.32 110.16 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.9 mt-30 -60.61 -49.46 77.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.971 0.415 . . . . 74.13 110.265 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -62.17 -42.23 99.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.519 -0.764 . . . . 75.41 111.326 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -104.7 4.58 32.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.776 0.658 . . . . 75.22 112.776 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.55 -20.04 4.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.641 0.608 . . . . 63.31 112.641 -172.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.617 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 8.3 pt-20 -65.05 -33.69 76.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.606 0.241 . . . . 74.02 111.129 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.617 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 23.2 m-80 -124.19 5.12 8.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.509 -0.314 . . . . 60.25 110.909 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 43' ' ' LEU . 51.2 t -137.17 141.36 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.906 0.384 . . . . 74.22 111.556 -173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.89 130.07 16.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.389 -0.597 . . . . 71.33 109.389 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 45' ' ' LEU . 23.7 mt -109.39 138.47 36.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 120.951 0.405 . . . . 73.14 110.411 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 93.7 m-85 -119.27 170.4 9.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.676 . . . . 62.14 110.47 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -140.74 96.51 3.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.403 -0.962 . . . . 62.33 108.403 -179.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 12.7 tt -72.84 116.44 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.207 0.527 . . . . 75.13 111.239 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -90.83 68.94 6.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.753 0.787 . . . . 60.11 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.726 HG12 HG21 ' A' ' 87' ' ' VAL . 11.0 tp -94.91 29.82 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.964 0.888 . . . . 65.23 109.897 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.23 -18.24 1.45 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.752 -1.113 . . . . 64.21 113.451 -174.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.49 -23.75 61.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.887 0.328 . . . . 63.52 111.887 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -147.09 156.53 43.08 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.964 0.412 . . . . 73.53 111.255 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -3.9 23.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.941 -0.572 . . . . 73.43 110.163 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 6.0 m-20 -50.71 -40.41 54.11 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.094 -0.503 . . . . 63.32 111.027 -176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 81' ' ' ILE . 85.5 t -54.27 -38.04 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 115.865 -0.607 . . . . 71.01 111.208 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.92 97.63 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.108 0.48 . . . . 74.24 109.963 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 m -62.63 -37.86 87.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 72.42 110.514 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 77.3 mm-40 -63.86 -54.92 27.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.797 -0.638 . . . . 52.44 110.706 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.09 -14.04 58.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.323 -0.399 . . . . 63.04 111.72 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.41 59.13 5.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.037 -0.602 . . . . 65.55 112.127 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.632 HG21 ' HZ2' ' A' ' 49' ' ' TRP . 78.6 t -67.56 109.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 75.31 110.8 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.0 t -67.7 -50.52 57.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.903 -0.59 . . . . 63.12 110.71 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.69 172.57 16.46 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.346 -0.388 . . . . 52.44 110.683 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.5 HG22 ' CD1' ' A' ' 49' ' ' TRP . 23.8 pt -113.6 148.37 39.58 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.923 -0.581 . . . . 75.51 109.835 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.694 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 72.1 Cg_endo -73.36 168.49 75.95 Favored 'Cis proline' 0 C--N 1.355 0.902 0 C-N-CA 124.21 -1.162 . . . . 64.14 112.788 -0.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.2 m -128.27 110.96 12.88 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.956 -0.566 . . . . 74.0 110.406 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.4 mm -114.85 110.9 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.165 -0.47 . . . . 62.41 110.435 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.493 HD13 ' CE1' ' A' ' 48' ' ' PHE . 8.5 mp -96.17 155.02 16.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.304 -0.258 . . . . 72.51 110.304 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.519 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 35.2 mtt -119.0 150.4 40.01 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 110.196 -0.298 . . . . 65.12 110.196 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -144.27 152.29 40.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.089 0.556 . . . . 73.14 109.609 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -148.03 122.5 9.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.513 -0.181 . . . . 74.24 110.513 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.56 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.9 m-20 57.67 32.53 22.0 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.292 0.568 . . . . 72.22 110.665 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.44 75.88 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.689 -0.687 . . . . 43.11 112.479 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -117.4 152.67 34.49 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.068 -0.345 . . . . 63.04 110.068 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 8.8 tmtt? -69.46 126.41 29.65 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.938 0.774 . . . . 71.43 111.286 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.506 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.6 mm? -126.44 168.99 13.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.225 1.41 . . . . 61.41 109.19 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -179.82 1.9 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.274 0.559 . . . . 72.41 111.879 -164.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -148.85 143.37 26.24 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.853 0.835 . . . . 74.54 111.009 -172.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 t -123.43 130.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 113.843 -1.526 . . . . 70.11 109.753 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.1 124.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.483 . . . . 62.14 109.697 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.94 149.21 21.2 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.544 -0.622 . . . . 60.32 111.544 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.64 87.52 7.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.777 0.323 . . . . 33.13 110.972 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -130.28 100.11 5.27 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.432 -0.581 . . . . 64.24 109.432 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 66' ' ' LEU . 9.7 tp -61.01 -33.22 54.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.58 . . . . 62.15 111.084 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 120' ' ' ILE . 34.2 t -63.85 -50.08 70.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 72.2 110.482 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.53 -45.03 92.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.5 -0.318 . . . . 55.14 110.302 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.476 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -58.13 -53.39 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.358 . . . . 62.22 110.719 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -61.5 -39.49 83.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 110.062 -0.347 . . . . 72.14 110.062 -178.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.634 ' HA ' HD21 ' A' ' 124' ' ' ASN . 67.2 m -59.44 -49.94 75.87 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.542 -0.299 . . . . 43.12 110.528 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -61.27 -37.75 84.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.407 -0.36 . . . . 73.04 110.483 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.1 mt -59.43 -56.22 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.518 0.199 . . . . 73.41 110.938 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.634 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.5 p30 -70.25 -25.6 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.757 -0.377 . . . . 70.22 110.386 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -69.4 -38.05 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 72.2 110.284 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.519 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 93.1 m-20 -87.88 -18.6 28.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.697 -0.683 . . . . 71.2 111.519 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 123' ' ' ILE . 78.9 mt -78.3 -45.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 54.51 110.126 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.571 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.634 -0.698 . . . . 71.43 109.921 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.8 mmm . . . . . 0 C--O 1.233 0.198 0 N-CA-C 109.333 -0.617 . . . . 71.32 109.333 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -65.34 88.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.1 -0.704 . . . . 62.2 109.1 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 17.0 tt0 -67.8 111.81 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.599 -0.728 . . . . 70.14 109.679 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.2 135.75 33.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 71.41 110.88 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.4 pt -139.39 175.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.888 -0.596 . . . . 73.54 110.29 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -121.86 -167.83 13.2 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.267 -0.424 . . . . 75.43 112.177 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.23 -54.28 38.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.727 0.411 . . . . 65.03 112.007 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -66.68 -29.34 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.392 -0.367 . . . . 74.42 110.925 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.416 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 4.8 mm-40 -84.18 -21.31 31.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 75.54 112.005 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 26' ' ' ILE . 86.8 t80 -55.74 -61.9 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.623 0.249 . . . . 65.25 111.461 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.09 -43.49 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 73.42 110.506 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -52.58 -57.46 9.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.78 -0.645 . . . . 43.22 111.063 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 26' ' ' ILE . 47.8 mmtm -70.95 -38.14 72.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 63.34 111.473 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.58 -37.89 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.632 0.254 . . . . 74.14 110.94 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.5 p -83.04 -22.49 33.54 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.728 0.299 . . . . 53.41 110.99 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t -64.86 -5.14 5.36 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.328 -0.397 . . . . 74.54 111.71 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 104' ' ' ASN . 85.8 m -62.66 106.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.536 0.208 . . . . 55.23 110.514 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -61.24 -68.23 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.286 -0.415 . . . . 72.42 111.269 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -147.05 128.96 15.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.659 0.266 . . . . 63.42 111.551 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.66 24.54 5.59 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.644 0.778 . . . . 72.45 112.046 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 50.2 mm -78.61 113.61 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.591 -0.277 . . . . 70.51 110.262 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB3' HG22 ' A' ' 74' ' ' VAL . 2.5 tm? -90.21 112.3 23.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.422 0.629 . . . . 72.33 109.583 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 49.3 mt -101.76 135.23 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.504 -0.771 . . . . 72.45 111.003 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.4 mp -111.07 116.99 32.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.773 -0.825 . . . . 73.21 108.773 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.4 t -99.12 105.03 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.978 -0.378 . . . . 72.45 109.978 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.508 ' HA ' HD13 ' A' ' 99' ' ' ILE . 7.7 t70 -77.04 139.55 40.07 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.826 -0.624 . . . . 62.13 111.335 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -107.51 87.21 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.641 -0.874 . . . . 65.22 108.641 170.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 27.1 t-105 -43.34 130.38 4.9 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.671 -1.149 . . . . 74.34 112.974 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.09 103.85 51.56 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.638 -0.71 . . . . 54.33 109.642 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.18 -26.19 75.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.761 2.307 . . . . 64.33 112.684 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -121.36 105.45 10.54 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.388 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -174.15 146.73 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 63.3 110.544 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.67 -66.83 1.28 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.229 -0.441 . . . . 43.4 112.828 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.78 -28.69 59.49 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.587 2.191 . . . . 54.22 112.308 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 59.1 m -56.59 -31.92 64.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.076 -0.511 . . . . 71.35 111.159 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.603 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -54.35 -60.86 2.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.358 0.599 . . . . 74.44 109.858 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.532 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 50.3 m -55.43 -38.26 68.75 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 114.448 -1.251 . . . . 70.35 111.695 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 3.6 mm? -57.77 -34.95 70.12 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.335 -0.393 . . . . 64.1 110.941 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.4 mt-10 -55.94 -64.07 2.65 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.228 -0.415 . . . . 65.12 111.052 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 57' ' ' ARG . 33.4 Cg_endo -64.77 -24.75 61.39 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.788 1.658 . . . . 64.23 112.18 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.0 mt-30 -63.26 -44.17 95.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.306 -0.558 . . . . 75.21 110.077 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.0 mt -68.4 -39.62 81.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.903 -0.589 . . . . 74.14 110.099 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 46.5 mt-10 -60.93 -35.82 77.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.002 -0.544 . . . . 65.51 110.281 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.51 -56.21 24.84 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.031 0.443 . . . . 74.54 110.264 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 116' ' ' ILE . 59.3 mt -56.26 -39.06 72.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.659 -0.701 . . . . 74.51 109.572 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -61.8 -48.24 81.49 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.115 -0.948 . . . . 43.32 110.251 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -55.93 -42.42 76.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 74.13 110.805 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -66.65 -45.09 80.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.003 -0.544 . . . . 75.41 111.303 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -101.71 5.47 41.4 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.996 0.739 . . . . 75.22 112.996 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.44 -19.61 3.77 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.334 0.865 . . . . 63.31 113.334 -169.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.8 -29.59 66.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 74.02 111.211 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -119.28 -11.03 9.62 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.896 -0.593 . . . . 60.25 111.275 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 43' ' ' LEU . 57.2 t -125.62 142.7 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.056 0.455 . . . . 74.22 111.656 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 5.2 tppp? -145.63 131.73 19.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 71.33 109.578 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.5 mt -103.72 120.69 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.0 -0.37 . . . . 73.14 110.0 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 50.2 m-85 -107.37 153.75 22.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.667 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.766 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 24.9 ttpt -131.32 120.18 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.274 -0.639 . . . . 62.33 109.274 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 81' ' ' ILE . 39.9 mt -73.1 106.82 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.23 -1.026 . . . . 75.13 108.23 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.13 73.0 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.044 0.45 . . . . 60.11 111.394 -171.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 87' ' ' VAL . 26.5 pt -147.0 31.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.385 -0.825 . . . . 65.23 109.165 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -62.65 -20.31 64.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.639 -0.709 . . . . 64.21 111.474 -175.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.1 -27.85 62.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.21 0.529 . . . . 63.52 109.907 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.45 76.87 9.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.555 -0.748 . . . . 73.53 109.078 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -62.62 -27.87 69.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.188 -0.915 . . . . 73.43 110.624 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 27.2 t70 -50.11 -41.74 49.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.847 -0.615 . . . . 63.32 110.56 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.528 HG21 HD12 ' A' ' 81' ' ' ILE . 92.3 t -54.24 -40.36 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 71.01 110.788 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -62.3 -47.3 84.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.424 0.631 . . . . 74.24 109.823 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.9 m -64.7 -33.41 75.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.444 -0.798 . . . . 72.42 110.867 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.6 mm-40 -68.43 -44.54 74.75 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.192 -0.458 . . . . 52.44 110.862 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.16 0.31 57.14 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.239 -0.437 . . . . 63.04 111.619 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.21 43.72 20.06 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.031 -0.604 . . . . 65.55 113.401 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.461 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 95.9 t -74.82 106.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.297 -0.631 . . . . 75.31 109.297 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.0 m -61.76 -39.32 91.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.316 . . . . 63.12 111.738 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.61 145.65 24.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.472 -0.331 . . . . 52.44 110.606 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.5 pt -104.32 141.43 22.51 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.219 -0.446 . . . . 75.51 110.098 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -85.21 169.86 47.46 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.712 -1.37 . . . . 64.14 112.116 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -145.53 155.57 43.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.969 -0.56 . . . . 74.0 109.554 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 47' ' ' ASP . 47.7 mm -118.67 110.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.395 -0.82 . . . . 62.41 109.926 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.75 123.01 41.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.064 -0.717 . . . . 72.51 109.064 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.6 mtt -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 65.12 110.397 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -144.87 145.79 31.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.614 -0.513 . . . . 73.14 109.614 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -142.11 119.79 11.81 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.925 -0.398 . . . . 74.24 109.925 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.623 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 13.7 p30 51.21 25.61 2.53 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.997 0.919 . . . . 72.22 112.099 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.59 64.96 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.835 -0.62 . . . . 43.11 113.166 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 47.9 tptt -73.12 142.14 47.5 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 117.067 0.433 . . . . 63.04 110.37 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 2.5 tmtp? -68.88 122.52 18.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.824 -0.626 . . . . 71.43 110.009 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -118.1 168.8 10.22 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.273 1.029 . . . . 61.41 109.749 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 101' ' ' MET . 0.3 OUTLIER -69.73 166.94 18.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.485 0.659 . . . . 72.41 112.566 -159.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 57.2 tt0 -129.25 136.84 50.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.211 1.005 . . . . 74.54 111.326 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.47 121.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.256 -1.793 . . . . 70.11 109.608 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.2 mt -107.02 133.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 110.269 -0.271 . . . . 62.14 110.269 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.54 168.24 36.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.322 -0.466 . . . . 60.32 112.465 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.43 98.99 11.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.641 0.258 . . . . 33.13 110.884 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.2 t70 -143.55 100.61 3.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.548 -0.538 . . . . 64.24 109.548 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.466 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -62.96 -38.45 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.895 -0.593 . . . . 62.15 111.577 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -66.54 -43.65 84.58 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.095 0.474 . . . . 72.2 110.147 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -61.41 -48.06 82.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 55.14 110.295 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 115' ' ' ASP . 73.8 mt -61.78 -47.15 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 62.22 111.519 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.24 -41.76 92.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.211 0.529 . . . . 72.14 110.233 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.4 t -56.22 -45.73 79.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.795 -0.639 . . . . 43.12 109.465 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 39.5 mm-40 -70.2 -32.39 70.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 73.04 111.491 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 120' ' ' ILE . 80.1 mt -54.55 -55.01 17.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 N-CA-C 108.936 -0.764 . . . . 73.41 108.936 173.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.416 ' ND2' HD13 ' A' ' 120' ' ' ILE . 45.5 m-80 -66.82 -36.07 81.5 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.391 . . . . 70.22 111.093 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.8 t30 -63.37 -42.06 98.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.216 -0.447 . . . . 72.2 111.294 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -93.66 -15.3 25.44 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.448 -0.342 . . . . 71.2 111.671 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 123' ' ' ILE . 38.7 mt -61.45 -43.59 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.231 -1.025 . . . . 54.51 108.231 166.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.982 172.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.478 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 96.0 mmm . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.548 0.214 . . . . 71.32 111.221 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.419 HG21 ' HE2' ' A' ' 78' ' ' LYS . 20.8 mm -77.33 93.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.114 -0.698 . . . . 62.2 109.114 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.2 tp10 -68.4 122.76 19.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 70.14 111.152 -175.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -90.93 122.13 33.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.436 -0.347 . . . . 71.41 110.353 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.8 pt -126.94 165.08 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.299 -0.409 . . . . 73.54 111.258 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.34 -167.56 40.99 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.87 -0.604 . . . . 75.43 113.479 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.48 -54.3 30.33 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 65.03 111.448 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 t -74.67 -28.19 60.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.225 0.536 . . . . 74.42 110.359 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.23 -17.55 64.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 75.54 111.636 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.4 t80 -58.4 -62.04 2.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.8 0.333 . . . . 65.25 110.16 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.16 -45.72 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.156 0.503 . . . . 73.42 110.207 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -56.15 -57.47 12.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.381 -0.827 . . . . 43.22 111.484 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.67 -29.61 65.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.223 -0.444 . . . . 63.34 111.456 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 31' ' ' PHE . 49.4 t -68.33 -41.59 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.648 0.261 . . . . 74.14 110.758 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 p -81.25 -18.88 44.44 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.872 0.367 . . . . 53.41 111.028 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 t -61.67 -21.75 64.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.136 -0.484 . . . . 74.54 111.529 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.703 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 22.9 p -59.62 122.09 13.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.606 0.241 . . . . 55.23 110.601 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.77 -69.18 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.148 -0.478 . . . . 72.42 111.844 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -161.42 135.76 7.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 63.42 110.934 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 16.6 m-80 59.36 17.1 5.58 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.704 0.628 . . . . 72.45 112.156 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.2 mm -87.85 114.01 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 70.51 110.292 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.537 HD21 ' SD ' ' A' ' 101' ' ' MET . 0.3 OUTLIER -78.82 109.19 12.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 72.33 109.387 178.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 38' ' ' CYS . 43.6 mt -97.68 121.64 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.951 -0.568 . . . . 72.45 110.482 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.673 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.9 mp -106.37 116.0 31.18 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.526 -0.546 . . . . 73.21 109.526 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.4 t -99.64 105.86 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 110.269 -0.271 . . . . 72.45 110.269 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -81.58 132.87 35.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.085 -0.507 . . . . 62.13 110.427 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -89.19 137.86 31.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.642 -0.503 . . . . 65.22 109.642 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -46.24 -51.06 15.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.594 0.559 . . . . 74.34 111.944 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 67.58 153.03 0.13 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.636 0.585 . . . . 54.33 111.828 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.2 173.92 9.77 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.426 2.084 . . . . 64.33 112.092 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -49.89 120.45 4.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.089 -0.505 . . . . 73.15 110.958 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.65 147.33 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 63.3 111.103 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -64.09 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.182 -0.463 . . . . 43.4 112.642 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.18 -30.55 32.93 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.208 2.605 . . . . 54.22 113.191 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 19.9 p -57.75 -29.01 64.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 71.35 111.285 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -54.3 -39.55 67.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.538 0.209 . . . . 74.44 111.276 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.649 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 45.1 m -75.11 -42.21 56.97 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.651 0.739 . . . . 70.35 110.48 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -61.61 -31.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.311 -0.859 . . . . 64.1 112.07 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 43.1 mt-10 -59.28 -60.93 8.94 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 117.803 0.274 . . . . 65.12 110.749 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 28.8 Cg_endo -62.98 -29.38 75.65 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.846 1.697 . . . . 64.23 112.174 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.0 mt-30 -64.51 -44.7 90.09 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.058 -0.657 . . . . 75.21 110.161 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.605 HD21 HD13 ' A' ' 119' ' ' ILE . 85.7 mt -64.43 -45.68 86.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 74.14 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.6 mt-10 -63.16 -34.08 76.85 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.031 -0.531 . . . . 65.51 110.563 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.79 -47.29 87.01 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.827 0.346 . . . . 74.54 110.21 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.49 -35.64 79.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.907 -0.588 . . . . 74.51 109.731 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.39 -42.68 98.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.785 -0.643 . . . . 43.32 110.234 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.1 mt-30 -67.16 -44.3 80.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 74.13 110.082 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -67.27 -38.74 85.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.482 -0.781 . . . . 75.41 111.352 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -105.14 4.63 31.57 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.756 0.65 . . . . 75.22 112.756 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.43 -19.93 4.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.424 0.527 . . . . 63.31 112.424 -172.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.03 -29.03 70.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.793 0.33 . . . . 74.02 110.875 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -130.62 4.65 4.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.3 -0.409 . . . . 60.25 111.021 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 43' ' ' LEU . 62.4 t -133.49 149.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.941 0.4 . . . . 74.22 111.242 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.16 127.96 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.345 -0.613 . . . . 71.33 109.345 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.673 HG12 ' HB2' ' A' ' 45' ' ' LEU . 42.2 mt -106.12 141.27 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.738 0.304 . . . . 73.14 111.01 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.7 m-85 -123.51 171.72 9.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 62.14 109.821 176.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' HG21 ' A' ' 23' ' ' ILE . 21.1 ttmm -146.6 139.06 25.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 62.33 109.94 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.7 mm -96.6 99.14 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.23 -0.656 . . . . 75.13 109.23 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.7 -19.14 61.46 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.093 -0.503 . . . . 60.11 110.943 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.71 87.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 65.23 110.462 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.34 -18.52 63.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 64.21 111.385 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.85 -15.77 60.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.124 -0.489 . . . . 63.52 111.406 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -86.04 93.73 9.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.056 0.455 . . . . 73.53 109.972 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -87.59 -20.6 26.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 73.43 110.212 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.01 -58.54 2.39 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.959 -0.564 . . . . 63.32 111.149 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.53 -34.09 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.731 -0.668 . . . . 71.01 111.001 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -67.91 -47.22 69.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.066 0.46 . . . . 74.24 110.518 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.8 m -67.42 -40.95 85.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 72.42 110.627 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.16 -44.56 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 52.44 111.789 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -99.12 -4.19 32.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.833 0.308 . . . . 63.04 111.833 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.47 83.41 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.214 -0.517 . . . . 65.55 113.271 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 88' ' ' ALA . 85.7 t -81.05 144.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.371 -0.603 . . . . 75.31 109.371 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.42 ' HB2' HG21 ' A' ' 112' ' ' ILE . 31.2 m -138.62 -63.72 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.691 0.281 . . . . 63.12 111.489 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.92 178.01 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 52.44 111.354 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 10.3 pt -112.35 116.2 48.95 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.46 -0.791 . . . . 75.51 110.87 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -92.02 -162.54 1.43 Allowed 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 124.219 -1.159 . . . . 64.14 111.947 -3.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.414 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.6 m -138.08 118.17 13.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.231 -0.441 . . . . 74.0 109.935 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mm -110.14 130.46 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.735 -0.666 . . . . 62.41 110.584 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 110' ' ' GLN . 40.9 mt -107.18 143.98 34.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.926 -0.768 . . . . 72.51 108.926 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.537 ' SD ' HD21 ' A' ' 43' ' ' LEU . 3.2 mtt -109.92 149.48 29.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.117 0.417 . . . . 65.12 110.666 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.0 m-85 -146.82 162.03 39.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.789 -0.641 . . . . 73.14 109.472 175.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 4.9 ttmp? -160.49 131.27 5.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.277 -0.268 . . . . 74.24 110.277 176.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.498 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 3.5 m-20 58.19 27.17 14.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.149 0.5 . . . . 72.22 110.58 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.43 27.93 71.95 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.836 -0.62 . . . . 43.11 112.266 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -126.83 149.6 49.63 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.491 -0.559 . . . . 63.04 109.491 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.589 ' O ' HD22 ' A' ' 108' ' ' LEU . 26.9 ttpt -68.75 143.91 54.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.747 0.784 . . . . 71.43 112.438 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 107' ' ' LYS . 1.4 mm? -144.68 169.3 18.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.841 -1.527 . . . . 61.41 108.379 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.62 173.71 5.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.773 0.797 . . . . 72.41 112.51 -162.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.471 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.1 tt0 -127.66 150.57 49.69 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.027 -0.988 . . . . 74.54 110.793 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 119' ' ' ILE . 2.3 t -127.69 111.63 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 114.514 -1.221 . . . . 70.11 109.418 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 94' ' ' SER . 60.1 mt -114.23 121.83 67.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.483 -0.326 . . . . 62.14 110.183 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.39 145.17 9.19 Favored Glycine 0 C--N 1.328 0.134 0 N-CA-C 111.76 -0.536 . . . . 60.32 111.76 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.14 72.19 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.13 0.491 . . . . 33.13 110.906 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -125.88 93.34 3.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.025 -0.731 . . . . 64.24 109.025 175.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.95 -25.09 34.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.334 -0.848 . . . . 62.15 111.511 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 t -67.67 -46.14 73.21 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.292 -0.633 . . . . 72.2 109.292 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.3 tptt -61.41 -45.88 92.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.619 -0.719 . . . . 55.14 109.744 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.605 HD13 HD21 ' A' ' 63' ' ' LEU . 69.9 mt -56.71 -56.09 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.062 -0.517 . . . . 62.22 111.292 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.503 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.0 -37.51 78.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 116.5 -0.318 . . . . 72.14 110.272 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.506 ' HA ' HD21 ' A' ' 124' ' ' ASN . 36.8 t -56.63 -51.53 68.33 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.164 -0.471 . . . . 43.12 109.898 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 20.9 mm-40 -58.58 -44.39 89.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.054 -0.521 . . . . 73.04 110.135 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.8 mt -54.4 -56.14 11.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.489 -0.323 . . . . 73.41 111.011 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.5 p30 -68.51 -33.05 73.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.486 -0.486 . . . . 70.22 110.56 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -68.48 -31.92 71.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.287 -0.415 . . . . 72.2 110.854 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.484 ' OD1' HD12 ' A' ' 108' ' ' LEU . 23.6 m-80 -90.86 -14.09 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.35 -0.386 . . . . 71.2 111.565 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.0 mt -81.52 -60.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.553 -0.536 . . . . 54.51 109.553 168.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.448 -0.787 . . . . 71.43 110.8 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.2 mmm . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.741 0.305 . . . . 71.32 110.943 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.481 HG21 ' HE2' ' A' ' 78' ' ' LYS . 26.7 mm -87.89 101.03 11.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.241 -0.651 . . . . 62.2 109.241 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 8.8 tp10 -64.47 122.68 17.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.296 0.569 . . . . 70.14 110.534 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -100.53 109.61 21.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 71.41 110.22 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.3 pt -119.51 166.78 13.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.733 -0.667 . . . . 73.54 111.275 -174.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.65 -158.59 33.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.687 -0.688 . . . . 75.43 112.111 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.11 -51.17 41.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.052 0.454 . . . . 65.03 111.55 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.4 t -69.5 -36.77 76.81 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.924 -0.58 . . . . 74.42 111.646 -172.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 1.9 mp0 -65.16 -14.99 61.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 75.54 111.97 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.426 ' O ' HG23 ' A' ' 35' ' ' VAL . 81.5 t80 -51.85 -61.27 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.717 0.294 . . . . 65.25 110.926 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.11 -44.97 83.78 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.421 . . . . 73.42 110.394 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -53.69 -57.76 9.65 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.725 0.774 . . . . 43.22 110.662 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.3 mmtt -64.75 -38.1 89.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.083 -0.962 . . . . 63.34 111.354 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.8 t -70.62 -35.54 61.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.44 -0.345 . . . . 74.14 110.823 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -81.88 -14.99 55.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.653 0.263 . . . . 53.41 111.126 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -66.07 2.52 1.1 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.208 0.448 . . . . 74.54 112.208 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' SG ' HD12 ' A' ' 44' ' ' ILE . 89.9 m -60.54 169.37 1.78 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.294 0.569 . . . . 55.23 112.041 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.03 -82.01 0.61 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.401 -0.818 . . . . 72.42 109.138 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -162.05 137.92 7.61 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.45 -0.574 . . . . 63.42 109.45 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 61.92 10.47 3.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.645 0.378 . . . . 72.45 111.408 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.76 108.18 17.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.263 -0.643 . . . . 70.51 109.263 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 126' ' ' ASN . 68.0 tp -83.46 121.67 27.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.177 0.513 . . . . 72.33 110.699 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.517 HD12 ' SG ' ' A' ' 38' ' ' CYS . 27.9 mt -105.83 118.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 72.45 110.084 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 3.6 mp -104.28 114.29 28.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.885 -0.783 . . . . 73.21 108.885 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.2 t -102.86 104.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.374 -0.232 . . . . 72.45 110.374 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.448 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 18.8 t0 -76.6 129.04 35.86 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.179 -0.674 . . . . 62.13 109.179 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -83.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 65.22 111.047 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -167.6 151.21 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 74.34 110.9 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.57 97.13 6.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.624 -0.717 . . . . 54.33 109.513 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.68 -50.42 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.581 2.187 . . . . 64.33 112.17 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -130.98 123.36 28.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.332 -0.618 . . . . 73.15 109.332 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.2 t -163.26 136.74 5.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 63.3 110.873 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -86.76 -66.52 1.37 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.955 -0.566 . . . . 43.4 112.249 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' A' ' 54' ' ' GLY . 15.3 Cg_endo -55.13 -26.79 52.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.165 2.577 . . . . 54.22 113.066 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 79.0 m -55.7 -23.55 29.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.482 -0.326 . . . . 71.35 111.866 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 12.2 ptm180 -54.34 -44.36 72.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.694 0.283 . . . . 74.44 110.504 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 18.6 m -75.5 -35.61 60.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.239 0.542 . . . . 70.35 110.79 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -64.83 -36.46 84.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.45 0.537 . . . . 64.1 112.45 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.8 tt0 -58.18 -58.9 15.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 120.351 -0.54 . . . . 65.12 110.363 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.25 -32.99 95.01 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.819 1.68 . . . . 64.23 112.435 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 58' ' ' SER . 46.4 mt-30 -63.4 -44.19 95.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.028 0.442 . . . . 75.21 110.377 176.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.77 -37.82 82.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.963 -0.562 . . . . 74.14 110.222 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 52.9 mt-10 -65.51 -36.17 83.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.281 -0.418 . . . . 65.51 110.26 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -56.53 -52.07 66.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.016 0.436 . . . . 74.54 109.848 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 116' ' ' ILE . 27.0 mt -68.33 -31.32 70.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 74.51 109.634 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.578 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -70.85 -13.37 62.01 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.643 -0.708 . . . . 43.32 110.982 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -96.06 -50.83 4.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.295 -0.411 . . . . 74.13 110.861 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.24 -43.05 99.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.36 0.6 . . . . 75.41 110.793 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.53 5.35 47.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.303 -0.862 . . . . 75.22 111.494 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.3 t -52.83 -25.88 12.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.258 0.836 . . . . 63.31 113.258 -168.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.75 -19.0 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.615 0.245 . . . . 74.02 111.403 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.7 2.0 7.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.521 -0.309 . . . . 60.25 110.991 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.71 144.48 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.784 0.326 . . . . 74.22 111.324 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -147.05 119.89 8.67 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.275 -0.639 . . . . 71.33 109.275 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.02 132.11 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.803 0.335 . . . . 73.14 110.558 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 74.3 m-85 -122.08 166.02 15.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 62.14 109.475 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HE2' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -148.72 142.58 25.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.411 -0.359 . . . . 62.33 110.371 172.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 31' ' ' PHE . 61.3 mt -102.02 103.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 75.13 109.231 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -84.1 12.72 5.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 60.11 111.306 -174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm -78.3 78.87 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.021 -0.733 . . . . 65.23 109.021 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -18.48 43.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 64.21 112.622 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.5 -11.66 60.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.756 0.312 . . . . 63.52 111.537 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.76 51.21 1.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.194 0.521 . . . . 73.53 110.281 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -61.42 -61.86 2.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.56 -0.746 . . . . 73.43 110.841 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 7.7 m-20 -52.83 -36.98 59.47 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.421 -0.809 . . . . 63.32 111.031 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.01 -42.16 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 71.01 110.202 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.85 -51.57 64.03 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.269 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.6 m -62.09 -31.48 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 72.42 111.01 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 25.3 mm-40 -68.81 -51.78 37.15 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.495 -0.32 . . . . 52.44 110.872 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -76.22 -10.91 59.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.494 -0.321 . . . . 63.04 111.415 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.42 44.34 2.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.814 -0.708 . . . . 65.55 113.694 167.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 98' ' ' THR . 72.4 t -77.83 106.13 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.557 -0.534 . . . . 75.31 109.557 173.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.549 ' HB3' HG21 ' A' ' 112' ' ' ILE . 22.8 t -92.91 -40.24 10.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 63.12 110.536 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.85 158.19 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 52.44 110.233 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.782 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.61 140.95 22.15 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.45 . . . . 75.51 110.406 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.43 -179.35 24.48 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.06 -1.225 . . . . 64.14 111.529 -3.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.51 HG21 HG22 ' A' ' 93' ' ' VAL . 93.7 m -139.78 116.42 10.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.926 0.393 . . . . 74.0 110.206 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.446 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.1 mm -109.8 110.82 33.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 62.41 110.8 -173.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 123.44 33.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.737 -0.468 . . . . 72.51 109.737 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.622 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 17.7 mmt -90.19 140.14 29.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.221 -0.445 . . . . 65.12 110.078 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.4 144.44 36.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.219 -0.66 . . . . 73.14 109.219 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -138.42 112.43 8.51 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.587 -0.445 . . . . 74.24 110.671 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.51 32.33 22.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.615 0.722 . . . . 72.22 110.453 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.51 68.25 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 115.684 -0.689 . . . . 43.11 112.649 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -83.12 143.59 30.44 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.777 -0.453 . . . . 63.04 109.777 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' HD22 ' A' ' 108' ' ' LEU . 21.5 tptm -65.88 130.62 43.9 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.83 0.706 . . . . 71.43 111.013 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -131.39 168.94 16.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.581 -1.191 . . . . 61.41 109.19 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 101' ' ' MET . 1.3 m -69.55 176.19 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.309 0.576 . . . . 72.41 111.937 -163.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.49 131.53 29.82 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.856 0.836 . . . . 74.54 110.992 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.83 107.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.926 -1.488 . . . . 70.11 109.752 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 94' ' ' SER . 64.0 mt -102.77 121.87 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.046 -0.524 . . . . 62.14 110.108 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.01 149.97 18.04 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.954 -0.458 . . . . 60.32 111.954 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.76 85.97 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.682 0.277 . . . . 33.13 111.129 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.8 t70 -132.64 92.11 3.01 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.349 0.595 . . . . 64.24 109.822 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 66' ' ' LEU . 9.2 tp -59.31 -32.89 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.265 -0.88 . . . . 62.15 111.651 -174.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.8 t -64.17 -48.49 75.77 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.898 0.38 . . . . 72.2 110.055 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -62.09 -43.37 98.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.013 -0.54 . . . . 55.14 109.711 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 71.2 mt -58.4 -56.27 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.036 -0.529 . . . . 62.22 111.117 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.517 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.34 -35.04 67.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 120.758 0.313 . . . . 72.14 110.187 -177.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.497 ' HA ' HD21 ' A' ' 124' ' ' ASN . 23.2 t -58.04 -51.9 67.77 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.109 -0.496 . . . . 43.12 109.791 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -61.64 -37.57 84.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.876 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.8 mt -58.51 -55.95 19.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.3 -0.409 . . . . 73.41 110.92 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.497 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.1 p30 -67.94 -31.42 71.15 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.651 -0.419 . . . . 70.22 110.011 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -58.06 -43.6 87.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.756 -0.656 . . . . 72.2 110.566 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.449 ' HB2' HD22 ' A' ' 43' ' ' LEU . 26.7 m-80 -78.26 -38.94 41.54 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.254 0.465 . . . . 71.2 112.254 -177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.6 mt -58.07 -47.75 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.372 . . . . 54.51 110.939 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.926 -0.559 . . . . 71.43 110.657 -176.519 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.7 mmm . . . . . 0 C--O 1.234 0.238 0 N-CA-C 108.831 -0.803 . . . . 71.32 108.831 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 ' HD2' ' A' ' 78' ' ' LYS . 17.9 mm -64.99 93.69 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.368 -0.975 . . . . 62.2 108.368 171.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 9.7 tp10 -52.27 144.31 12.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.469 0.652 . . . . 70.14 111.98 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -101.67 115.61 30.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.157 -0.929 . . . . 71.41 110.276 -176.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.479 HG21 ' HG3' ' A' ' 34' ' ' LYS . 50.6 pt -133.96 179.94 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.956 0.408 . . . . 73.54 110.911 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.34 -153.52 7.93 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.896 -0.593 . . . . 75.43 111.852 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.97 -53.18 22.1 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.404 0.282 . . . . 65.03 111.487 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -70.82 -29.96 66.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.828 0.347 . . . . 74.42 111.565 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 mp0 -72.36 -27.3 62.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.438 . . . . 75.54 111.009 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -51.89 -61.83 2.01 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.13 0.269 . . . . 65.25 111.192 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 36' ' ' THR . 9.2 t70 -51.09 -53.59 32.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.986 -0.552 . . . . 73.42 110.549 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -54.07 -57.28 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.131 -0.941 . . . . 43.22 111.31 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 77' ' ' TYR . 75.9 mmtt -62.28 -33.37 74.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 63.34 111.014 -175.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.455 ' HA ' HD13 ' A' ' 44' ' ' ILE . 21.7 t -69.09 -55.66 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.185 -0.461 . . . . 74.14 112.16 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 32' ' ' ASP . 10.2 t -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.383 0.512 . . . . 53.41 112.383 -170.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 t -75.81 2.57 11.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.135 0.42 . . . . 74.54 112.135 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.81 ' SG ' HD11 ' A' ' 44' ' ' ILE . 92.0 m -82.8 128.62 34.57 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.666 0.27 . . . . 55.23 110.49 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.29 -72.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.769 0.655 . . . . 72.42 112.769 -172.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.43 121.93 35.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 63.42 111.361 -166.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 58.21 11.19 1.47 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.625 -1.171 . . . . 72.45 113.395 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 47.9 mm -73.04 95.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.971 0.415 . . . . 70.51 110.072 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -71.0 110.38 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.857 -0.794 . . . . 72.33 108.857 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.81 HD11 ' SG ' ' A' ' 38' ' ' CYS . 86.4 mt -94.38 123.24 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.393 -0.822 . . . . 72.45 110.526 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.681 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.3 mp -110.11 109.75 20.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.242 -0.651 . . . . 73.21 109.242 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.06 105.16 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.028 -0.36 . . . . 72.45 110.028 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -81.01 147.66 30.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.382 -0.372 . . . . 62.13 110.215 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 88' ' ' ALA . 88.2 t80 -87.91 115.65 25.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.36 . . . . 65.22 110.624 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.573 ' HE1' ' HA ' ' A' ' 82' ' ' GLU . 51.6 t-105 -56.35 115.37 2.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.813 -0.631 . . . . 74.34 110.844 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -111.86 107.88 56.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 54.33 110.089 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 18.9 Cg_endo -59.81 -21.59 64.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.537 2.158 . . . . 64.33 111.79 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -131.95 128.63 38.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.531 -0.758 . . . . 73.15 109.383 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 47.6 t -164.37 175.13 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.889 0.376 . . . . 63.3 110.694 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -136.58 -61.17 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.553 -0.748 . . . . 43.4 111.435 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.463 ' O ' HD23 ' A' ' 59' ' ' LEU . 52.7 Cg_exo -55.0 -26.03 47.51 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.005 2.47 . . . . 54.22 112.684 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 56.6 m -57.29 -28.57 63.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.978 -0.555 . . . . 71.35 111.476 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -53.59 -49.12 68.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.935 0.398 . . . . 74.44 111.594 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.4 m -75.3 -38.17 60.46 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.765 0.793 . . . . 70.35 110.95 177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 55' ' ' PRO . 4.4 mm? -73.71 -24.24 59.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.607 -0.724 . . . . 64.1 112.043 -172.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.5 mt-10 -59.56 -59.06 15.08 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.786 -0.449 . . . . 65.12 109.786 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.73 -34.46 31.51 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.819 1.679 . . . . 64.23 112.376 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.63 ' HB3' HD13 ' A' ' 116' ' ' ILE . 40.2 mt-30 -62.61 -42.7 99.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.145 -0.622 . . . . 75.21 110.97 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.638 HD21 HD13 ' A' ' 119' ' ' ILE . 67.6 mt -64.76 -38.62 91.6 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.48 -0.327 . . . . 74.14 110.132 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.0 mt-10 -58.11 -43.53 87.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 116.419 -0.355 . . . . 65.51 110.087 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -56.07 -53.43 57.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.093 -0.503 . . . . 74.54 111.09 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 123' ' ' ILE . 34.8 mt -63.26 -37.29 86.67 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.639 -0.504 . . . . 74.51 109.639 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.18 -26.9 68.35 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.588 -0.733 . . . . 43.32 110.906 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.5 mt-30 -80.15 -48.83 12.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.819 0.342 . . . . 74.13 110.599 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -47.62 83.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.436 0.636 . . . . 75.41 109.806 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -90.54 4.47 51.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.294 -0.866 . . . . 75.22 112.416 -175.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -53.16 -21.28 4.8 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.848 0.356 . . . . 63.31 111.664 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.35 -35.26 78.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 74.02 110.962 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -133.9 15.71 3.91 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.494 -0.321 . . . . 60.25 111.19 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 43' ' ' LEU . 41.9 t -135.29 139.69 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.071 0.462 . . . . 74.22 111.351 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 24' ' ' GLU . 61.0 tptt -145.25 119.81 9.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 71.33 109.14 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.681 HG12 ' HB2' ' A' ' 45' ' ' LEU . 29.2 mt -101.79 141.65 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.227 -0.286 . . . . 73.14 110.227 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 91.4 m-85 -130.22 161.25 31.59 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.55 0.34 . . . . 62.14 110.518 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.642 ' HD2' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -163.54 154.86 16.73 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 62.33 109.147 168.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 28.1 pt -79.53 152.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.394 -0.225 . . . . 75.13 110.394 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -107.26 6.62 28.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.626 0.25 . . . . 60.11 111.342 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 81' ' ' ILE . 3.0 mp -78.5 96.58 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 65.23 110.167 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HA ' ' HE1' ' A' ' 49' ' ' TRP . 7.5 tm-20 -61.62 -26.8 68.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.946 -0.57 . . . . 64.21 110.333 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.72 -9.01 57.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.686 -0.688 . . . . 63.52 111.28 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -91.4 105.83 18.05 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.093 0.473 . . . . 73.53 111.155 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -121.54 -32.91 3.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 73.43 109.776 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.3 m-20 -49.51 -43.18 45.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.011 -0.995 . . . . 63.32 111.939 -173.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.2 -34.05 26.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.283 -0.417 . . . . 71.01 111.403 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . . . -60.19 -49.23 78.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.15 0.5 . . . . 74.24 109.978 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 m -66.73 -35.49 80.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.437 -0.801 . . . . 72.42 110.642 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 72.8 mm-40 -61.34 -55.41 32.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.128 -0.487 . . . . 52.44 110.691 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.97 -11.87 51.91 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.462 -0.335 . . . . 63.04 111.815 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.59 42.28 14.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.75 -0.738 . . . . 65.55 112.354 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t -75.3 114.43 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -98.03 -74.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 63.12 111.05 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.74 136.44 33.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.76 0.314 . . . . 52.44 110.899 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.67 151.98 46.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 75.51 109.845 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.86 169.35 64.19 Favored 'Cis proline' 0 C--N 1.354 0.836 0 C-N-CA 124.157 -1.184 . . . . 64.14 112.921 1.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 112' ' ' ILE . 89.0 m -139.02 114.13 9.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.715 -0.675 . . . . 74.0 109.879 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.459 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 32.4 mm -109.79 110.7 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 62.41 111.012 -173.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -97.83 123.36 41.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.745 -0.835 . . . . 72.51 108.745 171.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.482 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 37.9 mtt -93.43 150.83 20.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.965 0.412 . . . . 65.12 110.923 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.7 m-85 -143.33 153.82 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.416 -0.957 . . . . 73.14 108.416 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -150.91 115.3 5.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 74.24 110.62 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.76 25.38 15.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.663 0.744 . . . . 72.22 110.171 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.29 -0.42 87.2 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.636 -0.711 . . . . 43.11 112.276 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -91.68 145.21 24.77 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 122.812 -0.228 . . . . 63.04 110.819 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' HD22 ' A' ' 108' ' ' LEU . 3.7 tppp? -63.31 132.51 51.83 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.916 0.76 . . . . 71.43 110.765 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 1.2 mm? -137.19 169.43 17.79 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 125.036 1.334 . . . . 61.41 108.788 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.25 172.18 7.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.459 0.54 . . . . 72.41 112.459 -162.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -140.14 126.04 19.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.081 -0.508 . . . . 74.54 110.605 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.1 m -115.3 122.47 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.191 0.519 . . . . 70.11 110.422 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 98' ' ' THR . 51.3 mt -108.18 140.56 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.718 -0.674 . . . . 62.14 109.485 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.12 157.49 32.45 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.991 -0.623 . . . . 60.32 112.13 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.46 97.3 9.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.927 0.343 . . . . 33.13 111.927 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.9 t0 -146.1 104.27 3.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.317 0.579 . . . . 64.24 110.677 169.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 62' ' ' GLN . 8.7 tp -59.13 -32.97 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.148 -0.933 . . . . 62.15 110.809 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.0 m -67.91 -48.56 65.66 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.196 -0.456 . . . . 72.2 111.14 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -60.51 -47.66 85.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.374 -0.375 . . . . 55.14 110.301 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.638 HD13 HD21 ' A' ' 63' ' ' LEU . 78.5 mt -57.9 -55.56 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 62.22 111.081 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.436 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.86 -36.97 75.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.907 -0.405 . . . . 72.14 109.907 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -57.16 -52.02 66.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.847 -0.615 . . . . 43.12 110.082 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.86 -40.31 96.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.314 -0.403 . . . . 73.04 110.383 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.7 mt -55.32 -56.05 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.556 -0.293 . . . . 73.41 110.691 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.2 -30.65 66.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.624 -0.431 . . . . 70.22 110.007 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.53 -34.43 76.9 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.907 -0.588 . . . . 72.2 111.214 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -92.62 -30.36 15.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 71.2 112.006 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.464 HD11 ' CG2' ' A' ' 74' ' ' VAL . 79.0 mt -67.81 -51.6 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 54.51 110.253 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.9 m120 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.527 -0.76 . . . . 71.43 110.515 -175.816 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 85.1 mmm . . . . . 0 C--O 1.232 0.153 0 N-CA-C 109.929 -0.397 . . . . 71.32 109.929 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.14 113.27 10.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.705 -0.679 . . . . 62.2 109.862 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 3.5 tp10 -81.72 126.41 31.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.036 0.446 . . . . 70.14 111.166 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -80.35 119.37 22.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.804 -0.635 . . . . 71.41 109.697 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.3 pt -126.69 146.47 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.158 0.504 . . . . 73.54 111.726 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.44 -162.61 26.26 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.221 -0.899 . . . . 75.43 111.522 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.94 -55.46 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.717 0.294 . . . . 65.03 110.98 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 m -61.58 -37.73 84.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.265 0.555 . . . . 74.42 110.644 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -65.33 -36.65 84.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.518 -0.765 . . . . 75.54 111.573 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.9 t80 -51.97 -61.69 2.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.732 0.271 . . . . 65.25 111.732 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -55.66 -46.67 77.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.099 0.476 . . . . 73.42 110.853 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.97 -57.22 13.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.611 -0.722 . . . . 43.22 110.88 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 33.7 mmtp -61.8 -32.48 72.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 63.34 111.369 -175.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 31' ' ' PHE . 76.8 t -72.51 -48.11 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.716 0.293 . . . . 74.14 110.808 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.0 p -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 53.41 110.97 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.4 t -65.84 -4.1 6.16 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.17 -0.468 . . . . 74.54 112.06 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.5 p -65.29 112.77 3.63 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.298 -0.251 . . . . 55.23 110.788 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.37 -77.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 72.42 111.059 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -147.63 129.06 14.89 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.627 0.251 . . . . 63.42 110.851 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 52.33 21.48 1.71 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.84 -0.618 . . . . 72.45 112.045 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.0 111.09 14.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.349 -0.387 . . . . 70.51 109.989 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.4 tp -77.26 107.0 9.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.323 0.582 . . . . 72.33 110.113 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 101' ' ' MET . 27.4 mt -95.05 120.7 44.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.529 -0.76 . . . . 72.45 110.672 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 74' ' ' VAL . 5.8 mp -105.83 123.59 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.327 -0.62 . . . . 73.21 109.327 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.58 106.8 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.228 -0.286 . . . . 72.45 110.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.69 132.53 41.75 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.845 0.355 . . . . 62.13 110.21 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -89.12 62.78 6.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.487 . . . . 65.22 110.9 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.475 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 11.9 t90 70.68 -70.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.575 -0.739 . . . . 74.34 112.173 171.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 64.59 74.21 0.42 Allowed Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 123.13 0.572 . . . . 54.33 111.495 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -88.5 -66.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.85 2.367 . . . . 64.33 113.833 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -85.56 79.43 9.39 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.826 0.346 . . . . 73.15 110.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.5 p -171.38 139.08 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.571 . . . . 63.3 110.276 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.573 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -75.7 -66.22 1.92 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 116.008 -0.542 . . . . 43.4 112.556 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.82 -28.6 4.95 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.337 2.691 . . . . 54.22 113.686 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 81.5 m -52.96 -34.92 58.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.571 -0.286 . . . . 71.35 111.668 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 17.5 ptm180 -59.63 -38.01 80.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.585 -0.279 . . . . 74.44 110.56 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.5 t -75.21 -37.94 60.93 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.423 0.63 . . . . 70.35 110.319 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.3 mm? -61.24 -34.85 75.81 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 64.1 111.877 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.72 -58.3 20.47 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.313 -0.375 . . . . 65.12 111.262 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.67 -30.67 85.71 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.859 1.706 . . . . 64.23 111.909 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -63.32 -39.95 95.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.596 -0.442 . . . . 75.21 109.896 174.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.503 HD21 HD13 ' A' ' 119' ' ' ILE . 82.7 mt -69.85 -35.81 75.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.977 -0.556 . . . . 74.14 110.093 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 75.8 mt-10 -59.24 -42.59 91.46 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.118 -0.492 . . . . 65.51 109.97 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -58.11 -54.28 48.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.461 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 123' ' ' ILE . 56.6 mt -62.17 -30.56 71.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.883 0.373 . . . . 74.51 110.038 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.539 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -69.67 -41.82 74.98 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.89 -0.596 . . . . 43.32 110.628 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.3 mt-30 -70.59 -40.46 73.22 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.04 0.447 . . . . 74.13 110.72 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -75.66 -35.82 60.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.805 -0.634 . . . . 75.41 111.012 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.7 5.35 36.21 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.018 -0.537 . . . . 75.22 112.006 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.8 t -52.44 -18.99 1.9 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.994 0.517 . . . . 63.31 112.167 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.97 -35.84 64.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.312 -0.404 . . . . 74.02 111.13 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -133.87 -11.16 2.66 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.717 0.266 . . . . 60.25 111.717 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.567 HG13 HD13 ' A' ' 45' ' ' LEU . 55.2 t -105.35 141.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.032 0.444 . . . . 74.22 112.047 -172.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -144.56 121.93 11.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 71.33 109.02 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.7 mt -109.93 143.36 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.012 0.434 . . . . 73.14 111.51 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 90.7 m-85 -126.73 172.87 9.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.629 -0.714 . . . . 62.14 110.438 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 49' ' ' TRP . 14.2 tppt? -138.73 115.85 10.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 62.33 110.418 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.65 99.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.051 -0.722 . . . . 75.13 109.051 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -108.37 30.81 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 60.11 111.023 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.71 74.25 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.443 -0.577 . . . . 65.23 109.443 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -35.58 25.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.137 -0.938 . . . . 64.21 112.54 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.58 -35.89 70.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 63.52 111.144 -176.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -93.86 42.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.697 0.761 . . . . 73.53 110.446 -171.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.38 -15.45 60.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.246 -0.888 . . . . 73.43 110.491 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.09 -33.91 58.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.757 -0.656 . . . . 63.32 111.086 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.6 t -56.21 -34.41 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.795 -0.639 . . . . 71.01 110.874 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.01 75.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.09 -0.505 . . . . 74.24 110.648 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -64.35 -41.76 96.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.963 -0.562 . . . . 72.42 110.562 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -63.69 -53.19 55.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.143 -0.48 . . . . 52.44 111.371 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.42 -18.06 60.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 63.04 111.106 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.74 55.67 3.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.988 -0.625 . . . . 65.55 112.507 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -69.53 106.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.559 -0.534 . . . . 75.31 109.559 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' ' 112' ' ' ILE . 23.3 t -65.72 -56.93 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 63.12 110.984 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.94 27.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.679 0.276 . . . . 52.44 110.682 -177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 pt -95.16 149.31 36.03 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.873 -0.603 . . . . 75.51 110.602 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.47 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.2 Cg_exo -71.01 170.46 63.79 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.147 -1.189 . . . . 64.14 112.516 -1.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.3 m -139.55 125.75 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.649 -0.5 . . . . 74.0 109.649 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 49.9 mm -110.37 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 62.41 110.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -88.81 123.12 32.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.423 -0.584 . . . . 72.51 109.423 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 43.2 mtt -102.08 142.24 33.65 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.305 0.502 . . . . 65.12 111.32 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.57 144.96 33.11 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.478 -0.934 . . . . 73.14 108.478 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 40.1 ttpt -146.42 115.97 7.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.457 -0.497 . . . . 74.24 111.342 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 62.58 25.72 15.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.823 -0.626 . . . . 72.22 110.54 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.83 -7.97 80.72 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.804 -0.635 . . . . 43.11 112.658 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -85.46 151.26 24.11 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 122.3 0.24 . . . . 63.04 110.952 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.5 tmtt? -77.56 116.95 18.53 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.558 0.694 . . . . 71.43 109.972 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.415 ' CD2' ' HB3' ' A' ' 103' ' ' LYS . 4.2 mm? -112.05 168.85 9.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.534 -1.212 . . . . 61.41 110.377 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -177.21 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 72.41 111.863 -162.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -147.49 147.12 29.83 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.681 0.753 . . . . 74.54 111.019 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 13.5 t -122.8 135.43 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 114.066 -1.424 . . . . 70.11 109.698 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.458 HG21 ' HB3' ' A' ' 94' ' ' SER . 65.5 mt -123.68 127.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.559 -0.291 . . . . 62.14 110.414 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.76 162.31 38.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.216 -0.516 . . . . 60.32 112.415 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.56 78.58 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.931 0.396 . . . . 33.13 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.474 ' O ' HG13 ' A' ' 119' ' ' ILE . 43.3 t0 -126.38 91.41 3.36 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.048 0.451 . . . . 64.24 109.799 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 66' ' ' LEU . 9.0 tp -61.89 -27.5 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.605 -0.725 . . . . 62.15 110.654 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -69.87 -44.62 69.44 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.197 -0.456 . . . . 72.2 109.828 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -67.24 -38.96 86.07 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.69 -0.485 . . . . 55.14 109.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.503 HD13 HD21 ' A' ' 63' ' ' LEU . 76.3 mt -60.32 -56.1 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.067 -0.515 . . . . 62.22 110.954 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -39.83 86.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.774 0.321 . . . . 72.14 110.197 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.453 ' HA ' HD21 ' A' ' 124' ' ' ASN . 32.9 t -56.74 -47.58 79.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.151 -0.477 . . . . 43.12 109.862 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -66.43 -40.83 89.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 73.04 110.793 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 66' ' ' LEU . 96.9 mt -54.41 -56.18 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.79 -0.364 . . . . 73.41 110.125 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.453 HD21 ' HA ' ' A' ' 121' ' ' SER . 8.6 p30 -67.42 -39.19 85.45 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.49 -0.484 . . . . 70.22 110.388 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.29 -38.4 90.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 72.2 111.86 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -83.15 -21.25 33.62 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.713 -0.221 . . . . 71.2 110.798 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.4 mt -72.4 -48.43 47.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.831 -0.433 . . . . 54.51 109.831 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.514 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.659 -0.686 . . . . 71.43 110.901 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.407 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 83.4 mmm . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 120.704 0.288 . . . . 71.32 111.279 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -75.17 112.26 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 62.2 110.108 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.573 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 7.6 tp10 -71.07 150.27 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 70.14 110.74 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -118.06 126.63 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.567 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 31' ' ' PHE . 24.9 pt -143.13 166.63 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.236 -0.438 . . . . 73.54 111.16 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -100.87 -164.38 27.93 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.909 -0.587 . . . . 75.43 112.561 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.426 ' N ' HD11 ' A' ' 81' ' ' ILE . 12.3 t70 -69.12 -57.04 5.93 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.821 0.344 . . . . 65.03 111.361 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.35 -0.386 . . . . 74.42 110.236 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 45.5 mt-10 -68.86 -31.39 70.3 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.54 110.569 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.7 t80 -52.85 -60.12 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.074 0.464 . . . . 65.25 110.009 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.46 -45.91 73.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 73.42 110.848 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -66.39 -57.36 7.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 43.22 111.613 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG3' HG21 ' A' ' 26' ' ' ILE . 46.8 mmtm -60.52 -31.14 70.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.683 . . . . 63.34 111.214 -176.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 31' ' ' PHE . 68.1 t -73.43 -44.75 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.687 -0.233 . . . . 74.14 110.663 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.9 p -72.11 -14.62 61.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.995 0.426 . . . . 53.41 110.966 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.9 t -71.24 0.53 7.72 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.834 -0.621 . . . . 74.54 111.351 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.78 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.0 p -58.65 120.3 8.66 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.698 0.285 . . . . 55.23 110.739 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -67.65 -73.35 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.402 -0.363 . . . . 72.42 111.152 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -156.77 125.62 5.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.361 -0.381 . . . . 63.42 110.449 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 59.49 5.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.623 0.601 . . . . 72.45 112.623 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 73' ' ' ASN . 40.0 mm -68.13 112.72 3.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 70.51 110.73 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.478 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.1 tt -80.34 120.87 24.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.831 -0.803 . . . . 72.33 108.831 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.96 114.16 46.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.459 -0.791 . . . . 72.45 110.472 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.0 mp -101.93 137.36 40.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.587 -0.894 . . . . 73.21 108.587 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -124.74 110.44 25.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 110.21 -0.293 . . . . 72.45 110.21 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.51 122.16 22.64 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.53 -0.544 . . . . 62.13 109.53 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -69.11 -74.7 0.12 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.573 -0.528 . . . . 65.22 109.573 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.655 ' HZ3' ' HA ' ' A' ' 80' ' ' ASN . 8.5 t-105 -171.89 160.53 5.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.15 -0.477 . . . . 74.34 109.861 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.636 ' HB1' ' SG ' ' A' ' 53' ' ' CYS . . . -164.37 96.3 0.94 Allowed Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.276 0.36 . . . . 54.33 110.538 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.74 -77.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.936 2.424 . . . . 64.33 112.063 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -98.69 90.88 4.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.783 -0.451 . . . . 73.15 109.783 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.636 ' SG ' ' HB1' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -134.53 -58.75 0.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.652 -0.703 . . . . 63.3 110.78 -178.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.52 -85.83 0.4 Allowed Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.028 -0.606 . . . . 43.4 112.574 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.68 -22.04 42.23 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.999 2.466 . . . . 54.22 111.876 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.5 p -52.72 -33.27 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.621 -0.718 . . . . 71.35 110.986 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -60.65 -36.2 78.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.375 0.607 . . . . 74.44 110.041 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.8 m -74.56 -35.87 63.08 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.824 0.821 . . . . 70.35 110.042 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.5 mm? -65.59 -22.1 66.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.232 -0.895 . . . . 64.1 111.464 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 -57.92 -62.23 5.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.969 -0.382 . . . . 65.12 109.969 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 40.0 Cg_endo -67.08 -31.55 36.49 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 121.891 1.727 . . . . 64.23 112.079 176.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.561 ' HB2' ' HA ' ' A' ' 59' ' ' LEU . 79.5 mt-30 -60.3 -45.79 92.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.054 0.455 . . . . 75.21 110.824 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 119' ' ' ILE . 73.4 mt -64.75 -40.78 95.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.127 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 30.0 mt-10 -57.57 -43.78 84.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.433 -0.349 . . . . 65.51 110.323 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.71 -57.22 9.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.008 -0.542 . . . . 74.54 110.688 178.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.479 HD13 HD12 ' A' ' 123' ' ' ILE . 19.7 mt -64.88 -34.92 79.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.941 -0.572 . . . . 74.51 109.654 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.566 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -66.58 -27.96 68.14 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.694 -0.684 . . . . 43.32 111.355 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.3 mt-30 -85.22 -37.11 20.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.832 0.349 . . . . 74.13 110.847 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.85 -37.99 70.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 75.41 110.953 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -104.89 5.89 33.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.577 -0.738 . . . . 75.22 111.925 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -22.66 5.5 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.578 0.955 . . . . 63.31 113.578 -169.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -77.42 -18.81 56.92 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.288 -0.258 . . . . 74.02 111.362 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.471 ' HA ' HD13 ' A' ' 42' ' ' ILE . 6.3 t30 -134.34 6.68 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.499 -0.319 . . . . 60.25 110.826 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 43' ' ' LEU . 54.6 t -139.13 139.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.71 0.29 . . . . 74.22 110.879 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 20.6 tptm -142.46 123.0 14.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 71.33 109.757 173.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 45' ' ' LEU . 54.7 mt -98.08 125.39 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 73.14 110.508 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.552 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 62.3 m-85 -111.27 174.39 5.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.395 -0.594 . . . . 62.14 109.395 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HB2' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -156.08 152.71 28.34 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.295 -0.631 . . . . 62.33 109.295 167.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 34.4 pt -106.26 172.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.765 0.317 . . . . 75.13 111.016 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.655 ' HA ' ' HZ3' ' A' ' 49' ' ' TRP . 12.8 m120 -113.04 -90.19 0.52 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.961 -0.563 . . . . 60.11 109.523 171.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 81' ' ' ILE . 19.8 mm 52.69 23.26 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.075 0.464 . . . . 65.23 111.488 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -47.83 -28.48 2.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.401 0.68 . . . . 64.21 111.951 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -72.25 -35.66 68.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.783 -0.644 . . . . 63.52 111.592 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.21 99.16 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 73.53 110.681 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -73.33 6.56 2.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.971 -0.559 . . . . 73.43 111.68 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -45.19 -40.07 6.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.117 -0.492 . . . . 63.32 110.744 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.0 t -61.51 -39.9 84.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.679 -0.692 . . . . 71.01 110.703 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.37 -46.2 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.259 0.552 . . . . 74.24 110.076 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.5 m -67.38 -39.47 85.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.142 -0.935 . . . . 72.42 111.22 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -67.09 -43.04 83.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.351 -0.386 . . . . 52.44 111.625 -177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -92.58 -12.27 32.18 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.703 0.26 . . . . 63.04 111.703 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.3 45.52 6.52 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.951 -0.642 . . . . 65.55 113.562 171.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.33 128.52 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.063 -0.347 . . . . 75.31 110.063 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 -16.66 7.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.489 -0.323 . . . . 63.12 111.071 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.4 168.44 25.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.421 -0.354 . . . . 52.44 110.104 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.1 pp -127.84 140.14 37.3 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.514 -0.312 . . . . 75.51 110.672 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 96.4 Cg_endo -78.78 -176.02 17.85 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 123.875 -1.302 . . . . 64.14 112.919 -0.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 m -147.6 124.5 11.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.686 -0.688 . . . . 74.0 109.638 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 48.7 mm -109.82 111.08 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.557 -0.292 . . . . 62.41 110.54 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 100' ' ' LEU . 1.9 mm? -88.12 123.5 32.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 72.51 109.283 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 109' ' ' SER . 26.3 mtt -103.36 142.12 34.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.729 0.299 . . . . 65.12 110.662 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -140.06 142.78 36.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.214 -0.662 . . . . 73.14 109.214 172.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 23.6 tptm -124.08 104.06 8.65 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.08 -0.248 . . . . 74.24 110.94 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.78 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.3 t30 40.8 40.69 1.02 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.967 0.507 . . . . 72.22 112.28 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.99 53.03 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.169 -0.539 . . . . 43.11 113.214 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -120.79 148.94 43.32 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 122.935 0.494 . . . . 63.04 109.846 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.617 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.4 tmtt? -64.48 130.36 43.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.292 0.568 . . . . 71.43 109.752 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.617 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -136.29 167.79 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.148 -0.933 . . . . 61.41 109.244 -173.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.511 ' H ' HD13 ' A' ' 108' ' ' LEU . 8.9 m -70.69 179.44 2.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.714 0.768 . . . . 72.41 112.731 -165.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.505 ' HG3' HD13 ' A' ' 100' ' ' LEU . 50.2 tt0 -148.78 131.97 16.41 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.233 -0.894 . . . . 74.54 109.963 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 6.5 t -110.57 113.87 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.55 -1.204 . . . . 70.11 109.995 -172.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.0 mm -97.8 120.65 47.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.081 -0.508 . . . . 62.14 109.979 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.12 -173.19 30.09 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.657 -0.577 . . . . 60.32 111.657 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.45 98.41 7.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.647 0.26 . . . . 33.13 111.059 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -142.32 101.68 3.95 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.067 0.461 . . . . 64.24 110.482 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.561 ' HB ' ' OE1' ' A' ' 62' ' ' GLN . 11.4 tp -66.0 -30.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 62.15 110.853 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.1 t -58.67 -50.63 73.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.16 0.505 . . . . 72.2 110.009 176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -63.77 -46.78 83.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.65 -0.704 . . . . 55.14 110.515 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 63' ' ' LEU . 77.0 mt -57.17 -56.3 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.19 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.16 -38.91 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.893 -0.41 . . . . 72.14 109.893 -177.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.447 ' HA ' HD21 ' A' ' 124' ' ' ASN . 22.2 t -57.21 -51.25 70.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.174 -0.466 . . . . 43.12 110.047 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.0 -40.53 98.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 73.04 110.772 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 66' ' ' LEU . 96.8 mt -56.98 -56.68 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.992 -0.283 . . . . 73.41 111.001 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' A' ' 121' ' ' SER . 8.1 p30 -69.36 -35.98 76.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.872 0.368 . . . . 70.22 110.232 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.95 -36.61 84.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 72.2 110.961 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -95.73 -9.18 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 71.2 111.54 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 74' ' ' VAL . 78.1 mt -82.83 -44.27 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.311 0.577 . . . . 54.51 109.773 165.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.559 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-N 115.502 -0.772 . . . . 71.43 110.424 -177.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.542 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.1 mmm . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 112.002 0.371 . . . . 71.32 112.002 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.536 HG22 ' HG2' ' A' ' 78' ' ' LYS . 10.8 mm -67.04 130.93 32.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 120.679 0.276 . . . . 62.2 110.771 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 77' ' ' TYR . 2.6 pt-20 -105.39 161.28 14.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.848 -0.427 . . . . 70.14 109.848 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 3.9 pp0? -118.35 147.01 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.457 0.17 . . . . 71.41 110.772 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 pt -139.41 156.38 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.784 0.326 . . . . 73.54 110.823 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.1 179.01 48.31 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.908 -0.587 . . . . 75.43 112.492 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.58 -44.97 96.03 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.957 0.408 . . . . 65.03 111.342 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -65.08 -30.15 71.09 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.295 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -80.96 -20.31 42.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.836 -0.62 . . . . 75.54 111.474 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.1 t80 -57.63 -61.91 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.482 0.182 . . . . 65.25 111.138 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.78 -44.6 96.58 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.071 0.462 . . . . 73.42 110.237 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -53.62 -57.53 10.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.262 -0.881 . . . . 43.22 110.998 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -62.01 -43.64 98.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.223 -0.444 . . . . 63.34 111.162 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.658 HG12 ' HA2' ' A' ' 105' ' ' GLY . 73.9 t -62.67 -36.93 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.34 -0.391 . . . . 74.14 111.524 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -86.43 -29.2 23.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.047 0.388 . . . . 53.41 112.047 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -83.76 11.06 8.03 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.363 0.505 . . . . 74.54 112.363 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.2 p -59.4 143.89 48.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.244 -0.28 . . . . 55.23 110.244 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.4 -74.12 0.06 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.634 0.254 . . . . 72.42 110.715 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -161.74 126.22 3.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.159 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 57.05 12.27 1.21 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.672 0.619 . . . . 72.45 112.672 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 51.1 mm -64.09 117.89 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.519 -0.549 . . . . 70.51 109.519 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.1 112.2 13.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 72.33 110.105 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 38' ' ' CYS . 72.4 mt -98.7 105.64 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.001 -0.545 . . . . 72.45 110.634 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 74' ' ' VAL . 5.1 mp -90.51 116.29 28.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.082 -0.71 . . . . 73.21 109.082 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.72 105.26 18.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.768 -0.456 . . . . 72.45 109.768 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.454 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 56.5 t0 -84.28 123.24 29.93 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.854 -0.612 . . . . 62.13 110.381 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 100' ' ' LEU . 76.8 m-85 -102.9 125.3 49.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 65.22 110.592 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -117.35 148.32 41.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.03 -0.532 . . . . 74.34 111.103 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . -109.25 -178.19 0.54 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.093 -0.958 . . . . 54.33 109.245 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 85.6 Cg_exo -46.15 -26.6 3.83 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.515 2.143 . . . . 64.33 112.628 173.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -142.81 178.9 7.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.715 . . . . 73.15 109.648 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.641 ' HA ' HG12 ' A' ' 96' ' ' ILE . 14.1 p -157.8 165.4 35.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.426 -0.213 . . . . 63.3 110.426 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.52 -108.15 1.05 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.217 -0.516 . . . . 43.4 113.374 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.442 ' O ' HD23 ' A' ' 59' ' ' LEU . 95.1 Cg_endo -80.65 45.52 2.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.257 2.638 . . . . 54.22 113.514 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 95.9 m -65.33 -22.63 66.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.464 -0.334 . . . . 71.35 111.85 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 57' ' ' ARG . 35.0 ttt180 -54.06 -60.92 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.61 0.243 . . . . 74.44 111.458 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.4 m -75.58 -41.6 54.2 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.408 0.623 . . . . 70.35 111.615 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.552 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -67.84 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.881 0.697 . . . . 64.1 112.881 -169.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 42.5 mt-10 -59.54 -60.48 10.43 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 120.225 -0.59 . . . . 65.12 110.286 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.82 -36.53 96.87 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.615 1.543 . . . . 64.23 112.007 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -60.73 -47.01 88.24 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.805 -0.358 . . . . 75.21 110.86 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 119' ' ' ILE . 91.9 mt -67.4 -41.01 85.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 74.14 110.618 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 31.5 mt-10 -69.5 -24.18 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 65.51 110.712 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -68.43 -49.83 57.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.239 -0.282 . . . . 74.54 110.239 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.452 HD13 HD12 ' A' ' 123' ' ' ILE . 51.5 mt -62.54 -30.98 71.7 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.685 -0.487 . . . . 74.51 109.685 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.76 -51.55 64.34 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.927 -0.579 . . . . 43.32 109.772 173.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.542 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 35.7 mm-40 -51.97 -48.77 64.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.12 -0.491 . . . . 74.13 111.259 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -76.15 -36.8 58.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.744 -0.662 . . . . 75.41 111.577 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -104.53 3.88 32.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.989 0.737 . . . . 75.22 112.989 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.6 t -53.82 -19.43 4.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.934 0.397 . . . . 63.31 112.019 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.39 -24.18 64.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 74.02 111.168 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -134.48 1.19 3.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.347 -0.388 . . . . 60.25 110.781 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 45' ' ' LEU . 5.2 t -127.32 138.75 53.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.851 0.357 . . . . 74.22 111.381 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -134.57 129.71 35.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.404 -0.961 . . . . 71.33 108.404 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 45' ' ' LEU . 17.1 mt -119.67 115.89 48.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.14 0.495 . . . . 73.14 110.778 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.43 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 87.3 m-85 -106.17 151.64 24.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 62.14 110.871 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.536 ' HG2' HG22 ' A' ' 23' ' ' ILE . 61.0 mmtt -109.43 125.78 52.78 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.331 -0.849 . . . . 62.33 109.742 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -93.98 67.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.989 -1.486 . . . . 75.13 106.989 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.54 89.52 6.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.227 -0.897 . . . . 60.11 110.854 -171.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.5 mt -132.44 112.94 20.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.542 -0.91 . . . . 65.23 108.542 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -18.15 58.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 64.21 110.948 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' H ' HG22 ' A' ' 81' ' ' ILE . 65.3 m-20 -83.68 17.02 2.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.566 -0.288 . . . . 63.52 111.753 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -76.25 52.37 0.75 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.856 0.687 . . . . 73.53 112.856 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -82.73 -61.14 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.765 -0.828 . . . . 73.43 108.765 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.2 m-20 -48.66 -49.18 38.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.988 -1.005 . . . . 63.32 110.985 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.49 -36.85 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 71.01 110.628 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.22 75.39 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.864 -0.421 . . . . 74.24 109.864 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 72.42 110.669 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.4 mm100 -75.03 -48.49 23.75 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.963 -0.562 . . . . 52.44 111.167 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.56 -10.27 52.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 63.04 111.381 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.34 56.11 11.0 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.109 -0.567 . . . . 65.55 111.887 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.4 t -77.25 109.37 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 75.31 110.468 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.447 ' HB2' HG21 ' A' ' 112' ' ' ILE . 12.1 m -63.27 -54.08 42.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.277 -0.419 . . . . 63.12 111.186 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.31 138.92 18.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 52.44 110.488 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.835 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.31 147.43 33.11 Favored Pre-proline 0 C--O 1.236 0.377 0 O-C-N 123.364 0.415 . . . . 75.51 110.504 -178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.479 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.3 Cg_exo -70.57 166.03 77.31 Favored 'Cis proline' 0 C--N 1.357 1.021 0 C-N-CA 124.24 -1.15 . . . . 64.14 113.12 3.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.546 HG23 HG12 ' A' ' 112' ' ' ILE . 88.6 m -145.8 130.75 18.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.642 . . . . 74.0 109.839 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.463 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 42.8 mm -109.8 110.79 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 62.41 111.193 -173.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' A' ' 48' ' ' PHE . 8.4 mp -101.13 123.41 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.501 -0.555 . . . . 72.51 109.501 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.539 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 22.2 mtt -92.26 145.6 24.36 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.138 -0.319 . . . . 65.12 110.138 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.4 m-85 -142.12 152.56 43.37 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.747 -0.464 . . . . 73.14 109.747 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -145.24 114.88 7.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.444 0.164 . . . . 74.24 110.814 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.517 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 32.0 t-20 57.4 41.04 26.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.371 0.605 . . . . 72.22 110.396 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.658 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 71.04 2.81 49.35 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 115.942 -0.572 . . . . 43.11 112.843 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -101.19 147.3 26.42 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 120.732 0.301 . . . . 63.04 110.797 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -56.62 129.57 41.55 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.638 1.212 . . . . 71.43 112.161 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -136.61 167.95 20.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.138 -1.392 . . . . 61.41 108.287 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.21 172.01 8.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.823 0.675 . . . . 72.41 112.823 -163.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -138.34 138.19 38.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.65 -0.704 . . . . 74.54 110.558 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.0 m -126.47 139.92 50.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.197 -0.456 . . . . 70.11 109.876 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.546 HG12 HG23 ' A' ' 98' ' ' THR . 38.7 mt -127.16 142.99 41.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.946 -0.57 . . . . 62.14 109.88 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.27 -152.16 21.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.036 -0.602 . . . . 60.32 112.417 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -125.98 93.18 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 33.13 111.741 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.5 t70 -145.03 91.21 2.12 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 64.24 108.655 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 tp -64.54 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.614 -0.721 . . . . 62.15 110.752 -171.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -66.93 -45.35 78.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.076 -0.511 . . . . 72.2 110.082 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' HD3' ' HG2' ' A' ' 122' ' ' GLU . 14.9 tppt? -69.19 -39.82 78.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 55.14 110.277 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 63' ' ' LEU . 78.1 mt -58.66 -56.08 18.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.383 -0.371 . . . . 62.22 110.509 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.4 -37.37 77.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.726 -0.472 . . . . 72.14 109.726 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.496 ' HA ' HD21 ' A' ' 124' ' ' ASN . 37.5 t -54.04 -52.01 62.21 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.102 -0.499 . . . . 43.12 110.491 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -72.17 -28.33 63.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 73.04 110.917 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 120' ' ' ILE . 97.6 mt -59.49 -56.21 18.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 120.634 -0.427 . . . . 73.41 110.143 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.496 HD21 ' HA ' ' A' ' 121' ' ' SER . 9.1 p30 -71.19 -25.37 62.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.727 0.298 . . . . 70.22 110.325 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.469 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 30.4 t30 -62.31 -48.21 80.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.618 -0.719 . . . . 72.2 110.598 175.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.539 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.3 m-20 -80.88 -26.81 36.61 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.526 -0.761 . . . . 71.2 111.671 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 74' ' ' VAL . 71.1 mt -74.86 -49.84 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.689 0.28 . . . . 54.51 110.814 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.578 -0.725 . . . . 71.43 110.673 -174.368 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.9 mmm . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.761 0.315 . . . . 71.32 111.058 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -91.03 100.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.023 -0.732 . . . . 62.2 109.023 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 28.9 tt0 -94.06 112.26 24.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 70.14 110.641 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.588 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 2.1 mp0 -72.36 132.0 43.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 71.41 110.089 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.513 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.2 pt -130.85 152.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 73.54 110.208 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.69 165.31 45.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.131 -0.557 . . . . 75.43 112.421 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -50.87 -39.05 52.86 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.843 0.457 . . . . 65.03 111.465 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -71.15 -36.84 72.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 74.42 110.546 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.44 -13.59 60.4 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 115.837 -0.62 . . . . 75.54 111.265 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 35' ' ' VAL . 75.8 t80 -56.36 -62.15 1.92 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.594 0.235 . . . . 65.25 110.714 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.79 -47.49 80.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 73.42 110.484 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.13 -57.57 10.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.619 -0.719 . . . . 43.22 111.094 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.6 mmtt -64.95 -36.98 86.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 63.34 111.236 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 31' ' ' PHE . 74.7 t -64.07 -41.72 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.96 0.41 . . . . 74.14 110.735 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.2 p -86.24 -9.96 55.52 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.31 -0.405 . . . . 53.41 111.702 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.3 t -74.42 -2.96 27.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.281 0.233 . . . . 74.54 111.556 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.612 ' SG ' HD11 ' A' ' 44' ' ' ILE . 59.3 m -70.05 134.21 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.612 -0.267 . . . . 55.23 111.157 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -65.97 -78.03 0.06 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.833 -0.803 . . . . 72.42 108.833 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -162.49 156.43 21.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.316 -0.624 . . . . 63.42 109.316 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.659 ' HA ' ' HE2' ' A' ' 103' ' ' LYS . 53.2 m-20 62.06 13.08 5.42 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.1 0.56 . . . . 72.45 111.915 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 49.6 mm -86.85 106.65 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.897 -0.409 . . . . 70.51 109.897 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.51 109.13 16.45 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.804 -0.635 . . . . 72.33 109.437 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.612 HD11 ' SG ' ' A' ' 38' ' ' CYS . 46.3 mt -92.0 121.93 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.576 . . . . 72.45 110.836 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.564 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.7 mp -103.66 110.92 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.226 -0.657 . . . . 73.21 109.226 173.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.95 107.21 19.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.067 -0.345 . . . . 72.45 110.067 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.29 96.49 1.43 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.993 -0.743 . . . . 62.13 108.993 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 35.7 t80 -60.84 99.35 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.175 -0.92 . . . . 65.22 111.579 -172.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.454 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 59.05 -82.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.632 -0.713 . . . . 74.34 111.863 173.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 51' ' ' PRO . . . 53.69 48.3 4.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.185 0.594 . . . . 54.33 111.856 -175.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 50' ' ' ALA . 2.8 Cg_exo -75.29 -19.88 16.83 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.541 2.16 . . . . 64.33 112.345 -173.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -75.3 -38.58 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 73.15 110.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 8.3 t 54.95 82.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.441 -0.799 . . . . 63.3 111.084 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.93 -78.81 1.12 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.582 -0.607 . . . . 43.4 111.582 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.471 ' O ' HD23 ' A' ' 59' ' ' LEU . 6.0 Cg_exo -76.51 11.77 1.79 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.212 2.608 . . . . 54.22 111.81 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 5.6 p -63.73 -23.6 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.598 -0.728 . . . . 71.35 111.325 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -54.43 -52.48 61.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.492 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.553 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.9 m -75.29 -48.14 24.62 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.87 0.843 . . . . 70.35 111.806 178.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.1 mm? -68.09 -28.1 67.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 64.1 112.516 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.2 tt0 -58.56 -59.88 12.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.98 -0.378 . . . . 65.12 109.98 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 37.1 Cg_endo -66.04 -37.1 27.25 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.67 1.58 . . . . 64.23 112.107 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.87 -45.32 86.49 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.273 -0.571 . . . . 75.21 110.823 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 119' ' ' ILE . 84.8 mt -66.04 -41.18 91.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.416 -0.356 . . . . 74.14 110.678 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 51.9 mt-10 -57.41 -41.42 80.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.727 0.299 . . . . 65.51 110.344 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.04 -56.07 22.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.304 -0.407 . . . . 74.54 111.264 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.55 -34.71 71.32 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 74.51 109.902 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.11 -49.15 71.05 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.509 -0.769 . . . . 43.32 110.571 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.8 mt-30 -62.27 -41.56 98.58 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.004 0.43 . . . . 74.13 110.725 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -68.25 -38.49 81.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 75.41 110.937 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -104.49 4.18 32.84 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.347 0.499 . . . . 75.22 112.347 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.4 t -54.03 -19.66 5.17 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.785 0.661 . . . . 63.31 112.785 -172.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -61.3 -36.64 80.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.043 0.449 . . . . 74.02 110.094 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -120.57 -4.49 9.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.877 -0.601 . . . . 60.25 111.281 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.472 HG13 HD13 ' A' ' 45' ' ' LEU . 43.8 t -123.02 148.15 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.016 0.436 . . . . 74.22 111.569 -174.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.2 tptm -149.44 133.15 16.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.773 -0.649 . . . . 71.33 109.41 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 45' ' ' LEU . 52.6 mt -108.99 135.76 46.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.888 0.375 . . . . 73.14 111.082 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 49.3 m-85 -130.77 168.04 17.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.734 -0.666 . . . . 62.14 110.176 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB2' ' HZ2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -174.18 153.46 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 62.33 109.997 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tp -121.02 119.68 60.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.51 -0.922 . . . . 75.13 108.51 170.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -94.96 44.31 1.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.23 -0.441 . . . . 60.11 111.689 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.0 pt -71.05 78.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 122.105 0.955 . . . . 65.23 109.409 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -47.48 -44.69 25.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 113.9 -1.5 . . . . 64.21 114.092 -167.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.726 0.298 . . . . 63.52 111.393 -173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.41 51.61 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 73.53 110.136 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -85.53 3.17 41.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.97 -0.559 . . . . 73.43 111.986 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.49 -39.0 64.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.19 0.519 . . . . 63.32 110.055 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.03 -34.45 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.195 -0.912 . . . . 71.01 110.495 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HB2' ' HE2' ' A' ' 48' ' ' PHE . . . -64.46 -52.08 59.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.212 -0.449 . . . . 74.24 110.301 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.8 m -62.25 -32.72 73.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 72.42 111.034 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -53.89 16.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.466 -0.334 . . . . 52.44 111.346 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -79.51 -10.24 59.76 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.507 -0.315 . . . . 63.04 111.732 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.23 43.01 5.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.926 -0.654 . . . . 65.55 113.558 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.98 135.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.52 -0.548 . . . . 75.31 109.52 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.8 m -133.04 1.42 3.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.057 0.391 . . . . 63.12 112.057 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.98 156.57 47.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.016 0.436 . . . . 52.44 111.635 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 pt -125.98 122.02 24.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.749 -0.659 . . . . 75.51 110.074 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.31 -172.62 9.13 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.737 -1.36 . . . . 64.14 112.647 -0.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.51 HG23 HD13 ' A' ' 112' ' ' ILE . 47.2 m -145.06 128.29 16.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.501 -0.772 . . . . 74.0 109.177 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 47.6 mm -110.13 116.08 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.578 0.228 . . . . 62.41 111.018 -174.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.3 mt -99.02 123.48 43.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.312 -0.625 . . . . 72.51 109.312 174.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.3 mtt -97.96 144.38 27.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.203 -0.295 . . . . 65.12 110.203 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.43 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -143.6 144.83 32.09 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.003 -0.369 . . . . 73.14 110.003 175.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 41' ' ' ASN . 52.9 tttm -131.82 105.2 7.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.092 -0.243 . . . . 74.24 110.57 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 59.1 t30 58.9 30.67 20.46 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.717 0.77 . . . . 72.22 110.199 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.74 -16.37 54.62 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.614 -0.721 . . . . 43.11 112.517 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 2.4 tmmm? -76.1 140.19 41.71 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 109.608 -0.515 . . . . 63.04 109.608 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 106' ' ' LYS . 2.3 tmtp? -57.68 139.09 54.6 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.196 0.935 . . . . 71.43 110.742 -176.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -146.51 168.36 21.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.967 -1.015 . . . . 61.41 108.636 -171.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 m -70.32 175.45 4.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.601 0.963 . . . . 72.41 113.601 -161.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -141.01 142.03 34.28 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.956 -1.02 . . . . 74.54 110.769 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 15.3 t -123.55 114.56 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.995 -1.457 . . . . 70.11 109.946 -174.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.51 HD13 HG23 ' A' ' 98' ' ' THR . 46.2 mm -106.71 121.1 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.763 -0.653 . . . . 62.14 109.972 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.03 163.96 33.69 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.433 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.513 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -85.6 79.99 9.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.288 . . . . 33.13 111.021 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.7 t70 -124.52 91.9 3.54 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.398 -0.593 . . . . 64.24 109.398 175.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.57 -31.94 52.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.883 -0.599 . . . . 62.15 111.205 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.6 t -62.7 -44.08 97.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.16 -0.473 . . . . 72.2 109.978 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -70.52 -37.47 74.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 55.14 109.952 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.506 HG12 HG11 ' A' ' 111' ' ' VAL . 72.8 mt -56.74 -56.27 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.257 -0.429 . . . . 62.22 110.674 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.523 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.54 -37.91 81.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 110.22 -0.289 . . . . 72.14 110.22 -177.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.523 ' HA ' HD21 ' A' ' 124' ' ' ASN . 22.9 t -56.99 -51.97 67.13 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.937 -0.394 . . . . 43.12 109.937 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.49 -41.83 97.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.121 -0.49 . . . . 73.04 110.755 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.1 mt -53.06 -56.18 9.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.625 0.25 . . . . 73.41 110.412 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.523 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.0 p30 -71.57 -35.46 70.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.718 -0.393 . . . . 70.22 110.727 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -63.97 -35.18 79.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 72.2 111.208 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.421 ' HB3' HD11 ' A' ' 108' ' ' LEU . 84.8 m-20 -91.21 -31.15 16.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 71.2 111.707 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 123' ' ' ILE . 71.9 mt -58.55 -53.26 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 54.51 110.599 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 . . . . . 0 C--O 1.25 1.11 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.358 -175.556 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.533 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.7 mmm . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.202 0.525 . . . . 71.32 109.832 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -78.92 133.69 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.404 -0.816 . . . . 62.2 110.3 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -94.18 155.36 17.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 70.14 110.111 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -119.0 139.45 51.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.028 -0.73 . . . . 71.41 109.028 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 31' ' ' PHE . 32.6 pt -141.75 159.72 21.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.031 0.444 . . . . 73.54 111.558 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.72 -168.52 33.78 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.475 -0.784 . . . . 75.43 112.203 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.12 -48.87 72.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.657 0.383 . . . . 65.03 111.451 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 t -72.0 -40.83 68.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.42 110.371 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.31 -23.92 64.58 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.267 -0.424 . . . . 75.54 111.08 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.5 t80 -49.97 -58.2 5.95 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.851 0.357 . . . . 65.25 110.288 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -56.4 -57.52 11.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.89 -0.596 . . . . 73.42 110.599 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.87 -50.44 63.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.719 -0.673 . . . . 43.22 111.453 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.3 mmtt -68.32 -41.82 80.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 63.34 111.561 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 44' ' ' ILE . 76.1 t -70.46 -36.26 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 111.791 0.293 . . . . 74.14 111.791 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.3 p -85.96 -37.32 19.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.833 0.309 . . . . 53.41 111.833 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.5 t -83.82 10.83 8.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.033 0.383 . . . . 74.54 112.033 -173.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.812 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 19.9 p -59.99 146.99 40.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 110.32 -0.252 . . . . 55.23 110.32 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -45.98 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.406 0.682 . . . . 72.42 111.996 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.75 122.62 3.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.419 -0.215 . . . . 63.42 110.419 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.536 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.8 OUTLIER 62.56 7.25 2.34 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.787 0.435 . . . . 72.45 112.024 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.26 137.46 22.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.872 0.367 . . . . 70.51 111.247 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -81.12 123.61 28.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.534 -0.913 . . . . 72.33 108.534 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 82.1 mt -115.44 121.57 67.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.266 -0.425 . . . . 72.45 110.207 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -109.86 113.08 25.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.111 -0.7 . . . . 73.21 109.111 175.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.25 105.0 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.946 -0.39 . . . . 72.45 109.946 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.92 127.89 32.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.81 -0.632 . . . . 62.13 110.692 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -94.59 125.82 39.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.528 -0.916 . . . . 65.22 108.528 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -53.49 139.8 30.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.17 0.509 . . . . 74.34 111.622 -174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -95.33 108.49 39.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.446 -0.797 . . . . 54.33 111.102 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 21.0 Cg_endo -60.74 -32.27 92.82 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.402 2.068 . . . . 64.33 111.061 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -101.16 93.08 5.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.485 -0.931 . . . . 73.15 108.485 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.468 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 10.4 t -91.82 89.23 6.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 63.3 110.32 -174.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.49 -86.25 1.62 Allowed Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.735 -0.666 . . . . 43.4 111.449 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.72 -11.92 16.22 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.139 2.559 . . . . 54.22 112.153 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 15.4 p -50.62 -43.59 56.93 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.534 -0.757 . . . . 71.35 110.948 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -54.89 -41.02 70.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.513 -0.767 . . . . 74.44 111.524 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.3 m -75.88 -53.39 8.51 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.991 0.9 . . . . 70.35 111.701 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -61.28 -44.42 97.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.853 -1.067 . . . . 64.1 111.914 -168.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.3 -52.63 73.07 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 119.516 -0.278 . . . . 65.12 111.336 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 58' ' ' SER . 17.7 Cg_endo -61.67 -31.66 86.58 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.512 1.475 . . . . 64.23 112.137 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.1 mt-30 -62.88 -35.98 81.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.185 -0.606 . . . . 75.21 109.75 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.79 -39.08 76.8 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.792 -0.64 . . . . 74.14 109.937 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 mt-10 -53.69 -47.74 70.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.801 -0.444 . . . . 65.51 109.801 175.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -58.79 -52.45 65.65 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.942 -0.572 . . . . 74.54 111.251 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 116' ' ' ILE . 48.9 mt -62.26 -34.89 77.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.912 0.387 . . . . 74.51 110.093 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.07 -43.41 95.55 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.946 -0.57 . . . . 43.32 109.99 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 51.3 mt-30 -64.86 -46.49 81.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.05 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -72.87 -34.41 66.71 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.996 0.427 . . . . 75.41 111.21 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -104.7 4.04 32.09 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.328 0.492 . . . . 75.22 112.328 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -53.32 -19.55 3.43 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.957 0.408 . . . . 63.31 111.536 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.63 -38.08 69.04 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.981 -0.554 . . . . 74.02 110.836 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -135.21 12.08 3.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.075 -0.511 . . . . 60.25 111.331 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.55 139.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.064 0.459 . . . . 74.22 111.617 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -143.63 119.93 10.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.419 -0.81 . . . . 71.33 109.187 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 45' ' ' LEU . 40.5 mt -104.8 137.25 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.715 0.293 . . . . 73.14 110.706 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.45 151.15 40.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.935 -0.575 . . . . 62.14 109.895 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -120.8 102.74 8.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.624 -0.88 . . . . 62.33 108.624 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.7 tt -80.47 102.2 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.613 0.72 . . . . 75.13 110.134 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.82 75.46 10.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 60.11 111.172 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.403 HD11 HG11 ' A' ' 87' ' ' VAL . 29.5 pt -124.03 24.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.011 -0.737 . . . . 65.23 109.011 171.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -58.02 -18.64 25.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.552 -1.204 . . . . 64.21 111.561 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.16 -23.23 62.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.317 0.58 . . . . 63.52 109.661 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.35 95.25 7.94 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.508 -0.923 . . . . 73.53 108.508 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.211 -0.45 . . . . 73.43 111.667 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 14.5 m-20 -56.61 -32.96 65.79 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.471 -0.331 . . . . 63.32 111.286 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 81' ' ' ILE . 75.0 t -53.06 -38.63 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.467 -0.333 . . . . 71.01 110.537 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.7 -48.81 75.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.17 0.509 . . . . 74.24 109.827 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -59.34 -36.99 76.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.486 -0.779 . . . . 72.42 110.726 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 11.6 mm-40 -71.7 -51.27 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.006 -0.543 . . . . 52.44 110.492 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -73.98 -13.32 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.221 -0.445 . . . . 63.04 111.548 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.8 21.44 36.57 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.904 -0.665 . . . . 65.55 112.777 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.478 HG13 ' OG1' ' A' ' 98' ' ' THR . 64.5 t -70.42 117.28 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.156 -0.312 . . . . 75.31 110.156 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 t -136.45 8.03 3.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 63.12 110.985 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.597 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -147.18 164.06 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.794 -0.447 . . . . 52.44 109.794 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.618 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -122.51 122.0 27.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.439 -0.346 . . . . 75.51 111.207 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 66.5 Cg_endo -87.06 -166.78 3.92 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.825 -1.323 . . . . 64.14 112.022 -3.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 112' ' ' ILE . 81.5 m -138.92 120.35 14.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.535 -0.302 . . . . 74.0 110.202 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 111' ' ' VAL . 47.5 mm -110.35 117.34 54.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.86 -0.609 . . . . 62.41 110.881 -174.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -100.59 123.22 44.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.535 -0.543 . . . . 72.51 109.535 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 109' ' ' SER . 11.6 mmt -87.65 148.08 24.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.686 0.279 . . . . 65.12 110.42 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.6 m-85 -145.45 160.99 40.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.956 -0.757 . . . . 73.14 108.956 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -148.79 109.46 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.621 0.248 . . . . 74.24 110.88 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.812 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER 59.9 31.84 20.91 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.746 -0.661 . . . . 72.22 110.352 177.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.494 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 87.52 -14.43 58.06 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.918 -0.583 . . . . 43.11 112.411 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -81.76 139.56 34.76 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 110.301 -0.259 . . . . 63.04 110.301 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -58.88 149.6 26.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.812 -0.631 . . . . 71.43 111.511 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -154.39 168.01 28.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.127 0.971 . . . . 61.41 108.845 -170.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 101' ' ' MET . 3.1 m -70.35 148.17 48.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.571 0.7 . . . . 72.41 112.875 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -110.14 118.52 36.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 74.54 110.204 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.647 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.5 m -101.62 116.0 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 70.11 109.527 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.597 HG22 ' HB3' ' A' ' 95' ' ' ALA . 47.4 mt -107.59 120.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 62.14 110.577 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.11 160.84 12.44 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.246 -0.502 . . . . 60.32 112.238 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.76 83.42 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 33.13 111.017 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.5 t70 -133.75 92.22 2.94 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.344 -0.613 . . . . 64.24 109.344 174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.536 HD11 HD11 ' A' ' 66' ' ' LEU . 8.8 tp -62.3 -32.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 62.15 111.413 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -65.29 -43.62 90.54 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.151 0.501 . . . . 72.2 110.065 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 14.8 tppt? -68.38 -43.13 78.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.935 -0.575 . . . . 55.14 110.19 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 59' ' ' LEU . 70.8 mt -57.25 -51.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.709 -0.223 . . . . 62.22 110.676 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.522 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.02 -35.63 75.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.957 -0.386 . . . . 72.14 109.957 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.5 t -54.11 -51.23 64.86 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.147 0.498 . . . . 43.12 110.094 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 12.7 mm-40 -71.09 -31.84 68.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 73.04 110.766 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 120' ' ' ILE . 88.7 mt -58.15 -56.26 17.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.902 0.382 . . . . 73.41 110.037 176.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -65.8 -36.58 83.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.76 -0.459 . . . . 70.22 109.76 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -58.71 -41.57 86.65 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.097 -0.501 . . . . 72.2 110.966 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.403 ' HB2' HD11 ' A' ' 43' ' ' LEU . 81.5 m-20 -87.2 -12.75 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 71.2 111.371 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 123' ' ' ILE . 74.3 mt -80.88 -48.36 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.032 -0.359 . . . . 54.51 110.032 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.464 -0.779 . . . . 71.43 110.739 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.436 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 92.5 mmm . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.882 0.372 . . . . 71.32 110.725 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' A' ' 78' ' ' LYS . 18.3 mm -78.13 87.98 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.744 -0.835 . . . . 62.2 108.744 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.06 112.12 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.635 -0.711 . . . . 70.14 111.341 -171.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -72.83 132.36 43.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.692 -0.485 . . . . 71.41 109.692 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.53 HG21 ' HG3' ' A' ' 34' ' ' LYS . 39.0 pt -133.12 160.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.794 0.33 . . . . 73.54 110.952 -176.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.22 -177.36 40.45 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.921 -0.581 . . . . 75.43 112.95 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.01 -43.24 99.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.96 0.504 . . . . 65.03 111.622 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -74.09 -37.17 64.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.074 0.464 . . . . 74.42 110.67 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.85 -26.74 68.75 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.783 -0.644 . . . . 75.54 110.762 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.456 ' HD2' HG21 ' A' ' 79' ' ' ILE . 88.8 t80 -46.14 -61.66 1.67 Allowed 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.33 0.394 . . . . 65.25 111.122 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -50.31 69.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.914 -0.585 . . . . 73.42 110.891 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.75 -57.39 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.74 . . . . 43.22 110.75 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.4 mmtt -58.01 -44.19 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.12 -0.945 . . . . 63.34 111.181 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.04 -48.13 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.714 0.292 . . . . 74.14 111.313 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.4 p -77.43 -15.28 59.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.701 0.286 . . . . 53.41 111.595 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 t -69.55 -5.38 23.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.322 -0.399 . . . . 74.54 111.983 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 13.4 p -62.41 108.63 1.15 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.621 0.248 . . . . 55.23 110.501 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -58.43 -73.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.185 -0.462 . . . . 72.42 111.625 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -153.97 121.89 6.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.7 0.286 . . . . 63.42 110.913 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 61.3 8.3 2.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.6 0.76 . . . . 72.45 111.968 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -73.89 113.85 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.245 -0.434 . . . . 70.51 110.123 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -82.21 119.26 23.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.103 -0.499 . . . . 72.33 109.656 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.45 119.98 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.596 -0.729 . . . . 72.45 110.483 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -103.95 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.052 -0.721 . . . . 73.21 109.052 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 98.3 t -115.71 109.57 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.07 -0.344 . . . . 72.45 110.07 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.3 t70 -87.0 127.86 35.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 62.13 111.949 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -101.46 87.31 3.16 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.393 -0.595 . . . . 65.22 109.393 170.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.37 119.84 11.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.408 -0.815 . . . . 74.34 110.508 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 144.4 29.61 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.446 . . . . 54.33 110.397 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.51 -34.38 85.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.701 2.267 . . . . 64.33 112.523 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -119.76 119.16 32.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 73.15 110.087 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' ' HB ' ' A' ' 96' ' ' ILE . 47.9 t -163.88 140.79 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.3 110.567 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.03 -72.14 1.21 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.216 -0.447 . . . . 43.4 112.652 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.35 -22.36 20.5 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.056 2.504 . . . . 54.22 113.29 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 98.3 m -54.17 -24.91 19.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.57 -0.286 . . . . 71.35 111.375 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -53.95 -49.95 67.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.38 0.61 . . . . 74.44 110.165 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 12.6 m -75.0 -40.72 60.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.399 -0.819 . . . . 70.35 111.079 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.4 mm? -62.42 -41.6 98.82 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.774 0.657 . . . . 64.1 112.774 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -55.43 -54.64 48.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 117.873 0.306 . . . . 65.12 111.272 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HG2' ' O ' ' A' ' 58' ' ' SER . 21.1 Cg_endo -63.15 -35.73 62.36 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.524 1.483 . . . . 64.23 112.005 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.9 mt-30 -64.01 -31.12 72.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.643 -0.423 . . . . 75.21 110.584 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 76.0 mt -70.0 -42.02 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 74.14 109.982 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -63.53 -34.02 76.87 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 120.866 -0.334 . . . . 65.51 110.337 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 36.7 ttmt -55.6 -57.18 13.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.784 0.326 . . . . 74.54 110.298 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD12 ' A' ' 123' ' ' ILE . 33.0 mt -66.61 -38.42 86.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 74.51 110.367 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.32 -45.86 90.17 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.733 -0.667 . . . . 43.32 110.515 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.436 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 16.8 mm-40 -69.85 -46.08 66.34 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.393 -0.367 . . . . 74.13 110.956 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.75 -41.95 82.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.856 -0.611 . . . . 75.41 110.953 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -104.66 4.3 32.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.687 -0.688 . . . . 75.22 112.235 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.1 t -53.16 -21.69 5.38 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.612 0.967 . . . . 63.31 113.612 -170.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -73.53 -18.7 61.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.797 0.332 . . . . 74.02 110.925 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.439 HD22 HG12 ' A' ' 127' ' ' ILE . 5.9 t30 -135.1 5.05 3.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.262 -0.426 . . . . 60.25 110.896 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 43' ' ' LEU . 43.5 t -139.34 145.26 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.913 0.387 . . . . 74.22 111.33 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -148.69 128.29 13.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 71.33 109.541 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.569 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.0 mt -106.56 128.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 120.852 0.358 . . . . 73.14 110.479 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -110.63 168.22 9.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.836 -0.62 . . . . 62.14 109.934 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 23' ' ' ILE . 22.6 ttmm -135.05 99.27 4.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.219 -0.66 . . . . 62.33 109.219 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -119.31 97.04 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.861 0.838 . . . . 75.13 108.942 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -150.49 94.9 2.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.193 -0.912 . . . . 60.11 110.089 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.7 mp -72.98 109.93 5.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.595 -0.891 . . . . 65.23 108.595 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.89 -31.09 68.28 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.059 0.457 . . . . 64.21 110.464 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.69 -19.08 49.83 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.946 -0.57 . . . . 63.52 111.608 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' H ' HG22 ' A' ' 81' ' ' ILE . 32.8 t30 -119.7 79.84 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.4 0.619 . . . . 73.53 110.132 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.78 -21.84 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.444 -0.798 . . . . 73.43 111.06 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 26.2 t70 -45.77 -47.62 15.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.011 -0.54 . . . . 63.32 111.809 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.66 -42.02 49.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.314 -0.403 . . . . 71.01 110.988 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.84 -45.02 87.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 74.24 110.551 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -68.39 -29.86 68.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 72.42 110.587 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.1 mm100 -70.49 -46.47 63.67 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.356 -0.384 . . . . 52.44 111.089 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -79.91 -17.19 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 63.04 111.092 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.06 64.46 0.95 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.772 -0.728 . . . . 65.55 113.091 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.427 HG13 ' OG1' ' A' ' 98' ' ' THR . 91.5 t -97.04 133.15 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.399 -0.593 . . . . 75.31 109.399 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.2 m -138.71 -64.68 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.472 -0.331 . . . . 63.12 110.833 -175.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -85.49 170.57 12.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.343 -0.39 . . . . 52.44 110.488 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -110.97 118.63 47.76 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.08 -0.509 . . . . 75.51 111.718 -175.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -92.62 -160.25 0.99 Allowed 'Cis proline' 0 C--N 1.352 0.738 0 C-N-CA 123.957 -1.268 . . . . 64.14 111.3 -6.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 112' ' ' ILE . 87.9 m -137.27 129.33 29.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.145 -0.317 . . . . 74.0 110.145 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.97 120.34 62.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.944 -0.571 . . . . 62.41 110.729 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 27.3 mt -88.23 146.55 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.208 -0.664 . . . . 72.51 109.208 172.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.537 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 14.6 mmt -112.37 143.24 43.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.54 -0.541 . . . . 65.12 109.54 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 89.2 m-85 -144.36 151.2 38.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.044 -0.724 . . . . 73.14 109.044 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.79 125.17 5.7 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.363 -0.535 . . . . 74.24 111.086 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 60.94 29.26 18.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.308 0.575 . . . . 72.22 110.836 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 38' ' ' CYS . . . 71.32 11.59 71.61 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.833 -0.621 . . . . 43.11 112.023 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -98.69 144.95 27.39 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.157 -0.682 . . . . 63.04 109.157 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -74.1 118.61 17.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.716 0.769 . . . . 71.43 109.768 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 3.5 mm? -113.57 169.59 8.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.19 -1.368 . . . . 61.41 110.204 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 101' ' ' MET . 8.0 m -69.49 -177.39 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.487 0.715 . . . . 72.41 112.432 -163.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 51.1 tt0 -141.63 136.27 30.81 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.301 1.048 . . . . 74.54 111.366 -172.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.86 107.27 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 113.335 -1.757 . . . . 70.11 109.332 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 95' ' ' ALA . 50.4 mt -105.66 118.73 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.051 -0.352 . . . . 62.14 110.051 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.09 151.71 11.01 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.164 -0.471 . . . . 60.32 112.102 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.93 80.17 1.17 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.145 0.498 . . . . 33.13 111.134 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 119' ' ' ILE . 63.5 t0 -126.41 89.85 3.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 64.24 109.849 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.19 -33.37 50.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.838 -0.619 . . . . 62.15 110.831 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.3 t -63.64 -46.29 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.91 -0.586 . . . . 72.2 109.905 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.442 ' NZ ' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -66.37 -38.56 87.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 55.14 110.003 -179.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 115' ' ' ASP . 78.0 mt -61.88 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.104 -0.498 . . . . 62.22 111.119 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.414 HD13 HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -61.66 -40.04 85.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.819 0.342 . . . . 72.14 110.089 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.554 ' HA ' HD21 ' A' ' 124' ' ' ASN . 30.7 t -54.92 -50.95 67.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.639 -0.709 . . . . 43.12 109.825 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.43 -33.06 74.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 73.04 111.528 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 119' ' ' ILE . 98.0 mt -61.23 -56.17 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 120.308 -0.557 . . . . 73.41 109.857 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.554 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.0 p30 -70.41 -25.26 63.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.842 -0.343 . . . . 70.22 110.801 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -69.99 -53.63 16.83 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.061 -0.518 . . . . 72.2 110.685 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -80.72 -18.51 47.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.008 0.373 . . . . 71.2 112.008 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 123' ' ' ILE . 49.9 mt -63.18 -49.98 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.084 0.469 . . . . 54.51 109.917 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.448 -0.787 . . . . 71.43 110.091 -178.606 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.63 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 62.4 mmm . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.603 0.24 . . . . 71.32 110.847 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -68.7 84.52 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.497 -0.927 . . . . 62.2 108.497 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.19 112.23 2.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.085 -0.961 . . . . 70.14 110.682 -169.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.93 131.35 35.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.005 -0.543 . . . . 71.41 110.732 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.0 pt -136.87 162.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.534 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.39 174.64 36.89 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.145 -0.55 . . . . 75.43 111.868 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.9 -47.8 73.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.007 0.432 . . . . 65.03 110.176 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 m -59.45 -25.19 64.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.649 -0.705 . . . . 74.42 111.252 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 24.3 mm-40 -88.58 -20.03 25.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 75.54 111.56 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -55.89 -61.7 2.2 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.727 0.298 . . . . 65.25 110.978 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.77 -48.97 79.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 73.42 109.945 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -49.87 -57.3 7.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.068 -0.969 . . . . 43.22 111.48 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -66.94 -43.97 81.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.066 -0.515 . . . . 63.34 111.278 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.85 -38.85 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.715 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.5 p -86.37 -31.07 21.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.222 0.453 . . . . 53.41 112.222 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 t -82.01 -8.64 59.68 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.407 0.521 . . . . 74.54 112.407 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 10.9 p -58.48 129.52 42.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.001 -0.279 . . . . 55.23 110.251 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -49.94 -74.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.68 0.622 . . . . 72.42 112.68 -168.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -161.7 131.71 4.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.919 -0.128 . . . . 63.42 110.716 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 51.86 25.67 3.15 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.659 0.6 . . . . 72.45 112.421 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.6 mm -83.41 99.18 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.462 -0.57 . . . . 70.51 109.462 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HB3' HG22 ' A' ' 74' ' ' VAL . 59.2 tp -67.72 107.4 2.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.669 . . . . 72.33 110.205 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -94.18 118.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 72.45 110.517 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.2 mp -100.26 108.27 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.5 -0.555 . . . . 73.21 109.5 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.29 104.98 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.312 -0.625 . . . . 72.45 109.312 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' THR . 37.3 t0 -91.6 145.16 24.82 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.162 -0.472 . . . . 62.13 110.069 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 100' ' ' LEU . 10.1 m-85 -103.2 92.17 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.016 -0.538 . . . . 65.22 110.202 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -86.48 168.63 13.57 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.615 -0.72 . . . . 74.34 111.004 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.03 154.95 10.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.331 -0.849 . . . . 54.33 108.778 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.74 -38.02 21.95 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.841 2.361 . . . . 64.33 111.795 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -123.92 84.13 2.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.565 -0.902 . . . . 73.15 108.565 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -52.31 5.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.424 -0.353 . . . . 63.3 111.469 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.558 ' N ' ' SG ' ' A' ' 56' ' ' CYS . . . 151.66 -116.86 0.78 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.703 -0.76 . . . . 43.4 112.717 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD3' ' HA3' ' A' ' 54' ' ' GLY . 5.9 Cg_exo -79.54 37.01 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.365 2.71 . . . . 54.22 111.384 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 1.8 m -59.94 -35.54 75.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.095 -0.957 . . . . 71.35 111.156 -171.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -54.18 -44.2 71.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.959 -0.564 . . . . 74.44 111.378 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.637 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.2 m -74.75 -42.98 57.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.635 0.731 . . . . 70.35 110.5 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.3 mm? -72.24 -17.57 61.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 64.1 111.982 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 44.9 mt-10 -56.93 -63.94 3.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.529 -0.545 . . . . 65.12 109.529 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 53.4 Cg_endo -68.66 -35.4 16.8 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.595 1.53 . . . . 64.23 112.179 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.6 mt-30 -63.33 -46.73 85.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.335 -0.546 . . . . 75.21 111.465 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.5 mt -70.32 -43.25 70.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.874 -0.148 . . . . 74.14 110.666 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.63 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 35.4 mt-10 -59.07 -35.78 73.95 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.16 -0.311 . . . . 65.51 110.16 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.19 -57.21 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 74.54 110.458 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 123' ' ' ILE . 41.6 mt -62.44 -32.58 73.46 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.306 -0.406 . . . . 74.51 109.947 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.65 -51.71 57.38 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.866 -0.606 . . . . 43.32 110.547 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -67.23 -30.32 70.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.747 0.308 . . . . 74.13 111.296 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -81.32 -38.31 26.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.101 -0.5 . . . . 75.41 110.818 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -104.87 5.39 32.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.959 -0.564 . . . . 75.22 112.142 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 9.8 t -53.47 -19.8 4.06 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.424 0.527 . . . . 63.31 112.424 -173.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.445 ' HG3' HD22 ' A' ' 73' ' ' ASN . 9.2 pt-20 -62.4 -32.66 73.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.808 0.337 . . . . 74.02 111.101 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.445 HD22 ' HG3' ' A' ' 72' ' ' GLU . 55.6 m-80 -133.56 14.04 4.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.277 -0.419 . . . . 60.25 110.748 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' THR . 50.5 t -140.84 142.57 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.965 0.412 . . . . 74.22 111.76 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -149.89 127.75 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.8 -0.637 . . . . 71.33 109.501 170.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.0 mt -99.14 122.21 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.099 -0.334 . . . . 73.14 110.099 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -110.81 155.42 22.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.322 -0.399 . . . . 62.14 110.137 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -137.83 130.87 30.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 81' ' ' ILE . 14.0 pt -79.07 149.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.025 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -74.8 30.18 0.09 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.929 0.395 . . . . 60.11 111.871 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.7 mm -99.01 19.19 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.481 0.657 . . . . 65.23 109.691 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.74 -19.03 24.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.677 -0.692 . . . . 64.21 112.231 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.14 -6.79 54.99 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.614 0.245 . . . . 63.52 111.547 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.455 ' HB2' HG22 ' A' ' 81' ' ' ILE . 30.5 m-80 -119.58 88.32 2.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.797 0.332 . . . . 73.53 110.717 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -64.72 -30.87 71.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.609 -0.515 . . . . 73.43 109.609 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.1 m-20 -43.55 -51.44 6.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.33 -0.85 . . . . 63.32 110.999 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.33 -36.16 51.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.46 -0.791 . . . . 71.01 111.054 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -63.93 -50.95 66.65 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.309 0.576 . . . . 74.24 109.674 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -60.38 -34.4 73.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.341 -0.845 . . . . 72.42 110.808 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -60.71 -55.15 36.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.958 0.409 . . . . 52.44 110.369 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -73.57 -15.24 61.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.199 -0.455 . . . . 63.04 112.21 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.44 0.69 18.38 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.506 -0.854 . . . . 65.55 112.99 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 88.4 t -67.78 109.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.047 0.451 . . . . 75.31 109.947 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 t -97.04 -7.12 33.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.856 -0.611 . . . . 63.12 111.404 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.44 158.66 42.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.973 -0.38 . . . . 52.44 109.973 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.12 144.56 52.08 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 110.186 -0.301 . . . . 75.51 110.186 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 114' ' ' ALA . 8.1 Cg_exo -73.32 -179.71 25.95 Favored 'Cis proline' 0 C--N 1.354 0.847 0 C-N-CA 124.33 -1.113 . . . . 64.14 112.323 -3.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' ASP . 18.5 m -160.36 137.24 9.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 74.0 110.717 -178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.585 ' HB ' HG22 ' A' ' 111' ' ' VAL . 36.1 mm -109.92 110.87 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.533 -0.758 . . . . 62.41 111.307 -174.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' A' ' 48' ' ' PHE . 7.3 mp -96.39 123.26 39.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.106 -1.072 . . . . 72.51 108.106 168.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.477 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 44.4 mtt -98.76 143.29 29.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.501 . . . . 65.12 110.995 -175.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -142.81 146.13 33.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.394 -0.965 . . . . 73.14 108.394 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 107.21 4.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.482 -0.487 . . . . 74.24 110.859 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.596 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 58.96 28.32 17.48 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.746 0.784 . . . . 72.22 110.469 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.85 -16.22 59.89 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.612 -0.722 . . . . 43.11 112.596 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 13.4 tmtt? -75.33 141.32 43.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.997 -0.742 . . . . 63.04 108.997 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.518 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.59 124.35 25.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.437 0.637 . . . . 71.43 111.529 -175.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -120.46 168.08 11.69 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.393 1.077 . . . . 61.41 109.981 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.63 176.68 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.224 0.535 . . . . 72.41 111.913 -164.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -141.11 126.86 19.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 74.54 110.524 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 99' ' ' ILE . 35.5 m -114.21 130.06 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.695 -0.483 . . . . 70.11 109.695 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.1 117.8 56.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.748 -0.66 . . . . 62.14 109.679 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.72 144.92 9.0 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.289 -0.724 . . . . 60.32 111.289 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.568 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . . . -83.21 72.34 10.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.852 0.358 . . . . 33.13 111.334 -176.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 119' ' ' ILE . 30.2 t70 -113.07 104.66 12.59 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.185 -0.461 . . . . 64.24 109.833 175.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -60.94 -34.07 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 62.15 111.422 -173.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 120' ' ' ILE . 21.1 t -64.45 -50.11 68.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 72.2 110.105 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.9 tptt -61.74 -46.69 88.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 55.14 110.174 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 111' ' ' VAL . 77.4 mt -57.67 -51.08 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.489 . . . . 62.22 111.146 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.51 -39.99 87.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 110.1 -0.333 . . . . 72.14 110.1 -177.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.7 m -55.81 -50.69 69.82 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.924 -0.399 . . . . 43.12 109.924 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 61.5 mm-40 -62.62 -44.29 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 73.04 110.711 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.7 mt -53.44 -56.39 8.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.603 0.239 . . . . 73.41 110.777 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -70.18 -32.0 69.74 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.624 -0.431 . . . . 70.22 110.322 -175.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -64.55 -33.8 76.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.906 -0.588 . . . . 72.2 111.361 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.99 -20.7 19.14 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 111.984 0.365 . . . . 71.2 111.984 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.0 mt -71.49 -58.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.027 0.441 . . . . 54.51 110.028 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.247 -0.883 . . . . 71.43 110.249 -175.562 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 54.7 mmm . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 109.418 -0.586 . . . . 71.32 109.418 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.511 HG23 HG22 ' A' ' 76' ' ' ILE . 12.1 mm -71.95 89.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.55 -1.278 . . . . 62.2 107.55 169.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.63 112.15 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.465 -0.789 . . . . 70.14 111.442 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.68 117.11 18.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.701 -0.681 . . . . 71.41 109.983 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.9 pt -110.55 159.18 10.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.842 -0.617 . . . . 73.54 111.254 -172.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.88 -177.72 36.48 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.681 -0.691 . . . . 75.43 112.975 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.96 -56.92 10.08 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.734 0.814 . . . . 65.03 111.947 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -73.19 -18.59 61.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.944 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -83.9 -12.41 55.5 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.125 0.417 . . . . 75.54 112.125 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.3 t80 -58.19 -61.45 2.55 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.688 -0.486 . . . . 65.25 109.688 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.82 -52.82 61.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.689 -0.687 . . . . 73.42 110.745 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -55.98 -57.34 12.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.605 -0.725 . . . . 43.22 111.717 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -65.41 -34.13 77.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.027 -0.533 . . . . 63.34 111.552 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 31' ' ' PHE . 69.8 t -70.26 -36.32 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.604 0.24 . . . . 74.14 110.96 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.87 -13.32 48.29 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.671 0.272 . . . . 53.41 111.172 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -62.83 -10.08 11.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.424 0.528 . . . . 74.54 112.424 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 17.4 p -76.7 116.97 17.86 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.927 -0.483 . . . . 55.23 110.695 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.12 -78.04 0.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.035 -0.53 . . . . 72.42 111.359 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.68 127.62 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.519 0.2 . . . . 63.42 110.844 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.5 14.0 5.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.781 -0.645 . . . . 72.45 111.378 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.7 mm -81.72 120.39 33.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.197 -0.456 . . . . 70.51 109.854 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.38 123.85 28.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 72.33 109.963 -178.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 38' ' ' CYS . 44.2 mt -113.94 117.55 55.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 72.45 110.077 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.4 mp -105.37 126.15 51.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 67.0 t -104.93 105.08 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.698 -0.482 . . . . 72.45 109.698 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.16 145.33 32.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 62.13 111.995 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 23.6 m-85 -108.57 98.57 8.06 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.402 -0.817 . . . . 65.22 109.181 169.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -42.96 139.06 1.83 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.901 -1.045 . . . . 74.34 112.484 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.54 112.7 56.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 54.33 111.083 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.39 -40.14 11.34 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.616 2.211 . . . . 64.33 111.256 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -164.75 139.89 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.149 -0.932 . . . . 73.15 109.399 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.8 p -166.33 -67.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 63.3 110.395 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.06 -94.87 0.16 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.992 -0.623 . . . . 43.4 112.927 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.91 -7.19 20.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.986 2.457 . . . . 54.22 113.249 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.584 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 5.3 m -55.11 -30.48 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.458 -0.337 . . . . 71.35 111.537 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -53.75 -30.59 44.98 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.231 -0.44 . . . . 74.44 111.574 -172.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 42.5 m -75.3 -37.26 60.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.349 0.595 . . . . 70.35 110.998 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.1 mm? -66.68 -47.56 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.937 -0.574 . . . . 64.1 112.434 -172.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -47.75 -55.28 17.89 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 118.115 0.416 . . . . 65.12 111.565 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -33.65 50.84 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.713 1.609 . . . . 64.23 112.164 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.5 mt-30 -66.12 -27.56 68.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.566 -0.454 . . . . 75.21 110.554 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 90.1 mt -76.84 -36.35 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.496 -0.557 . . . . 74.14 109.496 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 39.2 mt-10 -60.83 -36.96 80.44 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.134 -0.484 . . . . 65.51 109.706 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 58.5 tttm -57.53 -57.0 14.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.107 -0.497 . . . . 74.54 110.309 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.491 HD13 HD12 ' A' ' 123' ' ' ILE . 48.1 mt -63.07 -32.17 73.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.989 -0.551 . . . . 74.51 110.319 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.85 -42.53 94.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 43.32 110.839 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.54 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 52.9 mm-40 -74.61 -39.1 62.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.159 0.504 . . . . 74.13 110.841 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.33 -39.04 85.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.678 -0.692 . . . . 75.41 110.801 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.412 ' CD1' HG21 ' A' ' 123' ' ' ILE . 43.5 m-85 -105.05 5.29 32.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.475 -0.784 . . . . 75.22 112.047 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.88 -19.12 2.31 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.761 0.652 . . . . 63.31 112.761 -171.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -71.08 -27.46 63.63 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.647 0.24 . . . . 74.02 111.647 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -134.81 10.25 3.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.34 0.256 . . . . 60.25 111.329 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 43' ' ' LEU . 50.9 t -135.86 142.13 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.052 0.453 . . . . 74.22 111.153 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.0 119.78 9.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 23' ' ' ILE . 34.3 mt -102.45 129.31 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.612 0.244 . . . . 73.14 110.542 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -115.98 173.86 6.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.439 -0.578 . . . . 62.14 109.439 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -155.37 136.02 13.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.978 -0.379 . . . . 62.33 109.978 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.9 mt -79.71 79.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.073 -0.714 . . . . 75.13 109.073 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -81.23 56.18 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.385 0.612 . . . . 60.11 110.405 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -123.52 92.85 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.764 -0.653 . . . . 65.23 109.765 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -59.91 -17.66 39.03 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.84 -0.618 . . . . 64.21 111.211 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.66 -25.94 62.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.608 -0.724 . . . . 63.52 111.012 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -109.59 104.88 13.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.88 0.372 . . . . 73.53 110.324 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -99.13 -30.43 12.3 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.016 -0.538 . . . . 73.43 110.414 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 36.0 t70 -47.25 -47.13 24.91 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.611 -0.722 . . . . 63.32 111.883 -171.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.95 -41.05 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.237 -0.438 . . . . 71.01 111.128 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.37 95.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.222 0.534 . . . . 74.24 110.168 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 m -67.87 -33.24 74.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 72.42 110.697 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.9 mm-40 -66.27 -51.46 57.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 52.44 110.597 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -75.1 -17.33 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 63.04 110.461 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.26 45.07 20.63 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.011 -0.614 . . . . 65.55 112.533 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.418 HG13 ' OG1' ' A' ' 98' ' ' THR . 98.8 t -58.27 110.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.033 0.444 . . . . 75.31 110.175 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.7 m -85.94 -34.84 20.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.789 -0.642 . . . . 63.12 110.956 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.79 156.6 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 52.44 109.97 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.747 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.31 144.92 33.2 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.043 -177.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.584 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 4.9 Cg_exo -78.01 173.41 57.08 Favored 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.074 -1.219 . . . . 64.14 112.637 -0.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.554 HG23 HG12 ' A' ' 112' ' ' ILE . 27.8 m -138.39 127.05 23.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.706 . . . . 74.0 109.979 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 111' ' ' VAL . 48.6 mm -110.14 110.81 33.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.072 0.463 . . . . 62.41 110.984 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 2.8 mm? -90.63 123.69 34.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.403 -0.817 . . . . 72.51 109.519 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -92.49 135.99 33.59 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.689 -0.486 . . . . 65.12 109.689 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.522 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 85.2 m-85 -141.58 142.66 33.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.249 -1.019 . . . . 73.14 108.249 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 26.7 ttpp -147.23 126.95 13.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.236 -0.586 . . . . 74.24 110.89 -175.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t30 63.32 25.55 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.625 0.726 . . . . 72.22 109.603 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.69 19.37 74.84 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.317 -0.856 . . . . 43.11 111.926 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -117.85 153.94 32.67 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 122.216 0.206 . . . . 63.04 110.58 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.507 ' O ' HD22 ' A' ' 108' ' ' LEU . 16.6 tppt? -56.48 139.75 48.26 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 124.121 0.888 . . . . 71.43 111.668 -176.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -149.99 168.37 24.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.8 -1.091 . . . . 61.41 108.707 -171.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 101' ' ' MET . 39.6 m -70.64 -177.07 1.43 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.921 0.712 . . . . 72.41 112.921 -166.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.467 ' HG3' HD13 ' A' ' 100' ' ' LEU . 47.4 tt0 -146.07 148.38 32.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.154 -0.341 . . . . 74.54 111.085 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 99' ' ' ILE . 15.3 m -137.15 128.23 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.244 -0.434 . . . . 70.11 109.882 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 98' ' ' THR . 67.5 mt -114.92 138.08 46.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.29 -0.414 . . . . 62.14 110.331 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.86 161.42 21.0 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.147 -0.549 . . . . 60.32 112.227 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.84 86.28 6.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.854 0.359 . . . . 33.13 110.553 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.6 t0 -139.15 93.78 2.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.159 0.504 . . . . 64.24 110.251 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.1 tp -60.3 -32.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.596 -0.729 . . . . 62.15 111.018 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 t -68.95 -46.87 67.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.021 -0.536 . . . . 72.2 109.976 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -67.46 -43.31 81.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 55.14 110.217 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 115' ' ' ASP . 79.6 mt -58.75 -52.4 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.4 . . . . 62.22 110.956 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.98 -39.09 83.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 120.87 0.367 . . . . 72.14 110.034 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.571 ' HA ' HD21 ' A' ' 124' ' ' ASN . 58.7 m -54.56 -50.6 67.55 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.122 -0.49 . . . . 43.12 110.448 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.17 -39.06 93.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.62 -0.264 . . . . 73.04 111.193 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.491 HD12 HD13 ' A' ' 66' ' ' LEU . 97.7 mt -55.79 -55.81 15.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.643 -0.423 . . . . 73.41 110.314 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.571 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.3 p30 -69.79 -27.36 64.84 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.428 -0.509 . . . . 70.22 110.393 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -70.69 -33.87 71.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.254 -0.43 . . . . 72.2 110.837 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.527 HD22 ' N ' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -86.07 -29.94 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 71.2 110.565 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.86 -49.68 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 54.51 110.904 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.696 -0.669 . . . . 71.43 110.124 -175.352 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.507 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 91.9 mmm . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.036 0.446 . . . . 71.32 110.43 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.68 107.35 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 62.2 110.079 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.5 126.54 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.59 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.17 124.38 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.846 -0.798 . . . . 71.41 108.846 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 34' ' ' LYS . 28.8 pt -129.32 158.02 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 73.54 110.859 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.18 165.14 53.91 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.845 -0.616 . . . . 75.43 112.253 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.87 -50.11 61.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 65.03 111.057 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.5 m -71.87 -10.52 59.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 111.51 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -89.21 -4.96 58.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.689 -0.232 . . . . 75.54 111.233 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.576 ' HD2' HD11 ' A' ' 79' ' ' ILE . 83.1 t80 -58.11 -62.49 1.79 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.789 0.328 . . . . 65.25 110.9 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.54 -39.35 93.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 73.42 109.994 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.0 -57.37 10.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.402 -0.817 . . . . 43.22 110.634 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HG3' HG21 ' A' ' 26' ' ' ILE . 43.9 mmtm -79.22 -18.37 53.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.991 -0.55 . . . . 63.34 112.137 -172.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 31' ' ' PHE . 55.0 t -74.03 -36.16 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.801 0.334 . . . . 74.14 110.334 171.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.4 p -85.98 -20.07 29.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.774 0.321 . . . . 53.41 111.02 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -68.5 4.45 1.37 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.936 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.86 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.4 p -58.13 137.95 56.54 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.219 -0.289 . . . . 55.23 110.219 175.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.25 -67.21 0.43 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 110.247 -0.279 . . . . 72.42 110.247 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.488 ' H ' HG12 ' A' ' 42' ' ' ILE . 5.3 p-10 -162.06 128.7 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.171 -0.307 . . . . 63.42 110.171 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.84 18.17 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.042 0.537 . . . . 72.45 112.248 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.488 HG12 ' H ' ' A' ' 40' ' ' ASP . 49.2 mm -71.51 136.26 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 116.524 -0.307 . . . . 70.51 110.497 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 126' ' ' ASN . 57.2 tp -80.06 126.26 30.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 72.33 110.158 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.87 119.24 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 72.45 110.381 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 76' ' ' ILE . 3.3 mp -107.09 115.31 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 73.21 109.529 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.74 105.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.223 -0.658 . . . . 72.45 109.223 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' THR . 21.9 t0 -85.92 153.11 22.43 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.722 -0.217 . . . . 62.13 110.642 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.693 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 17.4 p90 -50.73 152.64 1.97 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.054 -0.521 . . . . 65.22 111.64 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -128.77 98.48 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.836 -0.62 . . . . 74.34 109.707 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.98 149.19 10.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 54.33 110.244 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.52 39.48 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.902 2.402 . . . . 64.33 112.209 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -145.03 131.49 19.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 73.15 110.375 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.41 ' HA ' HG12 ' A' ' 96' ' ' ILE . 25.9 p -166.18 154.55 10.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 63.3 109.912 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.77 -82.82 1.67 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 112.018 -0.433 . . . . 43.4 112.018 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.61 ' HB2' HD23 ' A' ' 59' ' ' LEU . 3.6 Cg_exo -77.66 50.32 3.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.295 2.663 . . . . 54.22 111.576 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.68 -51.61 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.643 -0.708 . . . . 71.35 110.837 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -54.32 -38.13 65.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.763 -0.653 . . . . 74.44 111.903 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.7 m -75.57 -59.19 2.86 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.706 0.765 . . . . 70.35 112.144 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 55' ' ' PRO . 4.5 mm? -66.28 -34.44 78.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.716 -0.675 . . . . 64.1 112.762 -168.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 48.9 mt-10 -56.61 -60.18 10.04 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 120.602 -0.439 . . . . 65.12 110.634 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.7 Cg_endo -63.19 -34.63 67.71 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.003 1.802 . . . . 64.23 112.199 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 58' ' ' SER . 41.8 mt-30 -59.89 -41.84 92.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.421 -0.512 . . . . 75.21 110.947 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.25 -42.69 79.27 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.479 -0.328 . . . . 74.14 110.432 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 44.3 mt-10 -57.75 -37.2 73.19 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.057 -0.52 . . . . 65.51 110.539 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -66.82 -53.0 37.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.239 -0.437 . . . . 74.54 111.156 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD12 ' A' ' 123' ' ' ILE . 55.4 mt -60.09 -34.98 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.039 0.447 . . . . 74.51 110.174 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.14 -53.37 50.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.753 -0.658 . . . . 43.32 110.151 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.507 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 15.6 mm-40 -57.08 -31.91 65.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.532 -0.304 . . . . 74.13 111.683 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -78.06 -47.15 18.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.162 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -104.59 4.79 33.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.586 . . . . 75.22 112.437 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.3 t -52.9 -19.69 2.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.411 0.523 . . . . 63.31 112.411 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.77 -39.98 78.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.8 0.333 . . . . 74.02 110.497 176.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -125.45 9.72 7.85 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.26 -0.427 . . . . 60.25 111.236 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' THR . 41.0 t -132.17 138.91 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.885 0.374 . . . . 74.22 111.587 -176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -144.87 133.67 22.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.942 -0.572 . . . . 71.33 109.492 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -113.98 143.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.498 0.19 . . . . 73.14 110.747 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -131.61 162.61 29.95 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.175 0.512 . . . . 62.14 111.129 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -137.1 142.71 42.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.013 -0.994 . . . . 62.33 108.606 170.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' A' ' 31' ' ' PHE . 43.8 mm -90.91 152.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.668 -0.493 . . . . 75.13 109.668 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -94.8 -169.31 1.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.205 -0.294 . . . . 60.11 110.205 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 mt 61.61 60.88 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 122.143 0.973 . . . . 65.23 109.699 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 28.2 mp0 -59.74 -18.81 45.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.528 -1.215 . . . . 64.21 110.75 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.15 -17.9 62.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.593 -0.731 . . . . 63.52 111.435 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.8 67.72 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.405 0.621 . . . . 73.53 111.143 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -61.05 -30.5 70.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.27 -0.877 . . . . 73.43 110.811 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.65 -42.23 33.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.925 -0.579 . . . . 63.32 110.736 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.58 -36.56 60.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 71.01 110.717 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.013 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 m -60.13 -40.69 90.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.882 -0.599 . . . . 72.42 110.922 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -65.59 -41.06 93.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.918 -0.583 . . . . 52.44 111.426 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -90.65 -7.48 52.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 63.04 111.428 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.28 21.6 58.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.24 -0.505 . . . . 65.55 113.072 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.501 HG22 HG21 ' A' ' 98' ' ' THR . 46.9 t -73.13 124.44 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.949 -0.389 . . . . 75.31 109.949 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 t -151.42 -42.26 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 63.12 110.324 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.4 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . . . -102.66 137.83 40.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.304 -0.407 . . . . 52.44 110.096 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.4 pp -110.09 154.51 42.72 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.387 -0.369 . . . . 75.51 111.592 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.07 171.9 63.12 Favored 'Cis proline' 0 C--N 1.352 0.753 0 C-N-CA 123.421 -1.491 . . . . 64.14 111.894 -5.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 48' ' ' PHE . 83.8 m -130.21 110.93 11.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.355 -0.609 . . . . 74.0 109.355 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.6 mm -115.37 112.78 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 62.41 110.626 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.6 mp -94.96 123.27 38.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.44 -0.578 . . . . 72.51 109.44 174.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.491 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 15.0 mmt -95.27 139.11 32.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.81 0.338 . . . . 65.12 110.499 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -141.04 149.33 41.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.075 -0.713 . . . . 73.14 109.075 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -133.85 116.31 15.51 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.595 -0.521 . . . . 74.24 109.595 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.86 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.8 p-10 48.15 32.51 3.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.316 0.646 . . . . 72.22 112.202 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.87 -14.8 60.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.395 -0.431 . . . . 43.11 112.609 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -75.43 140.08 42.69 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.192 0.597 . . . . 63.04 110.176 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' A' ' 108' ' ' LEU . 3.3 tmmm? -69.37 132.32 46.2 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.812 -0.631 . . . . 71.43 110.897 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.495 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.8 mm? -133.52 167.8 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.838 -1.074 . . . . 61.41 110.176 -175.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.71 179.45 2.61 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.476 0.655 . . . . 72.41 112.342 -169.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -137.85 151.4 48.03 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.657 -0.701 . . . . 74.54 110.221 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -121.9 131.2 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 114.879 -1.055 . . . . 70.11 109.996 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 95' ' ' ALA . 27.5 mm -129.85 125.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 62.14 109.992 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.06 153.31 19.2 Favored Glycine 0 C--N 1.323 -0.15 0 CA-C-N 115.834 -0.621 . . . . 60.32 112.234 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -79.66 80.03 6.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.062 0.458 . . . . 33.13 111.019 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.68 94.51 3.3 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.545 -0.752 . . . . 64.24 109.075 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.35 -26.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 62.15 110.567 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.7 t -66.55 -42.12 87.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.865 -0.607 . . . . 72.2 109.647 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.83 -44.43 77.25 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 55.14 109.916 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.2 mt -56.12 -56.2 14.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.14 -0.482 . . . . 62.22 110.824 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.61 -35.34 69.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.189 -0.46 . . . . 72.14 109.881 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.54 ' HA ' HD21 ' A' ' 124' ' ' ASN . 23.0 t -57.49 -46.35 83.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.003 -0.369 . . . . 43.12 110.003 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.56 -43.54 93.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.326 -0.397 . . . . 73.04 110.497 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.435 HD12 HD13 ' A' ' 66' ' ' LEU . 96.6 mt -53.45 -55.64 12.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.818 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.54 HD21 ' HA ' ' A' ' 121' ' ' SER . 8.4 p30 -70.95 -27.91 64.09 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.946 -0.302 . . . . 70.22 110.3 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -63.36 -33.23 75.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.036 0.446 . . . . 72.2 110.125 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.44 ' HB2' HD22 ' A' ' 43' ' ' LEU . 27.5 m-80 -79.71 -40.48 28.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.882 -0.599 . . . . 71.2 111.16 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.24 -42.21 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.085 0.469 . . . . 54.51 110.733 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.307 -0.854 . . . . 71.43 109.911 179.005 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.488 0.185 . . . . 75.42 110.516 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.39 123.46 0.8 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.517 -0.31 . . . . 34.04 110.522 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -91.41 61.6 4.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.516 0.674 . . . . 65.04 110.411 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -99.64 101.15 12.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.715 -0.675 . . . . 71.22 110.59 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -169.31 116.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 65.22 110.172 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -161.77 146.08 12.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.896 -0.593 . . . . 75.12 109.522 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -85.5 -78.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.848 0.356 . . . . 65.21 110.445 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -115.56 -158.8 0.69 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.979 -0.749 . . . . 74.33 108.979 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -135.62 120.27 18.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.951 0.405 . . . . 73.11 109.915 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.54 -161.84 11.75 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.165 -0.774 . . . . 70.45 111.165 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -72.53 78.51 1.06 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.756 0.789 . . . . 73.25 110.501 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.17 127.49 50.1 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.314 -0.995 . . . . 74.23 108.314 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.59 ' HG2' ' H ' ' A' ' 14' ' ' ALA . 30.4 tt0 -144.49 177.46 8.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.833 -0.432 . . . . 75.42 109.833 -174.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.59 ' H ' ' HG2' ' A' ' 13' ' ' GLU . . . -160.62 29.7 0.16 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.313 -0.625 . . . . 52.13 109.313 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.551 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 22.4 mm-40 57.81 18.72 5.09 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.303 -0.862 . . . . 70.34 110.72 -171.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.3 t -83.48 -171.58 3.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.377 -0.828 . . . . 70.15 109.338 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -146.28 -80.45 0.16 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.708 0.289 . . . . 71.4 110.298 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.27 163.66 39.2 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.263 -0.494 . . . . 74.21 112.313 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -73.18 122.97 8.45 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.638 2.225 . . . . 75.33 111.501 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.81 39.83 0.04 OUTLIER Glycine 0 C--O 1.236 0.229 0 N-CA-C 111.937 -0.465 . . . . 31.0 111.937 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 m -62.33 131.97 51.09 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.33 0.252 . . . . 70.35 111.213 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.3 mmm -102.34 -21.53 14.28 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.341 -0.39 . . . . 71.32 110.638 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.58 96.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.953 0.406 . . . . 62.2 110.019 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 7.3 tp10 -67.09 125.87 27.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.759 -0.655 . . . . 70.14 110.862 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 25' ' ' GLN . 5.4 pm0 -85.8 128.12 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 71.41 109.423 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.7 pt -134.62 146.37 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.728 0.299 . . . . 73.54 110.989 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.32 173.65 37.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.97 -0.559 . . . . 75.43 112.035 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.49 -47.21 27.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.074 0.549 . . . . 65.03 112.21 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -74.81 -20.97 59.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.107 -0.497 . . . . 74.42 111.513 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.8 -13.44 45.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 75.54 111.379 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 26' ' ' ILE . 72.4 t80 -56.03 -62.25 1.83 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.952 0.353 . . . . 65.25 111.952 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -39.25 94.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.157 0.503 . . . . 73.42 110.112 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -55.7 -53.71 53.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.81 . . . . 43.22 110.395 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.6 mmtt -69.07 -32.9 72.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.444 -0.798 . . . . 63.34 111.375 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 31' ' ' PHE . 77.7 t -66.93 -36.18 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.967 0.413 . . . . 74.14 110.652 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 p -86.06 -19.63 29.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.381 -0.372 . . . . 53.41 111.525 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -63.29 -11.15 19.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.205 -0.452 . . . . 74.54 112.103 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 21.6 p -61.11 139.9 57.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.224 0.21 . . . . 55.23 111.482 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -72.15 -88.78 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.558 -0.292 . . . . 72.42 110.732 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.5 136.07 24.25 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.088 -0.338 . . . . 63.42 110.088 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 m120 58.22 16.43 3.95 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.627 -0.715 . . . . 72.45 111.897 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 41.5 mm -76.22 105.24 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.533 -0.543 . . . . 70.51 109.533 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 74' ' ' VAL . 53.5 tp -73.52 117.7 15.6 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.548 0.69 . . . . 72.33 109.974 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -102.0 113.0 37.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.089 -0.959 . . . . 72.45 110.679 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.594 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.5 mp -97.28 118.75 34.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.313 -0.625 . . . . 73.21 109.313 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.83 107.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.935 -0.395 . . . . 72.45 109.935 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.67 136.69 36.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.983 -0.553 . . . . 62.13 111.246 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 100' ' ' LEU . 34.3 m-85 -111.13 81.9 1.51 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.435 0.636 . . . . 65.22 109.819 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.407 ' CZ2' ' SG ' ' A' ' 53' ' ' CYS . 23.0 t-105 -68.18 92.75 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.963 -1.017 . . . . 74.34 110.501 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.567 ' HB3' HG22 ' A' ' 96' ' ' ILE . . . -77.09 137.94 65.15 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.324 -0.398 . . . . 54.33 110.074 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.34 -8.44 8.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.374 2.716 . . . . 64.33 113.763 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.736 ' HB3' HG21 ' A' ' 96' ' ' ILE . 67.5 t-105 -65.6 -52.42 52.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.632 -0.507 . . . . 73.15 109.632 177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.407 ' SG ' ' CZ2' ' A' ' 49' ' ' TRP . 4.7 t 54.99 90.73 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.316 -0.856 . . . . 63.3 112.17 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.29 -100.88 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.138 -0.553 . . . . 43.4 111.949 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.93 6.29 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.017 2.478 . . . . 54.22 112.292 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.404 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 4.8 p -50.82 -29.74 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 71.35 111.449 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.07 -51.74 63.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.504 -177.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.2 m -75.33 -45.12 41.47 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.411 0.624 . . . . 70.35 111.286 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -63.35 -31.59 72.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 64.1 112.571 -172.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 1.9 tm-20 -61.55 -58.21 19.95 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.82 -0.352 . . . . 65.12 110.426 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 26.4 Cg_endo -63.39 -28.44 71.49 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.514 1.476 . . . . 64.23 112.039 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.587 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 42.8 mt-30 -69.53 -34.8 74.76 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 75.21 110.991 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 77.5 mt -68.89 -43.54 75.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.471 -0.566 . . . . 74.14 109.471 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 6.2 mm-40 -59.32 -35.8 74.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 65.51 110.218 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 11.6 ttmm -54.51 -57.69 10.4 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.386 0.612 . . . . 74.54 110.225 174.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.484 HD13 HD12 ' A' ' 123' ' ' ILE . 43.1 mt -69.47 -28.74 66.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.393 -0.821 . . . . 74.51 110.18 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.17 -44.6 79.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 43.32 110.273 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 85.9 mt-30 -73.69 -37.34 65.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.724 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -66.03 -45.26 82.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.028 0.442 . . . . 75.41 111.051 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -100.18 5.04 44.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.612 0.597 . . . . 75.22 112.612 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -53.64 -19.69 4.32 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.806 0.669 . . . . 63.31 112.806 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.601 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 10.5 pt-20 -66.98 -28.43 68.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.646 0.26 . . . . 74.02 111.13 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.601 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 44.7 m-80 -131.06 9.49 4.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.536 -0.302 . . . . 60.25 111.22 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 43' ' ' LEU . 39.7 t -136.39 141.2 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.989 0.423 . . . . 74.22 111.574 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -142.1 119.79 11.82 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.838 -0.801 . . . . 71.33 108.838 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -99.61 138.89 22.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.761 0.315 . . . . 73.14 110.388 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 87.6 m-85 -124.55 160.27 28.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.872 -0.604 . . . . 62.14 109.457 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -137.33 120.66 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.252 -1.018 . . . . 62.33 108.252 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.77 132.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.742 -0.663 . . . . 75.13 111.561 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.01 96.32 7.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.613 -0.721 . . . . 60.11 109.471 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 84' ' ' ASN . 10.6 tp -154.21 34.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 122.057 0.932 . . . . 65.23 108.921 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -18.82 1.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.473 -1.24 . . . . 64.21 113.751 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.67 -36.11 38.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.861 0.363 . . . . 63.52 111.167 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.497 ' HB3' HG13 ' A' ' 81' ' ' ILE . 4.6 t-20 -95.97 103.23 15.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 73.53 110.814 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.17 -22.44 55.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 73.43 110.387 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.9 m-20 -51.73 -36.1 45.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.034 -0.53 . . . . 63.32 111.089 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 81' ' ' ILE . 88.0 t -52.85 -37.23 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 71.01 110.712 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.63 -50.95 65.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.066 0.46 . . . . 74.24 110.002 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -62.56 -33.09 74.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.633 -0.712 . . . . 72.42 111.171 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -74.49 -47.22 34.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 52.44 111.229 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.467 ' HB3' HD21 ' A' ' 100' ' ' LEU . 58.8 m-85 -87.07 -7.86 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.354 -0.385 . . . . 63.04 111.59 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 44.26 6.24 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.833 -0.699 . . . . 65.55 113.053 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.12 123.54 39.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.392 -0.596 . . . . 75.31 109.392 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -136.03 6.69 3.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.441 -0.345 . . . . 63.12 111.041 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.24 176.26 11.02 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.641 0.258 . . . . 52.44 110.631 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.736 HG21 ' HB3' ' A' ' 52' ' ' TRP . 1.3 pp -128.13 108.2 19.79 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.179 -0.464 . . . . 75.51 110.997 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -89.47 -162.49 1.88 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.001 -1.25 . . . . 64.14 112.519 -0.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.3 m -146.95 126.29 13.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.578 -0.527 . . . . 74.0 109.578 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 111' ' ' VAL . 48.3 mm -113.25 119.56 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.912 -0.586 . . . . 62.41 111.217 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 48' ' ' PHE . 9.1 mp -100.85 149.85 23.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 72.51 109.328 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.51 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 24.6 mtt -115.69 146.67 41.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 65.12 110.631 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -143.93 150.73 38.8 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.253 -1.017 . . . . 73.14 108.253 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -149.28 120.65 7.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.613 -0.435 . . . . 74.24 110.942 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.642 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 5.7 t30 61.85 27.09 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.486 0.66 . . . . 72.22 109.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.89 -3.39 70.38 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.45 -0.796 . . . . 43.11 112.27 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -90.73 147.35 23.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.884 -0.413 . . . . 63.04 109.884 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.48 135.49 51.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.487 0.66 . . . . 71.43 110.845 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 0.7 OUTLIER -135.76 168.19 19.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.719 -1.128 . . . . 61.41 108.947 -172.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.17 166.95 18.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.624 0.726 . . . . 72.41 111.964 -165.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.68 128.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.209 -0.905 . . . . 74.54 110.042 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 99' ' ' ILE . 15.7 m -113.14 109.41 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.633 0.73 . . . . 70.11 109.728 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.18 122.93 49.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.888 . . . . 62.14 110.198 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.75 -163.72 14.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.173 -0.537 . . . . 60.32 111.792 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.26 72.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.007 0.432 . . . . 33.13 110.697 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.6 t70 -125.03 92.37 3.63 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.745 -0.661 . . . . 64.24 109.348 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.84 -28.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 62.15 110.758 -173.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.5 t -64.7 -45.8 85.07 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.041 -0.527 . . . . 72.2 109.93 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -67.96 -38.51 82.86 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.872 -0.603 . . . . 55.14 109.946 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.5 mt -60.25 -56.21 19.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.848 -0.615 . . . . 62.22 110.514 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.46 -39.46 82.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 120.762 0.315 . . . . 72.14 110.165 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -54.41 -52.16 62.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.928 -0.578 . . . . 43.12 110.252 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.88 -32.5 70.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.357 -0.383 . . . . 73.04 111.278 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 119' ' ' ILE . 96.7 mt -57.64 -56.2 16.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 120.59 -0.444 . . . . 73.41 110.112 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -68.42 -32.94 73.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.499 -0.481 . . . . 70.22 110.039 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.73 -29.25 69.19 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.696 -0.684 . . . . 72.2 110.991 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.498 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.2 m-20 -98.11 -20.83 17.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.436 -0.347 . . . . 71.2 111.82 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.9 mt -74.48 -47.64 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.768 -0.456 . . . . 54.51 109.768 172.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.419 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.697 -0.683 . . . . 71.43 109.579 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.958 0.409 . . . . 75.42 110.313 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.44 138.91 55.66 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.302 -0.408 . . . . 34.04 110.923 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -164.03 132.91 3.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.354 -0.385 . . . . 65.04 110.334 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.02 -55.87 2.3 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.043 0.449 . . . . 71.22 109.969 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -170.75 88.97 0.13 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.811 -0.631 . . . . 65.22 109.978 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -68.95 111.47 4.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.329 -0.619 . . . . 75.12 109.329 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -125.39 170.83 10.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.859 0.362 . . . . 65.21 110.705 -174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -94.49 152.12 18.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.49 -0.559 . . . . 74.33 109.49 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.4 mtm -77.6 78.59 4.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.045 0.45 . . . . 73.11 110.349 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.29 108.8 3.46 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.417 -0.673 . . . . 70.45 111.417 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.7 m -89.82 91.95 8.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.844 0.354 . . . . 73.25 111.145 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.2 mm? -85.95 66.64 9.69 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.47 -0.567 . . . . 74.23 109.47 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.504 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 38.7 tt0 50.82 76.55 0.15 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.573 -0.739 . . . . 75.42 110.479 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.13 77.26 4.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.864 -0.607 . . . . 52.13 111.173 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.504 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 15.7 mm100 -92.82 133.78 35.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.96 -0.564 . . . . 70.34 109.521 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.6 t -159.18 -179.62 8.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.521 -0.309 . . . . 70.15 110.604 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 62.39 15.99 8.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.422 0.629 . . . . 71.4 110.764 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.17 114.2 3.35 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 111.409 -0.677 . . . . 74.21 111.409 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.54 173.81 12.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.546 2.164 . . . . 75.33 112.216 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.49 -145.25 4.44 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.859 -0.496 . . . . 31.0 111.859 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -76.28 169.67 17.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.291 0.236 . . . . 70.35 110.395 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.443 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 81.8 mmm -74.85 -9.01 58.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.651 0.262 . . . . 71.32 111.444 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.464 HG21 ' HE2' ' A' ' 78' ' ' LYS . 13.2 mm -93.96 119.94 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.476 . . . . 62.2 109.716 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 31.0 tt0 -86.82 118.45 26.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.904 0.383 . . . . 70.14 110.601 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -80.72 137.77 36.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.222 -0.445 . . . . 71.41 110.339 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.507 HG21 ' HG3' ' A' ' 34' ' ' LYS . 42.0 pt -139.53 154.51 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.562 0.22 . . . . 73.54 110.991 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.66 176.53 28.72 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.3 -0.476 . . . . 75.43 112.716 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.06 -55.1 5.92 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.367 0.667 . . . . 65.03 112.177 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 t -70.39 -34.54 72.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.941 0.401 . . . . 74.42 110.673 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.22 -24.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 75.54 111.326 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.9 t80 -49.61 -56.96 8.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 65.25 110.473 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.25 -55.2 30.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.507 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -52.54 -46.37 66.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.431 -0.804 . . . . 43.22 111.405 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.2 mmtt -77.17 -24.28 51.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.394 -0.821 . . . . 63.34 111.56 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.7 t -79.18 -33.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.841 -0.429 . . . . 74.14 109.841 174.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.2 p -79.58 -19.64 48.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.974 0.416 . . . . 53.41 110.479 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -61.7 -23.38 66.08 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.863 -0.608 . . . . 74.54 111.722 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.4 p -74.78 91.46 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 55.23 110.572 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -69.98 -61.71 1.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 72.42 111.511 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' ILE . 5.8 m-20 -123.62 120.87 34.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.483 0.182 . . . . 63.42 110.511 -172.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 51.04 3.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.1 1.519 . . . . 72.45 115.1 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.5 mm -63.92 124.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 118.134 0.424 . . . . 70.51 110.824 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -88.65 110.45 20.96 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.876 -0.787 . . . . 72.33 108.876 177.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 101' ' ' MET . 70.8 mt -90.82 118.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 72.45 110.734 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.477 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -107.56 109.08 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.41 -0.589 . . . . 73.21 109.41 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 57.3 t -92.59 106.86 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.046 -0.353 . . . . 72.45 110.046 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.505 ' HA ' HD13 ' A' ' 99' ' ' ILE . 11.7 t70 -85.74 133.05 34.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.919 -0.582 . . . . 62.13 111.894 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -94.51 95.23 8.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.71 -0.677 . . . . 65.22 109.659 172.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.418 ' HZ3' ' HG3' ' A' ' 82' ' ' GLU . 52.4 t90 -66.32 136.26 55.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.48 -0.782 . . . . 74.34 111.634 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.52 127.25 25.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.547 -0.752 . . . . 54.33 109.192 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.85 -64.8 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.736 2.291 . . . . 64.33 112.498 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -95.94 116.8 29.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.128 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.9 t -158.36 158.65 34.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.284 -0.416 . . . . 63.3 110.58 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.57 -83.56 1.45 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 116.01 -0.541 . . . . 43.4 112.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.49 -25.45 74.03 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.9 2.4 . . . . 54.22 112.768 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 67.5 m -51.01 -37.26 44.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 71.35 111.49 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -62.89 -33.41 75.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.703 0.287 . . . . 74.44 110.914 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.536 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 10.6 m -74.96 -40.53 60.71 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.865 0.84 . . . . 70.35 110.112 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -65.81 -29.58 70.08 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.169 -0.923 . . . . 64.1 111.457 -176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.1 mt-10 -56.78 -60.92 7.96 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.737 -0.385 . . . . 65.12 110.692 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.4 Cg_endo -64.33 -33.16 59.91 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.662 1.575 . . . . 64.23 111.898 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.6 mt-30 -62.62 -38.43 90.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.335 -0.546 . . . . 75.21 110.63 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.448 HD21 HD13 ' A' ' 119' ' ' ILE . 77.5 mt -72.5 -43.34 63.77 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.127 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.8 mt-10 -60.56 -32.43 71.51 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.127 -0.488 . . . . 65.51 110.395 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 65' ' ' LYS . 33.4 ttmt -66.78 -56.82 8.77 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 116.025 -0.534 . . . . 74.54 110.599 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 116' ' ' ILE . 63.6 mt -58.19 -32.05 67.88 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.917 -0.583 . . . . 74.51 109.451 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.22 -52.62 53.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.669 -0.696 . . . . 43.32 110.127 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.2 mt-30 -53.37 -41.56 65.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.78 0.324 . . . . 74.13 110.806 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.94 -44.41 48.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.16 -0.473 . . . . 75.41 111.63 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -101.49 4.82 41.56 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.602 0.593 . . . . 75.22 112.602 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.0 t -53.31 -23.96 10.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.898 0.703 . . . . 63.31 112.898 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.04 -18.88 60.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 74.02 111.141 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -130.94 7.7 4.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.975 -0.557 . . . . 60.25 110.567 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 43' ' ' LEU . 21.5 t -141.15 139.95 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.81 0.338 . . . . 74.22 111.329 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 4.7 tppp? -142.29 128.12 19.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.85 -0.614 . . . . 71.33 109.587 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.7 mt -107.89 137.78 37.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.788 -0.449 . . . . 73.14 109.788 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CZ ' ' HG2' ' A' ' 75' ' ' LYS . 51.1 m-85 -120.77 147.03 45.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.782 0.325 . . . . 62.14 111.371 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE2' HG21 ' A' ' 23' ' ' ILE . 59.7 mttm -120.69 105.45 10.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.893 -0.78 . . . . 62.33 108.893 169.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mt -71.29 107.56 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.769 -0.456 . . . . 75.13 109.769 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.22 68.78 5.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.653 0.739 . . . . 60.11 111.846 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.7 pt -120.84 55.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.197 -1.408 . . . . 65.23 107.197 167.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' HZ3' ' A' ' 49' ' ' TRP . 36.5 tt0 -49.74 -32.67 14.16 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.137 -1.847 . . . . 64.21 113.202 -168.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 -2.9 58.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.209 0.448 . . . . 63.52 112.209 -174.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.47 78.86 1.4 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 73.53 111.046 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.74 -24.34 62.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.988 -0.551 . . . . 73.43 110.388 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.33 -35.04 25.96 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.411 -0.813 . . . . 63.32 111.447 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.54 -39.16 44.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.828 -0.624 . . . . 71.01 110.828 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.14 77.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.8 -0.636 . . . . 74.24 110.49 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.1 m -67.52 -34.17 76.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.596 . . . . 72.42 110.962 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.59 -38.93 92.69 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.79 0.329 . . . . 52.44 111.137 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -95.39 -6.63 40.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.554 -0.294 . . . . 63.04 111.624 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.85 59.56 2.07 Favored Glycine 0 C--O 1.236 0.235 0 C-N-CA 120.96 -0.638 . . . . 65.55 113.215 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.555 HG13 ' OG1' ' A' ' 98' ' ' THR . 81.4 t -89.22 117.75 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.843 0.354 . . . . 75.31 110.116 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.8 m -95.58 -38.14 10.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 63.12 110.91 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 155.23 50.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 52.44 110.46 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.86 132.28 24.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.209 -0.451 . . . . 75.51 111.08 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -91.15 -165.32 2.27 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 123.964 -1.265 . . . . 64.14 111.923 -4.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.555 ' OG1' HG13 ' A' ' 93' ' ' VAL . 54.9 m -143.3 141.2 30.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.23 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 47' ' ' ASP . 46.2 mm -120.76 113.98 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.971 -0.559 . . . . 62.41 110.794 -175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.493 HD23 ' HG3' ' A' ' 110' ' ' GLN . 47.4 mt -90.95 123.41 34.42 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.357 -0.609 . . . . 72.51 109.357 171.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 38.7 mtt -96.73 143.78 27.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.662 -0.415 . . . . 65.12 110.922 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.65 154.83 45.61 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.412 -0.588 . . . . 73.14 109.412 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -156.68 120.59 4.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.261 -0.176 . . . . 74.24 110.972 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.492 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 60.56 25.91 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.832 0.825 . . . . 72.22 110.182 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.66 -8.21 73.26 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.396 -0.82 . . . . 43.11 112.514 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -86.86 147.78 25.65 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.973 -0.38 . . . . 63.04 109.973 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -72.68 127.98 34.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.629 0.728 . . . . 71.43 110.844 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD12 ' OD1' ' A' ' 126' ' ' ASN . 3.9 mm? -119.72 168.71 10.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.48 -1.236 . . . . 61.41 109.315 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -178.91 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.254 0.55 . . . . 72.41 112.257 -162.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.493 ' HG3' HD23 ' A' ' 100' ' ' LEU . 47.0 tt0 -138.3 143.8 40.15 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 122.014 0.911 . . . . 74.54 111.205 -172.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 74.0 t -126.26 118.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.566 -1.652 . . . . 70.11 109.67 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.48 123.28 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.127 -0.323 . . . . 62.14 110.127 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.39 139.81 10.22 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.71 -0.556 . . . . 60.32 111.71 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.97 80.22 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 33.13 111.429 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 119' ' ' ILE . 22.2 t0 -123.37 102.45 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 64.24 110.162 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 66' ' ' LEU . 9.1 tp -60.06 -31.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 62.15 110.634 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.9 t -61.64 -56.63 17.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.395 -0.366 . . . . 72.2 110.181 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.29 -45.26 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 55.14 110.699 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.1 mt -61.2 -56.37 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.144 -0.48 . . . . 62.22 111.35 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.41 HD13 HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -62.24 -39.75 85.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.091 0.472 . . . . 72.14 110.222 -176.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.5 t -60.65 -48.16 83.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 43.12 109.591 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.69 -35.46 78.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.81 -0.632 . . . . 73.04 111.111 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 127' ' ' ILE . 93.4 mt -56.46 -55.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.199 -0.667 . . . . 73.41 109.199 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.41 HD22 HD13 ' A' ' 120' ' ' ILE . 46.6 m-80 -63.86 -35.69 81.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 70.22 110.919 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.85 -46.61 88.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.873 0.368 . . . . 72.2 111.041 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.496 ' HB2' HD11 ' A' ' 43' ' ' LEU . 56.1 m-80 -91.21 -5.19 55.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 71.2 111.507 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 123' ' ' ILE . 60.5 mt -78.82 -47.22 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.757 -0.46 . . . . 54.51 109.757 167.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.464 -0.779 . . . . 71.43 110.539 -177.141 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.999 0.428 . . . . 75.42 110.605 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.72 152.72 24.46 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.208 -0.451 . . . . 34.04 111.102 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.72 109.55 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 65.04 109.278 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -59.95 -55.95 27.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.095 -0.502 . . . . 71.22 111.308 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -167.68 94.07 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.591 . . . . 65.22 110.482 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -65.85 85.17 0.08 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.329 0.585 . . . . 75.12 110.105 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -75.4 153.37 37.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 65.21 111.017 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -94.04 158.48 15.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.163 -0.472 . . . . 74.33 110.388 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.9 mtm -76.57 160.05 29.78 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.018 -0.537 . . . . 73.11 110.443 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.67 159.64 9.48 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.044 -0.598 . . . . 70.45 112.269 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 13' ' ' GLU . 90.0 m -135.07 115.12 13.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.866 0.365 . . . . 73.25 110.076 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.0 mm? -88.98 24.21 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 74.23 110.745 -174.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' H ' HG22 ' A' ' 11' ' ' THR . 43.5 tt0 60.08 86.09 0.1 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.483 0.659 . . . . 75.42 110.692 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.52 92.83 0.9 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.154 -0.93 . . . . 52.13 109.121 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -74.39 99.58 3.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 70.34 110.326 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -65.25 159.77 23.01 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.739 -0.664 . . . . 70.15 110.97 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 17' ' ' GLN . 52.6 tt0 71.32 10.87 6.72 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.696 -0.684 . . . . 71.4 110.746 -175.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.9 112.37 4.96 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.671 -0.572 . . . . 74.21 111.671 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.21 154.42 19.02 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.666 2.244 . . . . 75.33 112.242 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.43 -139.84 4.06 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.01 -0.614 . . . . 31.0 112.358 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.5 m -83.7 170.15 14.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.5 0.32 . . . . 70.35 110.932 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.469 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 89.5 mmm -75.57 -16.95 60.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.159 -0.473 . . . . 71.32 111.016 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 22.0 mm -85.39 111.47 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 62.2 109.491 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -85.24 112.02 20.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.9 -0.591 . . . . 70.14 110.806 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -83.61 134.86 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.698 -0.482 . . . . 71.41 109.698 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.4 pt -132.4 167.72 25.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 120.994 0.426 . . . . 73.54 111.492 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 178.96 32.45 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.579 -0.737 . . . . 75.43 112.464 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.86 -55.43 35.03 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.059 0.543 . . . . 65.03 112.026 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 t -68.82 -2.7 10.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.227 -0.442 . . . . 74.42 111.888 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.11 -9.88 25.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.565 0.209 . . . . 75.54 111.565 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.73 -62.08 1.93 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.82 0.343 . . . . 65.25 110.761 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.55 -49.27 70.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.927 -0.579 . . . . 73.42 110.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.2 -53.68 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.361 -0.836 . . . . 43.22 111.05 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -63.77 -40.11 95.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.035 -0.529 . . . . 63.34 111.127 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HA ' HD13 ' A' ' 44' ' ' ILE . 80.0 t -71.29 -40.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.104 0.409 . . . . 74.14 112.104 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 p -86.06 -29.39 23.44 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.295 0.48 . . . . 53.41 112.295 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.7 t -82.37 10.39 7.15 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.341 0.497 . . . . 74.54 112.341 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.761 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.6 p -66.57 142.69 57.41 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.252 -0.28 . . . . 55.23 110.351 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.08 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.339 0.399 . . . . 72.42 112.06 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.29 128.85 17.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.37 -0.233 . . . . 63.42 110.37 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 55.92 11.41 0.71 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.477 0.547 . . . . 72.45 112.477 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 37.6 mm -62.87 131.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.671 0.272 . . . . 70.51 110.787 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.52 110.95 21.74 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.335 0.588 . . . . 72.33 109.544 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 38' ' ' CYS . 73.0 mt -100.32 114.19 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 72.45 110.659 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.61 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -99.68 128.45 45.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.394 -0.595 . . . . 73.21 109.394 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 85.6 t -107.42 110.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.738 0.304 . . . . 72.45 110.366 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' HA ' HD13 ' A' ' 99' ' ' ILE . 4.2 t70 -85.58 134.49 34.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.847 -0.615 . . . . 62.13 110.985 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -97.96 119.81 37.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.172 -0.467 . . . . 65.22 109.862 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.468 ' HB2' ' ND2' ' A' ' 80' ' ' ASN . 51.2 t90 -54.57 108.87 0.43 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.453 -0.794 . . . . 74.34 111.786 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.6 112.41 39.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.785 -0.643 . . . . 54.33 109.902 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.41 -68.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.765 2.31 . . . . 64.33 112.556 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -114.14 110.16 19.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.0 -0.37 . . . . 73.15 110.0 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.6 t -163.55 135.96 5.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.19 -0.459 . . . . 63.3 110.142 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.09 -76.78 0.59 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.227 -0.511 . . . . 43.4 112.599 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.23 -29.31 56.32 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.983 2.455 . . . . 54.22 112.928 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 78.8 m -55.48 -31.37 61.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.152 -0.476 . . . . 71.35 112.173 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 7.0 ptp85 -69.06 -30.42 68.75 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.997 -0.281 . . . . 74.44 110.404 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.5 m -74.94 -29.34 60.91 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.295 0.569 . . . . 70.35 109.798 174.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.6 mm? -66.64 -29.09 69.03 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.871 -0.604 . . . . 64.1 111.126 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 48.3 mt-10 -57.99 -57.74 23.67 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.93 -0.308 . . . . 65.12 110.588 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 36.5 Cg_endo -66.57 -31.41 41.31 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.113 1.875 . . . . 64.23 112.641 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.9 mt-30 -62.99 -41.67 99.64 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 120.428 -0.509 . . . . 75.21 110.286 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 67.9 mt -65.62 -34.96 79.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.057 -0.519 . . . . 74.14 109.66 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.56 -37.22 86.47 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.128 -0.487 . . . . 65.51 110.505 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 1.4 tpmt? -58.35 -56.4 22.63 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.213 0.53 . . . . 74.54 109.809 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.468 HD13 HD12 ' A' ' 123' ' ' ILE . 19.1 mt -63.51 -36.43 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.467 -0.788 . . . . 74.51 110.079 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.28 -53.74 44.22 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.125 -0.489 . . . . 43.32 110.176 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 98.2 mt-30 -55.35 -42.41 73.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.746 0.308 . . . . 74.13 110.909 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.84 -41.51 64.76 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.398 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -104.87 4.8 32.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.193 0.812 . . . . 75.22 113.193 -171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.0 t -53.5 -20.02 4.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.997 1.11 . . . . 63.31 113.997 -168.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.97 -18.77 61.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.323 . . . . 74.02 111.052 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -123.16 -25.77 4.45 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.954 -0.567 . . . . 60.25 110.5 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 45' ' ' LEU . 49.5 t -109.02 134.77 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.033 0.444 . . . . 74.22 111.766 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -138.21 127.36 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 71.33 109.284 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.61 HG12 ' HB2' ' A' ' 45' ' ' LEU . 41.1 mt -108.71 123.47 64.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.263 -0.273 . . . . 73.14 110.263 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 88.1 m-85 -107.54 131.9 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.371 -0.377 . . . . 62.14 111.025 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 58.9 mttm -97.22 99.86 11.33 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.327 -0.62 . . . . 62.33 109.327 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.3 mt -81.75 83.18 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.452 0.644 . . . . 75.13 109.338 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 49' ' ' TRP . 12.9 m120 -86.64 78.02 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.759 -0.655 . . . . 60.11 110.712 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' HB ' HD22 ' A' ' 84' ' ' ASN . 18.4 pt -112.68 64.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.405 -0.816 . . . . 65.23 109.337 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -52.39 -32.46 38.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.41 -1.268 . . . . 64.21 112.542 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.54 -15.58 62.29 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.976 0.417 . . . . 63.52 111.367 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.487 HD22 ' HB ' ' A' ' 81' ' ' ILE . 30.1 m-80 -105.53 76.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 73.53 110.573 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -62.94 -33.17 74.78 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.933 -0.576 . . . . 73.43 110.7 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.8 m-20 -51.55 -32.14 27.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.825 -0.625 . . . . 63.32 111.651 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -55.89 -39.64 58.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.37 . . . . 71.01 110.679 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.64 96.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 74.24 109.918 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.7 m -64.57 -39.24 93.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.551 -0.75 . . . . 72.42 110.744 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.5 mm100 -63.27 -52.21 62.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.176 -0.466 . . . . 52.44 110.727 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -81.52 -11.78 59.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.989 -0.55 . . . . 63.04 111.16 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.71 44.81 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.271 -0.49 . . . . 65.55 112.507 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.478 HG13 ' OG1' ' A' ' 98' ' ' THR . 87.9 t -60.14 112.83 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.137 0.494 . . . . 75.31 110.09 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.7 m -87.06 -44.9 11.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.495 -0.775 . . . . 63.12 111.561 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.93 163.5 32.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.438 -0.346 . . . . 52.44 110.445 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 25.7 pt -101.45 133.06 21.1 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 75.51 110.64 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 66.4 Cg_endo -90.21 -178.02 11.13 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.77 -1.346 . . . . 64.14 111.967 -3.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.478 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.2 m -136.24 130.9 33.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.328 -0.397 . . . . 74.0 110.008 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 47' ' ' ASP . 44.2 mm -119.46 115.88 49.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.604 -0.725 . . . . 62.41 110.264 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 19.8 mt -88.14 158.66 18.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.345 -0.613 . . . . 72.51 109.345 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 31.7 mtt -123.55 141.76 51.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.728 -0.471 . . . . 65.12 109.728 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -140.95 154.36 46.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.074 -0.713 . . . . 73.14 109.074 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.5 ttmm -150.47 110.52 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.042 -0.263 . . . . 74.24 110.542 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.761 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.7 t30 64.03 25.27 13.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.598 0.714 . . . . 72.22 110.3 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.76 -16.47 41.19 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.767 -0.651 . . . . 43.11 111.925 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 34.5 ttpt -75.12 145.29 42.35 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.805 0.442 . . . . 63.04 110.092 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -64.07 148.33 50.08 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.317 0.579 . . . . 71.43 110.849 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.49 168.18 26.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.872 -1.158 . . . . 61.41 107.872 -170.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 m -69.86 -177.99 1.43 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.0 0.741 . . . . 72.41 113.0 -164.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 51.7 tt0 -149.15 146.29 27.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.767 0.794 . . . . 74.54 110.7 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.19 119.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 113.93 -1.487 . . . . 70.11 109.542 -173.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.1 mt -113.34 123.96 69.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.144 -0.317 . . . . 62.14 110.144 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.31 152.36 24.39 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.605 -0.598 . . . . 60.32 111.605 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 72.38 4.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.85 0.357 . . . . 33.13 111.185 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 119' ' ' ILE . 8.5 t70 -115.59 88.1 2.81 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.293 0.568 . . . . 64.24 109.516 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 66' ' ' LEU . 10.1 tp -59.14 -33.09 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.502 -0.772 . . . . 62.15 111.289 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.3 m -61.2 -49.52 76.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.011 0.434 . . . . 72.2 110.518 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -60.32 -44.13 95.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.038 -0.528 . . . . 55.14 110.077 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 115' ' ' ASP . 66.7 mt -58.21 -56.54 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 62.22 111.317 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.03 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.001 0.429 . . . . 72.14 110.583 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 t -59.09 -52.14 67.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.773 -0.649 . . . . 43.12 110.362 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.94 -34.66 77.02 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.52 -0.309 . . . . 73.04 111.136 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.562 ' O ' HG13 ' A' ' 127' ' ' ILE . 81.7 mt -55.75 -56.57 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.514 -0.55 . . . . 73.41 109.514 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -63.37 -37.05 85.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.05 -0.523 . . . . 70.22 110.526 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.74 -36.15 78.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 72.2 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -103.26 -1.13 29.33 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.43 0.53 . . . . 71.2 112.43 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 123' ' ' ILE . 82.5 mt -84.8 -60.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 54.51 110.419 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.577 -0.738 . . . . 71.43 110.705 -172.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.984 -0.376 . . . . 75.42 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.03 145.15 22.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 34.04 110.783 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -88.86 98.25 11.62 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.49 -0.559 . . . . 65.04 109.49 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -70.61 -65.28 0.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.401 -0.592 . . . . 71.22 109.401 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 73.25 -52.2 0.7 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.69 0.796 . . . . 65.22 112.59 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -66.31 134.12 51.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.533 0.206 . . . . 75.12 111.109 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -152.93 149.04 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.155 -0.313 . . . . 65.21 110.155 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -89.88 137.03 32.68 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.546 -0.297 . . . . 74.33 110.541 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 mmt -76.48 -35.07 58.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.681 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.31 58.18 6.24 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.915 -0.66 . . . . 70.45 112.056 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.4 p -86.82 91.55 8.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.871 0.367 . . . . 73.25 111.422 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.97 97.02 6.94 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.348 -0.387 . . . . 74.23 109.959 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.25 154.49 18.98 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.787 -0.449 . . . . 75.42 109.787 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -143.42 176.01 9.5 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.976 0.417 . . . . 52.13 112.109 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -151.83 148.59 28.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.235 -0.893 . . . . 70.34 109.418 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.6 p -120.62 168.73 11.07 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 110.454 -0.202 . . . . 70.15 110.454 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -135.16 140.13 45.14 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.126 0.488 . . . . 71.4 111.137 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.43 131.65 5.61 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.032 -0.827 . . . . 74.21 111.032 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.6 -17.43 54.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.615 2.21 . . . . 75.33 112.479 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.99 -64.31 4.16 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.009 -0.541 . . . . 31.0 111.868 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 p -135.62 125.95 26.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.748 -0.464 . . . . 70.35 109.748 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 75.9 mmm -79.77 -29.33 40.38 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.249 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.55 HG21 ' HE2' ' A' ' 78' ' ' LYS . 5.6 mm -66.83 108.86 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.824 -0.625 . . . . 62.2 110.094 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 10.4 tp10 -88.9 134.96 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.234 -0.284 . . . . 70.14 110.234 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -96.18 119.06 33.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 71.41 110.464 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.475 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.8 pt -134.58 160.97 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.294 -0.412 . . . . 73.54 111.305 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.51 -170.68 27.98 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 116.095 -0.502 . . . . 75.43 112.301 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.9 -50.37 73.68 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.002 0.43 . . . . 65.03 111.281 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -61.0 -21.21 63.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.979 -0.555 . . . . 74.42 111.319 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.464 ' CB ' ' HB ' ' A' ' 26' ' ' ILE . 5.8 mm-40 -88.8 -14.08 37.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 75.54 111.657 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -57.34 -62.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 65.25 110.837 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.92 -50.57 72.15 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.089 0.471 . . . . 73.42 110.263 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -50.74 -57.44 8.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.284 -0.871 . . . . 43.22 111.593 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 26' ' ' ILE . 49.1 mmtm -75.39 -28.9 59.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.98 -0.554 . . . . 63.34 111.757 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.478 ' HA ' HD13 ' A' ' 44' ' ' ILE . 51.5 t -70.6 -37.51 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 121.1 -0.24 . . . . 74.14 111.292 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -86.44 -30.41 22.08 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.085 0.402 . . . . 53.41 112.085 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -74.33 7.44 2.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.043 0.386 . . . . 74.54 112.043 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 29.4 p -67.78 162.51 23.76 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.161 -0.311 . . . . 55.23 110.161 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -73.66 -82.71 0.05 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.637 0.256 . . . . 72.42 111.052 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -160.87 138.48 9.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.882 -0.414 . . . . 63.42 109.882 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 59.2 t30 62.09 1.99 0.75 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.97 0.508 . . . . 72.45 111.606 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -63.82 110.15 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.377 -0.374 . . . . 70.51 111.116 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HG22 ' A' ' 74' ' ' VAL . 55.4 tp -76.27 114.41 14.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.174 -0.676 . . . . 72.33 109.174 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 38' ' ' CYS . 77.8 mt -99.86 110.46 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.989 -1.005 . . . . 72.45 110.492 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.676 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.9 mp -93.45 121.51 34.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 73.21 109.436 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 60.2 t -103.31 105.48 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.401 -0.592 . . . . 72.45 109.401 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' HD13 ' A' ' 99' ' ' ILE . 27.2 t70 -83.63 129.37 34.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.872 0.368 . . . . 62.13 111.446 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.95 114.09 25.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.142 -1.059 . . . . 65.22 108.142 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.63 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 3.1 t90 -77.75 -42.26 34.76 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.486 0.491 . . . . 74.34 111.883 -164.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB2' HG21 ' A' ' 96' ' ' ILE . . . 69.92 134.61 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.805 0.691 . . . . 54.33 110.964 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.75 -31.35 94.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.508 2.139 . . . . 64.33 111.4 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -127.82 136.32 51.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.543 -0.753 . . . . 73.15 109.014 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 5.2 p -146.64 -82.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.348 -0.141 . . . . 63.3 111.245 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . 108.86 -85.83 0.42 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.072 -0.585 . . . . 43.4 111.662 -175.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 53' ' ' CYS . 19.4 Cg_endo -58.13 -9.83 7.05 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.916 2.411 . . . . 54.22 112.259 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.73 -37.52 63.42 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.004 -0.544 . . . . 71.35 110.676 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 14.2 ptm180 -56.88 -34.25 67.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.145 -0.48 . . . . 74.44 111.151 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.5 m -75.84 -54.86 6.27 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.8 0.81 . . . . 70.35 111.04 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -64.51 -41.99 96.08 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.188 -0.915 . . . . 64.1 113.222 -169.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.77 -53.92 60.67 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 117.962 0.346 . . . . 65.12 111.301 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.86 -27.88 58.98 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.678 1.585 . . . . 64.23 112.3 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.0 mt-30 -65.07 -38.82 92.04 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.426 -0.51 . . . . 75.21 110.069 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 95.8 mt -69.01 -40.04 78.92 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 74.14 109.499 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 5.7 mm-40 -53.85 -49.18 69.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.493 -0.776 . . . . 65.51 110.18 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -54.59 -52.39 62.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.711 -0.677 . . . . 74.54 110.775 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.473 HD13 HD12 ' A' ' 123' ' ' ILE . 52.0 mt -65.02 -33.38 75.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 74.51 110.103 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -72.53 -14.91 61.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.46 . . . . 43.32 110.969 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.4 mt-30 -93.69 -39.22 10.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.882 0.373 . . . . 74.13 110.666 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -69.59 -34.01 73.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.542 0.687 . . . . 75.41 110.301 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.87 6.29 33.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.039 -0.982 . . . . 75.22 111.533 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.1 t -52.97 -22.15 5.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.634 0.975 . . . . 63.31 113.634 -168.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -78.66 -23.04 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 74.02 111.166 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.19 5.59 6.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.132 -0.486 . . . . 60.25 111.483 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.547 HG22 ' HB3' ' A' ' 43' ' ' LEU . 65.6 t -139.81 145.1 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.695 0.283 . . . . 74.22 111.578 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 28.5 tptp -148.77 127.86 12.8 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.649 -0.5 . . . . 71.33 109.649 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.9 mt -103.14 145.17 12.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.006 0.432 . . . . 73.14 111.052 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 98.4 m-85 -126.87 167.84 15.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.73 -0.668 . . . . 62.14 110.147 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 9.7 tppt? -136.49 108.52 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.273 -1.01 . . . . 62.33 108.273 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.754 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -75.65 128.29 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 75.13 110.347 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.6 21.31 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.443 0.64 . . . . 60.11 110.503 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 pt -94.55 32.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.427 0.632 . . . . 65.23 109.834 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.31 -18.58 50.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.822 -1.081 . . . . 64.21 111.59 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -89.29 5.99 42.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 63.52 111.623 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.413 ' ND2' HG23 ' A' ' 87' ' ' VAL . 49.9 t30 -116.43 89.06 3.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.963 0.411 . . . . 73.53 110.307 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -67.88 -21.77 65.13 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 73.43 111.521 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -50.13 -45.8 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.398 . . . . 63.32 110.547 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.413 HG23 ' ND2' ' A' ' 84' ' ' ASN . 74.0 t -60.35 -34.48 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.795 -0.639 . . . . 71.01 110.525 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.28 -51.5 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.041 0.448 . . . . 74.24 110.058 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -61.87 -42.23 98.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 72.42 110.914 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.89 -50.31 71.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.121 -0.491 . . . . 52.44 111.07 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.06 -4.69 58.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.398 -0.365 . . . . 63.04 111.493 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.72 34.86 37.7 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.202 -0.523 . . . . 65.55 113.53 170.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.526 HG13 ' OG1' ' A' ' 98' ' ' THR . 83.9 t -68.29 130.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 75.31 110.361 176.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.4 m -129.82 -71.3 0.61 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 63.12 110.083 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.64 136.18 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 110.027 -0.36 . . . . 52.44 110.027 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 50' ' ' ALA . 2.2 pp -113.71 151.22 44.45 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.421 -0.354 . . . . 75.51 111.335 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.08 160.81 91.24 Favored 'Cis proline' 0 C--N 1.353 0.815 0 C-N-CA 124.079 -1.217 . . . . 64.14 112.365 -0.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.529 HG23 HG12 ' A' ' 112' ' ' ILE . 92.3 m -119.74 129.91 54.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 74.0 109.871 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 111' ' ' VAL . 45.8 mm -110.16 113.48 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 62.41 110.899 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 38.0 mt -91.04 152.46 20.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.553 -0.906 . . . . 72.51 108.553 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.426 ' HB3' HD11 ' A' ' 43' ' ' LEU . 36.9 mtt -124.12 141.38 52.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.883 0.31 . . . . 65.12 110.309 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.524 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 99.4 m-85 -143.94 154.94 43.83 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.851 -0.796 . . . . 73.14 108.851 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -144.19 104.86 4.16 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.683 -0.407 . . . . 74.24 111.04 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.682 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 7.9 t30 55.41 32.82 19.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.561 0.696 . . . . 72.22 110.627 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.0 -16.48 59.42 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.736 -0.666 . . . . 43.11 112.587 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -71.79 140.74 49.57 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 110.157 -0.312 . . . . 63.04 110.157 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.556 ' O ' HD22 ' A' ' 108' ' ' LEU . 12.2 mmmm -68.42 134.42 50.17 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.281 0.562 . . . . 71.43 110.961 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.556 HD22 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -139.0 168.84 18.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.44 -1.254 . . . . 61.41 109.057 -170.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -69.81 -178.62 1.57 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.252 0.834 . . . . 72.41 113.252 -163.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.428 ' HG3' HD23 ' A' ' 100' ' ' LEU . 48.4 tt0 -148.76 122.46 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.092 -0.958 . . . . 74.54 109.689 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.505 HG23 ' HB ' ' A' ' 99' ' ' ILE . 19.4 m -113.9 130.16 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.177 0.513 . . . . 70.11 110.028 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.529 HG12 HG23 ' A' ' 98' ' ' THR . 58.0 mt -116.08 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 62.14 109.711 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.2 148.08 14.4 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.896 -0.482 . . . . 60.32 111.896 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.61 72.12 6.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.825 0.345 . . . . 33.13 111.174 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.4 t70 -122.76 91.94 3.6 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.349 -0.612 . . . . 64.24 109.349 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -59.33 -30.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 62.15 111.207 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.0 t -63.49 -49.22 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 72.2 110.071 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.47 -43.05 99.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.801 -0.444 . . . . 55.14 109.801 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 123' ' ' ILE . 70.9 mt -57.73 -56.27 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.718 -0.674 . . . . 62.22 111.104 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.19 -39.4 82.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 120.675 0.274 . . . . 72.14 110.436 -177.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.44 ' HA ' HD21 ' A' ' 124' ' ' ASN . 66.9 m -54.78 -52.0 63.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.794 -0.447 . . . . 43.12 109.794 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 25.1 mm-40 -67.64 -32.19 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 73.04 111.478 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 127' ' ' ILE . 96.7 mt -60.2 -56.18 19.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.383 -0.527 . . . . 73.41 109.918 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.44 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.2 p30 -68.01 -28.3 67.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.52 -0.472 . . . . 70.22 109.89 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 6.6 t30 -65.09 -44.49 88.68 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.664 -0.698 . . . . 72.2 111.403 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -91.32 -8.78 47.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.548 -0.296 . . . . 71.2 111.628 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.8 mt -76.44 -50.36 22.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.159 0.504 . . . . 54.51 109.645 167.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.401 -0.809 . . . . 71.43 109.667 -176.482 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.73 0.3 . . . . 75.42 110.453 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.53 78.55 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.25 0.547 . . . . 34.04 109.699 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -70.14 121.4 17.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.476 -0.784 . . . . 65.04 110.701 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.8 m170 67.48 90.78 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.227 0.611 . . . . 71.22 111.337 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -153.06 93.82 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.893 -0.594 . . . . 65.22 110.357 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -72.11 87.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.688 -0.486 . . . . 75.12 109.688 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -59.75 129.92 44.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.778 -0.646 . . . . 65.21 110.339 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -84.96 148.92 25.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.39 -0.368 . . . . 74.33 110.493 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.1 ptp -102.19 140.25 36.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 73.11 110.086 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.46 165.96 39.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.035 -0.602 . . . . 70.45 111.739 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 t -84.63 126.17 33.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 73.25 110.412 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.3 mt -82.97 -6.31 59.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.903 -0.59 . . . . 74.23 109.751 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -81.93 77.26 8.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.841 -0.618 . . . . 75.42 110.778 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.68 -66.53 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.703 -0.851 . . . . 52.13 108.703 172.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 46.66 78.47 0.07 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.297 -0.865 . . . . 70.34 111.656 174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 t -168.96 145.72 3.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.904 -0.589 . . . . 70.15 110.304 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -86.06 -178.66 6.59 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.137 -0.483 . . . . 71.4 110.072 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.38 92.26 0.78 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.933 -0.467 . . . . 74.21 111.933 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.87 147.8 27.6 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.489 2.126 . . . . 75.33 111.937 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' O ' ' HG2' ' A' ' 22' ' ' MET . . . 128.34 -27.74 4.42 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.227 -0.749 . . . . 31.0 111.227 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 p -57.83 114.49 2.33 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.776 0.339 . . . . 70.35 110.836 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 20' ' ' GLY . 94.3 mmm -124.04 -41.56 2.21 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.983 -0.553 . . . . 71.32 110.507 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.751 HG22 ' HG3' ' A' ' 78' ' ' LYS . 3.3 mm -68.76 101.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.234 -0.654 . . . . 62.2 109.234 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 40.5 tt0 -90.65 127.2 36.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.888 -0.596 . . . . 70.14 111.532 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -85.51 128.53 34.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.799 0.333 . . . . 71.41 110.436 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.34 164.79 32.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.492 -0.322 . . . . 73.54 111.031 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 -178.56 38.96 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.825 -0.625 . . . . 75.43 112.404 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.36 -43.4 94.66 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.004 0.43 . . . . 65.03 110.995 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -64.99 -36.16 83.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 74.42 110.539 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -74.09 -17.45 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 75.54 111.859 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -52.93 -62.31 1.73 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.633 0.254 . . . . 65.25 111.22 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 36' ' ' THR . 24.7 t70 -64.38 -45.99 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.02 0.438 . . . . 73.42 110.686 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -56.63 -57.16 13.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.331 -0.85 . . . . 43.22 110.701 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HE3' ' CE2' ' A' ' 77' ' ' TYR . 24.1 mmmt -65.28 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.698 -0.683 . . . . 63.34 110.885 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.63 -51.72 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.667 0.27 . . . . 74.14 111.143 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 32' ' ' ASP . 8.9 t -86.01 -10.71 54.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.829 0.307 . . . . 53.41 111.829 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -72.81 -12.59 61.05 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.923 0.342 . . . . 74.54 111.923 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.693 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 15.5 p -55.13 143.59 26.79 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.591 0.234 . . . . 55.23 111.488 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -54.56 -79.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.067 -0.515 . . . . 72.42 111.588 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' H ' HG12 ' A' ' 42' ' ' ILE . 33.8 t70 -159.33 125.8 4.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.473 0.178 . . . . 63.42 110.793 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 59.21 15.33 4.13 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.885 0.474 . . . . 72.45 111.418 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.693 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -76.32 118.71 23.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.309 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 74' ' ' VAL . 63.7 tp -74.46 122.03 22.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.945 -0.57 . . . . 72.33 110.424 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 38' ' ' CYS . 37.6 mt -110.77 121.91 64.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.661 -0.7 . . . . 72.45 110.295 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 4.4 mp -104.79 112.59 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.243 -0.651 . . . . 73.21 109.243 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -93.95 104.67 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.944 -0.391 . . . . 72.45 109.944 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.21 146.65 30.37 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.982 -0.554 . . . . 62.13 110.916 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -107.89 129.04 55.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 65.22 109.819 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.41 140.52 45.39 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 74.34 111.576 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB1' HD12 ' A' ' 96' ' ' ILE . . . -99.33 107.94 47.54 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 54.33 110.922 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -52.46 -52.46 8.84 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.746 2.297 . . . . 64.33 111.471 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.576 ' HB2' HD11 ' A' ' 96' ' ' ILE . 45.3 m95 -80.15 75.85 6.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.407 -0.96 . . . . 73.15 108.407 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.445 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 7.6 t -75.65 79.19 2.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.502 -0.772 . . . . 63.3 110.27 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -108.57 -74.04 0.82 Allowed Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.5 -0.773 . . . . 43.4 111.432 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.88 -18.95 59.83 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.732 2.288 . . . . 54.22 111.612 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 27.8 p -52.13 -34.43 44.41 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.516 -0.765 . . . . 71.35 110.379 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -53.8 -49.37 68.47 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.948 -0.569 . . . . 74.44 111.083 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.623 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 48.0 m -75.24 -42.8 54.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.072 0.463 . . . . 70.35 111.526 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.7 -37.83 88.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.815 0.672 . . . . 64.1 112.815 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 58.5 mm-40 -55.81 -58.84 13.67 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 117.967 0.349 . . . . 65.12 110.736 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 36.4 Cg_endo -65.29 -27.53 55.71 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.938 1.759 . . . . 64.23 112.372 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.2 mt-30 -68.32 -40.62 81.61 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.698 -0.401 . . . . 75.21 110.71 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.99 -43.03 84.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.633 -0.506 . . . . 74.14 109.633 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 2.9 mm-40 -52.73 -47.14 67.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.722 -0.672 . . . . 65.51 110.131 174.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -52.29 -57.08 10.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.824 -0.626 . . . . 74.54 110.837 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.46 HD13 HD12 ' A' ' 123' ' ' ILE . 31.4 mt -65.78 -31.36 72.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.676 -0.693 . . . . 74.51 110.379 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -68.46 -44.2 75.36 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.873 -0.603 . . . . 43.32 110.223 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.0 mt-30 -71.38 -37.52 71.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.271 0.558 . . . . 74.13 110.581 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -73.4 -37.34 65.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.719 -0.673 . . . . 75.41 111.122 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.96 5.25 32.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.121 -0.491 . . . . 75.22 112.166 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.7 t -52.86 -21.17 3.92 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.135 0.791 . . . . 63.31 113.135 -171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.66 -28.27 69.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 74.02 110.472 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.14 8.37 3.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.2 -0.454 . . . . 60.25 111.765 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 43' ' ' LEU . 64.9 t -134.41 141.9 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.053 0.454 . . . . 74.22 112.068 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 57.0 tptt -145.17 126.09 14.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.429 -0.805 . . . . 71.33 109.31 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 45' ' ' LEU . 36.0 mt -108.31 140.25 27.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.742 0.306 . . . . 73.14 110.542 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 86.2 m-85 -121.39 170.5 9.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 62.14 109.712 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.751 ' HG3' HG22 ' A' ' 23' ' ' ILE . 28.8 mtpp -136.12 128.5 30.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.63 -0.507 . . . . 62.33 109.63 173.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.67 67.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.661 -1.237 . . . . 75.13 107.661 168.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -85.24 66.09 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.241 -0.891 . . . . 60.11 110.656 -170.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.5 mt -100.81 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.182 -1.044 . . . . 65.23 108.182 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -23.23 2.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.35 -1.296 . . . . 64.21 113.069 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.77 -36.47 23.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.689 0.255 . . . . 63.52 111.689 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -96.9 82.24 3.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.156 0.503 . . . . 73.53 111.258 -170.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -68.43 -20.59 64.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.628 . . . . 73.43 109.991 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.9 m-20 -47.97 -39.51 19.67 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.476 -0.784 . . . . 63.32 111.427 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.8 -36.98 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.903 -0.59 . . . . 71.01 110.935 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.07 79.02 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 74.24 110.44 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.6 m -67.56 -37.77 83.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.78 -0.645 . . . . 72.42 111.02 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.6 mm100 -63.62 -46.08 87.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 52.44 110.788 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -87.28 -15.07 39.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.345 -0.389 . . . . 63.04 111.631 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 41.94 9.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.165 -0.54 . . . . 65.55 112.911 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.449 HG13 ' OG1' ' A' ' 98' ' ' THR . 93.4 t -65.23 103.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.888 -0.412 . . . . 75.31 109.888 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -77.76 -37.86 48.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 63.12 111.526 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.522 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -140.68 138.47 34.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.359 -0.382 . . . . 52.44 110.186 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 52' ' ' TRP . 18.6 pt -106.51 140.77 21.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.075 -0.512 . . . . 75.51 110.777 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.22 -179.57 26.22 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.774 -1.344 . . . . 64.14 112.408 -0.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HG12 ' A' ' 112' ' ' ILE . 93.8 m -138.61 132.58 31.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 74.0 110.121 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 44.2 mm -115.86 110.84 33.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.956 -0.566 . . . . 62.41 111.001 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -93.22 123.3 36.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.436 -0.579 . . . . 72.51 109.436 174.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.532 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 12.1 mmt -91.56 140.61 29.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.308 . . . . 65.12 110.328 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -143.77 148.35 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.151 -1.055 . . . . 73.14 108.151 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -145.61 112.06 5.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.076 -0.65 . . . . 74.24 111.384 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.64 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.6 t-20 62.19 25.95 15.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.552 0.691 . . . . 72.22 110.434 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.34 -16.55 58.65 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.576 -0.738 . . . . 43.11 112.084 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -73.5 142.4 46.77 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.041 -0.355 . . . . 63.04 110.041 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.32 127.48 33.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.43 110.725 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 108' ' ' LEU . 2.8 mm? -126.93 168.5 14.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.095 . . . . 61.41 110.576 -172.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.24 163.25 26.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.608 -0.723 . . . . 72.41 111.913 -167.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -127.25 124.34 38.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 74.54 110.044 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 32.2 m -102.8 140.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 109.814 -0.439 . . . . 70.11 109.814 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' A' ' 95' ' ' ALA . 63.2 mt -127.92 134.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 62.14 110.03 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.21 145.24 13.4 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.093 -0.575 . . . . 60.32 111.672 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.8 79.77 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 33.13 111.101 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -132.19 98.32 4.38 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.57 -0.53 . . . . 64.24 109.57 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.96 -28.78 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 62.15 110.799 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 t -64.89 -43.68 92.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.764 -0.458 . . . . 72.2 109.764 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -67.02 -44.77 79.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.125 -0.489 . . . . 55.14 109.958 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.9 mt -56.66 -54.01 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.996 -0.547 . . . . 62.22 110.958 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.524 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.25 -37.33 79.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 116.318 -0.401 . . . . 72.14 110.199 -177.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.427 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 21.5 t -56.44 -48.81 76.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.451 -0.574 . . . . 43.12 109.451 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 49.4 mm-40 -66.47 -37.16 84.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.384 -0.371 . . . . 73.04 111.046 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.5 mt -53.27 -55.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 120.833 -0.347 . . . . 73.41 110.133 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' A' ' 121' ' ' SER . 7.7 p30 -69.12 -29.56 67.64 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.561 -0.456 . . . . 70.22 110.111 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 44.2 t30 -66.68 -32.81 74.36 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.411 . . . . 72.2 111.017 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.407 ' OD1' HD12 ' A' ' 108' ' ' LEU . 64.7 m-80 -86.91 -31.07 20.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.811 -0.177 . . . . 71.2 111.152 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.5 mt -69.25 -39.8 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.112 0.482 . . . . 54.51 110.108 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.474 -0.774 . . . . 71.43 110.032 -179.022 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.168 -0.308 . . . . 75.42 110.168 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.35 131.17 46.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.168 -0.469 . . . . 34.04 110.715 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -89.13 103.15 15.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.972 0.415 . . . . 65.04 110.373 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -112.5 114.66 27.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.332 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -116.86 111.13 19.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.502 -0.317 . . . . 65.22 110.439 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -157.69 152.58 25.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.188 -0.46 . . . . 75.12 110.266 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -123.97 117.7 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 65.21 110.106 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -131.94 129.27 40.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 74.33 110.13 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.6 mtm -119.62 8.84 11.32 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.399 -0.364 . . . . 73.11 110.77 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.73 -147.29 41.56 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.511 -0.852 . . . . 70.45 111.149 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.5 p 51.54 22.18 1.47 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.074 0.55 . . . . 73.25 112.011 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.7 mt -120.28 95.62 4.82 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.728 -0.471 . . . . 74.23 109.728 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 58' ' ' SER . 40.5 tt0 -179.26 90.86 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.064 -0.516 . . . . 75.42 110.517 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.17 66.05 7.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.001 -0.74 . . . . 52.13 109.001 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.15 95.92 0.19 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.498 -0.774 . . . . 70.34 111.659 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.665 ' H ' ' HG3' ' A' ' 61' ' ' PRO . 37.7 p -137.31 158.44 44.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.361 -0.836 . . . . 70.15 109.859 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -138.45 136.15 35.92 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.299 -0.26 . . . . 71.4 110.299 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.78 129.69 1.63 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.819 -0.512 . . . . 74.21 111.819 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.8 85.12 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.427 2.085 . . . . 75.33 112.022 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.42 41.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.755 -0.657 . . . . 31.0 111.624 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 m -78.88 162.67 25.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.269 . . . . 70.35 111.5 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.9 mmm -55.28 -30.35 59.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.553 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.688 HG22 ' HB2' ' A' ' 78' ' ' LYS . 11.8 mm -63.28 103.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.628 -0.714 . . . . 62.2 109.284 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.85 125.13 27.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 70.14 111.558 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.1 120.68 24.57 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.238 -0.437 . . . . 71.41 110.007 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.4 pt -130.32 151.76 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.872 0.368 . . . . 73.54 111.607 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.77 -160.59 29.77 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.707 -0.678 . . . . 75.43 112.685 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -56.87 12.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.564 0.346 . . . . 65.03 111.769 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -65.16 -37.33 87.05 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.1 0.476 . . . . 74.42 110.23 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.87 -30.23 70.34 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.805 -0.634 . . . . 75.54 110.824 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.1 t80 -54.65 -58.01 9.22 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.335 -0.246 . . . . 65.25 110.335 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -53.48 -54.69 33.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.782 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.5 -56.85 16.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.793 -0.64 . . . . 43.22 111.054 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.1 mmtt -58.13 -35.71 71.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.203 -0.908 . . . . 63.34 111.655 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.85 -40.04 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.795 0.331 . . . . 74.14 110.933 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.8 p -78.18 -9.49 59.22 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.909 0.385 . . . . 53.41 110.933 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -61.71 -13.49 23.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.859 -0.609 . . . . 74.54 111.666 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.643 ' SG ' HD12 ' A' ' 44' ' ' ILE . 75.7 m -49.79 113.79 0.92 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.681 0.277 . . . . 55.23 111.061 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -63.58 -69.37 0.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.238 -0.653 . . . . 72.42 109.238 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -161.88 133.2 5.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.943 -0.571 . . . . 63.42 110.59 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 58.4 15.61 3.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.971 0.508 . . . . 72.45 111.661 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 mm -75.83 124.51 34.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.84 0.352 . . . . 70.51 110.758 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -82.78 118.34 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.777 -0.647 . . . . 72.33 109.438 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.643 HD12 ' SG ' ' A' ' 38' ' ' CYS . 21.3 mt -114.02 117.49 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.39 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.618 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.9 mp -104.31 131.15 51.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.684 -0.858 . . . . 73.21 108.684 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.2 108.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.204 -0.295 . . . . 72.45 110.204 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 22.2 t0 -81.86 138.25 35.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 62.13 110.02 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -78.51 177.65 8.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 65.22 111.128 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 80' ' ' ASN . 20.1 t90 -85.81 129.1 34.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.653 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.07 86.62 7.57 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.846 -0.616 . . . . 54.33 109.912 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.37 -22.44 21.73 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.296 1.997 . . . . 64.33 111.982 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -117.77 111.17 18.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 73.15 110.339 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -175.86 135.88 0.3 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.114 -0.494 . . . . 63.3 110.387 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -74.91 0.95 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.355 -0.45 . . . . 43.4 112.418 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.19 -23.03 72.54 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 54.22 113.057 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.469 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 71.8 m -55.83 -30.71 61.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.595 -0.275 . . . . 71.35 111.446 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -59.45 -32.42 70.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.852 0.358 . . . . 74.44 110.774 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.559 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.5 m -74.67 -38.17 62.49 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.809 0.814 . . . . 70.35 110.138 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.5 mm? -67.33 -34.71 77.92 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.359 -0.837 . . . . 64.1 111.975 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 45.5 mt-10 -55.05 -58.43 14.82 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 120.994 -0.282 . . . . 65.12 110.817 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.665 ' HG3' ' H ' ' A' ' 16' ' ' THR . 38.2 Cg_endo -66.62 -31.11 41.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.106 1.87 . . . . 64.23 112.332 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.1 mt-30 -62.79 -40.75 98.3 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.296 -0.562 . . . . 75.21 110.18 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.8 mt -68.73 -33.77 74.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.871 -0.604 . . . . 74.14 109.991 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 40.8 mt-10 -62.49 -44.55 96.12 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.324 -0.398 . . . . 65.51 110.271 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -54.79 -52.48 62.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.127 -0.488 . . . . 74.54 110.474 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.471 HD13 HD12 ' A' ' 123' ' ' ILE . 47.5 mt -65.33 -37.19 86.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.519 . . . . 74.51 110.205 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.58 -36.46 83.87 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.86 -0.609 . . . . 43.32 110.879 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -74.43 -50.35 18.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 74.13 110.544 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -63.54 -34.66 78.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 75.41 110.914 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -104.97 5.07 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 75.22 112.203 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.4 t -53.34 -20.0 3.95 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.37 0.507 . . . . 63.31 112.37 -172.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.19 -39.22 92.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 74.02 110.739 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.46 -9.88 12.03 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.051 -0.522 . . . . 60.25 110.848 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 43' ' ' LEU . 68.2 t -125.85 145.63 32.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.037 0.446 . . . . 74.22 111.635 -171.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.11 128.64 13.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.324 -0.621 . . . . 71.33 109.324 171.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.6 mt -111.5 129.13 67.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.078 0.466 . . . . 73.14 110.964 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.5 m-85 -114.81 177.84 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 62.14 109.18 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HB2' HG22 ' A' ' 23' ' ' ILE . 59.0 tttp -148.17 123.5 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 62.33 110.532 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 81' ' ' ILE . 29.2 mm -86.49 108.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 75.13 109.857 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.596 ' HA ' ' HB2' ' A' ' 49' ' ' TRP . 30.4 p-10 -114.98 4.9 14.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.451 -0.341 . . . . 60.11 111.116 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.56 HG22 HG23 ' A' ' 79' ' ' ILE . 6.1 tt -65.47 105.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.34 0.59 . . . . 65.23 109.782 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -54.99 -31.0 60.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.046 -0.979 . . . . 64.21 112.756 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.85 -19.39 61.97 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.787 0.291 . . . . 63.52 111.787 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.487 HD22 HG21 ' A' ' 79' ' ' ILE . 45.1 t30 -87.9 88.11 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.062 0.458 . . . . 73.53 111.786 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -107.14 -30.49 8.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 73.43 109.324 171.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.55 -55.98 5.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.041 -0.981 . . . . 63.32 111.411 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.99 -34.22 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.734 -0.666 . . . . 71.01 111.071 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.39 62.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.076 0.465 . . . . 74.24 110.162 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -67.1 -31.53 72.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.611 -0.722 . . . . 72.42 111.096 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -75.17 -38.52 60.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.228 -0.442 . . . . 52.44 111.666 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -91.95 -11.66 35.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.757 0.281 . . . . 63.04 111.757 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.87 53.21 2.76 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.908 -0.663 . . . . 65.55 113.394 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 98' ' ' THR . 98.4 t -79.69 106.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.677 -0.49 . . . . 75.31 109.677 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -82.88 -43.27 16.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.875 -0.602 . . . . 63.12 111.402 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.24 12.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.594 -0.276 . . . . 52.44 110.59 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.808 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -109.3 150.68 41.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.262 -0.426 . . . . 75.51 110.426 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 95.9 Cg_endo -77.84 174.81 50.29 Favored 'Cis proline' 0 C--N 1.353 0.803 0 C-N-CA 123.696 -1.377 . . . . 64.14 112.244 -1.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.442 HG21 HG22 ' A' ' 93' ' ' VAL . 92.3 m -142.36 115.28 8.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.291 -0.413 . . . . 74.0 110.439 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' A' ' 111' ' ' VAL . 32.3 mm -109.81 111.42 36.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.723 -0.671 . . . . 62.41 110.373 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 100' ' ' LEU . 2.2 mm? -88.42 125.81 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.194 -0.912 . . . . 72.51 109.835 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.618 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -94.76 138.28 32.77 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.749 -0.463 . . . . 65.12 109.749 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -135.88 144.14 45.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.69 -0.485 . . . . 73.14 109.69 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.7 tptp -132.59 106.38 7.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.927 -0.309 . . . . 74.24 110.216 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.86 26.23 15.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.119 0.485 . . . . 72.22 110.709 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.53 -6.36 82.51 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.707 -0.679 . . . . 43.11 112.299 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -87.9 152.1 22.33 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 120.581 0.229 . . . . 63.04 110.647 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 7.8 tmtm? -56.86 134.8 55.62 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 124.262 0.976 . . . . 71.43 110.809 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.53 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -145.09 169.08 18.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.534 -1.212 . . . . 61.41 108.539 -175.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 101' ' ' MET . 40.7 m -70.01 -177.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.211 0.529 . . . . 72.41 111.927 -164.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.49 ' HG3' HD13 ' A' ' 100' ' ' LEU . 49.2 tt0 -147.14 142.77 27.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.132 -0.486 . . . . 74.54 110.141 -173.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.502 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.2 m -128.22 132.35 68.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.945 0.402 . . . . 70.11 110.247 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.31 135.69 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.802 -0.636 . . . . 62.14 109.424 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.92 154.53 21.27 Favored Glycine 0 C--O 1.235 0.156 0 C-N-CA 121.003 -0.618 . . . . 60.32 111.816 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.6 74.87 9.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.724 0.297 . . . . 33.13 111.377 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -123.96 93.61 3.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.292 0.568 . . . . 64.24 109.483 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -59.11 -30.6 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.524 -0.762 . . . . 62.15 111.047 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.0 t -67.82 -41.23 83.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.442 -0.345 . . . . 72.2 110.25 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -70.74 -40.96 72.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 110.08 -0.341 . . . . 55.14 110.08 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.71 -55.77 20.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.123 -0.49 . . . . 62.22 110.635 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.494 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.58 -35.57 70.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.514 -0.55 . . . . 72.14 109.514 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.434 ' HA ' HD21 ' A' ' 124' ' ' ASN . 48.1 t -53.69 -52.28 60.54 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.913 -0.585 . . . . 43.12 109.901 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 33.6 mm-40 -67.1 -38.38 85.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.23 -0.441 . . . . 73.04 111.371 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.471 HD12 HD13 ' A' ' 66' ' ' LEU . 98.4 mt -54.19 -55.77 12.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 120.571 -0.452 . . . . 73.41 110.303 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.434 HD21 ' HA ' ' A' ' 121' ' ' SER . 8.5 p30 -71.47 -27.3 63.15 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.751 -0.379 . . . . 70.22 110.525 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.415 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 54.5 t30 -73.16 -28.51 62.27 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.131 -0.486 . . . . 72.2 110.864 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.45 HD22 ' N ' ' A' ' 126' ' ' ASN . 0.9 OUTLIER -85.73 -36.86 19.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 71.2 110.192 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 123' ' ' ILE . 70.6 mt -67.67 -44.88 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.136 0.493 . . . . 54.51 110.201 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.711 -0.661 . . . . 71.43 109.967 -178.73 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.886 0.374 . . . . 75.42 110.622 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.17 -170.21 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.927 -0.579 . . . . 34.04 112.139 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -156.67 -39.97 0.07 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.572 -0.74 . . . . 65.04 109.488 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 71.75 -43.71 0.57 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.817 0.847 . . . . 71.22 111.346 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -57.06 95.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.111 0.481 . . . . 65.22 109.98 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -160.27 136.91 8.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.739 -0.664 . . . . 75.12 109.269 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.01 173.88 11.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.961 -0.385 . . . . 65.21 109.961 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.62 ' HB2' HG22 ' A' ' 89' ' ' THR . 19.0 p-80 -122.31 136.17 54.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 74.33 109.896 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tpt -92.76 -69.51 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 73.11 111.079 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 89' ' ' THR . . . -146.48 143.1 11.09 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.155 -0.545 . . . . 70.45 111.997 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -93.81 139.76 30.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.31 . . . . 73.25 111.094 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.17 179.53 7.16 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.806 -0.633 . . . . 74.23 109.356 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.7 172.6 13.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.765 0.316 . . . . 75.42 110.68 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.22 166.72 16.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 52.13 110.478 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.656 ' HG2' ' HB3' ' A' ' 51' ' ' PRO . 58.1 tp60 -154.78 149.06 26.06 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.436 -0.579 . . . . 70.34 109.436 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.857 HG21 ' HB3' ' A' ' 82' ' ' GLU . 3.1 p -141.75 99.2 3.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.085 0.469 . . . . 70.15 111.286 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' HG3' HE21 ' A' ' 15' ' ' GLN . 99.1 mt-30 -138.68 152.14 47.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.531 -0.759 . . . . 71.4 109.15 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 136.6 131.74 3.02 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.71 -0.556 . . . . 74.21 111.71 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -86.06 177.22 4.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.876 2.384 . . . . 75.33 112.133 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.51 81.37 0.08 OUTLIER Glycine 0 C--N 1.332 0.355 0 N-CA-C 111.529 -0.628 . . . . 31.0 111.529 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -99.48 -179.71 4.3 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.672 0.389 . . . . 70.35 110.391 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.3 ptm -68.13 -17.5 64.37 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.738 -0.838 . . . . 71.32 108.738 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.45 HG23 HG22 ' A' ' 76' ' ' ILE . 22.0 mm -67.34 93.37 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.811 -1.181 . . . . 62.2 107.811 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.77 111.83 6.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 70.14 111.759 -167.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 5.0 pm0 -69.97 129.38 39.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 71.41 110.202 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 36.8 pt -137.89 147.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.54 111.257 -174.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.53 -179.22 42.33 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.843 -0.617 . . . . 75.43 111.899 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.08 -48.4 67.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.745 0.418 . . . . 65.03 111.492 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 p -62.43 -35.35 78.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.039 -0.528 . . . . 74.42 111.158 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 44.8 mt-10 -77.49 -27.77 51.97 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.992 -0.549 . . . . 75.54 110.708 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.531 ' HA ' HD12 ' A' ' 26' ' ' ILE . 82.1 t80 -53.14 -61.02 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.165 0.291 . . . . 65.25 111.059 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.57 -52.61 61.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.159 0.504 . . . . 73.42 110.514 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -51.55 -57.24 9.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.086 -0.961 . . . . 43.22 111.035 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.6 mmtt -61.92 -46.56 88.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.201 -0.909 . . . . 63.34 111.234 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 31' ' ' PHE . 73.8 t -59.44 -38.75 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.686 0.279 . . . . 74.14 111.107 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -84.89 -16.7 40.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.702 0.286 . . . . 53.41 111.435 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -68.33 -13.39 62.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.381 -0.372 . . . . 74.54 111.471 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -55.16 122.17 10.44 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.707 -0.224 . . . . 55.23 110.7 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.12 -75.18 0.05 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.37 -0.377 . . . . 72.42 110.811 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -161.93 124.62 2.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.45 -0.341 . . . . 63.42 110.096 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.87 17.37 9.91 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.69 0.618 . . . . 72.45 111.347 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -78.22 104.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.435 -0.58 . . . . 70.51 109.435 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HB3' HG22 ' A' ' 74' ' ' VAL . 62.5 tp -68.9 108.18 3.38 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.509 0.671 . . . . 72.33 110.39 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 77' ' ' TYR . 35.9 mt -96.13 112.62 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.145 -0.934 . . . . 72.45 110.531 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.547 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.4 mp -96.22 141.02 30.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.437 -0.949 . . . . 73.21 108.437 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.09 114.2 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 110.315 -0.254 . . . . 72.45 110.315 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -82.89 129.22 34.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.009 0.433 . . . . 62.13 110.117 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.493 ' CE1' HD13 ' A' ' 100' ' ' LEU . 5.2 m-85 -90.05 -39.57 12.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.816 -0.629 . . . . 65.22 110.134 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.632 ' HZ2' HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -164.28 94.34 0.72 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.534 -0.303 . . . . 74.34 111.62 -176.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.694 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . . . -96.02 109.57 47.45 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.24 -0.436 . . . . 54.33 110.469 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 76.1 Cg_endo -92.07 130.08 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.996 2.464 . . . . 64.33 111.633 173.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -63.95 82.66 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.268 0.556 . . . . 73.15 111.164 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.665 ' H ' ' HB2' ' A' ' 56' ' ' CYS . 10.5 p -88.41 -169.21 2.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.472 -0.786 . . . . 63.3 109.567 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.11 -71.0 0.81 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.91 -0.662 . . . . 43.4 112.111 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.627 ' HD2' ' SG ' ' A' ' 53' ' ' CYS . 31.3 Cg_exo -60.3 -35.56 91.01 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.742 2.295 . . . . 54.22 112.468 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.665 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 14.2 m -60.24 -29.79 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.046 0.45 . . . . 71.35 110.595 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -53.42 -52.69 58.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.827 -0.624 . . . . 74.44 110.275 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.651 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.1 m -75.76 -30.53 59.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.056 -0.52 . . . . 70.35 111.521 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -59.23 -59.14 5.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.231 0.456 . . . . 64.1 112.231 -170.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.27 -51.24 51.56 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 111.798 0.295 . . . . 65.12 111.798 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.38 -48.37 22.35 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.701 1.601 . . . . 64.23 111.586 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.3 mt-30 -60.02 -29.85 68.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.944 -0.571 . . . . 75.21 111.147 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.33 -44.24 88.41 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.716 -0.476 . . . . 74.14 109.716 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 33.2 mt-10 -62.02 -37.38 84.69 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.046 -0.524 . . . . 65.51 110.062 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 22.0 ttmm -55.79 -53.81 52.14 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.005 0.431 . . . . 74.54 110.828 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.471 HD11 HD11 ' A' ' 116' ' ' ILE . 35.5 mt -63.79 -35.7 81.48 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.026 -0.534 . . . . 74.51 109.635 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.19 -44.31 95.72 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.445 -0.798 . . . . 43.32 110.16 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.9 mt-30 -60.61 -49.46 77.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.971 0.415 . . . . 74.13 110.265 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -62.17 -42.23 99.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.519 -0.764 . . . . 75.41 111.326 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -104.7 4.58 32.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.776 0.658 . . . . 75.22 112.776 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.55 -20.04 4.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.641 0.608 . . . . 63.31 112.641 -172.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.617 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 8.3 pt-20 -65.05 -33.69 76.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.606 0.241 . . . . 74.02 111.129 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.617 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 23.2 m-80 -124.19 5.12 8.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.509 -0.314 . . . . 60.25 110.909 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 43' ' ' LEU . 51.2 t -137.17 141.36 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.906 0.384 . . . . 74.22 111.556 -173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.89 130.07 16.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.389 -0.597 . . . . 71.33 109.389 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 45' ' ' LEU . 23.7 mt -109.39 138.47 36.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 120.951 0.405 . . . . 73.14 110.411 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 93.7 m-85 -119.27 170.4 9.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.676 . . . . 62.14 110.47 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -140.74 96.51 3.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.403 -0.962 . . . . 62.33 108.403 -179.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 12.7 tt -72.84 116.44 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.207 0.527 . . . . 75.13 111.239 -174.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -90.83 68.94 6.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.753 0.787 . . . . 60.11 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.726 HG12 HG21 ' A' ' 87' ' ' VAL . 11.0 tp -94.91 29.82 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.964 0.888 . . . . 65.23 109.897 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.857 ' HB3' HG21 ' A' ' 16' ' ' THR . 9.8 pt-20 -52.23 -18.24 1.45 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.752 -1.113 . . . . 64.21 113.451 -174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.49 -23.75 61.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.887 0.328 . . . . 63.52 111.887 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -147.09 156.53 43.08 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.964 0.412 . . . . 73.53 111.255 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -3.9 23.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.941 -0.572 . . . . 73.43 110.163 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 6.0 m-20 -50.71 -40.41 54.11 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.094 -0.503 . . . . 63.32 111.027 -176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 81' ' ' ILE . 85.5 t -54.27 -38.04 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 115.865 -0.607 . . . . 71.01 111.208 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.92 97.63 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.108 0.48 . . . . 74.24 109.963 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 8' ' ' HIS . 17.7 m -62.63 -37.86 87.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 72.42 110.514 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 77.3 mm-40 -63.86 -54.92 27.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.797 -0.638 . . . . 52.44 110.706 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.09 -14.04 58.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.323 -0.399 . . . . 63.04 111.72 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.41 59.13 5.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.037 -0.602 . . . . 65.55 112.127 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.632 HG21 ' HZ2' ' A' ' 49' ' ' TRP . 78.6 t -67.56 109.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 75.31 110.8 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.0 t -67.7 -50.52 57.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.903 -0.59 . . . . 63.12 110.71 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.69 172.57 16.46 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.346 -0.388 . . . . 52.44 110.683 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.5 HG22 ' CD1' ' A' ' 49' ' ' TRP . 23.8 pt -113.6 148.37 39.58 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.923 -0.581 . . . . 75.51 109.835 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.694 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 72.1 Cg_endo -73.36 168.49 75.95 Favored 'Cis proline' 0 C--N 1.355 0.902 0 C-N-CA 124.21 -1.162 . . . . 64.14 112.788 -0.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.2 m -128.27 110.96 12.88 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.956 -0.566 . . . . 74.0 110.406 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.4 mm -114.85 110.9 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.165 -0.47 . . . . 62.41 110.435 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.493 HD13 ' CE1' ' A' ' 48' ' ' PHE . 8.5 mp -96.17 155.02 16.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.304 -0.258 . . . . 72.51 110.304 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.519 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 35.2 mtt -119.0 150.4 40.01 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 110.196 -0.298 . . . . 65.12 110.196 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -144.27 152.29 40.59 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.089 0.556 . . . . 73.14 109.609 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -148.03 122.5 9.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.513 -0.181 . . . . 74.24 110.513 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.56 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.9 m-20 57.67 32.53 22.0 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.292 0.568 . . . . 72.22 110.665 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.44 75.88 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.689 -0.687 . . . . 43.11 112.479 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -117.4 152.67 34.49 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 110.068 -0.345 . . . . 63.04 110.068 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 8.8 tmtt? -69.46 126.41 29.65 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.938 0.774 . . . . 71.43 111.286 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.506 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 2.6 mm? -126.44 168.99 13.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.225 1.41 . . . . 61.41 109.19 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -179.82 1.9 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.274 0.559 . . . . 72.41 111.879 -164.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -148.85 143.37 26.24 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.853 0.835 . . . . 74.54 111.009 -172.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 t -123.43 130.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 113.843 -1.526 . . . . 70.11 109.753 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.1 124.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.483 . . . . 62.14 109.697 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.94 149.21 21.2 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.544 -0.622 . . . . 60.32 111.544 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.64 87.52 7.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.777 0.323 . . . . 33.13 110.972 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -130.28 100.11 5.27 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.432 -0.581 . . . . 64.24 109.432 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 66' ' ' LEU . 9.7 tp -61.01 -33.22 54.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.58 . . . . 62.15 111.084 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 120' ' ' ILE . 34.2 t -63.85 -50.08 70.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 72.2 110.482 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.53 -45.03 92.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.5 -0.318 . . . . 55.14 110.302 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.476 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -58.13 -53.39 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.358 . . . . 62.22 110.719 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -61.5 -39.49 83.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 110.062 -0.347 . . . . 72.14 110.062 -178.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.634 ' HA ' HD21 ' A' ' 124' ' ' ASN . 67.2 m -59.44 -49.94 75.87 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.542 -0.299 . . . . 43.12 110.528 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -61.27 -37.75 84.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.407 -0.36 . . . . 73.04 110.483 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.1 mt -59.43 -56.22 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.518 0.199 . . . . 73.41 110.938 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.634 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.5 p30 -70.25 -25.6 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.757 -0.377 . . . . 70.22 110.386 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -69.4 -38.05 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 72.2 110.284 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 93.1 m-20 -87.88 -18.6 28.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.697 -0.683 . . . . 71.2 111.519 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 123' ' ' ILE . 78.9 mt -78.3 -45.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 54.51 110.126 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.571 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.634 -0.698 . . . . 71.43 109.921 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.465 -0.569 . . . . 75.42 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.55 159.22 16.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.136 0.493 . . . . 34.04 111.065 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -144.77 30.97 1.17 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.158 -1.053 . . . . 65.04 108.158 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -82.52 80.3 8.71 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.492 -1.231 . . . . 71.22 109.982 -175.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -124.14 103.81 8.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.048 -0.524 . . . . 65.22 110.064 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.7 148.07 22.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.211 -0.45 . . . . 75.12 109.986 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -141.61 126.67 18.38 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.641 0.258 . . . . 65.21 110.382 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -175.14 137.75 0.41 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.038 -0.528 . . . . 74.33 109.906 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -146.57 170.38 17.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.559 0.219 . . . . 73.11 110.436 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.78 172.42 43.9 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.23 -0.509 . . . . 70.45 112.757 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.5 t -121.46 163.16 19.23 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.516 0.327 . . . . 73.25 110.205 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 12' ' ' LEU . 2.8 mm? -83.67 -26.66 29.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 74.23 110.632 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -140.44 138.64 34.86 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.388 -0.369 . . . . 75.42 110.568 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.76 86.56 3.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.867 -0.606 . . . . 52.13 110.083 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -95.82 -178.5 4.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.532 -0.758 . . . . 70.34 110.254 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 90.5 m -141.44 126.27 18.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.164 -0.471 . . . . 70.15 110.272 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -83.65 -36.23 23.98 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.434 -0.348 . . . . 71.4 111.068 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.07 101.38 0.16 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.124 -0.56 . . . . 74.21 112.088 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -88.84 -169.23 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.0 2.467 . . . . 75.33 112.143 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.62 126.2 18.05 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.335 -1.106 . . . . 31.0 110.335 171.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.437 ' HA ' ' OE2' ' A' ' 64' ' ' GLU . 49.5 m -43.53 103.94 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.257 0.466 . . . . 70.35 112.257 -172.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.8 mmm -75.17 -26.27 58.94 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.794 -0.639 . . . . 71.32 109.333 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -65.34 88.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.1 -0.704 . . . . 62.2 109.1 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 17.0 tt0 -67.8 111.81 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.599 -0.728 . . . . 70.14 109.679 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.2 135.75 33.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 71.41 110.88 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.4 pt -139.39 175.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.888 -0.596 . . . . 73.54 110.29 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -121.86 -167.83 13.2 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.267 -0.424 . . . . 75.43 112.177 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.23 -54.28 38.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.727 0.411 . . . . 65.03 112.007 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -66.68 -29.34 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.392 -0.367 . . . . 74.42 110.925 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 4.8 mm-40 -84.18 -21.31 31.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 75.54 112.005 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 26' ' ' ILE . 86.8 t80 -55.74 -61.9 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.623 0.249 . . . . 65.25 111.461 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.09 -43.49 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 73.42 110.506 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -52.58 -57.46 9.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.78 -0.645 . . . . 43.22 111.063 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 26' ' ' ILE . 47.8 mmtm -70.95 -38.14 72.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 63.34 111.473 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.58 -37.89 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.632 0.254 . . . . 74.14 110.94 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.5 p -83.04 -22.49 33.54 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.728 0.299 . . . . 53.41 110.99 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t -64.86 -5.14 5.36 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.328 -0.397 . . . . 74.54 111.71 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 104' ' ' ASN . 85.8 m -62.66 106.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.536 0.208 . . . . 55.23 110.514 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -61.24 -68.23 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.286 -0.415 . . . . 72.42 111.269 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -147.05 128.96 15.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.659 0.266 . . . . 63.42 111.551 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.66 24.54 5.59 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.644 0.778 . . . . 72.45 112.046 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 50.2 mm -78.61 113.61 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.591 -0.277 . . . . 70.51 110.262 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB3' HG22 ' A' ' 74' ' ' VAL . 2.5 tm? -90.21 112.3 23.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.422 0.629 . . . . 72.33 109.583 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 49.3 mt -101.76 135.23 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.504 -0.771 . . . . 72.45 111.003 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.4 mp -111.07 116.99 32.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.773 -0.825 . . . . 73.21 108.773 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.4 t -99.12 105.03 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.978 -0.378 . . . . 72.45 109.978 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.508 ' HA ' HD13 ' A' ' 99' ' ' ILE . 7.7 t70 -77.04 139.55 40.07 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.826 -0.624 . . . . 62.13 111.335 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -107.51 87.21 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.641 -0.874 . . . . 65.22 108.641 170.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 27.1 t-105 -43.34 130.38 4.9 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.671 -1.149 . . . . 74.34 112.974 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.09 103.85 51.56 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.638 -0.71 . . . . 54.33 109.642 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.18 -26.19 75.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.761 2.307 . . . . 64.33 112.684 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -121.36 105.45 10.54 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.388 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -174.15 146.73 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 63.3 110.544 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.67 -66.83 1.28 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.229 -0.441 . . . . 43.4 112.828 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.78 -28.69 59.49 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.587 2.191 . . . . 54.22 112.308 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 59.1 m -56.59 -31.92 64.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.076 -0.511 . . . . 71.35 111.159 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.603 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -54.35 -60.86 2.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.358 0.599 . . . . 74.44 109.858 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.532 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 50.3 m -55.43 -38.26 68.75 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 114.448 -1.251 . . . . 70.35 111.695 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 3.6 mm? -57.77 -34.95 70.12 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.335 -0.393 . . . . 64.1 110.941 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.4 mt-10 -55.94 -64.07 2.65 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.228 -0.415 . . . . 65.12 111.052 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 57' ' ' ARG . 33.4 Cg_endo -64.77 -24.75 61.39 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 121.788 1.658 . . . . 64.23 112.18 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.0 mt-30 -63.26 -44.17 95.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.306 -0.558 . . . . 75.21 110.077 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 83.0 mt -68.4 -39.62 81.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.903 -0.589 . . . . 74.14 110.099 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 46.5 mt-10 -60.93 -35.82 77.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.002 -0.544 . . . . 65.51 110.281 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.51 -56.21 24.84 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.031 0.443 . . . . 74.54 110.264 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 116' ' ' ILE . 59.3 mt -56.26 -39.06 72.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.659 -0.701 . . . . 74.51 109.572 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -61.8 -48.24 81.49 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.115 -0.948 . . . . 43.32 110.251 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -55.93 -42.42 76.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 74.13 110.805 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -66.65 -45.09 80.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.003 -0.544 . . . . 75.41 111.303 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -101.71 5.47 41.4 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.996 0.739 . . . . 75.22 112.996 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.44 -19.61 3.77 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.334 0.865 . . . . 63.31 113.334 -169.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.8 -29.59 66.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 74.02 111.211 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -119.28 -11.03 9.62 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.896 -0.593 . . . . 60.25 111.275 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 43' ' ' LEU . 57.2 t -125.62 142.7 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.056 0.455 . . . . 74.22 111.656 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 5.2 tppp? -145.63 131.73 19.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 71.33 109.578 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.5 mt -103.72 120.69 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.0 -0.37 . . . . 73.14 110.0 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 50.2 m-85 -107.37 153.75 22.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.667 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.766 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 24.9 ttpt -131.32 120.18 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.274 -0.639 . . . . 62.33 109.274 172.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 81' ' ' ILE . 39.9 mt -73.1 106.82 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.23 -1.026 . . . . 75.13 108.23 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.13 73.0 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.044 0.45 . . . . 60.11 111.394 -171.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 87' ' ' VAL . 26.5 pt -147.0 31.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.385 -0.825 . . . . 65.23 109.165 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -62.65 -20.31 64.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.639 -0.709 . . . . 64.21 111.474 -175.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.1 -27.85 62.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.21 0.529 . . . . 63.52 109.907 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.45 76.87 9.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.555 -0.748 . . . . 73.53 109.078 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -62.62 -27.87 69.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.188 -0.915 . . . . 73.43 110.624 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 27.2 t70 -50.11 -41.74 49.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.847 -0.615 . . . . 63.32 110.56 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.528 HG21 HD12 ' A' ' 81' ' ' ILE . 92.3 t -54.24 -40.36 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 71.01 110.788 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -62.3 -47.3 84.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.424 0.631 . . . . 74.24 109.823 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.9 m -64.7 -33.41 75.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.444 -0.798 . . . . 72.42 110.867 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.6 mm-40 -68.43 -44.54 74.75 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.192 -0.458 . . . . 52.44 110.862 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -93.16 0.31 57.14 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.239 -0.437 . . . . 63.04 111.619 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.21 43.72 20.06 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.031 -0.604 . . . . 65.55 113.401 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.461 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 95.9 t -74.82 106.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.297 -0.631 . . . . 75.31 109.297 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.0 m -61.76 -39.32 91.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.316 . . . . 63.12 111.738 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.61 145.65 24.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.472 -0.331 . . . . 52.44 110.606 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.5 pt -104.32 141.43 22.51 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.219 -0.446 . . . . 75.51 110.098 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -85.21 169.86 47.46 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.712 -1.37 . . . . 64.14 112.116 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -145.53 155.57 43.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.969 -0.56 . . . . 74.0 109.554 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 47' ' ' ASP . 47.7 mm -118.67 110.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.395 -0.82 . . . . 62.41 109.926 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.75 123.01 41.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.064 -0.717 . . . . 72.51 109.064 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.6 mtt -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.759 0.314 . . . . 65.12 110.397 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -144.87 145.79 31.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.614 -0.513 . . . . 73.14 109.614 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -142.11 119.79 11.81 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.925 -0.398 . . . . 74.24 109.925 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.623 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 13.7 p30 51.21 25.61 2.53 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.997 0.919 . . . . 72.22 112.099 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.59 64.96 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.835 -0.62 . . . . 43.11 113.166 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 47.9 tptt -73.12 142.14 47.5 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 117.067 0.433 . . . . 63.04 110.37 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 2.5 tmtp? -68.88 122.52 18.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.824 -0.626 . . . . 71.43 110.009 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -118.1 168.8 10.22 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.273 1.029 . . . . 61.41 109.749 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 101' ' ' MET . 0.3 OUTLIER -69.73 166.94 18.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.485 0.659 . . . . 72.41 112.566 -159.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 57.2 tt0 -129.25 136.84 50.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.211 1.005 . . . . 74.54 111.326 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.47 121.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.256 -1.793 . . . . 70.11 109.608 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.2 mt -107.02 133.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 110.269 -0.271 . . . . 62.14 110.269 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.54 168.24 36.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.322 -0.466 . . . . 60.32 112.465 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.43 98.99 11.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.641 0.258 . . . . 33.13 110.884 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.2 t70 -143.55 100.61 3.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.548 -0.538 . . . . 64.24 109.548 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.466 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -62.96 -38.45 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.895 -0.593 . . . . 62.15 111.577 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -66.54 -43.65 84.58 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.095 0.474 . . . . 72.2 110.147 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -61.41 -48.06 82.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 55.14 110.295 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 115' ' ' ASP . 73.8 mt -61.78 -47.15 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.004 -0.544 . . . . 62.22 111.519 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.24 -41.76 92.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.211 0.529 . . . . 72.14 110.233 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.4 t -56.22 -45.73 79.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.795 -0.639 . . . . 43.12 109.465 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 39.5 mm-40 -70.2 -32.39 70.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 73.04 111.491 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 120' ' ' ILE . 80.1 mt -54.55 -55.01 17.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 N-CA-C 108.936 -0.764 . . . . 73.41 108.936 173.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.416 ' ND2' HD13 ' A' ' 120' ' ' ILE . 45.5 m-80 -66.82 -36.07 81.5 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.391 . . . . 70.22 111.093 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.8 t30 -63.37 -42.06 98.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.216 -0.447 . . . . 72.2 111.294 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -93.66 -15.3 25.44 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.448 -0.342 . . . . 71.2 111.671 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 123' ' ' ILE . 38.7 mt -61.45 -43.59 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.231 -1.025 . . . . 54.51 108.231 166.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.982 172.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 110.408 -0.219 . . . . 75.42 110.408 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.13 103.28 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 34.04 110.336 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -68.98 142.0 54.78 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.216 -0.447 . . . . 65.04 110.572 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -55.99 135.22 52.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.242 -0.436 . . . . 71.22 111.126 -177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -157.82 129.15 6.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.05 -0.523 . . . . 65.22 110.592 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -152.18 147.18 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.326 -0.62 . . . . 75.12 109.326 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -95.82 166.66 11.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.873 0.368 . . . . 65.21 110.864 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -125.79 63.14 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.445 -0.946 . . . . 74.33 108.445 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.0 ptm -136.44 151.08 49.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.524 -0.762 . . . . 73.11 110.162 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.11 140.0 2.85 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.899 -0.667 . . . . 70.45 112.074 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 m -89.81 64.99 6.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.264 0.554 . . . . 73.25 110.151 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.32 99.33 12.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.03 -0.532 . . . . 74.23 110.336 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.27 90.05 6.6 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.989 -0.745 . . . . 75.42 108.989 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.51 111.37 19.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.817 -0.629 . . . . 52.13 111.165 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -95.46 171.59 8.6 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.026 -0.534 . . . . 70.34 109.972 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.3 m -69.83 94.36 0.82 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.493 -0.321 . . . . 70.15 110.78 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -77.23 -28.13 53.6 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.36 -0.608 . . . . 71.4 109.36 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.0 -164.35 30.65 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.055 -0.818 . . . . 74.21 111.055 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -83.62 148.89 12.69 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.724 2.282 . . . . 75.33 111.662 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.51 51.52 3.33 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.289 -0.482 . . . . 31.0 112.002 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -147.65 32.39 0.87 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.451 -0.574 . . . . 70.35 109.451 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.478 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 96.0 mmm -72.64 -24.63 61.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.795 -0.639 . . . . 71.32 111.221 -174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.419 HG21 ' HE2' ' A' ' 78' ' ' LYS . 20.8 mm -77.33 93.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.114 -0.698 . . . . 62.2 109.114 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.2 tp10 -68.4 122.76 19.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 70.14 111.152 -175.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -90.93 122.13 33.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.436 -0.347 . . . . 71.41 110.353 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.8 pt -126.94 165.08 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.299 -0.409 . . . . 73.54 111.258 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.34 -167.56 40.99 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.87 -0.604 . . . . 75.43 113.479 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.48 -54.3 30.33 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 65.03 111.448 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 t -74.67 -28.19 60.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.225 0.536 . . . . 74.42 110.359 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.23 -17.55 64.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 75.54 111.636 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.4 t80 -58.4 -62.04 2.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.8 0.333 . . . . 65.25 110.16 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.16 -45.72 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.156 0.503 . . . . 73.42 110.207 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -56.15 -57.47 12.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.381 -0.827 . . . . 43.22 111.484 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.67 -29.61 65.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.223 -0.444 . . . . 63.34 111.456 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 31' ' ' PHE . 49.4 t -68.33 -41.59 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.648 0.261 . . . . 74.14 110.758 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 p -81.25 -18.88 44.44 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.872 0.367 . . . . 53.41 111.028 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 t -61.67 -21.75 64.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.136 -0.484 . . . . 74.54 111.529 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.703 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 22.9 p -59.62 122.09 13.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.606 0.241 . . . . 55.23 110.601 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.77 -69.18 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.148 -0.478 . . . . 72.42 111.844 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -161.42 135.76 7.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 63.42 110.934 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 16.6 m-80 59.36 17.1 5.58 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.704 0.628 . . . . 72.45 112.156 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.2 mm -87.85 114.01 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 70.51 110.292 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.537 HD21 ' SD ' ' A' ' 101' ' ' MET . 0.3 OUTLIER -78.82 109.19 12.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 72.33 109.387 178.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 38' ' ' CYS . 43.6 mt -97.68 121.64 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.951 -0.568 . . . . 72.45 110.482 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.673 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.9 mp -106.37 116.0 31.18 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.526 -0.546 . . . . 73.21 109.526 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.4 t -99.64 105.86 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 110.269 -0.271 . . . . 72.45 110.269 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -81.58 132.87 35.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.085 -0.507 . . . . 62.13 110.427 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -89.19 137.86 31.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.642 -0.503 . . . . 65.22 109.642 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -46.24 -51.06 15.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.594 0.559 . . . . 74.34 111.944 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 67.58 153.03 0.13 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.636 0.585 . . . . 54.33 111.828 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.2 173.92 9.77 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.426 2.084 . . . . 64.33 112.092 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -49.89 120.45 4.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.089 -0.505 . . . . 73.15 110.958 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.65 147.33 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 63.3 111.103 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -64.09 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.182 -0.463 . . . . 43.4 112.642 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.18 -30.55 32.93 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.208 2.605 . . . . 54.22 113.191 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 19.9 p -57.75 -29.01 64.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 71.35 111.285 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -54.3 -39.55 67.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.538 0.209 . . . . 74.44 111.276 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.649 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 45.1 m -75.11 -42.21 56.97 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.651 0.739 . . . . 70.35 110.48 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -61.61 -31.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.311 -0.859 . . . . 64.1 112.07 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 43.1 mt-10 -59.28 -60.93 8.94 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 117.803 0.274 . . . . 65.12 110.749 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 28.8 Cg_endo -62.98 -29.38 75.65 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.846 1.697 . . . . 64.23 112.174 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.0 mt-30 -64.51 -44.7 90.09 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.058 -0.657 . . . . 75.21 110.161 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.605 HD21 HD13 ' A' ' 119' ' ' ILE . 85.7 mt -64.43 -45.68 86.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 74.14 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.6 mt-10 -63.16 -34.08 76.85 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.031 -0.531 . . . . 65.51 110.563 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.79 -47.29 87.01 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.827 0.346 . . . . 74.54 110.21 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.49 -35.64 79.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.907 -0.588 . . . . 74.51 109.731 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.39 -42.68 98.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.785 -0.643 . . . . 43.32 110.234 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.1 mt-30 -67.16 -44.3 80.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 74.13 110.082 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -67.27 -38.74 85.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.482 -0.781 . . . . 75.41 111.352 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -105.14 4.63 31.57 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.756 0.65 . . . . 75.22 112.756 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.5 t -53.43 -19.93 4.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.424 0.527 . . . . 63.31 112.424 -172.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.03 -29.03 70.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.793 0.33 . . . . 74.02 110.875 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -130.62 4.65 4.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.3 -0.409 . . . . 60.25 111.021 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 43' ' ' LEU . 62.4 t -133.49 149.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.941 0.4 . . . . 74.22 111.242 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.16 127.96 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.345 -0.613 . . . . 71.33 109.345 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.673 HG12 ' HB2' ' A' ' 45' ' ' LEU . 42.2 mt -106.12 141.27 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.738 0.304 . . . . 73.14 111.01 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.7 m-85 -123.51 171.72 9.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 62.14 109.821 176.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' HG21 ' A' ' 23' ' ' ILE . 21.1 ttmm -146.6 139.06 25.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 62.33 109.94 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.7 mm -96.6 99.14 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.23 -0.656 . . . . 75.13 109.23 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.7 -19.14 61.46 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.093 -0.503 . . . . 60.11 110.943 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.71 87.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 65.23 110.462 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.34 -18.52 63.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 64.21 111.385 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.85 -15.77 60.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.124 -0.489 . . . . 63.52 111.406 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -86.04 93.73 9.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.056 0.455 . . . . 73.53 109.972 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -87.59 -20.6 26.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 73.43 110.212 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.01 -58.54 2.39 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.959 -0.564 . . . . 63.32 111.149 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.53 -34.09 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.731 -0.668 . . . . 71.01 111.001 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -67.91 -47.22 69.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.066 0.46 . . . . 74.24 110.518 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.8 m -67.42 -40.95 85.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 72.42 110.627 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.16 -44.56 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 52.44 111.789 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -99.12 -4.19 32.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.833 0.308 . . . . 63.04 111.833 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.47 83.41 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.214 -0.517 . . . . 65.55 113.271 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 88' ' ' ALA . 85.7 t -81.05 144.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.371 -0.603 . . . . 75.31 109.371 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.42 ' HB2' HG21 ' A' ' 112' ' ' ILE . 31.2 m -138.62 -63.72 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.691 0.281 . . . . 63.12 111.489 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.92 178.01 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 52.44 111.354 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 10.3 pt -112.35 116.2 48.95 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.46 -0.791 . . . . 75.51 110.87 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -92.02 -162.54 1.43 Allowed 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 124.219 -1.159 . . . . 64.14 111.947 -3.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.414 ' OG1' HG13 ' A' ' 93' ' ' VAL . 95.6 m -138.08 118.17 13.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.231 -0.441 . . . . 74.0 109.935 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mm -110.14 130.46 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.735 -0.666 . . . . 62.41 110.584 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 110' ' ' GLN . 40.9 mt -107.18 143.98 34.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.926 -0.768 . . . . 72.51 108.926 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.537 ' SD ' HD21 ' A' ' 43' ' ' LEU . 3.2 mtt -109.92 149.48 29.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.117 0.417 . . . . 65.12 110.666 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.0 m-85 -146.82 162.03 39.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.789 -0.641 . . . . 73.14 109.472 175.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 4.9 ttmp? -160.49 131.27 5.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.277 -0.268 . . . . 74.24 110.277 176.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.498 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 3.5 m-20 58.19 27.17 14.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.149 0.5 . . . . 72.22 110.58 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.43 27.93 71.95 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.836 -0.62 . . . . 43.11 112.266 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -126.83 149.6 49.63 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.491 -0.559 . . . . 63.04 109.491 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.589 ' O ' HD22 ' A' ' 108' ' ' LEU . 26.9 ttpt -68.75 143.91 54.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.747 0.784 . . . . 71.43 112.438 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 107' ' ' LYS . 1.4 mm? -144.68 169.3 18.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.841 -1.527 . . . . 61.41 108.379 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.62 173.71 5.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.773 0.797 . . . . 72.41 112.51 -162.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.471 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.1 tt0 -127.66 150.57 49.69 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.027 -0.988 . . . . 74.54 110.793 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 119' ' ' ILE . 2.3 t -127.69 111.63 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 114.514 -1.221 . . . . 70.11 109.418 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 94' ' ' SER . 60.1 mt -114.23 121.83 67.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.483 -0.326 . . . . 62.14 110.183 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.39 145.17 9.19 Favored Glycine 0 C--N 1.328 0.134 0 N-CA-C 111.76 -0.536 . . . . 60.32 111.76 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.14 72.19 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.13 0.491 . . . . 33.13 110.906 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -125.88 93.34 3.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.025 -0.731 . . . . 64.24 109.025 175.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.95 -25.09 34.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.334 -0.848 . . . . 62.15 111.511 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 t -67.67 -46.14 73.21 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.292 -0.633 . . . . 72.2 109.292 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.3 tptt -61.41 -45.88 92.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.619 -0.719 . . . . 55.14 109.744 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.605 HD13 HD21 ' A' ' 63' ' ' LEU . 69.9 mt -56.71 -56.09 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.062 -0.517 . . . . 62.22 111.292 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.503 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.0 -37.51 78.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 116.5 -0.318 . . . . 72.14 110.272 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.506 ' HA ' HD21 ' A' ' 124' ' ' ASN . 36.8 t -56.63 -51.53 68.33 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.164 -0.471 . . . . 43.12 109.898 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 20.9 mm-40 -58.58 -44.39 89.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.054 -0.521 . . . . 73.04 110.135 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 127' ' ' ILE . 97.8 mt -54.4 -56.14 11.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.489 -0.323 . . . . 73.41 111.011 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.5 p30 -68.51 -33.05 73.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.486 -0.486 . . . . 70.22 110.56 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -68.48 -31.92 71.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.287 -0.415 . . . . 72.2 110.854 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.484 ' OD1' HD12 ' A' ' 108' ' ' LEU . 23.6 m-80 -90.86 -14.09 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.35 -0.386 . . . . 71.2 111.565 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.0 mt -81.52 -60.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.553 -0.536 . . . . 54.51 109.553 168.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.448 -0.787 . . . . 71.43 110.8 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.858 -0.423 . . . . 75.42 109.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.49 128.79 44.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.368 -0.378 . . . . 34.04 110.664 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -61.47 117.36 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 65.04 109.887 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -69.42 102.69 1.83 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.902 -0.777 . . . . 71.22 108.902 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -53.81 -27.5 29.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.105 -0.498 . . . . 65.22 111.924 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 t60 69.59 -67.48 0.22 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.445 0.466 . . . . 75.12 111.621 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -50.18 119.97 4.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.271 0.628 . . . . 65.21 111.067 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -140.6 145.73 37.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.003 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.8 tpt -69.68 102.53 1.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.759 -0.46 . . . . 73.11 109.759 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.94 48.91 0.41 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.357 -0.697 . . . . 70.45 111.357 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.3 m -81.68 97.67 8.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.603 -0.298 . . . . 73.25 110.381 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.31 140.64 31.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.203 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -63.16 -61.75 2.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 75.42 110.023 177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.28 7.14 2.12 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.863 -0.608 . . . . 52.13 112.442 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.92 89.09 7.16 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.304 -0.628 . . . . 70.34 109.304 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 p -125.01 148.43 48.47 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.737 -0.665 . . . . 70.15 110.992 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -69.66 98.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.838 0.351 . . . . 71.4 110.829 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.44 139.75 14.8 Favored Glycine 0 N--CA 1.453 -0.211 0 N-CA-C 111.575 -0.61 . . . . 74.21 111.575 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.06 -179.18 4.75 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 75.33 112.125 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.74 -159.75 8.56 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.56 -0.616 . . . . 31.0 111.56 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.6 t -63.61 97.94 0.16 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.524 -0.547 . . . . 70.35 109.524 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.2 mmm -86.42 -17.17 35.01 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.928 -0.578 . . . . 71.32 110.943 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.481 HG21 ' HE2' ' A' ' 78' ' ' LYS . 26.7 mm -87.89 101.03 11.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.241 -0.651 . . . . 62.2 109.241 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 8.8 tp10 -64.47 122.68 17.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.296 0.569 . . . . 70.14 110.534 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -100.53 109.61 21.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 71.41 110.22 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.3 pt -119.51 166.78 13.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.733 -0.667 . . . . 73.54 111.275 -174.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.65 -158.59 33.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.687 -0.688 . . . . 75.43 112.111 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -69.11 -51.17 41.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.052 0.454 . . . . 65.03 111.55 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.4 t -69.5 -36.77 76.81 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.924 -0.58 . . . . 74.42 111.646 -172.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 1.9 mp0 -65.16 -14.99 61.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 75.54 111.97 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.426 ' O ' HG23 ' A' ' 35' ' ' VAL . 81.5 t80 -51.85 -61.27 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.717 0.294 . . . . 65.25 110.926 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.11 -44.97 83.78 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.421 . . . . 73.42 110.394 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -53.69 -57.76 9.65 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.725 0.774 . . . . 43.22 110.662 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.3 mmtt -64.75 -38.1 89.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.083 -0.962 . . . . 63.34 111.354 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 31' ' ' PHE . 90.8 t -70.62 -35.54 61.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.44 -0.345 . . . . 74.14 110.823 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -81.88 -14.99 55.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.653 0.263 . . . . 53.41 111.126 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -66.07 2.52 1.1 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.208 0.448 . . . . 74.54 112.208 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' SG ' HD12 ' A' ' 44' ' ' ILE . 89.9 m -60.54 169.37 1.78 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.294 0.569 . . . . 55.23 112.041 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.03 -82.01 0.61 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.401 -0.818 . . . . 72.42 109.138 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -162.05 137.92 7.61 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.45 -0.574 . . . . 63.42 109.45 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 61.92 10.47 3.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.645 0.378 . . . . 72.45 111.408 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.76 108.18 17.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.263 -0.643 . . . . 70.51 109.263 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 126' ' ' ASN . 68.0 tp -83.46 121.67 27.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.177 0.513 . . . . 72.33 110.699 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.517 HD12 ' SG ' ' A' ' 38' ' ' CYS . 27.9 mt -105.83 118.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 72.45 110.084 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 3.6 mp -104.28 114.29 28.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.885 -0.783 . . . . 73.21 108.885 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.2 t -102.86 104.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.374 -0.232 . . . . 72.45 110.374 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.448 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 18.8 t0 -76.6 129.04 35.86 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.179 -0.674 . . . . 62.13 109.179 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -83.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 65.22 111.047 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -167.6 151.21 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 74.34 110.9 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.57 97.13 6.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.624 -0.717 . . . . 54.33 109.513 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.68 -50.42 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.581 2.187 . . . . 64.33 112.17 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -130.98 123.36 28.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.332 -0.618 . . . . 73.15 109.332 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.2 t -163.26 136.74 5.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 63.3 110.873 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -86.76 -66.52 1.37 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.955 -0.566 . . . . 43.4 112.249 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' A' ' 54' ' ' GLY . 15.3 Cg_endo -55.13 -26.79 52.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.165 2.577 . . . . 54.22 113.066 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 79.0 m -55.7 -23.55 29.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.482 -0.326 . . . . 71.35 111.866 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 12.2 ptm180 -54.34 -44.36 72.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.694 0.283 . . . . 74.44 110.504 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 18.6 m -75.5 -35.61 60.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.239 0.542 . . . . 70.35 110.79 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -64.83 -36.46 84.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.45 0.537 . . . . 64.1 112.45 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.8 tt0 -58.18 -58.9 15.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 120.351 -0.54 . . . . 65.12 110.363 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.25 -32.99 95.01 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.819 1.68 . . . . 64.23 112.435 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 58' ' ' SER . 46.4 mt-30 -63.4 -44.19 95.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.028 0.442 . . . . 75.21 110.377 176.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.77 -37.82 82.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.963 -0.562 . . . . 74.14 110.222 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 52.9 mt-10 -65.51 -36.17 83.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.281 -0.418 . . . . 65.51 110.26 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -56.53 -52.07 66.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.016 0.436 . . . . 74.54 109.848 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 116' ' ' ILE . 27.0 mt -68.33 -31.32 70.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 74.51 109.634 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.578 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -70.85 -13.37 62.01 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.643 -0.708 . . . . 43.32 110.982 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -96.06 -50.83 4.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.295 -0.411 . . . . 74.13 110.861 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.24 -43.05 99.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.36 0.6 . . . . 75.41 110.793 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.53 5.35 47.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.303 -0.862 . . . . 75.22 111.494 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.3 t -52.83 -25.88 12.83 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.258 0.836 . . . . 63.31 113.258 -168.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.75 -19.0 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.615 0.245 . . . . 74.02 111.403 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.7 2.0 7.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.521 -0.309 . . . . 60.25 110.991 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.71 144.48 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.784 0.326 . . . . 74.22 111.324 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -147.05 119.89 8.67 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.275 -0.639 . . . . 71.33 109.275 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.02 132.11 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.803 0.335 . . . . 73.14 110.558 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 24' ' ' GLU . 74.3 m-85 -122.08 166.02 15.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 62.14 109.475 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HE2' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -148.72 142.58 25.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.411 -0.359 . . . . 62.33 110.371 172.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 31' ' ' PHE . 61.3 mt -102.02 103.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 75.13 109.231 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -84.1 12.72 5.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 60.11 111.306 -174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm -78.3 78.87 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.021 -0.733 . . . . 65.23 109.021 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -18.48 43.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 64.21 112.622 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.5 -11.66 60.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.756 0.312 . . . . 63.52 111.537 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.76 51.21 1.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.194 0.521 . . . . 73.53 110.281 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -61.42 -61.86 2.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.56 -0.746 . . . . 73.43 110.841 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 7.7 m-20 -52.83 -36.98 59.47 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.421 -0.809 . . . . 63.32 111.031 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.01 -42.16 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 71.01 110.202 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.85 -51.57 64.03 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.269 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.6 m -62.09 -31.48 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 72.42 111.01 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 25.3 mm-40 -68.81 -51.78 37.15 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.495 -0.32 . . . . 52.44 110.872 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -76.22 -10.91 59.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.494 -0.321 . . . . 63.04 111.415 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.42 44.34 2.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.814 -0.708 . . . . 65.55 113.694 167.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 98' ' ' THR . 72.4 t -77.83 106.13 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.557 -0.534 . . . . 75.31 109.557 173.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.549 ' HB3' HG21 ' A' ' 112' ' ' ILE . 22.8 t -92.91 -40.24 10.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 63.12 110.536 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.85 158.19 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 52.44 110.233 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.782 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.61 140.95 22.15 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.45 . . . . 75.51 110.406 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.43 -179.35 24.48 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.06 -1.225 . . . . 64.14 111.529 -3.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.51 HG21 HG22 ' A' ' 93' ' ' VAL . 93.7 m -139.78 116.42 10.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.926 0.393 . . . . 74.0 110.206 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.446 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.1 mm -109.8 110.82 33.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 62.41 110.8 -173.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 123.44 33.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.737 -0.468 . . . . 72.51 109.737 172.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.622 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 17.7 mmt -90.19 140.14 29.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.221 -0.445 . . . . 65.12 110.078 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.4 144.44 36.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.219 -0.66 . . . . 73.14 109.219 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -138.42 112.43 8.51 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.587 -0.445 . . . . 74.24 110.671 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.51 32.33 22.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.615 0.722 . . . . 72.22 110.453 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.51 68.25 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 115.684 -0.689 . . . . 43.11 112.649 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -83.12 143.59 30.44 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.777 -0.453 . . . . 63.04 109.777 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' HD22 ' A' ' 108' ' ' LEU . 21.5 tptm -65.88 130.62 43.9 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.83 0.706 . . . . 71.43 111.013 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 107' ' ' LYS . 2.3 mm? -131.39 168.94 16.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.581 -1.191 . . . . 61.41 109.19 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 101' ' ' MET . 1.3 m -69.55 176.19 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.309 0.576 . . . . 72.41 111.937 -163.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.49 131.53 29.82 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.856 0.836 . . . . 74.54 110.992 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.83 107.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.926 -1.488 . . . . 70.11 109.752 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 94' ' ' SER . 64.0 mt -102.77 121.87 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.046 -0.524 . . . . 62.14 110.108 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.01 149.97 18.04 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.954 -0.458 . . . . 60.32 111.954 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.76 85.97 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.682 0.277 . . . . 33.13 111.129 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.8 t70 -132.64 92.11 3.01 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.349 0.595 . . . . 64.24 109.822 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 66' ' ' LEU . 9.2 tp -59.31 -32.89 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.265 -0.88 . . . . 62.15 111.651 -174.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.8 t -64.17 -48.49 75.77 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.898 0.38 . . . . 72.2 110.055 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -62.09 -43.37 98.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.013 -0.54 . . . . 55.14 109.711 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 71.2 mt -58.4 -56.27 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.036 -0.529 . . . . 62.22 111.117 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.517 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -62.34 -35.04 67.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 120.758 0.313 . . . . 72.14 110.187 -177.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.497 ' HA ' HD21 ' A' ' 124' ' ' ASN . 23.2 t -58.04 -51.9 67.77 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.109 -0.496 . . . . 43.12 109.791 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -61.64 -37.57 84.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.876 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.8 mt -58.51 -55.95 19.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.3 -0.409 . . . . 73.41 110.92 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.497 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.1 p30 -67.94 -31.42 71.15 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.651 -0.419 . . . . 70.22 110.011 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -58.06 -43.6 87.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.756 -0.656 . . . . 72.2 110.566 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.449 ' HB2' HD22 ' A' ' 43' ' ' LEU . 26.7 m-80 -78.26 -38.94 41.54 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.254 0.465 . . . . 71.2 112.254 -177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 123' ' ' ILE . 76.6 mt -58.07 -47.75 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.372 . . . . 54.51 110.939 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.926 -0.559 . . . . 71.43 110.657 -176.519 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.544 ' HA ' ' OD1' ' A' ' 128' ' ' ASN . 16.5 tpt . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.249 -0.278 . . . . 75.42 110.249 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.14 29.18 7.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.16 -0.473 . . . . 34.04 111.843 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -109.59 131.6 54.91 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.643 -0.253 . . . . 65.04 110.892 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -132.43 146.4 51.92 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.207 -0.451 . . . . 71.22 111.432 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -165.69 154.77 11.92 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.097 -0.705 . . . . 65.22 109.097 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -99.12 151.86 20.5 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.799 0.333 . . . . 75.12 110.939 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 78.1 t60 -170.62 -175.77 1.93 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.743 -0.836 . . . . 65.21 108.743 -175.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -168.36 150.48 5.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.97 -0.381 . . . . 74.33 109.97 169.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.2 mtp -132.23 169.92 15.76 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.823 0.449 . . . . 73.11 109.969 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.36 142.8 8.04 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.649 -0.786 . . . . 70.45 112.871 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' A' ' 55' ' ' PRO . 29.5 m -137.7 139.34 40.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.541 -0.911 . . . . 73.25 108.541 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.7 mt -104.64 22.18 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.039 0.385 . . . . 74.23 112.039 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -170.29 142.04 2.13 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.725 0.298 . . . . 75.42 111.162 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' HB2' ' A' ' 57' ' ' ARG . . . -104.66 101.99 11.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.974 -0.557 . . . . 52.13 110.076 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -130.7 21.98 5.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.541 . . . . 70.34 110.736 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -150.42 98.96 2.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.744 -0.207 . . . . 70.15 110.791 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -142.05 170.48 15.64 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.143 -0.317 . . . . 71.4 110.143 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.49 112.66 0.53 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.835 -0.506 . . . . 74.21 111.835 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.0 90.89 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.636 2.224 . . . . 75.33 111.148 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.43 53.93 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.161 -1.176 . . . . 31.0 110.161 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.36 171.55 8.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.269 -0.465 . . . . 70.35 111.123 -170.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.7 mmm -60.4 -31.41 70.34 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.831 -0.803 . . . . 71.32 108.831 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 ' HD2' ' A' ' 78' ' ' LYS . 17.9 mm -64.99 93.69 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.368 -0.975 . . . . 62.2 108.368 171.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 9.7 tp10 -52.27 144.31 12.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.469 0.652 . . . . 70.14 111.98 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -101.67 115.61 30.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.157 -0.929 . . . . 71.41 110.276 -176.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.479 HG21 ' HG3' ' A' ' 34' ' ' LYS . 50.6 pt -133.96 179.94 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.956 0.408 . . . . 73.54 110.911 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.34 -153.52 7.93 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.896 -0.593 . . . . 75.43 111.852 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.97 -53.18 22.1 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.404 0.282 . . . . 65.03 111.487 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -70.82 -29.96 66.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.828 0.347 . . . . 74.42 111.565 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 mp0 -72.36 -27.3 62.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.438 . . . . 75.54 111.009 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -51.89 -61.83 2.01 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.13 0.269 . . . . 65.25 111.192 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 36' ' ' THR . 9.2 t70 -51.09 -53.59 32.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.986 -0.552 . . . . 73.42 110.549 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -54.07 -57.28 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.131 -0.941 . . . . 43.22 111.31 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 77' ' ' TYR . 75.9 mmtt -62.28 -33.37 74.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 63.34 111.014 -175.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.455 ' HA ' HD13 ' A' ' 44' ' ' ILE . 21.7 t -69.09 -55.66 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.185 -0.461 . . . . 74.14 112.16 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 32' ' ' ASP . 10.2 t -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.383 0.512 . . . . 53.41 112.383 -170.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 t -75.81 2.57 11.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.135 0.42 . . . . 74.54 112.135 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.81 ' SG ' HD11 ' A' ' 44' ' ' ILE . 92.0 m -82.8 128.62 34.57 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.666 0.27 . . . . 55.23 110.49 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.29 -72.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.769 0.655 . . . . 72.42 112.769 -172.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.43 121.93 35.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 63.42 111.361 -166.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 58.21 11.19 1.47 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.625 -1.171 . . . . 72.45 113.395 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 47.9 mm -73.04 95.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.971 0.415 . . . . 70.51 110.072 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -71.0 110.38 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.857 -0.794 . . . . 72.33 108.857 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.81 HD11 ' SG ' ' A' ' 38' ' ' CYS . 86.4 mt -94.38 123.24 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.393 -0.822 . . . . 72.45 110.526 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.681 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.3 mp -110.11 109.75 20.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.242 -0.651 . . . . 73.21 109.242 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.06 105.16 17.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.028 -0.36 . . . . 72.45 110.028 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -81.01 147.66 30.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.382 -0.372 . . . . 62.13 110.215 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 88' ' ' ALA . 88.2 t80 -87.91 115.65 25.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.36 . . . . 65.22 110.624 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.573 ' HE1' ' HA ' ' A' ' 82' ' ' GLU . 51.6 t-105 -56.35 115.37 2.45 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.813 -0.631 . . . . 74.34 110.844 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -111.86 107.88 56.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 54.33 110.089 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 18.9 Cg_endo -59.81 -21.59 64.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.537 2.158 . . . . 64.33 111.79 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -131.95 128.63 38.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.531 -0.758 . . . . 73.15 109.383 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 47.6 t -164.37 175.13 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.889 0.376 . . . . 63.3 110.694 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -136.58 -61.17 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.553 -0.748 . . . . 43.4 111.435 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.463 ' O ' HD23 ' A' ' 59' ' ' LEU . 52.7 Cg_exo -55.0 -26.03 47.51 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.005 2.47 . . . . 54.22 112.684 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 56.6 m -57.29 -28.57 63.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.978 -0.555 . . . . 71.35 111.476 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.601 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 2.9 tmt_? -53.59 -49.12 68.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.935 0.398 . . . . 74.44 111.594 -172.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.4 m -75.3 -38.17 60.46 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.765 0.793 . . . . 70.35 110.95 177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 55' ' ' PRO . 4.4 mm? -73.71 -24.24 59.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.607 -0.724 . . . . 64.1 112.043 -172.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.5 mt-10 -59.56 -59.06 15.08 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.786 -0.449 . . . . 65.12 109.786 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.73 -34.46 31.51 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.819 1.679 . . . . 64.23 112.376 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.63 ' HB3' HD13 ' A' ' 116' ' ' ILE . 40.2 mt-30 -62.61 -42.7 99.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.145 -0.622 . . . . 75.21 110.97 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.638 HD21 HD13 ' A' ' 119' ' ' ILE . 67.6 mt -64.76 -38.62 91.6 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.48 -0.327 . . . . 74.14 110.132 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.0 mt-10 -58.11 -43.53 87.2 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 116.419 -0.355 . . . . 65.51 110.087 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -56.07 -53.43 57.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.093 -0.503 . . . . 74.54 111.09 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 123' ' ' ILE . 34.8 mt -63.26 -37.29 86.67 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.639 -0.504 . . . . 74.51 109.639 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.18 -26.9 68.35 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.588 -0.733 . . . . 43.32 110.906 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.5 mt-30 -80.15 -48.83 12.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.819 0.342 . . . . 74.13 110.599 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -47.62 83.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.436 0.636 . . . . 75.41 109.806 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -90.54 4.47 51.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.294 -0.866 . . . . 75.22 112.416 -175.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -53.16 -21.28 4.8 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.848 0.356 . . . . 63.31 111.664 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.35 -35.26 78.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 74.02 110.962 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -133.9 15.71 3.91 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.494 -0.321 . . . . 60.25 111.19 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 43' ' ' LEU . 41.9 t -135.29 139.69 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.071 0.462 . . . . 74.22 111.351 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 24' ' ' GLU . 61.0 tptt -145.25 119.81 9.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 71.33 109.14 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.681 HG12 ' HB2' ' A' ' 45' ' ' LEU . 29.2 mt -101.79 141.65 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.227 -0.286 . . . . 73.14 110.227 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 91.4 m-85 -130.22 161.25 31.59 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.55 0.34 . . . . 62.14 110.518 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.642 ' HD2' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -163.54 154.86 16.73 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 62.33 109.147 168.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 28.1 pt -79.53 152.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.394 -0.225 . . . . 75.13 110.394 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -107.26 6.62 28.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.626 0.25 . . . . 60.11 111.342 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 81' ' ' ILE . 3.0 mp -78.5 96.58 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 65.23 110.167 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HA ' ' HE1' ' A' ' 49' ' ' TRP . 7.5 tm-20 -61.62 -26.8 68.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.946 -0.57 . . . . 64.21 110.333 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.72 -9.01 57.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.686 -0.688 . . . . 63.52 111.28 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -91.4 105.83 18.05 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.093 0.473 . . . . 73.53 111.155 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -121.54 -32.91 3.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 73.43 109.776 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.3 m-20 -49.51 -43.18 45.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.011 -0.995 . . . . 63.32 111.939 -173.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.2 -34.05 26.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.283 -0.417 . . . . 71.01 111.403 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . . . -60.19 -49.23 78.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.15 0.5 . . . . 74.24 109.978 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 m -66.73 -35.49 80.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.437 -0.801 . . . . 72.42 110.642 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 72.8 mm-40 -61.34 -55.41 32.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.128 -0.487 . . . . 52.44 110.691 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.97 -11.87 51.91 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.462 -0.335 . . . . 63.04 111.815 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.59 42.28 14.19 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.75 -0.738 . . . . 65.55 112.354 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t -75.3 114.43 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -98.03 -74.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 63.12 111.05 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.74 136.44 33.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.76 0.314 . . . . 52.44 110.899 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.67 151.98 46.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 75.51 109.845 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.86 169.35 64.19 Favored 'Cis proline' 0 C--N 1.354 0.836 0 C-N-CA 124.157 -1.184 . . . . 64.14 112.921 1.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 112' ' ' ILE . 89.0 m -139.02 114.13 9.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.715 -0.675 . . . . 74.0 109.879 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.459 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 32.4 mm -109.79 110.7 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 62.41 111.012 -173.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -97.83 123.36 41.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.745 -0.835 . . . . 72.51 108.745 171.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.482 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 37.9 mtt -93.43 150.83 20.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.965 0.412 . . . . 65.12 110.923 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.7 m-85 -143.33 153.82 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.416 -0.957 . . . . 73.14 108.416 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -150.91 115.3 5.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 74.24 110.62 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.76 25.38 15.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.663 0.744 . . . . 72.22 110.171 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.29 -0.42 87.2 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.636 -0.711 . . . . 43.11 112.276 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -91.68 145.21 24.77 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 122.812 -0.228 . . . . 63.04 110.819 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' HD22 ' A' ' 108' ' ' LEU . 3.7 tppp? -63.31 132.51 51.83 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.916 0.76 . . . . 71.43 110.765 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 1.2 mm? -137.19 169.43 17.79 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 125.036 1.334 . . . . 61.41 108.788 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.25 172.18 7.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.459 0.54 . . . . 72.41 112.459 -162.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -140.14 126.04 19.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.081 -0.508 . . . . 74.54 110.605 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.1 m -115.3 122.47 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.191 0.519 . . . . 70.11 110.422 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 98' ' ' THR . 51.3 mt -108.18 140.56 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.718 -0.674 . . . . 62.14 109.485 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.12 157.49 32.45 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.991 -0.623 . . . . 60.32 112.13 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.46 97.3 9.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.927 0.343 . . . . 33.13 111.927 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.9 t0 -146.1 104.27 3.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.317 0.579 . . . . 64.24 110.677 169.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 62' ' ' GLN . 8.7 tp -59.13 -32.97 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.148 -0.933 . . . . 62.15 110.809 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 7' ' ' HIS . 41.0 m -67.91 -48.56 65.66 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.196 -0.456 . . . . 72.2 111.14 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -60.51 -47.66 85.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.374 -0.375 . . . . 55.14 110.301 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.638 HD13 HD21 ' A' ' 63' ' ' LEU . 78.5 mt -57.9 -55.56 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 62.22 111.081 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.436 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.86 -36.97 75.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.907 -0.405 . . . . 72.14 109.907 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -57.16 -52.02 66.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.847 -0.615 . . . . 43.12 110.082 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.86 -40.31 96.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.314 -0.403 . . . . 73.04 110.383 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 120' ' ' ILE . 96.7 mt -55.32 -56.05 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.556 -0.293 . . . . 73.41 110.691 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.2 -30.65 66.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.624 -0.431 . . . . 70.22 110.007 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.53 -34.43 76.9 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.907 -0.588 . . . . 72.2 111.214 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -92.62 -30.36 15.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 71.2 112.006 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.464 HD11 ' CG2' ' A' ' 74' ' ' VAL . 79.0 mt -67.81 -51.6 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 54.51 110.253 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.544 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 9.9 m120 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.527 -0.76 . . . . 71.43 110.515 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.728 -0.471 . . . . 75.42 109.728 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.06 128.92 7.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.534 -0.303 . . . . 34.04 110.468 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -119.95 141.94 49.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 65.04 109.904 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -122.76 112.73 18.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.827 -0.435 . . . . 71.22 109.827 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -96.72 -33.27 11.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.482 -0.326 . . . . 65.22 111.682 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -137.76 136.26 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.073 0.464 . . . . 75.12 111.673 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -148.71 88.33 1.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.265 -0.879 . . . . 65.21 109.14 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -86.89 106.17 17.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.914 -0.585 . . . . 74.33 110.92 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.7 ttm -167.15 92.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.979 0.419 . . . . 73.11 109.982 174.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.79 131.46 1.91 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.725 -0.67 . . . . 70.45 111.592 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.2 m -151.38 122.74 7.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.546 -0.538 . . . . 73.25 109.546 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD13 ' HD2' ' A' ' 65' ' ' LYS . 68.8 mt -56.68 99.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 74.23 111.789 -174.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -83.62 -33.04 25.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.073 -0.714 . . . . 75.42 109.073 173.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.31 85.18 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.519 -0.764 . . . . 52.13 109.994 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.35 140.09 55.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 70.34 110.782 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -153.85 133.88 13.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 70.15 109.841 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -60.74 144.82 51.52 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 123.538 0.524 . . . . 71.4 110.638 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.49 68.18 0.52 Allowed Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.199 -0.524 . . . . 74.21 112.028 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -96.51 13.7 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.339 2.693 . . . . 75.33 111.776 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.67 84.97 0.24 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.342 -0.703 . . . . 31.0 111.342 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.421 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 50.0 m -58.76 101.89 0.1 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.336 0.589 . . . . 70.35 111.562 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 85.1 mmm -72.68 -12.0 60.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.255 -0.884 . . . . 71.32 109.929 174.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.14 113.27 10.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.705 -0.679 . . . . 62.2 109.862 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 77' ' ' TYR . 3.5 tp10 -81.72 126.41 31.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.036 0.446 . . . . 70.14 111.166 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -80.35 119.37 22.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.804 -0.635 . . . . 71.41 109.697 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 31' ' ' PHE . 39.3 pt -126.69 146.47 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.158 0.504 . . . . 73.54 111.726 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.44 -162.61 26.26 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.221 -0.899 . . . . 75.43 111.522 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.94 -55.46 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.717 0.294 . . . . 65.03 110.98 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 m -61.58 -37.73 84.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.265 0.555 . . . . 74.42 110.644 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -65.33 -36.65 84.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.518 -0.765 . . . . 75.54 111.573 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.9 t80 -51.97 -61.69 2.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.732 0.271 . . . . 65.25 111.732 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -55.66 -46.67 77.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.099 0.476 . . . . 73.42 110.853 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.97 -57.22 13.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.611 -0.722 . . . . 43.22 110.88 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 33.7 mmtp -61.8 -32.48 72.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 63.34 111.369 -175.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 31' ' ' PHE . 76.8 t -72.51 -48.11 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.716 0.293 . . . . 74.14 110.808 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.0 p -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 53.41 110.97 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.4 t -65.84 -4.1 6.16 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.17 -0.468 . . . . 74.54 112.06 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.5 p -65.29 112.77 3.63 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.298 -0.251 . . . . 55.23 110.788 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.37 -77.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 72.42 111.059 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -147.63 129.06 14.89 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.627 0.251 . . . . 63.42 110.851 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 52.33 21.48 1.71 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.84 -0.618 . . . . 72.45 112.045 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.0 111.09 14.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.349 -0.387 . . . . 70.51 109.989 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.4 tp -77.26 107.0 9.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.323 0.582 . . . . 72.33 110.113 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 101' ' ' MET . 27.4 mt -95.05 120.7 44.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.529 -0.76 . . . . 72.45 110.672 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 74' ' ' VAL . 5.8 mp -105.83 123.59 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.327 -0.62 . . . . 73.21 109.327 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.58 106.8 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.228 -0.286 . . . . 72.45 110.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.69 132.53 41.75 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.845 0.355 . . . . 62.13 110.21 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -89.12 62.78 6.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.487 . . . . 65.22 110.9 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.475 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 11.9 t90 70.68 -70.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.575 -0.739 . . . . 74.34 112.173 171.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 64.59 74.21 0.42 Allowed Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 123.13 0.572 . . . . 54.33 111.495 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -88.5 -66.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.85 2.367 . . . . 64.33 113.833 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -85.56 79.43 9.39 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.826 0.346 . . . . 73.15 110.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.5 p -171.38 139.08 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.571 . . . . 63.3 110.276 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -75.7 -66.22 1.92 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 116.008 -0.542 . . . . 43.4 112.556 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.82 -28.6 4.95 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.337 2.691 . . . . 54.22 113.686 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 81.5 m -52.96 -34.92 58.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.571 -0.286 . . . . 71.35 111.668 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 17.5 ptm180 -59.63 -38.01 80.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.585 -0.279 . . . . 74.44 110.56 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.5 t -75.21 -37.94 60.93 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.423 0.63 . . . . 70.35 110.319 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.3 mm? -61.24 -34.85 75.81 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 64.1 111.877 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.72 -58.3 20.47 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 119.313 -0.375 . . . . 65.12 111.262 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.67 -30.67 85.71 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.859 1.706 . . . . 64.23 111.909 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -63.32 -39.95 95.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.596 -0.442 . . . . 75.21 109.896 174.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.503 HD21 HD13 ' A' ' 119' ' ' ILE . 82.7 mt -69.85 -35.81 75.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.977 -0.556 . . . . 74.14 110.093 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 75.8 mt-10 -59.24 -42.59 91.46 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.118 -0.492 . . . . 65.51 109.97 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.582 ' HD2' HD13 ' A' ' 12' ' ' LEU . 18.4 ttmm -58.11 -54.28 48.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.461 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 123' ' ' ILE . 56.6 mt -62.17 -30.56 71.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.883 0.373 . . . . 74.51 110.038 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.539 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -69.67 -41.82 74.98 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.89 -0.596 . . . . 43.32 110.628 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.3 mt-30 -70.59 -40.46 73.22 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.04 0.447 . . . . 74.13 110.72 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -75.66 -35.82 60.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.805 -0.634 . . . . 75.41 111.012 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.7 5.35 36.21 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.018 -0.537 . . . . 75.22 112.006 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.8 t -52.44 -18.99 1.9 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.994 0.517 . . . . 63.31 112.167 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.97 -35.84 64.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.312 -0.404 . . . . 74.02 111.13 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -133.87 -11.16 2.66 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.717 0.266 . . . . 60.25 111.717 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.567 HG13 HD13 ' A' ' 45' ' ' LEU . 55.2 t -105.35 141.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.032 0.444 . . . . 74.22 112.047 -172.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -144.56 121.93 11.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 71.33 109.02 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' A' ' 45' ' ' LEU . 30.7 mt -109.93 143.36 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.012 0.434 . . . . 73.14 111.51 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 90.7 m-85 -126.73 172.87 9.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.629 -0.714 . . . . 62.14 110.438 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 49' ' ' TRP . 14.2 tppt? -138.73 115.85 10.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 62.33 110.418 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.65 99.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.051 -0.722 . . . . 75.13 109.051 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -108.37 30.81 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 60.11 111.023 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.71 74.25 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.443 -0.577 . . . . 65.23 109.443 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -35.58 25.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.137 -0.938 . . . . 64.21 112.54 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.58 -35.89 70.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 63.52 111.144 -176.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -93.86 42.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.697 0.761 . . . . 73.53 110.446 -171.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.38 -15.45 60.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.246 -0.888 . . . . 73.43 110.491 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.09 -33.91 58.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.757 -0.656 . . . . 63.32 111.086 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.6 t -56.21 -34.41 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.795 -0.639 . . . . 71.01 110.874 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.01 75.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.09 -0.505 . . . . 74.24 110.648 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.5 m -64.35 -41.76 96.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.963 -0.562 . . . . 72.42 110.562 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -63.69 -53.19 55.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.143 -0.48 . . . . 52.44 111.371 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.42 -18.06 60.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 63.04 111.106 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.74 55.67 3.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.988 -0.625 . . . . 65.55 112.507 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -69.53 106.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.559 -0.534 . . . . 75.31 109.559 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' ' 112' ' ' ILE . 23.3 t -65.72 -56.93 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 63.12 110.984 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.94 27.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.679 0.276 . . . . 52.44 110.682 -177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 pt -95.16 149.31 36.03 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.873 -0.603 . . . . 75.51 110.602 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.47 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.2 Cg_exo -71.01 170.46 63.79 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.147 -1.189 . . . . 64.14 112.516 -1.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.3 m -139.55 125.75 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.649 -0.5 . . . . 74.0 109.649 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 49.9 mm -110.37 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 62.41 110.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -88.81 123.12 32.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.423 -0.584 . . . . 72.51 109.423 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 43.2 mtt -102.08 142.24 33.65 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.305 0.502 . . . . 65.12 111.32 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -142.57 144.96 33.11 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.478 -0.934 . . . . 73.14 108.478 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 40.1 ttpt -146.42 115.97 7.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.457 -0.497 . . . . 74.24 111.342 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 62.58 25.72 15.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.823 -0.626 . . . . 72.22 110.54 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.83 -7.97 80.72 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.804 -0.635 . . . . 43.11 112.658 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -85.46 151.26 24.11 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 122.3 0.24 . . . . 63.04 110.952 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.5 tmtt? -77.56 116.95 18.53 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.558 0.694 . . . . 71.43 109.972 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.415 ' CD2' ' HB3' ' A' ' 103' ' ' LYS . 4.2 mm? -112.05 168.85 9.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.534 -1.212 . . . . 61.41 110.377 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -177.21 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 72.41 111.863 -162.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -147.49 147.12 29.83 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.681 0.753 . . . . 74.54 111.019 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 13.5 t -122.8 135.43 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 114.066 -1.424 . . . . 70.11 109.698 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.458 HG21 ' HB3' ' A' ' 94' ' ' SER . 65.5 mt -123.68 127.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.559 -0.291 . . . . 62.14 110.414 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.76 162.31 38.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.216 -0.516 . . . . 60.32 112.415 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.56 78.58 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.931 0.396 . . . . 33.13 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.474 ' O ' HG13 ' A' ' 119' ' ' ILE . 43.3 t0 -126.38 91.41 3.36 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.048 0.451 . . . . 64.24 109.799 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 66' ' ' LEU . 9.0 tp -61.89 -27.5 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.605 -0.725 . . . . 62.15 110.654 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -69.87 -44.62 69.44 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.197 -0.456 . . . . 72.2 109.828 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -67.24 -38.96 86.07 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.69 -0.485 . . . . 55.14 109.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.503 HD13 HD21 ' A' ' 63' ' ' LEU . 76.3 mt -60.32 -56.1 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.067 -0.515 . . . . 62.22 110.954 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -39.83 86.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.774 0.321 . . . . 72.14 110.197 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.453 ' HA ' HD21 ' A' ' 124' ' ' ASN . 32.9 t -56.74 -47.58 79.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.151 -0.477 . . . . 43.12 109.862 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -66.43 -40.83 89.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 73.04 110.793 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 66' ' ' LEU . 96.9 mt -54.41 -56.18 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.79 -0.364 . . . . 73.41 110.125 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.453 HD21 ' HA ' ' A' ' 121' ' ' SER . 8.6 p30 -67.42 -39.19 85.45 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.49 -0.484 . . . . 70.22 110.388 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.29 -38.4 90.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 72.2 111.86 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -83.15 -21.25 33.62 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.713 -0.221 . . . . 71.2 110.798 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 123' ' ' ILE . 77.4 mt -72.4 -48.43 47.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.831 -0.433 . . . . 54.51 109.831 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.514 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.659 -0.686 . . . . 71.43 110.901 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.083 -0.34 . . . . 75.42 110.083 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.31 130.97 37.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.512 -0.313 . . . . 34.04 110.736 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -88.15 81.64 7.33 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.47 0.652 . . . . 65.04 109.84 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -133.6 135.76 44.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.324 -0.853 . . . . 71.22 110.904 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -141.06 -65.64 0.44 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.792 -0.447 . . . . 65.22 109.792 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -160.66 149.34 16.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.395 -0.594 . . . . 75.12 109.395 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -103.02 171.99 7.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.869 0.366 . . . . 65.21 110.883 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.546 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 44.6 t-80 -161.33 110.75 1.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.734 -0.666 . . . . 74.33 109.411 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 72.1 mtm -53.67 119.57 5.1 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 123.402 0.439 . . . . 73.11 110.875 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.7 154.65 52.45 Favored Glycine 0 C--N 1.33 0.208 0 CA-C-N 115.672 -0.695 . . . . 70.45 112.565 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.1 m -81.84 -72.63 0.42 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.441 0.162 . . . . 73.25 110.969 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -154.7 114.79 3.82 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.443 0.297 . . . . 74.23 111.251 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.671 ' HG2' ' HG2' ' A' ' 85' ' ' GLN . 12.3 pt-20 -109.53 106.87 16.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.154 -1.054 . . . . 75.42 108.154 168.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.511 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . . . -162.92 173.73 13.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.415 -0.357 . . . . 52.13 111.21 -173.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 74.72 97.33 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.117 0.886 . . . . 70.34 109.36 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.515 ' HA ' ' HZ2' ' A' ' 49' ' ' TRP . 45.0 p -56.71 120.14 7.33 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.324 -0.853 . . . . 70.15 112.559 -172.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.434 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 99.3 mt-30 -79.13 168.62 19.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.738 -0.665 . . . . 71.4 109.491 172.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.33 88.98 0.54 Allowed Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.865 -0.494 . . . . 74.21 111.865 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.457 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 93.8 Cg_endo -86.19 40.41 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.985 2.457 . . . . 75.33 112.482 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.66 49.68 3.42 Favored Glycine 0 C--N 1.328 0.107 0 N-CA-C 111.224 -0.75 . . . . 31.0 111.224 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.49 ' HB3' ' OE1' ' A' ' 64' ' ' GLU . 31.2 m -146.82 -161.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.938 -0.393 . . . . 70.35 109.938 -172.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.407 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 83.4 mmm -57.5 -25.39 59.75 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.704 0.288 . . . . 71.32 111.279 177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -75.17 112.26 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 62.2 110.108 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.573 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 7.6 tp10 -71.07 150.27 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 70.14 110.74 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -118.06 126.63 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.567 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 31' ' ' PHE . 24.9 pt -143.13 166.63 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.236 -0.438 . . . . 73.54 111.16 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -100.87 -164.38 27.93 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.909 -0.587 . . . . 75.43 112.561 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.426 ' N ' HD11 ' A' ' 81' ' ' ILE . 12.3 t70 -69.12 -57.04 5.93 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.821 0.344 . . . . 65.03 111.361 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.35 -0.386 . . . . 74.42 110.236 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 45.5 mt-10 -68.86 -31.39 70.3 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.54 110.569 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.7 t80 -52.85 -60.12 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.074 0.464 . . . . 65.25 110.009 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.46 -45.91 73.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 73.42 110.848 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -66.39 -57.36 7.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 43.22 111.613 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG3' HG21 ' A' ' 26' ' ' ILE . 46.8 mmtm -60.52 -31.14 70.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.683 . . . . 63.34 111.214 -176.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 31' ' ' PHE . 68.1 t -73.43 -44.75 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.687 -0.233 . . . . 74.14 110.663 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.9 p -72.11 -14.62 61.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.995 0.426 . . . . 53.41 110.966 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.9 t -71.24 0.53 7.72 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.834 -0.621 . . . . 74.54 111.351 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.78 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.0 p -58.65 120.3 8.66 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.698 0.285 . . . . 55.23 110.739 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -67.65 -73.35 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.402 -0.363 . . . . 72.42 111.152 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -156.77 125.62 5.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.361 -0.381 . . . . 63.42 110.449 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 59.49 5.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.623 0.601 . . . . 72.45 112.623 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 73' ' ' ASN . 40.0 mm -68.13 112.72 3.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 70.51 110.73 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.478 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.1 tt -80.34 120.87 24.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.831 -0.803 . . . . 72.33 108.831 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.96 114.16 46.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.459 -0.791 . . . . 72.45 110.472 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.0 mp -101.93 137.36 40.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.587 -0.894 . . . . 73.21 108.587 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -124.74 110.44 25.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 110.21 -0.293 . . . . 72.45 110.21 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.51 122.16 22.64 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.53 -0.544 . . . . 62.13 109.53 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -69.11 -74.7 0.12 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.573 -0.528 . . . . 65.22 109.573 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.655 ' HZ3' ' HA ' ' A' ' 80' ' ' ASN . 8.5 t-105 -171.89 160.53 5.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.15 -0.477 . . . . 74.34 109.861 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.636 ' HB1' ' SG ' ' A' ' 53' ' ' CYS . . . -164.37 96.3 0.94 Allowed Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.276 0.36 . . . . 54.33 110.538 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.74 -77.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.936 2.424 . . . . 64.33 112.063 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -98.69 90.88 4.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.783 -0.451 . . . . 73.15 109.783 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.636 ' SG ' ' HB1' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -134.53 -58.75 0.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.652 -0.703 . . . . 63.3 110.78 -178.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.52 -85.83 0.4 Allowed Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.028 -0.606 . . . . 43.4 112.574 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.68 -22.04 42.23 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.999 2.466 . . . . 54.22 111.876 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.5 p -52.72 -33.27 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.621 -0.718 . . . . 71.35 110.986 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -60.65 -36.2 78.09 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.375 0.607 . . . . 74.44 110.041 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.8 m -74.56 -35.87 63.08 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.824 0.821 . . . . 70.35 110.042 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.5 mm? -65.59 -22.1 66.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.232 -0.895 . . . . 64.1 111.464 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 -57.92 -62.23 5.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.969 -0.382 . . . . 65.12 109.969 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 40.0 Cg_endo -67.08 -31.55 36.49 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 121.891 1.727 . . . . 64.23 112.079 176.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.561 ' HB2' ' HA ' ' A' ' 59' ' ' LEU . 79.5 mt-30 -60.3 -45.79 92.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.054 0.455 . . . . 75.21 110.824 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 119' ' ' ILE . 73.4 mt -64.75 -40.78 95.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.127 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 21' ' ' SER . 30.0 mt-10 -57.57 -43.78 84.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.433 -0.349 . . . . 65.51 110.323 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -51.71 -57.22 9.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.008 -0.542 . . . . 74.54 110.688 178.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.479 HD13 HD12 ' A' ' 123' ' ' ILE . 19.7 mt -64.88 -34.92 79.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.941 -0.572 . . . . 74.51 109.654 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.566 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -66.58 -27.96 68.14 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.694 -0.684 . . . . 43.32 111.355 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.3 mt-30 -85.22 -37.11 20.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.832 0.349 . . . . 74.13 110.847 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.85 -37.99 70.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 75.41 110.953 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -104.89 5.89 33.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.577 -0.738 . . . . 75.22 111.925 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -22.66 5.5 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.578 0.955 . . . . 63.31 113.578 -169.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -77.42 -18.81 56.92 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.288 -0.258 . . . . 74.02 111.362 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.471 ' HA ' HD13 ' A' ' 42' ' ' ILE . 6.3 t30 -134.34 6.68 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.499 -0.319 . . . . 60.25 110.826 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 43' ' ' LEU . 54.6 t -139.13 139.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.71 0.29 . . . . 74.22 110.879 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 20.6 tptm -142.46 123.0 14.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 71.33 109.757 173.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 45' ' ' LEU . 54.7 mt -98.08 125.39 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 73.14 110.508 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.552 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 62.3 m-85 -111.27 174.39 5.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.395 -0.594 . . . . 62.14 109.395 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HB2' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -156.08 152.71 28.34 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.295 -0.631 . . . . 62.33 109.295 167.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 34.4 pt -106.26 172.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.765 0.317 . . . . 75.13 111.016 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.655 ' HA ' ' HZ3' ' A' ' 49' ' ' TRP . 12.8 m120 -113.04 -90.19 0.52 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.961 -0.563 . . . . 60.11 109.523 171.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 81' ' ' ILE . 19.8 mm 52.69 23.26 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.075 0.464 . . . . 65.23 111.488 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HG3' ' HA ' ' A' ' 14' ' ' ALA . 36.6 tt0 -47.83 -28.48 2.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.401 0.68 . . . . 64.21 111.951 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -72.25 -35.66 68.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.783 -0.644 . . . . 63.52 111.592 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.21 99.16 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 73.53 110.681 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.671 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 78.9 mt-30 -73.33 6.56 2.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.971 -0.559 . . . . 73.43 111.68 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -45.19 -40.07 6.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.117 -0.492 . . . . 63.32 110.744 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.0 t -61.51 -39.9 84.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.679 -0.692 . . . . 71.01 110.703 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.37 -46.2 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.259 0.552 . . . . 74.24 110.076 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 74.5 m -67.38 -39.47 85.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.142 -0.935 . . . . 72.42 111.22 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -67.09 -43.04 83.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.351 -0.386 . . . . 52.44 111.625 -177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -92.58 -12.27 32.18 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.703 0.26 . . . . 63.04 111.703 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 8' ' ' HIS . . . 83.3 45.52 6.52 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.951 -0.642 . . . . 65.55 113.562 171.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.33 128.52 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.063 -0.347 . . . . 75.31 110.063 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 -16.66 7.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.489 -0.323 . . . . 63.12 111.071 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.4 168.44 25.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.421 -0.354 . . . . 52.44 110.104 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.1 pp -127.84 140.14 37.3 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.514 -0.312 . . . . 75.51 110.672 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 96.4 Cg_endo -78.78 -176.02 17.85 Favored 'Cis proline' 0 C--N 1.352 0.741 0 C-N-CA 123.875 -1.302 . . . . 64.14 112.919 -0.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 m -147.6 124.5 11.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.686 -0.688 . . . . 74.0 109.638 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.417 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 48.7 mm -109.82 111.08 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.557 -0.292 . . . . 62.41 110.54 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 100' ' ' LEU . 1.9 mm? -88.12 123.5 32.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 72.51 109.283 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 109' ' ' SER . 26.3 mtt -103.36 142.12 34.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.729 0.299 . . . . 65.12 110.662 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -140.06 142.78 36.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.214 -0.662 . . . . 73.14 109.214 172.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 23.6 tptm -124.08 104.06 8.65 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.08 -0.248 . . . . 74.24 110.94 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.78 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.3 t30 40.8 40.69 1.02 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.967 0.507 . . . . 72.22 112.28 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.99 53.03 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.169 -0.539 . . . . 43.11 113.214 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -120.79 148.94 43.32 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 122.935 0.494 . . . . 63.04 109.846 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.617 ' HD3' ' N ' ' A' ' 108' ' ' LEU . 6.4 tmtt? -64.48 130.36 43.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.292 0.568 . . . . 71.43 109.752 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.617 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -136.29 167.79 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.148 -0.933 . . . . 61.41 109.244 -173.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.511 ' H ' HD13 ' A' ' 108' ' ' LEU . 8.9 m -70.69 179.44 2.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.714 0.768 . . . . 72.41 112.731 -165.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.505 ' HG3' HD13 ' A' ' 100' ' ' LEU . 50.2 tt0 -148.78 131.97 16.41 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.233 -0.894 . . . . 74.54 109.963 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 6.5 t -110.57 113.87 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.55 -1.204 . . . . 70.11 109.995 -172.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.0 mm -97.8 120.65 47.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.081 -0.508 . . . . 62.14 109.979 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.12 -173.19 30.09 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.657 -0.577 . . . . 60.32 111.657 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.45 98.41 7.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.647 0.26 . . . . 33.13 111.059 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -142.32 101.68 3.95 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.067 0.461 . . . . 64.24 110.482 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.561 ' HB ' ' OE1' ' A' ' 62' ' ' GLN . 11.4 tp -66.0 -30.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 62.15 110.853 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.1 t -58.67 -50.63 73.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.16 0.505 . . . . 72.2 110.009 176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -63.77 -46.78 83.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.65 -0.704 . . . . 55.14 110.515 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 63' ' ' LEU . 77.0 mt -57.17 -56.3 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.19 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.16 -38.91 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.893 -0.41 . . . . 72.14 109.893 -177.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.447 ' HA ' HD21 ' A' ' 124' ' ' ASN . 22.2 t -57.21 -51.25 70.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.174 -0.466 . . . . 43.12 110.047 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.0 -40.53 98.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 73.04 110.772 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 66' ' ' LEU . 96.8 mt -56.98 -56.68 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.992 -0.283 . . . . 73.41 111.001 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' A' ' 121' ' ' SER . 8.1 p30 -69.36 -35.98 76.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.872 0.368 . . . . 70.22 110.232 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.95 -36.61 84.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 72.2 110.961 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -95.73 -9.18 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 71.2 111.54 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 74' ' ' VAL . 78.1 mt -82.83 -44.27 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.311 0.577 . . . . 54.51 109.773 165.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.559 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-N 115.502 -0.772 . . . . 71.43 110.424 -177.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mtp . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.118 -0.327 . . . . 75.42 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.0 126.97 29.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 34.04 110.077 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -157.47 99.01 1.73 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.218 0.533 . . . . 65.04 111.132 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -164.43 112.94 1.12 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.623 -0.717 . . . . 71.22 109.18 173.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -100.31 146.84 26.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.526 . . . . 65.22 110.929 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -140.23 149.51 42.98 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.645 -0.502 . . . . 75.12 109.645 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -146.81 101.5 3.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.876 -0.416 . . . . 65.21 109.876 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 125' ' ' ASN . 19.9 t-160 -109.27 87.81 2.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.945 -0.571 . . . . 74.33 110.772 -175.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -79.15 133.95 36.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.779 -0.452 . . . . 73.11 109.779 175.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.24 86.46 0.22 Allowed Glycine 0 C--N 1.329 0.177 0 N-CA-C 111.697 -0.561 . . . . 70.45 111.697 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 p -82.75 92.25 7.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.996 0.427 . . . . 73.25 111.476 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -131.91 172.64 12.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.339 -0.615 . . . . 74.23 109.339 175.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.42 136.99 52.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.646 0.26 . . . . 75.42 110.635 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.99 161.0 13.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.293 -0.412 . . . . 52.13 110.619 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.648 ' HB2' ' HE3' ' A' ' 65' ' ' LYS . 11.7 mm100 -90.34 143.02 27.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.525 -0.307 . . . . 70.34 110.281 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 p -76.79 -4.68 44.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 70.15 111.422 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.38 90.41 1.29 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.098 -0.501 . . . . 71.4 110.852 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.08 79.47 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 CA-C-N 116.0 -0.545 . . . . 74.21 111.751 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -84.92 7.46 5.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.895 2.396 . . . . 75.33 113.071 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.44 122.98 5.43 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.385 -0.436 . . . . 31.0 112.491 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 p -67.35 143.64 56.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.839 0.352 . . . . 70.35 111.115 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.542 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.1 mmm -137.57 -39.28 0.58 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.249 -0.432 . . . . 71.32 112.002 -175.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.536 HG22 ' HG2' ' A' ' 78' ' ' LYS . 10.8 mm -67.04 130.93 32.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 120.679 0.276 . . . . 62.2 110.771 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 77' ' ' TYR . 2.6 pt-20 -105.39 161.28 14.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.848 -0.427 . . . . 70.14 109.848 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 3.9 pp0? -118.35 147.01 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.457 0.17 . . . . 71.41 110.772 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 pt -139.41 156.38 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.784 0.326 . . . . 73.54 110.823 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.1 179.01 48.31 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.908 -0.587 . . . . 75.43 112.492 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.58 -44.97 96.03 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.957 0.408 . . . . 65.03 111.342 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -65.08 -30.15 71.09 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.295 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -80.96 -20.31 42.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.836 -0.62 . . . . 75.54 111.474 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.1 t80 -57.63 -61.91 2.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.482 0.182 . . . . 65.25 111.138 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.78 -44.6 96.58 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.071 0.462 . . . . 73.42 110.237 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -53.62 -57.53 10.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.262 -0.881 . . . . 43.22 110.998 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -62.01 -43.64 98.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.223 -0.444 . . . . 63.34 111.162 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.658 HG12 ' HA2' ' A' ' 105' ' ' GLY . 73.9 t -62.67 -36.93 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.34 -0.391 . . . . 74.14 111.524 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -86.43 -29.2 23.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.047 0.388 . . . . 53.41 112.047 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -83.76 11.06 8.03 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.363 0.505 . . . . 74.54 112.363 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.2 p -59.4 143.89 48.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.244 -0.28 . . . . 55.23 110.244 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.4 -74.12 0.06 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.634 0.254 . . . . 72.42 110.715 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -161.74 126.22 3.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.159 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 57.05 12.27 1.21 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.672 0.619 . . . . 72.45 112.672 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 51.1 mm -64.09 117.89 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.519 -0.549 . . . . 70.51 109.519 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.1 112.2 13.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.124 -0.489 . . . . 72.33 110.105 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 38' ' ' CYS . 72.4 mt -98.7 105.64 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.001 -0.545 . . . . 72.45 110.634 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 74' ' ' VAL . 5.1 mp -90.51 116.29 28.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.082 -0.71 . . . . 73.21 109.082 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.72 105.26 18.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.768 -0.456 . . . . 72.45 109.768 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 56.5 t0 -84.28 123.24 29.93 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.854 -0.612 . . . . 62.13 110.381 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 100' ' ' LEU . 76.8 m-85 -102.9 125.3 49.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.177 -0.465 . . . . 65.22 110.592 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -117.35 148.32 41.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.03 -0.532 . . . . 74.34 111.103 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . -109.25 -178.19 0.54 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.093 -0.958 . . . . 54.33 109.245 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 85.6 Cg_exo -46.15 -26.6 3.83 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.515 2.143 . . . . 64.33 112.628 173.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -142.81 178.9 7.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.715 . . . . 73.15 109.648 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.641 ' HA ' HG12 ' A' ' 96' ' ' ILE . 14.1 p -157.8 165.4 35.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.426 -0.213 . . . . 63.3 110.426 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.52 -108.15 1.05 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.217 -0.516 . . . . 43.4 113.374 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' O ' HD23 ' A' ' 59' ' ' LEU . 95.1 Cg_endo -80.65 45.52 2.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.257 2.638 . . . . 54.22 113.514 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' SG ' ' HG3' ' A' ' 97' ' ' PRO . 95.9 m -65.33 -22.63 66.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.464 -0.334 . . . . 71.35 111.85 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 57' ' ' ARG . 35.0 ttt180 -54.06 -60.92 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.61 0.243 . . . . 74.44 111.458 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.4 m -75.58 -41.6 54.2 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.408 0.623 . . . . 70.35 111.615 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.552 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -67.84 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.881 0.697 . . . . 64.1 112.881 -169.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 42.5 mt-10 -59.54 -60.48 10.43 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 120.225 -0.59 . . . . 65.12 110.286 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.82 -36.53 96.87 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.615 1.543 . . . . 64.23 112.007 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.8 mt-30 -60.73 -47.01 88.24 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.805 -0.358 . . . . 75.21 110.86 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 119' ' ' ILE . 91.9 mt -67.4 -41.01 85.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 74.14 110.618 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 31.5 mt-10 -69.5 -24.18 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 65.51 110.712 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.648 ' HE3' ' HB2' ' A' ' 15' ' ' GLN . 17.3 ttmm -68.43 -49.83 57.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.239 -0.282 . . . . 74.54 110.239 171.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.452 HD13 HD12 ' A' ' 123' ' ' ILE . 51.5 mt -62.54 -30.98 71.7 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.685 -0.487 . . . . 74.51 109.685 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.76 -51.55 64.34 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.927 -0.579 . . . . 43.32 109.772 173.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.542 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 35.7 mm-40 -51.97 -48.77 64.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.12 -0.491 . . . . 74.13 111.259 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -76.15 -36.8 58.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.744 -0.662 . . . . 75.41 111.577 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -104.53 3.88 32.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.989 0.737 . . . . 75.22 112.989 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.6 t -53.82 -19.43 4.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.934 0.397 . . . . 63.31 112.019 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.39 -24.18 64.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 74.02 111.168 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -134.48 1.19 3.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.347 -0.388 . . . . 60.25 110.781 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 45' ' ' LEU . 5.2 t -127.32 138.75 53.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.851 0.357 . . . . 74.22 111.381 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -134.57 129.71 35.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.404 -0.961 . . . . 71.33 108.404 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 45' ' ' LEU . 17.1 mt -119.67 115.89 48.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.14 0.495 . . . . 73.14 110.778 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.43 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 87.3 m-85 -106.17 151.64 24.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 62.14 110.871 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.536 ' HG2' HG22 ' A' ' 23' ' ' ILE . 61.0 mmtt -109.43 125.78 52.78 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.331 -0.849 . . . . 62.33 109.742 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -93.98 67.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.989 -1.486 . . . . 75.13 106.989 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.54 89.52 6.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.227 -0.897 . . . . 60.11 110.854 -171.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.5 mt -132.44 112.94 20.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.542 -0.91 . . . . 65.23 108.542 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -18.15 58.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 64.21 110.948 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' H ' HG22 ' A' ' 81' ' ' ILE . 65.3 m-20 -83.68 17.02 2.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.566 -0.288 . . . . 63.52 111.753 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -76.25 52.37 0.75 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.856 0.687 . . . . 73.53 112.856 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -82.73 -61.14 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.765 -0.828 . . . . 73.43 108.765 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.2 m-20 -48.66 -49.18 38.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.988 -1.005 . . . . 63.32 110.985 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.49 -36.85 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 71.01 110.628 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.22 75.39 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.864 -0.421 . . . . 74.24 109.864 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 72.42 110.669 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.4 mm100 -75.03 -48.49 23.75 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.963 -0.562 . . . . 52.44 111.167 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.56 -10.27 52.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 63.04 111.381 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.34 56.11 11.0 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.109 -0.567 . . . . 65.55 111.887 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.4 t -77.25 109.37 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 75.31 110.468 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.447 ' HB2' HG21 ' A' ' 112' ' ' ILE . 12.1 m -63.27 -54.08 42.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.277 -0.419 . . . . 63.12 111.186 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.31 138.92 18.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 52.44 110.488 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.835 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -98.31 147.43 33.11 Favored Pre-proline 0 C--O 1.236 0.377 0 O-C-N 123.364 0.415 . . . . 75.51 110.504 -178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.479 ' HG3' ' SG ' ' A' ' 56' ' ' CYS . 12.3 Cg_exo -70.57 166.03 77.31 Favored 'Cis proline' 0 C--N 1.357 1.021 0 C-N-CA 124.24 -1.15 . . . . 64.14 113.12 3.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.546 HG23 HG12 ' A' ' 112' ' ' ILE . 88.6 m -145.8 130.75 18.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.642 . . . . 74.0 109.839 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.463 ' HB ' ' CG2' ' A' ' 111' ' ' VAL . 42.8 mm -109.8 110.79 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 62.41 111.193 -173.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' A' ' 48' ' ' PHE . 8.4 mp -101.13 123.41 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.501 -0.555 . . . . 72.51 109.501 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.539 ' SD ' ' ND2' ' A' ' 126' ' ' ASN . 22.2 mtt -92.26 145.6 24.36 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.138 -0.319 . . . . 65.12 110.138 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.4 m-85 -142.12 152.56 43.37 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.747 -0.464 . . . . 73.14 109.747 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -145.24 114.88 7.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.444 0.164 . . . . 74.24 110.814 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.517 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 32.0 t-20 57.4 41.04 26.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.371 0.605 . . . . 72.22 110.396 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.658 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 71.04 2.81 49.35 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 115.942 -0.572 . . . . 43.11 112.843 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -101.19 147.3 26.42 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 120.732 0.301 . . . . 63.04 110.797 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -56.62 129.57 41.55 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.638 1.212 . . . . 71.43 112.161 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -136.61 167.95 20.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.138 -1.392 . . . . 61.41 108.287 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.21 172.01 8.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.823 0.675 . . . . 72.41 112.823 -163.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -138.34 138.19 38.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.65 -0.704 . . . . 74.54 110.558 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 17.0 m -126.47 139.92 50.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.197 -0.456 . . . . 70.11 109.876 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.546 HG12 HG23 ' A' ' 98' ' ' THR . 38.7 mt -127.16 142.99 41.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.946 -0.57 . . . . 62.14 109.88 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.27 -152.16 21.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.036 -0.602 . . . . 60.32 112.417 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -125.98 93.18 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 33.13 111.741 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.5 t70 -145.03 91.21 2.12 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 64.24 108.655 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 tp -64.54 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.614 -0.721 . . . . 62.15 110.752 -171.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -66.93 -45.35 78.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.076 -0.511 . . . . 72.2 110.082 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' HD3' ' HG2' ' A' ' 122' ' ' GLU . 14.9 tppt? -69.19 -39.82 78.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 55.14 110.277 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 63' ' ' LEU . 78.1 mt -58.66 -56.08 18.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.383 -0.371 . . . . 62.22 110.509 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -61.4 -37.37 77.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.726 -0.472 . . . . 72.14 109.726 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.496 ' HA ' HD21 ' A' ' 124' ' ' ASN . 37.5 t -54.04 -52.01 62.21 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.102 -0.499 . . . . 43.12 110.491 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -72.17 -28.33 63.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 73.04 110.917 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 120' ' ' ILE . 97.6 mt -59.49 -56.21 18.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 120.634 -0.427 . . . . 73.41 110.143 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.496 HD21 ' HA ' ' A' ' 121' ' ' SER . 9.1 p30 -71.19 -25.37 62.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.727 0.298 . . . . 70.22 110.325 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 8' ' ' HIS . 30.4 t30 -62.31 -48.21 80.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.618 -0.719 . . . . 72.2 110.598 175.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.539 ' ND2' ' SD ' ' A' ' 101' ' ' MET . 92.3 m-20 -80.88 -26.81 36.61 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.526 -0.761 . . . . 71.2 111.671 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 74' ' ' VAL . 71.1 mt -74.86 -49.84 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.689 0.28 . . . . 54.51 110.814 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.578 -0.725 . . . . 71.43 110.673 -174.368 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.999 -0.371 . . . . 75.42 109.999 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.93 88.0 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.182 0.515 . . . . 34.04 112.081 -174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -118.42 26.03 9.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.101 -1.074 . . . . 65.04 108.101 169.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -82.59 112.09 19.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.436 -1.257 . . . . 71.22 111.106 -171.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -144.14 151.51 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 65.22 109.65 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -111.14 138.95 46.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 75.12 110.347 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -127.45 11.45 6.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 65.21 110.543 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -73.0 73.12 1.16 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.207 -0.664 . . . . 74.33 109.207 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.4 ttm -110.35 84.72 1.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.271 -0.877 . . . . 73.11 109.484 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.0 -175.07 44.67 Favored Glycine 0 C--O 1.238 0.376 0 CA-C-N 115.925 -0.58 . . . . 70.45 111.658 -175.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 p -78.47 87.17 4.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.086 0.469 . . . . 73.25 110.869 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 12' ' ' LEU . 2.5 pt? -79.1 5.81 11.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.855 -0.611 . . . . 74.23 111.265 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -124.69 115.78 21.31 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.322 -0.399 . . . . 75.42 110.413 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.91 139.46 0.29 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.3 -0.409 . . . . 52.13 111.034 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -137.06 152.57 50.21 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.408 -0.589 . . . . 70.34 109.408 173.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 p -129.36 170.76 13.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.62 -0.264 . . . . 70.15 110.811 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -86.47 18.27 3.37 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.313 0.578 . . . . 71.4 110.637 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.04 -61.14 3.58 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.594 -1.002 . . . . 74.21 110.594 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.18 -149.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.619 2.212 . . . . 75.33 110.678 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -168.14 104.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.37 -0.919 . . . . 31.0 112.739 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.4 t -68.15 141.64 55.97 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.097 -0.705 . . . . 70.35 109.097 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.9 mmm -110.84 6.58 21.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 71.32 111.058 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -91.03 100.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.023 -0.732 . . . . 62.2 109.023 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 28.9 tt0 -94.06 112.26 24.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 70.14 110.641 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.588 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 2.1 mp0 -72.36 132.0 43.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 71.41 110.089 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.513 HG21 ' HG3' ' A' ' 34' ' ' LYS . 38.2 pt -130.85 152.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 73.54 110.208 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.69 165.31 45.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.131 -0.557 . . . . 75.43 112.421 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -50.87 -39.05 52.86 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.843 0.457 . . . . 65.03 111.465 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -71.15 -36.84 72.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 74.42 110.546 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.44 -13.59 60.4 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 115.837 -0.62 . . . . 75.54 111.265 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 35' ' ' VAL . 75.8 t80 -56.36 -62.15 1.92 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.594 0.235 . . . . 65.25 110.714 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.79 -47.49 80.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 73.42 110.484 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.13 -57.57 10.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.619 -0.719 . . . . 43.22 111.094 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.6 mmtt -64.95 -36.98 86.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 63.34 111.236 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 31' ' ' PHE . 74.7 t -64.07 -41.72 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.96 0.41 . . . . 74.14 110.735 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.2 p -86.24 -9.96 55.52 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.31 -0.405 . . . . 53.41 111.702 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.3 t -74.42 -2.96 27.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.281 0.233 . . . . 74.54 111.556 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.612 ' SG ' HD11 ' A' ' 44' ' ' ILE . 59.3 m -70.05 134.21 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.612 -0.267 . . . . 55.23 111.157 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -65.97 -78.03 0.06 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.833 -0.803 . . . . 72.42 108.833 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -162.49 156.43 21.01 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.316 -0.624 . . . . 63.42 109.316 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.659 ' HA ' ' HE2' ' A' ' 103' ' ' LYS . 53.2 m-20 62.06 13.08 5.42 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.1 0.56 . . . . 72.45 111.915 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 49.6 mm -86.85 106.65 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.897 -0.409 . . . . 70.51 109.897 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.51 109.13 16.45 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.804 -0.635 . . . . 72.33 109.437 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.612 HD11 ' SG ' ' A' ' 38' ' ' CYS . 46.3 mt -92.0 121.93 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.576 . . . . 72.45 110.836 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.564 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.7 mp -103.66 110.92 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.226 -0.657 . . . . 73.21 109.226 173.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.95 107.21 19.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.067 -0.345 . . . . 72.45 110.067 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.29 96.49 1.43 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.993 -0.743 . . . . 62.13 108.993 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 35.7 t80 -60.84 99.35 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.175 -0.92 . . . . 65.22 111.579 -172.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.454 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 59.05 -82.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.632 -0.713 . . . . 74.34 111.863 173.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 51' ' ' PRO . . . 53.69 48.3 4.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.185 0.594 . . . . 54.33 111.856 -175.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 50' ' ' ALA . 2.8 Cg_exo -75.29 -19.88 16.83 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.541 2.16 . . . . 64.33 112.345 -173.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -75.3 -38.58 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 73.15 110.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 8.3 t 54.95 82.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.441 -0.799 . . . . 63.3 111.084 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.93 -78.81 1.12 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.582 -0.607 . . . . 43.4 111.582 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.471 ' O ' HD23 ' A' ' 59' ' ' LEU . 6.0 Cg_exo -76.51 11.77 1.79 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.212 2.608 . . . . 54.22 111.81 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 5.6 p -63.73 -23.6 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.598 -0.728 . . . . 71.35 111.325 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -54.43 -52.48 61.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.492 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.553 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 14.9 m -75.29 -48.14 24.62 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.87 0.843 . . . . 70.35 111.806 178.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.1 mm? -68.09 -28.1 67.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 64.1 112.516 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 34.2 tt0 -58.56 -59.88 12.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.98 -0.378 . . . . 65.12 109.98 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 37.1 Cg_endo -66.04 -37.1 27.25 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.67 1.58 . . . . 64.23 112.107 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.87 -45.32 86.49 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.273 -0.571 . . . . 75.21 110.823 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 119' ' ' ILE . 84.8 mt -66.04 -41.18 91.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.416 -0.356 . . . . 74.14 110.678 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 51.9 mt-10 -57.41 -41.42 80.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.727 0.299 . . . . 65.51 110.344 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.04 -56.07 22.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.304 -0.407 . . . . 74.54 111.264 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.55 -34.71 71.32 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 74.51 109.902 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.11 -49.15 71.05 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.509 -0.769 . . . . 43.32 110.571 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.8 mt-30 -62.27 -41.56 98.58 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.004 0.43 . . . . 74.13 110.725 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -68.25 -38.49 81.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 75.41 110.937 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -104.49 4.18 32.84 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.347 0.499 . . . . 75.22 112.347 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.4 t -54.03 -19.66 5.17 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.785 0.661 . . . . 63.31 112.785 -172.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -61.3 -36.64 80.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.043 0.449 . . . . 74.02 110.094 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -120.57 -4.49 9.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.877 -0.601 . . . . 60.25 111.281 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.472 HG13 HD13 ' A' ' 45' ' ' LEU . 43.8 t -123.02 148.15 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.016 0.436 . . . . 74.22 111.569 -174.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.2 tptm -149.44 133.15 16.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.773 -0.649 . . . . 71.33 109.41 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 45' ' ' LEU . 52.6 mt -108.99 135.76 46.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.888 0.375 . . . . 73.14 111.082 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 49.3 m-85 -130.77 168.04 17.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.734 -0.666 . . . . 62.14 110.176 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB2' ' HZ2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -174.18 153.46 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 62.33 109.997 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tp -121.02 119.68 60.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.51 -0.922 . . . . 75.13 108.51 170.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -94.96 44.31 1.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.23 -0.441 . . . . 60.11 111.689 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.0 pt -71.05 78.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 122.105 0.955 . . . . 65.23 109.409 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -47.48 -44.69 25.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 113.9 -1.5 . . . . 64.21 114.092 -167.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.726 0.298 . . . . 63.52 111.393 -173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.41 51.61 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 73.53 110.136 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -85.53 3.17 41.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.97 -0.559 . . . . 73.43 111.986 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.49 -39.0 64.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.19 0.519 . . . . 63.32 110.055 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.03 -34.45 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.195 -0.912 . . . . 71.01 110.495 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HB2' ' HE2' ' A' ' 48' ' ' PHE . . . -64.46 -52.08 59.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.212 -0.449 . . . . 74.24 110.301 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.8 m -62.25 -32.72 73.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 72.42 111.034 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -53.89 16.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.466 -0.334 . . . . 52.44 111.346 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -79.51 -10.24 59.76 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.507 -0.315 . . . . 63.04 111.732 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.23 43.01 5.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.926 -0.654 . . . . 65.55 113.558 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.98 135.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.52 -0.548 . . . . 75.31 109.52 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.8 m -133.04 1.42 3.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.057 0.391 . . . . 63.12 112.057 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.98 156.57 47.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.016 0.436 . . . . 52.44 111.635 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 pt -125.98 122.02 24.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.749 -0.659 . . . . 75.51 110.074 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.31 -172.62 9.13 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.737 -1.36 . . . . 64.14 112.647 -0.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.51 HG23 HD13 ' A' ' 112' ' ' ILE . 47.2 m -145.06 128.29 16.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.501 -0.772 . . . . 74.0 109.177 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 47.6 mm -110.13 116.08 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.578 0.228 . . . . 62.41 111.018 -174.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.3 mt -99.02 123.48 43.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.312 -0.625 . . . . 72.51 109.312 174.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 28.3 mtt -97.96 144.38 27.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.203 -0.295 . . . . 65.12 110.203 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.43 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -143.6 144.83 32.09 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.003 -0.369 . . . . 73.14 110.003 175.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 41' ' ' ASN . 52.9 tttm -131.82 105.2 7.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.092 -0.243 . . . . 74.24 110.57 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 59.1 t30 58.9 30.67 20.46 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.717 0.77 . . . . 72.22 110.199 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.74 -16.37 54.62 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.614 -0.721 . . . . 43.11 112.517 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 2.4 tmmm? -76.1 140.19 41.71 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 109.608 -0.515 . . . . 63.04 109.608 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 106' ' ' LYS . 2.3 tmtp? -57.68 139.09 54.6 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.196 0.935 . . . . 71.43 110.742 -176.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -146.51 168.36 21.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.967 -1.015 . . . . 61.41 108.636 -171.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 m -70.32 175.45 4.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.601 0.963 . . . . 72.41 113.601 -161.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -141.01 142.03 34.28 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.956 -1.02 . . . . 74.54 110.769 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 15.3 t -123.55 114.56 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.995 -1.457 . . . . 70.11 109.946 -174.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.51 HD13 HG23 ' A' ' 98' ' ' THR . 46.2 mm -106.71 121.1 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.763 -0.653 . . . . 62.14 109.972 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.03 163.96 33.69 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.433 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.513 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -85.6 79.99 9.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.288 . . . . 33.13 111.021 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.7 t70 -124.52 91.9 3.54 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.398 -0.593 . . . . 64.24 109.398 175.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.57 -31.94 52.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.883 -0.599 . . . . 62.15 111.205 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.6 t -62.7 -44.08 97.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.16 -0.473 . . . . 72.2 109.978 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -70.52 -37.47 74.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 55.14 109.952 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.506 HG12 HG11 ' A' ' 111' ' ' VAL . 72.8 mt -56.74 -56.27 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.257 -0.429 . . . . 62.22 110.674 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.523 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.54 -37.91 81.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 110.22 -0.289 . . . . 72.14 110.22 -177.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.523 ' HA ' HD21 ' A' ' 124' ' ' ASN . 22.9 t -56.99 -51.97 67.13 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.937 -0.394 . . . . 43.12 109.937 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.49 -41.83 97.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.121 -0.49 . . . . 73.04 110.755 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.1 mt -53.06 -56.18 9.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.625 0.25 . . . . 73.41 110.412 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.523 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.0 p30 -71.57 -35.46 70.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.718 -0.393 . . . . 70.22 110.727 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -63.97 -35.18 79.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 72.2 111.208 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.421 ' HB3' HD11 ' A' ' 108' ' ' LEU . 84.8 m-20 -91.21 -31.15 16.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 71.2 111.707 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 123' ' ' ILE . 71.9 mt -58.55 -53.26 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 54.51 110.599 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 . . . . . 0 C--O 1.25 1.11 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.358 -175.556 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.937 -0.394 . . . . 75.42 109.937 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.81 149.61 20.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.347 -0.388 . . . . 34.04 110.613 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -157.11 132.07 8.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.997 -0.742 . . . . 65.04 108.997 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -129.76 147.33 51.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.033 0.444 . . . . 71.22 111.53 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -106.97 171.46 7.36 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.499 -0.926 . . . . 65.22 108.499 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.434 ' HB3' ' NE2' ' A' ' 85' ' ' GLN . 28.6 t-80 -148.03 89.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.307 0.575 . . . . 75.12 110.869 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -70.86 125.57 27.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.596 -0.729 . . . . 65.21 109.358 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.82 174.21 11.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.8 -0.182 . . . . 74.33 110.966 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.0 tpt -156.1 101.02 2.06 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.579 0.55 . . . . 73.11 110.031 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.78 9.78 14.26 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 116.069 -0.514 . . . . 70.45 112.409 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.518 ' HA ' ' NE1' ' A' ' 49' ' ' TRP . 73.7 m -70.41 80.34 0.55 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.391 0.615 . . . . 73.25 111.584 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.434 HD12 ' HZ2' ' A' ' 49' ' ' TRP . 1.0 OUTLIER -90.34 57.55 3.73 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.718 -0.845 . . . . 74.23 108.718 170.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -48.33 133.96 15.33 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.44 -1.254 . . . . 75.42 112.252 -173.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.33 160.32 24.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.46 -0.791 . . . . 52.13 110.034 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -132.05 160.22 36.55 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.796 -0.446 . . . . 70.34 109.796 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -117.42 95.39 4.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.933 0.397 . . . . 70.15 110.058 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -50.82 126.4 15.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.376 -0.829 . . . . 71.4 110.956 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.7 -164.77 12.08 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.777 -0.647 . . . . 74.21 111.616 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.48 32.75 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.853 2.369 . . . . 75.33 112.503 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.09 -46.31 3.12 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.245 -0.502 . . . . 31.0 111.934 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.7 m -66.61 79.38 0.11 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.184 0.516 . . . . 70.35 111.319 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.533 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 82.7 mmm -87.48 -16.03 35.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.714 -0.676 . . . . 71.32 109.832 175.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -78.92 133.69 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.404 -0.816 . . . . 62.2 110.3 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -94.18 155.36 17.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 70.14 110.111 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -119.0 139.45 51.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.028 -0.73 . . . . 71.41 109.028 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 31' ' ' PHE . 32.6 pt -141.75 159.72 21.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.031 0.444 . . . . 73.54 111.558 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.72 -168.52 33.78 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.475 -0.784 . . . . 75.43 112.203 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.12 -48.87 72.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.657 0.383 . . . . 65.03 111.451 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 t -72.0 -40.83 68.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.42 110.371 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.31 -23.92 64.58 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.267 -0.424 . . . . 75.54 111.08 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.5 t80 -49.97 -58.2 5.95 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.851 0.357 . . . . 65.25 110.288 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -56.4 -57.52 11.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.89 -0.596 . . . . 73.42 110.599 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.87 -50.44 63.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.719 -0.673 . . . . 43.22 111.453 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.3 mmtt -68.32 -41.82 80.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 63.34 111.561 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 44' ' ' ILE . 76.1 t -70.46 -36.26 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 111.791 0.293 . . . . 74.14 111.791 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.3 p -85.96 -37.32 19.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.833 0.309 . . . . 53.41 111.833 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.5 t -83.82 10.83 8.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.033 0.383 . . . . 74.54 112.033 -173.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.812 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 19.9 p -59.99 146.99 40.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 110.32 -0.252 . . . . 55.23 110.32 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -45.98 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.406 0.682 . . . . 72.42 111.996 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.75 122.62 3.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.419 -0.215 . . . . 63.42 110.419 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.536 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.8 OUTLIER 62.56 7.25 2.34 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.787 0.435 . . . . 72.45 112.024 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.26 137.46 22.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.872 0.367 . . . . 70.51 111.247 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -81.12 123.61 28.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.534 -0.913 . . . . 72.33 108.534 176.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 82.1 mt -115.44 121.57 67.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.266 -0.425 . . . . 72.45 110.207 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -109.86 113.08 25.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.111 -0.7 . . . . 73.21 109.111 175.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.25 105.0 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.946 -0.39 . . . . 72.45 109.946 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.92 127.89 32.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.81 -0.632 . . . . 62.13 110.692 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -94.59 125.82 39.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.528 -0.916 . . . . 65.22 108.528 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.518 ' NE1' ' HA ' ' A' ' 11' ' ' THR . 74.4 t-105 -53.49 139.8 30.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.17 0.509 . . . . 74.34 111.622 -174.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . -95.33 108.49 39.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.446 -0.797 . . . . 54.33 111.102 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 21.0 Cg_endo -60.74 -32.27 92.82 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.402 2.068 . . . . 64.33 111.061 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -101.16 93.08 5.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.485 -0.931 . . . . 73.15 108.485 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.468 ' C ' ' SG ' ' A' ' 56' ' ' CYS . 10.4 t -91.82 89.23 6.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 63.3 110.32 -174.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.49 -86.25 1.62 Allowed Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.735 -0.666 . . . . 43.4 111.449 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.72 -11.92 16.22 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.139 2.559 . . . . 54.22 112.153 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 53' ' ' CYS . 15.4 p -50.62 -43.59 56.93 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.534 -0.757 . . . . 71.35 110.948 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -54.89 -41.02 70.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.513 -0.767 . . . . 74.44 111.524 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.3 m -75.88 -53.39 8.51 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.991 0.9 . . . . 70.35 111.701 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -61.28 -44.42 97.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.853 -1.067 . . . . 64.1 111.914 -168.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.3 -52.63 73.07 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 119.516 -0.278 . . . . 65.12 111.336 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 58' ' ' SER . 17.7 Cg_endo -61.67 -31.66 86.58 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.512 1.475 . . . . 64.23 112.137 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 58' ' ' SER . 72.1 mt-30 -62.88 -35.98 81.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.185 -0.606 . . . . 75.21 109.75 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.79 -39.08 76.8 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.792 -0.64 . . . . 74.14 109.937 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 mt-10 -53.69 -47.74 70.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.801 -0.444 . . . . 65.51 109.801 175.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -58.79 -52.45 65.65 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.942 -0.572 . . . . 74.54 111.251 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 116' ' ' ILE . 48.9 mt -62.26 -34.89 77.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.912 0.387 . . . . 74.51 110.093 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.07 -43.41 95.55 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.946 -0.57 . . . . 43.32 109.99 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 51.3 mt-30 -64.86 -46.49 81.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.05 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -72.87 -34.41 66.71 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.996 0.427 . . . . 75.41 111.21 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -104.7 4.04 32.09 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.328 0.492 . . . . 75.22 112.328 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -53.32 -19.55 3.43 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.957 0.408 . . . . 63.31 111.536 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.63 -38.08 69.04 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.981 -0.554 . . . . 74.02 110.836 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -135.21 12.08 3.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.075 -0.511 . . . . 60.25 111.331 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.55 139.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.064 0.459 . . . . 74.22 111.617 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -143.63 119.93 10.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.419 -0.81 . . . . 71.33 109.187 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 45' ' ' LEU . 40.5 mt -104.8 137.25 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.715 0.293 . . . . 73.14 110.706 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.45 151.15 40.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.935 -0.575 . . . . 62.14 109.895 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -120.8 102.74 8.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.624 -0.88 . . . . 62.33 108.624 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.7 tt -80.47 102.2 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.613 0.72 . . . . 75.13 110.134 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.82 75.46 10.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 60.11 111.172 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.403 HD11 HG11 ' A' ' 87' ' ' VAL . 29.5 pt -124.03 24.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.011 -0.737 . . . . 65.23 109.011 171.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -58.02 -18.64 25.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.552 -1.204 . . . . 64.21 111.561 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.16 -23.23 62.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.317 0.58 . . . . 63.52 109.661 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.35 95.25 7.94 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.508 -0.923 . . . . 73.53 108.508 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' NE2' ' HB3' ' A' ' 6' ' ' HIS . 25.6 tt0 -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.211 -0.45 . . . . 73.43 111.667 -172.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 14.5 m-20 -56.61 -32.96 65.79 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.471 -0.331 . . . . 63.32 111.286 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 81' ' ' ILE . 75.0 t -53.06 -38.63 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.467 -0.333 . . . . 71.01 110.537 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.7 -48.81 75.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.17 0.509 . . . . 74.24 109.827 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -59.34 -36.99 76.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.486 -0.779 . . . . 72.42 110.726 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 11.6 mm-40 -71.7 -51.27 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.006 -0.543 . . . . 52.44 110.492 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -73.98 -13.32 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.221 -0.445 . . . . 63.04 111.548 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.8 21.44 36.57 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.904 -0.665 . . . . 65.55 112.777 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.478 HG13 ' OG1' ' A' ' 98' ' ' THR . 64.5 t -70.42 117.28 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.156 -0.312 . . . . 75.31 110.156 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 t -136.45 8.03 3.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 63.12 110.985 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.597 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -147.18 164.06 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.794 -0.447 . . . . 52.44 109.794 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.618 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -122.51 122.0 27.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.439 -0.346 . . . . 75.51 111.207 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 66.5 Cg_endo -87.06 -166.78 3.92 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.825 -1.323 . . . . 64.14 112.022 -3.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 112' ' ' ILE . 81.5 m -138.92 120.35 14.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.535 -0.302 . . . . 74.0 110.202 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 111' ' ' VAL . 47.5 mm -110.35 117.34 54.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.86 -0.609 . . . . 62.41 110.881 -174.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -100.59 123.22 44.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.535 -0.543 . . . . 72.51 109.535 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 109' ' ' SER . 11.6 mmt -87.65 148.08 24.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.686 0.279 . . . . 65.12 110.42 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.6 m-85 -145.45 160.99 40.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.956 -0.757 . . . . 73.14 108.956 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -148.79 109.46 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.621 0.248 . . . . 74.24 110.88 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.812 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER 59.9 31.84 20.91 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.746 -0.661 . . . . 72.22 110.352 177.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.494 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 87.52 -14.43 58.06 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.918 -0.583 . . . . 43.11 112.411 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -81.76 139.56 34.76 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 110.301 -0.259 . . . . 63.04 110.301 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -58.88 149.6 26.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.812 -0.631 . . . . 71.43 111.511 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -154.39 168.01 28.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.127 0.971 . . . . 61.41 108.845 -170.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 101' ' ' MET . 3.1 m -70.35 148.17 48.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.571 0.7 . . . . 72.41 112.875 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -110.14 118.52 36.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 74.54 110.204 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.647 HG23 ' HB ' ' A' ' 99' ' ' ILE . 16.5 m -101.62 116.0 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 70.11 109.527 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.597 HG22 ' HB3' ' A' ' 95' ' ' ALA . 47.4 mt -107.59 120.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 62.14 110.577 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.11 160.84 12.44 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.246 -0.502 . . . . 60.32 112.238 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.76 83.42 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 33.13 111.017 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 119' ' ' ILE . 10.5 t70 -133.75 92.22 2.94 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.344 -0.613 . . . . 64.24 109.344 174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.536 HD11 HD11 ' A' ' 66' ' ' LEU . 8.8 tp -62.3 -32.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 62.15 111.413 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -65.29 -43.62 90.54 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.151 0.501 . . . . 72.2 110.065 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 14.8 tppt? -68.38 -43.13 78.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.935 -0.575 . . . . 55.14 110.19 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 59' ' ' LEU . 70.8 mt -57.25 -51.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.709 -0.223 . . . . 62.22 110.676 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.522 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.02 -35.63 75.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.957 -0.386 . . . . 72.14 109.957 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.5 t -54.11 -51.23 64.86 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.147 0.498 . . . . 43.12 110.094 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 12.7 mm-40 -71.09 -31.84 68.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 73.04 110.766 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 120' ' ' ILE . 88.7 mt -58.15 -56.26 17.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.902 0.382 . . . . 73.41 110.037 176.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -65.8 -36.58 83.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.76 -0.459 . . . . 70.22 109.76 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -58.71 -41.57 86.65 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.097 -0.501 . . . . 72.2 110.966 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.403 ' HB2' HD11 ' A' ' 43' ' ' LEU . 81.5 m-20 -87.2 -12.75 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 71.2 111.371 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 123' ' ' ILE . 74.3 mt -80.88 -48.36 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.032 -0.359 . . . . 54.51 110.032 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.464 -0.779 . . . . 71.43 110.739 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.944 0.402 . . . . 75.42 110.622 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.63 110.54 22.94 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.1 -0.5 . . . . 34.04 110.274 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -140.23 121.16 14.56 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.898 0.38 . . . . 65.04 110.561 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 68.23 74.38 0.28 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.144 -0.934 . . . . 71.22 111.959 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -131.48 94.99 3.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.324 -0.991 . . . . 65.22 108.324 171.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -61.44 105.72 0.55 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.092 -0.504 . . . . 75.12 112.217 -171.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -92.07 88.81 6.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.4 -0.592 . . . . 65.21 109.4 172.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -158.17 107.73 2.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.616 . . . . 74.33 110.742 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.458 ' C ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -105.54 165.88 10.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.216 -0.661 . . . . 73.11 109.216 172.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.69 115.75 1.13 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.112 -0.566 . . . . 70.45 112.079 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.9 p -96.05 9.35 41.08 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.071 0.463 . . . . 73.25 111.121 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 12' ' ' LEU . 2.5 pt? -82.91 27.65 0.53 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.244 0.545 . . . . 74.23 110.794 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -64.96 -21.14 66.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.82 -0.627 . . . . 75.42 111.593 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.02 134.76 54.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.376 . . . . 52.13 111.204 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.671 ' HA ' HE21 ' A' ' 15' ' ' GLN . 0.0 OUTLIER -98.24 -2.5 39.51 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.124 -0.695 . . . . 70.34 109.124 173.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.1 m -60.49 102.58 0.19 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.23 -0.896 . . . . 70.15 111.478 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -120.79 173.58 7.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.075 -0.511 . . . . 71.4 109.902 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.92 -163.47 33.99 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.299 -0.477 . . . . 74.21 112.482 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.72 19.5 1.2 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.95 2.433 . . . . 75.33 112.782 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.36 9.83 84.4 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.096 -0.573 . . . . 31.0 112.304 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.4 t -149.34 156.76 42.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.008 -0.367 . . . . 70.35 110.008 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.436 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 92.5 mmm -73.66 -20.63 60.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.26 -0.427 . . . . 71.32 110.725 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' A' ' 78' ' ' LYS . 18.3 mm -78.13 87.98 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.744 -0.835 . . . . 62.2 108.744 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.06 112.12 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.635 -0.711 . . . . 70.14 111.341 -171.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -72.83 132.36 43.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.692 -0.485 . . . . 71.41 109.692 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.53 HG21 ' HG3' ' A' ' 34' ' ' LYS . 39.0 pt -133.12 160.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.794 0.33 . . . . 73.54 110.952 -176.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.22 -177.36 40.45 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.921 -0.581 . . . . 75.43 112.95 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.01 -43.24 99.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.96 0.504 . . . . 65.03 111.622 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m -74.09 -37.17 64.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.074 0.464 . . . . 74.42 110.67 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.85 -26.74 68.75 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.783 -0.644 . . . . 75.54 110.762 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.456 ' HD2' HG21 ' A' ' 79' ' ' ILE . 88.8 t80 -46.14 -61.66 1.67 Allowed 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.33 0.394 . . . . 65.25 111.122 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -50.31 69.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.914 -0.585 . . . . 73.42 110.891 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.75 -57.39 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.74 . . . . 43.22 110.75 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.4 mmtt -58.01 -44.19 87.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.12 -0.945 . . . . 63.34 111.181 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.04 -48.13 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.714 0.292 . . . . 74.14 111.313 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.4 p -77.43 -15.28 59.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.701 0.286 . . . . 53.41 111.595 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 t -69.55 -5.38 23.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.322 -0.399 . . . . 74.54 111.983 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 13.4 p -62.41 108.63 1.15 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.621 0.248 . . . . 55.23 110.501 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -58.43 -73.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.185 -0.462 . . . . 72.42 111.625 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -153.97 121.89 6.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.7 0.286 . . . . 63.42 110.913 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 61.3 8.3 2.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.6 0.76 . . . . 72.45 111.968 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -73.89 113.85 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.245 -0.434 . . . . 70.51 110.123 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -82.21 119.26 23.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.103 -0.499 . . . . 72.33 109.656 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.45 119.98 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.596 -0.729 . . . . 72.45 110.483 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -103.95 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.052 -0.721 . . . . 73.21 109.052 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 98.3 t -115.71 109.57 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.07 -0.344 . . . . 72.45 110.07 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.3 t70 -87.0 127.86 35.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 62.13 111.949 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -101.46 87.31 3.16 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.393 -0.595 . . . . 65.22 109.393 170.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.37 119.84 11.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.408 -0.815 . . . . 74.34 110.508 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 144.4 29.61 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.446 . . . . 54.33 110.397 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.51 -34.38 85.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.701 2.267 . . . . 64.33 112.523 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -119.76 119.16 32.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 73.15 110.087 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' ' HB ' ' A' ' 96' ' ' ILE . 47.9 t -163.88 140.79 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.3 110.567 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.03 -72.14 1.21 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.216 -0.447 . . . . 43.4 112.652 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.35 -22.36 20.5 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.056 2.504 . . . . 54.22 113.29 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 98.3 m -54.17 -24.91 19.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.57 -0.286 . . . . 71.35 111.375 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -53.95 -49.95 67.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.38 0.61 . . . . 74.44 110.165 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 12.6 m -75.0 -40.72 60.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.399 -0.819 . . . . 70.35 111.079 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.4 mm? -62.42 -41.6 98.82 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.774 0.657 . . . . 64.1 112.774 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -55.43 -54.64 48.82 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 117.873 0.306 . . . . 65.12 111.272 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HG2' ' O ' ' A' ' 58' ' ' SER . 21.1 Cg_endo -63.15 -35.73 62.36 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.524 1.483 . . . . 64.23 112.005 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.9 mt-30 -64.01 -31.12 72.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.643 -0.423 . . . . 75.21 110.584 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 76.0 mt -70.0 -42.02 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 74.14 109.982 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -63.53 -34.02 76.87 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 120.866 -0.334 . . . . 65.51 110.337 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 36.7 ttmt -55.6 -57.18 13.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.784 0.326 . . . . 74.54 110.298 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD12 ' A' ' 123' ' ' ILE . 33.0 mt -66.61 -38.42 86.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 74.51 110.367 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.32 -45.86 90.17 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.733 -0.667 . . . . 43.32 110.515 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.436 ' HG2' ' HG3' ' A' ' 22' ' ' MET . 16.8 mm-40 -69.85 -46.08 66.34 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.393 -0.367 . . . . 74.13 110.956 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.75 -41.95 82.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.856 -0.611 . . . . 75.41 110.953 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -104.66 4.3 32.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.687 -0.688 . . . . 75.22 112.235 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.1 t -53.16 -21.69 5.38 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.612 0.967 . . . . 63.31 113.612 -170.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -73.53 -18.7 61.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.797 0.332 . . . . 74.02 110.925 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.439 HD22 HG12 ' A' ' 127' ' ' ILE . 5.9 t30 -135.1 5.05 3.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.262 -0.426 . . . . 60.25 110.896 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 43' ' ' LEU . 43.5 t -139.34 145.26 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.913 0.387 . . . . 74.22 111.33 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -148.69 128.29 13.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 71.33 109.541 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.569 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.0 mt -106.56 128.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 120.852 0.358 . . . . 73.14 110.479 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -110.63 168.22 9.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.836 -0.62 . . . . 62.14 109.934 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 23' ' ' ILE . 22.6 ttmm -135.05 99.27 4.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.219 -0.66 . . . . 62.33 109.219 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -119.31 97.04 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.861 0.838 . . . . 75.13 108.942 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -150.49 94.9 2.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.193 -0.912 . . . . 60.11 110.089 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.7 mp -72.98 109.93 5.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.595 -0.891 . . . . 65.23 108.595 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.89 -31.09 68.28 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.059 0.457 . . . . 64.21 110.464 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.69 -19.08 49.83 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.946 -0.57 . . . . 63.52 111.608 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' H ' HG22 ' A' ' 81' ' ' ILE . 32.8 t30 -119.7 79.84 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.4 0.619 . . . . 73.53 110.132 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.78 -21.84 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.444 -0.798 . . . . 73.43 111.06 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 26.2 t70 -45.77 -47.62 15.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.011 -0.54 . . . . 63.32 111.809 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.66 -42.02 49.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.314 -0.403 . . . . 71.01 110.988 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.84 -45.02 87.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 74.24 110.551 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.1 m -68.39 -29.86 68.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 72.42 110.587 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.1 mm100 -70.49 -46.47 63.67 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.356 -0.384 . . . . 52.44 111.089 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -79.91 -17.19 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 63.04 111.092 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.06 64.46 0.95 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.772 -0.728 . . . . 65.55 113.091 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.427 HG13 ' OG1' ' A' ' 98' ' ' THR . 91.5 t -97.04 133.15 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.399 -0.593 . . . . 75.31 109.399 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.2 m -138.71 -64.68 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.472 -0.331 . . . . 63.12 110.833 -175.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -85.49 170.57 12.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.343 -0.39 . . . . 52.44 110.488 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -110.97 118.63 47.76 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.08 -0.509 . . . . 75.51 111.718 -175.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 61.8 Cg_endo -92.62 -160.25 0.99 Allowed 'Cis proline' 0 C--N 1.352 0.738 0 C-N-CA 123.957 -1.268 . . . . 64.14 111.3 -6.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 112' ' ' ILE . 87.9 m -137.27 129.33 29.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.145 -0.317 . . . . 74.0 110.145 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.97 120.34 62.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.944 -0.571 . . . . 62.41 110.729 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 27.3 mt -88.23 146.55 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.208 -0.664 . . . . 72.51 109.208 172.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.537 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 14.6 mmt -112.37 143.24 43.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.54 -0.541 . . . . 65.12 109.54 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 89.2 m-85 -144.36 151.2 38.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.044 -0.724 . . . . 73.14 109.044 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.79 125.17 5.7 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.363 -0.535 . . . . 74.24 111.086 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 60.94 29.26 18.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.308 0.575 . . . . 72.22 110.836 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 38' ' ' CYS . . . 71.32 11.59 71.61 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.833 -0.621 . . . . 43.11 112.023 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -98.69 144.95 27.39 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.157 -0.682 . . . . 63.04 109.157 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -74.1 118.61 17.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.716 0.769 . . . . 71.43 109.768 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 3.5 mm? -113.57 169.59 8.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.19 -1.368 . . . . 61.41 110.204 -175.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 101' ' ' MET . 8.0 m -69.49 -177.39 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.487 0.715 . . . . 72.41 112.432 -163.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 51.1 tt0 -141.63 136.27 30.81 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.301 1.048 . . . . 74.54 111.366 -172.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.86 107.27 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 113.335 -1.757 . . . . 70.11 109.332 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 95' ' ' ALA . 50.4 mt -105.66 118.73 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.051 -0.352 . . . . 62.14 110.051 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.09 151.71 11.01 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.164 -0.471 . . . . 60.32 112.102 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.93 80.17 1.17 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.145 0.498 . . . . 33.13 111.134 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 119' ' ' ILE . 63.5 t0 -126.41 89.85 3.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 64.24 109.849 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.19 -33.37 50.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.838 -0.619 . . . . 62.15 110.831 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.3 t -63.64 -46.29 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.91 -0.586 . . . . 72.2 109.905 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.442 ' NZ ' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -66.37 -38.56 87.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 55.14 110.003 -179.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 115' ' ' ASP . 78.0 mt -61.88 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.104 -0.498 . . . . 62.22 111.119 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.414 HD13 HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -61.66 -40.04 85.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.819 0.342 . . . . 72.14 110.089 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.554 ' HA ' HD21 ' A' ' 124' ' ' ASN . 30.7 t -54.92 -50.95 67.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.639 -0.709 . . . . 43.12 109.825 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.43 -33.06 74.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 73.04 111.528 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 119' ' ' ILE . 98.0 mt -61.23 -56.17 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 120.308 -0.557 . . . . 73.41 109.857 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.554 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.0 p30 -70.41 -25.26 63.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.842 -0.343 . . . . 70.22 110.801 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -69.99 -53.63 16.83 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.061 -0.518 . . . . 72.2 110.685 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -80.72 -18.51 47.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.008 0.373 . . . . 71.2 112.008 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 123' ' ' ILE . 49.9 mt -63.18 -49.98 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.084 0.469 . . . . 54.51 109.917 170.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.448 -0.787 . . . . 71.43 110.091 -178.606 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.161 -0.311 . . . . 75.42 110.161 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.13 94.49 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.024 0.44 . . . . 34.04 111.455 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.11 16.62 2.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.938 -0.574 . . . . 65.04 110.277 173.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -71.59 132.27 44.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.104 -0.498 . . . . 71.22 110.272 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -69.54 165.27 21.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.958 -0.565 . . . . 65.22 111.555 -175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -139.43 153.5 47.6 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.853 -0.612 . . . . 75.12 110.166 -176.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -62.05 97.94 0.09 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.812 -0.81 . . . . 65.21 108.812 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 95' ' ' ALA . 33.4 p-80 -107.75 13.72 26.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.582 -0.736 . . . . 74.33 112.83 -164.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.1 64.37 4.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.736 0.779 . . . . 73.11 110.222 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.82 57.37 0.57 Allowed Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.347 -0.842 . . . . 70.45 111.748 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.707 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 8.8 t -129.1 151.45 49.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.65 -0.5 . . . . 73.25 109.65 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -129.17 -92.58 0.45 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.488 0.185 . . . . 74.23 111.294 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -152.87 134.2 14.31 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.789 0.328 . . . . 75.42 110.727 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.44 172.23 18.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.891 -0.595 . . . . 52.13 109.521 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -169.67 126.3 0.87 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.098 -0.334 . . . . 70.34 110.098 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 p 46.08 29.2 0.74 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.741 0.651 . . . . 70.15 111.281 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -101.58 119.42 38.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.73 -0.668 . . . . 71.4 111.209 -171.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.434 ' H ' ' HD3' ' A' ' 19' ' ' PRO . . . 154.06 59.51 0.01 OUTLIER Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.732 -0.667 . . . . 74.21 111.651 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' ' H ' ' A' ' 18' ' ' GLY . 67.4 Cg_endo -83.47 -174.54 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.19 2.593 . . . . 75.33 113.148 -173.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.82 124.47 35.65 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.761 -0.654 . . . . 31.0 112.135 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 p -156.89 -173.2 4.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.111 -0.329 . . . . 70.35 110.111 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.63 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 62.4 mmm -57.95 -20.53 38.4 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.603 0.24 . . . . 71.32 110.847 175.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -68.7 84.52 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.497 -0.927 . . . . 62.2 108.497 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.19 112.23 2.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.085 -0.961 . . . . 70.14 110.682 -169.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.93 131.35 35.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.005 -0.543 . . . . 71.41 110.732 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 33.0 pt -136.87 162.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.534 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.39 174.64 36.89 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.145 -0.55 . . . . 75.43 111.868 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.9 -47.8 73.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.007 0.432 . . . . 65.03 110.176 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 m -59.45 -25.19 64.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.649 -0.705 . . . . 74.42 111.252 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 24.3 mm-40 -88.58 -20.03 25.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 75.54 111.56 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -55.89 -61.7 2.2 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.727 0.298 . . . . 65.25 110.978 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.77 -48.97 79.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 73.42 109.945 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -49.87 -57.3 7.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.068 -0.969 . . . . 43.22 111.48 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -66.94 -43.97 81.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.066 -0.515 . . . . 63.34 111.278 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.85 -38.85 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.715 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.5 p -86.37 -31.07 21.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.222 0.453 . . . . 53.41 112.222 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 t -82.01 -8.64 59.68 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.407 0.521 . . . . 74.54 112.407 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 10.9 p -58.48 129.52 42.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.001 -0.279 . . . . 55.23 110.251 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -49.94 -74.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.68 0.622 . . . . 72.42 112.68 -168.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -161.7 131.71 4.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.919 -0.128 . . . . 63.42 110.716 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 51.86 25.67 3.15 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.659 0.6 . . . . 72.45 112.421 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.6 mm -83.41 99.18 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.462 -0.57 . . . . 70.51 109.462 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HB3' HG22 ' A' ' 74' ' ' VAL . 59.2 tp -67.72 107.4 2.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.669 . . . . 72.33 110.205 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -94.18 118.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 72.45 110.517 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 76' ' ' ILE . 6.2 mp -100.26 108.27 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.5 -0.555 . . . . 73.21 109.5 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.29 104.98 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.312 -0.625 . . . . 72.45 109.312 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' THR . 37.3 t0 -91.6 145.16 24.82 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.162 -0.472 . . . . 62.13 110.069 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 100' ' ' LEU . 10.1 m-85 -103.2 92.17 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.016 -0.538 . . . . 65.22 110.202 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -86.48 168.63 13.57 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.615 -0.72 . . . . 74.34 111.004 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.03 154.95 10.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.331 -0.849 . . . . 54.33 108.778 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.74 -38.02 21.95 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.841 2.361 . . . . 64.33 111.795 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -123.92 84.13 2.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.565 -0.902 . . . . 73.15 108.565 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -52.31 5.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.424 -0.353 . . . . 63.3 111.469 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.558 ' N ' ' SG ' ' A' ' 56' ' ' CYS . . . 151.66 -116.86 0.78 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.703 -0.76 . . . . 43.4 112.717 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.707 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.9 Cg_exo -79.54 37.01 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.365 2.71 . . . . 54.22 111.384 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 1.8 m -59.94 -35.54 75.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.095 -0.957 . . . . 71.35 111.156 -171.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -54.18 -44.2 71.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.959 -0.564 . . . . 74.44 111.378 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.637 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.2 m -74.75 -42.98 57.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.635 0.731 . . . . 70.35 110.5 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 4.3 mm? -72.24 -17.57 61.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 64.1 111.982 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 44.9 mt-10 -56.93 -63.94 3.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.529 -0.545 . . . . 65.12 109.529 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 53.4 Cg_endo -68.66 -35.4 16.8 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.595 1.53 . . . . 64.23 112.179 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.6 mt-30 -63.33 -46.73 85.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.335 -0.546 . . . . 75.21 111.465 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.5 mt -70.32 -43.25 70.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.874 -0.148 . . . . 74.14 110.666 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.63 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 35.4 mt-10 -59.07 -35.78 73.95 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.16 -0.311 . . . . 65.51 110.16 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.19 -57.21 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 74.54 110.458 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 123' ' ' ILE . 41.6 mt -62.44 -32.58 73.46 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.306 -0.406 . . . . 74.51 109.947 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.65 -51.71 57.38 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.866 -0.606 . . . . 43.32 110.547 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -67.23 -30.32 70.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.747 0.308 . . . . 74.13 111.296 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -81.32 -38.31 26.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.101 -0.5 . . . . 75.41 110.818 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -104.87 5.39 32.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.959 -0.564 . . . . 75.22 112.142 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 9.8 t -53.47 -19.8 4.06 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.424 0.527 . . . . 63.31 112.424 -173.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.445 ' HG3' HD22 ' A' ' 73' ' ' ASN . 9.2 pt-20 -62.4 -32.66 73.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.808 0.337 . . . . 74.02 111.101 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.445 HD22 ' HG3' ' A' ' 72' ' ' GLU . 55.6 m-80 -133.56 14.04 4.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.277 -0.419 . . . . 60.25 110.748 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' THR . 50.5 t -140.84 142.57 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.965 0.412 . . . . 74.22 111.76 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -149.89 127.75 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.8 -0.637 . . . . 71.33 109.501 170.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.0 mt -99.14 122.21 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.099 -0.334 . . . . 73.14 110.099 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -110.81 155.42 22.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.322 -0.399 . . . . 62.14 110.137 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -137.83 130.87 30.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 81' ' ' ILE . 14.0 pt -79.07 149.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.025 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -74.8 30.18 0.09 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.929 0.395 . . . . 60.11 111.871 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.7 mm -99.01 19.19 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.481 0.657 . . . . 65.23 109.691 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.74 -19.03 24.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.677 -0.692 . . . . 64.21 112.231 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.14 -6.79 54.99 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.614 0.245 . . . . 63.52 111.547 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.455 ' HB2' HG22 ' A' ' 81' ' ' ILE . 30.5 m-80 -119.58 88.32 2.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.797 0.332 . . . . 73.53 110.717 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -64.72 -30.87 71.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.609 -0.515 . . . . 73.43 109.609 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 5.1 m-20 -43.55 -51.44 6.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.33 -0.85 . . . . 63.32 110.999 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.33 -36.16 51.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.46 -0.791 . . . . 71.01 111.054 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -63.93 -50.95 66.65 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.309 0.576 . . . . 74.24 109.674 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -60.38 -34.4 73.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.341 -0.845 . . . . 72.42 110.808 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.8 mm100 -60.71 -55.15 36.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.958 0.409 . . . . 52.44 110.369 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -73.57 -15.24 61.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.199 -0.455 . . . . 63.04 112.21 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.44 0.69 18.38 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.506 -0.854 . . . . 65.55 112.99 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 88.4 t -67.78 109.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.047 0.451 . . . . 75.31 109.947 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 t -97.04 -7.12 33.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.856 -0.611 . . . . 63.12 111.404 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' HD2' ' A' ' 8' ' ' HIS . . . -152.44 158.66 42.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.973 -0.38 . . . . 52.44 109.973 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.8 pt -128.12 144.56 52.08 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 110.186 -0.301 . . . . 75.51 110.186 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 114' ' ' ALA . 8.1 Cg_exo -73.32 -179.71 25.95 Favored 'Cis proline' 0 C--N 1.354 0.847 0 C-N-CA 124.33 -1.113 . . . . 64.14 112.323 -3.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' ASP . 18.5 m -160.36 137.24 9.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 74.0 110.717 -178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.585 ' HB ' HG22 ' A' ' 111' ' ' VAL . 36.1 mm -109.92 110.87 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.533 -0.758 . . . . 62.41 111.307 -174.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' A' ' 48' ' ' PHE . 7.3 mp -96.39 123.26 39.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.106 -1.072 . . . . 72.51 108.106 168.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.477 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 44.4 mtt -98.76 143.29 29.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.501 . . . . 65.12 110.995 -175.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -142.81 146.13 33.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.394 -0.965 . . . . 73.14 108.394 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 107.21 4.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.482 -0.487 . . . . 74.24 110.859 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.596 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 23.0 t-20 58.96 28.32 17.48 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.746 0.784 . . . . 72.22 110.469 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.85 -16.22 59.89 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.612 -0.722 . . . . 43.11 112.596 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 13.4 tmtt? -75.33 141.32 43.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.997 -0.742 . . . . 63.04 108.997 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.518 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.59 124.35 25.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.437 0.637 . . . . 71.43 111.529 -175.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 101' ' ' MET . 4.0 mm? -120.46 168.08 11.69 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.393 1.077 . . . . 61.41 109.981 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.63 176.68 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.224 0.535 . . . . 72.41 111.913 -164.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -141.11 126.86 19.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 74.54 110.524 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 99' ' ' ILE . 35.5 m -114.21 130.06 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.695 -0.483 . . . . 70.11 109.695 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.5 mt -112.1 117.8 56.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.748 -0.66 . . . . 62.14 109.679 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.72 144.92 9.0 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.289 -0.724 . . . . 60.32 111.289 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.568 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . . . -83.21 72.34 10.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.852 0.358 . . . . 33.13 111.334 -176.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 119' ' ' ILE . 30.2 t70 -113.07 104.66 12.59 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.185 -0.461 . . . . 64.24 109.833 175.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 tp -60.94 -34.07 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.86 -0.609 . . . . 62.15 111.422 -173.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 120' ' ' ILE . 21.1 t -64.45 -50.11 68.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 72.2 110.105 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 57.9 tptt -61.74 -46.69 88.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 55.14 110.174 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 111' ' ' VAL . 77.4 mt -57.67 -51.08 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.489 . . . . 62.22 111.146 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.51 -39.99 87.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 110.1 -0.333 . . . . 72.14 110.1 -177.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.7 m -55.81 -50.69 69.82 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.924 -0.399 . . . . 43.12 109.924 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 61.5 mm-40 -62.62 -44.29 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 73.04 110.711 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 127' ' ' ILE . 89.7 mt -53.44 -56.39 8.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.603 0.239 . . . . 73.41 110.777 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -70.18 -32.0 69.74 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.624 -0.431 . . . . 70.22 110.322 -175.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -64.55 -33.8 76.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.906 -0.588 . . . . 72.2 111.361 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.99 -20.7 19.14 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 111.984 0.365 . . . . 71.2 111.984 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 123' ' ' ILE . 81.0 mt -71.49 -58.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.027 0.441 . . . . 54.51 110.028 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.247 -0.883 . . . . 71.43 110.249 -175.562 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.743 0.306 . . . . 75.42 110.551 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.13 62.92 5.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.262 0.553 . . . . 34.04 110.146 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -83.22 -9.19 59.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.617 -0.72 . . . . 65.04 110.775 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -75.72 87.64 2.77 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.988 0.423 . . . . 71.22 110.384 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -74.12 96.49 2.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.738 -0.838 . . . . 65.22 108.738 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -77.92 132.74 38.04 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.851 0.685 . . . . 75.12 112.851 -166.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -153.98 163.21 40.44 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.213 -0.903 . . . . 65.21 108.945 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -127.75 147.14 50.4 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.683 -0.488 . . . . 74.33 109.683 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.1 mtt -97.92 -67.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.982 0.42 . . . . 73.11 110.504 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.55 -176.02 38.52 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.121 -0.792 . . . . 70.45 111.121 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 t -158.39 159.28 35.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.991 0.396 . . . . 73.25 110.807 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.633 HD13 ' N ' ' A' ' 13' ' ' GLU . 2.5 tm? -154.02 151.23 29.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.695 -0.854 . . . . 74.23 108.695 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.633 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -133.54 91.99 2.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.41 0.624 . . . . 75.42 110.312 178.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' GLU . . . -76.24 -87.71 0.04 OUTLIER 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.19 -0.459 . . . . 52.13 110.171 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 174.11 158.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.389 -0.597 . . . . 70.34 109.389 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -158.91 162.74 36.92 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.852 -0.425 . . . . 70.15 109.852 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.431 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 51.6 tp60 -148.4 23.43 1.03 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.263 -0.643 . . . . 71.4 109.263 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.1 97.28 1.17 Allowed Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.575 -0.738 . . . . 74.21 112.232 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 17' ' ' GLN . 55.8 Cg_endo -89.92 37.53 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.22 2.614 . . . . 75.33 111.931 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.58 164.51 15.61 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.766 -0.652 . . . . 31.0 112.062 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p 169.68 163.88 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.313 0.645 . . . . 70.35 109.531 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 54.7 mmm -57.17 -27.63 62.08 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.418 -0.586 . . . . 71.32 109.418 170.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.511 HG23 HG22 ' A' ' 76' ' ' ILE . 12.1 mm -71.95 89.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.55 -1.278 . . . . 62.2 107.55 169.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.63 112.15 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.465 -0.789 . . . . 70.14 111.442 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.68 117.11 18.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.701 -0.681 . . . . 71.41 109.983 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 31' ' ' PHE . 26.9 pt -110.55 159.18 10.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.842 -0.617 . . . . 73.54 111.254 -172.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.88 -177.72 36.48 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.681 -0.691 . . . . 75.43 112.975 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.96 -56.92 10.08 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.734 0.814 . . . . 65.03 111.947 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -73.19 -18.59 61.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.944 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -83.9 -12.41 55.5 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.125 0.417 . . . . 75.54 112.125 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.3 t80 -58.19 -61.45 2.55 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.688 -0.486 . . . . 65.25 109.688 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.82 -52.82 61.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.689 -0.687 . . . . 73.42 110.745 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -55.98 -57.34 12.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.605 -0.725 . . . . 43.22 111.717 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -65.41 -34.13 77.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.027 -0.533 . . . . 63.34 111.552 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 31' ' ' PHE . 69.8 t -70.26 -36.32 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.604 0.24 . . . . 74.14 110.96 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.87 -13.32 48.29 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.671 0.272 . . . . 53.41 111.172 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -62.83 -10.08 11.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.424 0.528 . . . . 74.54 112.424 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 17.4 p -76.7 116.97 17.86 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.927 -0.483 . . . . 55.23 110.695 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.12 -78.04 0.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.035 -0.53 . . . . 72.42 111.359 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.68 127.62 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.519 0.2 . . . . 63.42 110.844 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.5 14.0 5.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.781 -0.645 . . . . 72.45 111.378 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.7 mm -81.72 120.39 33.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.197 -0.456 . . . . 70.51 109.854 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.38 123.85 28.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 72.33 109.963 -178.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 38' ' ' CYS . 44.2 mt -113.94 117.55 55.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 72.45 110.077 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HG ' ' SD ' ' A' ' 101' ' ' MET . 2.4 mp -105.37 126.15 51.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 100' ' ' LEU . 67.0 t -104.93 105.08 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.698 -0.482 . . . . 72.45 109.698 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.16 145.33 32.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 62.13 111.995 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 23.6 m-85 -108.57 98.57 8.06 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.402 -0.817 . . . . 65.22 109.181 169.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -42.96 139.06 1.83 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.901 -1.045 . . . . 74.34 112.484 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.54 112.7 56.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 54.33 111.083 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.39 -40.14 11.34 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.616 2.211 . . . . 64.33 111.256 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -164.75 139.89 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.149 -0.932 . . . . 73.15 109.399 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.8 p -166.33 -67.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 63.3 110.395 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.06 -94.87 0.16 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.992 -0.623 . . . . 43.4 112.927 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.91 -7.19 20.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.986 2.457 . . . . 54.22 113.249 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.584 ' SG ' ' HD3' ' A' ' 97' ' ' PRO . 5.3 m -55.11 -30.48 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.458 -0.337 . . . . 71.35 111.537 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -53.75 -30.59 44.98 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.231 -0.44 . . . . 74.44 111.574 -172.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 42.5 m -75.3 -37.26 60.91 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.349 0.595 . . . . 70.35 110.998 174.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.1 mm? -66.68 -47.56 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.937 -0.574 . . . . 64.1 112.434 -172.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -47.75 -55.28 17.89 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 118.115 0.416 . . . . 65.12 111.565 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -33.65 50.84 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.713 1.609 . . . . 64.23 112.164 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.5 mt-30 -66.12 -27.56 68.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.566 -0.454 . . . . 75.21 110.554 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 90.1 mt -76.84 -36.35 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.496 -0.557 . . . . 74.14 109.496 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 22' ' ' MET . 39.2 mt-10 -60.83 -36.96 80.44 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.134 -0.484 . . . . 65.51 109.706 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 58.5 tttm -57.53 -57.0 14.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.107 -0.497 . . . . 74.54 110.309 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.491 HD13 HD12 ' A' ' 123' ' ' ILE . 48.1 mt -63.07 -32.17 73.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.989 -0.551 . . . . 74.51 110.319 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.85 -42.53 94.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 43.32 110.839 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.54 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 52.9 mm-40 -74.61 -39.1 62.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.159 0.504 . . . . 74.13 110.841 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.33 -39.04 85.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.678 -0.692 . . . . 75.41 110.801 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.412 ' CD1' HG21 ' A' ' 123' ' ' ILE . 43.5 m-85 -105.05 5.29 32.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.475 -0.784 . . . . 75.22 112.047 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.88 -19.12 2.31 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.761 0.652 . . . . 63.31 112.761 -171.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -71.08 -27.46 63.63 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.647 0.24 . . . . 74.02 111.647 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -134.81 10.25 3.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.34 0.256 . . . . 60.25 111.329 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 43' ' ' LEU . 50.9 t -135.86 142.13 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.052 0.453 . . . . 74.22 111.153 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.0 119.78 9.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 23' ' ' ILE . 34.3 mt -102.45 129.31 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.612 0.244 . . . . 73.14 110.542 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -115.98 173.86 6.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.439 -0.578 . . . . 62.14 109.439 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -155.37 136.02 13.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.978 -0.379 . . . . 62.33 109.978 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.9 mt -79.71 79.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.073 -0.714 . . . . 75.13 109.073 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -81.23 56.18 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.385 0.612 . . . . 60.11 110.405 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -123.52 92.85 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.764 -0.653 . . . . 65.23 109.765 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 12.3 pt-20 -59.91 -17.66 39.03 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.84 -0.618 . . . . 64.21 111.211 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 33.3 t70 -71.66 -25.94 62.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.608 -0.724 . . . . 63.52 111.012 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -109.59 104.88 13.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.88 0.372 . . . . 73.53 110.324 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -99.13 -30.43 12.3 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.016 -0.538 . . . . 73.43 110.414 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 36.0 t70 -47.25 -47.13 24.91 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.611 -0.722 . . . . 63.32 111.883 -171.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.95 -41.05 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.237 -0.438 . . . . 71.01 111.128 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.37 95.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.222 0.534 . . . . 74.24 110.168 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 m -67.87 -33.24 74.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 72.42 110.697 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 28.9 mm-40 -66.27 -51.46 57.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.174 -0.466 . . . . 52.44 110.597 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -75.1 -17.33 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 63.04 110.461 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.26 45.07 20.63 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.011 -0.614 . . . . 65.55 112.533 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.418 HG13 ' OG1' ' A' ' 98' ' ' THR . 98.8 t -58.27 110.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.033 0.444 . . . . 75.31 110.175 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.7 m -85.94 -34.84 20.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.789 -0.642 . . . . 63.12 110.956 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.79 156.6 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 52.44 109.97 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.747 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -115.31 144.92 33.2 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.043 -177.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.584 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 4.9 Cg_exo -78.01 173.41 57.08 Favored 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.074 -1.219 . . . . 64.14 112.637 -0.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.554 HG23 HG12 ' A' ' 112' ' ' ILE . 27.8 m -138.39 127.05 23.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.706 . . . . 74.0 109.979 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 111' ' ' VAL . 48.6 mm -110.14 110.81 33.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.072 0.463 . . . . 62.41 110.984 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 2.8 mm? -90.63 123.69 34.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.403 -0.817 . . . . 72.51 109.519 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 18.8 mmt -92.49 135.99 33.59 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.689 -0.486 . . . . 65.12 109.689 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.522 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 85.2 m-85 -141.58 142.66 33.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.249 -1.019 . . . . 73.14 108.249 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 26.7 ttpp -147.23 126.95 13.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.236 -0.586 . . . . 74.24 110.89 -175.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t30 63.32 25.55 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.625 0.726 . . . . 72.22 109.603 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.69 19.37 74.84 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.317 -0.856 . . . . 43.11 111.926 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -117.85 153.94 32.67 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 122.216 0.206 . . . . 63.04 110.58 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.507 ' O ' HD22 ' A' ' 108' ' ' LEU . 16.6 tppt? -56.48 139.75 48.26 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 124.121 0.888 . . . . 71.43 111.668 -176.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -149.99 168.37 24.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.8 -1.091 . . . . 61.41 108.707 -171.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 101' ' ' MET . 39.6 m -70.64 -177.07 1.43 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.921 0.712 . . . . 72.41 112.921 -166.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.467 ' HG3' HD13 ' A' ' 100' ' ' LEU . 47.4 tt0 -146.07 148.38 32.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.154 -0.341 . . . . 74.54 111.085 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 99' ' ' ILE . 15.3 m -137.15 128.23 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.244 -0.434 . . . . 70.11 109.882 174.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 98' ' ' THR . 67.5 mt -114.92 138.08 46.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.29 -0.414 . . . . 62.14 110.331 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.86 161.42 21.0 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.147 -0.549 . . . . 60.32 112.227 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.84 86.28 6.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.854 0.359 . . . . 33.13 110.553 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 15.6 t0 -139.15 93.78 2.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.159 0.504 . . . . 64.24 110.251 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.1 tp -60.3 -32.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.596 -0.729 . . . . 62.15 111.018 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 t -68.95 -46.87 67.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.021 -0.536 . . . . 72.2 109.976 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -67.46 -43.31 81.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 55.14 110.217 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 115' ' ' ASP . 79.6 mt -58.75 -52.4 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.321 -0.4 . . . . 62.22 110.956 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.98 -39.09 83.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 120.87 0.367 . . . . 72.14 110.034 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.571 ' HA ' HD21 ' A' ' 124' ' ' ASN . 58.7 m -54.56 -50.6 67.55 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.122 -0.49 . . . . 43.12 110.448 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.17 -39.06 93.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.62 -0.264 . . . . 73.04 111.193 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.491 HD12 HD13 ' A' ' 66' ' ' LEU . 97.7 mt -55.79 -55.81 15.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.643 -0.423 . . . . 73.41 110.314 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.571 HD21 ' HA ' ' A' ' 121' ' ' SER . 10.3 p30 -69.79 -27.36 64.84 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.428 -0.509 . . . . 70.22 110.393 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -70.69 -33.87 71.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.254 -0.43 . . . . 72.2 110.837 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.527 HD22 ' N ' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -86.07 -29.94 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 71.2 110.565 -177.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.86 -49.68 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 54.51 110.904 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.696 -0.669 . . . . 71.43 110.124 -175.352 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.664 0.269 . . . . 75.42 110.632 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.54 -173.68 2.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.602 -0.272 . . . . 34.04 110.675 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -136.05 -177.59 4.76 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.845 -0.428 . . . . 65.04 109.845 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -73.48 88.46 1.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 71.22 109.975 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -93.29 -4.83 51.03 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.177 -0.465 . . . . 65.22 110.552 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -63.83 91.14 0.06 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.817 -0.629 . . . . 75.12 109.462 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -111.44 -42.39 3.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 65.21 111.225 -171.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -122.24 129.64 52.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.449 -0.341 . . . . 74.33 110.411 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.7 mtp -96.37 169.6 9.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 73.11 110.519 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 11' ' ' THR . . . -79.75 -47.81 7.01 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.747 -0.941 . . . . 70.45 110.747 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 10' ' ' GLY . 3.1 t 64.92 -49.61 0.34 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.79 1.636 . . . . 73.25 113.522 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.718 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 93.1 mt -72.51 103.12 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.993 0.425 . . . . 74.23 109.983 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.04 117.85 7.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.866 -0.606 . . . . 75.42 110.749 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.54 16.01 10.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.173 -0.467 . . . . 52.13 111.638 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.718 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 78.8 mt-30 -124.28 -173.55 2.8 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.896 -0.409 . . . . 70.34 109.896 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -150.81 -172.63 4.25 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.733 -0.469 . . . . 70.15 109.733 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -57.06 136.11 56.33 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.169 -0.308 . . . . 71.4 110.169 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.74 115.43 7.79 Favored Glycine 0 CA--C 1.521 0.415 0 O-C-N 123.372 0.42 . . . . 74.21 112.753 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.8 101.9 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.438 2.092 . . . . 75.33 111.551 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.5 -63.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.646 -0.582 . . . . 31.0 111.646 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -67.73 80.7 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 70.35 110.508 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.507 ' SD ' ' NE2' ' A' ' 68' ' ' GLN . 91.9 mmm -85.72 -1.79 57.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 71.32 110.43 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.68 107.35 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 62.2 110.079 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.5 126.54 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.59 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.17 124.38 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.846 -0.798 . . . . 71.41 108.846 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 34' ' ' LYS . 28.8 pt -129.32 158.02 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 73.54 110.859 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.18 165.14 53.91 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.845 -0.616 . . . . 75.43 112.253 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.87 -50.11 61.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 65.03 111.057 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.5 m -71.87 -10.52 59.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 111.51 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -89.21 -4.96 58.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.689 -0.232 . . . . 75.54 111.233 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.576 ' HD2' HD11 ' A' ' 79' ' ' ILE . 83.1 t80 -58.11 -62.49 1.79 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.789 0.328 . . . . 65.25 110.9 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.54 -39.35 93.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 73.42 109.994 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.0 -57.37 10.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.402 -0.817 . . . . 43.22 110.634 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HG3' HG21 ' A' ' 26' ' ' ILE . 43.9 mmtm -79.22 -18.37 53.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.991 -0.55 . . . . 63.34 112.137 -172.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 31' ' ' PHE . 55.0 t -74.03 -36.16 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.801 0.334 . . . . 74.14 110.334 171.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.4 p -85.98 -20.07 29.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.774 0.321 . . . . 53.41 111.02 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -68.5 4.45 1.37 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.936 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.86 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.4 p -58.13 137.95 56.54 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.219 -0.289 . . . . 55.23 110.219 175.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.25 -67.21 0.43 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 110.247 -0.279 . . . . 72.42 110.247 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.488 ' H ' HG12 ' A' ' 42' ' ' ILE . 5.3 p-10 -162.06 128.7 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.171 -0.307 . . . . 63.42 110.171 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.84 18.17 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.042 0.537 . . . . 72.45 112.248 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.488 HG12 ' H ' ' A' ' 40' ' ' ASP . 49.2 mm -71.51 136.26 26.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 116.524 -0.307 . . . . 70.51 110.497 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 126' ' ' ASN . 57.2 tp -80.06 126.26 30.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 72.33 110.158 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.87 119.24 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 72.45 110.381 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 76' ' ' ILE . 3.3 mp -107.09 115.31 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 73.21 109.529 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.74 105.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.223 -0.658 . . . . 72.45 109.223 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' THR . 21.9 t0 -85.92 153.11 22.43 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.722 -0.217 . . . . 62.13 110.642 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.693 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 17.4 p90 -50.73 152.64 1.97 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.054 -0.521 . . . . 65.22 111.64 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -128.77 98.48 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.836 -0.62 . . . . 74.34 109.707 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.98 149.19 10.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 54.33 110.244 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.52 39.48 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.902 2.402 . . . . 64.33 112.209 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -145.03 131.49 19.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 73.15 110.375 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.41 ' HA ' HG12 ' A' ' 96' ' ' ILE . 25.9 p -166.18 154.55 10.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 63.3 109.912 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.77 -82.82 1.67 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 112.018 -0.433 . . . . 43.4 112.018 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.61 ' HB2' HD23 ' A' ' 59' ' ' LEU . 3.6 Cg_exo -77.66 50.32 3.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.295 2.663 . . . . 54.22 111.576 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.68 -51.61 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.643 -0.708 . . . . 71.35 110.837 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -54.32 -38.13 65.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.763 -0.653 . . . . 74.44 111.903 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 6.7 m -75.57 -59.19 2.86 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.706 0.765 . . . . 70.35 112.144 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 55' ' ' PRO . 4.5 mm? -66.28 -34.44 78.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.716 -0.675 . . . . 64.1 112.762 -168.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 48.9 mt-10 -56.61 -60.18 10.04 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 120.602 -0.439 . . . . 65.12 110.634 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 30.7 Cg_endo -63.19 -34.63 67.71 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.003 1.802 . . . . 64.23 112.199 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 58' ' ' SER . 41.8 mt-30 -59.89 -41.84 92.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.421 -0.512 . . . . 75.21 110.947 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.25 -42.69 79.27 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.479 -0.328 . . . . 74.14 110.432 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 44.3 mt-10 -57.75 -37.2 73.19 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.057 -0.52 . . . . 65.51 110.539 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -66.82 -53.0 37.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.239 -0.437 . . . . 74.54 111.156 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD12 ' A' ' 123' ' ' ILE . 55.4 mt -60.09 -34.98 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.039 0.447 . . . . 74.51 110.174 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -64.14 -53.37 50.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.753 -0.658 . . . . 43.32 110.151 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.507 ' NE2' ' SD ' ' A' ' 22' ' ' MET . 15.6 mm-40 -57.08 -31.91 65.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.532 -0.304 . . . . 74.13 111.683 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -78.06 -47.15 18.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.162 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -104.59 4.79 33.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.586 . . . . 75.22 112.437 -169.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.3 t -52.9 -19.69 2.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.411 0.523 . . . . 63.31 112.411 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.77 -39.98 78.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.8 0.333 . . . . 74.02 110.497 176.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -125.45 9.72 7.85 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.26 -0.427 . . . . 60.25 111.236 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' THR . 41.0 t -132.17 138.91 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.885 0.374 . . . . 74.22 111.587 -176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -144.87 133.67 22.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.942 -0.572 . . . . 71.33 109.492 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -113.98 143.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.498 0.19 . . . . 73.14 110.747 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -131.61 162.61 29.95 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.175 0.512 . . . . 62.14 111.129 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -137.1 142.71 42.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.013 -0.994 . . . . 62.33 108.606 170.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' A' ' 31' ' ' PHE . 43.8 mm -90.91 152.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.668 -0.493 . . . . 75.13 109.668 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -94.8 -169.31 1.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.205 -0.294 . . . . 60.11 110.205 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 mt 61.61 60.88 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 122.143 0.973 . . . . 65.23 109.699 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 28.2 mp0 -59.74 -18.81 45.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.528 -1.215 . . . . 64.21 110.75 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.15 -17.9 62.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.593 -0.731 . . . . 63.52 111.435 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.8 67.72 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.405 0.621 . . . . 73.53 111.143 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -61.05 -30.5 70.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.27 -0.877 . . . . 73.43 110.811 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.65 -42.23 33.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.925 -0.579 . . . . 63.32 110.736 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.58 -36.56 60.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 71.01 110.717 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.013 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 m -60.13 -40.69 90.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.882 -0.599 . . . . 72.42 110.922 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -65.59 -41.06 93.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.918 -0.583 . . . . 52.44 111.426 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -90.65 -7.48 52.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 63.04 111.428 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.28 21.6 58.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.24 -0.505 . . . . 65.55 113.072 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.501 HG22 HG21 ' A' ' 98' ' ' THR . 46.9 t -73.13 124.44 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.949 -0.389 . . . . 75.31 109.949 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 t -151.42 -42.26 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 63.12 110.324 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.4 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . . . -102.66 137.83 40.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.304 -0.407 . . . . 52.44 110.096 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.4 pp -110.09 154.51 42.72 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.387 -0.369 . . . . 75.51 111.592 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.07 171.9 63.12 Favored 'Cis proline' 0 C--N 1.352 0.753 0 C-N-CA 123.421 -1.491 . . . . 64.14 111.894 -5.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 48' ' ' PHE . 83.8 m -130.21 110.93 11.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.355 -0.609 . . . . 74.0 109.355 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 45' ' ' LEU . 37.6 mm -115.37 112.78 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 62.41 110.626 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.6 mp -94.96 123.27 38.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.44 -0.578 . . . . 72.51 109.44 174.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.491 ' SD ' ' HG ' ' A' ' 45' ' ' LEU . 15.0 mmt -95.27 139.11 32.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.81 0.338 . . . . 65.12 110.499 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -141.04 149.33 41.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.075 -0.713 . . . . 73.14 109.075 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -133.85 116.31 15.51 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.595 -0.521 . . . . 74.24 109.595 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.86 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.8 p-10 48.15 32.51 3.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.316 0.646 . . . . 72.22 112.202 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.87 -14.8 60.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.395 -0.431 . . . . 43.11 112.609 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -75.43 140.08 42.69 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.192 0.597 . . . . 63.04 110.176 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' A' ' 108' ' ' LEU . 3.3 tmmm? -69.37 132.32 46.2 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.812 -0.631 . . . . 71.43 110.897 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.495 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.8 mm? -133.52 167.8 19.8 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.838 -1.074 . . . . 61.41 110.176 -175.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' MET . 0.4 OUTLIER -70.71 179.45 2.61 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.476 0.655 . . . . 72.41 112.342 -169.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -137.85 151.4 48.03 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.657 -0.701 . . . . 74.54 110.221 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -121.9 131.2 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 114.879 -1.055 . . . . 70.11 109.996 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 95' ' ' ALA . 27.5 mm -129.85 125.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 62.14 109.992 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.06 153.31 19.2 Favored Glycine 0 C--N 1.323 -0.15 0 CA-C-N 115.834 -0.621 . . . . 60.32 112.234 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -79.66 80.03 6.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.062 0.458 . . . . 33.13 111.019 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.68 94.51 3.3 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.545 -0.752 . . . . 64.24 109.075 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.35 -26.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 62.15 110.567 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.7 t -66.55 -42.12 87.63 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.865 -0.607 . . . . 72.2 109.647 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.83 -44.43 77.25 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 55.14 109.916 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.2 mt -56.12 -56.2 14.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.14 -0.482 . . . . 62.22 110.824 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -62.61 -35.34 69.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.189 -0.46 . . . . 72.14 109.881 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.54 ' HA ' HD21 ' A' ' 124' ' ' ASN . 23.0 t -57.49 -46.35 83.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.003 -0.369 . . . . 43.12 110.003 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.56 -43.54 93.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.326 -0.397 . . . . 73.04 110.497 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.435 HD12 HD13 ' A' ' 66' ' ' LEU . 96.6 mt -53.45 -55.64 12.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.818 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.54 HD21 ' HA ' ' A' ' 121' ' ' SER . 8.4 p30 -70.95 -27.91 64.09 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.946 -0.302 . . . . 70.22 110.3 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -63.36 -33.23 75.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.036 0.446 . . . . 72.2 110.125 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.44 ' HB2' HD22 ' A' ' 43' ' ' LEU . 27.5 m-80 -79.71 -40.48 28.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.882 -0.599 . . . . 71.2 111.16 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.24 -42.21 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.085 0.469 . . . . 54.51 110.733 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.307 -0.854 . . . . 71.43 109.911 179.005 . . . . . . . . 0 0 . 1 stop_ save_